ID	SpeciesID	SpeciesName	GeneID	GeneName	PhenotypeID	PhenotypeName	Alteration	AuthenticCrypticDistance	Utilisation	SpliceSiteExIn	ReadingFrameChange	NucleotideSequence	Comment	InTerminalExon	GTUsedInVivo	InMAG	SSAuthentic	MEMAuthentic	MEMCryptic	SSCryptic	MDDMAuthentic	MDDMCryptic	WMMAuthentic	WMMCryptic	FOMMCryptic	FOMMAuthentic	HBSAuthentic	HBSCryptic	FEAuthentic	FECryptic	BPAuthentic	NNCryptic	BPCryptic	NNAuthentic	PhenotypeOMIMNumber	GeneEnsemblNumber	EXPR1	SpliceID	GeneFullName
97	1	Human	46	DMD	133	Muscular dystrophy	IVS32+1G>A	-98	NULL	Exon	2	AAAAAATTACAAGATGTCTCCATGAAGTTTCGATTATTCCAGAAACCAGCCAATTTTGAGCAGCGTCTACAAGAAA/GTAAGATGATTTTAGATGAAGTGAAGATGCACTTGCCTGCATTGGAAACAAAGAGTGTGGAACAGGAAGTAGTACAGTCACAGCTAAATCATTGTGTG(g>a)tatgtatttctggtggcaaatacgcaggtaccccttgactttcctcattaagaagtaactgctcttttataagagagaattgttttcagataaccataataattatactatgtaattttaagattgagaacaaaaattggcacatgtattgtggcctattctgtgtgtcttttttgagt	distance +96 nt in the paper	No	NULL	In	80.69	7.64	6.91	82.08	10.78	10.88	8.19	8.19	6.87	7.04	16.7	12.4	-3.9	-2.8	8	0.72	6	0.96	181350	ENSG00000198947	75	97	dystrophin
98	1	Human	46	DMD	133	Muscular dystrophy	IVS32+1G>C	-98	NULL	Exon	2	AAAAAATTACAAGATGTCTCCATGAAGTTTCGATTATTCCAGAAACCAGCCAATTTTGAGCAGCGTCTACAAGAAA/GTAAGATGATTTTAGATGAAGTGAAGATGCACTTGCCTGCATTGGAAACAAAGAGTGTGGAACAGGAAGTAGTACAGTCACAGCTAAATCATTGTGTG(g>c)tatgtatttctggtggcaaatacgcaggtaccccttgactttcctcattaagaagtaactgctcttttataagagagaattgttttcagataaccataataattatactatgtaattttaagattgagaacaaaaattggcacatgtattgtggcctattctgtgtgtcttttttgagt	distance +96 nt in the paper	No	NULL	In	80.69	7.64	6.91	82.08	10.78	10.88	8.19	8.19	6.87	7.04	16.7	12.4	-3.9	-2.8	8	0.72	6	0.96	181350	ENSG00000198947	75	98	dystrophin
266	1	Human	46	DMD	133	Muscular dystrophy	IVS32+1G>A	32	NULL	Intron	2	AAAAAATTACAAGATGTCTCCATGAAGTTTCGATTATTCCAGAAACCAGCCAATTTTGAGCAGCGTCTACAAGAAAGTAAGATGATTTTAGATGAAGTGAAGATGCACTTGCCTGCATTGGAAACAAAGAGTGTGGAACAGGAAGTAGTACAGTCACAGCTAAATCATTGTGTG(g>a)tatgtatttctggtggcaaatacgcag/gtaccccttgactttcctcattaagaagtaactgctcttttataagagagaattgttttcagataaccataataattatactatgtaattttaagattgagaacaaaaattggcacatgtattgtggcctattctgtgtgtcttttttgagt	NULL	No	NULL	In	80.69	7.64	8.63	69.66	10.78	11.98	5.03	5.03	7.51	7.04	16.7	14	-3.9	-4.8	8	0.92	6	0.96	181350	ENSG00000198947	75	266	dystrophin
267	1	Human	46	DMD	133	Muscular dystrophy	IVS32+1G>C	32	NULL	Intron	2	AAAAAATTACAAGATGTCTCCATGAAGTTTCGATTATTCCAGAAACCAGCCAATTTTGAGCAGCGTCTACAAGAAAGTAAGATGATTTTAGATGAAGTGAAGATGCACTTGCCTGCATTGGAAACAAAGAGTGTGGAACAGGAAGTAGTACAGTCACAGCTAAATCATTGTGTG(g>c)tatgtatttctggtggcaaatacgcag/gtaccccttgactttcctcattaagaagtaactgctcttttataagagagaattgttttcagataaccataataattatactatgtaattttaagattgagaacaaaaattggcacatgtattgtggcctattctgtgtgtcttttttgagt	NULL	No	NULL	In	80.69	7.64	8.63	69.66	10.78	11.98	5.03	5.03	7.51	7.04	16.7	14	-3.9	-4.8	8	0.92	6	0.96	181350	ENSG00000198947	75	267	dystrophin
71	1	Human	143	SBDS	162	Shwachman-Diamond syndrome	IVS2+2T>C	-8	100	Exon	2	aaaccccatctctactaaaaatacaaagttagccgggtgtggtggcgcatgcctgtaatcccagttactcaggaggctgaggcgggagaatcacttgaacccgggaggctgaggttacagtgacccgagatcgcgccattgcactccagcctgggcaaaaacagtgaaattccatctaggggcgggggttggggggtaagaaaaagaaaactgccctctacactaaaggtcatcagggggatttgttgtgtcttgccgttcatgttgttgccatctcgtatttaaatgtaaatgcatgtccaagtttcaagtatattcacataggactttctctcctgccctcacaagGGAAAAAGACCTCGATGAAGTTCTGCAGACCCACTCAGTGTTTGTAAATGTTTCTAAAGGTCAGGTTGCCAAAAAGGAAGATCTCATCAGTGCGTTTGGAACAGATGACCAAACTGAAATCT/GTAAGCAGg(t>c)gggtaacagctgcagcatagctaaccctaataaccatttataacgtatttgtagatatattaaacattaaaggctgtttttctggaggaaagactaaccaagcaataatgtgaactgcacagtgtcacttctaataataaagaacttggtggttttgtttgttttttgtggtttttttttttttttttttgccaaaacctcctgaaatcagattttctactaaattacctcatttttctataaattgccccatttatagaatgtggtatacctgaaaactgaatttgttttcaagtatttcatctttcagatccttttttttttgggtggggggacagagtcttgctctgttgcccaggctggagtgcagtgcacttcactgcactcagctcactgcaacctctgcctcctggattcaagcgattctcttgcctcagcttccagggtagctgggattacaggtgcccaccaccctgcctggctaatttttggatttttagtagagatggggtttcaccatgttggccaggttggtctcaaactcctgaccttgggtgatatgcccgccttagccacccaaagtgctgggattacagatgtgagccactgagcccagccaaaagattcttgcatcttttgggcaaagctcaaaccattacttacatattgatagctggagaggatgaaatttaattttctctccatccagttactcattttttatggttagttaataaatagtgtgtgatagagaaagatagtgatttcttaaatgtgttggcatttttttag	NULL	No	NULL	In	84.26	8.56	4.33	71.25	13.38	9.78	3.35	3.35	4.74	8.54	17.5	12.2	-9	-2.6	9	0.5	5	0.87	260400	ENSG00000126524	59	71	Shwachman-Bodian-Diamond syndrome
301	1	Human	165	XPA	181	Xeroderma pigmentosum	IVS4+8A>G	7	95	Intron	1	aaagtattttatatgtcctttttgctgtgtgtgcccctaagttgctgggctatttgcaaacttagcttatttaaaataactaatttatataatggacttaatctgttttcagAGATGCTGATGATAAACACAAGCTTATAACCAAAACAGAGGCAAAACAAGAATATCTTCTGAAAGACTGTGATTTAGAAAAAAGAGAGCCACCTCTTAAATTTATTGTGAAGAAGAATCCACATCATTCACAATGGGGTGATATGAAACTCTACTTAAAGTTACAGgtctcta/(a>g)taagttgtatttattatttttcactctggtaaattcttaataacaaactagtcataattggtttggcttttgcttacagagtgtggaaaaactcttttccctagttttgcatatgcttcacagtcatgtataatgacatttaataacatgttttctcattttgcttttttcttttcttttttcaaacaataaggtctcactctgtcactcaggctggagtgcagtggtgagatcatggctcactgcagccttgacctcccgggctcaggtaatccttccacctcagccttctgagtagcacctggctagttttttgtattttttgtagagatggggttttaccatattgcccaggctggtctcgaactccagggctcaagtgatcctcctgctttggcctcgcaaagtgctgggattacaggcatgagccgccacgcctggcctcattttgcttctaatatggcactttgaaagaaacctgttgctattgggtgatgttaagagtacaatttggaaactaaaaaaggttggaatgggagtcaggccctgtttccttaccctctttcacctccatctcccaccaaaaaagaaatattttaaaaaaagaaaaatttcaagaatttcataaatacctaaaatctaactctacccatctggaatgctagcgagtgtccatatagctctataatctcagagcagatcgtctcaactccacttgctgcagatgggttataggtgtgccaagacggtgatccacttagtggctaggactgctagtgcccaggccagtttctttgagtcacaagcagcctcttgtatctacctcagagtggtacaaatattgtaatattctttttgtgctgttagcttaaaatattgggaggcattgctttagagcacagtttgaatatatactatactagaaaatcccatatctccaaataaaattaagaagccatattgtaaaacaaaacgtgtactgaatttcattaaatactaagattctgttgattagaacattcactattgttttatgtaccattaaatatttttaaatgccgctgattaaaatcaacatatgctttcttatcacttgatgctttttatacttggtgaaatagtgccattagactttattatagtttgtcatatatcacgacttttgcacacataaaagggaaaatgcaagtgcaaaagacttatgaaggtattcctaaactttacattcagagtccaattcttctgcaccactttttgactcacagttgttaaagtaccattaagtgcattggtgatgcagcattttcagggatgttaaattgcggaaaacgtgatgtctcagaatatacgaaatatgagtgtatcacttgattatgttaaatttgagtttggctatgctgattaatattatggtccttttaacatattgtgagaggtatcctgagcataattcttagtgtgtaaattctcttaaaatctaagtaaatactataaagagtaaaggtatataatgtaaagttttaaaagtagaatgaagactttttacatcatcttggtaccaaaattaaaaaaaaatatatcctgcagatcagaagtcaagtcgatagagacaattattgatcttgaaggagatgagtagtagtaattggtaatttcctgcggttggagatttttggagatgacctcatatttaggtctgatgtggctaatctgtcaacaaactgtttctttggtgagcccaccacagttgatcaaactcactgaccacgtgtacttttgattcctgtgacaatacagtcagaggacaacttttctatttataatctaattcagcatacgtttactgacagtttcataggtttagatagatgttttattagagttgtttctgatcattaatatttaaaatctttaaatttctaataagtatttataaatttatacttgagttagatcattctttggtacctttggatttgacagttataactataatatttcgcaagtctgaatcacaacttatttaaatatggattttgtgttgtagATTGTGAAGAGGTCTCTTGAAGTTTGGGGTAGTCAAGAAGCATTAGAAGAAGCAAAGGAAGTCCGACAGGAAAACCGAGAAAAAATGAAACAGAAGAAATTTGATAAAAAAGTAAAAGgtagatggccacatt	NULL	No	1	Out	66.01	1.07	8.78	78.68	5.98	13.38	7.87	7.87	6.62	1.9	11.8	14	-3.3	-4.2	6	0.91	8	0.01	278700	ENSG00000136936	224	301	"xeroderma pigmentosum, complementation group A"
247	1	Human	136	PTEN	40	Cowden's disease	IVS7+1G>A	75	NULL	Intron	0	aaatcgtttttgacagtttgacagttaaaggcatttcctgtgaaataatactggtatgtatttaaccatgcagATCCTCAGTTTGTGGTCTGCCAGCTAAAGGTGAAGATATATTCCTCCAATTCAGGACCCACACGACGGGAAGACAAGTTCATGTACTTTGAGTTCCCTCAGCCGTTACCTGTGTGTGGTGATATCAAAGTAGAGTTCTTCCACAAACAGAACAAGATGCTAAAAAAG(g>a)tttgtactttactttcattgggagaaatatccaaaataaggacagattaaaagctatattttattttatgacat/gtaaggaactataatttgttttctattagatctgcaggtgttttgcttactctggcattggtgagacattataagggtaaataatcctgtttgaaggaaaaggccttatggcattgtaacatgagaggaatttttcttaacaaggatggttaactgagaagaaat	NULL	No	NULL	In	79.01	7.81	6.57	81.57	11.58	11.48	8.02	8.02	6.34	6.11	13.2	14.3	-4.7	-4	8	0.92	7	0.97	158350	ENSG00000171862	172	247	phosphatase and tensin homolog
22	1	Human	129	PKP1	51	Ectodermal dysplasia-skin fragility (McGrath) syndrome	IVS9+1G>A	-45	NULL	Exon	0	aaccacgaccctgaggctggggggatggggacagaatgcctgggttgtgtcctctcacaaggctccccattgacccccctgaccggctctttatcctcagAACAACAACTATGACTGCCCCCTGCCTGAGGAAGAGACCAACCCCAAGGGCAGCGGCTGGTTGTACCATTCAGATGCCATCCGCACCTACCTGAACCTCATGGGCAAGAGCAAGAAAGATGCTACCCTGGAG/GCCTGTGCTGGTGCCCTGCAGAACCTGACAGCCAGCAAGGGGCTG(g>a)tgagtgggactgtaccttctctactgcagcagccccatcctccagccaccgtccagcctctgctccctccttttccccccagcctgtcccctgacttcg	NULL	No	NULL	In	85.92	10.1	-2.36	61.17	14.48	2.02	-3.35	-3.35	-2.6	9.36	15.8	NULL	-7.2	-1.4	9	0	6	0.87	604536	ENSG00000081277	19	22	plakophilin 1 (ectodermal dysplasia/skin fragility syndrome)
#8	1	Human	35	COLQ	34	Congenital acetylcholinesterase deficiency	IVS16+3A>G	-30	NULL	Exon	0	aaggagtacctttcccacccctgggaggaagtcaaggcatgccccccagcagtgcctttggaccaaaaccaatgacctccctgcctgcggctgcctgggtatgccatgctccagttaatgctgtgtgcttctttggccagCTGACCCCTTTCTACCCTGTGGATTACACTGCAGACCAGCACGGCACCTGTGGGGATGGGCTCCTGCAGCCTGGGGAGGAGTGTGACGACG/GTAACAGCGATGTGGGTGACGACTGCATCCgtgagtgaggcccagaccaggaggacctgaggcctgaacagcaggggggtgggactcagggccagccctggacaccagctgtggtgctttgggacctttctagagccagagaagggtatacccaggccaccttgtgccacccaccccagtccctgctgccccagtttcagcccaaatattaactcttccaccacccaagcacctcaccaggggcggatgtcaaggatcctgcccccagttaggccttctttatctcaaaatgtagccaccaggtcctcccagtcctacatcttagcaaaacccatgttacaggtgcagaagataaaggtgatgggctctcactttgcatggagtagtgaaaggcaaaagggagaggccaagaatctgaatgagggctcatttaccaggtagagctctagtagcaaagccctccgtaggggaaactgggccagccagagctgctgtcagcctcgtgggctgctgccttaactggtaggcagcaggctctggagggcttgcttttgtttgtttttgtttttgtttttaatcaagtaacaaaaccaggaggtgtgatggaaagcaggagctttagagtcaacagaggttgaatgcaggccctgagaaacaccaaccaccctcaggctcaaggcagaggccacatggtgggtggggtaatggggggcaatttacagctctgagcctcactttccttgcctgtaaaatgggtatgatgtgctggctgctcaagtccctagagatcctgtgagctaacatgtgcagagattatctggatatagtaagggttcaaccaccattcactgaattcatttagggcttgtggtttaagcccctgctctaaagatccaggctggggctcagggctggatgtgtggatgcaaagtcatggtccttgctctcaagaagctcaggggaggctgggcacagtggctcatgcctgtaatctcaacactttgggaagctgaggttggaggatcacttgagcccaggagttcaagaccagcctgggcaacagagcaagacccaatctctacaaaaaaaaataaaaattaaaaaaattagccaggcctggtggtgcgcacttgtagtcccagctgcttaggagggtgaggtgggaggatgatttgagcccaggggttcaaggctgcagtgaactgcgattgcaccactgcactccaggctgggaaacagagcgagaccctgtctcaaaaaaaaaaaaaaaaaaaaaacagttcaggggaaggatgacagggcagagtgggtggcgggagatgctgctgactgtctcagtgtggccgaactgtctcccgacagctccagggatggcatcccctagaaggctggccctgcccagagtcccttctgcctctggtgcacagtgtcaaataggagctctcacagtaggaaggaactaatggactgtccctgccctgtgaaaacaacgctgggatccatactccaacaccctcccatcgtgtgagagcagaggtctttgctgaagatcatgtggctccccagggacacaaggctgggctcaccagtgtcacacagaagctctctgttgacagatgagagtcaccatgcaccctcactggggctcagcagtcttccaaccctcactcccgggacccccacactggctttatgaggtggaggtcatgtcagtgtcccagttttgcagataacaacctggagtctccccacccctcagctagtaagttgtgaggcggggctggagccaggatctccttcttcttgtcccatggcacatcgctgtgggaccagagcctgtgggcagtccctggaggagtgtgaagcttaatggaggtcagttctttaaggggtgcagcacttaggttggatcccttgggccgcatggtccttacaagctgaggcaagcctatcgcctctgctccttctcaagactgcacctccttatgtcccctcagGCTGTCACCGTGCCTACTGTGGAGATGGTCACCGGCATGAGGGTGTGGAGGACTGTGACGGCTCTGACTTTGGCTACCTGACATGCGAGACCTATCTCCCTGGgt(a>g)gggatgactcccctccctccctctcccccttctttctccctccctcctctttgctttccttctttccttcacaaatattttgagtgcctctccactttgtggtgccttctagacactgaggtatggtgatgaatgacacaacacgtgctccctgcctaccacgtgccctcttggtca	Minigene assays only; trimmed introns.	No	NULL	In	71.43	8.93	6.72	71.9	11.48	8.38	5.18	5.18	6.62	7.02	12.1	12	-4.2	-3.9	6	0.76	5	0.93	603033	ENSG00000206561	7	8	collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase
#9	1	Human	35	COLQ	34	Congenital acetylcholinesterase deficiency	IVS16+3A>G	-19	NULL	Exon	1	aaggagtacctttcccacccctgggaggaagtcaaggcatgccccccagcagtgcctttggaccaaaaccaatgacctccctgcctgcggctgcctgggtatgccatgctccagttaatgctgtgtgcttctttggccagCTGACCCCTTTCTACCCTGTGGATTACACTGCAGACCAGCACGGCACCTGTGGGGATGGGCTCCTGCAGCCTGGGGAGGAGTGTGACGACGGTAACAGCGAT/GTGGGTGACGACTGCATCCgtgagtgaggcccagaccaggaggacctgaggcctgaacagcaggggggtgggactcagggccagccctggacaccagctgtggtgctttgggacctttctagagccagagaagggtatacccaggccaccttgtgccacccaccccagtccctgctgccccagtttcagcccaaatattaactcttccaccacccaagcacctcaccaggggcggatgtcaaggatcctgcccccagttaggccttctttatctcaaaatgtagccaccaggtcctcccagtcctacatcttagcaaaacccatgttacaggtgcagaagataaaggtgatgggctctcactttgcatggagtagtgaaaggcaaaagggagaggccaagaatctgaatgagggctcatttaccaggtagagctctagtagcaaagccctccgtaggggaaactgggccagccagagctgctgtcagcctcgtgggctgctgccttaactggtaggcagcaggctctggagggcttgcttttgtttgtttttgtttttgtttttaatcaagtaacaaaaccaggaggtgtgatggaaagcaggagctttagagtcaacagaggttgaatgcaggccctgagaaacaccaaccaccctcaggctcaaggcagaggccacatggtgggtggggtaatggggggcaatttacagctctgagcctcactttccttgcctgtaaaatgggtatgatgtgctggctgctcaagtccctagagatcctgtgagctaacatgtgcagagattatctggatatagtaagggttcaaccaccattcactgaattcatttagggcttgtggtttaagcccctgctctaaagatccaggctggggctcagggctggatgtgtggatgcaaagtcatggtccttgctctcaagaagctcaggggaggctgggcacagtggctcatgcctgtaatctcaacactttgggaagctgaggttggaggatcacttgagcccaggagttcaagaccagcctgggcaacagagcaagacccaatctctacaaaaaaaaataaaaattaaaaaaattagccaggcctggtggtgcgcacttgtagtcccagctgcttaggagggtgaggtgggaggatgatttgagcccaggggttcaaggctgcagtgaactgcgattgcaccactgcactccaggctgggaaacagagcgagaccctgtctcaaaaaaaaaaaaaaaaaaaaaacagttcaggggaaggatgacagggcagagtgggtggcgggagatgctgctgactgtctcagtgtggccgaactgtctcccgacagctccagggatggcatcccctagaaggctggccctgcccagagtcccttctgcctctggtgcacagtgtcaaataggagctctcacagtaggaaggaactaatggactgtccctgccctgtgaaaacaacgctgggatccatactccaacaccctcccatcgtgtgagagcagaggtctttgctgaagatcatgtggctccccagggacacaaggctgggctcaccagtgtcacacagaagctctctgttgacagatgagagtcaccatgcaccctcactggggctcagcagtcttccaaccctcactcccgggacccccacactggctttatgaggtggaggtcatgtcagtgtcccagttttgcagataacaacctggagtctccccacccctcagctagtaagttgtgaggcggggctggagccaggatctccttcttcttgtcccatggcacatcgctgtgggaccagagcctgtgggcagtccctggaggagtgtgaagcttaatggaggtcagttctttaaggggtgcagcacttaggttggatcccttgggccgcatggtccttacaagctgaggcaagcctatcgcctctgctccttctcaagactgcacctccttatgtcccctcagGCTGTCACCGTGCCTACTGTGGAGATGGTCACCGGCATGAGGGTGTGGAGGACTGTGACGGCTCTGACTTTGGCTACCTGACATGCGAGACCTATCTCCCTGGgt(a>g)gggatgactcccctccctccctctcccccttctttctccctccctcctctttgctttccttctttccttcacaaatattttgagtgcctctccactttgtggtgccttctagacactgaggtatggtgatgaatgacacaacacgtgctccctgcctaccacgtgccctcttggtca	Minigene assays only; trimmed introns.	No	NULL	In	71.43	8.93	2.02	71.22	11.48	6.58	4	4	3.31	7.02	12.1	8	-4.2	-3.4	6	0.14	7	0.93	603033	ENSG00000206561	7	9	collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase
299	1	Human	106	LMNA	133	Muscular dystrophy	E2+157G>A	45	NULL	Intron	0	aatcaggggcccagaaaaggtgagggaggtggcagaggcagcgctgttcgactggttatagctaaagctttacccactttgaggagcagggagGCTTAAAGCTGGGGCCCAGATGGACCTGGAGGCCTGGGATCCACATCTGGAACCAGATGCTGAGGCTATGGTAGATGGgtagggctcagccttctcccagggcacggatgaggcaggagggagggaggcagggacccctctgttcagtgcagatcagggcacccagactgggtcctgagaaaggaaagggtcaatattgtgcctggtcatccttgtctgaggtccctctgagctctaaccagactttccttccccacagtcccacatgtgtaaaagggactaggagaggtgaccagtacctttggggctcagatcgagaagtgctagggacatgtgggccatgagcttagttgtcaggctcctcagagggagggaagcttggccaaagggaagtgagtagagtccagggagaaggctaagtaaggccctgtgtgggaaggggcaggagacaaaggtacccctgtctctttgggaaagaatgggaggagagagagggaaaagcattcatatcacggggtagagctctgcccttggccccaggcacgttcctgagccctgagtcatgggaagggtggagaagcaggaagggggttttcaaggaccttggggaggtgggagcccagccccagaggcaagcagatgcaaaccaacctaatgcaaggatgccctctcctggtaattgcaggcatagcagcgccagcccccatggctgacctcctgggagcctggcactgtctaggcacacagactccttctcttaaatctactctcccctctcttctttagCAATACCAAGAAGGAGGGTGACCTGATAGCTGCTCAGGCTCGGCTGAAGGACCTGGAGGCTCTGCTGAACTCCAAGGAGGCCGCACTGAGCACTGCTCTCAGTGAGAAGCGCACGCTGGAGGGCGAGCTGCATGATCTGCGGGGCCAGGTGGCCAA(G>A)gtgaggccaccctgcagggcccacccatggccccacctaacacat/gtacactcactcttctacctaggccctcccccatgtggtgcctggtctgacctgtcacctgatttcagagccattcacctgtcctagagtcattttacccactgaggtcacatcttatcctaatttggctgccaatgggatctaccacagtgaatttaaaataatccaggaggccgggcatggtggttcacgcctgtaatcccagcactttaggaggccgaggtgggccgatcacgaggtcaggagatcgagatcatcctgactaacatggtgaaaccccgtctctactaaaaatacaa	NULL	No	NULL	In	89.44	9.16	-2.91	57.28	13.98	0.68	1.29	1.29	2.11	9.62	15.7	9.3	-8.5	0.6	7	0.13	5	1	181350	ENSG00000160789	222	299	lamin A/C
74	1	Human	149	SLC35A1	38	"Congenital disorder of glycosylation, type II"	IVS6+286insCACT	-130	100	Exon	1	aatgtagcttataaacttcccaattagttattattctatatactctgtaaaaacataaatttataatgtacagtatgtcatgtgtcacacaacctacataataaatgcacatttaagtaaagtatgttttgttccccaaatcatatactttatatatctctagggtattgttctaaatgaaagacattttaagttaatttatagtaatctttaatatttgcatgtctaattttctttcagGAGTATATTTTGAAAAAGTTTTAAAGAGTTCAGATACTTCTCTTTGG/GTGAGAAACATTCAAATGTATCTATCAGGGATTATTGTGACATTAGCTGGCGTCTACTTGTCAGATGGAGCTGAAATTAAAGAAAAAGGATTTTTCTATGGTTACACATATTATGTCTGGTTTGTCATCTgtaagtatccaggaattaaaggttcttagtagatcctttattttttttttaagttagatgtccattttaagctgttataacattttgaaattaatcctttgatactgtaaataccagtttgaatataattttcattttgttgacttagttttgattgtgaaggcaaaattgctttgggatagcaatgccccaaaatatctaacattagcaaaaaatgtgtaaaatttaatagaccacatagccctctgggcattgttttggaaaaacagtgttatataggaactac[cact]caattttagtacaaactctcagatggctccttctaaggaaaacagtattttccttttcctaggtaaagtatggcatctctggggatgaaaattgcctcaccattatgtaatgtttcatttatttgagtgataagattttatttctctctgtatacaagTTCTTGCAAGTGTTGGTGGCCTCTACACTTCTGTTGTGGTTAAGTACACAGACAACATCATGAAAGGCTTTTCTGCAGCAGCGGCCATTGTCCTTTCCACCATTGCTTCAGTAATGCTGTTTGGATTACAGATAA	NULL	No	NULL	In	77.36	7.96	6.04	79.78	12.38	11.18	6.03	6.03	6.72	6.31	17	13.8	-4	-7.9	6	0.79	7	0.89	608750	ENSG00000164414	62	74	"solute carrier family 35 (CMP-sialic acid transporter), member A1"
49	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS27b+1del9	-69	NULL	Exon	0	aattatagacttttttacatactcagtagacaacataaagcctcataattactctgttatttttcttttagGCATCAGGTACATGAAAAAGAAGAATTCAAGGCTTTGAAAAC/GTTAAGTATTTTCTACCAAGCTGGGACTTCCAAAGCTGGGAATCCTATTTTTTATTATGTTGCACGGAG(gtaagaaat)actatgttttgggtctcttaacagaattttttaaattatagcaaatatagagagatggcaagtttggtttttcccagttgacttaacaggaattgaagacaagtttacttgggagcatatagcagggtaaatagcctgcgtttcctaaaatgatggtcggtatctagtagctgcttttcatactacccatttcatattgcttactctgtcctacatcattttttaaaatactgcctgcaatggattaattaccaagagttaaaaacccacaaagaatcttttgttttcaagtatattctgattaaatagtactcacaacatgataactgggaactttttttaaaggaagaaataaaactataagagcctatttctgagaacttttaaaaatatgctgtgtaagacagcatc	NULL	No	NULL	In	94.5	10.06	-14.85	57.89	13.38	2.88	0.51	0.51	-6.76	10.14	17.3	2.3	-7.5	0.6	7	0	5	0.99	162200	ENSG00000196712	38	49	neurofibromin 1
41	1	Human	69	GAA	77	"Glycogen storage disease, type II"	IVS18+2T>A	-21	NULL	Exon	0	accagcctagcattcccgggccctggaggcctccacctccaccagggtggggatgatgacatcacgtgtccttccctttccagGGCCCTGGCCTCACAACCACAGAGTCCCGCCAGCAGCCCATGGCCCTGGCTGTGGCCCTGACCAAGGGTGGGGAGGCCCGAGGGGAGCTGTTCTGGGACGATGGAGAGAGCCTGGAAGTGCTGGAGCGAGGGGCCTACACACAG/GTCATCTTCCTGGCCAGGAATg(t>a)gagtcctggggctgctcaggctggtgggcaggggccggctcggggttgagaaggggtgaggggacctgggcttgggggtcccacgatggctacctgccactaggacactctagcaggtggcctggggtcctagagtgagcagtggggccgtgcactctgccctttcgtgtacacagagggaggtcacctccctgatgccatcatgagtccctgttctcatgggtgttcctgccccagctgtctgctgacacctccacattctctgccttttcatctctctctgctcggcccagAACACGATCGTGAATGAGCTGGTACGTGTGAC	NULL	No	NULL	In	81.78	7.8	2.07	70.77	12.18	7.88	3.42	3.42	2.74	7.06	12.5	11.9	-3.9	-3.3	7	0.18	6	0.93	232300	ENSG00000171298	30	41	"glucosidase, alpha; acid"
329	1	Human	92	IDS	96	"Mucopolysaccharidosis, type II"	IVS7+3083A>G	-32768	100	Intron	-32768	acctacccattcatcagccctcgtgggtcaaggctgcctcgtcctccccgagagagtggagaggtcgagcagtggggatgcccctcaggccccggggcttactgactggggcgggtgtcagggggaactccctctctttctgagctccactgagctatctgaaagtccccaccatactccccagtactgacagccagagggaggaacggctcaccagaatcattgggcatctctgatgggcatcaagtctgctttgattattgatgagtgggtaagagggtcctctcaacttggggtctccttgggaaagcactgtcaactcagaacaggtttcagccctgttctggagaccacaggccctggaaggctgggacatcatttgcagccccagcgtcatctattagacggagccagcaaggtctcatgctgtgcggtacatttcaacactttctcaaatttacccgtggcagcttttggtgtgtttggttatttttataacactactcactgtacaatttctgtcatgcacattttttgtatcaaaaagggtgctgtaactttaaaagactgggtatttccaacttggaatattcaaaccatcttttgcaagggatgttttaaataggcatgaagggttgtttttaattgaggttaaggatctgaaatgagaggttttggtttaccctatctatggtatgtcttaaaaatcaacgaagatgtccttgtcttttttgaatttgccgagtgtgttgcagttccacagctcactgttaggtggcacataccccaaactgaaaacctgacctcgtagggcatgagtcaaaagacaggtaggcacaggacagggcagtggtgacactacagctttcagggttcccagcctgtcaagaatgagcatgtcttagcaggggaggaacgcatgtgtgggaaccgccacagagtcctacgttaggtatatgttgctagtagtttgttaagatatttgagtttgggaatttaattattttttcttttttaaag/GTTTCCTCATGAGGACAAATACCTGATTTTGAATAAAGCAGCATTCAGTTGAAATAACCCTTTCTGTGGTAATTCCAA/gtga(a>g)tatttttcttctaggtgatgagtttctacttcctctggtttttacaacaggaaatgaaatggtatctaaaataaacaagctgtggtatgatgattattcattttctgtcattctgtgctttttatgaactagGGTGGGCTCTAGGTGAACATGGAGAATGGGCCAAATACAGCAATTTTGATGTTGCTACCCATGTTCCCCTGATATTCTATGTTCCTGGAAGGACGGCTTCACTTCCGGAGGCAGGCGAGAAGCTTTTCCCTTACCTCGACCCTTTTGATTCCGCCTCACAGTTGATGGAGCCAG	Creates pseudoexon	No	5	Out	NULL	NULL	9.1	82.41	NULL	12.88	NULL	8.53	8.34	NULL	NULL	17.2	NULL	-4.1	NULL	0.98	8	NULL	309900	ENSG00000010404	248	329	iduronate 2-sulfatase
68	1	Human	98	ITGA2B	72	Glanzmann thrombastenia	IVS15+1G>A	-8	100	Exon	2	ACCTGATCGTGGGAGCTTACGGGGCCAACCAGGTGGCTGTGTACAGgtgagcactggctccaggggcgggatggggaaggtcctgtgccatcaagaggaggccaggccaggaggagccacaatggcaagcctaccccatcaccctatcccatcagAGCTCAGCCAGTGGTGAAGGCCTCTGTCCAGCTACTGGTGCAAGATTCACTGAATCCTGCTGTGAAGAGCTGTGTCCTACCTCAGACCAAGACACCC/GTGAGCTG(g>a)tgaggaggcagagggcatgggccttaaaggatctgggacctcagaaaggctccaacccctgagccccacttacgtctttgcag	NULL	No	NULL	In	80.53	8.3	3.59	65.33	12.08	9.98	5.27	5.27	5.82	7.67	14	10.1	-7	-2.8	8	0.48	6	0.83	273800	ENSG00000005961	56	68	"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)"
232	1	Human	163	WISP3	149	Progressive pseudorheumatoid dysplasia (PPD)	E3+243G>C	27	100	Intron	0	ACCTTGTAGCTGTTGGGTGCGAGTTCAACCAGGTACATTATCATAATGGCCAAGTGTTTCAGCCCAACCCCTTGTTCAGCTGCCTCTGTGTGAGTGGGGCCATTGGATGCACACCTCTGTTCATACCAAAGCTGGCTGGCAGTCACTGCTCTGGAGCTAAAGGTGGAAAGAAGTCTGATCAGTCAAACTGTAGCCTGGAACCATTACTACAGCAGCTTTCAACAAGCTACAAAACAATGCCA(G>C)gtgctcagaagtagagctatttttcac/gtatgaccttggtggtattccttcatgttccttttacgtatcataggtactcagtaagtacttgttgattggtggtcagagtgagatatagtttgagtgtatcattttacttaatctttgcctcagacagggataaatatctgcaaaggaaattttataatgttttagaattttctggtaaaacatttaaaaacatttttaaaagatctactaggtcaggaagctctactaaaatcttacacctctgcttatttctaacctcttctcaggaaaattgaccaaatattgttcacatgtaccctagaacaacttatttttattgttctattatgggcaagaagtttgaccattcacttccccaaattttaaaaggtaacatttctatgtgatacaggcagaaatgggaggctactgctgaaaaatatttaagaactgacacatattttgaacttgtaaatattatttctaaaaat	NULL	No	NULL	In	64.95	3.6	4.31	70.31	8.68	6.28	5.93	5.93	5.93	4.18	11.8	10.8	-4.5	0.4	6	0.64	7	0.2	208230	ENSG00000112761	180	232	WNT1 inducible signaling pathway protein 3
122	1	Human	144	SCN5A	25	Brugada syndrome	IVS27+3_6dup(GGGT)	-96	NULL	Intron	0	actctctgtggcagtgttgcaggggctttgggctcactagagggtagagtgggagggtgggtggtctgggatgagaggcagcaacaggcatttgccagcctccccaagggccctgctgagcactttccatttgcctctcctttcagAACAAGTACCAGGGCTTCATATTCGACATTGTGACCAAGCAGGCCTTTGACGTCACCATCATGTTTCTGATCTGCTTGAATATGGTGACCATGATGGTGGAGACAGATGACCAAAGTCCTGAGAAAATCAACATCTTGGCCAAGATCAACCTGCTCTTTGTGGCCATCTTCACAG/GCGAGTGTATTGTCAAGCTGGCTGCCCTGCGCCACTACTACTTCACCAACAGCTGGAATATCTTCGACTTCGTGGTTGTCATCCTCTCCATCGTGGgtgggt(gggt)ataaagtcagctggacggagaagccctccccagccaggcctctcctccagcccctgggtctctgctgaatgccatgtacaaccctagcttctttcataatttttttcagtgcatttctcaccccccttctcccctcacacatacacgcacacacacctctccagagagaacttatctggaaggccccacttgggccaaggagaccaatctggcagaggacccagcacttgctcctggccccaccctccagaggaactgggaacacagttctctaactgcttagagagcttcaaggatgagtctgggaatgggagtgggtgctgtggaggctaattctgcctgcacttaggttgaaggagaaggaagctcaggatgagatgggtccccagggatgggggataggtggccctccagagtagaaattatccctgaagatggaaaattctggagctaaccgccaaggtgtatgccagactccttcagacatcacctgcctcatgcaattcacccagtcaattcagcaccaaaggagggagattgtgcagctagggagaagcagagacccaatcctgacccatgtctgtttgacctcggagcccagatcttttttttatataacagctttactgagacataattcacataccataaaattcacggttaactttaaagtcactttaaagtatacaattcagtgttttttaatatatgcacagagctttgcaaccatcaccactatctaattttagaatatattcctttccccaaaggaaactctacccatttaatagtcaatccccattcatttcccctctccctcacccctgaaaaccacttatctaaagttttgagggaccaccaaactgtttttcaatatggctgcacctttttacattctcgctgtcaatgtatgaggattccaattattttgccctcaccaacacttgttattgcctgcattctttttataggagccctcctagtgagtatgaagtgatatctcactgaggttttggtttgcaaaagcaaatgactgatgactaacgatgcaggacatctttccatgtgcatgttggtcatttatatatcttccttggagaaatctctattcagatccttagctcatttttaattgggttatttctctttttcttgttgagttgtaagagttctttacatattctggatcatagtctcttatcagatatatgatttaaaaatattttctcctagtctgtgagttttttcatttcctagtggtgtccattaaagcacaaaagttttacatgttaatgaagtccagtttacttatattttttcttttgtcacttgtgctcggagcccaaactctttaactctacccccaaggggctctgccttgcggtgactgtgactttcatctttctgccatatacaacctctgcctctggtaaatgtaaaggataatgcaggggctaaggcaggcactgctgtggctatagtgacgggaagatggaagcacaaagtagggtcaggaatctctggggggtctcaagcaggatgagggtgagagcgtgccttatgggactggagaggagttttagagaatgcaggatgtcagcagcaggaatggaaccattgagggacagtctcagaggctttggaaggttcagcatgtactttgggatctctcctggcccgctgtttgggcggtaccagagaggaggagtggttaagagatcaacttggagcccgaacgtctgagtcaaatcccagcttctcactcactaggtggcaacttgggtaagttacctcacctctgtttcctcttctggaagataaggatgatggcatctgctcacttcctaggacaatgggaaggactaaatgaaatgatggctataaagtgctcggcccattgccccagtgatcgtaaacactggacccatgtcagtcagtgacattattatataaggagtctggaaagggcacttgggccatataagacaagtttatttcactctttattccatgatttatatccatgccccttaaaactccaaacccaggtagtcacaggagacccaggggcagtgacgccctcaaaggaggcagagttaggagagcgataagaaccatcacagagaagctgagagaagacactggccatggcgtggcatcagggagcactgatttctgggccagtgtttcatgcccttcgatgggcacataaatcatctgggcttcttaagatgcaatgggctggggtggagctgagattctgcatttctgataagcacctaggagatcccaaggctgctggtcctcaaaccacactttgaatagcaaggagctaaaagacctgagttctggcccaagctgggtgggcaagatactaagcagatcccctctggcctgagaacccaagatgtagaagatgggcctaggacagctctattgtgtaggtacacactgaagattaaggaatgagggggctgagaaggaaccctgcaaaggacccatttttctgggtcacagatgcagacatggagactcaaacagacaggagcaggcagagtcctagcatgcccagtggacgcaatcctggaagggccgcctctccttggctccttgccatatagagaccccccccccaccgccaacccctgcacagtgatgctggctggaagacagaggtgccaccagtagccacagtctctgttgtttcccacag	NULL	No	-98	Out	74.71	3.82	2.92	76.98	9.48	7.12	3.94	3.94	4.12	5.02	15	NULL	-8.8	-5.8	8	NULL	8	0.18	601144	ENSG00000183873	96	122	"sodium channel, voltage-gated, type V, alpha subunit"
122	1	Human	144	SCN5A	25	Brugada syndrome	IVS27+3_6dup(GGGT)	-96	NULL	Intron	0	actctctgtggcagtgttgcaggggctttgggctcactagagggtagagtgggagggtgggtggtctgggatgagaggcagcaacaggcatttgccagcctccccaagggccctgctgagcactttccatttgcctctcctttcagAACAAGTACCAGGGCTTCATATTCGACATTGTGACCAAGCAGGCCTTTGACGTCACCATCATGTTTCTGATCTGCTTGAATATGGTGACCATGATGGTGGAGACAGATGACCAAAGTCCTGAGAAAATCAACATCTTGGCCAAGATCAACCTGCTCTTTGTGGCCATCTTCACAG/GCGAGTGTATTGTCAAGCTGGCTGCCCTGCGCCACTACTACTTCACCAACAGCTGGAATATCTTCGACTTCGTGGTTGTCATCCTCTCCATCGTGGgtgggt(gggt)ataaagtcagctggacggagaagccctccccagccaggcctctcctccagcccctgggtctctgctgaatgccatgtacaaccctagcttctttcataatttttttcagtgcatttctcaccccccttctcccctcacacatacacgcacacacacctctccagagagaacttatctggaaggccccacttgggccaaggagaccaatctggcagaggacccagcacttgctcctggccccaccctccagaggaactgggaacacagttctctaactgcttagagagcttcaaggatgagtctgggaatgggagtgggtgctgtggaggctaattctgcctgcacttaggttgaaggagaaggaagctcaggatgagatgggtccccagggatgggggataggtggccctccagagtagaaattatccctgaagatggaaaattctggagctaaccgccaaggtgtatgccagactccttcagacatcacctgcctcatgcaattcacccagtcaattcagcaccaaaggagggagattgtgcagctagggagaagcagagacccaatcctgacccatgtctgtttgacctcggagcccagatcttttttttatataacagctttactgagacataattcacataccataaaattcacggttaactttaaagtcactttaaagtatacaattcagtgttttttaatatatgcacagagctttgcaaccatcaccactatctaattttagaatatattcctttccccaaaggaaactctacccatttaatagtcaatccccattcatttcccctctccctcacccctgaaaaccacttatctaaagttttgagggaccaccaaactgtttttcaatatggctgcacctttttacattctcgctgtcaatgtatgaggattccaattattttgccctcaccaacacttgttattgcctgcattctttttataggagccctcctagtgagtatgaagtgatatctcactgaggttttggtttgcaaaagcaaatgactgatgactaacgatgcaggacatctttccatgtgcatgttggtcatttatatatcttccttggagaaatctctattcagatccttagctcatttttaattgggttatttctctttttcttgttgagttgtaagagttctttacatattctggatcatagtctcttatcagatatatgatttaaaaatattttctcctagtctgtgagttttttcatttcctagtggtgtccattaaagcacaaaagttttacatgttaatgaagtccagtttacttatattttttcttttgtcacttgtgctcggagcccaaactctttaactctacccccaaggggctctgccttgcggtgactgtgactttcatctttctgccatatacaacctctgcctctggtaaatgtaaaggataatgcaggggctaaggcaggcactgctgtggctatagtgacgggaagatggaagcacaaagtagggtcaggaatctctggggggtctcaagcaggatgagggtgagagcgtgccttatgggactggagaggagttttagagaatgcaggatgtcagcagcaggaatggaaccattgagggacagtctcagaggctttggaaggttcagcatgtactttgggatctctcctggcccgctgtttgggcggtaccagagaggaggagtggttaagagatcaacttggagcccgaacgtctgagtcaaatcccagcttctcactcactaggtggcaacttgggtaagttacctcacctctgtttcctcttctggaagataaggatgatggcatctgctcacttcctaggacaatgggaaggactaaatgaaatgatggctataaagtgctcggcccattgccccagtgatcgtaaacactggacccatgtcagtcagtgacattattatataaggagtctggaaagggcacttgggccatataagacaagtttatttcactctttattccatgatttatatccatgccccttaaaactccaaacccaggtagtcacaggagacccaggggcagtgacgccctcaaaggaggcagagttaggagagcgataagaaccatcacagagaagctgagagaagacactggccatggcgtggcatcagggagcactgatttctgggccagtgtttcatgcccttcgatgggcacataaatcatctgggcttcttaagatgcaatgggctggggtggagctgagattctgcatttctgataagcacctaggagatcccaaggctgctggtcctcaaaccacactttgaatagcaaggagctaaaagacctgagttctggcccaagctgggtgggcaagatactaagcagatcccctctggcctgagaacccaagatgtagaagatgggcctaggacagctctattgtgtaggtacacactgaagattaaggaatgagggggctgagaaggaaccctgcaaaggacccatttttctgggtcacagatgcagacatggagactcaaacagacaggagcaggcagagtcctagcatgcccagtggacgcaatcctggaagggccgcctctccttggctccttgccatatagagaccccccccccaccgccaacccctgcacagtgatgctggctggaagacagaggtgccaccagtagccacagtctctgttgtttcccacag	NULL	No	-98	Out	74.71	3.82	2.92	76.98	9.48	7.12	3.94	3.94	4.12	5.02	15	NULL	-8.8	-5.8	8	NULL	8	0.18	601144	ENSG00000183873	225	122	"sodium channel, voltage-gated, type V, alpha subunit"
302	1	Human	144	SCN5A	25	Brugada syndrome	IVS27+3_6dup(GGGT)	4	NULL	Intron	1	actctctgtggcagtgttgcaggggctttgggctcactagagggtagagtgggagggtgggtggtctgggatgagaggcagcaacaggcatttgccagcctccccaagggccctgctgagcactttccatttgcctctcctttcagAACAAGTACCAGGGCTTCATATTCGACATTGTGACCAAGCAGGCCTTTGACGTCACCATCATGTTTCTGATCTGCTTGAATATGGTGACCATGATGGTGGAGACAGATGACCAAAGTCCTGAGAAAATCAACATCTTGGCCAAGATCAACCTGCTCTTTGTGGCCATCTTCACAGGCGAGTGTATTGTCAAGCTGGCTGCCCTGCGCCACTACTACTTCACCAACAGCTGGAATATCTTCGACTTCGTGGTTGTCATCCTCTCCATCGTGGgtgg/gt(gggt)ataaagtcagctggacggagaagccctccccagccaggcctctcctccagcccctgggtctctgctgaatgccatgtacaaccctagcttctttcataatttttttcagtgcatttctcaccccccttctcccctcacacatacacgcacacacacctctccagagagaacttatctggaaggccccacttgggccaaggagaccaatctggcagaggacccagcacttgctcctggccccaccctccagaggaactgggaacacagttctctaactgcttagagagcttcaaggatgagtctgggaatgggagtgggtgctgtggaggctaattctgcctgcacttaggttgaaggagaaggaagctcaggatgagatgggtccccagggatgggggataggtggccctccagagtagaaattatccctgaagatggaaaattctggagctaaccgccaaggtgtatgccagactccttcagacatcacctgcctcatgcaattcacccagtcaattcagcaccaaaggagggagattgtgcagctagggagaagcagagacccaatcctgacccatgtctgtttgacctcggagcccagatcttttttttatataacagctttactgagacataattcacataccataaaattcacggttaactttaaagtcactttaaagtatacaattcagtgttttttaatatatgcacagagctttgcaaccatcaccactatctaattttagaatatattcctttccccaaaggaaactctacccatttaatagtcaatccccattcatttcccctctccctcacccctgaaaaccacttatctaaagttttgagggaccaccaaactgtttttcaatatggctgcacctttttacattctcgctgtcaatgtatgaggattccaattattttgccctcaccaacacttgttattgcctgcattctttttataggagccctcctagtgagtatgaagtgatatctcactgaggttttggtttgcaaaagcaaatgactgatgactaacgatgcaggacatctttccatgtgcatgttggtcatttatatatcttccttggagaaatctctattcagatccttagctcatttttaattgggttatttctctttttcttgttgagttgtaagagttctttacatattctggatcatagtctcttatcagatatatgatttaaaaatattttctcctagtctgtgagttttttcatttcctagtggtgtccattaaagcacaaaagttttacatgttaatgaagtccagtttacttatattttttcttttgtcacttgtgctcggagcccaaactctttaactctacccccaaggggctctgccttgcggtgactgtgactttcatctttctgccatatacaacctctgcctctggtaaatgtaaaggataatgcaggggctaaggcaggcactgctgtggctatagtgacgggaagatggaagcacaaagtagggtcaggaatctctggggggtctcaagcaggatgagggtgagagcgtgccttatgggactggagaggagttttagagaatgcaggatgtcagcagcaggaatggaaccattgagggacagtctcagaggctttggaaggttcagcatgtactttgggatctctcctggcccgctgtttgggcggtaccagagaggaggagtggttaagagatcaacttggagcccgaacgtctgagtcaaatcccagcttctcactcactaggtggcaacttgggtaagttacctcacctctgtttcctcttctggaagataaggatgatggcatctgctcacttcctaggacaatgggaaggactaaatgaaatgatggctataaagtgctcggcccattgccccagtgatcgtaaacactggacccatgtcagtcagtgacattattatataaggagtctggaaagggcacttgggccatataagacaagtttatttcactctttattccatgatttatatccatgccccttaaaactccaaacccaggtagtcacaggagacccaggggcagtgacgccctcaaaggaggcagagttaggagagcgataagaaccatcacagagaagctgagagaagacactggccatggcgtggcatcagggagcactgatttctgggccagtgtttcatgcccttcgatgggcacataaatcatctgggcttcttaagatgcaatgggctggggtggagctgagattctgcatttctgataagcacctaggagatcccaaggctgctggtcctcaaaccacactttgaatagcaaggagctaaaagacctgagttctggcccaagctgggtgggcaagatactaagcagatcccctctggcctgagaacccaagatgtagaagatgggcctaggacagctctattgtgtaggtacacactgaagattaaggaatgagggggctgagaaggaaccctgcaaaggacccatttttctgggtcacagatgcagacatggagactcaaacagacaggagcaggcagagtcctagcatgcccagtggacgcaatcctggaagggccgcctctccttggctccttgccatatagagaccccccccccaccgccaacccctgcacagtgatgctggctggaagacagaggtgccaccagtagccacagtctctgttgtttcccacag	NULL	No	NULL	Out	74.71	3.82	3.82	74.71	9.48	9.48	5	5	5.02	5.02	15	15	-8.8	-8.8	8	0.01	8	0.18	601144	ENSG00000183873	225	302	"sodium channel, voltage-gated, type V, alpha subunit"
249	1	Human	64	FBN1	118	Marfan syndrome	IVS46+1G>A	33	NULL	Intron	0	agaagttctcagcctatggatgaggcctggtgaaccctaaaatgctctttagccactgtaaccgtgtaaccactttttctacttataattatgtttctttatggcctttcttcctactagACATAAATGAATGTGAAAGAGATGCCTGTGGGAATGGAACTTGCCGGAACACAATTGGTTCCTTCAACTGCCGCTGCAATCATGGTTTCATCCTTTCTCACAACAATGACTGTATAG(g>a)tgcgtgtgcaaaattgtgcatcagcaaaggaa/gtcagttttatatgtgttctttgtaattagcatcatctctagtgttccagctgtcttttaaaaatgtatgctatcttatgcataacaattggttatgggacttgtcaaatacaatgtgctcaacatgaaatatattacagaagtctc	NULL	No	NULL	In	83.6	6.6	1.02	77	12.18	6.58	4.18	4.18	-0.36	6.97	13.5	7.8	-5	-1.4	8	0.12	6	0.91	154700	ENSG00000166147	188	249	fibrillin 1
283	1	Human	76	GH-V (GH2)	94	Splice-site mutation in the human growth hormone-variant gene	IVS2+1G>A	12	NULL	Intron	0	agagagaaaaaaaaaaacccagctcctggaacagggagagcgctggcctcttgctctccagctccctctgttgccctccggtttctccccagGCTCCCGGACGTCCCTGCTCCTGGCTTTTGGCCTGCTCTGCCTGTCCTGGCTTCAAGAGGGCAGTGCCTTCCCAACCATTCCCTTATCCAGGCTTTTTGACAACGCTATGCTCCGCGCCCGTCGCCTGTACCAGCTGGCATATGACACCTATCAGGAGTTT(g>a)taagctcttgg/gtaatgggtgcgcttcagaggtggcaggaaggggtgactttcccccgctgggaagtaatgggaggagactaaggagctcagggttgttttctgaagtgaaaatgcaggcagatgagcatacgctgagtgaggttcccagaaaagtaacaatgggagctggtctccagcatagaccttggtgggcggtccttctcctag	NULL	No	NULL	In	71.95	3.93	5.68	72.52	9.18	6.98	3.92	3.92	4.46	3.82	12	12	-2.6	-5.8	5	0.44	6	0.04	139240	ENSG00000136487	213	283	growth hormone 2
214	1	Human	150	SOST	159	Sclerosteosis	IVS1+3A>T	214	NULL	Intron	1	AGAGCCTGTGCTACTGGAAGGTGGCGTGCCCTCCTCTGGCTGGTACCATGCAGCTCCCACTGGCCCTGTGTCTCGTCTGCCTGCTGGTACACACAGCCTTCCGTGTAGTGGAGGGCCAGGGGTGGCAGGCGTTCAAGAATGATGCCACGGAAATCATCCCCGAGCTCGGAGAGTACCCCGAGCCTCCACCGGAGCTGGAGAACAACAAGACCATGAACCGGGCGGAGAACGGAGGGCGGCCTCCCCACCACCCCTTTGAGACCAAAGgt(a>t)tggggtggaggagagaattcttagtaaaagatcctggggaggttttagaaacttctctttgggaggcttggaagactggggtagacccagtgaagattgctggcctctgccagcactggtcgaggaacagtcttgcctggaggtgggggaagaatggctcgctggtgcagccttcaaattcaggtgcagaggcatgaggcaacagacgctg/gtgagagcccagggcagggaggacgctggggtggtgagggtatggcatcagggcatcagaacaggctcaggggctcagaaaagaaaaggtttcaaagaatctcctcctgggaatataggagccacgtccagctgctggtaccactg	NULL	Yes	NULL	In	84.21	9.26	7.54	80.42	12.58	12.48	8.31	8.31	7.72	8.34	13.8	13.8	-4.1	-5.8	7	0.78	8	0.97	269500	ENSG00000167941	169	214	sclerostin
33	1	Human	114	MSH2	32	Colorectal carcinoma	E7+199A>G	-48	NULL	Exon	0	agcctcccaagtagatgggatcacaggcatgagccaccatgcctggctaattttgtattttttgtacagacggggtttctccatgttggtcaggccagtctcgaactccctacctcaggtgatctgcctgcctcggcctctcaaagtgctgggattacaggtgtgagccactgcgcccagcagattcaagctttttaaatggaattttgagctgatttagttgagacttacgtgcttagttgataaattttaattttatactaaaatattttacattaattcaagttaatttatttcagATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGG/GTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGA(A>G)Ggtaacaagtgattttgtttttttgttttccttcaactcatacaatatatacttggcaatgtgctgtcctcataaagttggtggtggtgactcactcttaggacacattcagatttcttttttttttttttttgagaaggagtcttgctccgttgccaaggctagagtgcagtggcacaatctcagctcactgcaacctctgcctcctgggttcaagcgattctcctgcctcagcttcctgagtggctgggattacaggcatgtgccaccatgcccggctaatttttgtacttttagtttt	NULL	No	NULL	In	81.5	8.92	2.31	62.21	12.68	7.68	2.68	2.68	3.77	6.99	14.1	10.2	-5.1	-4.7	6	0.28	6	0.91	191170	ENSG00000095002	26	33	"mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)"
212	1	Human	120	PCCB	150	Propionic acidemia	IVS1+2T>C	20	NULL	Intron	2	AGCGCCGTACCCACGCTTTAGCACATGCGTACTCAGGTGCGCCGGTAGGGGACGCGCCGGCACAGCAAAAATGGCGGCGGCATTACGGGTGGCGGCGGTCGGGGCAAGGCTCAGCGTTCTGGCGAGCGGTCTCCGCGCCGCGGTCCGCAGCCTTTGCAGCCAGGCCACCTCTGTTAACGAACGCATCGAAAACAAGCGCCGGACCGCGCTGCTGGGAGGGGGCCAACGCCGTATTGACGCGCAGCACAAGCGAg(t>c)gagtcctgaggggcctaa/gtgagtcccgcccctggcgtccgcgacctatcactgcgtgcccggcttgcggcgtccgaggcctccctgccaatccgcacggtgcctggaggggccggagcaagggtgttcaccttgaaaacctgtagcgtttctcgtggaggcgggtataaccagcagaagcacctgtgtgctttttcatactgtttaacccttgggatttagacggatctggctcgtctctagccagctcaacacttaacataagcttttgggcaacttattaaatctctgtgggtcattttaataataattcttccttcacaagtgtatcgttagaccatagatagcaaaatgataggcgctcagtaaaaaccatgtgcttattctcgtgccccatgaaagagtgatggtaggttct	NULL	No	NULL	In	72.86	8.49	6.43	82.41	11.18	11.78	6.49	6.49	5.55	7.86	12.1	12.5	-4.1	-4.1	8	0.96	8	0.95	606054	ENSG00000114054	167	212	"propionyl CoA carboxylase, beta polypeptide"
310	1	Human	86	HLA-A*110X	2	Aberrant HLA class I molecule	IVS5+17G>A	18	60	Intron	0	AGCTGTCTTCCCAGCCCACCATCCCCATCGTGGGCATCATTGCTGGCCTGGTTCTCCTTGGAGCTGTGATCACTGGAGCTGTGGTCGCTGCCGTGATGTGGAGGAGGAAGAGCTCAGgtggagaaggggtgaa(g>a)g/gtggggtctgagatttcttgtctcactgagggttccaagccccagctagaaatgtgccctgtctcattactgggaagcaccttccacaatcatgggccgacccagcctgggccctgtgtgccagcacttactcttttgtaaagcacctgttaaaatgaaggacagatttatcaccttgattacggcggtgatgggacctgataccagcagtcacaagtcacaggggaaggtccctgaggacagacctcaggagggctattggtccaggacccacacctgctttcttcatgtttcctgatcccgccctgggtctgcagt	NULL	No	-2	Out	66.52	2.57	2.21	69.33	8.88	7.48	5.74	5.74	4.1	4.44	11.8	9.1	-5.4	-8.6	6	0.04	7	0.06	142871	ENSG00000206441	233	310	NULL
12	1	Human	17	CAV3	111	Limb girdle muscular dystrophy	IVS1+2T>C	-42	20	Exon	0	AGGAAACGCTAGGCCCTCTGCACCCTCTCCTGAGGCCCAGTGCCCTGAGGCAGCCCCCTTTAAGGAGCGATCGGCCTTCCAGAAGAGCTCCAGTCTTAATTTTAGCTTGGAGGCCTGCCACAGGAGGCTTTAGAGAGAGGCAGGCTGAAGTTATGTGGGACAGCTGTCAGCCGGCATGCTGGGTGGGGCCTATTTAGCTGGCAGGGACATAAGTCTGGGGACACTGAATTGGTCTCTCTGCCCCAAGTATTTTCAGCCCCAGCCGGCCACACAGCTCGGATCTCCTCCTGTGGATCCCCCCAGCTCTGCGATGATGGCAGAAGAGCACACAGATCTCGAGGCCCAGATCGTCAAGGATATCCACTGCAAGGAGATTGACCTG/GTGAACCGAGACCCCAAGAACATTAACGAGGACATAGTCAAGg(t>c)aggctctgcaggcctgcctcggcgggcggagagtgtcaggtttgcgagacgtgggcgcttggcaggggagggtatctgctgcagacacagtttccctgaaaagagacttgttgctctgttgtctctgtatcacccccccaaccccaccccacccccaaaaaaaggcttctaaatcaccgaaggatctttagcaaaatcaagagcaaaaaattagcctcatctccatgacctaagtgctaatcagggcaggaggagcgagtcacaaagaaaatccctccttactactgtgacgctcctgccactcactcctggctctcaccctgggaggaacaggaacgggcggccaagttgggctcctttctgtgccaaggggcatttctgcggtctctccagtgggtgcagggttaatccccagagggcagcttccagcagggccggcagcccctcgaggtacactcactcccccagagcactgcccaatatctgtccccaaggccgagggccatgcccagccctcccctagctaccccctcaccccaggtctagtggccaggacagggcagacggcacccgggaccctcgaagagaaagctcgggg	NULL	No	NULL	In	83.33	10.08	1.51	67.47	14.18	6.58	4.98	4.98	4.12	8.6	14	8.8	-7.2	-3.8	7	0.07	7	0.98	253601	ENSG00000182533	10	12	caveolin 3
176	1	Human	17	CAV3	111	Limb girdle muscular dystrophy	IVS1+2T>C	41	70	Intron	2	AGGAAACGCTAGGCCCTCTGCACCCTCTCCTGAGGCCCAGTGCCCTGAGGCAGCCCCCTTTAAGGAGCGATCGGCCTTCCAGAAGAGCTCCAGTCTTAATTTTAGCTTGGAGGCCTGCCACAGGAGGCTTTAGAGAGAGGCAGGCTGAAGTTATGTGGGACAGCTGTCAGCCGGCATGCTGGGTGGGGCCTATTTAGCTGGCAGGGACATAAGTCTGGGGACACTGAATTGGTCTCTCTGCCCCAAGTATTTTCAGCCCCAGCCGGCCACACAGCTCGGATCTCCTCCTGTGGATCCCCCCAGCTCTGCGATGATGGCAGAAGAGCACACAGATCTCGAGGCCCAGATCGTCAAGGATATCCACTGCAAGGAGATTGACCTGGTGAACCGAGACCCCAAGAACATTAACGAGGACATAGTCAAGg(t>c)aggctctgcaggcctgcctcggcgggcggagagtgtcag/gtttgcgagacgtgggcgcttggcaggggagggtatctgctgcagacacagtttccctgaaaagagacttgttgctctgttgtctctgtatcacccccccaaccccaccccacccccaaaaaaaggcttctaaatcaccgaaggatctttagcaaaatcaagagcaaaaaattagcctcatctccatgacctaagtgctaatcagggcaggaggagcgagtcacaaagaaaatccctccttactactgtgacgctcctgccactcactcctggctctcaccctgggaggaacaggaacgggcggccaagttgggctcctttctgtgccaaggggcatttctgcggtctctccagtgggtgcagggttaatccccagagg	NULL	Yes	NULL	In	83.33	10.08	4.86	72.91	14.18	8.08	3.95	3.95	5.11	8.6	14	11.8	-7.2	-3.3	7	0.13	8	0.98	253601	ENSG00000182533	10	176	caveolin 3
57	1	Human	15	C3	83	Hereditary C3 deficiency	IVS18+1G>A	-61	100	Exon	1	aggaagtaggtcggctctctttttgtttgttttttgtttttgttttcagatggagtctgtctctgtcgcctgggctggagtgtagtcgtgtgatctcagctcactgcaacctccacctcctgggttcaagtgattctgctgcctcagcctccacagtagctgggatcacaggcacgcgccaccacacccagctaatttttgtgtttttagtagagatggggtttcaccatgttgtccaggctggtctcaaagtcctgacctcaagcgatccacccacctcagcctcccaaagtgctgggattacaggggtgagccaccgtgcccagccttaatttttgtatttttagtagagatgggtttcaccatgttagctaggctggtctccaactcctggcctcaagtgatccacctgccttggcctccctaagtgctgggatttcaggcatgagccatggcaactggcctgctctgttctaaatgcagatctaaaccccctgcagGTAACCTGGATGAGGACATCATTGCAGAAGAGAACATCGTTTCCCGAA/GTGAGTTCCCAGAGAGCTGGCTGTGGAACGTTGAGGACTTGAAAGAGCCACCGAAAAATGG(g>a)taaggccggggtacccccggtacaacccaccccagagtcagaccgtttaatttgcatgcacctgctatctctggtcttctctggaatcacagtgcaaccccacagcccaacctagaaaaatcaggaattgggtgacctacatggaggcacccccagacccttccagcctgtcccttggggtccctctgcaccagttcttcccctctaccaccctgctagatgacatctcctaataccccaacctcttctccatccag	NULL	No	NULL	In	85.06	9.08	7.97	82.41	12.18	12.08	7.32	7.32	7.37	7.54	15	12.5	-9.2	-4.1	7	0.97	7	1	120700	ENSG00000125730	45	57	complement component 3
158	1	Human	99	ITGB3	72	Glanzmann thrombastenia	E11+125C>T	-100	100	Exon	1	agggagagagttttggggcctgtgaggccttttgccatcatcaagtcacaccgtcaaggctactgagtgccctgtgtaggttcagggctgtggctttgtgctgtgtcagccaaactagaagggctaaagagcttgcttctagttcttagactagaaggaactaagtcttctaagcctcctaccctttctcttgcctttctcagaaggcagaggtattcagaaaagggcaagagagagggcaagaggcccaggagacttagttcctgagaatcttttgctctacagtggctccgagcaagtcctgccataccttgggacccctagaaaactgagtttgtccctgctgggtaggactcccctgggtggtgagccaattccctgccaacctggaggatcattatctgtgtggttgggagagcaggatggtcgtgtgtagcctgctgccatgggagtggagctctcgccagcgggtccaccttcctgggctgtgtgttttcagGCCATGGCCAGTGCAGCTGTGGGGACTGCCTGTGTGACTCCGACTGGACCGGCTACTACTGCAACTGTACCACGCGTACTGACACCTGCATGTCCAGCAATGGGCTGCTGTGCAGCGGCCGCG/G(C>T)AAGTGTGAATGTGGCAGCTGTGTCTGTATCCAGCCGGGCTCCTATGGGGACACCTGTGAGAAGTGCCCCACCTGCCCAGATGCCTGCACCTTTAAGAAgtgagtgtggagtctggagagagccgggaggctgggaggtaggagaggatcccctgactagaatccccagctctccaggtgtgtttcttgctcaccagagccttagggagaggagtccactccagccagatggctgtctctccttttgccaaaggctttgggcaagttggaatagagccaactgtgaaggagccaaagttgaacgagctggacttcgattgagaatgtcctctcctagggtgacatcctgactccctctgagctgggaggaaggctaaaccagtctgaggaacaatccagtgctaatgttctgattcagtgggagatgtgagggctggaattatggaggacactctgtgaaactactacaaacctcccactttaggggccagaggaagccccatcagcctgagtccatggcactgccattctgcttaccactttaagcagggccagatttacgagtgtgcaacctatgca	NULL	No	2	Out	82.41	7.97	11.37	90.4	12.08	15.48	9.53	9.53	11.28	7.37	13.6	18.1	-4.1	-7.6	7	1	7	0.79	273800	ENSG00000056345	126	158	"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)"
16	1	Human	132	PRKAR1A	42	Cushing's syndrome	E1B+102G>A	-53	NULL	Exon	2	AGGGAGGGGGTGGAAAGGAGGGAGAAAAGGCAGAGGCGTCAAGGGAGGCCGGAGGGAGAGTGGGGTGGACAGAGGAGCGGAGGGACGAGAGGGAAGCGCACGATAGCTGCGCGGAGAGAGAGCGAAGAGCAGGCGGAGGAACAAAGGCGACCCAAGACACCCAGAGAGGGACAGgtaaggaggggcaggtgagcaggaaggaggagagaaccgggctagggagactgcggaaaggagaagtggcgggcgtgaggaaactgctgtggataagggacgagtaagatggaaagaatggcggaagacgaacgaccgcagagtgagggtccttccaagagcgaccaggggggaggaactggggctgttgcgcccttaaggttgctaaggcgacggttctggccagagcgaggcgcattgacgtcagtagccgaacgctgattggctgcggccaggccgtttccggtggagctgtcgcctagccGCTATCGCAGAGTGGAGCGGGGCTGGGAGCAAAGCGCTGAGGGAGCTCG/GTACGCCGCCGCCTCGCACCCGCAGCCTCGCGCCCGCCGCCGCCCGTCCCCA(G>A)gtgagtggggtcggccgggggctcaggcgaggtgagcttcgtcgcttcgcagccggtttgcgggagctggaccgatccaagatggcgtcacggggagcgacctgcagggggacggccgcaccccctgcccctccccggcccggcgggcgcctccccgcaggcctcacgcccccggctccgagtctgcatcctcaaggccgtctgggcgttggctttggtgcggggctccccagccgccccgctcgcgctcgctgcccccaccccacggctcctggggccctgggccctccgcggccctccccggccgccttcgcccccgcgcgccgcggcctcttcgctcaccctcccccatttcctgaaggacaacggctctattttactggggtccgccatcgtctcgtccgccggtcctggctcttcttgtaagccggtagttttcctctccacttttgacgactcgtcattgctagcagtagcctttcctcttcatagcggagtgatctttcccccaacacgacggtcttagtcgggctcctgaatttcctcttgtcccctttcacctctctccctttcccaattttgcccccctgaggcctcctcgccaccactgtggccttccgactggcgtagcttgaagtctcggcttcccttcattttgtggtcatgaccgtggcctacgtgaagtgaagggcattttcctgcccttcttctagaaaatacacggtacctattaacctcttcagctcagagcctgtggtgacgaccgtcctactccttgagagattcccaagagatccgtctttttagcagagcgaggaaagcaaacacttactcaagatgaccctaggggagccgtaacttggctggtctaagggggtgcggtctgaatcaggaacagtttctcaaagtgtttttatttatttcccagaatgtaatcctttcgaaacaattttgtcacaactgaattttcaaaagaatgaatctgagtgttttgttttacatagagacaatgcagcgaaagttttaaagcagttaaataattgtgtgtggggagggaaggctaggttgttgggctttacaaataagtacacatagagaatccgggtaactcgattaaaaatattaagactgtgaagtctggttattcagggatttacatggtgactgcattaattttggtacatttctgttcgtatactgtcctattaccggtggctatctttttggttttcgtaatacattagttgtttcaaacaaaaacacagtttcactccttaggcccagttctctcatctctaccagccaaagacctgatcttagaatgattgatcatttgaatgttcttaaaatatgacaatgctttgaagcatgaaagatctgatttatgattgttcttggtggcctttaagtattatttgaaatgcagacaattctactgaagtggatcttcagttcatatgattgcctgacctggagaagtggcttgtataaatctatcctaaagtaaatgcgcgtttttgtttttgttttgcctgtttaaagtagcagcatgattatttttccatggcttctaatttatgtgcttgtcttggagccacgaactttctaatggtctgttaattagtctacttgttgttgacctttatggtgaaagttgtcaaaacaaaatgagtaacagtgtagcactttagaatagctctttactctgttaattctttctataagttcttttaaatttacagtttcatctcaatagtttacaatgcattataattggaaaagtctgattagtattgaattcagttgctgagtggaggggaccacactcttgtcttctactcttaagtgcttagtaattaggagttggaaggaaaacagtatatgaccctgttgttaaattagtaaacttttaattctagggtaaggttagctgctcatcattatctctgtttgctttactttacataaaggtaccataattcgaatcctctaaaatccattaaatgcaatttatccattaaatgtaatccattaaatgcaatttatctattgaatcttcatgcaagtttgaaacttaagtgttttaacattctcctgtcaagatgaagaaaatattttgacaattttctgtccaaatgttttacagtttatgtggtaagaattctcccctcccccaactaaggattttccttcttttaccactagtgtattatcatttaggggtggaatctggcaaacgagtctggaataaaggttgcttttaaaactcatctaattttcttgtgtgtttttaaaaattttgattatgctagtagttggctaatcagatcctcactccagtggtttgctctgtg	NULL	No	NULL	In	94.83	10.67	8.59	73.07	14.88	12.38	4.48	4.48	8.82	11.87	19.4	11.7	-9.5	-2.8	9	0.86	5	0.99	160980	ENSG00000108946	14	16	"protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)"
102	1	Human	115	MTHFR	124	Methylenetetrahydrofolate reductase deficiency	IVS5+1G>A	-57	NULL	Exon	0	aggtgcaagatcagagcccccaaagcagaggactctctctgcccagtccctgtggtctcttcatccctcgccttgaacaggtggaggccagcctctcctgactgtcatccctattggcagGTTACCCCAAAGGCCACCCCGAAGCAGGGAGCTTTGAGGCTGACCTGAAGCACTTGAAGGAGAAGGTGTCTGCGGGAGCCGATTTCATCATCACGCAGCTTTTCTTTGAGGCTGACACATTCTTCCGCTTTGTGAAG/GCATGCACCGACATGGGCATCACTTGCCCCATCGTCCCCGGGATCTTTCCCATCCAG(g>a)tgaggggcccaggagagcccataagctccctccaccccactctcaccgcaccgtcctcgcacaggctgggggctctgggtggagtgctgagttcgctgagttcttcccagatctcctct	NULL	No	NULL	In	89.44	10.07	1.8	65.65	13.38	5.32	0.78	0.78	0.71	10.18	17.4	NULL	-9.3	-0.9	8	NULL	6	0.98	236250	ENSG00000177000	78	102	methylenetetrahydrofolate reductase (NAD(P)H)
208	1	Human	8	ATP7A	123	Menkes disease	IVS6+1G>A	4	98	Intron	1	agtaattataacattactctttttaaaaagaatgttatctgtattgtttttcttatcaatgctcttagGAATATATTCTATACTTGTGGCCCTGATGGCTGGCAAGGCAGAAGTAAGGTATAATCCTGCTGTTATACAACCCCCAATGATAGCAGAGTTCATCCGAGAACTTGGATTTGGAGCCACTGTGATAGAAAATGCTGATGAAGGAGATGGTGTTTTGGAACTTGTT(g>a)taa/gtaagattttttgtgtgattaataaaacttccagaaaaaaaacttggtaaggttcagagaagagttgtgaagataattaaaggtggggaaaatattatgaaaattaaggaaactggaaaatggaaggataaggtatgatctaatggtactcttcaagcatggaatttaaaaagataattgtcgtatctctgttaaccaaaaaagaattgggtatgaatgaataaatgaaaattaacatttaaaatataatatgattcctatctagtagcatgtaattgaataaattccagtgcattaaagactcaaattttataaagtcataaaacctgtgtaaggcatattgatttaaagtgatc	NULL	No	NULL	In	78.05	8.3	5.17	82.08	12.08	9.98	6.52	6.52	4.64	5.48	15.7	12.4	-4	-2.8	6	0.25	7	0.8	309400	ENSG00000165240	164	208	"ATPase, Cu++ transporting, alpha polypeptide"
209	1	Human	8	ATP7A	123	Menkes disease	IVS6+5G>A	50	-97	Intron	2	agtaattataacattactctttttaaaaagaatgttatctgtattgtttttcttatcaatgctcttagGAATATATTCTATACTTGTGGCCCTGATGGCTGGCAAGGCAGAAGTAAGGTATAATCCTGCTGTTATACAACCCCCAATGATAGCAGAGTTCATCCGAGAACTTGGATTTGGAGCCACTGTGATAGAAAATGCTGATGAAGGAGATGGTGTTTTGGAACTTGTTgtaa(g>a)taagattttttgtgtgattaataaaacttccagaaaaaaaacttg/gtaaggttcagagaagagttgtgaagataattaaaggtggggaaaatattatgaaaattaaggaaactggaaaatggaaggataaggtatgatctaatggtactcttcaagcatggaatttaaaaagataattgtcgtatctctgttaaccaaaaaagaattgggtatgaatgaataaatgaaaattaacatttaaaatataatatgattcctatctagtagcatgtaattgaataaattccagtgcattaaagactcaaattttataaagtcataaaacctgtgtaaggcatattgatttaaagtgatc	NULL	No	NULL	In	78.05	8.3	8.92	85.71	12.08	12.68	8.07	8.07	7.4	5.48	15.7	15	-4	-7.1	6	0.99	7	0.8	309400	ENSG00000165240	164	209	"ATPase, Cu++ transporting, alpha polypeptide"
3	1	Human	11	BRCA1	24	Breast cancer predisposition	E4+77A>G	-22	NULL	Exon	1	agtattctttctacaaaaggaagtaaattaaattgttctttctttctttataatttatagATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTAT/GTAAGAATGATATAACCAAA(A>G)Ggtatataatttggtaatgatgctaggttggaagcaaccacagtaggaaaaagtagaaattatttaataacatagcgttcctataaaaccattcatcagaaaaatttataaaagagtttttagcacacagtaaattatttccaaagttattttcctgaaagttttatgggacatctgccttatacaggtattagaaacttactgcctttctctaatgcttctagtgtaaaaacttgcagac	NULL	No	NULL	In	77.25	7.84	3.54	81.46	11.08	9.48	5.57	5.57	3.6	6.68	12.3	13.9	-4.1	-2.6	7	0.91	7	0.92	113705	ENSG00000012048	2	3	"breast cancer 1, early onset"
219	1	Human	13	BTK	184	agammaglobulinemia	IVS16+1G>C	60	NULL	Intron	0	agtgctttacctaggactacacagcaggttgctttccacgtggtggaaatgaatcaaaatttcttggtggcatcaacagattcctattaggtgggaaggtgtctgtagtcgaaggagatgaagcttccctggcttcattctactggtcagcagaagctttgtgcctttaacctctgtgctggggacggagtctcactggtctctgtttgcactacagGCAGCTCGAAACTGTTTGGTAAACGATCAAGGAGTTGTTAAAGTATCTGATTTCGGCCTGTCCAG(g>c)tgagtgtggctttttcatctttccctccagaagtaaaaatagcacagtatgaaacatgg/gtaggtgttacagttttaatcctctccttttcttttttttctcattctagcgttttctgccgatctttctattctttttcttcctctgagttatttaagccacctctttcatccttttgttttattgtcatatccctttccttcctttctccctttatctctacctcctcttttttaaatctatttccccaataccttatcttgatctattaatcctgatgactttactccattcctccttctttcttaatcagtctaattcccagtgacaactgcagataaaaggaagggaaggagaagagcagagaaaggaaaggtggatagagaagaggaagggagtacctactagatcttatttcacttcatccttcttgtaaccatattgtcaatcaggaaagctcaatcagatacaaaaacaggaaattcgttaaaagtaacgtttgtagaagatactagttgaggaggagagacttttgagaaagcctgtgtgtgtttgtgacactcttgtgaccgtgccaagaaaacgtaagcaaatatcaagcctccaaatcctaatgcaacaagtcctgaatcccttgcag	NULL	No	NULL	In	94.83	10.67	6.86	79.89	14.88	10.88	6.38	6.38	7.22	11.87	20.5	15	-9.5	-9.2	9	0.89	8	1	300300	ENSG00000010671	46	219	Bruton agammaglobulinemia tyrosine kinase
317	1	Human	77	GLA	56	Fabry disease	IVS4+919G>A	-32768	70	Intron	-32768	AGTGGCCTCTTTATATGTGGCCCTTTCAAAAGgtgagatagtgagcccagaatccaatagaactgtactgatagatagaacttgacaacaaaggaaaccaaggtctccttcaaagtccaacgttacttactatcatcctaccatctctcccaggttccaaccacttctcaccatccccactgctgtaattatagcctaagctaccatcacctggaaagtcatccttgtgtcttcccctttatttcaccattcatgtcctgtctatcaacagtccttccaccagtatctctaaaatatctcctgaatcagcccacttccttccatcttcactacatgcaccctggccttccaagctactatcggctctcaaccagactgctgggaccacctgatctctctgcttccactctgtctcaacccccatctattttccaagcagcactagagttatcatattaaaatgtaaatatcagttttttttttaaagaaaaaaaccctgagacttaacagagttataaaaaatataaatgtcatcatcagttccctgcttaaaacccttaactcgcttccaattgcacttggaatgaaaccaaactgcactgatccagcccttgcctgcctccccaaagtccaaggggtcatggctctttccctggctacactggttttctttctgtccctcaacactgcaagcctattgctgccccagggcctttacacttgctttttttctgcctagaacagttcttccccaaagatttttaaagggccgggctccttaacattgaagtcgcagaccaaacgccacatatgcagacagttcttctctaactactttaaaatagccctctgtccattcattcttcatcacattaacctgtttaattttcttctcagAGCTCCACACTATTTGGAAGTATTTGTTGACTTGTTACCATGTCTCCCCACTA(G>A)AGT/gtaagtttcatgagggcagggaccttgtctgactttgactgtatctctcgcatatggttaagtgttgaatagttatttatggaatgaatccctattattccctcattatctctgcaaaatagtcttttttctcaacatcttaaacctgatatcccacctgcctatctacaaactttttttttgcgacagagtctcactgtcacccaggctagagtgcagtggcgccatctcggctcactgcaacctccgcctcccgggtttaagcgattctcttgcctcagcctcccagtagctgggattataggcgtgcgctaccacatctggctaatttttgtatt	Creates pseudoexon. Mutation-induced transcript was found at low levels (~5%) in normal tissues.	No	-4	Out	NULL	NULL	8.46	77.41	NULL	12.38	NULL	6.31	6.66	NULL	NULL	14.5	NULL	-4.6	NULL	0.98	6	NULL	301500	ENSG00000102393	240	317	"galactosidase, alpha"
303	1	Human	152	TAZ	16	Barth syndrome	IVS3+110G>A	106	100	Intron	1	agttggggcatgaagcctttcctgtcctctagGGATCCTGAAACTCCGCCACATCTGGAACCTGAAGTTGATGCGTTGgtgaggaggaatgggcccctcgaagtgggccgggccggccccacctgcctctgcccagatttgccctcctcctgctctgcccaggaggtggcgtccagcagtccag/gca(g>a)ggcatggggtggggccccgcaggccctcccctgtgcctcccttctgcatgctgatgctgggggcagggtggtggagcggggtgcagggggcaggactaattgcatctgtccctgcttagGACCCCTGCAGCTGCAGACATCTGCTTCACCAAGGAGCTACACTCCCACTTCTTCAGCTTGGGCAAGTGTGTGCCTGTGTGCCGAGgtgagctgctcctccagcgagtgcagggaggcacttctggggcaggaaagctggtggccagtgtctctgttttggagggacctatgggggtaggcatcccgggagccaacatgaggcccagctccatcacatgccagcagaggggaca	De novo 5'ss has a GC consensus. Splice site verified by exon trapping experiments.	No	4	Out	80.53	6.9	3.33	76.77	11.28	7.22	4.39	4.39	3.3	6.52	13.8	NULL	-7	-5.4	7	NULL	7	0.39	302060	ENSG00000102125	226	303	tafazzin
82	1	Human	83	HBB	19	Beta-thalassemia	E1+268G>C	-38	NULL	Exon	2	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAG/GTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCA(G>C)gttggtatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	5.54	76.37	11.68	10.08	6.65	6.65	6.07	7.2	16.4	10.7	-7	-5.3	9	0.21	6	0.64	603902	ENSG00000221842	65	82	"hemoglobin, beta"
75	1	Human	83	HBB	19	Beta-thalassemia	IVS1+1G>A	-38	40	Exon	2	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAG/GTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAG(g>a)ttggtatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	5.54	76.37	11.68	10.08	6.65	6.65	6.07	7.2	16.4	10.7	-7	-5.3	9	0.21	6	0.64	603902	ENSG00000221842	63	75	"hemoglobin, beta"
84	1	Human	83	HBB	19	Beta-thalassemia	IVS2+2T>G	-38	10	Exon	2	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAG/GTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGg(t>g)tggtatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	5.54	76.37	11.68	10.08	6.65	6.65	6.07	7.2	16.4	10.7	-7	-5.3	9	0.21	6	0.64	603902	ENSG00000221842	65	84	"hemoglobin, beta"
80	1	Human	83	HBB	19	Beta-thalassemia	IVS1+5G>C	-38	NULL	Exon	2	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAG/GTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGgttg(g>c)tatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	5.54	76.37	11.68	10.08	6.65	6.65	6.07	7.2	16.4	10.7	-7	-5.3	9	0.21	6	0.64	603902	ENSG00000221842	63	80	"hemoglobin, beta"
86	1	Human	83	HBB	19	Beta-thalassemia	IVS1+5G>T	-38	NULL	Exon	2	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAG/GTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGgttg(g>t)tatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	Minigene assay only	No	NULL	In	78.85	8.08	5.54	76.37	11.68	10.08	6.65	6.65	6.07	7.2	16.4	10.7	-7	-5.3	9	0.21	6	0.64	603902	ENSG00000221842	66	86	"hemoglobin, beta"
78	1	Human	83	HBB	19	Beta-thalassemia	IVS1+6T>C	-38	50	Exon	2	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAG/GTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGgttgg(t>c)atcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	5.54	76.37	11.68	10.08	6.65	6.65	6.07	7.2	16.4	10.7	-7	-5.3	9	0.21	6	0.64	603902	ENSG00000221842	63	78	"hemoglobin, beta"
83	1	Human	83	HBB	19	Beta-thalassemia	E1+268G>C	-16	100	Exon	1	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTG/GTGAGGCCCTGGGCA(G>C)gttggtatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	6.13	80.53	11.68	10.48	7.52	7.52	6.62	7.2	16.4	13.6	-7	-7	9	0.54	7	0.64	603902	ENSG00000221842	65	83	"hemoglobin, beta"
76	1	Human	83	HBB	19	Beta-thalassemia	IVS1+1G>A	-16	60	Exon	1	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTG/GTGAGGCCCTGGGCAG(g>a)ttggtatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	6.13	80.53	11.68	10.48	7.52	7.52	6.62	7.2	16.4	13.6	-7	-7	9	0.54	7	0.64	603902	ENSG00000221842	63	76	"hemoglobin, beta"
85	1	Human	83	HBB	19	Beta-thalassemia	IVS2+2T>G	-16	90	Exon	1	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTG/GTGAGGCCCTGGGCAGg(t>g)tggtatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	6.13	80.53	11.68	10.48	7.52	7.52	6.62	7.2	16.4	13.6	-7	-7	9	0.54	7	0.64	603902	ENSG00000221842	65	85	"hemoglobin, beta"
81	1	Human	83	HBB	19	Beta-thalassemia	IVS1+5G>C	-16	NULL	Exon	1	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTG/GTGAGGCCCTGGGCAGgttg(g>c)tatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	6.13	80.53	11.68	10.48	7.52	7.52	6.62	7.2	16.4	13.6	-7	-7	9	0.54	7	0.64	603902	ENSG00000221842	63	81	"hemoglobin, beta"
87	1	Human	83	HBB	19	Beta-thalassemia	IVS1+5G>T	-16	NULL	Exon	1	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTG/GTGAGGCCCTGGGCAGgttg(g>t)tatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	NULL	No	NULL	In	78.85	8.08	6.13	80.53	11.68	10.48	7.52	7.52	6.62	7.2	16.4	13.6	-7	-7	9	0.54	7	0.64	603902	ENSG00000221842	66	87	"hemoglobin, beta"
79	1	Human	83	HBB	19	Beta-thalassemia	IVS1+6T>C	-16	50	Exon	1	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTG/GTGAGGCCCTGGGCAGgttgg(t>c)atcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	6.13	80.53	11.68	10.48	7.52	7.52	6.62	7.2	16.4	13.6	-7	-7	9	0.54	7	0.64	603902	ENSG00000221842	63	79	"hemoglobin, beta"
244	1	Human	83	HBB	19	Beta-thalassemia	E1+268G>C	12	NULL	Intron	0	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCA(G>C)gttggtatcaag/gttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	"No patient RNA available, only in vitro splicing analysis"	No	NULL	In	78.85	8.08	-0.83	70.91	11.68	6.58	2.58	2.58	2.02	7.2	16.4	10.2	-7	-2.5	9	0.26	6	0.64	603902	ENSG00000221842	65	244	"hemoglobin, beta"
240	1	Human	83	HBB	19	Beta-thalassemia	IVS1+1G>A	12	NULL	Intron	0	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAG(g>a)ttggtatcaag/gttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	-0.83	70.91	11.68	6.58	2.58	2.58	2.02	7.2	16.4	10.2	-7	-2.5	9	0.26	6	0.9	603902	ENSG00000221842	63	240	"hemoglobin, beta"
245	1	Human	83	HBB	19	Beta-thalassemia	IVS2+2T>G	12	NULL	Intron	0	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGg(t>g)tggtatcaag/gttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	"No patient RNA available, only in vitro splicing analysis"	No	NULL	In	78.85	8.08	-0.83	70.91	11.68	6.58	2.58	2.58	2.02	7.2	16.4	10.2	-7	-2.5	9	0.26	6	0.64	603902	ENSG00000221842	65	245	"hemoglobin, beta"
243	1	Human	83	HBB	19	Beta-thalassemia	IVS1+5G>C	12	NULL	Intron	0	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGgttg(g>c)tatcaag/gttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	-0.83	70.91	11.68	6.58	2.58	2.58	2.02	7.2	16.4	10.2	-7	-2.5	9	0.26	6	0.64	603902	ENSG00000221842	63	243	"hemoglobin, beta"
246	1	Human	83	HBB	19	Beta-thalassemia	IVS1+5G>T	12	NULL	Intron	0	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGgttg(g>t)tatcaag/gttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	Minigene assay only	No	NULL	In	78.85	8.08	-0.83	70.91	11.68	6.58	2.58	2.58	2.02	7.2	16.4	10.2	-7	-2.5	9	0.26	6	0.64	603902	ENSG00000221842	66	246	"hemoglobin, beta"
242	1	Human	83	HBB	19	Beta-thalassemia	IVS1+6T>C	12	NULL	Intron	0	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGgttgg(t>c)atcaag/gttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	In vitro splicing	No	NULL	In	78.85	8.08	-0.83	70.91	11.68	6.58	2.58	2.58	2.02	7.2	16.4	10.2	-7	-2.5	9	0.46	6	0.64	603902	ENSG00000221842	63	242	"hemoglobin, beta"
23	1	Human	102	KRT14	54	Epidermolysis bullosa	IVS4+1G>A	-18	NULL	Exon	0	atagaattgtgatggtgggagggcagtattcaggcctaaggaacaccaatccgctgccatggtggaactcctgactgtggactgtccctggctgtgcagGAGATGAATGCCCTGAGAGGCCAGGTGGGTGGAGATGTCAATGTGGAGATGGACGCTGCACCTGGCGTGGACCTGAGCCGCATTCTGAACGAGATGCGTGACCAGTATGAGAAGATGGCAGAGAAGAACCGCAAGGATGCCGAG/GAATGGTTCTTCACCAAG(g>a)tgggtgtcatttgaggtggaaggaacccagaccacctgccttctggggccttctggtgtgaatggcattctcttttttgcag	NULL	No	NULL	In	84.26	8.23	0.79	66.36	13.78	2.19	-0.19	-0.19	-0.26	7.98	15.2	NULL	-8.2	-1	8	NULL	6	0.91	120120	ENSG00000186847	20	23	keratin 14
275	1	Human	110	MCFD2	192	Factor 5 and Factor 8 deficiency	IVS2+5G>A	161	NULL	Intron	2	ATATTGATGACCATGAGATCCCTGCTCAGAACCCCCTTCCTGTGTGGCCTGCTCTGGGCCTTTTGTGCCCCAGGCGCCAGGGCTGAGGAGCCTGCAGCCAGCTTCTCCCAACCCGGCAGCATGGGCCTGGATAAGAACACAGTGCACGACCAAGAgtac(g>a)tattcagcccgggctgtggtccagtggcctccccatcatctgcagctgagccagcggcaagggcatgctcagtcctcctttccttcttcctgtttctatggctccttgacattcttcaaggatgattcttattccttattgccacctataagtcag/gtattcttttttcatcattgtatcacaggtggaagatctttaggcccaaatggggcacattacttgtctgaatccggtctctcctttttttcaccacagacagacacacacacatacaaatagacacacaggtacacatacacagtcatagtagcagaatccagaaaatagctaaggtttcttgactataacaagaccttttttaaatcaacacattcaaacattgaatcatttgttgcagcttttgtcttgggccagttagcctcacgcattatactcggttatcctttgtttttaaggctgggtgcagtggctcaca	NULL	No	NULL	In	66.81	6.58	6.49	70.95	9.08	10.58	5	5	5.48	6.84	13.7	14	-2.3	-4.9	5	0.76	7	0.86	227300	ENSG00000180398	206	275	multiple coagulation factor deficiency 2
339	1	Human	46	DMD	133	Muscular dystrophy	IVS9+46806C>T	-32768	NULL	Intron	-32768	ATCACGGTCAGTCTAGCACAGGGATATGAGAGAACTTCTTCCCCTAAGCCTCGATTCAAGAGCTATGCCTACACACAGGCTGCTTATGTCACCACCTCTGACCCTACACGGAGCCCATTTCCTTCACAGgtctgtcaacatttactctctgttgtacaaaccagagaactgcttccaagataatctaacactgcttttacttgcttgaatttttcagtgccttttatctcctcgtgaagagctggtttgtttttccaagttttattgattccctcatgtgattctgctttgttattgagtcttctctaggtttacta.........gaacccagaagggagaggctgcagtgagccgagatcccaccattgcactccagcctgggcaggaagagcaatactcaatctcaaaaaaacagaaaaaaaaaaagttatattatatttttttaaaagtgctgttgcttagactcttaattcattttcttcatttaaag/AGATTGATCATATTGGGATAAAGACGTGTTTTGGAATCCAAACAACCTGGTTTTAAGTCCCAGAACCACCAGTTACCTTTGTGACCTTTG/g(c>t)aagtcatctaatttttctatttccatttcctcatcctactaatttctatcaccctgatctgttgtagtgaaaaatgatataatgcgtgttaagtgattagcaaattgactgacactaagtactcaataaataatggcagctgttgttattgctgttgtatatgcggtagtagttgtatttgttgttgattgttgccctaacagcaggccatgatttttcct.........gtggattttgaccgctatttgaaaattgatgtatgcatgaggaagttaaaatgaaaactccctattgtctgtatctgctgttcctgtgtttgataatgccagtggacagtcctagcattttaaatatttcattcgattcatcatttaatgtactggaacaatctgcaaagacattaattgtgtaacacccaatttattttattgtgcagCATTTGGAAGCTCCTGAAGACAAGTCATTTGGCAGTTCATTGATGGAGAGTGAAGTAAACCTGGACCGTTATCAAACAGCTTTAGAAGAAGTATTATCGTGGCTTCTTTCTGCTGAGGACACATTGCAAGCACAAGGAGAGATTTCTAATGATGTGGAAGTGGTGAAAGACCAGTTTCATACTCATGAG	Creates pseudoexon	No	2	Out	NULL	NULL	10.47	91.1	NULL	15.08	NULL	9	9.09	NULL	NULL	17	NULL	-7.3	NULL	0.99	8	NULL	181350	ENSG00000198947	257	339	dystrophin
234	1	Human	130	PLP1	109	Leukodystrophy	IVS4+1G>A	10	NULL	Intron	1	atcctttggcggctgaacatgtgtgggttccagcaatgtctttttgtggccagcagttagcttagaaaggttttgtatctgaaattttaatctcctattggctttgttcaatggctagggaacaaaaatgttcctatggcaaggaacatgttctaagctcagcctaaggcacaaaatggcacgactttctttcaagatctgttttgatttctttacaccttatctgcccaaaaacatcctctgaagcctctctaacccagggatcctcctcactcttcccctacccattccccccaccctccgttatactggggccagttatctagtagatactgccaattacccttggcagaggtgccctgctcactaatttcatttgaaggagagccctggaacctggttttaatgtctggcacacgccactccaggatctcccagtttgtgtttctacatctgcaggctgatgctgatttctaaccaccccatgtcaatcattttagTTTGTGGGCATCACCTATGCCCTGACCGTTGTGTGGCTCCTGGTGTTTGCCTGCTCTGCTGTGCCTGTGTACATTTACTTCAACACCTGGACCACCTGCCAGTCTATTGCCTTCCCCAGCAAGACCTCTGCCAGTATAGGCAGTCTCTGTGCTGATGCCAGAATGTATG(g>a)tgagttagg/gtacgggtgctttggctctcctacccactatggaagcactatatatttggttattttcttagtgtaaggagggtggtgattatgagaaaaatataagatgatgaatgattgggtcttagtttattaatccttccctactgaaaccagagaggtttcttccccgggaagggaacttggaagtggtgggagttttcttggccattcacattggcctactctagttgactgctgttcacaaccccaaagcagcacatttcaataacaaacacaaggtttcaccactgttcaataccaccttctcttttttgtaaacctgtagaaaagaggatcctgattgttggtagaatccaactttacagccaggataattagagatggaagaagggctctgggggaaagtctccatgtggccccgtaactccataaagcttaccctgcttgctttttgtgtcttacttag	NULL	No	NULL	In	85.92	10.13	7.86	73.84	14.08	9.88	6.51	6.51	7.56	9.22	15.6	11.7	-7.2	-4.6	8	0.64	6	0.95	300401	ENSG00000123560	182	234	proteolipid protein 1
7	1	Human	24	CFTR	43	Cystic fibrosis	IVS4+1G>T	-93	31.5	Exon	0	atgaaatttaatttctctgtttttccccttttgtagGAAGTCACCAAAGCAGTACAGCCTCTCTTACTGGGAAGAATCATAGCTTCCTATGACCCGGATAACAAGGAGGAACGCTCTATCGCGATTTATCTAGGCATAGGCTTATGCCTTCTCTTTATT/GTGAGGACACTGCTCCTACACCCAGCCATTTTTGGCCTTCATCACATTGGAATGCAGATGAGAATAGCTATGTTTAGTTTGATTTATAAGAAG(g>t)taatacttccttgcacaggccccatggcacatatattctgtatcgtacatgttttaatgtcataaattaggtagtgagctggtacaagtaagggataaatgctgaaattaatttaatatgcctattaaataaatggcaggaataattaatgctcttaattatccttgataatttaattgacttaaactgataattattgagtatcttctgtaaactgcctctgttgtagttttttttttctcctaatcatgttatcatttttttggaatccatggtttcctgttaagatgactcacacagcctacataaaagtaattgacaaaatatcatcttatagtaaaatgccacatatctttatgttcagcaagaagagtataatatatgattgttaatgataacccaaacaacaaaagatttca	NULL	No	NULL	In	81.96	8.49	2.87	67.49	12.48	7.98	4.24	4.24	4.29	6.83	14.1	10.3	-5.2	-3.7	6	0.12	5	0.75	602421	ENSG00000001626	6	7	"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
6	1	Human	24	CFTR	43	Cystic fibrosis	IVS4+3A>G	-93	28.3	Exon	0	atgaaatttaatttctctgtttttccccttttgtagGAAGTCACCAAAGCAGTACAGCCTCTCTTACTGGGAAGAATCATAGCTTCCTATGACCCGGATAACAAGGAGGAACGCTCTATCGCGATTTATCTAGGCATAGGCTTATGCCTTCTCTTTATT/GTGAGGACACTGCTCCTACACCCAGCCATTTTTGGCCTTCATCACATTGGAATGCAGATGAGAATAGCTATGTTTAGTTTGATTTATAAGAAGgt(a>g)atacttccttgcacaggccccatggcacatatattctgtatcgtacatgttttaatgtcataaattaggtagtgagctggtacaagtaagggataaatgctgaaattaatttaatatgcctattaaataaatggcaggaataattaatgctcttaattatccttgataatttaattgacttaaactgataattattgagtatcttctgtaaactgcctctgttgtagttttttttttctcctaatcatgttatcatttttttggaatccatggtttcctgttaagatgactcacacagcctacataaaagtaattgacaaaatatcatcttatagtaaaatgccacatatctttatgttcagcaagaagagtataatatatgattgttaatgataacccaaacaacaaaagatttca	NULL	No	NULL	In	81.96	8.49	2.87	67.49	12.48	7.98	4.24	4.24	4.29	6.83	14.1	10.3	-5.2	-3.7	6	0.12	5	0.75	602421	ENSG00000001626	5	6	"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
58	1	Human	13	BTK	184	agammaglobulinemia	IVS8+1G>A	-136	NULL	Exon	1	atgcacacactaccatgcccagctgatttttgcatttttagtagagatggggtttcgtcacgttggccaggctggtctcgaactcctggcctcaactgatccgcccgccttggcctccgaaagtacattggaatttaaaagttccatacatggtctttatatgtgtgcaaggctgagaactcctgcactggtgcttaaaaatggttgttgaatgactgctgagtaatattttagtatgcctgatttgggtgtcttgagtaagccagagagttgggagagaagagaagagtgcttggtatcttgacaaaccctcctaccttttctcctaactacatagATCTTGAAAAAGCCACTACCGCCTGAGCCAGCAGCAGCACCAGTCTCCACAA/GTGAGCTGAAAAAGGTTGTGGCCCTTTATGATTACATGCCAATGAATGCAAATGATCTACAGCTGCGGAAGGGTGATGAATATTTTATCTTGGAGGAAAGCAACTTACCATGGTGGAGAGCACGAGATAAAAATGG(g>a)tgagtccacaccagcccttcctgagcctggtgcctgcccactccctacacgcaaaaagtgctgcggcataattcccgtgatcagcatcctcatcagagactgttcttcccacaccagactgaacatgctctccctccaagtacttcccagcgtgcagctccctatacatggcctctgccacatctctgagcctctgttgttgggcacatataaccaatgcaacatgtgcataagctctgcacctcactggctcactgcctaaccatgcatcagagacatgattgtctttgagggaggtg	NULL	No	NULL	In	85.28	8.73	6.39	76.3	13.18	10.28	7.3	7.3	6.77	8.36	15.6	12.2	-9.3	-2.7	8	0.53	7	0.99	300300	ENSG00000010671	46	58	Bruton agammaglobulinemia tyrosine kinase
196	1	Human	46	DMD	133	Muscular dystrophy	IVS26+2T>G	116	NULL	Intron	2	atgccaaataaacagacatgtcttattttcacacttatgggaaattgagtgtatctgatccccatgagttattttcttatgcatataagctttttacttctttatcattactatctaagctttctgttatttacatactgatgaaataatataataataatgtttcatcactgtcaataatcgtgttttgtttgtttgttttgtggaagGTCTATGCCAGAAAGGAGGCCTTGAAGGGAGGTTTGGAGAAAACTGTAAGCCTCCAGAAAGATCTATCAGAGATGCACGAATGGATGACACAAGCTGAAGAAGAGTATCTTGAGAGAGATTTTGAATATAAAACTCCAGATGAATTACAGAAAGCAGTTGAAGAGATGAAGg(t>g)aaaaaaaaaaaaagaaaaactaagtaaaacaaaggaaataaatggaaaaagaaagaaatgcaacaatgcttgaagttgtatacagtctgctctttcctggttctaagagaagag/gttgatttttaattaataattttaatttagcttcaagtttaatatacattttaacaaccttaaactgtttaattttaatgcattgtggtcaattatgaaaattgaaaatcacaatttgaaacaattttcccttgaaatcatgtagtattaagagagcagaatcaactcatttcattaactgtctgtagctgatgtaaatgtacgttgaaactgtgcaaaagtat	NULL	No	NULL	In	82.16	8.38	1.52	66.51	13.28	3.98	1.09	1.09	2.13	7	14.1	10.1	-5.4	-2.6	6	0.04	6	0.91	181350	ENSG00000198947	156	196	dystrophin
64	1	Human	146	SERPINA1	7	Alpha-1 antitrypsin deficiency	IVS2+1G>T	-84	NULL	Exon	0	ATGCCGTCTTCTGTCTCGTGGGGCATCCTCCTGCTGGCAGGCCTGTGCTGCCTGGTCCCTGTCTCCCTGGCTGAGGATCCCCAGGGAGATGCTGCCCAGAAGACAGATACATCCCACCATGATCAGGATCACCCAACCTTCAACAAGATCACCCCCAACCTGGCTGAGTTCGCCTTCAGCCTATACCGCCAGCTGGCACACCAGTCCAACAGCACCAATATCTTCTTCTCCCCAGTGAGCATCGCTACAGCCTTTGCAATGCTCTCCCTGGGGACCAAGGCTGACACTCACGATGAAATCCTGGAGGGCCTGAATTTCAACCTCACGGAGATTCCGGAGGCTCAGATCCATGAAGGCTTCCAGGAACTCCTCCGTACCCTCAACCAGCCAGACAGCCAGCTCCAGCTGACCACCGGCAATGGCCTGTTCCTCAGCGAGGGCCTGAAGCTAGTGGATAAGTTTTTGGAGGATGTTAAAAAGTTGTACCACTCAGAAGCCTTCACTGTCAACTTCGGGGACACCGAAGAGGCCAAGAAACAGATCAACGATTACGTGGAGAAGG/GTACTCAAGGGAAAATTGTGGATTTGGTCAAGGAGCTTGACAGAGACACAGTTTTTGCTCTGGTGAATTACATCTTCTTTAAAG(g>t)taaggttgctcaaccagcctgagctgttcccatagaaacaagcaaaaatattctcaaaccatcagttcttgaactctccttggcaatgcattatgggccatagcaatgcttttcagcgtggattcttcagttttctacacacaaacacta	Minigene assay only	No	NULL	In	94.61	10.51	3.58	60.58	15.58	7.98	2.31	2.31	3.66	10.49	17.1	10.2	-8.6	-4.6	7	0.08	5	0.99	107400	ENSG00000197249	52	64	"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1"
#304	1	Human	21	CDKN2A	63	Familial melanoma	IVS2-105A>G	2554	NULL	Intron	1	atgcgggaagggaaaggccacatcttcacgccttcgcgcctggcattgtgagcaaccactgagactcattatataacactcgttttcttcttgcaaccctgcgggccgcgcggtcgcgctttctctgccctccgccgggtggacctggagcgcttgagcggtcggcgcgcctggagcagccaggcgggcagtggactagctgctggaccagggaggtgtgggagagcggtggcggcgggtacatgcacgtgaagccattgcgagaactttatcc/(a>g)taagtatttcaatgccggtagggacggcaagagaggagggcgggatgtgccacacatctttgacctcaggtttctaacgcctgttttctttctgccctctgcagACATCCCCGATTGAAAGAACCAGAGAGGCTCTGAGAAACCTCGGGAAACTTAGATCATCAGTCACCGAAGGTCCTACAGGGCCACAACTGCCCCCGCCACAACCCACCCCGCTTTCGTAGTTTTCATTTAGAAAATAGAGCTTTTAAAAATGTCCTGCCTTTTAACGTAGATATATGCCT	NULL	No	1	Out	89.44	10.07	10.27	76.61	13.38	13.38	5.84	5.84	7.81	10.18	17.6	17	-9.3	-4.3	8	0.95	6	1	155600	ENSG00000147889	227	304	"cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)"
274	1	Human	11	BRCA1	24	Breast cancer predisposition	IVS17+1G>T	153	NULL	Intron	0	ATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAG(g>t)tataccaagaacctttacagaataccttgcatctgctgcataaaaccacatgaggcgaggcacggtggcgcatgcctgtaatcgcagcactttgggaggccgaggcgggcagatcacgagattaggagatcgagaccatcctggccagcatg/gtgaaaccccgtctctactaaaaaataaaaaaattagctgggtgtggtcgcgtgcgcctgtagtcccagctactcgtgaggctgaggcaggagaatcacttgaaccggggagatggaggttgcagtgagccgagatcatgccactgcattccagcctggcgacagagcaaggctccgtctcaaaaaaaaaaaaaaaaaacgtgaaaaaataagaatatttgttgagcatagcatggatgatagtcttctaatagtcaatcaattactttatgaaagacaaataatagttttgctgcttccttacctccttttgttttgggttaagatttggagtgtgggccaggcacggtggctcacacctgtaatctcagcactttgggaggccgaggcgggtggatcacctgaggtcaggagttcgagaccagcctggccaacgtgttgaaaccccgtctctactaaaaatataaaaattaggtgggcgtggtggcaggcacctgtaatcccagc	NULL	No	NULL	In	71.15	7.48	0.56	68.08	11.38	6.18	4.49	4.49	4.04	6.47	14	8.6	-4.9	-3.8	7	0.13	6	0.92	113705	ENSG00000012048	205	274	"breast cancer 1, early onset"
148	1	Human	159	VDR	176	Vitamin D resistant rickets	E8+119C>G	-56	NULL	Exon	2	atgctgctgaaagaggcagagagagtcccagagggaagcctggggctgaagggtgacctgtggagtcactgtgggattcccagctggctctgctgccagggcacaccaggtttttgcagggtctggcaggagggggcctggtccaagtatccttaaatagctccttctcttccctcatctctcccagACATGATGGACTCGTCCAGCTTCTCCAATCTGGATCTGAGTGAAGAAGATTCAGATGACCCTTCTGTGACCCTAGAGCTGTCCCAGCTCTCCATGCTGCCCCACCTGGCTGACCTG/GT(C>G)AGTTACAGCATCCAAAAGGTCATTGGCTTTGCTAAGATGATACCAGGATTCAGgtaagaaacttctgcaatctctggggaacagagtcagagtcctagactgagctacaagaagggttggagatcactcatccaccacttcttttttttattttttatttttttaaacggcatcttgctctgtcacgcaggctggagtgcagtggcgcgatctcggctcactgcaacctccgcctcctaggttcaagcgattctcctgcctcaacctcccaagtagctgggattacaggcaccagacaccacgcccggctaatttatttatttatttatttatttatttatttttattttttt	NULL	No	3	Out	94.5	10.77	10.1	85.92	14.98	14.48	9.66	9.66	9.36	11.11	19	15.8	-8.2	-7.2	8	0.97	9	1	277440	ENSG00000111424	116	148	"vitamin D (1,25- dihydroxyvitamin D3) receptor"
315	1	Human	59	F9	81	Haemophilia B	IVS5+13A>G	12	NULL	Intron	0	ATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGgtcataatctga/(a>g)taagattttttaaagaaaatctgtatctgaaacttcagcattttaacaaacctacataattttaattcctacttgaatctgcttccttttgaaatcatagaaaatatcagtagcttgaattagaccaattaattttctagattgcatcatattttaaatataaactatgtaatcatctacaacctgaattctttctgtgtccaatttgtccaatttttttctctaac	NULL	No	1	Out	71.38	3	5.11	72.54	7.98	8.28	4.25	4.25	5.18	3.54	11.9	12	-3.3	-2.8	6	0.41	5	0.21	306900	ENSG00000101981	238	315	coagulation factor IX
91	1	Human	100	KRT5	54	Epidermolysis bullosa	IVS1+1G>A	-66	NULL	Exon	0	ATGTCTCGCCAGTCAAGTGTGTCCTTCCGGAGCGGGGGCAGTCGTAGCTTCAGCACCGCCTCTGCCATCACCCCGTCTGTCTCCCGCACCAGCTTCACCTCCGTGTCCCGGTCCGGGGGTGGCGGTGGTGGTGGCTTCGGCAGGGTCAGCCTTGCGGGTGCTTGTGGAGTGGGTGGCTATGGCAGCCGGAGCCTCTACAACCTGGGGGGCTCCAAGAGGATATCCATCAGCACTAGTGGTGGCAGCTTCAGGAACCGGTTTGGTGCTGGTGCTGGAGGCGGCTATGGCTTTGGAGGTGGTGCCGGTAGTGGATTTGGTTTCGGCGGTGGAGCTGGTGGTGGCTTTGGGCTCGGTGGCGGAGCTGGCTTTGGAGGTGGCTTCGGTGGCCCTGGCTTTCCTGTCTGCCCTCCTGGAGGTATCCAAGAGGTCACTGTCAACCAGAGTCTCCTGACTCCCCTCAACCTGCAAATCGACCCCAGCATCCAGAGG/GTGAGGACCGAGGAGCGCGAGCAGATCAAGACCCTCAACAATAAGTTTGCCTCCTTCATCGACAAG(g>a)tgagctacgatcttttgtaaaaaatcactgtgggtctgaaataaatgccaaagagagagaaagaaggaagatgttttggctttgtgcaaatacttttatagttgtacagttctgtgtttccgtttgtttctgtgccctggatttgtggacacgttctgaattagactggcagctgggaa	NULL	No	NULL	In	88.72	9.6	7.13	79.89	14.48	11.18	8.11	8.11	7.43	9.74	15.7	13.8	-7.3	-9.1	7	0.92	7	0.99	120120	ENSG00000186081	70	91	keratin 5
322	1	Human	24	CFTR	43	Cystic fibrosis	IVS19+11505C>G	-32768	NULL	Intron	-32768	attatttcaagagagggatactattcttatgcaggataaatacaataagatattttaaatgaattttaactacatctctggcagtttcatctcaatagtagttgtaattttatctcccagaccttattatagactagcagctctctatgaaaattagtgacagtgtgagtgtattttaattcaaagttaatcaagaatgactgagtcaagagttagctacccctgaaagtaactcataattcagaatttaaaatattacatgtggaacaatcatgactatatgccttttactttctctatcattatttagGTTGTGGGCTTTGGGTCCTTTTCACATCCGTTAACAGTGGGCTTGACTTCAAAGGATTATTTTCTTGAATCTTGAATAATTGCTGAAGACAATTTGAAGATATTTTCAAGATGAAGGAAACTGAAGCACAGAATCACTAGAGTGAAAAAAGAACTTCACAAACAGTGCAGGCTTGATCAATGGCATGGGAAAACAGGCAATACAGTTAGAATTG/(c>g)taagatggaattttaacgttcaattaaggatctatctctaaactcctctgctttatccaccaatcattccatattaaagatgaagaattgttcccatttcaccttttgataaggaaaaatagaaataacagaagcaaatacacttttgcccacatttttttccaaaaagaataatttttgaagtctaaacgtttg	Creates pseudoexon	No	1	Out	NULL	NULL	8.85	85.6	NULL	13.08	NULL	7.65	7.46	NULL	NULL	15	NULL	-5.9	NULL	0.96	7	NULL	602421	ENSG00000001626	243	322	"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
220	1	Human	136	PTEN	40	Cowden's disease	IVS4+2T>C	4	NULL	Intron	1	attcaggcaatgtttgttagtattagtacttttttttcttcctaagtgcaaaagataactttatatcacttttaaacttttcttttagTTGTGCTGAAAGACATTATGACACCGCCAAATTTAATTGCAGAGg(t>c)ag/gtatgaatgtactgtactatgttgtataacttaaacccgatagactgtatcttactgtcataacaataatgagtcatccagattatcgagtgagatacatatttaagaattatctt	NULL	No	NULL	In	89.44	9.65	9.46	84.1	13.18	11.98	8.78	8.78	8.96	9.76	19	17	-8.7	-4.9	8	0.9	8	0.98	158350	ENSG00000171862	172	220	phosphatase and tensin homolog
290	1	Human	3	ADAMTS13	126	Thrombotic thrombocytopenic purpura	IVS13+5G>A	69	100	Intron	0	attgccttaggaggtgggatgtggggaagatagaaacccttgccccagatgcaaaggatgaagctgggtgggggctgggggacttgcccctcctgctcggttcaggacaccctttttcactctgccctcccagGGGATGCTCTGTGCAGACACATGTGCCGGGCCATTGGCGAGAGCTTCATCATGAAGCGTGGAGACAGCTTCCTCGATGGGACCCGGTGTATGCCAAGTGGCCCCCGGGAGGACGGGACCCTGAGCCTGTGTGTGTCGGGCAGCTGCAGGgtag(g>a)cgtgtgtggacattggcgatggccctggggcctacctgtcctatcggaaggctcctgggggcag/gttggtgggtgctggccctgatggagctgcagtgccctctgcaggggagtggtgctggggaaaaggatctggacttggagtcagcctgggttaagggctgcagtgtgaccttgggcaagtcactgagccctctaagcttgcttcctgtgtagatggtggggtgctatagaagtgttgctggttttgtggatcccagaatctcagagctggcagggctgcagagtcattgag	NULL	No	NULL	In	73.79	7.26	8.08	78.85	10.08	11.68	5.75	5.75	7.2	6.41	11.9	13.4	-7.8	-7	7	0.38	9	0.69	274150	ENSG00000160323	216	290	"ADAM metallopeptidase with thrombospondin type 1 motif, 13"
344	1	Human	70	GALC	75	Globoid-cell leukodystrophy	Not determined	-32768	100	Intron	-32768	ATTTGGAATGAGAGGTCATATAATGCCAATTATATTAAGgtgtgtacaactttagtatctttttgtttttaactttttagtgaataattccttatggttcctaacacagaaaatagtaggaaatttgtgttggaaataccgtattttttatactacagttatttattttgctggttgtgacataaaattcaagcaaaatcttaacaatgtttatattcctgatattaaagcatatgtaattctttgtgagccccgaattacctttgtctaaagagttgtgttgaatttttctattttaaaattcattagttttggaattctgataaattttatgaaacaattatatcattttagatttttagaacttcaagaaatgtagctttttttctttgtcttttgtcaaaacttatggcatatattctaattcttgttttctattggagtgtgttatagtacatgtttctctttgtgattagcaaagaggtagcagtaacatctgccaattgtgttatttttgttccacttttcctatttatctccatttaattctcacaaccttacctatgaggtaactactgtaattgctattttccaggaaaggaaaaacagaataataacttctgccattggaaaaaaaatggcagtttcacttttcaggtggagctaatctttagtttacttttcacttccttttgtcttcttgtatgtatcttttctctaagaaatataattttgggacagtattttatttcaagttttcaaaaatttttatattaatttttttttatttccatag/GTTTTTGGAGAATAGGTGGTATTTGGTTACATGA/gtaagttccttagtggttatttgtgagattttggtgcacccatcactggagcagtatacactgaaccaaatttgtagtcttttatccctcacctccttcccatcctttccccgagtccctaaagtccattgtatcattcttatgcctttgcatcctcgtaacttagctcccacttatgagtgagaacatacgatgttttgttttccatt	Creates pseudoexon	No	NULL	Out	NULL	NULL	8.82	78.03	NULL	11.98	NULL	5.59	6.82	NULL	NULL	14	NULL	-4.2	NULL	0.94	6	NULL	245200	ENSG00000054983	220	344	galactosylceramidase
10	1	Human	108	LPL	114	Lipoprotein lipase deficiency	IVS8+2T>C	-134	-100	Exon	2	atttggagaggagaaaaaaaagtggggggcagggagagctgatctctataactaaccaaatttattgcttttttgtttagGCCTGAAGTTTCCACAAATAAGACCTACTCCTTCCTAATTTACACAGAG/GTAGATATTGGAGAACTACTCATGTTGAAGCTCAAATGGAAGAGTGATTCATACTTTAGCTGGTCAGACTGGTGGAGCAGTCCCGGCTTCGCCATTCAGAAGATCAGAGTAAAAGCAGGAGAGACTCAGAAAAAg(t>c)aattaaatgtatttttcttccttcactttagacccccacctgatgtcaggacctaggggctgtatttcaggggccttcacaattcagggagagctttaggaaaccttgtatttattactgtatgatgtagattttctttaggagtcttcttttattttcttatttttggggggcagggggggggaagtgacagtatttttgtatttcatgtaaggaaaacataagccctgaatcgctcacagttattcagtgagagctgggattagaagtcaggaatctcagcttctcatttggcactgtttcttgtaagtacaaaatagttagggaacaaacctccgagatgctacctggataatcaaagattcaaaccaacctcttcaagaagggtgagattccaagataatctcaacctgtctccgcagccccacccatgtgtacccataaaatgaattacacagagatcgctataggatttaaagcttttatactaaatgtgctgggattttgcaaactatagtgtgctgttattgttaatttaaaaaaactctaagttaggattgacaaattatttctctttagtcatttgcttgtatcacca	NULL	No	NULL	In	75.04	3.64	6.04	77.09	6.48	10.08	6.04	6.04	5.66	3.48	10.8	13.3	-1.7	-5.1	6	0.92	7	0.62	609708	ENSG00000175445	8	10	lipoprotein lipase
141	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E10b+74A>G	-62	NULL	Exon	2	atttggtagtataaaaaatagcttttttcaaaggtttttaataataaatttcttttaaaaggttggatagctattatcctgagtcttatgtctgataccatgtttttgttttgtttttagAGTCTTACATTTAAAGAAAAAGTAACAAGCCTTAAATTTAAAGAAAAACCTACAGACCTGGAGACAAGAAGCT/(A>G)TAAGTATCTTCTCTTGTCCATGGTGAAACTAATTCATGCAGATCCAAAGCTCTTGCTTTGTgtaagtatttttttatgaaatgtctcaaaattatcacactaagttaattgggtttagctgaaacgccaagaccttgaggataatttttagctcaagagcacttactgatcctttctgatcatacctgaaaactaagacgtctctaagaaaactaatgtataatgaatactaatataattagatcagattcttaattgcccttatcatttcctaacatttctctttcttcttaatttccctatcattaaactaacatactttgatgagatctctgttctcatcctattactaagttatata	NULL	No	1	Out	77.41	7.65	8.56	77.36	11.48	12.68	5.41	5.41	6.46	5.9	17	17	-4	-4	6	0.97	6	0.86	162200	ENSG00000196712	38	141	neurofibromin 1
#255	1	Human	92	IDS	96	"Mucopolysaccharidosis, type II"	IVS7-1:+1GG>TT	22	NULL	Intron	1	attttggctgagaaaatcattaagggcatcaactaaggggtagggattgggagagatgcacaggcaagcattatctctgtatgccttggcaatttaaattgcagtcactctcatttttattttttttcaatttgcagCGGAAAATCCGCCAGAGCTACTTTGCCTCTGTGTCATATTTGGATACACAGGTCGGCCGCCTCTTGAGTGCTTTGGACGATCTTCAGCTGGCCAACAGCACCATCATTGCATTTACCTCGGATCAT(Gg>Tt)taagcattttgaaattccctg/gtgagtcaaaacatctgaactttcctgtgaaacatgctttgcaaaattgccattgacataaacatgggtgtgttctcttttgtgaaccagtggttcacaaacaaagtgggatcctggggcatttttatgatcagcttgttagtcctgagacctctgtcttagatgcttgacggataggtgtgggtgggtgggggagggtcttgtagcaacttttttttttttcttgatgaatgcagcaggaaccctccatttgtgtggcagagctcttgtaacccccatttttaacctggagggttggaggacttttagtttgggtggagaggatccagaacaatcctggcagagcccagcaagctcttcacgcctggctccagccctcccacccctatccccgctgtcttctctgccgagagcctgggcttttcaagtctttatctccccctaaggctgtttcctac	NULL	No	NULL	In	84.99	9.26	10.1	85.92	14.28	14.48	9.66	9.66	9.36	8.53	16.5	15.8	-5.9	-7.2	7	0.99	9	1	309900	ENSG00000010404	192	255	iduronate 2-sulfatase
282	1	Human	92	IDS	96	"Mucopolysaccharidosis, type II"	IVS3+1G>A	1237	NULL	Intron	0	CAAGCAGTGTGCGCCCCGAGCCGCGTTTCTTTCCTCACTGGCAGGAGACCTGACACCACCCGCCTGTACGACTTCAACTCCTACTGGAGGGTGCACGCTGGAAACTTCTCCACCATCCCCCAGTACTTCAAGGAGAATGGCTATGTGACCATGTCGGTGGGAAAAGTCTTTCACCCTG(g>a)tactgctccatgtccagagtctgggttctcttggtttgtggtgtctgaatccagcattcccatcctggggatggggctgtctttgcagagccctcttctggctgggcgagtccctcgctagtcagtgcttcctttctaaaaaactgacttgtcaacccagccacgttttcacccaaagtgaaaaagggtagaaagagctttgcttcctttcagaaaccactgagggtgtgctgttgggtctttcagctcctcgggtggtagggaggacacaggctggggaggtggcagtgttgggtggagtccagctcagggccccaccctctcccctgcagggtacctgtcagtaaacctaggggtggggtgaggacacctgagggcctcccgtgtggccagcattgctgttgctgacttattgcccaatgagggggctgtgcttaggtaggggctgctatccactctggaaattaagtcagaaagatgagtgtaatctggtacccaggatctatagggtcccagagacggacattccttacctcaaatgctgcctgataaactggctctctttaatgccaatatggggatagtgaaaagcaaacaaactttaaaactttttatttatagaagtaatgcatgagtatttgagaaaaaaaatggagaaaaaagtattggaagacaagagcaccatagggacaataatgcttatcatttgggaatgacgaatgttttcagtctctttccctttgctcagtggttacaccggcaggcttggcagccttctgcaggagctcagctggccagcccaggttgagagtgacattcagctctactaagtcaggccagtttcagaggtgaacctgtcaggaatcatattgcacagccaaaagtccagtgtcaggagaactttctgcagtttggtgttctcattaccataccccttgcccaaatgcagctggagggaagtgatgattttggagagaggaggaaacacagcagagggaggagattgtgctttgggaggggaaaccaggcaaggactgagtgatgttgcttgacctcctccctcctgatgattggattttggcaccaggctctaagcaccatgtccttctcagagaataaacctttccctgcag/CCCTTGTGGGAACACATTTTTCAGCTGAATCTTTGTTCTCAAGACCTTTTTCTGTTAGCATTGGGCCTGCTTCAAGATGACAGTAGCCACCACTGTGTGCCAG/gtatgtaccgtttaccatgctggccactcctttaatcctcccaacagcaagcaaggtgggtttttatcatcatcatcatttcccaaggaagacatgaaggctcatgggagtcaagtagcttgccagaggttgcaaggatgctaagaggcagcatcaggatttggacctgtggttgttggcttcctgtgtgctctttccacagtgcttgctgtcttcataggccctccacccgctgccctctttctctccattcctgtctcttctggtactccctatgggagtcccactgtgtgactgctgctgatgctttctcacgaggttctgcctgtgatcccctccactcccagctaaccactataggcagcacttcccttcagatccctcacaggcctcactggctcctagaagtcctccctgccagtcctcacctgactcacaataacctctgtgcttggaggatcccccacttggcacttcgatgcttttgaaagctggaagtccttccttggtttccagtgctgttatactgtcttcacaaataaactataaactactaagcttaagggtgggtttctgcttcatgaatgagcacttgaacttggaattctaaaacaaggttttgagtcctggctcccttatctaatatctggttagcataggtaagtcacataccttccctgagcctccctctcctgcccccatcggctccctgatggtgctgatgcctctgctgcctccttcatagggtgagagataggtttcagcatgggctctaaggagctgactgatcttgtccttgtgggtcccttccacagagcctagcacaaatcatcagggcttagggaccaggaagtcagatgcttagttctcaaatagaaactagagagtttggctttagaggggacttttgtagatgaggaaactgagccccaaagaagggaggttccacttgcccatttgtttacagagttttaattatggggagtggggtgttgaaagactcatcatgttttaacaacctttttttttttccaagGGATATCTTCTAACCATACCGATGATTCTCCGTATAGCTGGTCTTTTCCACCTTATCATCCTTCCTCTGAGAAGTATGAAAACACTAAG	Creates pseudoexon	No	NULL	In	NULL	NULL	9.8	89.6	NULL	13.08	NULL	10.13	10.59	NULL	NULL	19.2	NULL	-6.2	NULL	1	9	NULL	309900	ENSG00000010404	212	282	iduronate 2-sulfatase
63	1	Human	37	CSPG2	178	Wagner syndrome	IVS8+1G>A	-21	NULL	Exon	0	CACACTCTACTTCTGCTTCTGCCACCTATGGGGTCGAGGCAGGTGTGGTGCCTTGGCTAAGTCCACAGACTTCTGAGAGGCCCACGCTTTCTTCTTCTCCAGAAATAAACCCTGAAACTCAAGCAGCTTTAATCAGAGGGCAGGATTCCACGATAGCAGCATCAGAACAGCAAGTGGCAGCGAGAATTCTTGATTCCAATGATCAGGCAACAGTAAACCCTGTGGAATTTAATACTGAGGTTGCAACACCACCATTTTCCCTTCTGGAGACTTCTAATGAAACAGATTTCCTGATTGGCATTAATGAAGAGTCAGTGGAAG/GCACGGCAATCTATTTACCAG(g>a)taagatcacaacattgataaatctgtttccaaacctggaaacagtcccttggtgctaacgtttatatgtatgtaatttttattgtgatgttaaatcaatggagagtttcatattattcacataacagcaggccaggccacagtattgagttcataatgagatgaaatgacagtaagtatagattagttttggactttagaagtagactttgtatttttctgggttttagaaataatatacaattacaacatggaaaagatgaaattattaatgttataaaaattcaatttgtttttactcacaactagagtattgctttgtcatatgtctcatagttatacatgttaggtttaaaagtagaaaaaaagtcctatttttaaaaaccctcccattgatggatgctattgctgtagtatcaaaatctgtcaggcctttaacatttgggagtagtacgtagctctaataattatttcagagtttgtgcagtatcaatatcagc	NULL	No	NULL	In	94.5	10.77	2.5	65.54	14.98	6.42	1.03	1.03	1.99	11.11	18.8	NULL	-8.2	-0.9	8	NULL	5	1	143200	ENSG00000038427	51	63	versican
210	1	Human	23	CFC1	172	Transposition of great arteries	E4+113dup20	20	100	Intron	2	cacacttggctggaggctgattttactgcctcccctgggcggccacgttcggccccgtccctgcggggagggccacgggccgcggggggcgcggggctgacgcccgggtgaccccgcagGTGCGTCCGCGCGGCCGCGCTGCTGCAGGAACGGCGGTACCTGCGTGCTGGGCAGCTTCTGCGTGTGCCCGGCCCACTTCACCGGCCGCTACTGCGAGCATGACCAGAGGCG[CAGGtgggcacaggggtgcg][cag/gtgggcacaggggtgcg]cggggtggggacgggggtgggcgccgggtgagggacctgcgggtctgggggcgcgggagtaggcgtcaggagaggggcgcgcgggtgcgggggcgcgggagtgggcgccgggcgatgggcgcgcgggttggggggcgcgggagttggcgccgggggagggatgcgcgggtgggggagcggcgcaggagtgggcgccgggcgaggggcgcgcgggccaccgcattgatgcaggtccccgtcttctcagTGAATGCGGCGCCCTGGAGCACGGAGCCTGGACCCTCCGCGCCTGCCACCTCTGCAGGTGCATCTTCGGGGCCCTGCACTGCCTCCCCCTCCAGACGCCTGACCGCTGTG	NULL	No	NULL	In	78.16	8.07	8.07	78.16	11.98	11.98	8.1	8.1	6.97	6.97	13.1	13.1	-7.6	-7.6	8	0.68	8	0.38	608808	ENSG00000136698	165	210	"cripto, FRL-1, cryptic family 1"
211	1	Human	20	CDH23	175	Usher syndrome type 1D	E35+129G>C	103	100	Intron	1	cacgtgggcagaggaggaccagggagtcccccttggcttgacctggccacctctcctccacacctgctcacccctcaccctctcttctccccacagGTGGTCTTCTCCCTGGCCTCTGGCAACATCGCGGGGGCCTTTGAGATCGTCACCACCAATGACTCCATTGGCGAAGTGTTTGTGGCCAGGCCCCTGGACAGAGAAGAGCTGGATCACTACATCCTCCA(G>C)gtggggcctggcctcccttggactgagagaccactggctaagtgcctagaccggtcactactctccatccaggagagagcctgtccatcagcacactctggtg/gtcagtgcccctgctgtcaccaagtaacatggggccagctgcacccatcggggccaagagcacagtgaggctgacccaggatagggaaacctgggagggaccttagatacccaggaggaggtagttgaggtgtcttc	Exon trapping only.	No	NULL	In	78.87	6.92	4.85	80.51	11.48	8.88	5.31	5.31	5.34	6.85	12.9	13.1	-8.8	-4.5	8	0.3	7	0.89	601067	ENSG00000107736	166	211	cadherin-related 23
289	1	Human	19	CDH1	60	Familial gastric cancer	E7+176G>T	7	NULL	Intron	1	cagggcagaattggattaagcagtattgacccagtcccaaagtgcagcttgtctaaaccttcatctccttgaactcttccagGAACCTCTGTGATGGAGGTCACAGCCACAGACGCGGACGATGATGTGAACACCTACAATGCCGCCATCGCTTACACCATCCTCAGCCAAGATCCTGAGCTCCCTGACAAAAATATGTTCACCATTAACAGGAACACAGGAGTCATCAGTGTGGTCACCACTGGGCTGGACCGAGA(G>T)gtcaggg/gtcaggaggatccagagggtgtggaggacaaatgtgtattagctcaatcccgtggacaaagcaaaatcctgctaggccagttgtcagttaatacagtgatggtctaagctttgcatctaagcttgtgcccagaggttccgtgcctagaagacaggcaggctggcatgaagcac	NULL	No	NULL	In	84.03	4.94	0.43	74.48	9.48	5.98	4.14	4.14	3.23	6.23	13.2	11.3	-5.9	-6.4	6	0.07	6	0.65	137215	ENSG00000039068	215	289	"cadherin 1, type 1, E-cadherin (epithelial)"
224	1	Human	2	ADA	5	Adenosine deaminase deficiency	IVS10+1G>A	4	100	Intron	1	cagggtagggtgcagaggggaaggctggagagggtggcagccggagggggatgttgctttcttggctcccacccccacgcccccaccggctgccattctgcctggttcccatgtctggcccctctgctgcctttgcccagctctggtcttcaggatgggctggattctggactttctggttacatagacttgaacaagtcacctaagttctgaatttatttccccctctgcacaaggatcagatctttcagatctgtttgaggctgctgtgaggatcaaaggcgggtgaacgtcaatgtgttctgactatttatgtaagagtaaaaggaggctgattctctcctcctccctcttctgcagGCTCAAAAATGACCAGGCTAACTACTCGCTCAACACAGATGACCCGCTCATCTTCAAGTCCACCCTGGACACTGATTACCAGATGACCAAACGGGACATGGGCTTTACTGAAGAGGAGTTTAAAAGGCTG(g>a)tga/gtgggtgtgagccatactggccttgactcgggtttgggagtatggtatctacaggtccagtccggggcctggaatctttggagagagggagtgagtctgcctcaacagtccaagacaagcccaacctagacactttccacagagaagacatctttgtgttgacgtcctgacctaggaccaggtttttgatcctttgcttgggttgagtgcctttaaagaatccagtgaaagctgtcaaccctctccccagaaaggtgtgtgcagcagctatgaagtcttgcacactctcttcaggttgttcttaaatcccaggctgaataagtccattcctgcacgtgtctgcgaggtgtctctggccccctacatgccaccctgtctctcaaaggtttctccaacttccttctcacagccctttt	NULL	No	NULL	In	85.92	10.1	-0.56	62.29	14.48	5.08	1.84	1.84	2.76	9.36	15.8	8.7	-7.2	-3.6	9	0.01	6	0.92	102700	ENSG00000196839	175	224	adenosine deaminase
230	1	Human	36	CSHL1	45	Developmental regulation of chorionic somatommatropin-like genes	IVS4+1G>A	20	NULL	Intron	2	caggtttggggcttatgaatgtgagtatcgccatctaaggccagatatttggccaatctctgaatgttcctggtctctggagggatggagagagagaaaaaaacaaacagctcctggagcagggagagcgctggcctcttcctctccggctccctccattgccctccggtttctccccagGCTCCCGGACGTCCCTGCTCCTGGCTTTTGCCCTGCTCTGCCTGCCCTGGCTTCAAGAGGCTGGTGCCGTCCAAACCGTTCCGTTATCCAGGCTTTTTGACCACGCTATGCTCCAAGCCCATCGCGCGCACCAGCTGGCCATTGACACCTACCAGGAGTTT(g>a)taagttcttggggaatgg/gtgcgggtcaggggtggcaagaaggggtgactttcccccactggggaagtaatgggaggagactaaggagctcagggttgttttctgaagcgaaaatgcaggcagatgagcataggctgagccaggttcccagaaaagcaacaatgggagctggtctccagcatagaaaccagcagtccttcttggtggggggtccttctcctag	NULL	No	NULL	In	78.05	7.4	3.47	68.67	11.78	8.08	3.46	3.46	4.56	5.39	14	8.3	-4	-4.3	6	0.06	6	0.78	603515	ENSG00000204414	178	230	chorionic somatomammotropin hormone-like 1
146	1	Human	13	BTK	184	agammaglobulinemia	E2+149A>G	-23	NULL	Exon	2	catccattatacctgaaacctgacagagctgggggctgtgggaggaggttggtaggaagaaattattttgtgagctgtgcacatttttgttccatttgaaactaggtagctaggctgagggggaaccaagagggatgaggattaatgtcctgggtcctcaggaactttcattatcaacagCACACAGGTGAACTCCAGAAAGAAGAAGCTATGGCCGCAGTGATTCTGGAGAGCATCTTTCTGAAGCGATCCCAACAGAAAAAGAAAACATCACCTCTAAACTTCAAGAAGCGCCTGTTTCTCTTGACCGTGCACAAACTCTCCTACT/(A>G)TGAGTATGACTTTGAACGTGGGgtaagtttctcgactatgaaaactgagtttcaagatatcaaggacttggccttagatctttcttggggaagaggtaaattttcgttggtaggaggaggggagtagaatggacctaagttctttcaaattcagcaaaatatttcctagcctataactagctaaagccggaaagtcaaaggt	NULL	No	1	Out	90.45	9.65	7.94	72.18	13.78	11.38	4.86	4.86	6.57	8.77	17.5	15.1	-9.4	-3.9	8	0.85	6	0.99	300300	ENSG00000010671	46	146	Bruton agammaglobulinemia tyrosine kinase
105	1	Human	87	HMBS	3	Acute intermittent porphyria	E10+114G>T	-9	NULL	Exon	0	cattaagctgagagctggaagatgactgaaagtcagccagctagagagggaaagacagactcaggcagagggaaccgcacgaggccccagattgcccgacactgtggtccttagcaactctccacagCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGG/GTGGGGCA(G>T)gtagggcctgcccctatcctctccccagctcatctgcatctcctttctgccttacagtcatccccaatttaggatttttagactttatgattgtgtgaaagcgatatacgttcagtagaaactgtacttagtacccatacagccattctgttttttactttcagtacagtattcattaca	NULL	No	NULL	In	84.05	9.46	3.69	69.33	13.08	7.88	6.11	6.11	5.1	9.04	15.7	9.5	-9.2	-8.6	8	0.13	8	0.63	176000	ENSG00000149397	81	105	hydroxymethylbilane synthase
195	1	Human	162	WFS1	180	Wolfram syndrome	IVS7+1G>A	86	NULL	Intron	2	CCAAGAACTACATCGCGCTGGATGACTTTGTGGAGATCACTAAGAAGTACGCCAAGGGCGTCATCCCCAGCAGCCTGTTCCTGCAGGACGACGAAGATGATGACGAGCTGGCGGGGAAGAGCCCTGAGGACCTGCCACTGCGTCTGAAG(g>a)tgagtgaccaagaccccggtcaggccggagcctgcctcccaaggactcgcgcacctcaggcagggcaccttccaggaagctgcag/gtggggaggttcgcgcctaacaaagagtgtcttacagccgtgccgctggtacctttgggtcatcatctatcgtcataaggatgtgtcctcgggagagaggcctttcttttctgcgccgtcaggctcagaaaccaggggcggtgttgggcaggagtgctaggatggcaagcaaggggcccctgggtctttctgtgcagtgtagggggcagtggggcgggctggacgcagactttcatctagacttcatcacttagcagatttctccatgtatggtccagagtggaggccagtgccttgaagatgccttccccgaaaacaaagtgccgtgtccgtcaggccagggaggacgtgcagaggcgcctactgcccctggatctgcaagggctcagggagcgaggccagtgtgggagcgtg	NULL	No	NULL	In	94.83	10.47	6.92	78.87	15.28	11.48	8.39	8.39	6.85	11.31	17.7	13.1	-8.7	-8.8	8	0.37	8	1	222300	ENSG00000109501	155	195	Wolfram syndrome 1 (wolframin)
292	1	Human	61	FAH	92	"Tyrosinemia, type I"	E2+111G>T	94	NULL	Intron	1	CCAAGACCGAGGATAGGTGTGGCCATTGGCGACCAGATCCTGGACCTCAGCATCATCAAGCACCTCTTTACTGGTCCTGTCCTCTCCAAACACCAGGATGTCTTCAATCA(G>T)gtaggacattgtgaaacgacttgtccctgacctcagtggcacttactgtggatgccaacaagagaatgctccttgcgttccatttccgatagag/gtaatgccatcgaaggtctcagaggttatacttggataaggctggggttgttttgagacagacaaactggtaggaggtggccttgggacaattcagggtggcttctcacctcagggcgagttcctaggtgaaaaaagtgtcagtgtctgcagtcctgggtcgttcctagttgtctatgagatgaagctcttcaggaactctggttacttttcttgtcaagctgtttgagcctctgcctgtccaagggctgtgtgggcccccaagggagggagctacgagcccagccctccagttctgtggaagcagctacggaggagtcagcctgaagtacatgttcacatgggatggacatgaatttgcttccctgtaaatggtcatctactttgatatagcatcttctcattgcatgggtcaggaaggagggtgggatttatgggtacctcttgtgtgccaggagcttcgcacacatcctctccttcaatcctcctgaccaccctctggcataggaattggaattcctatgggggcctgagcatctagatggggacctgaacttctggaatgagacatggttttcccaagctgcacagctagaagtatcagagctgggactggaactctgactc	NULL	No	NULL	In	83.94	9.79	8.73	82.07	13.08	11.98	7.03	7.03	7	9.1	15.7	14.1	-8	-5.3	8	0.85	6	0.94	276700	ENSG00000103876	218	292	fumarylacetoacetate hydrolase (fumarylacetoacetase)
190	1	Human	112	MLH1	89	Hereditary nonpolyposis colorectal cancer	E11+154G>C	59	20	Intron	2	ccacgcccggccacttggcatgaatttaattcccgccataaacctgtgagataggtaattctgttatatccactttacaaatgaagagactgaggcaaagaaagatgatgtaacttacgcaaagctacacagctcttaagtagcagtgccaatatttgaacacactcagactcgatcctgaggttttgaccactgtgtcatctggcctcaaatcttctggccaccacatacaccatatgtgggctttttctccccctcccactatctaaggtaattgttctctcttattttcctgacagTTTAGAAATCAGTCCCCAGAATGTGGATGTTAATGTGCACCCCACAAAGCATGAAGTTCACTTCCTGCACGAGGAGAGCATCCTGGAGCGGGTGCAGCAGCACATCGAGAGCAAGCTCCTGGGCTCCAATTCCTCCAGGATGTACTTCACCCA(G>C)gtcagggcgcttctcatccagctacttctctggggcctttgaaatgtgcccggccagac/gtgagagcccagatttttgcctgttatttaggaactttctttgcaagtattacctggatagttttaacattttcttctttgaacctagttataaaggtattgtgctgttgttcctaggcttagagtcataaggcctgagctcacttcctcactttgcctccatctggaaccttagaccaacttcctaggaaaacgagctgtctgaaaacagaatagggtgcctcttcaatgtgctcttcac	NULL	No	NULL	In	84.03	7.2	4.22	75.54	11.08	8.88	6.29	6.29	6.32	7.21	14.9	10.5	-6.6	-2.8	7	0.63	6	0.86	609310	ENSG00000076242	151	190	"mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)"
342	1	Human	22	CEP290	107	Leber congenital amaurosis	IVS26+1655A>G	-32768	NULL	Intron	-32768	ccaggctggagtgcagtggcgccatcttggctcactgcaagctccacctcccgggttcaggccgttctcctgcctcagcctcctgagtagctggtaccacaggcacccaccatcatgcccggctaattttttgtatttttagTAGAGATGGGGTTTCACCTTGTTAGCCAGGATGGTGTCGATCTCCTGAACTCGTGATCCACCCGCCTCGGCCTCCTAAAGTGCTGGGATTACAGATGTGAGCCACCGCACCTGGCCCCAGTTGTAATT/gtga(a>g)tatctcatacctatccctattggcagtgtcttagttttattttttattatctttattgtggcagccattattcctgtctctatctccagtcttacatcctccttactgccacaagaatgatcattctaaacatgaatcctaccctgtgactcccatgtgactccccgccttaaaaactgtcaaaagctaccggttacctgaaggg	Creates pseudoexon	No	5	Out	NULL	NULL	-4.55	60.33	NULL	-6.42	NULL	1.27	0.96	NULL	NULL	7.8	NULL	-0.3	NULL	0	5	NULL	204000	ENSG00000198707	260	342	centrosomal protein 290kDa
207	1	Human	135	PSEN1	10	Alzheimer disease	IVS4+1delG	3	NULL	Intron	0	ccaggtctaaccgttaccttgattctgctgagaatctgatttactgaaaatgtttttcttgtgcttatagAATGACAATAGAGAACGGCAGGAGCACAACGACAGACGGAGCCTTGGCCACCCTGAGCCATTATCTAATGGACGACCCCAGGGTAACTCCCGGCAGGTGGTGGAGCAAGATGAGGAAGAAGATGAGGAGCTGACATTGAAATATGGCGCCAAGCATGTGATCATGCTCTTTGTCCCTGTGACTCTCTGCATGGTGGTGGTCGTGGCTACCATTAAGTCAGTCAGCTTTTATACCCGGAAGGATGGGCAGCT(g)tac/gtatgagttttgttttattattctcaaagccagtgtggcttttctttacagcatgtcatcatcaccttgaaggcctctgcattgaaggggcatgacttagctggagagcccatcctctgtgatggtcaggagcagttgagagagcgaggggttattacttcatgttttaagtggagaaaaggaacactgcagaagtatgtttcctgtatggtattactggatagggctgaagttat	NULL	No	NULL	In	66.13	5.68	2.15	70.31	8.88	5.18	3.89	3.89	3.14	5.71	13.7	9.1	-0.6	0.4	5	0.21	7	0.21	607822	ENSG00000080815	163	207	presenilin 1
295	1	Human	62	FANCA	64	Fanconi anaemia	IVS7+5G>A	30	100	Intron	0	CCATCCCGACATGCATGCTGTGGGATCGTGGCTCTTCAGGAATCTGTGCTGCCTTTGTGAACAGATGGAAGCATCCTGCCAGCATGCTGACGTCGCCAGGGCCATGCTTTCTGgtgc(g>a)ttcatgacaagatgcgggttcttgg/gtaaaactcattttgatctgtgataatgccttctgctctcaagagctctgcgaggcagaacagcctgtctctccgtggccgtgggaacctggcatgacagactccca	NULL	No	NULL	In	74.7	8.29	3.28	72.61	11.78	7.28	3.96	3.96	4.05	7.25	10.5	12	-3.6	-6	8	0.19	6	0.69	227650	ENSG00000187741	219	295	"Fanconi anemia, complementation group A"
296	1	Human	62	FANCA	64	Fanconi anaemia	IVS7+5G>T	30	100	Intron	0	CCATCCCGACATGCATGCTGTGGGATCGTGGCTCTTCAGGAATCTGTGCTGCCTTTGTGAACAGATGGAAGCATCCTGCCAGCATGCTGACGTCGCCAGGGCCATGCTTTCTGgtgc(g>t)ttcatgacaagatgcgggttcttgg/gtaaaactcattttgatctgtgataatgccttctgctctcaagagctctgcgaggcagaacagcctgtctctccgtggccgtgggaacctggcatgacagactccca	NULL	No	NULL	In	74.7	8.29	3.28	72.61	11.78	7.28	3.96	3.96	4.05	7.25	10.5	12	-3.6	-6	8	0.19	6	0.69	227650	ENSG00000187741	219	296	"Fanconi anemia, complementation group A"
27	1	Human	21	CDKN2A	122	Melanoma	E1+420A>C	-69	NULL	Exon	0	CCCAACCTGGGGCGACTTCAGGGGTGCCACATTCGCTAAGTGCTCGGAGTTAATAGCACCTCCTCCGAGCACTCGCTCACGGCGTCCCCTTGCCTGGAAAGATACCGCGGTCCCTCCAGAGGATTTGAGGGACAGGGTCGGAGGGGGCTCTTCCGCCAGCACCGGAGGAAGAAAGAGGAGGGGCTGGCTGGTCACCAGAGGGTGGGGCGGACCGCGTGCGCTCGGCGGCTGCGGAGAGGGGGAGAGCAGGCAGCGGGCGGCGGGGAGCAGCATGGAGCCGGCGGCGGGGAGCAGCATGGAGCCTTCGGCTGACTGGCTGGCCACGGCCGCGGCCCGGGGTCGGGTAGAGGAG/GTGCGGGCGCTGCTGGAGGCGGGGGCGCTGCCCAACGCACCGAATAGTTACGGTCGGAGGCCGATCC(A>C)Ggtgggtagagggtctgcagcgggagcaggggatggcgggcgactctggaggacgaagtttgcaggggaattggaatcaggtagcgcttcgattctccggaaaaaggggaggcttcctggggagttttcagaaggggtttgtaatcacagacctcctcctggcgacgccctgggggcttgggaagccaaggaagaggaatg	NULL	No	NULL	In	84.26	8.56	6.79	78.21	13.38	10.38	6.57	6.57	7.1	8.54	17.5	10.4	-9	-3.8	9	0.35	6	0.94	109700	ENSG00000147889	23	27	"cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)"
140	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	E3+75G>T	-111	NULL	Exon	0	cccaggttggtgtggaagtttaatgactaagaggtgtttgttataaagtttaatgtatgaaactttctattaaattcctgattttatttctgtagGACTGAACGTCTTGCTCGAGATGTGATGAAGGAGATGGGAGGCCATCACATTGTAGCCCTCTGTGTGCTCAAG/G(G>T)GGGCTATAAATTCTTTGCTGACCTGCTGGATTACATCAAAGCACTGAATAGAAATAGTGATAGATCCATTCCTATGACTGTAGATTTTATCAGACTGAAGAGCTATTGTgtgagtatatttaatatatgattctttttagtggcaacagtaggttttcttatattttctttgaatctctgcaaaccatacttgctttcatttcacttggttacagtgagatttttctaacatattcactagtactttacatcaaagccaatactgtttttttaaaactagtcaccttgg	NULL	No	2	Out	72.23	5.84	7.93	78.16	9.58	12.58	7.73	7.73	6.41	5.48	15.1	11.2	-3.9	-6.8	6	0.57	7	0.74	300322	ENSG00000165704	112	140	hypoxanthine phosphoribosyltransferase 1
#129	1	Human	5	AR	12	Androgen insensitivity syndrome	E8+60C>T	-32768	NULL	Exon	0	ccctcagtgactccatggagaccatttctttctctctctctcgctgtctctctctaacacacacacacacacacacgacctcatgggggaggaccaaggaagtacggggaagggggaggaaacaaaaggctgaaagaccaaaaatcagaggttggggaagaggctagcagaggccacctccttgtcaaccctgtttttctccctcttattgttccctacagATTGCGAGAGAGCTGCATCAGTTCACTTTTGACCTGCTAATCAAGTCACACATG/GTGAG(C>T)GTGGACTTTCCGGAAATGATGGCAGAGATCATCTCTGTGCAAGTGCCCAAGATCCTTTCTGGGAAAGTCAAGCCCATCTATTTCCACACCCAGTGAAGCATTGGAAACCCTATTTCCCCACCCCAGCTCATGCCCCCTTTCAGATGTCTTCTGCCTGTTATAACTCTGCACTACTCCTCTGCAGTGCCTTGGGGAATTTCCTCTATTGATGTACAGTCTGTCATGAACATGTTCCTGAATTCTATTTGCTGGGCTTTTTTTTTCTCTTTCTCTCCTTTCTTTTTCTTCTTCCCTCCCTATCTAACCCTCCCATGGCACCTTCAGACTTTGCTTCCCATTGTGGCTCCTATCTGTGTTTTGAATGGTGTTGTATGCCTTTAAATCTGTGATGATCCTCATATGGCCCAGTGTCAAGTTGTGCTTGTTTACAGCACTACTCTGTGCCAGCCACACAAACGTTTACTTATCTTATGCCACGGGAAGTTTAGAGAGCTAAGATTATCTGGGGAAATCAAAACAAAAACAAGCAAAC	NULL	Yes	6	Out	NULL	NULL	10.13	85.92	NULL	14.08	NULL	9.29	9.22	NULL	NULL	16.7	NULL	-7.2	NULL	0.97	8	NULL	313700	ENSG00000169083	102	129	androgen receptor
127	1	Human	44	CYP27A1	28	Cerebrotendinous xanthomatosis	E2+180G>T	-13	69.5	Exon	1	cccttcctcacctcatctcctgtcctgggagcacctgcccagcttggcccagttattcagttttgattgaactccacagGTGCTTTACAAGGCCAAGTACGGTCCAATGTGGATGTCCTACTTAGGGCCTCAGATGCACGTGAACCTGGCCAGTGCCCCGCTCTTGGAGCAAGTGATGCGGCAAGAGGGCAAGTACCCAGTACGGAACGACATGGAGCTATGGAAGGAGCACCGGGACCAGCACGACCTGACCTATG/G(G>T)CCGTTCACCACgtgagctggggcctgaagggactggaacagggccccagagggccagggcgaaagacagtgggcacagggcaggcaggtggataaccggcagaatagtaccctctgcatcctctgagcctgatggtctagagagcagttgttgggaggtgctgaagcccagggaccattcattggctctccactaataaatattaggttggtgcaaaagtcattgtggttttcaccatttaaaattatggcaaaaaccacacctgtaatcccagcactttgggaggctgaggtgggcggatcacttgagttcaggggttcgagatcagcttggccaacacggtgaaaccccgtctctactaaaaacacaaaaattagccaggtgtggtggtgggcacctgtaatcccagctacttgggaggctgaggcaggaggatcgtttgaacccaggaggtggaggttgcagtgagccgagatcatgccactgcactccagcctgggcaacagagtgagactccatctcaaaaaagaaaaaaaaaaaaactttttaacttgacatctgccactgagggtaagatttaggttgcaggttttcactgggccaggccacctatgacatgacagctcagatttagaatcggagctaaacattatgtagagccctttgtaatctatttacatttttttctctaaagccagtttcctgaatagatgatatcatatgcatgcatttaaaagctcttttgtgaatctttgagtcagatgactggggaaaaaaagctattctgctaactcatgataagtttggggttctcaaatttttgttttaacatatatatttttaaaatatcattttatgaagcattgtttcctccaagtgattttttaacaaccacgtttaagttctgtatatccgattcctactgttgagagagttttacttttggaacaacgtgaagtcccaacaaataggtctattctggttttcatttctttttcagcaacactttcagtttatctttttgcaatttt	NULL	No	2	Out	74.93	5.62	3.18	69.29	10.78	7.38	3.16	3.16	2.78	7.36	12.2	9.4	-2.8	-1.2	7	0.04	6	0.88	213700	ENSG00000135929	100	127	"cytochrome P450, family 27, subfamily A, polypeptide 1"
180	1	Human	87	HMBS	3	Acute intermittent porphyria	IVS1+1G>A	67	NULL	Intron	1	CCGGAAGTGACGCGAGGCTCTGCGGAGACCAGGAGTCAGACTGTAGGACGACCTCGGGTCCCACGTGTCCCCGGTACTCGCCGGCCGGAGCCCCCGGCTTCCCGGGGCCGGGGGACCTTAGCGGCACCCACACACAGCCTACTTTCCAAGCGGAGCCATGTCTGGTAACGGCAATGCGGCTGCAACGGCG(g>a)tgagtgctgagccggtgaccagcacactttgggcttctggacgagccgtgcagcgattggccccag/gttgccatcctcagtcgtctattggtcagaacggctatctttttttttttttttttttttttttttttggtccgagtagcttttaaagggccagtagctcggttgccctccggaaggaatggggaaatcagagagcggtgatactgggttaagagtggaaggattgtttggaacggaactccggtccctgcgggcatctgggtgggattcccatcaggcctgggatgcacggctctagatttagtgacccagaccaagaacgttcgtctacacagacggggtcctttcattcgaggctgggctgaggcggatgcagatacggcccctttgggaagacacgttccacttttgattcataggagagagtatcagccaagcctccgaactgcacacaaacgtcttagaagtgcgccttctttttgtgttatagtggtctcccagccacagccaacgctccaagtccccagctgtgacacacctactgaattactaccgtgggtgggaggccgccgtgggcctttccattacgagcctgcttgccgagccctgggcttgtgcacagacaaactgcagagctggtggaggccactgccaggccgagataagaaagagatggggagctgctaatctccccctgtccagcctgttggtgagggctgggatctttgctcttgcagtcattccagagccctggactaggagtaggaagatctgaattgtggccccaactctctttcggttattagctctgtgaccctaggcaagtcacctcatcccttgatgccacccgttgcttctgtaacatggtcccaaaggtgcctgtcttgtccacctgataggatttttgagacgacaacaatatgcaaaagcaatagcttcaacatagaagtgctcagtgttttattttttaatgaaacggtttgacttggatatgctgtgcacattcaatgaacttaaggaattgtttgaacctagtagttctgggaccttagagtcctttctgtgggctccctgtggcccagaattttggtggccacgtttaatatcaagcctagcctaatttgcaaagggtctcccagggttaatttattggagtgatcacatggagtagaccagagtctgagggcagaaagctgtcacctgcttcggcaatagaggccccagatgtctgggtgcaaaagaactccatagcaccccgaccaacatggtgaaaccccgtctctactaaaaatataaaaattaggccgggcacagtggctcatgcctgtaatcctagcactttgggaggccgaggcaggtggattgcctgagctcaggagttcgagaccagcctagggaacacagtgaaaccccgtttctactaaaaatacaaaaaattagccgacgtggtggcatgcgcctgtagtcccagctacttgggaggctaagacaggagaatcgcttgaacctgggaggtggaggttgcactgagccgagaccgcgccattgcactccagcctgggtgacagagcgcgactccccctcaaaaaaagaaaaaaaaaaaaaatatatatatatatatacacacacacacatattttagctgggcatggtggtgtgcgtctgtagtagtcccagctacttgggaggctgagtcaggagaatcgcttgaacctggaaggcagtggttgtagttagctgagaacatgccactgcactccagcctgggcaacagagggagactctgtctcaaaaaaaaaaaaaaaaggaactacataggatgaacatcccagatcagggaatgttgactgtcgacagtatcagtatctacagtggctactgtctgatgtagaaagaaatgggatcaggctaggcgtggtggctcacgcctgtaatcccagcactttgggaggctggggcaggaggatcacaagttcgagaccagcctggccaacacagtgaaaccccgtctctactaaaaatgtgaaaattagctgggcatggtggaacatgcctgtagttccagcttgaacccaggggtggaggttgtagtgagcctagatcacgccactgcactccagcctgagcaaaacagtgagactctgtctaaaaaaaaaaaaaaaaaaagagagaaatgggacctccgtcttagactgaagaattcagttctacgtgcttagcagtgaatacttttgtccaaggtactctggcaggaggaagaggcgtgtcctcttgagttcttgacttgggctctggcctgttaatatttccatgttggtgaaaccagaggcagcactctaggtgcacgaactttaggcagcgcagcctcctagtcttatggaacatctgaggcagaagaaacctgagtccaaccttttcattttatagatgaacaaacagatcctggtgggacagtgtacccaaggtcacccagccaagaggctgagcaggactgtacgtcagatccgtttacctcagtccttaatgcatgcagtccagccagattaagggacccttaatactgtcagctttccccactgtgggatcttcatcctcttgacttcttttgtagccagacatctgggcctcttgctggagaaggtggcagcttgctgctcttagactctagtctactccatgtggcatctggatggcactgaaattttctcaagtgccttgtctgttgtagataatgaatctatcctccagtgactcagcacaggttccccagtgtggtcctggctgccctgcccctgccagctgcaggccccacccttcctgtggccaggctgatgggccttatctctttacccacctggctgtgcacagcactcccactgacaactgccttggtcaaggtgggcttcagggctcagtgtcctggttactgcagcggcagcaacagcaggtcctactatcgcctccctctagtctctgcttctctggatccctgaggagggcagaaggtactgaggaaggttaaagggaccagccttggagtatttccccactctgagactcagctggccacaggccaggttctgaagttcctttcttccaagccagtgattctggttcttggacaaggtgttgaggaacactagaaacagaggggactgtgacctggggactttttctgcagGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAG	NULL	No	NULL	In	85.22	10.49	-2.52	59.74	14.08	4.68	0.69	0.69	2.34	10.4	15.6	11.8	-7.5	-3.3	7	0.01	6	0.99	176000	ENSG00000149397	144	180	hydroxymethylbilane synthase
182	1	Human	87	HMBS	3	Acute intermittent porphyria	IVS1+2T>A	67	NULL	Intron	1	CCGGAAGTGACGCGAGGCTCTGCGGAGACCAGGAGTCAGACTGTAGGACGACCTCGGGTCCCACGTGTCCCCGGTACTCGCCGGCCGGAGCCCCCGGCTTCCCGGGGCCGGGGGACCTTAGCGGCACCCACACACAGCCTACTTTCCAAGCGGAGCCATGTCTGGTAACGGCAATGCGGCTGCAACGGCGg(t>a)gagtgctgagccggtgaccagcacactttgggcttctggacgagccgtgcagcgattggccccag/gttgccatcctcagtcgtctattggtcagaacggctatctttttttttttttttttttttttttttttggtccgagtagcttttaaagggccagtagctcggttgccctccggaaggaatggggaaatcagagagcggtgatactgggttaagagtggaaggattgtttggaacggaactccggtccctgcgggcatctgggtgggattcccatcaggcctgggatgcacggctctagatttagtgacccagaccaagaacgttcgtctacacagacggggtcctttcattcgaggctgggctgaggcggatgcagatacggcccctttgggaagacacgttccacttttgattcataggagagagtatcagccaagcctccgaactgcacacaaacgtcttagaagtgcgccttctttttgtgttatagtggtctcccagccacagccaacgctccaagtccccagctgtgacacacctactgaattactaccgtgggtgggaggccgccgtgggcctttccattacgagcctgcttgccgagccctgggcttgtgcacagacaaactgcagagctggtggaggccactgccaggccgagataagaaagagatggggagctgctaatctccccctgtccagcctgttggtgagggctgggatctttgctcttgcagtcattccagagccctggactaggagtaggaagatctgaattgtggccccaactctctttcggttattagctctgtgaccctaggcaagtcacctcatcccttgatgccacccgttgcttctgtaacatggtcccaaaggtgcctgtcttgtccacctgataggatttttgagacgacaacaatatgcaaaagcaatagcttcaacatagaagtgctcagtgttttattttttaatgaaacggtttgacttggatatgctgtgcacattcaatgaacttaaggaattgtttgaacctagtagttctgggaccttagagtcctttctgtgggctccctgtggcccagaattttggtggccacgtttaatatcaagcctagcctaatttgcaaagggtctcccagggttaatttattggagtgatcacatggagtagaccagagtctgagggcagaaagctgtcacctgcttcggcaatagaggccccagatgtctgggtgcaaaagaactccatagcaccccgaccaacatggtgaaaccccgtctctactaaaaatataaaaattaggccgggcacagtggctcatgcctgtaatcctagcactttgggaggccgaggcaggtggattgcctgagctcaggagttcgagaccagcctagggaacacagtgaaaccccgtttctactaaaaatacaaaaaattagccgacgtggtggcatgcgcctgtagtcccagctacttgggaggctaagacaggagaatcgcttgaacctgggaggtggaggttgcactgagccgagaccgcgccattgcactccagcctgggtgacagagcgcgactccccctcaaaaaaagaaaaaaaaaaaaaatatatatatatatatacacacacacacatattttagctgggcatggtggtgtgcgtctgtagtagtcccagctacttgggaggctgagtcaggagaatcgcttgaacctggaaggcagtggttgtagttagctgagaacatgccactgcactccagcctgggcaacagagggagactctgtctcaaaaaaaaaaaaaaaaggaactacataggatgaacatcccagatcagggaatgttgactgtcgacagtatcagtatctacagtggctactgtctgatgtagaaagaaatgggatcaggctaggcgtggtggctcacgcctgtaatcccagcactttgggaggctggggcaggaggatcacaagttcgagaccagcctggccaacacagtgaaaccccgtctctactaaaaatgtgaaaattagctgggcatggtggaacatgcctgtagttccagcttgaacccaggggtggaggttgtagtgagcctagatcacgccactgcactccagcctgagcaaaacagtgagactctgtctaaaaaaaaaaaaaaaaaaagagagaaatgggacctccgtcttagactgaagaattcagttctacgtgcttagcagtgaatacttttgtccaaggtactctggcaggaggaagaggcgtgtcctcttgagttcttgacttgggctctggcctgttaatatttccatgttggtgaaaccagaggcagcactctaggtgcacgaactttaggcagcgcagcctcctagtcttatggaacatctgaggcagaagaaacctgagtccaaccttttcattttatagatgaacaaacagatcctggtgggacagtgtacccaaggtcacccagccaagaggctgagcaggactgtacgtcagatccgtttacctcagtccttaatgcatgcagtccagccagattaagggacccttaatactgtcagctttccccactgtgggatcttcatcctcttgacttcttttgtagccagacatctgggcctcttgctggagaaggtggcagcttgctgctcttagactctagtctactccatgtggcatctggatggcactgaaattttctcaagtgccttgtctgttgtagataatgaatctatcctccagtgactcagcacaggttccccagtgtggtcctggctgccctgcccctgccagctgcaggccccacccttcctgtggccaggctgatgggccttatctctttacccacctggctgtgcacagcactcccactgacaactgccttggtcaaggtgggcttcagggctcagtgtcctggttactgcagcggcagcaacagcaggtcctactatcgcctccctctagtctctgcttctctggatccctgaggagggcagaaggtactgaggaaggttaaagggaccagccttggagtatttccccactctgagactcagctggccacaggccaggttctgaagttcctttcttccaagccagtgattctggttcttggacaaggtgttgaggaacactagaaacagaggggactgtgacctggggactttttctgcagGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAG	NULL	No	NULL	In	85.22	10.49	-2.52	59.74	14.08	4.68	0.69	0.69	2.34	10.4	15.6	11.8	-7.5	-3.3	7	0.01	6	0.99	176000	ENSG00000149397	144	182	hydroxymethylbilane synthase
248	1	Human	87	HMBS	3	Acute intermittent porphyria	IVS1+3G>T	67	NULL	Intron	1	CCGGAAGTGACGCGAGGCTCTGCGGAGACCAGGAGTCAGACTGTAGGACGACCTCGGGTCCCACGTGTCCCCGGTACTCGCCGGCCGGAGCCCCCGGCTTCCCGGGGCCGGGGGACCTTAGCGGCACCCACACACAGCCTACTTTCCAAGCGGAGCCATGTCTGGTAACGGCAATGCGGCTGCAACGGCGgt(g>t)agtgctgagccggtgaccagcacactttgggcttctggacgagccgtgcagcgattggccccag/gttgccatcctcagtcgtctattggtcagaacggctatctttttttttttttttttttttttttttttggtccgagtagcttttaaagggccagtagctcggttgccctccggaaggaatggggaaatcagagagcggtgatactgggttaagagtggaaggattgtttggaa	NULL	No	NULL	In	85.22	10.49	-2.52	59.74	14.08	4.68	0.69	0.69	2.34	10.4	15.6	11.8	-7.5	-3.3	7	0.01	6	0.99	176000	ENSG00000149397	187	248	hydroxymethylbilane synthase
181	1	Human	87	HMBS	3	Acute intermittent porphyria	IVS1+5G>C	67	NULL	Intron	1	CCGGAAGTGACGCGAGGCTCTGCGGAGACCAGGAGTCAGACTGTAGGACGACCTCGGGTCCCACGTGTCCCCGGTACTCGCCGGCCGGAGCCCCCGGCTTCCCGGGGCCGGGGGACCTTAGCGGCACCCACACACAGCCTACTTTCCAAGCGGAGCCATGTCTGGTAACGGCAATGCGGCTGCAACGGCGgtga(g>c)tgctgagccggtgaccagcacactttgggcttctggacgagccgtgcagcgattggccccag/gttgccatcctcagtcgtctattggtcagaacggctatctttttttttttttttttttttttttttttggtccgagtagcttttaaagggccagtagctcggttgccctccggaaggaatggggaaatcagagagcggtgatactgggttaagagtggaaggattgtttggaacggaactccggtccctgcgggcatctgggtgggattcccatcaggcctgggatgcacggctctagatttagtgacccagaccaagaacgttcgtctacacagacggggtcctttcattcgaggctgggctgaggcggatgcagatacggcccctttgggaagacacgttccacttttgattcataggagagagtatcagccaagcctccgaactgcacacaaacgtcttagaagtgcgccttctttttgtgttatagtggtctcccagccacagccaacgctccaagtccccagctgtgacacacctactgaattactaccgtgggtgggaggccgccgtgggcctttccattacgagcctgcttgccgagccctgggcttgtgcacagacaaactgcagagctggtggaggccactgccaggccgagataagaaagagatggggagctgctaatctccccctgtccagcctgttggtgagggctgggatctttgctcttgcagtcattccagagccctggactaggagtaggaagatctgaattgtggccccaactctctttcggttattagctctgtgaccctaggcaagtcacctcatcccttgatgccacccgttgcttctgtaacatggtcccaaaggtgcctgtcttgtccacctgataggatttttgagacgacaacaatatgcaaaagcaatagcttcaacatagaagtgctcagtgttttattttttaatgaaacggtttgacttggatatgctgtgcacattcaatgaacttaaggaattgtttgaacctagtagttctgggaccttagagtcctttctgtgggctccctgtggcccagaattttggtggccacgtttaatatcaagcctagcctaatttgcaaagggtctcccagggttaatttattggagtgatcacatggagtagaccagagtctgagggcagaaagctgtcacctgcttcggcaatagaggccccagatgtctgggtgcaaaagaactccatagcaccccgaccaacatggtgaaaccccgtctctactaaaaatataaaaattaggccgggcacagtggctcatgcctgtaatcctagcactttgggaggccgaggcaggtggattgcctgagctcaggagttcgagaccagcctagggaacacagtgaaaccccgtttctactaaaaatacaaaaaattagccgacgtggtggcatgcgcctgtagtcccagctacttgggaggctaagacaggagaatcgcttgaacctgggaggtggaggttgcactgagccgagaccgcgccattgcactccagcctgggtgacagagcgcgactccccctcaaaaaaagaaaaaaaaaaaaaatatatatatatatatacacacacacacatattttagctgggcatggtggtgtgcgtctgtagtagtcccagctacttgggaggctgagtcaggagaatcgcttgaacctggaaggcagtggttgtagttagctgagaacatgccactgcactccagcctgggcaacagagggagactctgtctcaaaaaaaaaaaaaaaaggaactacataggatgaacatcccagatcagggaatgttgactgtcgacagtatcagtatctacagtggctactgtctgatgtagaaagaaatgggatcaggctaggcgtggtggctcacgcctgtaatcccagcactttgggaggctggggcaggaggatcacaagttcgagaccagcctggccaacacagtgaaaccccgtctctactaaaaatgtgaaaattagctgggcatggtggaacatgcctgtagttccagcttgaacccaggggtggaggttgtagtgagcctagatcacgccactgcactccagcctgagcaaaacagtgagactctgtctaaaaaaaaaaaaaaaaaaagagagaaatgggacctccgtcttagactgaagaattcagttctacgtgcttagcagtgaatacttttgtccaaggtactctggcaggaggaagaggcgtgtcctcttgagttcttgacttgggctctggcctgttaatatttccatgttggtgaaaccagaggcagcactctaggtgcacgaactttaggcagcgcagcctcctagtcttatggaacatctgaggcagaagaaacctgagtccaaccttttcattttatagatgaacaaacagatcctggtgggacagtgtacccaaggtcacccagccaagaggctgagcaggactgtacgtcagatccgtttacctcagtccttaatgcatgcagtccagccagattaagggacccttaatactgtcagctttccccactgtgggatcttcatcctcttgacttcttttgtagccagacatctgggcctcttgctggagaaggtggcagcttgctgctcttagactctagtctactccatgtggcatctggatggcactgaaattttctcaagtgccttgtctgttgtagataatgaatctatcctccagtgactcagcacaggttccccagtgtggtcctggctgccctgcccctgccagctgcaggccccacccttcctgtggccaggctgatgggccttatctctttacccacctggctgtgcacagcactcccactgacaactgccttggtcaaggtgggcttcagggctcagtgtcctggttactgcagcggcagcaacagcaggtcctactatcgcctccctctagtctctgcttctctggatccctgaggagggcagaaggtactgaggaaggttaaagggaccagccttggagtatttccccactctgagactcagctggccacaggccaggttctgaagttcctttcttccaagccagtgattctggttcttggacaaggtgttgaggaacactagaaacagaggggactgtgacctggggactttttctgcagGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAG	NULL	No	NULL	In	85.22	10.49	-2.52	59.74	14.08	4.68	0.69	0.69	2.34	10.4	15.6	11.8	-7.5	-3.3	7	0.01	6	0.99	176000	ENSG00000149397	144	181	hydroxymethylbilane synthase
17	1	Human	90	HRPT2	148	Primary hyperthyroidism	IVS1+1G>A	-30	NULL	Exon	0	ccggcggcggggccttgccttacagcgcggggtcctcggcggcctgggtgGCTACTGCCCCTGCTGCTGTCGTAGGCGAGGACGGCTGTTAGTGCTGCTGCTGTTGGTTCGTCGCGGCGGCGAAGGAGGAGGAGGAAGAGGGCGAGGCGACAAGAGAAGAAGGAGGCAGGCGCGGCGGCAGCGGCGGCGCCCCGAGCCGGCGGAGGCGAGGGGGGGGAAGATGGCGGACGTGCTTAGCGTCCTGCGACAGTACAACATCCAGAAGAAGGAGATTGTGGTGAAGGGAGACGAAGTGATCTTCGGGGAGTTCTCCTGGCCCAA/GAATGTGAAGACCAACTATGTTGTTTGGGG(g>a)taagtccggcatggctgtggcccaggggtggcagggcagagttgggcgcccccaggcgacctctttcttaacccctccccccgtttcccctggggatgggataaaacgggtgttcggggaaaagaaagtttctctctagagcagaagttgcacttttagggtaaggaaagaaggggcggagctctagagcagttcatca	NULL	No	NULL	In	90.45	9.65	-0.74	59.33	13.78	1.29	-1.22	-1.22	-1.27	8.77	17	NULL	-9.4	0.8	8	NULL	7	1	145001	ENSG00000134371	15	17	"cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)"
54	1	Human	5	AR	12	Androgen insensitivity syndrome	IVS4+1G>T	-123	100	Exon	0	cctattttgttgatgcctccattgcagcattttccagtccaacgttttctagaattgattgtggccaggctaccagactgggccagggcctgtgtcttttctgtcacccagaagcaaaggtctaacaatggatatctgctgaatgaatgaacgaaaatgaatcattaatatattagtaaatacgttaattaaagttccaggtatgaatactgaaggctgcattcaggcagagctggatccaaggatatgctaggttggtctagcacaagaatcagagttttcctctgcaagctatgaaaaatttgggtttagcaggtatttgggatgatgaattatacatttaaccagtgttgaatgagcacttgtccttaaggagtttagagtctgtgaccagggagaatggtgattttcttagctagggcagtttttctaaaaaggtagttgcattgtgtgtttttgaccactgatgataaattcaagtctctcttccttcccaatagCCCGGAAGCTGAAGAAACTTGGTAATCTGAAACTACAGGAGGAAGGAGAGGCTTCCAGCACCACCAGCCCCACTGAGGAGACAACCCAGAAGCTGACAGTGTCACACATTGAAGGCTATGAATGTCAGCCCATCTTTCTGAATGTCCTGGAAGCCATTGAGCCAG/GTGTAGTGTGTGCTGGACACGACAACAACCAGCCCGACTCCTTTGCAGCCTTGCTCTCTAGCCTCAATGAACTGGGAGAGAGACAGCTTGTACACGTGGTCAAGTGGGCCAAGGCCTTGCCTG(g>t)taaggaaaagggaagtgggagcatgagataagggggatcatatttagtgaacgctcctatggaccagccaccatgtctggtgcttttctgcccattaactcaggcagtcttcatcataaccctgtgggagagggattgttacaagtctcaatttaaacatacagggatcgaaactcagaaagcaaagagaaagatagtattatcgggtgtcttatgtggcccacattgatgcacagcagtcatgctttcatattcaactcacaaaaatggtcagcaaattttccattaatcacaaatcacatagacatacccatatatgccttaggatgctcttctatatttgcacacacaggctcaccccaaagataatctctagtttgactgacattctgtcttcaatgtcatctttaggagctatatcatgggaactctcataatatggtatggtggaaagaacatgaggttgggaatcagaacacttcgggtctgctcttagctc	NULL	No	NULL	In	85.71	9.68	3.1	66.68	13.48	8.88	4.36	4.36	3.93	8.54	15.4	11.8	-7.1	-4.6	8	0.03	6	0.99	313700	ENSG00000169083	42	54	androgen receptor
145	1	Human	151	SPTA1	84	Hereditary elliptocytosis	E8+129A>G	-27	NULL	Exon	0	cctcatggtattattaaatgaataatataaaatgagaacgttcatgtaaagtacttagcataatgagagactgaaaagtacttagtgaattgtaattatcaatgtagtacattagtatattaatagaaatctattcatatgtcgatttctaaattattattattcatatgattttttatacctctcccacaaagctttgccagggggagtcagagtacttggatttcctactaggtttctttttcatcccaaagGTGAAGGAGTTATGTGCTAAAGCAGAGAAGCTGACACTTTCCCATCCTTCAGATGCACCTCAGATCCAGGAGATGAAAGAAGATCTGGTCTCCAGCTGGGAGCATATTCGTGCCCTGGCCACCAGCAG/(A>G)TATGAAAAACTGCAGGCTACTTATTGgtgggaaatccctcccctttattgctctacctatctctacagggcccagatataatagcgagagaagaaataagagtaaagggagtcaaatagcgagagaatcagctctcctgcctgctcagtagagacaaaatatttaagttgccaaaggaagtcctttgtgactgatataatatagtagcacccccttatctgtggtttcagttaccagcagtcaaccacagtttgaaaatgttaaatggaaaattccagtaataaataacttataagttttaaattgcttattattctaa	NULL	No	1	Out	69.86	0.91	9.46	84.1	7.98	11.98	8.78	8.78	8.96	3.25	9.3	15.7	-5.3	-4.9	7	0.94	8	0.06	130600	ENSG00000163554	114	145	"spectrin, alpha, erythrocytic 1 (elliptocytosis 2)"
21	1	Human	93	IGHG2	4	Acute lymphoblastic leukemia	IVS1+4A>G	-16	NULL	Exon	1	CCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCGCCCTGCTCCAGGAGCACCTCCGAGAGCACAGCGGCCCTGGGCTGCCTGGTCAAGGACTACTTCCCCGAACCGGTGACGGTGTCGTGGAACTCAGGCGCTCTGACCAGCGGCGTGCACACCTTCCCGGCTGTCCTACAGTCCTCAGGACTCTACTCCCTCAGCAGCGTGGTGACCGTGCCCTCCAGCAACTTCGGCACCCAGACCTACACCTGCAACGTAGATCACAAGCCCAGCAACACCAAG/GTGGACAAGACAGTTGgtg(a>g)gaggccagctcagggagggagggtgtctgctggaagccaggctcagccctcctgcctggacgcaccccggctgtgcagccccagcccagggcagcaaggcaggccccatctgtctcctcacccggaggcctctgcccgccccactcatgctcagggagagggtcttctggctttttccaccaggctccaggcaggcacaggctgggtgcccctaccccaggcccttcacacacaggggcaggtgcttggctcagacctgccaaaagccatatccgggaggaccctgcccctgacctaagccgaccccaaaggccaaactgtccactccctcagctcggacaccttctctcctcccagatccgagtaactcccaatcttctctctgcagAGCGCAAATGTTGTGTCGAGTGCCCACCGTGCCCAG	NULL	No	NULL	In	60.24	-3.49	2.93	65.81	-1.68	7.78	4.27	4.27	3.11	-3.53	NULL	NULL	0.4	-4.6	6	0.28	5	NULL	147110	ENSG00000211893	18	21	immunoglobulin heavy constant gamma 2 (G2m marker)
95	1	Human	49	ECM1	112	Lipoid proteinosis	IVS1+1G>C	-85	100	Exon	1	cctcttgctcctggattctctgaatcagtttctcttgaaggtcataagaatgttctcctctaatcagtcccattcttctcaatcctctgaggaggcttcagggtgactttgggaggagtggcttccagaggaggagcagctgggactgagtcatggcaggaagctgaggagggcgggagatcacaccagacaattataaaAGAAGAGCTGGTCCTGAAGCTCACAACCGTAACAGCCACCAGACAAGCTTCAGTGGCCGGCCCTTCACATCCAGACTTGCCTGAGAGGACCCACCTCTGAGTGTCCAGTG/GTCAGTTGCCCCAGGATGGGGACCACAGCCAGAGCAGCCTTGGTCTTGACCTATTTGGCTGTTGCTTCTGCTGCCTCTGAGGGAG(g>c)tgagttgggggatcagcacttaggagggggtctgggcttgcatggcaggggtctgggtccaggcatcccagacggctcatcactagcagagtgattctccgtttggctttccttttctgagcaggcccaaagtgggcctaggccagtggagcctttaaccaaggaggcagagagcaggggcacagaaggagaggggttcctagaaactgctgccaagaaacacagaatcccagtcaaatagacaactgagtggggggtgggttcacagagtgagggtctcctgctgatgaggatgtagggaggtggctggtgggagaggcaagggagggaaaaggggcccccaggctgctcaaaaccggattgctggcccagcaagcctcgactgactccctgtctgattagaggagttgaggggtgtccatccacagacccaccctccatccagcacaaacacattctttatctgctttgatgcctgaacaaaacaggaacccctcaa	NULL	No	NULL	In	94.83	10.03	4.85	80.51	14.48	8.88	5.31	5.31	5.34	10.9	17.7	13.1	-8.8	-4.5	8	0.18	7	0.98	247100	ENSG00000143369	73	95	extracellular matrix protein 1
15	1	Human	135	PSEN1	10	Alzheimer disease	IVS4+1delG	-169	NULL	Exon	1	cctgaatgccttcagtgaacaatgatagataatctagacttttaaactgcatacttcctgtacattgttttttcttgcttcaggtttttagaactcatagtgacgggtctgttgttaatcccaggtctaaccgttaccttgattctgctgagaatctgatttactgaaaatgtttttcttgtgcttatagAATGACAATAGAGAACGGCAGGAGCACAACGACAGACGGAGCCTTGGCCACCCTGAGCCATTATCTAATGGACGACCCCAGG/GTAACTCCCGGCAGGTGGTGGAGCAAGATGAGGAAGAAGATGAGGAGCTGACATTGAAATATGGCGCCAAGCATGTGATCATGCTCTTTGTCCCTGTGACTCTCTGCATGGTGGTGGTCGTGGCTACCATTAAGTCAGTCAGCTTTTATACCCGGAAGGATGGGCAGCT(g)tacgtatgagttttgttttattattctcaaagccagtgtggcttttctttacagcatgtcatcatcaccttgaaggcctctgcattgaaggggcatgacttagctggagagcccatcctctgtgatggtcaggagcagttgagagagcgaggggttattacttcatgttttaagtggagaaaaggaacactgcagaagtatgtttcctgtatggtattactggatagggctgaagttatgctgaattgaacacataaattcttttccacctcagggccattgggcgcccattgctcttctgcctagaatattctttccttttctaactttggtggattaaattcctgtcatccccctcctcttggtgttatatataaagttttggtgccgcaaaagaagtagcactcgaatataaaattttccttttaattctcagcaaggcaagttacttctatatagaagggtgcacccttacagatggaacaatggcaagcgcacatttggacaagggaggggaaagggttcttatccctgacacacgtggtccctgctgctgtgttcttcccctactgactagggttagactgcacaggctaaactaattccaattggctaatttaaagagaatgatggggtgagtgctttggcaggagtcagggaagagcaggtagcaggtaactggaatgagggtggagcaggtaatggaaaaacattgctttacgaggaagttaagtttaaaagtagaaggcaaagaattgaacatactggcgtattaattctttgaaatttagaactcacatctaacattggcttaaatgttaaatcctcaaagataacattcctgtttctcctaacacgattaagtccttcttggtatcttttctcatagcaacttgtcctttctcacttgtcacaatttgcaaatatatatttatttacattgtttatttaatgcctaatttccttctttattgcaaggcctgtgagggtactgagtctccagggtgaggtgtataataaatggccaaacgaattgttaattgaaaggatgaacaactaattcaagccagcactctctagactcctggggggctatcatgtgggttccctggtgctgctgatgtcagcccttggcctccaagaaaaatgcttgattcaaatgtcatctagttccatctctacgactctcatggggtcca	NULL	No	NULL	In	66.13	5.68	5.8	77.44	8.88	9.48	6.59	6.59	5.13	5.71	13.7	12	-0.6	-5.7	5	0.97	7	0.21	607822	ENSG00000080815	13	15	presenilin 1
15	1	Human	135	PSEN1	10	Alzheimer disease	IVS4+1delG	-169	NULL	Exon	1	cctgaatgccttcagtgaacaatgatagataatctagacttttaaactgcatacttcctgtacattgttttttcttgcttcaggtttttagaactcatagtgacgggtctgttgttaatcccaggtctaaccgttaccttgattctgctgagaatctgatttactgaaaatgtttttcttgtgcttatagAATGACAATAGAGAACGGCAGGAGCACAACGACAGACGGAGCCTTGGCCACCCTGAGCCATTATCTAATGGACGACCCCAGG/GTAACTCCCGGCAGGTGGTGGAGCAAGATGAGGAAGAAGATGAGGAGCTGACATTGAAATATGGCGCCAAGCATGTGATCATGCTCTTTGTCCCTGTGACTCTCTGCATGGTGGTGGTCGTGGCTACCATTAAGTCAGTCAGCTTTTATACCCGGAAGGATGGGCAGCT(g)tacgtatgagttttgttttattattctcaaagccagtgtggcttttctttacagcatgtcatcatcaccttgaaggcctctgcattgaaggggcatgacttagctggagagcccatcctctgtgatggtcaggagcagttgagagagcgaggggttattacttcatgttttaagtggagaaaaggaacactgcagaagtatgtttcctgtatggtattactggatagggctgaagttatgctgaattgaacacataaattcttttccacctcagggccattgggcgcccattgctcttctgcctagaatattctttccttttctaactttggtggattaaattcctgtcatccccctcctcttggtgttatatataaagttttggtgccgcaaaagaagtagcactcgaatataaaattttccttttaattctcagcaaggcaagttacttctatatagaagggtgcacccttacagatggaacaatggcaagcgcacatttggacaagggaggggaaagggttcttatccctgacacacgtggtccctgctgctgtgttcttcccctactgactagggttagactgcacaggctaaactaattccaattggctaatttaaagagaatgatggggtgagtgctttggcaggagtcagggaagagcaggtagcaggtaactggaatgagggtggagcaggtaatggaaaaacattgctttacgaggaagttaagtttaaaagtagaaggcaaagaattgaacatactggcgtattaattctttgaaatttagaactcacatctaacattggcttaaatgttaaatcctcaaagataacattcctgtttctcctaacacgattaagtccttcttggtatcttttctcatagcaacttgtcctttctcacttgtcacaatttgcaaatatatatttatttacattgtttatttaatgcctaatttccttctttattgcaaggcctgtgagggtactgagtctccagggtgaggtgtataataaatggccaaacgaattgttaattgaaaggatgaacaactaattcaagccagcactctctagactcctggggggctatcatgtgggttccctggtgctgctgatgtcagcccttggcctccaagaaaaatgcttgattcaaatgtcatctagttccatctctacgactctcatggggtcca	NULL	No	NULL	In	66.13	5.68	5.8	77.44	8.88	9.48	6.59	6.59	5.13	5.71	13.7	12	-0.6	-5.7	5	0.97	7	0.21	607822	ENSG00000080815	163	15	presenilin 1
56	1	Human	73	GCK	120	Maturity-onset diabetes of the young (MODY)	IVS9+del15(tgggccgggtggagg)	-24	50	Exon	0	cctggtcagtcagcagagcattcagcagtatccagttccatggagaggcccgtgtgaggggagtcggggctggtcttcagtaaggatgggtggccagggcccctagaagtagaaaaggagactccgggtgctggagacagaaatcaaggatgtgcctccatgtggagcctcaggaatagctggccaggcctgaggctgaacctcacaaggttcagctgggagggctaggctgacagagcacagccgggccagggaccagcctgccctgtgttgccttgtcccgagggccactgtcagcaggtctctggcatgggggaggcttagggcctgagcccaacaagcagcagcggaagaggagagggaaactgtggacaggcctggcattcagtggccaggtgttgcagtgtccctgaggaatagcttggcttgaggccgtggggagggctgccggccagcgcacccccccatgccagatggtcaccatggcgtgcatcttccagCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCT/GTGAGGCACGAAGACATCGATAAGg(tgggccgggtggagg)ggcagaaggcagatgaggggaggcacaggcaccccagaggaactctgccttcaaatgtagcccccataccatgtgctcagaagggagatctggattcaaattgtggccatgtcacctgccacctctaatgctgtggaaaagaagcatcacattagctaattctggctgtgcgccttgtgaggcaccagctatgatcaccccactccagtggaaagagcagctgg	NULL	No	NULL	In	78.16	7.93	3.69	66.79	12.58	8.78	4.3	4.3	4.57	6.41	11.2	10.1	-6.8	-3.7	7	0.1	6	0.75	138079	ENSG00000106633	44	56	glucokinase (hexokinase 4)
120	1	Human	103	L1CAM	186	X-linked hydrocephalus	IVS4+5G>A	-80	NULL	Exon	2	cgccatctcccagtccatcccctgggggccctggctgcttgcacctgtccctccagcctgttccagcccccgttgggttccagggcctcaggcctctgggcctttttccgcccacagGTTCCGCTGGACGAGGGATGGTGTCCACTTCAAACCCAAGGAAGAGCTGGGTGTGACCGTGTACCAGTCGCCCCACTCTGGCTCCTTCACCATCACGGGCAACAACAGCAACTTTGCTCAGAG/GTTCCAGGGCATCTACCGCTGCTTTGCCAGCAATAAGCTGGGCACCGCCATGTCCCATGAGATCCGGCTCATGGCCGAGGgtgc(g>a)aggcgctgcagggaccagggagggcaggtcccggagttcgtgtgggattgtgggctggaagctgctgtcagccagttgtctcgtggcgaggggcctgggtgtcctgccagccctccaccccaccccagcttctcccctggcccatcttgtttcttgtgcagtctcctcctttgcc	NULL	No	NULL	In	68.56	4.08	-4.64	59.69	8.88	4.48	-1.25	-1.25	1.04	5.38	8.3	10.1	-4.3	-2.6	6	0.13	5	0.36	307000	ENSG00000198910	94	120	L1 cell adhesion molecule
70	1	Human	81	HBA1	8	Alpha-thalassemia	E1+161G>A	-48	100	Exon	0	cgcgccagccaatgagcgccgcccggccgggcgtgcccccgcgccccaagCATAAACCCTGGCGCGCTCGCGGCCCGGCACTCTTCTGGTCCCCACAGACTCAGAGAGAACCCACCATGGTGCTGTCTCCTGCCGACAAGACCAACGTCAAGGCCGCCTGGG/GTAAGGTCGGCGCGCACGCTGGCGAGTATGGTGCGGAGGCCCTGGAGA(G>A)gtgaggctccctcccctgctccgacccgggctcctcgcccgcccggacccacaggccaccctcaaccgtcctggccccggacccaaaccccacccctcactctgcttctccccgcag	NULL	No	NULL	In	89.44	8.41	8.05	85.06	11.78	11.38	8.66	8.66	7.08	9.2	15.7	15	-8.6	-9.2	7	0.95	7	0.89	141750	ENSG00000206172	58	70	"hemoglobin, alpha 1"
69	1	Human	82	HBA2	8	Alpha-thalassemia	E1+135C>T	-28	100	Exon	1	cgcgccagccaatgagcgccgcccggccgggcgtgcccccgcgccccaagCATAAACCCTGGCGCGCTCGCGGCCCGGCACTCTTCTGGTCCCCACAGACTCAGAGAGAACCCACCATGGTGCTGTCTCCTGCCGACAAGACCAACGTCAAGGCCGCCTGGGGTAAGGTCGGCGCGCACGCTG/G(C>T)GAGTATGGTGCGGAGGCCCTGGAGAGgtgaggctccctcccctgctccgacccgggctcctcgcccgcccggacccacaggccaccctcaaccgtcctggccccggacccaaaccccacccctcactctgcttctccccgcag	NULL	No	NULL	In	89.44	8.41	10.1	85.92	11.78	14.48	9.66	9.66	9.36	9.2	15.7	18.8	-8.6	-7.2	7	0.99	9	0.89	141750	ENSG00000188536	57	69	"hemoglobin, alpha 2"
144	1	Human	11	BRCA1	24	Breast cancer predisposition	E4+56T>G	-22	100	Exon	1	cgcttgatcacagatgtatgtatgagtttatttctgtactgtcaattccattttattgatgtatgtgtctattcttatgctattaccacactttcttgattactatagctttgtggtgaggtgttgagattttaaactaattataagcatcttacatgaactacttaccgtttatatttgattatgcagcatgaaataattatgaatatatcattaaatatgccatattaacttttattaagttttatgtgatcataacagtaagccatatgcatgtaagttcagttttcatagatcattgcttatgtagtttaggtttttgcttatgcagcatccaaaaacaattaggaaactattgcttgtaattcacctgccattactttttaaatggctcttaagggcagttgtgagattatcttttcatggctatttgccttttgagtattctttctacaaaaggaagtaaattaaattgttctttctttctttataatttatagATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTA(T>G)/GTAAGAATGATATAACCAAAAGgtatataatttggtaatgatgctaggttggaagcaaccacagtaggaaaaagtagaaattatttaataacatagcgttcctataaaaccattcatcagaaaaatttataaaagagtttttagcacacagtaaattatttccaaagttattttcctgaaagttttatgggacatctgccttatacaggtattagaaacttactgcctttctctaatgcttctagtgtaaaaacttgcagacttatgtaaagtagggctgtatcgccgtgcccccattgtctgttaatcttgtttttatatttttgattgtgtttccttttctttttttttttttttttaagacagggtcctgctctgtcactgaggctggagtgcagtggcgtgatctcggctcactgtagcctctgtctcccagcctcttcctgccttagcctcccaaatagctgggactacaggcacacgctaccatgcccggccaatttttgtattttttgtagagat	NULL	No	-1	Out	77.25	7.84	9.14	94.5	11.08	12.18	9.69	9.69	8.32	6.68	12.3	18.6	-4.1	-7.3	7	1	8	0.92	113705	ENSG00000012048	113	144	"breast cancer 1, early onset"
276	1	Human	92	IDS	96	"Mucopolysaccharidosis, type II"	IVS7+5G>C	22	100	Intron	1	CGGAAAATCCGCCAGAGCTACTTTGCCTCTGTGTCATATTTGGATACACAGGTCGGCCGCCTCTTGAGTGCTTTGGACGATCTTCAGCTGGCCAACAGCACCATCATTGCATTTACCTCGGATCATGgtaa(g>c)cattttgaaattccctg/gtgagtcaaaacatctgaactttcctgtgaaacatgctttgcaaaattgccattgacataaacatgggtgtgttctcttttgtgaaccagtggttcacaaacaaagtgggatcctggggcatttttatgatcagcttgttagtcctgagacctctgtcttagatgcttgacggataggtgtgggtgggtgggggagggtcttgtagcaacttttttttttttcttgatgaatgcagcaggaaccctccatttgtgtggcagagctcttgtaacccccatttttaacctggagggttggaggacttttagtttgggtggagaggatccagaacaatcct	NULL	No	NULL	In	84.99	9.26	10.1	85.92	14.28	14.48	9.66	9.66	9.36	8.53	16.5	15.8	-5.9	-7.2	7	0.99	9	1	309900	ENSG00000010404	207	276	iduronate 2-sulfatase
262	1	Human	96	IRF5	145	Predisposition to systemic lupus erythematosus	IVS1+198G>T	196	NULL	Intron	0	cggagctcagcagcagctgcccaggggcgggggcggcaagacgcggaagtGCCCGGCAGGTTGGCGGACCGGCGGGAGGCGCAGCCTGGGCAGAGCTCAGCTTGGTCCCGCCGCCCGGCCGGTGCTCCCTGGCGCAGCCACGCAGGCGCACCGCAGACAGgtgggtcccggccgccgcgctctcctctctgcgtccgcgcccggcgcgccccgagggtggcgggagcggtgccggctactgcccccaagtctaggcctagactgggccccgcgccccccaggcacctgcgggcggcgggatgaagactggagtagggcggggtccgcgtccagctgcgcctggaaagcgagctcgg/g(g>t)gggtgcctacagcagggtgcgcccggccggcctgggacttccaaagcgcctcccacgccccgatcggtttggggtgctggcgcccggggagcccagtgacccaggcggcggagtgggcagcgctgcggggggcgccggctctgctgctctccctccccctcgccatcgcccagaatgggggttcccgggagccccgctggaggctggcttggaccacagagg	NULL	No	NULL	Out	NULL	NULL	6.14	74.71	NULL	10.28	NULL	7.04	6.79	NULL	NULL	12.4	NULL	-8.8	NULL	0.18	9	NULL	152700	ENSG00000128604	197	262	interferon regulatory factor 5
340	1	Human	46	DMD	133	Muscular dystrophy	IVS62+62296A>G	-32768	NULL	Intron	-32768	CGTCTGTCCAGGGTCCCTGGGAGAGAGCCATCTCGCCAAACAAAGTGCCCTACTATATCAAgtaagttggaagtatcacatttttaaaagagcatttattgtgactaacctgtatattcacaagtgagtttatttttaaaatgcgacattagcctggcctacaatacctgtgtcttttttttcctgaggaagcttggataaaaaacttattctaaaattaccattgtaaatttgctgatgcaatggggaacgacttttaagaaaagtttatttaatgcaggatatatggtgtgttttgtga........agaaaaaacactctgaaataatgggaagaaggaagttatgatatattagtcaggcagtagatataccttaagctgaaatgaaatacaggtatcatggatatgagatctgtatatgtagaggaaagagtaatggaaaaatgtcaggggcagtgaaagcaaatgagaagtgagatgatttatatttattgaactaatgtccggtatctctttgacagagttgaataataatcagttgtcggtgtcctttctgtag/TGTTCCACATTGGATGGGTGAAGAAGTCCTGATAGTCGATTATTGATCACATAACAAG/gtca(a>g)tttatcataactgaagtgcgatcgatttgtgggtgcaaagaagaaacaaattctggaaccgaataatgtttatattgcttttctctttggaaacaaagcagaaaggggcctttctgcttgtaagataaacatttcttcaatacactatggaagcgctttgaaataaagattccgaatggttcaaaagcaaaaatcatgttgttgttattgttgttttcttttttcctgttttcttgactactcattgtaaatgctaaagtctttctttatgttttgtgttttagCCACGAGACTCAAACAACTTGCTGGGACCATCCCAAAATGACAGAGCTCTACCAGTCTTTAG	Creates pseudoexon	No	5	Out	NULL	NULL	8.68	89.42	NULL	12.58	NULL	8.19	8.34	NULL	NULL	15.7	NULL	-6	NULL	0.94	7	NULL	181350	ENSG00000198947	258	340	dystrophin
55	1	Human	47	DPYD	48	Dihydropyrimidine dehydrogenase deficiency	IVS11+1G>T	-141	100	Exon	0	ctacagagtttctctagtctttttctcctacctaccattctaatcatgtacttgcacagattggctcacccactttattgacttttttccagcttggatgtatgcaacctggtaataaacagaagtatttattttaatatgcagcatgattaaaaaaagagaccttaatctactgaattgaaaacataaaaataataggctactatggtcagaaacctcacaaactaccaaatgtagagcatgcagtacttaaaacttgagaaataccttatgatgccgtgatctataaacgtccacattacaactccaattcaagactccctgagtcagtgatttacaaaatgcaaataactggtaactgaaactcaggtttggtgaaagaaaaagctgcatattgacttaatatcataagctttagcatgtgtaattcaattagaaatcaaatactgtgtggaataagaaacattttcaagtttcttctctgttctgttttgttttagATGGAACTTGCTAAGGAAGAAAAGTGTGAATTTCTGCCATTCCTGTCCCCACGGAAGGTTATAGTAAAAG/GTGGGAGAATTGTTGCTATGCAGTTTGTTCGGACAGAGCAAGATGAAACTGGAAAATGGAATGAAGATGAAGATCAGATGGTCCATCTGAAAGCCGATGTGGTCATCAGTGCCTTTGGTTCAGTTCTGAGTGATCCTAAAG(g>t)tacagtgctgggagctgaaatgtgtgatgcaattgtctgttattttagtgctgtaatagtttctagctttcagggaattgtttttcactttaaaatttattttcctcttctagttaagaagtaaaagcaatcttgattcaaaaggcttagaaatgttatttaatgcttatatagaattatttttaaagtggcaagtattgaaaagaacattaatctttcttttaagcttataaccaaaacacatattctactctataatgatatttgccttgtttcttatagaagaatggctttttcttcaattagactagagtaagaaaatgaggcagagtagttggaacagccagtcttcaatgattcagacaaatcaaaatctaatgaatggccaaaaatagaatttgtgtttattaccatccttgtgccagatcatcacttcagatgtcagaattatcaaattagaaagtttaaatgtctgtcattttcacctggatggcataaa	NULL	No	NULL	In	71.04	8.04	6.03	78.77	12.68	12.08	7.61	7.61	6.34	7.04	12.3	11.2	-4	-6.8	5	0.71	7	0.94	274270	ENSG00000188641	43	55	dihydropyrimidine dehydrogenase
172	1	Human	11	BRCA1	24	Breast cancer predisposition	IVS16+6T>C	69	100	Intron	0	CTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTgtgag(t>c)gtatccatatgtatctccctaatgactaagacttaacaacattctggaaagagttttatgtag/gtattgtcaattaataacctagaggaagaaatctagaaaacaatcacagttctgtgtaatttaatttcgattactaatttctgaaaatttagatctagataaagctatagtgtggattattttatgtatatttacttgagaaaataattattaaatattagtggaaaagctatactttggg	NULL	No	NULL	In	72.88	5.91	5.64	71.66	9.88	7.98	3.25	3.25	4.08	4.98	13.2	12.3	-3.9	-4	6	0.1	7	0.66	113705	ENSG00000012048	138	172	"breast cancer 1, early onset"
108	1	Human	105	LGMD2B	111	Limb girdle muscular dystrophy	IVS45+5G>A	-79	30	Exon	1	CTATGACCTCCTCTCCAAGGACGAAAAGATCG/GTGAGACGGTCGTCGACCTGGAGAACAGGCTGCTGTCCAAGTTTGGGGCTCGCTGTGGACTCCCACAGACCTACTGTGTgtac(g>a)tggatgggggctggctgcctgcttctctgacaacacaccacccctgtcttctctgacaacacaccaccactgagcacttactgtgtgccagccctgggcttagcacttc	NULL	No	NULL	In	66.18	3.32	8.51	79.73	7.68	12.88	5.97	5.97	8.62	5.15	10.7	13.6	-0.6	-6.1	5	0.95	6	0.08	253601	ENSG00000135636	84	108	"dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive)"
#277	1	Human	25	CLN6	136	Neuronal ceroid lipofuscinosis (NCLs)	IVS5+5G>T	-386	20	Intron	2	CTCATCGAGCGGTCCCCCCGCACCCTGCCACGCTCCATCACGTACGTGAGCATCATCATCTTCATCATGGGTGCCAGCATCCACCTGGTGGGTGACTCTGTCAACCACCGCCTGCTCTTCAGTGGCTACCAGCACCACCTGTCTGTCCGTGAGAACCCCATCATCAAGAATCTCAAGCCGGAGACGCTGgtgaggccacctcctgctccctgcct/gtaagccctaggagcacagtctgtcctgggaggctgaagaaatggcccccacccctcgccgcacctgtcctttcaccaaaggcattctgctaggtgagggcactgtcgcctgccccaagctaggatgctcaagtgttcttaggaagtggtgcacagactgcctcccacctgggcccctgtaacagaaggcgaggccccgggtagggaataaggcagtgggggaggcctgggactgggagaagggtggtcagaggggatgcttggggccccagcacctccctggactgacatcgacatcccccgactctgccctgcccgttcctccctcagATCGACTCCTTTGAGCTGCTCTACTATTATGATGAGTACCTGGGTCACTGCATGTGgtga(g>t)tgatgggcccatctgtctatcccaggggccccaactaccggctagccctgtcactggctcagggacacactgagcaaggctgtctgggctgcgggtctccatgtgttgagtctcatcccctgtaaaggcactgtgagctcaacctccagtgaagttgtccccgaggttgcccgggagacccagctgctgtcccaggctccaggccccggcttccagccagcatccccccagcatcgccacccccgcccagccctcagtgcccgctgtggccagcagagggcagcgagtggctttggtccttcctcgccaagcctgagccctgagggtgggggaggaggacgcgtccctgataaacaacccccagatggtgatggcagggggtgggggcacagccagggacccccacccgtgtcgggcctgctctttgggagtggaggaagctgcggggagccagctggatcaggctggggaggggcgtgctgtttgcgctccccc	NULL	No	NULL	In	85.92	8.95	3.69	71.25	12.88	10.88	5.39	5.39	5.11	8.31	15.6	12	-7.2	-2.6	8	0.89	6	0.91	601780	ENSG00000128973	208	277	"ceroid-lipofuscinosis, neuronal 6, late infantile, variant"
#278	1	Human	25	CLN6	136	Neuronal ceroid lipofuscinosis (NCLs)	IVS5+5G>T	-293	20	Intron	2	CTCATCGAGCGGTCCCCCCGCACCCTGCCACGCTCCATCACGTACGTGAGCATCATCATCTTCATCATGGGTGCCAGCATCCACCTGGTGGGTGACTCTGTCAACCACCGCCTGCTCTTCAGTGGCTACCAGCACCACCTGTCTGTCCGTGAGAACCCCATCATCAAGAATCTCAAGCCGGAGACGCTGgtgaggccacctcctgctccctgcctgtaagccctaggagcacagtctgtcctgggaggctgaagaaatggcccccacccctcgccgcacctgtcctttcaccaaaggcattctgctag/gtgagggcactgtcgcctgccccaagctaggatgctcaagtgttcttaggaagtggtgcacagactgcctcccacctgggcccctgtaacagaaggcgaggccccgggtagggaataaggcagtgggggaggcctgggactgggagaagggtggtcagaggggatgcttggggccccagcacctccctggactgacatcgacatcccccgactctgccctgcccgttcctccctcagATCGACTCCTTTGAGCTGCTCTACTATTATGATGAGTACCTGGGTCACTGCATGTGgtga(g>t)tgatgggcccatctgtctatcccaggggccccaactaccggctagccctgtcactggctcagggacacactgagcaaggctgtctgggctgcgggtctccatgtgttgagtctcatcccctgtaaaggcactgtgagctcaacctccagtgaagttgtccccgaggttgcccgggagacccagctgctgtcccaggctccaggccccggcttccagccagcatccccccagcatcgccacccccgcccagccctcagtgcccgctgtggccagcagagggcagcgagtggctttggtccttcctcgccaagcctgagccctgagggtgggggaggaggacgcgtccctgataaacaacccccagatggtgatggcagggggtgggggcacagccagggacccccacccgtgtcgggcctgctctttgggagtggaggaagctgcggggagccagctggatcaggctggggaggggcgtgctgtttgcgctccccc	NULL	No	NULL	In	85.92	8.95	7.65	89.44	12.88	10.58	8.72	8.72	7.39	8.31	15.6	15.7	-7.2	-8.4	8	0.96	8	0.91	601780	ENSG00000128973	208	278	"ceroid-lipofuscinosis, neuronal 6, late infantile, variant"
151	1	Human	152	TAZ	16	Barth syndrome	E6+65G>A	-19	100	Exon	1	ctccgagagcggtcggctggcagccagggcctggctggggagggagggcaggtggtgcgctgacctggggatctttgagagtgtgcaggagtatgtggctgaagcggcccagctggtgagccactgaagatgggggtcataggtagatggaggaattgccaggtcagaatctcggtaggagatgacttgagctgatgctgcctggcacataggggtttagaagatattaggaaggaagccccacagcgtgcccaagtgccatgcaggccctggagacggtcattggagggcgtctgtggatggcgcagtgggggatgggaagtccctaatctgctggggctttcccagcaagcagggactgagggggatagtccccaacacatgggccccagggagaagggcctgtttcattgaggtttggagagtgttgagggtaagctaacctgtcaccccacgcccccgagaatggttactgatagggagaggccttttccttgcagGAGATGGCGTCTACCAGAAGGGGATGGACTTCATTTTGGAGAAGCTCAACCATGGGGACTGG/GT(G>A)CATATCTTCCCAGAAGgtcagcagggctgactgggtcgagcccccccagtatgagcgggatgggctcccaagcctcgcctctgtgctctctcaccag	NULL	No	3	Out	83.32	7.09	1.38	66.88	12.18	6.28	2.32	2.32	4.08	6.77	13.4	11	-4.6	-4.6	6	0.15	6	0.86	302060	ENSG00000102125	119	151	tafazzin
109	1	Human	28	COL1A2	137	Osteogenesis imperfecta	IVS40+5G>A	-66	NULL	Exon	0	ctctcttccaggcccttggtgattaacagaaaggaaatgaccttgtacatttgctcatagGGTATTTCTGGCCCTCCTGGTCCCCCTGGTCCTGCTGGGAAAGAAGGGCTTCGTGGTCCTCGTGGTGACCAAGGTCCAGTTGGCCGAACTGGAGAA/GTAGGTGCAGTTGGTCCCCCTGGCTTCGCTGGTGAGAAGGGTCCCTCTGGAGAGGCTGGTACTGCTgtaa(g>a)tgatttccaactcctctttcttaataccttatgctgaattaaaataaagcccctacacaaatcttcaagtggcatctatttgttgatgagtattgcaggctctcaagtagagctcagttgagccaggaaatctgtccagcacacactgaggggctgtggcttccaagatgctca	NULL	No	NULL	In	77.36	8.56	6.22	77.02	12.68	8.98	6.33	6.33	6.08	6.46	14	11.3	-4	-4	6	0.71	7	0.96	166210	ENSG00000164692	85	109	"collagen, type I, alpha 2"
59	1	Human	104	LDLR	61	Familial hypercholesterolemia	IVS15+1G>A	-121	NULL	Exon	1	ctgagtagctgggagtacaggtgtgcaccaccacacctggctaatttttttttttttttttgtatatagagatggtattttgccatgttgaccaggctagtcttaaactcctggactcactcaagagatcctcctgccttggcctcccaaggtcatttgagactttcgtcattaggcgcacacctatgagaagggcctgcaggcacgtggcactcagaagacgtttatttattctttcagAGGCTGAGGCTGCAGTGGCCACCCAGGAGACATCCACCGTCAGGCTAAAG/GTCAGCTCCACAGCCGTAAGGACACAGCACACAACCACCCGACCTGTTCCCGACACCTCCCGGCTGCCTGGGGCCACCCCTGGGCTCACCACGGTGGAGATAGTGACAATGTCTCACCAAG(g>a)taaagactgggccctccctaggcccctcttcacccagagacgggtcccttcagtggccacgaacattttggtcacgagatggagtccaggtgtcgtcctcactcccttgctgaccttctctcacttgggccgtgtgtctctgggccctcagtttccctatctgtaaagtgggtctaataacagttcttgccctctttgcaaggattaaatgggccaaatcatatgaggggccaggtccttcaggctcctggttcccaaagtcagccacgcaccgtgtgggtcccaaaattttat	NULL	No	NULL	In	82.26	9.06	7.09	83.32	13.78	12.18	6.96	6.96	6.77	7.72	14.1	13.2	-5.4	-4.6	6	0.88	6	0.99	144010	ENSG00000130164	47	59	low density lipoprotein receptor
221	1	Human	104	LDLR	61	Familial hypercholesterolemia	IVS15+1G>A	90	NULL	Intron	0	ctgagtagctgggagtacaggtgtgcaccaccacacctggctaatttttttttttttttttgtatatagagatggtattttgccatgttgaccaggctagtcttaaactcctggactcactcaagagatcctcctgccttggcctcccaaggtcatttgagactttcgtcattaggcgcacacctatgagaagggcctgcaggcacgtggcactcagaagacgtttatttattctttcagAGGCTGAGGCTGCAGTGGCCACCCAGGAGACATCCACCGTCAGGCTAAAGGTCAGCTCCACAGCCGTAAGGACACAGCACACAACCACCCGACCTGTTCCCGACACCTCCCGGCTGCCTGGGGCCACCCCTGGGCTCACCACGGTGGAGATAGTGACAATGTCTCACCAAG(g>a)taaagactgggccctccctaggcccctcttcacccagagacgggtcccttcagtggccacgaacattttggtcacgagatggagtccag/gtgtcgtcctcactcccttgctgaccttctctcacttgggccgtgtgtctctgggccctcagtttccctatctgtaaagtgggtctaataacagttcttgccctctttgcaaggattaaatgggccaaatcatatgaggggccaggtccttcaggctcctggttcccaaagtcagccacgcaccgtgtgggtcccaaaattttat	NULL	No	NULL	In	82.26	9.06	3.7	66.02	13.78	8.28	3.98	3.98	3.95	7.72	14.1	11.8	-5.4	-4.6	6	0.04	6	0.99	144010	ENSG00000130164	47	221	low density lipoprotein receptor
337	1	Human	142	RYR1	132	Multi-minicore disease	IVS100+2990A>G	-32768	NULL	Intron	-32768	CTGGTGATGACCGTGGGCCTTCTGGCGGTGGTCGTCTACCTGTACACCGTGGTGGCCTTCAACTTCTTCCGCAAGTTCTACAACAAGAGCGAGGATGAGGATGAACCTGACATGAAGTGTGATGACATGATGACGgtgagcccctcccctagcactctgggacccttccttctcgcatctgttgaaggagttaataatggtacctccaggccgggcgtggtgcctccagcctgcaatcccagtgcgtcgggaggccgaggcgggacgattacttgagtccaggagttggaaaccagcctgggcaacaaagcaaaaatcctgtctctataaaaaaaaatttaaacgttagctgggtgttgtgttgtgtgcctggaggctaaggcaagaggatcacttggtcccagcagtttgaggctttagtgagctacgaatgggccactacactccatcctggcagacagacagagaccctatctctaaaaaatgaaaatagtacctacagtttggcaagctgatgcatgccaggcacattttttttttttttttttgagatggagtctcactgtgttgccaggctagagtgcagtggcgcaatctcagctcactgcaacctccgcttcctgggttcaagtgattctcctgcctcagcctcccaagtagctgggactacaggcgcatgccaccacacccagatactttttgtattcttaattttctttctttcttttttttttgagacagagtctggcccaggctggagtgcagtggcgtgatctcagctcactgcaagctccgcctcccgggttcatgccattctcctgcctctgcctcccgagtagctgggacaacaggcgcccgccaccacgcctggcaaattttttgtatttttagtagagccggggtttcaccatgttagccaggatggtctcgatctcctgacctggtgatccgcccgcctgggcctcccaaagtgctgggattacaggcatgagccactgcgcccggccaatttttgtattcttagtagagacggagtttcaccatgttggccag.....tggccaacgtggtgaaaccctgtctccactaaaaatacaaaaattagtgggatgtggtggtgggcgcctataatcccagctacctgggaggctgaggcaggagaatctcttgaaccccggaggcggaggttgcagtgagccgagatcacgccattgcactccagcctgggcaacaagagcaaaactccatctcaaaaaaaaaaaaaaaagaaaaaagtacaaaaattagctgggtggggtgacacgcacctgtattcccgactactcag/GAGGCTGAGGCAGGAGAATCTCTTGAACTCGGTGGTGGAGGTCGCAGTGAGCCAATATTGCACCACAGCACTCCAGCCTGGGCAACAGAGCAAGACTCTGTCTCAAAAAAAAAAAAAAAC/(a>g)tatgtaaagttgttcccaaatgccaggtagaccatgctccctccccacccccactcagacccttcttgtggctccccagcccactgtagataaagtcgaatcaccctgccgtggcttacaaagcctgggaagggctggccctgcctgggtctaaccgcaaaccctcttgctttttgctttctagccgcctggtcctctttcagttcccctaggactgtgtgttttctcccaattcaagccctttgcacctgatgttctctctgtcccctaccccaggcctgacatacacacacaccccattcacttgatacctcacctttccacttaaatgccacatcctacaggaagccccttgaccgcgggctgggccagggcccacagagccacatgcccaggccctgcctcatctctccctgctctcctgcacaggagctctattttccagc.........cccccttatcctggccctgattcccctgccagtgccccccatcccagccctgacccctctgcctgtgccccccttatcctggccctgacccctctgcctgtgccccccatcctggccctgacccctctgcctgcgccccacacccaacctggccctcacccccctgcccgtgctgttcctgtcacagccctgaccatttctggctgttggtccctgtctgatgccgtatctgtgagccctttgagggcagggcccagggctgtctcagtcgttaccatgtcttcagccctgcctatcccggggccttggctggtactcagtgaatgtcgaatgaatgagtgaccagtgtgctcccctccctcagTGTTACCTGTTTCACATGTACGTGGGTGTCCGGGCTGGCGGAGGCATTGGGGACGAGATCGAGGACCCCGCGGGTGACGAATACGAGCTCTACAGGGTGGTCTTCGACATCACCTTCTTCTTCTTCGTCATCGTCATCCTGTTGGCCATCATCCAGGG	Creates pseudoexon	No	1	Out	NULL	NULL	7.69	75.8	NULL	9.78	NULL	6.91	7.01	NULL	NULL	12.8	NULL	-0.9	NULL	0.94	7	NULL	117000	ENSG00000196218	256	337	ryanodine receptor 1 (skeletal)
175	1	Human	1	ABCD1	183	X-linked adrenoleukodystrophy	E1+99G>A	9	NULL	Intron	0	CTGGTGGCAGAGGAGGCGCGGCGGAAGGGGGAGCTGCGCTACATGCACTCGCGTGTGGTGGCCAACTCGGAGGAGATCGCCTTCTATGGGGGCCATGA(G>A)gtggggcag/gttggggtgccgggcacggagggaagcgtgtggcagggaggcccgggggcaggcagccgtgagcggtggggacagtctggggcgggccggggctgatgccaaaggtgtgggcaggccatgggagagccgggctggggtgggcagggcctttgggcagccgtggactcaggc	NULL	No	NULL	In	78.87	4.41	5.26	73.47	9.88	8.68	4.82	4.82	5.51	5.87	11.2	11.8	-8.1	-6.8	7	0.09	8	0.2	300100	ENSG00000101986	140	175	"ATP-binding cassette, sub-family D (ALD), member 1"
153	1	Human	117	MVK	100	Hyperimmunoglobulinemia D with periodic fever syndrome	E1+91C>T	-5	100	Exon	2	ctggttctgacatctagagatctttgctcttctcattggctttcccttttAGGATTCCCAGGAGCCATGTTGTCAGAAGTCCTACTGGTGTCTGCTCCGGGGAAAGTCATCCTTCATGGAGAACATGCCGTGGTACATG/G(C>T)AAGgtacaaagccgttagagcctttaaggattgggtaccccttctccctgatgctaattttgtaagaaggtaaaaggacaccctgaggcacagcttgggagcagatcagagagatcaggttctccccagccaggcaaggaaaagatttcttatgcccactgaagggattcttgggcctcgctcggtatgatagcaaaaagatgattataatataaagccctgtgagtggaatgagatcacctaggagtgagctttgatgcagaaggaaagaggtttgagaactgagctccggggcactaagacatttagaagttggaaggatgatctagcaaaggagttgaaaacatccattatctcattttacccttacagctacccccaaggcatacccttttattatcctattttacaaatgtgcaaactgaggcttaggagagaagtggtaacttgatccaagtcctatataccttggtagagcttggtgtgaacctaagtctgtctga	NULL	No	2	Out	70.93	6.82	9.33	85.71	12.18	13.08	9.74	9.74	8.41	6.32	12.3	15	-4	-7.1	5	0.99	7	0.89	260920	ENSG00000110921	121	153	mevalonate kinase
265	1	Human	46	DMD	133	Muscular dystrophy	IVS5+1G>C	31	NULL	Intron	1	cttaccttcaaatgttttacccctttctttaacagGTTGATTTAGTGAATATTGGAAGTACTGACATCGTAGATGGAAATCATAAACTGACTCTTGGTTTGATTTGGAATATAATCCTCCACTGGCAG(g>c)taagaatcctgatgaatggtttccttttgg/gtaacattaatcttgttttttaatttttacccttgacgtgtgaaacaaatgtgtatttctaacaataacaaaccctgctccatagtgct	NULL	No	NULL	In	94.5	10.77	3.35	71.95	14.98	6.68	3.58	3.58	4.04	11.11	20.3	12	-8.2	-5.7	8	0.21	6	0.99	181350	ENSG00000198947	75	265	dystrophin
18	1	Human	14	BTNL2	157	Sarcoidosis	E5+348G>A	-4	NULL	Exon	1	CTTCTTTAAAAGTGAATGGACCTTCCCAGCCCATCCTCGTCAGAGTGGGAGAAGATATACAGCTAACCTGTTACCTGTCCCCCAAGGCGAATGCACAGAGCATGGAGGTGAGGTGGGACCGATCCCACCGTTACCCTGCTGTGCATGTGTATATGGATGGGGACCATGTGGCTGGAGAGCAGATGGCAGAGTACAGAGGGAGGACTGTACTGGTGAGTGACGCCATTGACGAGGGCAGACTGACCCTGCAGATACTCAGTGCCAGACCTTCGGACGACGGGCAGTACCGCTGCCTTTTTGAAAAAGATGATGTCTACCAGGAGGCCAGTTTGGATCTGAAGGTG/GTA(G>A)gtaagaattctagatagatattttgtattcaatacctgctcctgccactttaatatgctagttcctggacaatttctctgacatttgaaattttcttaatgcttattcatcatcaaatttatatcaaatcctccagtgtgtgaaactgtcatagttacttaaaatccacaaactcaaatggatgaaatttaattatttgg	NULL	No	NULL	In	94.5	9.14	10.36	91.1	12.18	14.28	9.83	9.83	9.19	8.32	18.6	18.7	-7.3	-7.3	8	1	8	0.98	181000	ENSG00000204290	16	18	butyrophilin-like 2 (MHC class II associated)
241	1	Human	134	PROS1	151	Protein S deficiency	IVS4+1G>A	48	NULL	Intron	0	cttgtagatttttaatttttcagaaaggtagatggaaacatttagtgttgcattttgaagactgaatcttgtgaatctacaggagcataaatgtcctacctcttgggacagttcctaccatgaattcagatcaagtatgtgtgtctactctaagaagattatgtttgtttttattttcagTTTGTCTTCGCTCTTTTCAAACTGGGTTATTCACTGCTGCACGTCAGTCAACTAATGCTTATCCTGACCTAAGAAGCTGTGTCAATG(g>a)taagcacttctaccatcaattgaaaaaacaaaacaaaaactctgtag/gtaaagtacacccatggtaatataaactaacgtttaaaaattgagaaatgatcctttgatgggttgtatgcccagcaaggaagtattttcaaactgcatttctaatacttgtttatagttgtaaatgctcctgtattactcaaaatgaatttttttgcctaatgtttaaactgaacagtgttctctgttcct	NULL	No	NULL	In	84.99	9.26	6.93	82.26	14.28	11.08	6.65	6.65	5.49	8.53	15.2	14.1	-5.9	-5.3	7	0.34	7	1	176880	ENSG00000184500	186	241	protein S (alpha)
254	1	Human	46	DMD	133	Muscular dystrophy	IVS26+2T>G	117	NULL	Intron	0	ctttctgttatttacatactgatgaaataatataataataatgtttcatcactgtcaataatcgtgttttgtttgtttgttttgtggaagGTCTATGCCAGAAAGGAGGCCTTGAAGGGAGGTTTGGAGAAAACTGTAAGCCTCCAGAAAGATCTATCAGAGATGCACGAATGGATGACACAAGCTGAAGAAGAGTATCTTGAGAGAGATTTTGAATATAAAACTCCAGATGAATTACAGAAAGCAGTTGAAGAGATGAAGg(t>g)aaaaaaaaaaaaagaaaaactaagtaaaacaaaggaaataaatggaaaaagaaagaaatgcaacaatgcttgaagttgtatacagtctgctctttcctggttctaagagaagag/gttgatttttaattaataattttaatttagcttcaagtttaatatacattttaacaaccttaaactgtttaattttaatgcattgtggtcaattatgaaaattgaaaatcacaatttgaaacaattttcccttgaaatcatgtagtatta	NULL	No	NULL	In	82.16	8.38	1.52	66.51	13.28	3.98	1.09	1.09	2.13	7	14.1	10.1	-5.4	-2.6	6	0.04	6	0.91	181350	ENSG00000198947	156	254	dystrophin
321	1	Human	126	PHEX	189	X-linked hypophosphatemia	IVS7+1268G>T	-32768	NULL	Intron	-32768	ctttgagtacagagtgaaaataaaagacatttatttctacctgctattttctgctcttccatgtctctcaaacatatttcctaagaagctattgtcatggtcactttgttctttatttcttacagTATCGGGATGCCCTTTACAAGTTCATGGTGGATACTGCCGTGCTTTTAGGAGCTAACAGTTCCAGAGCAGAGCATGACATGAAGTCAGTGCTCAGATTGGAAATTAAGATAGCTGAGgtaagtcttcactgaaaatctctttctttcctttactttcttttcttttcctttactttcttttcctttccttttattaaaggcagtatatcctgaatgaaaatataaattgcaaacaaataatagcgttttgtgtcattgcccattgggcccaaggtagaactaatagcatcccctctaggaagtaacaaggactgtgacagaaaagctcctcattccttccacctccctggtttaagcccattcagtgtccatacgttgctcagctgtggccaaagaatagcagcagagagaccctctgaccgtttttcctggagaaactcatgtttggcttaaatagaagatagatgtttaataaatccttagtaatctggcttgaatggaaggttgcttttaatccagcccatgttttatgctatccccactcagagtcattctggcttaagttctgggctcagggaaatctgtccaccaatactggatataaaagttggtatagaaataggtaggacatgctggtaagcatttttaaacgacctttctggtattactttgtacctgcccctgtttttcattattttcttgccctactttaatgaatatcattgtgtcatatacatgacacagaactacatgtctatgtaaattaccttaacttcttgttggctcattgtagagacaaaaagatgtaaaaacaaacttgtgggcaaaataatgagaactcctaaatggttagctttgtttatggaataacttttttctagaagaaagaaagtgtaaaaatctctctatatgttcctaggccaagagggaataaatgtggtaaaatctgcttctggggaaaccctgtagtgaaaaaaatgatactttttaccaagaaagttttgcgtatgtgttgggaatcttttacaagagaagttggtaaaaatctcgagatgaataagagtccaaatgttgattggttttgtttggcgaggtggtggtggtgtgttgaggtatggagtagggatgaaggataagggtaaggaggaattggtctctctctctttgccgtggtgatgttcgtgtatagctctctccaaactcctacttgcag/(3?ss1)TGCAAAAAGTTCATTCCTGCATGTCACCTTTGAAGACTGTGAAGACTGCTGCAGATGTTTCGAAGTCCAG/(3?ss2)GACTGTGCCTCTGAGCCATGTCTAGAGTCTGTCTGAATTCTCTTTCCAG/(3?ss3)GCACATAGGAGGCCCAGGGCTCTCATTTGGACTAAAACTCTGAAACAGCAG/g(g>t)aaggccttgccctgagccagggatttggaccaaaaagggaactaaaaacagctgggctgaggcaagactgggaattgtcaaaaggctaaatgaagtgacaaatctattgtgtggaggggagtggctggcagagagctgaaaacagctctgaggccaaagggctccaacttggggctgtgagactccgagggcggaggagggattggtggaagaggagtgtggatatcctctgaggcaatgattcacaccgagccaggaggctgtttgtaagttacatgtggtctctcctgtggagggtgaagaaagggaagctaaggacactgaagcatttagcaaagaggggccagacgtctgccagtcagccctctgtaatttttaccttgaaaaatcactgctagtaatgctcacttccatatcttacactacacatcactaggtacttttaaaattagtgggatacatagtcctatggaaacttctgaagctgggaagacaagacagtccagcccagccaaatacgtccttgtaattacaaccagggaagcatatacttaaccaatccagctagagagatgtgtgcacaaggagaggttttattgatggagtagcccttgtgattggaaccaagtggagtgtaattggaaaggcttgctagatgcagtgagtcttgggcagtcctgagtcatagttcaaaccatggaggtggtgatggtggataggagatgcaagagtcggagagtcatgtgtgcagtgggaaggtggcaagtttaatgcaagggaattagatgatggaaggcccgaaggcaaagtcatgacgtgattgaggggtggatatgtgagctactgctggtcaatggaagtgattaagatgatccttgaggaagataatcattgctgctgttcttaggttaaacatagtggaggctagaagctcagatttggtgttggccaaatggccaagagcatgagtattaggaattgaaagagtatagagccagggctagagagaggcaagttttgaaatgtgtgtccaggcggtgactaaatccatacccccagcaatggggctagggaaatctcaaggccaaagagacaagaggggaaatgagggaatgagctgttgacaaaatgatcacggggaacagtggcatccagatagtcttgtgttcatcagtgaaaatttgcccctagaggtgaagggatggtctgtggttcatgaaatattgaaatcattatctggagaccacaggtgacaatgggatgtttacctcaatgtccaacttaagtttgattgtcaaaattgagccagcaatagattttgcccatccacattatagattgggagggagatttggggtagttctttttgtactggggacaatatttcacacagaggaggatatgaaagtttattttcttaatcctgcctaaagtgatgtctttttttctcttccccgagttggggaccacaccaaagccttgaaaaactttataatactatgcagatgttttggcacatgtaggaagtaatcatacagtaagaaatggttcacttgaaaaaaaataacaaaaatctcttttcaacagATAATGATTCCACATGAAAACCGAACCAGCGAGGCCATGTACAACAAAATGAACATTTCTGAACTGAGTGCTATGATTCCCCAGgttggtgaaaactatccagaaaactttctctcaactcatcattttagaagggattggattTcatctctgtgtaaatttgtgtcttgtaaaacctgctctcagtcttggttatcatcatct	Creates pseudoexon with 3 alternative 3'ss	No	2	Out	NULL	NULL	11.08	94.61	NULL	14.98	NULL	12.14	11.06	NULL	NULL	18.8	NULL	-9.4	NULL	1	8	NULL	307800	ENSG00000102174	242	321	"phosphate regulating endopeptidase homolog, X-linked"
314	1	Human	112	MLH1	89	Hereditary nonpolyposis colorectal cancer	IVS13+13T>A	13	NULL	Intron	1	cttttcttcattgcagAAAGAGACATCGGGAAGATTCTGATGTGGAAATGGTGGAAGATGATTCCCGAAAGGAAATGACTGCAGCTTGTACCCCCCGGAGAAGGATCATTAACCTCACTAGTGTTTTGAGTCTCCAGGAAGAAATTAATGAGCAGGGACATGAGGgtacgtaaacgc(t>a)/gtggcctgcctgggatgcatagggcctcaactgccaaggttttggaaatggagaaagcagtcatgttgtcagagtggccactacagttttgctgggcaagctcctcttcctttactaacccacaatagcatcagcttaaagacaatttttgattgggagaaaagggagaaaaataatctctgtttattttaattagcattaattggtattcttgttaaaccatagga	Accession number not available from the reference	No	-1	Out	79.23	9.15	-12.55	43.13	12.28	-4.22	-2.46	-2.46	-1.64	9.25	15.4	4.5	-6	-1.4	7	0	3	0.99	609310	ENSG00000076242	237	314	"mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)"
61	1	Human	134	PROS1	90	Protein S deficiency	IVS10+1G>A	-32	90	Exon	2	cttttgatgaataaaccaacgatgaaattgtaacacattttatgatcacttatggatacagcaaaaacaaaaacaaacaaaaaagaacaacaacaaaaaaaactaccacttcttaatgtcagattatatagtgtataaaaggctccaggagagatatagtatgcctgatacttatacctgtgtattaatttcagcatttggaaggtgctatcaaaatatatgtcaaagaaagatgacaaattaccaaagcatctgttccctggggaaaagattccaagaataagcaagaaaatataataacttaattttaaacgtacatggaaccagagataatacatgagcagtctaattctgcccttctcttttattaattccagaaaaagaaataaataattgactctttgtctgtgttactgtttgtcagtacaagaaaaaaagaataatgcattgagctttctgtatttcttactcttaaggatctctctttgtccattgtttagATTTTCAGCAGAATTTGATTTCCGGACATATGATTCAGAAGGCGTGATACTGTACGCAGAATCTATCGATCACTCAGCGTGGCTCCTGATTGCACTTCGTGGTGGAAAGATTGAAGTTCAGCTTAAGAATGAACATACATCCAAAATCACAACTGGAG/GTGATGTTATTAATAATGGTCTATGGAATATG(g>a)tacgtttgcagatttcatcaatatcttcccactttgatgcagtctgtataaaatcataatttatttttatagtgataccaaaccaaaatggatttggagttatctgatgctatatgaggtatattctacatactgtaaatccctgaagcatcctgagaaataatattctcacttaatatattagaatcattgtttttagttatttgcttgaactactctgtctttaactttttaccttttttagttgctgtttggtgaacagtggtgttagggactattaggaggcctaacatttttttttttttttgagacagagttttgctcttgttgcccaggctggagtgcagtggcgtgatctcagctcactgcaacctccacctcccaggttcaagtgattctcctgttttggcctctcgagtagctgggattacaggcatgcgccaccatgcccggctaattttgtgtttttagtagagacggggtttctccgtgttggtcc	NULL	No	NULL	In	79.87	9.89	4.44	76.89	12.78	8.88	5.65	5.65	6.13	9.35	14.2	10.7	-3.9	-5.2	7	0.05	6	0.99	176880	ENSG00000184500	49	61	protein S (alpha)
300	1	Human	98	ITGA2B	72	Glanzmann thrombastenia	E1+220G>A	7	NULL	Intron	1	gaaaagacttcctgtggaggaatctgaagggaaggaggaggagctggcccATTCCTGCCTGGGAGGTTGTGGAAGAAGGAAGATGGCCAGAGCTTTGTGTCCACTGCAAGCCCTCTGGCTTCTGGAGTGGGTGCTGCTGCTCTTGGGACCTTGTGCTGCCCCTCCAGCCTGGGCCTTGAACCTGGACCCAGTGCAGCTCACCTTCTATGCAGGCCCCAATGGCAGCCAGTTTGGATTTTCACTGGACTTCCACAAGGACAGCCATGGGA(G>A)gtgagcc/gtaagggaagttggggtattgggagagagcaggacccctccccatcactgcttctgggggcttcgagtttcccatttgcgatagcagttgagc	NULL	No	NULL	In	88.72	8.7	5.46	71.22	12.28	10.88	5.73	5.73	6.27	9.33	15.7	12	-7.4	-4.1	7	0.4	5	0.96	273800	ENSG00000005961	223	300	"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)"
101	1	Human	155	TP53	32	Colorectal carcinoma	IVS5+5G>C	-46	NULL	Exon	1	gaaaagctcctgaggtgtagacgccaactctctctagctcgctagtgggttgcaggaggtgcttacgcatgtttgtttctttgctgccgtcttccagttgctttatctgttcacttgtgccctgactttcaactctgtctccttcctcttcctacagTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAG/GTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGgtga(g>c)cagctggggctggagagacgacagggctggttgcccagggtccccaggcctctgattcctcactgattgctcttag	NULL	No	NULL	In	79.82	8.27	-2.93	60.92	12.88	3.58	-0.29	-0.29	1.04	7.65	13.8	10.1	-5.8	-5.4	7	0.01	5	0.93	191170	ENSG00000141510	77	101	tumor protein p53
72	1	Human	141	RPGR	147	Primary ciliary dyskinesia	631_IVS6+9del	-92	100	Exon	2	gaatgggaaagggtgattgtaggaaagggcattctgtctttgctatcgagataaaaatatggtcaggacttaagtgatttacaatcaggctgttctgtgttctttatcattatagaagcatttcacaatataaattgaactcttaagtagctagctggtgtaaatgtcttagtagtactttattgttaagatacataatttttatgaactaataaaataaatggtcttttggaagtataatagcttcagagcctggctaccttttaaaaccttttctcccccttttatttttctttatagAGGATGGAAGACTTTTTATGTGGGGTGACAATTCCGAAGGGCAAATTGGTTTAAAAAAT/GTAAGTAATGTCTGTGTCCCTCAGCAAGTGACCATTGGGAAAC(CTGTCTCCTGGATCTCTTGTGGATATTACCATTCAGCTTTTGTAACAAgtaagacac)attttgaagtcatcatgttatctcccacttctatgttgttattaaattaataatgaaatgatatagtctctggttctatagaaataatgccatggttgtccatgtaatgaaattattttggtctgttttaggtcacagtatttccccatttatataataagagttcataatttcaaactctgtctgacatgatcactttttaggtgaatatagagagctcagcatgggatatagtttcctttggtgggactttctcagcattcccaacttctccctttcctggacccactg	NULL	No	NULL	In	82.08	7.61	8.62	86.96	11.08	14.08	8.59	8.59	7.47	7.43	14.1	16.1	-2.8	-4	7	0.97	7	0.92	242650	ENSG00000156313	60	72	retinitis pigmentosa GTPase regulator
110	1	Human	92	IDS	96	"Mucopolysaccharidosis, type II"	E6+171G>C	-28	NULL	Exon	1	GAATTTCAGAAGTTGTATCCCTTGGAGAACATCACCCTGGCCCCCGATCCCGAGGTCCCTGATGGCCTACCCCCTGTGGCCTACAACCCCTGGATGGACATCAGGCAACGGGAAGACGTCCAAGCCTTAAACATCAGTGTGCC/GTATGGTCCAATTCCTGTGGACTTTCA(G>C)gtatcaaggacatagtttggggatgtattggacactgatgacatagtgtcgtaggtgaaaccactcttctcagtagacacaactccacctataatgtcttattaagagctttctttgtgtgagttatcaggcaaagtgctggggtggaggtgtcctataggtatttaggacacaggcagtgttgcctggatcaggactctcccaaccagtgtcttactttctaaagaagggaatgtccag	NULL	No	NULL	In	71.09	7.33	1.66	60.81	10.88	5.58	2.79	2.79	4.12	6.05	14	8.7	-4.9	-0.1	7	0.01	5	0.75	309900	ENSG00000010404	86	110	iduronate 2-sulfatase
73	1	Human	153	TCIRG1	95	Human malignant infantile osteopetrosis	IVS2+4A>T	-42	100	Exon	0	GACCATGGGCTCCATGTTCCGGAGCGAGGAGGTGGCCCTGGTCCAGCTCTTTCTGCCCACAGCGGCTGCCTACACCTGC/GTGAGTCGGCTGGGCGAGCTGGGCCTCGTGGAGTTCAGAGACgtg(a>t)gttgggtgggcaggcgtgggaagggggctactgccaaggttagcccggaggccggtccaggatggggactgccccccctccgccatagggccctggccccatttgaaccccagcggcccctgccatgggcactgctcatgggaagcccgcagctgaggcccctgagctggctcctccccataccctcctggggcatggggtctggtctgtgctctgatctgcgtcttgtggctcccagggcactccacacctttctggaggaggcagctaaggcctggggagagtcaggcctgggctctagggtgaggagctccctgacccccttcccgggacactcacccctccgtgtggcacccacag	NULL	No	NULL	In	81.03	9.22	7.55	71.48	12.58	10.58	4.52	4.52	6.58	7.95	12.5	12.1	-4.2	-4.2	7	0.97	6	0.92	259700	ENSG00000110719	61	73	"T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3"
279	1	Human	241	SEDL/TRAPPC2	164	Spondyloepiphyseal dysplasia tarda	IVS4+4T>C	115	100	Intron	1	GACGACCATCGTCATCTGAACCAGTTCATAGCTCATGCTGCTCTCGACCTCGTAGATGAGAACATGTGGCTATCGAACAACATGTACTTGAAAACTGTGGACAAGTTCAACGAGTGGTTTGTGTCGGCATTTGTCACTGCGGGGCata(t>c)ccttaccttcttagtaaaggtaactaactaaagtttgggctcacaaaccagaagaacatggaacatagatgccaggctctgagtctgtagacttcacagtcaggtgaaaat/gtaagtttccatttatggggctacttttctttttttaggggggaaaaacattttgtttaatagctaattttaaaactaagtctcatacacaaaaagagtttatctggaccctatcaagggtgattttactttattttacagttattttctaactttgaaagcttatgttctctttatgataaaactaagctaattttaaacccagtttatatattcaacttttccatcacaaatacactgcatgtgactaatttgaagaatactgtatcaacgaactggttgctttttgtttttcatttctaagaaagattatgccttaattatttcacatat	atypical donor site	No	NULL	In	29.3	-12.94	8.62	86.96	-7	14.08	8.59	8.59	7.47	-7.57	NULL	14.9	0.7	-4	3	0.98	7	NULL	313400	ENSG00000196459	209	279	trafficking protein particle complex 2
293	1	Human	13	BTK	184	agammaglobulinemia	IVS13+2delT	20	100	Intron	2	GACTCATATCCAGGCTCAAATATCCAGTGTCTCAACAAAACAAGAATGCACCTTCCACTGCAGGCCTGGGATACGg(t)aactccttatttctctggg/gtagggtggactggccagttgcaaaaactacctttgctggccttgccttagggagtgtccttgaggtacactgttctgcagcagctgcctcaaggacgctcaagacagatccaagcaaaagttattcactgattttcttcctctagtggctacgac	NULL	No	NULL	In	77.39	7.53	3.94	74.5	8.48	7.68	6.28	6.28	5.06	6.94	12	11.9	-3.9	-9	6	0.34	7	0.99	300300	ENSG00000010671	89	293	Bruton agammaglobulinemia tyrosine kinase
36	1	Human	109	MAN2B1	6	Alpha mannosidase	IVS7+2T>G	-12	NULL	Exon	0	gactcccctcttgcctgcagGGCCGGTATTACCGCACCAACCACACTGTGATGACCATGGGCTCGGACTTCCAATATGAGAATGCCAACATGTGGTTCAAGAACCTTGACAAGCTCATCCGGCTG/GTAAATGCGCAGg(t>g)cagtgcgcctaccctgtggtacccttgtgcacatgtgcgcttgcatccgggggccttgggttatgtgcatagctctcagtgctgtctttgttttctattgttctattgtggtcattctataacaaatgaccacacacttagcagctcaaaacaacagaaatacattgtcttacagttc	Minigene assay only	No	NULL	In	89.42	8.94	6.06	78.75	12.18	9.88	7.58	7.58	5.77	8.9	16.9	12.2	-6.8	-3.9	8	0.69	8	0.83	248500	ENSG00000104774	28	36	"mannosidase, alpha, class 2B, member 1"
191	1	Human	151	SPTA1	91	Hereditary pyropoikilocytosis	IVS22+5G>A	36	20	Intron	0	GACTGGTGGAAGGTGGAAGCTGCTGATCATCAGGGCATTGTCCCAGCTGTCTATGTCAGAAGACTGGCCCACGATGAGTTCCCGATGCTCCCACAGCGGCGACGAGAAGAGCCAGGAAACATCACCCAGCGCCAGGAGCAGATTGAGAACCAgtaa(g>a)ttctggagcctggagaactgaacagtatttg/gtcagacatttttcgccaaaggcatttcttctcatgaccctgcatctgttagatttgagatgccacagaaaatctgaagattttaagaatcgaaagtaaacctagaatcttttaaatgtttcggtttctttttgaggaaaggcaaccccagaatcattccatcaatttcctgaggtcatacacttcacagagctcttctgattccctgccccacattctttcaaggttattaaagtctcctgacatctatatgaactttgtttactatgccaggcttttcatatccaattgtcagttaccatgtaaaaatgtcacttttatgaaatgggaaaggaatgttgccagtcatactattgggtcactggcatttttactatttttaaatgcaatcctatgtgtttatctttttgcccccaaggctgttttccttctaagtttatttcctcctctcttctactattcttttgcttttgatttgttttccctttcatttttgttccttctttctctatgtttgtcactcagcctctactcttctgtattttctccttcttttattccacttttcccaattctccatccagATACCGCTCCCTCTTGGATCGGGCAGAAGAACGCAGACGTCGTCTATTGCAACGTTATAATGAATTTTTATTGGCCTATGAGGCAGGAGACATGCTGGAATGGATTCAAGAGAAAAAGGCAGAAAACACTGGAGTGGAACTAGATGATGTTTGGGAGCTGCAGAAAAAGTTTGATGAGTTCCAAAAG	NULL	No	NULL	In	77.98	9.09	2	75.02	13.98	7.68	3.14	3.14	3.61	7.5	14	11.1	-4.2	-3.1	7	0.04	6	0.99	266140	ENSG00000163554	152	191	"spectrin, alpha, erythrocytic 1 (elliptocytosis 2)"
192	1	Human	151	SPTA1	91	Hereditary pyropoikilocytosis	IVS22+5G>A	261	10	Intron	0	GACTGGTGGAAGGTGGAAGCTGCTGATCATCAGGGCATTGTCCCAGCTGTCTATGTCAGAAGACTGGCCCACGATGAGTTCCCGATGCTCCCACAGCGGCGACGAGAAGAGCCAGGAAACATCACCCAGCGCCAGGAGCAGATTGAGAACCAgtaa(g>a)ttctggagcctggagaactgaacagtatttggtcagacatttttcgccaaaggcatttcttctcatgaccctgcatctgttagatttgagatgccacagaaaatctgaagattttaagaatcgaaagtaaacctagaatcttttaaatgtttcggtttctttttgaggaaaggcaaccccagaatcattccatcaatttcctgaggtcatacacttcacagagctcttctgattccctgccccacattctttcaag/gttattaaagtctcctgacatctatatgaactttgtttactatgccaggcttttcatatccaattgtcagttaccatgtaaaaatgtcacttttatgaaatgggaaaggaatgttgccagtcatactattgggtcactggcatttttactatttttaaatgcaatcctatgtgtttatctttttgcccccaaggctgttttccttctaagtttatttcctcctctcttctactattcttttgcttttgatttgttttccctttcatttttgttccttctttctctatgtttgtcactcagcctctactcttctgtattttctccttcttttattccacttttcccaattctccatccagATACCGCTCCCTCTTGGATCGGGCAGAAGAACGCAGACGTCGTCTATTGCAACGTTATAATGAATTTTTATTGGCCTATGAGGCAGGAGACATGCTGGAATGGATTCAAGAGAAAAAGGCAGAAAACACTGGAGTGGAACTAGATGATGTTTGGGAGCTGCAGAAAAAGTTTGATGAGTTCCAAAAG	NULL	No	NULL	In	77.98	9.09	4.15	76.87	13.98	6.48	3.85	3.85	2.19	7.5	14	11.6	-4.2	-2.5	7	0.14	7	0.99	266140	ENSG00000163554	152	192	"spectrin, alpha, erythrocytic 1 (elliptocytosis 2)"
217	1	Human	11	BRCA1	24	Breast cancer predisposition	E22+61G>A	5	NULL	Intron	2	gagaaatgatgggctgggccagtgccccacccctgtaatcacaacactgggaggccaaggtgggagaatcgcttgagcctgggagctgaagaccagcctgggcaatacagtaggacctcatgtctacaaaaaaattattaaaaattagccaaggctgggtgcggtggctcatgcctataatcccgggggtgaagttgagcccaggagtttgagaccagcctgggcaacatggcaaaaccctgtctctaccaaaaatacaaaaaaattagccaggggtggtggtacgtgtctgtagttccagctacttaggaggctgagatggaaggattgcttgagcccaggaggcagaggtggcagtgagctgagatcacaccactgcactccagcctgggtgacagagcaagaccctgtctcaaaaacaaacaaaaaaaatgatgaagtgacagttccagtagtcctactttgacactttgaatgctctttccttcctggggatccagGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCAT(G>A)gtaag/gtgcctgcatgtacctgtgctatatggggtccttttgcatgggtttggtttatcactcattacctggtgcttgagtagcacagttcttggcacattttaaatatttgttgaatgaatggctaaaatgtctttttgatgtttttattgttatttgttttatattgtaaaagtaatacatgaactgtttccatggggtgggagtaagatatgaatgttcatcacaaaaacataaatcaaggccgggcatggtggctcatgcctataattccagcactttgggaggtcaagatggaggtcaaggtgggagcctagaagttcgagaccagcctgggcaacataaggagacttcatctgtacaacaaatttaaaaagtagctgggtgtggtggcagatgcctgtagtcgcagctacttgggaagctgaggtgggaggatcacttgagctcaggaggttgatgcttcagtgagccacgatcacaccactgtactccagcct	NULL	No	NULL	In	85.71	9.33	5.39	70.59	13.08	8.58	4.5	4.5	4.64	8.41	15	10.1	-7.1	-3.7	7	0.35	6	0.99	113705	ENSG00000012048	113	217	"breast cancer 1, early onset"
331	1	Human	7	ATM	14	Ataxia-telangiectasia	IVS37+1126A>G	-32768	100	Intron	-32768	gagagttgaccagaactctgaagaaatagtgtagtaggcctataatttgaataggtaggaatcgatgtctcataagtgtgtatggtggtggtaggggtggttggtaaagaatgagagggagaggtgagtgaaaaatgaaatgtttttaagcctaaatgcattaatatcttaaaaaattaattcctatgtagtcttaaaccattcttcttctctagtagaaaaagaagttttatgcttttcagtgtctttgcttctggttattttaccttagagttttataccagattatcttctgaggaggcctatcagaagctttaatgtagtggagagcatttgttttcttggtgttgggaggcagttttacctttgagtcattcatttcag/ACTTACCATTGGGGTAGAATGGTGTTGACATTAGCAGGAGTTGGAGAAGATAAAAATTCTTCATATTCCATTTTAATGCTGAATAAGATCCTGAAGAATATTCCTGGAGAAAGTATGAATGGGATATAGAAAAACGG/gtaa(a>g)gacatgcattcaagtccaagcttgtgctgtgtaaaaattacttgttatcctgtacagtatgttgggcaaaaacaaagaacaacaataaaacaacaacaacaaaaaaattgcttgctgtctttgaacctcagtcttatcatctttcaaaatcagaataatgtctgtagtgtcttcctttccatggggaaattatttcacttctctgaacttaacattcatcggaaaattaactttagttgagtgcttgctgtgtagtagggtgtgccttattcatcagctttgcaggcattatttaattgttgcacccattctccaaggtccatgttgttccagcatttgcaagtaaggaaactaggaaactgaggtttaagaagttaagttgctgaagatcacacagctggtagtaggcaatatagctagatttgaacctacctgtattgtacttcaacactagtgctcttaagcactaccatgtcccatctctacaatgctagttttgaaaaagatactatctatggtccctttcaatcttgacctacctattaacacagtggaagatttttattaagtaactcaacctaggcaatacattaaggagaaaataagtcacaataggaaagacatgtatttgtgtcttagatgaaacaatattttttattaaattgactgtttta	Creates pseudoexon	No	5	Out	NULL	NULL	10.17	85.06	NULL	12.98	NULL	9.86	9.31	NULL	NULL	15.6	NULL	-9.2	NULL	1	8	NULL	208900	ENSG00000149311	250	331	ataxia telangiectasia mutated
134	1	Human	67	FLNA	140	Periventricular nodular heterotopia and frontometaphyseal dysplasia	E42+159C>A	-21	50	Exon	0	gagcctgttaacatgcaggggatatggtgttcacggtaacctttcttaggaggcagcaaggcctgggtttggcttgtaaaagatttccgtcccaatgcaccctgacggtgggcagcttgagtgtctaaaccttcggccctcaggaggtctgctgcggggtgcaggtgcccagcgtggctgggctcacactgatggaccggcaaaatggggagggccagggttgaggctgttcctcacagacaccatctgctggtttgaggaggggccccaggcccacagcatgactccctgctcctcagATAAGTATGCTGTGCGCTTCATCCCTCGGGAGAATGGCGTTTACCTGATTGACGTCAAGTTCAACGGCACCCACATCCCTGGAAGCCCCTTCAAGATCCGAGTTGGGGAGCCTGGGCATGGAGGGGACCCAGGCTTGGTGTCTGCTTACGGAGCAG/GT(C>A)TGGAAGGCGGTGTCACAGgtaagtctgtcggtgcggctgcacgtgtgcacacagctgctaggcccttgcctccaagctcttggtgacaacaggaggcacctggaggtgacaagcctgtgctgggtggccgaggacagggaggcaggccagtctggctctgcctgacctcctgtgctcccagGGAACCCAGCTGAGTTCGTCGTGAACACGAGCAATGCGGGAGCTGGTGCCCTGTCGGTGACCATTGACGGCCCCTCCAAGGTGAAGATGGATTGCCAGGAGTGCCCTGAGGGCTACCGCGTCACCTATACCCCCATGGCACCTGGCAGCTACCTCATCTCCATCAAGTACGGCGGCCCCTACCACATTGGGGGCAGCCCCTTCAAGGCCAAAGTCACAG	NULL	No	3	Out	100	10.86	9.99	84.21	15.08	11.98	9.2	9.2	8.9	12.75	21.3	15.7	-9.6	-4.9	9	0.85	8	1	300049	ENSG00000196924	106	134	"filamin A, alpha"
52	1	Human	52	ELN	168	Supravalvular aortic stenosis	E26+121G>A	-4	NULL	Exon	1	GAGCTGCAGCTGGGCTTGGTGCTGGCATCCCTGGACTTGGAGTTGGTGTCGGCGTCCCTGGACTTGGAGTTGGTGCTGGTGTTCCTGGACTTGGAGTTGGTGCTGGTGTTCCTGGCTTCC(G>A)G/GCAGgtgcagatgagggagttaggcggagcctgtcccctgagctcagggaaggagatccctcctcctctcagcacctccccagcaccccctcatcacccaggggtgcatagtaaaatccttgttaggttctcctaagcatctgggggtaacagatagcgggaggagggcagaccaggccaaggg	NULL	No	NULL	In	65.86	4.95	2.53	71.59	10.08	5.82	2.95	2.95	2.98	5.36	11.8	NULL	-4.5	-5.4	6	NULL	8	0.1	185500	ENSG00000049540	40	52	elastin
308	1	Human	123	PDS	139	Pendred syndrome	IVS4+7A>G	6	90	Intron	0	gaggactttctgcatactgtaactttggtttgtgaatgtaatcactttgcatgtgctttcagGGATGGCATATGCCCTACTAGCTGCAGTTCCTGTCGGATATGGTCTCTACTCTGCTTTTTTCCCTATCCTGACATACTTTATCTTTGGAACATCAAGACATATCTCAGTTGgtaatt/(a>g)taagtatattttacaattatatttgctcatgtttaaagtgttttggctatattaagtgcattatacctctattaggttggtgcaaaagtaattgcggttttcacaattatacttttaattgtgaaaaccgcaattacttttgcaccaacctaatatatctgtgttaatgttgtcagggaaatgggatttcagtgttttgcctgctttttctattcactgatgttaggtaacttttttaatgaagtggaaaaataaaaaaactgaaaatgacagcctactttaacattttagcatgttttgctttttaaaaacgtgatcaatttgactccatttttggagtcataatgacagggaaaaaatgacacaaggtctttgaacctaccattttactggattaacttagaaattactaagtatgttcatcaaatacatgttcatgatttaattaaagagcatacttattttaaatcactaatattagaagactggcaaaatcttaccaaaacaatttagaagctaagcttggctttctttcttggtatggcttataataagttttcctgctattcctaaaatttgaattctcgtttgttagaatgtcctagtaaatgagtgttttaatgctattttgtgactttgacatttatactagagaaaattttgctcctacatccatctgctggctagacatgtctacctcgatgatcctcttgaaataaatgcaaccatctactttatccccaacccatgtttttgtccttagttgtatttccttagaaggagatcagaaagaggttttgattgaaagaacttccacaccttggagaatcaatcagtgttgagtgcttgactagatgaggaacatggaagctggtttttctctttggtattctatacattgagatattccaggtgactggggttgggttttgagacctcaaaaccataaagccttccatgatgagagggtagaatcatcatcatcgtcatggataaaaataacagtagtgaacggagcaattgctgaaaaaaaaatattttttaaaatataaaatcttacagattgacatttgatatgaaaaaatgttttgtcttacaaaaagagaaagaaacttcatactccctttgctgtttttttaatcctaacttcgaccctgtgatattgatcaaggtactcagatccacagagatcaggacattggacactctaggaaattaatgagattatatgaaataaaagttgagcggaacaagtaaacactcaatgtatgtgctacctttgccagaaaacctttcctgacaactctcatccctgtccccaccacccatacacatgaggatcacacacagacaggttagacgaccttttgatatactcacgaagcatcctgaatgttgtattctaataactacctacgtgtctctctcgcctatttctaggtcatgaatgcctcgagatatctgcgtttttagcttctttttgttgttgttgagacagaatctggctctgtcacctaggctggagtgcggtggcgtgatctcagctcactgcagcctccacctccccagctcaagcaatccccccacctcagcctcccgagtagctgggaccataggcacgcaccaccacacccagctaatttttgtcttattttggtagagatggggttttactatgttgcttaggctggtctggaactcctgggctcaagcgatcttcccacctcagtctcccaaagtgctgcggttacagatgtgagccactgggtccggctcagcttctttcgtgaacaaacaatattttcctagtcacagctaaatcttttatacattttttaaaccctatgcagacacattgaacatttgtgattaataactgattaattgttagagactttttttccccag	NULL	No	1	Out	78.55	5.73	8.54	78.05	5.88	12.68	6.55	6.55	6.4	4.07	14.7	17	-3.7	-4	7	0.98	6	0.89	274600	ENSG00000091137	231	308	"solute carrier family 26, member 4"
273	1	Human	62	FANCA	64	Fanconi anaemia	IVS26+2T>C	129	NULL	Intron	0	GAGTCCAGGTCTGCGCTCCCAGAGGTGGATGTGGGTCCTCCTGCACCTGGTGCTGGCCTTCCTGTCCCTGCGCTCTTTGACAGCCTCCTGACCTGTAGGACGAGGGATTCCTTGTTCTTCTGCCTGAAg(t>c)gagctcttcttccacagtcgcgtcttctctcctctctctcgaaaagtgacacatgctcgtttgataaaattagaagagacagacatgcagacataccacccaaagataaccactttttagcattttg/gtatatatccttccagaattttatctgtcatttgtttataatatgcgtgcgtttgtttctttgttcataaaaatgagatcatattatactaaactgctgaaattaatagta	NULL	No	NULL	In	76.3	5.01	1.75	68.34	9.48	4.38	2.6	2.6	3.59	5.8	10.5	11	-2.7	-2.6	6	0.19	7	0.27	227650	ENSG00000187741	204	273	"Fanconi anemia, complementation group A"
28	1	Human	21	CDKN2A	122	Melanoma	E2+307G>T	-74	NULL	Exon	2	gatataatggaattcattgtgtactgaagaatggatagagaactcaagaaggaaattggaaactggaagcaaatgtaggggtaattagacacctggggcttgtgtgggggtctgcttggcggtgagggggctctacacaagcttcctttccgtcatgccggcccccaccctggctctgaccattctgttctctctggcagGTCATGATGATGGGCAGCGCCCGAGTGGCGGAGCTGCTGCTGCTCCACGGCGCGGAGCCCAACTGCGCCGACCCCGCCACTCTCACCCGACCCGTGCACGACGCTGCCCGGGAGGGCTTCCTGGACACGCTGGTGGTGCTGCACCGGGCCGGGGCGCGGCTGGACGTGCGCGATGCCTGGGGCCGTCTGCCCGTGGACCTGGCTGAGGAGCTGGGCCATCGCGATGTCGCACG/GTACCTGCGCGCGGCTGCGGGGGGCACCAGAGGCAGTAACCATGCCCGCATAGATGCCGCGGAAGGTCCCTCA(G>T)gtgaggactgatgatctgagaatttgtaccctgagagcttccaaagctcagagcattcattttccagcacagaaagttcagcccgggagaccagtctccggtcttgcctcagctcacgcgccaatcggtgggacggcctgagtctccctatcgccctgccccgccagggcggcaaatgggaaataatcccgaaatggact	NULL	No	NULL	In	89.44	10.07	6.79	66.17	13.38	7.38	3.54	3.54	6.5	10.18	17.6	10.2	-9.3	-2.8	8	0.37	5	1	109700	ENSG00000147889	23	28	"cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)"
119	1	Human	21	CDKN2A	122	Melanoma	IVS2+1G>T	-74	NULL	Exon	2	gatataatggaattcattgtgtactgaagaatggatagagaactcaagaaggaaattggaaactggaagcaaatgtaggggtaattagacacctggggcttgtgtgggggtctgcttggcggtgagggggctctacacaagcttcctttccgtcatgccggcccccaccctggctctgaccattctgttctctctggcagGTCATGATGATGGGCAGCGCCCGAGTGGCGGAGCTGCTGCTGCTCCACGGCGCGGAGCCCAACTGCGCCGACCCCGCCACTCTCACCCGACCCGTGCACGACGCTGCCCGGGAGGGCTTCCTGGACACGCTGGTGGTGCTGCACCGGGCCGGGGCGCGGCTGGACGTGCGCGATGCCTGGGGCCGTCTGCCCGTGGACCTGGCTGAGGAGCTGGGCCATCGCGATGTCGCACG/GTACCTGCGCGCGGCTGCGGGGGGCACCAGAGGCAGTAACCATGCCCGCATAGATGCCGCGGAAGGTCCCTCAG(g>t)tgaggactgatgatctgagaatttgtaccctgagagcttccaaagctcagagcattcattttccagcacagaaagttcagcccgggagaccagtctccggtcttgcctcagctcacgcgccaatcggtgggacggcctgagtctccctatcgccctgccccgccagggcggcaaatgggaaataatcccgaaatggact	NULL	No	NULL	In	89.44	10.07	6.79	66.17	13.38	7.38	3.54	3.54	6.5	10.18	17.6	10.2	-9.3	-2.8	8	0.37	5	1	109700	ENSG00000147889	23	119	"cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)"
294	1	Human	13	BTK	184	agammaglobulinemia	IVS14+5G>A	90	100	Intron	0	GATCATGGGAAATTGATCCAAAGGACCTGACCTTCTTGAAGGAGCTGGGGACTGGACAATTTGGGGTAGTGAAGTATGGGAAATGGAGAGGCCAGTACGACGTGGCCATCAAGATGATCAAAGAAGGCTCCATGTCTGAAGATGAATTCATTGAAGAAGCCAAAGTCATGATgtga(g>a)ttatagcccaaactcaactctcaatctatttgctggagtctaggaattcacacaacaacccactgaggcttaaagatgacttaca/gtaagagaggtttgggacgagggactgaagtttacctttaactggcggtagtcctaagtgctaagataatagtttctgtgccttagatattggttgagaatagtggtgatcatgggtgtgtaccatctcagtagcatttgggggtagatgtagaaaattaaactttcaagagaaatattctaatttagccttagcgttctttcattcctg	NULL	No	NULL	In	81.78	7.77	5.96	72.48	11.58	10.08	5.85	5.85	6.16	6.64	12.5	12	-3.9	-2.8	7	0.8	5	0.96	300300	ENSG00000010671	89	294	Bruton agammaglobulinemia tyrosine kinase
157	1	Human	80	HADHB	167	Sudden infant death syndrome	E9+146insT	-37	NULL	Exon	1	gatcctctttagagatcctctgcttgtcttggacttgattgattaatggtagacaaatagattttaacttttccaaataacacagaacaatcctaggtgttagcataacaccggttaacagtgtacctgctccttggatatctcctttcccagCTCCCTGCGGTTTCTGAGTTCTCCACCAGTGAGACCATGGGCCACTCTGCAGACCGACTGGCCGCTGCCTTTGCTGTTTCTCGGCTGGAACAGGATGAATATGCACTGCGCTCTCACAGTCTAGCCAAGAAGGCACAGGATGAAG/G[T]ACTCCTTTCTGATGTGGTACCCTTCAAAGTACCAGgtgaaatgaaatgcttcatgacacttattagggagttctgaattgctcctaaaactcaaaaacatcccgagtgatttttccataagtatgttggttctgtttccaaagtattcagcctttattcttaaatatggatgcaaattttgatttatgttgtaacaataggttaacattttttaatgtttctataagagtgtccttttaagatctgagcactaatctcagcactttgggaggctg	NULL	No	2	Out	76.98	5.07	7.46	70.13	10.68	11.28	4.59	4.59	5.85	6.68	12.4	12.3	-6.1	-4	7	0.73	5	0.42	143450	ENSG00000138029	125	157	"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit"
269	1	Human	54	EP300	23	Breast cancer cell line	IVS30+2T>A	28	NULL	Intron	1	GATCCTGATCCTCTCATCCCCTGCGATCTGATGGATGGTCGGGATGCGTTTCTCACGCTGGCAAGGGACAAGCACCTGGAGTTCTCTTCACTCCGAAGAGCCCAGTGGTCCACCATGTGCATGCTGGTGGAGCTGCACACGCAGAGCCAGGACCGCTTTGTCTACACCTGCAATGAATGCAAGCACCATGTGGAGACACGCTGGCACTGTACTGTCTGTGAGg(t>a)aggcaccgggttgtgggaaggaggag/gtgagctccgcagggttgttctgaggggccatgcagccacgtattttatagaggcctgtgggatgctaggggcttggcctcgtgtttgaggggcagagctgaagaggctagtttttgttctacgaaaggggcttttctagcccaaacaatatctaaaatacttttgaatgacttaaatcttggagagtttacgtgcacctcctgttttttccctagGATTATGACTTGTGTATCACCTGCTATAACACTAAAAACCATGACCACAAAATGGAGAAACTAGGCCTTGGCTTAGATGATGAGAGCAACAACCAGCAGGCTGCAGCCACCCAGAGCCCA	NULL	Yes	NULL	In	83.33	8.99	8.7	88.72	11.98	12.28	9.26	9.26	9.33	8.19	14.2	15.7	-7.3	-7.4	7	0.73	7	0.97	602700	ENSG00000100393	201	269	E1A binding protein p300
111	1	Human	68	FRAS1	67	Fraser syndrome	IVS53+1G>T	-1	100	Exon	1	GCAACCAACCTGATCACCAAGAAGGAACTGCTGACCATGGACCCAGACACCGAGGACGCGCAGCTTGTCTATGAGATAACGACGGGCCCTAAGCATGGCTTTGTGGAGAACAAGCTGCAGCCTGGCAGAGCTGCTGCCACTTTCACCCAG/G(g>t)tggggactctctgggaacttagaaatgggagaaatctatgctaatgtcacactgcctatctcccagattcttctcacagccacttccagctacttatgcccaagtaaccactttgcagagatcttctagtgcttaaccatccaacttaagaattttatttctcctgatttttttccctg	NULL	No	NULL	In	69.33	2.21	5.26	73.47	7.48	8.68	4.82	4.82	5.51	4.1	9.3	11.8	-8.6	-6.8	7	0.64	8	0.08	219000	ENSG00000138759	87	111	Fraser syndrome 1
104	1	Human	148	SIL1	119	Marinesco-Sjogren Syndrome	IVS6+2T>C	-90	NULL	Exon	0	GCAAGGCAGGCTGAGGTAAAGCGGCTCTTCCGCCCCATTGAGGAACTGAAGAAAGACTTTGATGAGCTGAATGTTGTCATTGAGACTGACATGCAGATCATG/GTACGGCTGATCAACAAGTTCAATAGTTCCAGCTCCAGTTTGGAAGAGAAGATTGCTGCGCTCTTTGATCTTGAATATTATGTCCATCAGg(t>c)actgtatttcttcgtccataagtcagacttttaacagctccaaaaataaatcccccttccctaagccctaagaaaatagcatcaacatctttacttctctcccagagcacagactatttttaatctagtcttgttatcttttgtagtaagatacagtcttagaggccagagccaacttctttttctttttttgtctgagtcagagtctcactcggtcacccagcctggagtgcagtggcgcgatctcggctcactgcaacctccacctcctgggttcaagctattctcctgcctcagc	NULL	No	NULL	In	70.84	9.04	8.21	74.48	12.38	10.38	6.75	6.75	7.66	7.81	14	11.7	-4.8	-2.5	6	0.92	6	0.82	248800	ENSG00000120725	80	104	"SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae)"
338	1	Human	46	DMD	133	Muscular dystrophy	IVS60+80228G>T	-32768	NULL	Intron	-32768	GCACTTCGAGGAGAAATTGCGCCTCTGAAAGAGAACGTGAGCCACGTCAATGACCTTGCTCGCCAGCTTACCACTTTGGGCATTCAGCTCTCACCGTATAACCTCAGCACTCTGGAAGACCTGAACACCAGATGGAAGCTTCTGCAGgtaagcacattgtaaacattgttgtcctttgttacagtaaaataatatacagataaaatttgtaaagaacaatgaaagtacttttttcatgtaatgttcatggtaatatttgtgaggataggatattttatattagttt......gctttgtggttcttgagcaacttaaatacgttgctctgaatagttattgtgatgaggtaatttgtaacaacttttaggatcaatgctaattttcttaaatgtttctgtagtttcccctttattataaagtatattaggctggactcttggctgtaagtgacagaaaactcaactcagattagttaagaaacaaaagggtgttggtgacagtggtggctttcagactattgctgcaggcccacctgccatcctcttaacaccctcaacataccctgcagaaaagagagagctactctgacccgagagcttaaagactggtcaagtatgggcttgactctttatggcccaaattgggtcacatgcccacctaggctaggggaatggaatcgtggaattgattgattgattattgttgcag/GTTGAGTCCTCCAAGAAGCAGATGCCAGGGCAGATTTATTGCAGAATAACACCTGTGAAGAAATAGGGGTGGAAGCAGAATTGAACAAG/g(g>t)aagccatcagatcacaatgcagatcttctagactctgtgtcagcacaacaaggaatgccagagcaaagactgccaattagaggaatactgaattgggcagatctgacaatagtctgtatataactcgggactgttaacttctccttcctcaaccagttatagacatagaataggactctcttatctcaaacatcaatatctgtgtatatgaagtagagggtgaaagtttactgtacactagtggttctcaaccaagagcaagtctgtcccccaggggacatggcaatttctggagacattttcagttgtcccaactggtgaggaggtgctactggcatctagtgggtagaagttgtggatgctgctaggcattctctataattcgtgggatagatagcacaacaaaaaattgcccaggccaaaatgtcaataatgctgaagttgagaaacc.......atgaaatgttgctttagtgttctcagtcttggagactcaaagtatcttatcagaaaggatacattgttttaattgttcctcattatatagaatgagagaacatcatttctctccttttcctcccagGTGGCCGTCGAGGACCGAGTCAGGCAGCTGCATGAAGCCCACAGGGACTTTGGTCCAGCATCTCAGCACTTTCTTTCCA	Creates pseudoexon	No	2	Out	NULL	NULL	10.22	93.9	NULL	16.08	NULL	11.48	10.62	NULL	NULL	17.1	NULL	-7.4	NULL	1	7	NULL	181350	ENSG00000198947	257	338	dystrophin
94	1	Human	157	UGT1A1	41	"Crigler-Najjar syndrome, type I"	IVS1+1G>C	-141	NULL	Exon	0	GCAGCGGGTGAAGAACATGCTCATTGCCTTTTCACAGAACTTTCTGTGCGACGTGGTTTATTCCCCGTATGCAACCCTTGCCTCAGAATTCCTTCAGAGAGAG/GTGACTGTCCAGGACCTATTGAGCTCTGCATCTGTCTGGCTGTTTAGAAGTGACTTTGTGAAGGATTACCCTAGGCCCATCATGCCCAATATGGTTTTTGTTGGTGGAATCAACTGCCTTCACCAAAATCCACTATCCCAG(g>c)tgtgtattggagtgggacttttacatgcgtatattctttcagatgtattactttggatcgattaactagccccagatatatgctgagcaagcattctgagataatttaaaatgccctcttttgttaatttttgactcctaggtttgagtc	Minigene assay only	No	NULL	In	84.42	6.99	5.88	81.82	12.88	8.68	6.65	6.65	6.03	7.28	17.1	11.5	-5.9	-5.1	9	0.56	7	0.99	218800	ENSG00000167165	72	94	"UDP glucuronosyltransferase 1 family, polypeptide A1"
138	1	Human	83	HBB	19	Beta-thalassemia	E1+129G>A	-16	NULL	Exon	1	gcaggagccagggctgggcataaaagtcagggcagagccatctattgcttACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTG/GT(G>A)AGGCCCTGGGCAGgttggtatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttagGCTGCTGGTGGTCTACCCTTGGACC	"Cryptic 5'ss is activated in erythroid cells, not in HeLa cells"	No	3	Out	78.85	8.08	8.37	85.71	11.68	11.88	8.9	8.9	7.5	7.2	16.4	15	-7	-7.1	9	0.98	7	0.64	603902	ENSG00000221842	110	138	"hemoglobin, beta"
311	1	Human	79	GUSB	129	Mucopolysaccharidosis Type VII	IVS8+617_2delTC	-32768	NULL	Intron	-32768	GCAGTTCTTCAACAACGTTTCTCTGCATCACCACATGCAGGTGATGGAAGAAGTGGTGCGTAGGGACAAGAACCACCCCGCGGTCGTGATGTGGTCTGTGGCCAACGAGCCTGCGTCCCACCTAGAATCTGCTGGCTACTACTTGAAgtgagtgctccctccctgccctcggctagagtgggaaggagaccctggcaggtggctggcctcggtgggcatgtgctgttcaagatcggcctcgtgtccagcccaatgggaaggccgtccatacccagatagttcaggggaccaaatatctacccacccaaattgtggttttcttttttgttctttttttttctttttgagatggagtctcactatatggcccaggctggagtgcagtggggtgatctccgctcattacaacctctgcctcctgggttcaagtgattctcctgcctcagtctcctgagtagctaggattacaggcacccatgaaccactgtgctggggctgtttttttttttcaaaatgggttctcactctggttgcccaggttggagtgcagcggtgcagttttggcttactgcagccttgacttcccaggctcaggtgatcctcctgtctcagcctcccaagtagctgggattctagatgtgtgtcatcacgcccagctaatttttgctttattttttattttttggatatgcagTCTCCCTCTATTGCCCAGGATGGAGTGCAGGGGCATGATCTCAGCTCACTGCAACCTCTGCCGCTCAG/gt(tc)aagtgattctccagcctcagcctcccgagtagctgggattacaggcacatgccaccacgcccagctaagttttccttttttcctttttatgagatggagtctcactccgtggccaggctggagtgcagtggcgcaatctcgtctcactgcaaccttcaccttccaggttcaagtgattctcctgcctcagcctcctgaggagttgggattacaggcacacgccaacataccctgctaatttttgtatttttagcagagacggggtttcaccattttggctaggatggtctcgatctcttgaactcatgatccgcctgcctcggcctcctgaagtgctcggattacaggcgtgagctaccacgcctggccaacttttgcatttttcagtagagacggggtttcactatgttgggccaggctggtcttggactactgacctcaggagatccacttacctcggcG	Creates pseudoexon containing Alu.	No	3	Out	NULL	NULL	10.86	100	NULL	15.08	NULL	13.07	12.75	NULL	NULL	20.8	NULL	-9.6	NULL	1	9	NULL	253220	ENSG00000169919	234	311	"glucuronidase, beta"
177	1	Human	147	SERPINF2	143	Plasmin inhibitor deficiency	IVS2+1G>A	22	100	Intron	1	gcatgaaatatgaaacaccagaaactaaaaagggggagaagccagggcggatgtcccagctgcaggagtgggagccgctgctcgtgtgtttggggtctgttctgattctggagcctgcttcttccccttggcaatcatgacccaggacttggcgttatctgtgatcgcgtgggtaggattccctggcgggcgtggggatgtgagatgggaacagagctttctgtccctgccacagGAACATGGCGCTGCTCTGGGGGCTCCTGGTGCTCAGCTGGTCCTGCCTGCAAGGCCCCTGCTCCGTG(g>a)tgaggctgggctgaagtcaag/gtggggtggggtggagggggaagaagaggggcgttggcatggagggagggcttggctccgaggggacctcctatcctcatccctttctccacagTTCTCCCCTGTGAGCGCCATGGAGCCCTTGGGCCGGCAGgtactggggagtgaggagcctgtgatggggggaaggtcccgggggtctcactggtggcttgggcagggtggggggcctgtgggaagggtcggtctccatctgcttgctcctttccgcagCTAACTAGCGGGCCGAACCAGGAGCAGGTGTCCCCACTTACCCTCCTCAAGTTGGGCAACCAGgtacaaccaggtgg	Minigene assay only	No	NULL	In	80.53	6.13	5.87	78.87	10.48	12.08	8.02	8.02	6.29	6.62	13.6	11.2	-7	-8	7	0.74	7	0.91	262850	ENSG00000167711	141	177	"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2"
124	1	Human	101	KRIT1	26	Cerebral cavernous malformations	E7+55A>G	-76	100	Exon	1	gccagctgtagcattccagatatatttttccaggcatacttaggttaaaaagttcagtatcttaagtagcattggaaatcttattaatgagttttacagcattgttgaggaagataaagatgaaacagtttctgcagtcctccaaaattctaaatgttgcatttacctgagtggacaaggtcacagagctagtcatcacttgaatccaggccttctaattccaaatctagaacaatttattttatacttaacaagttttcattttctaacatgtatttttagatgaaaacatgcagatgtaaaccttttatatggtagcataattcttcatttttctttttcagATAATACTAAATACACATATACCCCAGGATGCCCAATTTTTTACTGCTTACAAG/(A>G)TATTATGCGAGTCTGTAGTGAATCCAGTACTCATTTTGCTACACTTACAGCAAGGATGTTAATAGCCTTGGATAAgtaagaaatgccgttagaagtatcttttaattaatcaaatacatgtttatagtagaaattagttgtcatagatacagacactttgagaagaaaataatgaaaataatatatgtattaaaaaatggtaagtttttcaattctaatataaaaatgaaaaacccgaagataaggttgtcctggcctgggtacagcatgttaattttatttttcagaaatggtaaacactgccctggcttaagaattaagatttacctgttatgaaactatacatttaatattgagttactcttatcagtgaagaagtcattcaacctcttatgcctttgtctttctgtaagaacagggctaatgtcacctacatctcagtagtttgaattttaacagtacttttatgttttttgaaaggagtttttattactataatggcacatacatttaaaaaatttatttgctgtatccattaacaaaacttttattaataaatgaagtatttgtatactgacttgatctttatagatcatatgaacatattatcacatgtgcccctaaagtatgtacagtattatgcatgtttttttgttaaaaaaatcaatttgcaatataaataaattttaaaaataataaagtacttaactaacactaaattaaaattataaaaatctgaaggtaatattcacaagtgtcatatatcagagttagatagtaatctatctttttcatcttcactttcgaatggctacttctacctgtttttttattttgccagGTGGTTAGATGAACGTCATGCACAATCTC	NULL	No	1	Out	82.08	5.17	7.04	71.56	9.98	10.18	4.51	4.51	5.72	4.64	12.6	12.3	-2.8	-4.1	7	0.42	6	0.65	116860	ENSG00000001631	98	124	"KRIT1, ankyrin repeat containing"
178	1	Human	30	COL3A1	52	Ehlers-Danlos syndrome	IVS42+1G>A	30	NULL	Intron	0	gccatccagagtcactgagcaagttagaaaatgcaagaagcttgctcccccatattttttcccatagcaggcatagttttaattttaaaattcaatgaagattaaataaaataagttttttacctgaaaataaagatatctgataacaccattttaattgatttcttaagttgaaacaaaatgtttttcattcctttgtatacagGGTGAAAGTGGGAAACCAGGAGCTAACGGTCTCAGTGGAGAACGTGGTCCCCCTGGACCCCAGGGTCTTCCTGGTCTGGCTGGTACAGCTGGTGAACCTGGAAGAGAT(g>a)tgagtagcagtttttattcaaccagccag/gtagaatttgataatttatttcagcaaaggtgaaattgagctttaatgtctaagagtgtaaatatggccacatagcaaagttcttctatctctaataacagaaattctttcattacaatttaggatagacttaaaagctcttgttcattagtatttacccaatgaataatcatttgtggagaaaatattatctctaactaaattaggaaaaaagttagtggggagaaccacaattgacatgttttctgagtgaaaatattctacggttatctatggttagtcttttattatttttaaagaatttaaaattaatattatttataattaacaaatcataattgtatacatttataaggtacaatgtgatgttttaatatatgtatacaatgt	NULL	No	NULL	In	81.78	7.77	6.68	71.59	11.58	11.48	5.9	5.9	5.91	6.64	14.2	14	-3.9	-5.8	7	0.89	7	0.97	120150	ENSG00000168542	142	178	"collagen, type III, alpha 1"
264	1	Human	30	COL3A1	52	Ehlers-Danlos syndrome	IVS42+5G>A	30	NULL	Intron	0	gccatccagagtcactgagcaagttagaaaatgcaagaagcttgctcccccatattttttcccatagcaggcatagttttaattttaaaattcaatgaagattaaataaaataagttttttacctgaaaataaagatatctgataacaccattttaattgatttcttaagttgaaacaaaatgtttttcattcctttgtatacagGGTGAAAGTGGGAAACCAGGAGCTAACGGTCTCAGTGGAGAACGTGGTCCCCCTGGACCCCAGGGTCTTCCTGGTCTGGCTGGTACAGCTGGTGAACCTGGAAGAGATgtga(g>a)tagcagtttttattcaaccagccag/gtagaatttgataatttatttcagcaaaggtgaaattgagctttaatgtctaagagtgtaaatatggccacatagcaaagttcttctatctctaataacagaaattctttcattacaatttaggatagacttaaaagctcttgttcattagtatttacccaatgaataatcatttgtggagaaaatattatctctaactaaattaggaaaaaagttagtggggagaaccacaattgacatgttttctgagtgaaaatattctacggttatctatggttagtcttttattatttttaaagaatttaaaattaatattatttataattaacaaatcataattgtatacatttataaggtacaatgtgatgttttaatatatgtatacaatgt	NULL	No	NULL	In	81.78	7.77	6.68	71.59	11.58	11.48	5.9	5.9	5.91	6.64	14.2	14	-3.9	-5.8	7	0.89	7	0.97	120150	ENSG00000168542	199	264	"collagen, type III, alpha 1"
238	1	Human	3	ADAMTS13	126	Thrombotic thrombocytopenic purpura	IVS3+1G>A	27	NULL	Intron	0	GCCGCCCTCCTTCCCCTGGCTTCCAGAGGCAGAGGCAGAGGCAGAGGCGGGCTGCAGGCGGCATCCTACACCTGGAGCTGCTGGTGGCCGTGGGCCCCGATGTCTTCCAGGCTCACCAGGAGGACACAGAGCGCTATGTGCTCACCAACCTCAACATC(g>a)tgagtgccccacgctggactgtgcag/gtccccacggccagggctggtgaccaatgtctgtgggctggtgtatctggtagtctgaatacagtgggttaaactcaggtagaatggctcggggttcttcctcttctccctccctcccctgggtggaggtgggtgaggtcccacaccctctctaggctccatggcacatgcacaccctgcagcctctcactactcaagtcccttcacctggggccaccctcaagcctggcctcttccccagtatccatttgacccccacaaagctcagctaaagcaaccctggcaaatgggatacgggctgctcacactgccctctgcaccccgaccctgccctctctccattctcttgtcccccgctcagagtggcgaggacaggtcacccgtctgaagtctaaacagagactgctggcaaaggagatgcccaccttcatttcttgctagcacctgaatccctgcagccccccttcacttga	Minigene assay only	No	NULL	In	72.13	8.88	0.35	59.08	11.78	6.98	0.51	0.51	0.93	7.28	12.1	11.8	-4.2	-3.3	6	0.01	5	0.96	274150	ENSG00000160323	185	238	"ADAM metallopeptidase with thrombospondin type 1 motif, 13"
114	1	Human	19	CDH1	85	Gastric cancer	IVS4+2T>A	-63	100	Exon	0	GCCTCCGTTTCTGGAATCCAAGCAGAATTGCTCACATTTCCCAACTCCTCTCCTGGCCTCAGAAGACAGAAGAGAGACTGG/GTTATTCCTCCCATCAGCTGCCCAGAAAATGAAAAAGGCCCATTTCCTAAAAACCTGGTTCAGg(t>a)agagaaagaagttctctgtttctctgggagggatttggcagagaagtaccaaggagagaaagggaaaagacccagtgttgggatccttctttactaattctttt	NULL	No	NULL	In	71.7	7.1	-3.18	67.33	11.98	0.48	-0.1	-0.1	-0.77	6.63	14	8.1	-5.8	-3.1	7	0.02	7	0.37	137215	ENSG00000039068	90	114	"cadherin 1, type 1, E-cadherin (epithelial)"
307	1	Human	156	TSC2	173	Tuberous sclerosis	IVS8+281C>T	-32768	NULL	Intron	-32768	gcctgccagcccctgacacgcattgtgtctcgcagCTGATGCGGAACCTCCTTGGCACCCACCTGGGCCACAGCGCCATCTACAACATGTGCCACCTCATGGAGGACAGgtgagtgtggtgggtggggcgcagggcagtggaggccagcacagccctcggggcagctccagtgtcccttgccaagcacacactggcttagagagtccttgtcctctcgggcagctgttccagaggctgccactagagcgaggcccatgacttctaggatccagcccctgtcctctccttcctctgtcagTTCAACAGAATATCCACACCCAGCTCAGTGCCTGCCCCATGCTCGGACGTCCTCCAGCGGTGCTCCCCAACTACTTAGCCTGTTACAAG/g(c>t)gaggctcggggtcttggcttgacgttgcccttgccctcacccccacagccaggctgtggccacttttgttgctttagccattagagatggctcagctctgcccacaccctggcctcccacccatgctgccagctccccctcctgctctcctgtatccatccgcgcctcctgaagcccactccatgcagcacccgggtggcctttttctgacacagatatgtcggtgtcaccctttgctggaagccaggtggttcccagcgcccttgggatgtaggcttctcctatggaaccaggccctggggccagccctgcctcagccctgcatctctcccagccctgcctcggcccctgcatctctcccagccctgcctcggcccctgcatctctcccagccctgcctcggcccctgcatctctcccagccctgcctcggcccctgcatctctcccagccctgcctcggcccctgcatctctcccagccctgcctcggcccctgcatctctcccagccctgcctcggcccctgcatctctcccagccctgcctcggcccctgcatctctcccagccctgcctcggccctgcatctttccttccctccatccttggaaccaggccctggggcccagccctgcctcagccctgcatctctcctagccctgcctcagcccctgcatctctccctccctcctcccgtagaaccaggccctgggggccagccctgcctcagcctgcatctctcccagccctgccccaccccctgcatctctcctttcctccatcttgccttctcccctccaccaagggcttgtgcatgccctgattcctcttgccagcaggttcttccacctttgccgagttactctgtttactgaggtcttagcgtggtcactgactcccccacctccctgagtagtttttgctgtggctttccttcttggctgtgattggaggaagagattttgcgtttacctgggagattatgtggctggcgcctgtctcccccagactgcgaggctgtgggccatccctcttgcctgcttcctgtccctggcatgacctgtagctcacagcgtggtcagcagtgatgggctgccgcctgtgcgcaggagtgaacaagagtgttactgctggcctctgttccctgcccttccccagcggtgctcctgccccccccaagcacagggacctctggggctgctgcaggagcctcggcaacctcacacatccatggcggaccctgggacagggccctgctcacattccgtctctctggggaacacttttagAGCCTACATGGAGGACGCGCCCCTGCTGAGAGGAGCCGTGTTTTTTGTGGGCATGGCTCTCTGGGGAGCCCACCGGCTCTATTCTCTCAGGAACTCGCCGACATCTGTGTTGCCATCATTTTACCAGgtaaggcggtttctgtgtgcagtgagctggcaggaacgggagagctcccctcacgcctgc	Creates pseudoexon	No	2	Out	NULL	NULL	9.16	89.44	NULL	13.98	NULL	10.39	9.62	NULL	NULL	15.7	NULL	-8.5	NULL	0.99	7	NULL	191100	ENSG00000103197	230	307	tuberous sclerosis 2
34	1	Human	165	XPA	181	Xeroderma pigmentosum	IVS1+2T>G	-103	NULL	Exon	1	gcgcatacccagactccgcccagcgcccgggcaggccaccccgagccccttaactgcgcaggcgctctcactcagaaaggccgctgggtgcggggagcgcagaggcggtgcagggcggctGGCTCGCCTCGGCGTGCAGTGCGCGTGCGTGGAGCTGGGAGCTAGGTCCTCGGAGTGGGCCAGAGATGGCGGCGGCCGACGGGGCTTTGCCGGAGGCGGCGGCTTTAGAGCAACCCGCGGAGCTGCCTGCCTCG/GTGCGGGCGAGTATCGAGCGGAAGCGGCAGCGGGCACTGATGCTGCGCCAGGCCCGGCTGGCTGCCCGGCCCTACTCGGCGACGGCGGCTGCGGCTACTGGAGg(t>g)ttgggccgcgtccgcgctttccccttccctctccccgcctccccggtccccagactggctcgtgcaagccgagtcccggggcccgggggtcgcgtcaactccgctggcgtatgtgtc	NULL	No	NULL	In	73.63	3.53	0.91	55.51	5.98	5.38	2.88	2.88	3.62	4.01	10.1	4.8	-3.3	0.7	7	0.01	6	0.18	278700	ENSG00000136936	27	34	"xeroderma pigmentosum, complementation group A"
35	1	Human	165	XPA	181	Xeroderma pigmentosum	IVS1+2T>G	-97	NULL	Exon	1	gcgcatacccagactccgcccagcgcccgggcaggccaccccgagccccttaactgcgcaggcgctctcactcagaaaggccgctgggtgcggggagcgcagaggcggtgcagggcggctGGCTCGCCTCGGCGTGCAGTGCGCGTGCGTGGAGCTGGGAGCTAGGTCCTCGGAGTGGGCCAGAGATGGCGGCGGCCGACGGGGCTTTGCCGGAGGCGGCGGCTTTAGAGCAACCCGCGGAGCTGCCTGCCTCGGTGCGG/GCGAGTATCGAGCGGAAGCGGCAGCGGGCACTGATGCTGCGCCAGGCCCGGCTGGCTGCCCGGCCCTACTCGGCGACGGCGGCTGCGGCTACTGGAGg(t>g)ttgggccgcgtccgcgctttccccttccctctccccgcctccccggtccccagactggctcgtgcaagccgagtcccggggcccgggggtcgcgtcaactccgctggcgtatgtgtc	NULL	No	NULL	In	73.63	3.53	2.14	67.43	5.98	6.22	1.66	1.66	2.37	4.01	10.1	NULL	-3.3	-5.6	7	NULL	8	0.18	278700	ENSG00000136936	27	35	"xeroderma pigmentosum, complementation group A"
168	1	Human	41	CYBA	29	Chronic granulomatous disease	IVS1+4_7delAGTG	79	100	Intron	1	gcggggcctgggcggggcggggttcggccgggagcgcaggggcggcagtgCGCGCCTAGCAGTGTCCCAGCCGGGTTCGTGTCGCCATGGGGCAGATCGAGTGGGCCATGTGGGCCAACGAACAGGCGCTGGCGTCCGGCCTGAgtg(agtg)cacgtcagggacggtggaggctgcagcctggaggggtgtcccaagaccccagccgggacctcgggctacttacagg/gtggggaagtggggcgccaggcgggccaggccgggccggggtcaggccaggagggtgcggggaacgggggcgggaccctcaggccgcgggctggaaggaggagttctgagaccccca	NULL	No	NULL	In	72.86	6.51	2.21	69.33	10.08	7.48	5.74	5.74	4.1	6.09	12.1	9.3	-4.1	-8.6	6	0.12	7	0.71	233710	ENSG00000051523	135	168	"cytochrome b-245, alpha polypeptide"
235	1	Human	131	PRDM1	46	Diffuse large B-cell lymphoma	E2+249G>A	100	100	Intron	1	GCTGCCCCCAAGTGTAACTCCAGCACTGTGAGGTTTCAGGGATTGGCAGAGGGGACCAAGGGGACCATGAAAATGGACATGGAGGATGCGGATATGACTCTGTGGACAGAGGCTGAGTTTGAAGAGAAGTGTACATACATTGTGAACGACCACCCCTGGGATTCTGGTGCTGATGGCGGTACTTCGGTTCAGGCGGAGGCATCCTTACCAAGGAATCTGCTTTTCAAGTATGCCACCAACAGTGAAGA(G>A)gtaagcctctggtttattgacaagaagattggggacctggtgccaaatctccctacttgcccttgaggccttgtatatctctgaaaacctctgagaatct/gtaagtatcagtaaataattgattgctctattcaattcttgcattgctttctctttccctaaaccatttccttctcatttcttccagccttcaactgttcctcactaattagtaaacagttaaatattttggcaaattggcatgtcttagaaaagcaacttgcagcatagggtgggtgaaattgtcagtgaacttcaagaaagctctgggcccactggccctagtgtccctgttgtacaatatctcttaagggagaaaactttttcttggaaaaaaaagttttaatatttcttttgtctgtctttggtaattagttggctttactctttttaacaagccagctttattagctgggtttctaaaactatcctcaaaactttgacgtgtttatgaagtgaag	NULL	No	NULL	In	93.9	9.85	7.96	77.36	13.88	12.38	4.57	4.57	6.31	10.2	17.1	17	-7.5	-4	7	0.97	6	1	603423	ENSG00000057657	183	235	"PR domain containing 1, with ZNF domain"
236	1	Human	131	PRDM1	46	Diffuse large B-cell lymphoma	IVS2+2T>G	100	100	Intron	1	GCTGCCCCCAAGTGTAACTCCAGCACTGTGAGGTTTCAGGGATTGGCAGAGGGGACCAAGGGGACCATGAAAATGGACATGGAGGATGCGGATATGACTCTGTGGACAGAGGCTGAGTTTGAAGAGAAGTGTACATACATTGTGAACGACCACCCCTGGGATTCTGGTGCTGATGGCGGTACTTCGGTTCAGGCGGAGGCATCCTTACCAAGGAATCTGCTTTTCAAGTATGCCACCAACAGTGAAGAGg(t>g)aagcctctggtttattgacaagaagattggggacctggtgccaaatctccctacttgcccttgaggccttgtatatctctgaaaacctctgagaatct/gtaagtatcagtaaataattgattgctctattcaattcttgcattgctttctctttccctaaaccatttccttctcatttcttccagccttcaactgttcctcactaattagtaaacagttaaatattttggcaaattggcatgtcttagaaaagcaacttgcagcatagggtgggtgaaattgtcagtgaacttcaagaaagctctgggcccactggccctagtgtccctgttgtacaatatctcttaagggagaaaactttttcttggaaaaaaaagttttaatatttcttttgtctgtctttggtaattagttggctttactctttttaacaagccagctttattagctgggtttctaaaactatcctcaaaactttgacgtgtttatgaagtgaag	NULL	No	NULL	In	93.9	9.85	7.96	77.36	13.88	12.38	4.57	4.57	6.31	10.2	17.1	17	-7.5	-4	7	0.97	6	1	603423	ENSG00000057657	183	236	"PR domain containing 1, with ZNF domain"
270	1	Human	83	HBB	19	Beta-thalassemia	IVS2+1G>A	47	NULL	Intron	2	GCTGCTGGTGGTCTACCCTTGGACCCAGAGGTTCTTTGAGTCCTTTGGGGATCTGTCCACTCCTGATGCTGTTATGGGCAACCCTAAGGTGAAGGCTCATGGCAAGAAAGTGCTCGGTGCCTTTAGTGATGGCCTGGCTCACCTGGACAACCTCAAGGGCACCTTTGCCACACTGAGTGAGCTGCACTGTGACAAGCTGCACGTGGATCCTGAGAACTTCAGG(g>a)tgagtctatgggacgcttgatgttttctttccccttcttttctatg/gttaagttcatgtcataggaaggggataagtaacagggtacagtttagaatgggaaacagacgaatgattgcatcagtgtggaagtctcaggatcgttttagtttcttttatttgctgttcataacaattgttttcttttgtttaattcttgctttctttttttttcttctccgcaatttttactattatacttaatgccttaacattgtgtataacaaaaggaaatatctctgagatacattaagtaacttaaaaaaaaactttacacagtctgcctagtacattactatttggaatatatgtgtgcttatttgcatattcataatctccctactttattttcttttatttttaattgatacataatcattatacatatttatgggttaaagtgtaatgttttaatatgtgtacacatattgaccaaatcagggtaattttgcatttgtaattttaaaaaatgctttcttcttttaatatacttttttgtttatcttatttctaatactttccctaatctctttctttcagggcaataatgatacaatgtatcatgcctctttgcaccattctaaagaataacagtgataatttctgggttaaggcaatagcaatatctctgcatataaatatttctgcatataaattgtaactgatgtaagaggtttcatattgctaatagcagctacaatccagctaccattctgcttttattttatggttgggataaggctggattattctgagtccaagctaggcccttttgctaatcatgttcatacctcttatcttcctcccacagCTCCTGGGCAACGTGCTGGTCTGTGTGCTGGCCCATCACTTTGGCAAAGAATTCACCCCACCAGTGCAGGCTGCCTATCAGAAAGTGGTGGCTGGTGTGGCTAATGCCCTGGCCCACAAGTATCACTAAGCTCGCTTTCTTGCTGTCCAATTTCTATTAAAGGTTCCTTTGTTCCCTAAGTCCAACTACTAAACTGGGGGATATTATGAAGGGCCTTGAGCATCTGGATTCTGCCTAATAAAAAACATTTATTTTCATTGCAA	Minigene assay only	No	NULL	In	85.28	9.25	-1.78	62.78	13.58	3.68	1.33	1.33	0.66	9.12	16.1	8.1	-9.3	-1.2	8	0	6	0.99	603902	ENSG00000221842	202	270	"hemoglobin, beta"
335	1	Human	83	HBB	19	Beta-thalassemia	IVS2+645C>T	-32768	NULL	Intron	-32768	GCTGCTGGTGGTCTACCCTTGGACCCAGAGGTTCTTTGAGTCCTTTGGGGATCTGTCCACTCCTGATGCTGTTATGGGCAACCCTAAGGTGAAGGCTCATGGCAAGAAAGTGCTCGGTGCCTTTAGTGATGGCCTGGCTCACCTGGACAACCTCAAGGGCACCTTTGCCACACTGAGTGAGCTGCACTGTGACAAGCTGCACGTGGATCCTGAGAACTTCAGGgtgagtctatgggacgcttgatgttttctttccccttcttttctatggttaagttcatgtcataggaaggggataagtaacagggtacagtttagaatgggaaacagacgaatgattgcatcagtgtggaagtctcaggatcgttttagtttcttttatttgctgttcataacaattgttttcttttgtttaattcttgctttctttttttttcttctccgcaatttttactattatacttaatgccttaacattgtgtataacaaaaggaaatatctctgagatacattaagtaacttaaaaaaaaactttacacagtctgcctagtacattactatttggaatatatgtgtgcttatttgcatattcataatctccctactttattttcttttatttttaattgatacataatcattatacatatttatgggttaaagtgtaatgttttaatatgtgtacacatattgaccaaatcagggtaattttgcatttgtaattttaaaaaatgctttcttcttttaatatacttttttgtttatcttatttctaatactttccctaatctctttctttcag/GGCAATAATGATACAATGTATCATGCCTCTTTGCACCATTCTAAAGAATAACAGTGATAATTTCTGGGTTAAG/g(c>t)aatagcaatatctctgcatataaatatttctgcatataaattgtaactgatgtaagaggtttcatattgctaatagcagctacaatccagctaccattctgcttttattttatggttgggataaggctggattattctgagtccaagctaggcccttttgctaatcatgttcatacctcttatcttcctcccacagCTCCTGGGCAACGTGCTGGTCTGTGTGCTGGCCCATCACTTTGGCAAAGAATTCACCCCACCAGTGCAGGCTGCCTATCAGAAAGTGGTGGCTGGTGTGGCTAATGCCCTGGCCCACAAGTATCACTAAGCTCGCTTTCTTGCTGTCCAATTTCTATTAAAGGTTCCTTTGTTCCCTAAGTCCAACTACTAAACTGGGGGATATTATGAAGGGCCTTGAGCATCTGGATTCTGCCTAATAAAAAACATTTATTTTCATTGCAA	"Creates pseudoexon. No patient RNA available, only minigene analysis."	No	2	Out	NULL	NULL	8.49	81.96	NULL	12.48	NULL	7.46	6.83	NULL	NULL	14.1	NULL	-5.2	NULL	0.93	6	NULL	603902	ENSG00000221842	254	335	"hemoglobin, beta"
336	1	Human	83	HBB	19	Beta-thalassemia	IVS2+705T>G	-32768	NULL	Intron	-32768	GCTGCTGGTGGTCTACCCTTGGACCCAGAGGTTCTTTGAGTCCTTTGGGGATCTGTCCACTCCTGATGCTGTTATGGGCAACCCTAAGGTGAAGGCTCATGGCAAGAAAGTGCTCGGTGCCTTTAGTGATGGCCTGGCTCACCTGGACAACCTCAAGGGCACCTTTGCCACACTGAGTGAGCTGCACTGTGACAAGCTGCACGTGGATCCTGAGAACTTCAGGgtgagtctatgggacgcttgatgttttctttccccttcttttctatggttaagttcatgtcataggaaggggataagtaacagggtacagtttagaatgggaaacagacgaatgattgcatcagtgtggaagtctcaggatcgttttagtttcttttatttgctgttcataacaattgttttcttttgtttaattcttgctttctttttttttcttctccgcaatttttactattatacttaatgccttaacattgtgtataacaaaaggaaatatctctgagatacattaagtaacttaaaaaaaaactttacacagtctgcctagtacattactatttggaatatatgtgtgcttatttgcatattcataatctccctactttattttcttttatttttaattgatacataatcattatacatatttatgggttaaagtgtaatgttttaatatgtgtacacatattgaccaaatcagggtaattttgcatttgtaattttaaaaaatgctttcttcttttaatatacttttttgtttatcttatttctaatactttccctaatctctttctttcag/GGCAATAATGATACAATGTATCATGCCTCTTTGCACCATTCTAAAGAATAACAGTGATAATTTCTGGGTTAAGGCAATAGCAATATCTCTGCATATAAATATTTCTGCATATAAATTGTAACTGA(T>G)/gtaagaggtttcatattgctaatagcagctacaatccagctaccattctgcttttattttatggttgggataaggctggattattctgagtccaagctaggcccttttgctaatcatgttcatacctcttatcttcctcccacagCTCCTGGGCAACGTGCTGGTCTGTGTGCTGGCCCATCACTTTGGCAAAGAATTCACCCCACCAGTGCAGGCTGCCTATCAGAAAGTGGTGGCTGGTGTGGCTAATGCCCTGGCCCACAAGTATCACTAAGCTCGCTTTCTTGCTGTCCAATTTCTATTAAAGGTTCCTTTGTTCCCTAAGTCCAACTACTAAACTGGGGGATATTATGAAGGGCCTTGAGCATCTGGATTCTGCCTAATAAAAAACATTTATTTTCATTGCAA	"Creates pseudoexon. No patient RNA available, only minigene analysis."	No	-1	Out	NULL	NULL	10.06	94.5	NULL	13.38	NULL	10.53	10.14	NULL	NULL	17.1	NULL	-7.5	NULL	1	7	NULL	603902	ENSG00000221842	255	336	"hemoglobin, beta"
323	1	Human	83	HBB	19	Beta-thalassemia	IVS2+745C>G	-32768	100	Intron	-32768	GCTGCTGGTGGTCTACCCTTGGACCCAGAGGTTCTTTGAGTCCTTTGGGGATCTGTCCACTCCTGATGCTGTTATGGGCAACCCTAAGGTGAAGGCTCATGGCAAGAAAGTGCTCGGTGCCTTTAGTGATGGCCTGGCTCACCTGGACAACCTCAAGGGCACCTTTGCCACACTGAGTGAGCTGCACTGTGACAAGCTGCACGTGGATCCTGAGAACTTCAGGgtgagtctatgggacgcttgatgttttctttccccttcttttctatggttaagttcatgtcataggaaggggataagtaacagggtacagtttagaatgggaaacagacgaatgattgcatcagtgtggaagtctcaggatcgttttagtttcttttatttgctgttcataacaattgttttcttttgtttaattcttgctttctttttttttcttctccgcaatttttactattatacttaatgccttaacattgtgtataacaaaaggaaatatctctgagatacattaagtaacttaaaaaaaaactttacacagtctgcctagtacattactatttggaatatatgtgtgcttatttgcatattcataatctccctactttattttcttttatttttaattgatacataatcattatacatatttatgggttaaagtgtaatgttttaatatgtgtacacatattgaccaaatcagggtaattttgcatttgtaattttaaaaaatgctttcttcttttaatatacttttttgtttatcttatttctaatactttccctaatctctttctttcag/(3'SS)GGCAATAATGATACAATGTATCATGCCTCTTTGCACCATTCTAAAGAATAACAGTGATAATTTCTGGGTTAAGGCAATAGCAATATCTCTGCATATAAATATTTCTGCATATAAATTGTAACTGATGTAAGAGGTTTCATATTGCTAATAGCAGCTACAATCCAG/(c>g)taccattctgcttttattttatggttgggataaggctggattattctgagtccaagctaggcccttttgctaatcatgttcatacctcttatcttcctcccacagCTCCTGGGCAACGTGCTGGTCTGTGTGCTGGCCCATCACTTTGGCAAAGAATTCACCCCACCAGTGCAGGCTGCCTATCAGAAAGTGGTGGCTGGTGTGGCTAATGCCCTGGCCCACAAGTATCACTAAGCTCGCTTTCTTGCTGTCCAATTTCTATTAAAGGTTCCTTTGTTCCCTAAGTCCAACTACTAAACTGGGGGATATTATGAAGGGCCTTGAGCATCTGGATTCTGCCTAATAAAAAACATTTATTTTCATTGCAA	"Creates pseudoexon. No patient RNA available, only minigene analysis."	No	1	Out	NULL	NULL	7.88	70.27	NULL	12.08	NULL	4.91	7.11	NULL	NULL	14	NULL	-4.8	NULL	0.94	6	NULL	603902	ENSG00000221842	63	323	"hemoglobin, beta"
305	1	Human	45	DBT	117	Maple syrup urine disease	IVS8-550A>G	3507	NULL	Intron	0	GCTGCTTCCTTGGGATTACTACAGTTTCCTATCCTTAACGCTTCTGTGGATGAAAACTGCCAGAATATAACATATAAGgttggctatgcagagtaaaaatgttcttattattaatagaagatggggcaaatgtgcttgtagattagagacttctattgtacctcaaatagtgatcttttttagactagaattaaaggtatggggtaaaacattaaacttaagtctaattcattgttgttgtttttgtgttaataatactgtttagagattcttaaaactatttttaagcttttttttttcctgcttaaaataatggaaatacatagctgtatggcagattatgttacccactctacttaccctctcaaaaagaagcagctctttcaaaattgaattcctggaattttaatattattattcttattcttcttcttcttcttcttcttattattattattattattggcagagtctcactctgtcaccagtttggaatgcagtgttgtgattgtggctcactgcagcctcaacctctcaggcccaagcaatccttctgccccagcctcctgtgtagctgggactataggcatgcgccactatgcccaactaatttttaaattttttgtagagacgtggtctcattatgttgcccaggctggtcttgaacttctggtctaagcaatcctcctgcctcagcctcccaaagtgctgggattacaggcatgaaccactgtgcctggcaaattcctggaattttaatattaagaataatttaagtgagaaaaataataaaagtttgaattcaatttgagtaaactcttctgtgagtagtgaaagtttcttaagaccgaaaactctttttgagatgcctttcctgaagtttacttatcattagaagtgcacaaccagaggctgggcacggtggctcacgcctataatcccagcactttgggaggctgaggcgggtggatcatgtgaggtcaggagtttgagaccagcctggccaacatggtgaaaccctgtctctactaaaaatacaaaaattagccagccgtggtggccagcgcctatagtcccaactactcaggaggctgaggtgggagaattgcttgaacccaggaggcggaggttgcagtgagccaagattgtgccactgcactccagcgtgggcgacaagagcaaaactccatttcaaaaagagaattaaaaaaagaaaaaaaagaaaagacatgtacaaccagaaagtgagcttagatattctgggaggtcagctcccatacggttaatacagtcagctgtattaattttaattttaatatctcctgattaagtatatacttattaaaaaaatttcaggcaagaaaatgatgttggccgggtgtggtggctcctgcctgtaatcccagcactttgggggacagaggtaggaggatggcttgagcctaggaattcaagaccagcatgggcaacaaagttaggaggccccatctctacagaaaaaaaaaattagccaggcatggtggtgcatgcctatagttttagctgcttgggaggctgaggcaggagaatcatatgatacctgggagatggaggttgcagtgagttgtgatcatgccactgcactccagcctaggtgacaaagtgaaaccctgcctttgtcaaaaaaaaaaaaagaaaagaaaagaaaagaaaaaagaaaacaaagatgtttaccctcaattccatgaccctaagatagctcactgtttatgttgagatatacatctttctaggatttcatttttacatactttttacaagatatagaattatttatattttctttaacttgcttttttctttttcttttttttttttttttgatacagagtcttgctctgttgcctatctaaagtattccccatagagaatatctatgctgtggtgtaatcatcgcctcactgcagtgtccacctcccaccgcagccttctgagtagctgggactataggcacgtgccaccatgcccagctaatttttgtactttttttttttttttgtagaaatggggtcttgccatgttgcccaggctggtctctaactcctgggctcaagtgatccacccacctcagcctcccaaagtgctgggttacaggcatgagccactgtgcccagcctcttcattttcatttactatattgtagacatcattgtcaacaagtatagctttgttatttatttagccagtgacctatttataaacatcatgattatttgcagtttctcaaacttataaacagtgtgtactcaacatccctgtgtatccctacatacttctgcacttagttccttaacacgaatttttataaatgttggttcatgttgtcatatgttctccagaaagtctctacagtttaagtatccgttacctgaaatgcttgggaccagaagcgtttttggatttaagatttttttggattatggaatatttgcatatacaaaggagatatcttgaggacaggactcaagtgcaaacatgaaattcacttatgtttcatttacccctcatacacatagcctaaaggtaattttatacaatatttttaacatttttgtgcatgaaacaaagttggatttgtttttttttgtttttgttttggagacagagtcttgctctgtggcccaggctggagtgcagtgctgcgatctcggctcactgcaaactctgcctcctgggttcatgccattctcctgcttcagcctcctgagtaggtggtactgcaggaggctgccactacgcctggctaatttctttttgtatttttcgtacagatggggtttcactgtgttagccaggatggtctccatctcctgacctcgtgatccgcccgcctcggcctcccaaagtgccgggattacaggcgtgagccactgtgcccggccacaaagttttttttttttctttttttgacacagagttttgctctgtcacccatgcataatcatagcttattgtaacctaaaactcttgaggtcaaatgatcctcccacctcagcctcccaagtagctgagactataggcatgtgccataatttaaaaaaaaatttttgtagctaattaaaaaaaatttttttgtagagatggagtcttgctatgttgcccaggctggtctcaaactcctggcctcaagcaatccttctgtgtcagtctcccaaagtgttgggattataggcatgagccactatgccctgccagaacaatggctgcatttttctcttttttttttattgatgggctctgatatgattaaatattataaaatgagaactgtttcaacaactatgcagcataatgtttaaggacaaaatattgaatatactttttattatatatgtattttatcacatagtaaggaatgctgaggtgcttaatccatccaataaattgaaaataaaatctttacatttctatatttgtcagTATACAGAATTCTGAAGATGGATCTTGACTCAGGGTGATAAATCAGTTTTCAAGGAAATTGGCTACATCACATGACGTCATTTCAGCCCCCAGAAGTTTCAGATGTTGGAGCATTTCAGATTTCAG/(a>g)tatttggactagggatgctcaacctgtaccagttacattcccactaacgatgttgggaaatagcctattgcctacattcttatcaataaaaaattatcatctttttttggacagagtctcactctgtctcccaggctggagtgcagtggcacaatctcggcccactgcaacctccacctcccaggttcaagcgattctcgtgcctcagcctcccgagtagctgggatcacaggcctgtgccaccatgctaatttttgtatttttagtaaagatggggtttcactatgttggccaggctggtcttgaactcatgacctcaggtaatccagcca	pseudoexon	No	1	Out	72.75	6.1	7.51	77.05	9.78	10.78	6.22	6.22	6.62	5.07	10.1	14	-4.8	-4.9	7	0.39	8	0.46	248600	ENSG00000137992	228	305	dihydrolipoamide branched chain transacylase E2
132	1	Human	106	LMNA	98	Hutchinson-Gilford progeria	E11+124G>A	-150	NULL	Exon	0	gctgtacaacccttccctggccctgacccttggacctggttccatgtccccaccagGAAGTGGCCATGCGCAAGCTGGTGCGCTCAGTGACTGTGGTTGAGGACGACGAGGATGAGGATGGAGATGACCTGCTCCATCACCACCACGTGAGTGGTAGCCGCCGCTGAGGCCGAGCCTGCACTGGGGCCACCCAGCCAGGCCTGGGGGCAGCCTCTCCCCAGCCTCCCCGTGCCAAAAATCTTTTCATTAAAGAATGTTTTGGAACTTTActcgctggcctggcctttcttctctctcctccctataccttgaacagggaacccaggtgtctgggtgccctactctggtaaggaagggagtgggaactttctgatgccatggaatattcctgtgggagcagtggacaagggtctggatttgtcttctgggaaagggaggggaggacagacgtggggcatgcccgccctgcctctctcccccattcttgttgcatgcatatcctctcatttccctcatttttcctgcaagaatgttctctctcattcctgaccgcccctccactccaattaatagtgcatgcctgctgccctacaagcttgctcccgttctctcttcttttcctcttaagctcagagtagctagaacagagtcagagtcactgctctggttctctgtccccaagtcttcctgagccttctccccttttatgtcttccctctcctcctccgggcccctagcctcccaaacccccattgcccgctggctccttgggcacagaaccacaccttcctgcctggcggctgggagcctgcaggagcctggagcctggttgggcctgagtggtcagtcccagactcgccgtcccgcctgagccttgtctcccttcccagGGCTCCCACTGCAGCAGCTCGGGGGACCCCGCTGAGTACAACCTGCGCTCGCGCACCGTGCTGTGCGGGACCTGCGGGCAGCCTGCCGACAAGGCATCTGCCAGCGGCTCAGGAGCCCAG/GTG(G>A)GCGGACCCATCTCCTCTGGCTCTTCTGCCTCCAGTGTCACGGTCACTCGCAGCTACCGCAGTGTGGGGGGCAGTGGGGGTGGCAGCTTCGGGGACAATCTGGTCACCCGCTCCTACCTCCTGGGCAACTCCAGCCCCCGAACCCAGgtgagttgtctctgctttgtctccaaatcctgcaggcgggtccctggtcatcgaggggtaggacgaggtggccttgcaggggggagagcctgccttctcttccgcagcccgggggagtgggagcctcctccccacagcctgagtcctagacagcccacctctgcatcctgcccctcttgtctgagccccagactggagggcaggggcagggctggagtgtgagggatgggggagatgctacctcccttctaggggccaggggagggagggtctgggtccaggccctgctgctcacacctctctcctctgttttctctcttagAGCCCCCAGAACTGCAGCATCATGTAATCTGGGACCTGCCAGGCAGGGGTGGGGGTGGAGGCTTCCTGCGTCCTCCTCACCTCATGCCCACCCCCTGCCCTGCACGTCATGGGAGGGGGCTTGAAGCCAAAGAAAAATAACCCTTTGGTTTTTTTCTTCTGTATTTTTTTTTCTAAGAGAAGTTATTTTCTACAGTGG	NULL	No	4	Out	94.83	10.67	9.6	88.72	14.88	13.88	10.47	10.47	10.3	11.87	19.4	17.4	-9.5	-8.1	9	0.99	8	0.99	176670	ENSG00000160789	104	132	lamin A/C
131	1	Human	106	LMNA	98	Hutchinson-Gilford progeria	E11+126C>T	-150	NULL	Exon	0	gctgtacaacccttccctggccctgacccttggacctggttccatgtccccaccagGAAGTGGCCATGCGCAAGCTGGTGCGCTCAGTGACTGTGGTTGAGGACGACGAGGATGAGGATGGAGATGACCTGCTCCATCACCACCACGTGAGTGGTAGCCGCCGCTGAGGCCGAGCCTGCACTGGGGCCACCCAGCCAGGCCTGGGGGCAGCCTCTCCCCAGCCTCCCCGTGCCAAAAATCTTTTCATTAAAGAATGTTTTGGAACTTTActcgctggcctggcctttcttctctctcctccctataccttgaacagggaacccaggtgtctgggtgccctactctggtaaggaagggagtgggaactttctgatgccatggaatattcctgtgggagcagtggacaagggtctggatttgtcttctgggaaagggaggggaggacagacgtggggcatgcccgccctgcctctctcccccattcttgttgcatgcatatcctctcatttccctcatttttcctgcaagaatgttctctctcattcctgaccgcccctccactccaattaatagtgcatgcctgctgccctacaagcttgctcccgttctctcttcttttcctcttaagctcagagtagctagaacagagtcagagtcactgctctggttctctgtccccaagtcttcctgagccttctccccttttatgtcttccctctcctcctccgggcccctagcctcccaaacccccattgcccgctggctccttgggcacagaaccacaccttcctgcctggcggctgggagcctgcaggagcctggagcctggttgggcctgagtggtcagtcccagactcgccgtcccgcctgagccttgtctcccttcccagGGCTCCCACTGCAGCAGCTCGGGGGACCCCGCTGAGTACAACCTGCGCTCGCGCACCGTGCTGTGCGGGACCTGCGGGCAGCCTGCCGACAAGGCATCTGCCAGCGGCTCAGGAGCCCAG/GTGGG(C>T)GGACCCATCTCCTCTGGCTCTTCTGCCTCCAGTGTCACGGTCACTCGCAGCTACCGCAGTGTGGGGGGCAGTGGGGGTGGCAGCTTCGGGGACAATCTGGTCACCCGCTCCTACCTCCTGGGCAACTCCAGCCCCCGAACCCAGgtgagttgtctctgctttgtctccaaatcctgcaggcgggtccctggtcatcgaggggtaggacgaggtggccttgcaggggggagagcctgccttctcttccgcagcccgggggagtgggagcctcctccccacagcctgagtcctagacagcccacctctgcatcctgcccctcttgtctgagccccagactggagggcaggggcagggctggagtgtgagggatgggggagatgctacctcccttctaggggccaggggagggagggtctgggtccaggccctgctgctcacacctctctcctctgttttctctcttagAGCCCCCAGAACTGCAGCATCATGTAATCTGGGACCTGCCAGGCAGGGGTGGGGGTGGAGGCTTCCTGCGTCCTCCTCACCTCATGCCCACCCCCTGCCCTGCACGTCATGGGAGGGGGCTTGAAGCCAAAGAAAAATAACCCTTTGGTTTTTTTCTTCTGTATTTTTTTTTCTAAGAGAAGTTATTTTCTACAGTGG	NULL	No	6	Out	94.83	10.67	8.56	84.26	14.88	13.38	9.32	9.32	8.54	11.87	19.4	15.8	-9.5	-9	9	0.61	9	0.99	176670	ENSG00000160789	104	131	lamin A/C
309	1	Human	62	FANCA	64	Fanconi anaemia	IVS28+83C>G	83	NULL	Intron	2	gctgttgatggtctgtttccacctgagcatttgctcagccactcacagtgaaacttgcgcaatgaagaaacggccgggtcactctctgtttcagTTTCAGTTCCTCATGTTCAGATTGTTCTCAGAGGCCCGACAGCCTCTTTCTGAGGAGGACGTAGCCAGCCTTTCCTGGAGACCCTTGCACCTTCCTTCTGCAGACTGGCAGAGAGCTGCCCTCTCTCTCTGGACACACAGAACCTTCCGAGAGGTGTTGAAAGAGGAAGATGTTCACgtaggtgaccgttccttctcctgcatcatgccacgtcctgagtctagggtttgtgtgtgctcctcgggcaagaacagcagca(c>g)/gtaggtgaccgttccttcccctgcatcatgccacgtcccgagtctagggtgtgtgtgtgccgactgtctcctcgtctcgagtctagggtgcgtgtgccgactgtctcctcagaggcaagaacagcagcacttagatggtttgattggaatcttgactaaaatcgttgtggcctcatgtgcagctcttaagaaattatacagatactgggcacggtgctcacacctgtgatcccagcactgtgggaggccaaggcgggttgatcacctgaactcaggagttcaagaccagcccgggcaacatagtgaaaccccatctctacaaagaatgcaaaaattagctgggcacagttgtgtgcacctttggttccagctacttgggaggctgaggcaagagaaatcacttgagcccaggaggtggaggttgcagtgagccaagatcacgccactctattccagccaggatgacacagcaagaccctgtctcaaaaaaatatattaataaatacagagaaaccctgctatactttctcagtttctcccaacacgaacttctttttttatttttactgatatattttttgagacaacgtctcgctgtgctcagtggtgcagtcttggctcactgcagcctctgcctcctgggttcaagcaattctcatgcctcagcctctccagtagctgggactacaggcgcctgccaccacgcccgactaattttggtatctttagtacagacggggtttcaccatgttgtccaggctggtcttaaactcctggcctcaaattacccacacgccttggcctcccaaaatgctggaattacaggcgtgagccattgcgcccgagaacttgttttttgttgttgttgttgttttgttttttttttctggtggagtcttactctggggcacagtggcgcaatcttggctcactgcagcctctgcctctctggttcaagtgattctcctgcctcagcctcccaagtagctgggactacaggcgcgcaccaccacgcctggctaagttttgtatttttagtagagatggggtttcaccatgttaggctggtctcgacctcctgacctcgtgatctgcccgccttggcctcccaaagtgctgggattacaggtgtgagccactgcgctcggcccctgggaacttgttttaaacatgtctgccaggctgtgtggtggtcactcagggtctctgggctcacccatgtgtgcctggttactggagctggcattgctctcaccagtgtgccttggtactgatttatttctgaggatgtttgcctggttgttttggtctttagaaaagaatttcaaggtggctgggcacagtggctcatgcctataatcccagcactttgggaggctgagatgtcaggagattgagaccatcctgggtaacacgatgaagccccatctctactaaaaataggaaaaagtgatccttctgctttggcctgccaatatgttgagattgcaagtgtgagccactgtgccaagccttttgtgaaattattttattatttttaaattattatttttttttttggagatggaatcttcctctgttgcccaggctggagtgc	NULL	No	-1	Out	75.64	6.85	6.85	75.64	10.28	10.28	7.85	7.85	7.71	7.71	13	13	-4.1	-4.1	8	0.47	8	0.68	227650	ENSG00000187741	232	309	"Fanconi anemia, complementation group A"
324	1	Human	7	ATM	14	Ataxia-telangiectasia	IVS20+1874delGTAA	-32768	-50	Intron	-32768	gctgttgtgcccttctcttagtgttaatgagtgctttttatttttagGTGCCATTAATCCTTTAGCTGAAGAATATCTGTCAAAGCAAGATCTACTTTTCTTAGACATGCTCAAGTTCTTGTGTTTGTGTGTAACTACTGCTCAGACCAATACTGTGTCCTTTAGGGCAGCTGATATTCGGAGGAAATTGTTAATGTTAATTGATTCTAGCACGCTAGAACCTACCAAATCCCTCCACCTGCATATGgtgagttacgttaaatgaagaagctcttggattttatctgatgttgctgactaaatgtaatgagttgacatgtaagaatcacatggtgtctttgaagaattgaaattgctttcttgagaaatgaacctgagactagttggaaaataacacttttaacgtgctgtgagcaaatttaagtggatgctgaaatattaaaacttagatgggttttggatagatttattctctttaggtttaattgttataaattattttaattaggctaagaaacatagaccctgaatgtaaaaatattacataacattgtgtttgaagttggaaccttgcctttgaccttagtttatatattttcagttttttggatttgatttcaaaatgatagtgaagttacaagaatactacagttaacgttttaccatatttgcttaatcattccctctctccacacacacactcatacgcagatacacacatcattttctctgaaccattttgagatgaaatcgcacacgtgatgctccttatacttcagtgtatatttcctaaaaacaaggatacacttctgtttagccacagtataatcatcaaaatcaggaagttaacattttgtcattgcatttaggtgtgtagtctgtttagtctccttcaatctggaacagttcttttttttatttatcatgaccttcatatatttgaatagtacaggtcccttgctctgagtttgtctgatgtttccttatgattaaatttatactttgacgagaatgttgcaaaagtaattcctcttctgccttcaccctgtccatttatctgtctgttgatagatatcttcaaatccaagccaacatcacacagtttatctttttttctgtccaaatttataaattgctttactagcagttaaaaaaaacaccccaaaacctgactatccactcaacctgaatgcatttacttatttgctcaacaaccttatatataactaatctaaccatgtgggccattttcttagccctagccccagtgtatgtggaggtagagcctctggcctagcgagtagcaagttgggtcctaggtcatgtccccagttccagcaaattgtcacacatgcctggtgagtccctaattagaacctctgatcacagtaaattgtaggctgagtcattggtggaatccctggtcatgtttcccacccttggtgaaaatgcacgtcaatcccttagagtgagaagacaagtttggttgtgccctgtttgggcccctggtttaggtcctcgcagatactcaagtctctatccctgaccaagaggaagttacatgcttttcttgaagtattgatgtttcaagtcacttcagaacattcagtaacctcatgtacatgactctcatgtcaaataatgaaaaggatcatttaatttcctttgttaatatctgaaaaggattaagaaatatattattctatatgtaaataggaaaaaaaatcccttattatttcagtatagccagaaaattatttggtagttctcggaaactggctgcccagataataactaccattataactggtcgttgcagcagccctttctgtgcatagtaccataaagagccttacaagattgccttatgggaagataggtcaaggtttttgacttcttccctgcccatgattatctctgctttccaaaattcattaatagttttcaaccactggtctattatccccaagcattattttgggagagtggagacttacagtttcagaatcttgctcaagctcttaactgcaacagtggtaataatgatcatttattgaattccacaatagaagctagacttttacgtttattttctctaatcctcacagTTATCTGGCCAG(GTAA)GTGATATATCTTCACTCTACTGATGAGGGTACGAAGGCCCTAGATGACATAAG/gcaagttttttaccagaaaagttaaggctgtggtactgggatttgaattttctgtttgacttcaaagccttttgtttttactatacacctcttaaatatttacagctgtgtgtgtgtgtgtatgtgtgtgcatgtatgaatttatgtttatatacttaaaaaaaatttttttttgagacggaatctcgctctgttgcccgggctggagtgcagtggcgcgatctcggctcactgcaaccttcgcctcccaggttcaagcgattctcctgcctcagcctcctgagtagctgggattataggcgcctgccaccacccctggctaatttttgtgtttttagtagagatggagtttcaccatattggccaggctgttctcaaactcctgaccttgtgatctgcctgcttcagcctcccaaagtgctgggattacaggtgtgagccactgcacccggcctatgtttatatactttttaaagtaaatgatttgtggataaacctgatttttttccctcctaccatcttagTATCTAATGCTTTTAAAGGAGCTTCCTGGAGAAGAGTACCCCTTGCCAATGGAAGATGTTCTTGAACTTCTGAAACCACTATCgtaagaaattaaaaccttatgttatgttcactttaaagttataaaataactgatgtgttcTgttaagcttataaagttgaactttttttttttttttaccacag	Creates pseudoexon	No	-53	Out	NULL	NULL	3.24	82.16	NULL	7.72	NULL	4.95	4.43	NULL	NULL	NULL	NULL	-4.8	NULL	NULL	7	NULL	208900	ENSG00000149311	244	324	ataxia telangiectasia mutated
332	1	Human	58	F8	80	Haemophilia A	IVS1+1567A>G	-32768	100	Intron	-32768	GCTTAGTGCTGAGCACATCCAGTGGGTAAAGTTCCTTAAAATGCTCTGCAAAGAAATTGGGACTTTTCATTAAATCAGAAATTTTACTTTTTTCCCCTCCTGGGAGCTAAAGATATTTTAGAGAAGAATTAACCTTTTGCTTCTCCAGTTGAACATTTGTAGCAATAAGTCATGCAAATAGAGCTCTCCACCTGCTTCTTTCTGTGCCTTTTGCGATTCTGCTTTAGTGCCACCAGAAGATACTACCTGGGTGCAGTGGAACTGTCATGGGACTATATGCAAAGTGATCTCGGTGAGCTGCCTGTGGACGCAAGgtaaaggcatgtcctgtagggtctgatcggggccaggattgtggggatgtaagtctgcttggaggaaggtgcagacatcgggttaggatggttgtgatgctacctgggccccaaagaaacatttctgggtaaggtgtgcacacatctgtgttattagcagaaatgctaactgccaattcttttcataggtctgacctatttgttgatattttgttctgttttgtccattgcttctcttcgtcatatgctgctcctccagaatctagagactggagtagagggagggtgaagggacaaagacaaaacttccctctgcctgcccaagcttccatagagagaatcaaggcaatgaaatccaatcaatatcacacacaagtttcatgtctggttctcttgtgtgtacatgcaatgtgtgtttttataatatcttttcctactttgggtgtaaggataatatgagccttgagttcagaagcttttcgtgttttgggggttctggtgcatttaggcagagtattaaataactttatcaatattgtctatggtcatcagttgattcagatttttctacctcttcttcagtaaatattggtatattttggtctatactttcatagaaagcaatctactgtccctagatttgataatgtattggtatcaagttatgtaagagtctcctgtgattttgttaaactgttctgtgtctgtagttatattttctttttcattccttatgttgtatatgttctcttcctctcttttaaaaataatatttccaggagttttcttgattttattggtcttgtcaagaattttcttttggtttgatttatcaatctcttttttctttctgttgcatcagtttctgcttctactttcattgatttattccttccttctaatttcctttggttcattttgttgttagatttttgcttcttgagttgaatgctgaaatcatttattttatttttttgtcttctttaaatgtgtattataaagatttaaatataatacatagattgtggctgtgtaaacattaaatgtggtcatgttgtacatactttatattctttttggttctttctgtttggctccccaccctctttccacatcagtccccttctcccccacctcagctaggtaaccccagtatgataatatatattcacatacacatacacacacacaaaggttttcttggacattatttgttttataaaattgggacattatacacacatttctcactcattaacacgtactagaactctaagtcaattggtatagctttaattcattatttttattggctatataagattctatggtatggctgtatcacaatttagtcaatatgttcactttattccag/TTTTTGGCTACTATATCCTATATCATTACATACTGGTGCTTTTACTTCTGTTGAACAAACTTGCAAGAGGAATATTAATGGAACGAAGGGAATGTTTCCTTCTAAGTTTTAATTTCCAAAGAGGTCAGAACTTTTCAAACATTTCTACCATCGAAGTATGAAAATGGCCTTCTCTCTGCATTCACATAGCG/(a>g)taagttttatcctgtttttaaaatttgccaattttacaggtgtagagtgatattgcatcattactttcattgtgttatttttatttctaataagttgagcatctttttaaatgcttgttggctattggatttatttgggggatttaattagtcatatgatttgcccattattctttggactctttcatttaaaaaaattatgagaacccttttattattacaaatattaactctttgtcatgtatattgcagttttccccaagatctattgtttgtctgttgactttcttata	Creates pseudoexon	No	1	Out	NULL	NULL	11.37	90.4	NULL	15.48	NULL	9.53	11.28	NULL	NULL	17.5	NULL	-7.6	NULL	1	7	NULL	306700	ENSG00000185010	251	332	"coagulation factor VIII, procoagulant component"
#251	1	Human	27	COL1A1	137	Osteogenesis imperfecta	IVS8+5G>A	-96	NULL	Intron	0	gctttcctacagagggatcaccatgacccccctttcttctccctctatagGGTCCCTCTGGTCCTCGTGGTCTCCCTGGCCCCCCTGGTGCACCTgtgagtatccaggacgtcttcatatgcctccttgggctttggtcttttggagggaagactgggatgagggcaggagagatgctcagagatctcttg/gtaagattggagaaggttgacagggacttgtcttctaacccatctttttccttcttctcaagGGTCCCCAAGGCTTCCAAGGTCCC(C>G)CTGGTGAGCCTGGCGAGCCTGGAGCTTCAgtaa(g>a)cactctctatacagattcatactccttctacaaacacacagactctcctatagaagaactcccaggcctggggtcttccttacctcttcccttcaatcccagccttccccttctttttttcttatccatattctaaccacctcttctatcttttctag	NULL	No	NULL	In	72.18	7.21	8.85	85.6	11.58	13.08	7.65	7.65	7.46	6.27	15.1	15	-3.9	-5.9	7	0.99	7	0.95	166210	ENSG00000108821	189	251	"collagen, type I, alpha 1"
333	1	Human	38	CTDP1	36	Congenital cataracts facial dysmorphism neuropathy syndrome	IVS6+389C>T	-32768	100	Intron	-32768	GCTTTTTAGACCCCGAGAAGAAGCTTTTTTCTCACCGAATATTATCAAGGGATGAATGTATTGACCCATTTTCTAAAACGGGAAACCTTAGgtatgtacccagccgcgctcctcacaaagacctcgctgttcatttcccatttcaaaaatcgcatcttgaaatttagagcagtatttctttttttctttttttttgagacggagtcttgctgttgcccaggctagagtgcagtggcgcgatctcggctcactgcaagctctgcttccagagttcacgccattctcctgcctcagcctcctgagtagctaggactacaggcacccaccacctcgcccggcaattttttttttttttttttttttttttttttttgtatttttag/TACAGACGGTGGTTTCACTGTGTTAGCCAGGATGGCCTCGATCTCCTGACCTCGTGATCTTCCCGCCTCAGCCTCCCAAAGTGTTGGGATTACAG/g(c>t)atgagccactgcacccggcctagagcagtatttctgtattgatgttttttaggaatttaacatcccctttccagttttcattgttagcctcagaatacttagaaagttcctttctaacctgtactcccactgtctcccaggtgcctgagccctggtgcttgtgcagggcccccaatccaggctctgccccatcccaatagccctgtcctgccctgaaactgcccttgagctgggcttttgtgtctgtggaggcggggactgtcatcctctctgcctcgtctctgttagacagcacaattcgatgtcagcccgccacctgacgttgtgtatctgtcatcctctctgcctcatctctgtcagacggcactgattcgatgtcagcccgccacctgacgttgtgtatctgtttgcttaaccaaccctggcatatgtgatcattctagtcccttgacctccaaattttcattcctatgcgaagacctggcatcgagatttgtggttggagaggcaggaggcaggcgtgtgtccccacagtagccagctgtgaaggatttggcccttttgcctctga	Creates pseudoexon	No	2	Out	NULL	NULL	9.46	84.1	NULL	11.98	NULL	8.78	8.96	NULL	NULL	15.5	NULL	-4.9	NULL	0.97	8	NULL	604168	ENSG00000060069	252	333	"CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1"
118	1	Human	28	COL1A2	52	Ehlers-Danlos syndrome	IVS24+1G>C	-8	NULL	Exon	2	ggaaagccacaaaaaaatagaagaaaaatttcagaactcttttcacacttcccagctagtggctaatattcctaatgatttaccctaggcaacaaacaaaaagtcgggggaaaaggtgcctttgttagacttcagttaatctaaggcttgagtatgtaagttaaagtgccaatataaaaacatcctcatttattttatagGGTCTTCCTGGTTCCCCTGGAAATATCGGCCCCGCTGGAAAAGAAG/GTCCTGTC(g>c)taagtattgctcattttccattatattttcaaggacacttattgcacccttatcaagtctattttgtggcttatttatacatgaacacattgaaaataaatatcagacacatacatcatctgggaatgcagagtaatagattgtaattatggagtccaaatgaatacaggactgaaagcagagcaggggagagaaaaac	NULL	No	NULL	In	77.3	9.9	-0.19	60.26	13.08	6.88	0.36	0.36	0.67	7.17	17	10.1	-4.3	-2.5	6	0.01	4	0.96	120150	ENSG00000164692	93	118	"collagen, type I, alpha 2"
345	1	Human	12	BRIP1	64	Fanconi anaemia	IVS11+2767A>T	-32768	NULL	Intron	-32768	GGACATTTTTCTGCTGTTCTTCAAAAAGAGGAAAAAATCTCACCAATTTATGGTAAAGAGGAGGCAAGAGAAGTACCTGTTATTAGTGCATCAACTCAAATAATGCTTAAAGGACTTTTTATGGTACTTGACTATCTTTTTAGGCAAAATAGCAGgtaagtgaagataactagtatgtattttccttttaaaaatagcctaatttggatgctagcatgtgtttaatacatacctattttgggtgagtaaataggagaattgaaaacaagtgttatagatattattatatatttgctcttattgacacagacttagaggaattgaaattagtctgatgcttttttgagacagggacttctctgtcacccaggctgaagtgcagttgcatgatcacagctcactgcaactttgacctcctgggcttaagcaatcctcccacctgtttcctgagtagctgggattacaggtgtgcaacacccacacccagctaattttttaatttttattttttttgtagagatgagatctcactatgttgatcaggatggtcttgaactcctggcctcaagtgatcctcccacctcagcctcccaaagtgctaggattgtaagtgtgagcccatgcctggccaaaattagtcttttatattaatgaatattgaaatcattaaataaatatatttaattaattcatattaaattatcttctattgctaaagttttcttatgttcctacagtgtcagaaagtcccttttttattgtatgaactgtggaaaatgaaaaacaaccaatccctctcatcctgtaacttaaattatagtagtacctagttctggtattttttttttattgtggtaaaatatacataaaatacaccattttaaccattttacgtatacaactcagtgccattaagtacagtatatttgcaatgttgtacattgtactcatttccagagatttccagaaattttttattattccaaataggaattctgtacccatgaaataataacccctagagtctttcccctcatcacctgctaacctgtattctattttcatcttatgaagtcctttctaggtatttcacataagagcgatcatacaatgtttgtctttttgtgtctggcttatttcaattcatttggcacagtgttttcagagttcatttatgtagtagcatatatcagaatttcattcctttctatggctgaataatactccattgtatgtatataccacaatttgttaatttattcttatgttaatggacatttgggttgttttcatcttttgcctattgtaaacaatgctactatgaacgttggtgtacaaatatctgagttctgctttcagttcttctgggtgtatataagtacctagcagtggaattgcagaatcatatggtaatgctgcatttaactttttgaggactcaccatactgtttctcacagcaactgcattattttccattctcattatcaatgcacaagggttccaatttctacacatccttgccaacagtttatgtagcagcatatatcagaattgtttttgctgacactcgttattttattttttgtataatagccatcctaataggtatcaagtgatatcatctggtttttatttgtatttcctaatgactagagaagttgagaatcttttcatgtgcttattggccaattgtatgtctttttttggagaaatatctattgaagtcttttgcccacttttgaattattgggtttttttgttgttgttgttgagctgtagttatttagatattctggatgtcagtcctgtaagagatatatactttacaaatattttctctcattctgtgggttgttttttcatttattcatagtgtcctttgatgcagaaaaggtttttaatcttgttgaagtccaatttatctttctcttttcttgttgttgcctgtacttttag/TGTCACATCCAGTAAATCATGGCCAAATCTGATATGAAGATTTCCCCTATGTTTTCTTTTCCTTTTTTTTTTTTTTTTTCTGAGACGGGAGTCTCGCTCTGTCACCCAGGTTGGAGTGCAGTGGCGCGATCTCGGCTCACTGCAAGCTCAGCCTCCCGGGTTCATGCCATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGACTACAGGCGCCCGCCACTAAGCCCGGCTAATTTTTTGTATTTTCTAGTAGAGACGGGGTTTCACCGTGTTAGCCAGAATGGTCTCGATCTCCTGACCTCGTGATCCGCCCACCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCATCGCACCCGGTCTCCCCTTTGTTTTAAGAGTTTTACAGTTTTTGGCTCCCAGTATTTTTATAAGATTCTCTCCACAGTTGTTAAGTTCCCAACTTTAATTTTGAGATCTAATCTCTCTAGGAGTGAAATGAATAAGGAAATACTATAGCGAAGACATGGTAGAGAATATCACATTTTACTTTTTTTTTTTTTTTTGAGATGGAGTCTTGCTCCGTCACCCAGGCTACAGTGCAGTGGCGCTATCTCAGCTCACTGCAACCTCCACCTCCCGGGTTCAAGTGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGGTTACAGGCGACTGCCACCACACCTGGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTCCTGACCTCGTGATCCACCTGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGTGTGAACCACCGCGCCTGGCCACATTTTATTATTTTTAAGCTTAACCATTTTCTAGATTCTTATTGAAAGCAGTTATACACTGGATGGGATCACAGATATCATCTGGTTCAGCACCTTCATTAAAAGTAGATGAAGGCTGAGACTCAGGTTTCAAAG/g(a>t)atgtaagaattttataacttgttgctaatactttaaaaactttcagtaaaaattatccttctattttctcatttaataaaaaagtataacccaccttttagtctctttaaccataatactgttttctattttgtaactcatcatgtagtagagcatgcagagagctctggactgggagttaggaggcctggattttaattctgcttctgccatgacatatgtaatgtttgaaaatgaggttaggaagtagctgataaaagatagatggttagatgatttctaatattccctctgagaatcagttgattctatgattaatggctttattaatatcagaattactgaatttaattaatggtaaggagaatgttatttttgaatgggaaggtaccagctctttcaaatgagttttaatgtaatcagtttttatattgtatgtagctgggtcataggttttaaaagttttgccacttaattagcactttctttgcatctagATTTGCAGATGATTATAAAATTGCGATTCAACAGACTTACTCCTGGACAAATCAGATTGATATTTCAGACAAAAATGGGTTGTTGGTTCTACCAAAAAATAAGAAACGTTCACGACAGAAAACTGCAGTTCATGTGCTAAACTTTTGGTGCTTAAATCCAGCTGTG	creates pseudoexon	No	2	Out	NULL	NULL	9.79	89.6	NULL	13.48	NULL	9.76	10.03	NULL	NULL	17.5	NULL	-5.4	NULL	1	8	NULL	227650	ENSG00000136492	262	345	BRCA1 interacting protein C-terminal helicase 1
99	1	Human	34	COL7A1	54	Epidermolysis bullosa	E3+159A>G	-104	NULL	Exon	2	ggagaatgacagaacgaagggacccctcaagagagcctgatacccgtaaccctcaccctagaggcctcctcaaggccagggccagaagagatcctgagtcctagcctgttgccacccctaccctccaacagGACAGAGTTCGGCCTGGATGCACTTGGCTCTGGGGGTGATGTGATCCGCGCCATCC/GTGAGCTTAGCTACAAGGGGGGCAACACTCGCACAGGGGCTGCAATTCTCCATGTGGCTGACCATGTCTTCCTGCCCCAGCTGGCCCGACCTGGTGTCCCCA(A>G)Ggtgatccctacccctaccatgcctcccaagatgaccccaaatgaagtgtccaggggaaccgtgatttgacccctgcacctgtcccag	NULL	No	NULL	In	76.18	4.41	4.32	65.33	9.28	8.88	3.23	3.23	5.45	5.14	10.7	10.1	-5.1	-2.8	6	0.1	5	0.84	120120	ENSG00000114270	76	99	"collagen, type VII, alpha 1"
346	1	Human	91	HSPG2	158	Schwartz-Jampel syndrome	IVS6+481C>T	-32768	100	Intron	-32768	GGAGCTGGATGGCTGGGTTTTTGTGGAGCTGGATGTGGGCTCGGAAGGGAATGCGGATGGGGCTCAGATTCAGGAGATGCTGCTCAGGGTCATCTCCAGCGGCTCTGTGGCCTCCTACGTCACCTCTCCCCAGGGATTCCAGTTCCGACGCCTGGGCACAGgtgagcctatcctggtgtctgggatcgcctcctccagactcgtggggtcccctttcagtgtctctgccataggctcccaacttgggcttgcacaccactagaaacagggagctcactactcctgagtctgccccatcgatctttacacaatcttggcttggtagagcacagactgtttcctctagcacatacccgttagacccgagttctgctccttccttctagacctctgcacattgacaataggtaatcaggcctttatttatcctgtacttccaagtccaaaacacattagtacttaataataatgagcaactgtttactgagcactgactgcctttatttccag/CCTCCGGGTCAGTCTTCACAGCAATTCCTATGAAGGAGATGTTATTCCTCCTGTTTCAGAGACGAGGGAACTGAGGCCCAGAAAGGAAAATCTAAATTTGTCCAGAATCAGATGGGCAGATAGTGAAAAG/g(c>t)gaggatttcaaacaaactcggtgtctgtgacagtcttgccagaacctgtgatgacagaagcaggagaaactgaggcacagagagactaggaaactggtccaaagccacacagcggttaggtgcagaatcctggcctttgtactctgggtcagcccagatttccttctactgtgcctttggtctcctgttttaacctcctgagtctcttttttttctctagaccgaacagccctagttcatccttcacaggtgtggttctcggccctgtctccatctcagttccctgtctctgggaagaccctgactcagtggaactcagaatggaacaaactccatcccctactatggtgtagcccaat	Creates pseudoexon	No	2	Out	NULL	NULL	9.16	89.44	NULL	13.98	NULL	10.39	9.62	NULL	NULL	17.2	NULL	-8.5	NULL	0.99	7	NULL	255800	ENSG00000142798	88	346	heparan sulfate proteoglycan 2
88	1	Human	141	RPGR	191	X-linked retinitis pigmentosa	IVS5+1G>T	-76	100	Exon	1	ggatagtgatagctttcaactttcttcactgttaatagaggaaatcgctgctatacactgacctgtctcataaaaagggggactctatagtctattgacgttttcttttccatgtgcagAAGGAGGCAATGTATATGCAACTGGTGGAAATAATGAAGGACAGTTGGGGCTTGGTGACACCGAAGAAAGAAACACTTTTCAT/GTAATTAGCTTTTTTACATCCGAGCATAAGATTAAGCAGCTGTCTGCTGGATCTAATACTTCAGCTGCCCTAACTG(g>t)tgagacttgtttctttttcagtctgggacacattcctttcctgtagatcaatatatgccaactcagtaaaccgaagggagcattgctgtttagttttctttcatcgactatctatgtgctttcagaaaacatttaaaatataactttaaatcttgacatactgcaattttatgcttatttatgcttattttatgcttatttgtgcttatttaaatatacatttaaaaagtaattggcaaataagctctaagctatgccgtctgtctactcctttagatattcttaaatattatttttgttgtgtgctcttaaagttatacttgcagttttaactgaagttgctgtcagaaacatccaca	NULL	No	NULL	In	80.42	7.54	1.05	74.41	12.48	1.18	5.05	5.05	3	7.72	13.8	12.5	-5.8	-0.6	8	0.1	7	0.95	300455	ENSG00000156313	67	88	retinitis pigmentosa GTPase regulator
297	1	Human	70	GALC	75	Globoid-cell leukodystrophy	E2+293G>C	126	100	Intron	0	GGCGGCGGCGGCGTCAGCATCAGCGGCCTCCTGCCCGTATCTATCGTGGCGGCGACGGGACCCGCCTCCCTGGGCGCCGGAGTCATGTGACCCACACAATGGCTGAGTGGCTACTCTCGGCTTCCTGGCAACGCCGAGCGAAAGCTATGACTGCGGCCGCGGGTTCGGCGGGCCGCGCCGCGGTGCCCTTGCTGCTGTGTGCGCTGCTGGCGCCCGGCGGCGCGTACGTGCTCGACGACTCCGACGGGCTGGGCCGGGAGTTCGACGGCATCGGCGCGGTCAGCGGCGGCGG(G>C)gtgagcggcaagctgcggggatacgcggggggcggcaagagcccgccccgtggggccagccccacaagcccccgcggcgttgccctgcgtttccaccggctccactctccgccgcattcccctagg/gtgccagtcagcaggcggttggggcgggcccgctgcggggctggggcgggtgctttctcgtttaacacgaaccagacaggcagttaggtttgaacaaatgaggatccggaggtccagagagtataggtgcagagagtaaagtgacaggtctaagtagtgaagtagccggggctggaaccctcgtcccaggcagtggggcacaggctgtcttcatcgcggagatggcagtcggggagcgtcgctccagaaagggccagggagtgcgggagcgtccgtgtgcgaaagagaacgccccagtgggatgctttggctgtgtctctcccttttggaggagttggtgggtggtggagtcgttaagtcccgtgcagttgttagtgcagggtaagaatgggctcctccagagagggtagcgccgaataggatttcgtttggaggcaggactggtgcctcaaggtctctttaaaaggaagataagcgagcggcctgaaactaccgggtactccctctgggcccatgggcttcatggtggccgacctttgggtgagaaggtttttgttttttggttttgtatccgaaattacatctagggctaat	NULL	No	NULL	In	79.18	5.97	-2.33	55.55	11.18	5.18	0.88	0.88	2.13	6.33	13.6	8	-7.9	-4.3	7	0.01	5	0.67	245200	ENSG00000054983	220	297	galactosylceramidase
268	1	Human	87	HMBS	3	Acute intermittent porphyria	IVS7+2T>C	15	NULL	Intron	0	ggctggctgctcataccctttctctttgcccccctctcccatctctatagAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAg(t>c)aagagtcttgcaa/gtaaggggcttgggcaggggtaggcatcatgtgaacctttgcctttccctttggggcctgaccctctgcttcagggttatctcctctgccctgaggagtgttgactggtggcagaaaactcaagaaataccagtgagttggcaatcgagagagaatagaggtgatctgaacttaaatctcttccctcattctgtgcccttccctcctcccccagGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGgtaagtggggcctggataggcagcttggtgggatgtgcccagaagatgcagggatgggaggaggaggaaaggaacagtgactgcctagtgttaaaatctcattgtaacttctctctgggcag	NULL	No	NULL	In	82.08	7.61	7.66	82.19	11.08	11.98	8.97	8.97	7.38	7.43	14.1	14.1	-2.8	-4	7	0.76	7	0.9	176000	ENSG00000149397	200	268	hydroxymethylbilane synthase
326	1	Human	46	DMD	133	Muscular dystrophy	IVS65+1215A>G	-32768	NULL	Intron	-32768	gggaaggttttctgaaaagagttgcaaaacaactgttttgccttttacctttgttgtagacttctactaccttttgaactaaaatttatacctttttttctttcttattttgataaggtattgctttttaaaatttcaggaccacctgactattacattcatcatagtcatctaccaagtccttgaacatgtcggatttcaattgtgaactacgttcacattagttttgataagagtttgtattcaggtttcccctcaaatatattttggcactgttttctttgcagATGACATGTGAATGCATTCTGAATGTATAACTTCCTTCTACCTGACTGAAAAGTATTTGGTGACAATTTTAACTCCTTGAAGACCTGAGTTGCTGTATAAAGTGGATTTGTTAAATTTTGATCTACCTTTTCTTAAGAGGGAGAAAG/(a>g)taagaaaattttccagtgataggaatttgtttagtccattagtgcccaggatttctttttgactgagggatttaataaattttagtagctggaagttgagcatattgttcaccgaaaataaccgccattgggacctatcctttgtgattttgaagtgctaataggcgaattattctgaaatattttctcctttttctttttaccaatatctaagggccagtagct	Creates pseudoexon	No	1	Out	NULL	NULL	10.57	94.5	NULL	15.58	NULL	11.36	10.55	NULL	NULL	17.3	NULL	-7.4	NULL	1	7	NULL	181350	ENSG00000198947	75	326	dystrophin
343	1	Human	137	PTHR1	21	Blomstrand osteochondrodysplasia type I and II	IVS9+29C>T	27	100	Intron	0	gggaatgaccttgtggacagcagccacagtcctgcacactgtccccctctgtgcccacagGTCTGCCCGCTGTCTTCGTGGCTGTGTGGGTCAGTGTCAGAGCTACCCTGGCCAACACCGGgtaggtccaggtggagaaggggcccag/g(c>t)aagaagcacccctgggtcccttttcttccaggaagcatgtgagagggcctcctgtaccctggcctcaaacggcccagcctcaggagttctcagtccagcctcaagccaggagcaccctcagggtcacaggaggctacttccaaagaggcctgtgagggaggcctcaggcctggccacacccagcacccctgccctgtgtcctcaacagctaatgtcagaccagaccaaatctgggtctctgtgggcagtcttaggatgggaacaggagggatgggagctaatgcctcaacctcccccag	NULL	No	2	Out	79.89	8.53	10.77	94.5	11.68	14.98	11.73	11.73	11.11	8.98	14.3	19	-9.2	-8.2	9	1	8	0.99	215045	ENSG00000160801	261	343	parathyroid hormone 1 receptor
62	1	Human	113	MRP2	49	Dubin-Johnson syndrome	IVS8+4A>G	-20	100	Exon	2	gggccccagtgacctcatcttaatttggttacatctgcaaagaccttctttcgaaataaggcacattttaaggtattgggggttagggcttcaacatagcttttgggggtggggatacaattcaacccataacatctcacagcaaccatgaaaagaacaagcatgaaaagaacagaaaggacctctcagcatcatgcccaggcccttcactctcaggactgcccctcaggcccccacgcagatgggtctctctttttacatgggactcttaccagcttagttgcctggttttctaatctaaaatagattacaagtatcagttaggagcgggagagtggaacagtgaaggcagctagaagggcagaagcaactaggccagggagagatgatcaaaacctgtacagagaaggccacggggctcacaggctgaccaccctggagctgctcaggccagtaacagacataactctgtggacactgttgtttggttttgtacctagGAAGATGTTGAAAAGAAAAAAAAGAAGTCTGGGACCAAAAAAGATGTTCCAAAATCCTGGTTGATGAAGGCTCTGTTCAAAACTTTCTACATGGTGCTCCTGAAATCATTCCTACTGAAGCTAGTGAATGACATCTTCACGTTT/GTGAGTCCTCAGCTGCTGAAgtg(a>g)gtctccaggcctcagatggtcctttcagggcctcctctgccaccctcctttttgccactgtgtatgcaagcaggagcttttcttaaattcccattttttaaaaatgctcgtaattttcttccaccttaaccttacagcattgtgttcatgaagaccgcaggcagttttcaagatgtatgatgatatgtactttagcctctctcttttccatgtctgtctcctcatagggggccgggtaattgttaggggctgtttcttgttaaactgctaagggctgagccagatccaagtggcgggtagcatacccctggagagtaactgacttcatctctccatcgcagccttccacgggaggttcaggttaatcttgacaagacttcacaatctgtcatgacctgtggagtgaaccacctgcagggaaagacagggccaaagcattgcagtgacagctaggtggagcatttctgtcattatccattctcacagccatgggtta	NULL	No	NULL	In	82.41	7.97	5.91	72.88	12.08	9.88	3.5	3.5	4.98	7.37	13	12.1	-4.1	-3.9	7	0.51	6	0.96	237500	ENSG00000023839	50	62	"ATP-binding cassette, sub-family C (CFTR/MRP), member 2"
291	1	Human	32	COL5A1	52	Ehlers-Danlos syndrome	IVS28+1G>A	178	100	Intron	1	gggcgctggcctcatctgtcagcttcagcgagctcagcctgtcttgacacgcctgcgacagctctagaaaggctgagacttgtaaccattcactcctttttcttttcccacccgcacagGGGGCCGATGGCATCCGTGGTCTGAAGGGCACAAAGGGCGAGAAG(g>a)taagtctctccttgcagccacggggccccctgcttagtccggagccgaattccagccagcggggccctcccacaatgcttcttccatgaaaccagctgaggtggatgtcgcctctgagtactgagggggatggatgccactctgtggaaagtgtctctgtttgcagacggaagaaga/gtaagttgaggataggccctcgggtccccaggggcacatctcctagcagagctgagtgggtccagggtttgtgtctctgcacaaggagaaggccttggccccagagacaacacacggccccccacgtgcctgcaggggccagtggacacctgtcaccctccccactcccaggtgggccgccttgcat	NULL	No	NULL	In	100	11	9.35	78.03	15.48	12.88	7.26	7.26	7.58	12.19	19.6	14	-8.8	-4.6	8	0.99	6	1	120150	ENSG00000130635	217	291	"collagen, type V, alpha 1"
325	1	Human	71	GALT	69	Galactose-1-phosphate uridyl transferase	IVS10+56C>T	54	NULL	Intron	0	GGGCTCCCACAGGATCAGAGGCTGGGGCCAACTGGAACCATTGGCAGCTGCACGCTCATTACTACCCTCCGCTCCTGCGCTCTGCCACTGTCCGGAAATTCATGGTTGGCTACGAAATGCTTGCTCAGGCTCAGAGGGACCTCACCCCTGAGCAGgtcaggactcagaacagtctggcgtctccagactctcacatgcagtatgtgcag/g(c>t)acctgatacttctgttgcccttgtgctccagtcattgcacaaggcagaaaacagctctggcaggaagggactgccaaagttaggagccctagggcctggaaggagagtatggtcctcagatccc	NULL	No	2	Out	84.03	7.2	8.16	75.77	11.08	12.18	6.25	6.25	7.44	7.21	15.1	14	-6.6	-4.8	7	0.9	7	0.69	606999	ENSG00000213930	245	325	galactose-1-phosphate uridylyltransferase
43	1	Human	51	ELA2	161	Severe congenital neutropenia	IVS4+1G>A	-30	NULL	Exon	0	ggggagggtcatcatcactgccccgtgtgacgcgctgacgatctgtccccaccgccacagCTCAACGGGTCGGCCACCATCAACGCCAACGTGCAGGTGGCCCAGCTGCCGGCTCAGGGACGCCGCCTGGGCAACGGGGTGCAGTGCCTGGCCATGGGCTGGGGCCTTCTGGGCAGGAACCGTGGGATCGCCAGCGTCCTGCAGGAGCTCAACGTGACGGTGGTGACGTCCCTCTGCCGTCGCAGCAACGTCTGCACTCTC/GTGAGGGGCCGGCAGGCCGGCGTCTGTTTC(g>a)tacgtgccctgggtgtccctctgctccccacccgctcccagcccggactgcagcaacaggcaccgtggctagaccctaggagggacttcccaaccctgacaggcggcgggcaggtgggcagggcctcgcagtccagcttccccaccttgtctgcctccacagGGGGACTCCGGCAGCCCCTTGGTCTGCAACGGGCTAATCCACGGAATTGCCTCCTTCGTCCGGGGAGGCTGCGCCTCAGGGCTCTACCCCGATGCCTTTGCCCCGGTGGCACAGTTTGTA	NULL	Yes	NULL	In	66.08	6.44	3.7	66.74	8.98	9.18	5.87	5.87	5.73	6.33	10.7	10.1	-0.9	-4	5	0.28	7	0.65	202700	ENSG00000197561	32	43	"elastase, neutrophil expressed"
115	1	Human	40	CUL4B	190	X-linked mental retardation	E20+173G>A	-80	70	Exon	2	ggggatggagtggaagctagattgaggtagaatgtcgtagttgttcatgctggtaacaaataactaaacctctgtttcttcttcagAGGATGGAGAGTTAAGGAGAACACTGCAGTCATTAGCCTGTGGCAAAGCTAGAGTTCTGGCGAAAAATCCAAAGGGCAAAGACATTGAAGATG/GTGACAAGTTCATTTGTAATGATGATTTCAAACATAAACTTTTCAGGATAAAGATCAATCAAATCCAGATGAAAGAAAC(G>A)gtatttctttcactttctcttagtcctaacacactggaattatacatgttaataatcaaaatatataaagatttttatacctgtaatactgccaataccattaatattttttgtgtctatgtccagctaaatatgtttcctgatttgattttgggtgtttgggagagtggttgtacagga	NULL	No	NULL	In	67.45	5.46	0.78	67.42	5.98	5.58	4.11	4.11	4.03	5.68	10.2	8.6	-2.9	-3.5	6	0.02	6	0.57	300304	ENSG00000158290	91	115	cullin 4B
116	1	Human	40	CUL4B	190	X-linked mental retardation	E20+173G>A	-65	30	Exon	2	ggggatggagtggaagctagattgaggtagaatgtcgtagttgttcatgctggtaacaaataactaaacctctgtttcttcttcagAGGATGGAGAGTTAAGGAGAACACTGCAGTCATTAGCCTGTGGCAAAGCTAGAGTTCTGGCGAAAAATCCAAAGGGCAAAGACATTGAAGATGGTGACAAGTTCATTT/GTAATGATGATTTCAAACATAAACTTTTCAGGATAAAGATCAATCAAATCCAGATGAAAGAAAC(G>A)gtatttctttcactttctcttagtcctaacacactggaattatacatgttaataatcaaaatatataaagatttttatacctgtaatactgccaataccattaatattttttgtgtctatgtccagctaaatatgtttcctgatttgattttgggtgtttgggagagtggttgtacagga	NULL	No	NULL	In	67.45	5.46	-5.16	60.12	5.98	-5.62	0.04	0.04	0.62	5.68	10.2	9	-2.9	-0.4	6	0	4	0.57	300304	ENSG00000158290	91	116	cullin 4B
213	1	Human	55	EVC	53	Ellis-van Creveld syndrome	IVS13+5G>T	115	NULL	Intron	1	ggggcagaaagggatttaaaaaagaaacgcacacaaacaagaaacaaaatgcacaatcctagcaagcaggattgttgaagtgagtaaccacatgcctgctctgtccctctgtcccgagttcagGTGTGGATGGAGGAGTGTGCGCTGTCCAGCGTGCTGCAGACACACCTGCGGGAGGACCACGAGGGCACCATCCGCGGCGTCTTGGGCCGACTGGGCGGCCTCACTGAAGAgtga(g>t)tacagctccctgaaggcccagggctttgtgtcctgcatgatgctccctccagcctcagtgtcctcatctgtacagtgggcacgctgactgcccctcagcttcctttgaat/gtaaatgacttaacgtttcttagcctcgatttcctcatctataaaatgggataatgctatctatttgatagagttgtctgtcataggaacttttttaaacagcttttttcaggtatagtttacatacatttattttacgagtacaattcagtgattgttagtaaattttacagagttctaccccatcaccacaatccaaatttagaacatttctatcaccccaaaaattgctacaacgcaattgt	NULL	No	NULL	In	72.86	7.36	2.37	74.61	10.98	1.48	5.14	5.14	3	6.86	13.8	9.4	-4.5	-0.6	6	0.11	6	0.96	225500	ENSG00000072840	168	213	Ellis van Creveld syndrome
26	1	Human	122	PDHX	152	Pyruvate dehydrogenase deficiency	IVS1+1G>A	-85	NULL	Exon	1	gggggcgggggttcaagtctgagagacctaaaggcaccgctagcgtctggGGGCGTGGCCAACCATGCGGGAGGCGGGGCCTTGATGCTGGACATCAGGCTGTGCTGCGGGCAGCCAGTGAGAAGGCCGTCAAGATGGCGGCCTCCTGGAGGCTGGGCTGTGATCCGCGGCTGCTGCGTTATCTTGTGGGCTTCCCCGGCCGCCGAAGC/GTAGGGCTGGTGAAGGGGGCTCTTGGGTGGTCTGTAAGCCGCGGAGCTAATTGGAGATGGTTTCACAGCACGCAGTGGCTTCGGG(g>a)tgagtggccggggctcgctcagcttctctgtgtagctgagtgatgggcctgggacaggggcagttatgattgagggcctgcttttgggtgtgaaggtgcgcgggctccttattccctttcctctttctccggttggggtccgccgacttggcctaatgcatgctgtgaagggctttcttggcagctgagagaactcgactctgccctaggccccctggtttgtatggctttgtgaccttgccttggaatttgggttatttgtgaggcgcagagagggttcccaaactctcctccctcag	NULL	No	NULL	In	85.28	7.93	-0.25	60.71	12.38	5.58	4.26	4.26	4.44	7.89	15.6	8.9	-9.3	-4.2	8	0.03	5	0.97	300502	ENSG00000110435	22	26	"pyruvate dehydrogenase complex, component X"
123	1	Human	72	GBA	71	Gaucher disease	E6+162A>G	-12	100	Exon	0	gggtgggagggtggaggctaatggctgaaccggatgcactggttgggctagtatgtgttccaactctgggtgcttctctcttcactacctttgtctctagATACCCCTGATTCACCGAGCCCTGCAGTTGGCCCAGCGTCCCGTTTCACTCCTTGCCAGCCCCTGGACATCACCCACTTGGCTCAAGACCAATGGAGCGGTGAATGGGAAGGGGTCACTCAAGGGACAGCCCGGAGACATCTACCACCAGACCTGGGCCAG/(A>G)TACTTTGTGAAgtaagggatcagcaaggatgtgggatcaggactggcctcccatttagccatgctgatctgtgtcccaaccctcaacctagttccacttccagatctgcct	NULL	No	1	Out	82.19	6.38	8.17	76.23	11.18	11.98	6.18	6.18	7.55	6.4	12.4	14	-4	-4.8	6	0.64	7	0.84	231000	ENSG00000177628	97	123	"glucosidase, beta, acid"
263	1	Human	98	ITGA2B	72	Glanzmann thrombastenia	IVS10+5G>T	38	100	Intron	2	gggtggtgagccaattccctgccaacctggaggatcattatctgtgtggttgggagagcaggatggtcgtgtgtagcctgctgccatgggagtggagctctcgccagcgggtccaccttcctgggctgtgtgttttcagGCCATGGCCAGTGCAGCTGTGGGGACTGCCTGTGTGACTCCGACTGGACCGGCTACTACTGCAACTGTACCACGCGTACTGACACCTGCATGTCCAGCAATGGGCTGCTGTGCAGCGGCCGCGGCAAGTGTGAATGTGGCAGCTGTGTCTGTATCCAGCCGGGCTCCTATGGGGACACCTGTGAGAAGTGCCCCACCTGCCCAGATGCCTGCACCTTTAAGAAgtga(g>t)tgtggagtctggagagagccgggaggctgggag/gtaggagaggatcccctgactagaatccccagctctccaggtgtgtttcttgctcaccagagccttagggagaggagtccactccagccagatggctgtctctccttttgccaaaggctttgggcaagttggaatagagccaactgtgaaggagccaaagttgaacgagctggacttcgattgagaatgtcctctcctagggtgacatcctgactccctctgagctgggaggaaggctaaaccagtctgaggaacaatccagtgctaatgttctgattcagtgggagatgtgagggctggaattatggaggacactctgtgaaactactacaaacctcccactttaggggccagaggaagccccatcagcctgagtccatgg	Exon trapping vectors only.	No	NULL	In	82.41	7.97	8.24	83.94	12.08	11.48	8.15	8.15	8.12	7.37	13.6	14	-4.1	-7.3	7	0.79	7	0.79	273800	ENSG00000005961	198	263	"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)"
298	1	Human	77	GLA	56	Fabry disease	E1+254G>C	14	NULL	Intron	2	ggtagacgacgaccagaactacttctgctcacgtaagcgagtaatcacgtgagcgcctacgtcatgtgagatctcggtcacgtgagcaactctcggcttaaactcgggatcactaaggtgccgcacttccttctggtatggaaatagggcgggtcaatatcaagaaaggaagagggtgattggttagcggaacgtcttacgtgactgattattggtctacctctggggataaccgtcccagttgccagagaaacaataacgtcattatttaataagtcatcggtgattggtccgcccctgAGGTTAATCTTAAAAGCCCAGGTTACCCGCGGAAATTTATGCTGTCCGGTCACCGTGACAATGCAGCTGAGGAACCCAGAACTACATCTGGGCTGCGCGCTTGCGCTTCGCTTCCTGGCCCTCGTTTCCTGGGACATCCCTGGGGCTAGAGCACTGGACAATGGATTGGCAAGGACGCCTACCATGGGCTGGCTGCACTGGGAGCGCTTCATGTGCAACCTTGACTGCCAGGAAGAGCCAGATTCCTGCATCA(G>C)gtatcagatattgg/gtactcccttccctttgcttttccatgtgtttgggtgtgtttggggaactggagagtctcaacgggaacagttgagcccgagggagagctcccccacccgactctgctgctgcttttttatccccagcaaactgtcccgaatcaggactagccctaaactttctctgtgtgacctttcctgggatgggagtccggccagcggcccctgtttctttctctctctctctctctctcgttctccttctctttctctttctcttctttcctctctctttctctctctccc	NULL	No	NULL	In	71.09	7.33	1.92	60.58	10.88	5.28	0.64	0.64	2.9	6.05	14	10.2	-4.9	-4.6	7	0.09	5	0.5	301500	ENSG00000102393	221	298	"galactosidase, alpha"
185	1	Human	34	COL7A1	54	Epidermolysis bullosa	IVS81+1G>C	25	100	Intron	1	GGTCTGCAGGGTCCAAGAGGCCCCCCTGGCCCAGTGgtgagtacccaagaaccttcacctgtcttgcccccatcctgtgccctgccccagtgaccagtactgcctcagtttccttggtggggtgcggctaactccccctcatcagactctttttcgccacaacagGGTGGTCATGGAGACCCTGGACCACCTGGTGCCCCG(g>c)tgagtgaccagggaacactgcctg/gtgagggtctggaagggctgggataggcattggccacagctgatgagccaggccttctctgtgttaatccctgagccctgttccctgcccttgacccttttctctag	NULL	No	NULL	In	85.22	10.9	8.3	80.53	15.68	12.08	8.72	8.72	7.67	10.63	15.8	13.8	-7.5	-7	8	0.94	8	0.99	120120	ENSG00000114270	147	185	"collagen, type VII, alpha 1"
185	1	Human	34	COL7A1	54	Epidermolysis bullosa	IVS81+1G>C	25	100	Intron	1	GGTCTGCAGGGTCCAAGAGGCCCCCCTGGCCCAGTGgtgagtacccaagaaccttcacctgtcttgcccccatcctgtgccctgccccagtgaccagtactgcctcagtttccttggtggggtgcggctaactccccctcatcagactctttttcgccacaacagGGTGGTCATGGAGACCCTGGACCACCTGGTGCCCCG(g>c)tgagtgaccagggaacactgcctg/gtgagggtctggaagggctgggataggcattggccacagctgatgagccaggccttctctgtgttaatccctgagccctgttccctgcccttgacccttttctctag	NULL	No	NULL	In	85.22	10.9	8.3	80.53	15.68	12.08	8.72	8.72	7.67	10.63	15.8	13.8	-7.5	-7	8	0.94	8	0.99	120120	ENSG00000114270	181	185	"collagen, type VII, alpha 1"
136	1	Human	34	COL7A1	54	Epidermolysis bullosa	E53+30C>T	-17	NULL	Exon	2	GGTGAAGTTGGAGAGAAAGGTGACGAGGGTCCTCCGgtgagactccttcccactgtggtttctgatcctttacccttgaactaggatcccagtaggctggtgctccaccagttcatccatccactccctgcctcctgtccagctgctgctcagacccttctctgtcccctctccctgagtgagttagatcctgactgccctgtgcagtatgacttttctctctatcaccagGGTGACCCGGGTTTGCCTGGAAAAGCAG/G(C>T)GAGCGTGGCCTTCGGgtgagtcttggcagagagaagtaacaggggtgatgggaggtgggcatgaaggtgataggaaaggctgaggggggtaaggggtgatgggagtccctgcagggaggcatggggtgatgggaacctctgatgtggattttggagtaatggggaacctggggcagtgtagcgggtcataggggcacctgcaaaatattgggagggtctgtctcaggccagctgctcttcttagGGGGCACCTGGAGTTCGGGGGCCTGTGGGTGAAAAGGGAGACCAGGGAGATCCTGGAGAGGATGGACGAAAT	NULL	No	2	Out	85.28	9.89	9.6	88.72	13.98	13.88	10.47	10.47	10.3	10.12	16.5	17.4	-9.3	-8.1	9	0.96	8	0.99	120120	ENSG00000114270	108	136	"collagen, type VII, alpha 1"
186	1	Human	34	COL7A1	54	Epidermolysis bullosa	IVS51+1G>A	32	100	Intron	2	GGTGACTCAGGGCCTCCTGGAGAGAAGGGAGACCCTGGGCGGCCTGGCCCCCCAGGACCTGTTGGCCCCCGAGGACGAGAT(g>a)taagaggctggagtcgggggagtcatggcgg/gtaagggagtagggctgttgccagcatcatgggggttcttggaaccagggctgactctcatgtttcacagGGTGAAGTTGGAGAGAAAGGTGACGAGGGTCCTCCGgtgagactccttcccactgtggtttctgatcctttacccttgaactaggatcccagtaggctggtgctccaccagttcatccatccactccctgcctcctgtccagctgctgctcagacccttctctgtcccctctccctgagtgagttagatcctgactgccctgtgcagtatgacttttctctctatcaccagGGTGACCCGGGTTTGCCTGGAAAAGCAGGCGAGCGTGGCCTTCGG	NULL	No	NULL	In	81.46	5.46	10.17	85.06	9.78	12.98	9.86	9.86	9.31	5.42	12.4	15.4	-2.6	-9.2	6	0.97	8	0.91	120120	ENSG00000114270	148	186	"collagen, type VII, alpha 1"
30	1	Human	21	CDKN2A	122	Melanoma	E1+353G>C	-204	NULL	Exon	0	ggtgggagtgggggtggggtgggggtgggggtgaaggtggggggcgggcgCGCTCAGGGAAGGCGGGTGCGCGCCTGCGGGGCGGAGATGGGCAGGGGGCGGTGCGTGGGTCCCAGTCTGCAGTTAAGGGGGCAGGAGTGGCGCTGCTCACCTCTGGTGCCAAAGGGCGGCGCAGCGGCTGCCGAGCTCGGCCCTGGAG/GCGGCGAGAACATGGTGCGCAGGTTCTTGGTGACCCTCCGGATTCGGCGCGCGTGCGGCCCGCCGCGAGTGAGGGTTTTCGTGGTTCACATCCCGCGGCTCACGGGGGAGTGGGCAGCGCCAGGGGCGCCCGCCGCTGTGGCCCTCGTGCTGATGCTACTGAGGAGCCAGCGTCTAGGGCAGCAGCCGCTTCCTAGAAGACCA(G>C)gtaggaaaggccctcgaaaagtccggggcgcattcggcacttgttttgtttggtgtgatttcgtaaacagataattcgtctctagcccaggctaggaggaggaggagataaccgccggtggaggcttccccattcgggttacaacgacttagacatgtggttctcgcagtaccattgaacctggacctcccttcacacagcccctcaatcgtgggaaactgaggcgaacagagcttctaaacccacctcagaagtcagtgagtcccgaatatcctgggtgggaatgactaagacacacac	NULL	No	NULL	In	83.94	9.79	-7.35	48.02	13.08	-0.98	-4.41	-4.41	-4.23	9.1	15.9	NULL	-8	-1	8	NULL	3	0.95	109700	ENSG00000147889	25	30	"cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)"
31	1	Human	21	CDKN2A	122	Melanoma	IVS1+1G>A	-204	NULL	Exon	0	ggtgggagtgggggtggggtgggggtgggggtgaaggtggggggcgggcgCGCTCAGGGAAGGCGGGTGCGCGCCTGCGGGGCGGAGATGGGCAGGGGGCGGTGCGTGGGTCCCAGTCTGCAGTTAAGGGGGCAGGAGTGGCGCTGCTCACCTCTGGTGCCAAAGGGCGGCGCAGCGGCTGCCGAGCTCGGCCCTGGAG/GCGGCGAGAACATGGTGCGCAGGTTCTTGGTGACCCTCCGGATTCGGCGCGCGTGCGGCCCGCCGCGAGTGAGGGTTTTCGTGGTTCACATCCCGCGGCTCACGGGGGAGTGGGCAGCGCCAGGGGCGCCCGCCGCTGTGGCCCTCGTGCTGATGCTACTGAGGAGCCAGCGTCTAGGGCAGCAGCCGCTTCCTAGAAGACCAG(g>a)taggaaaggccctcgaaaagtccggggcgcattcggcacttgttttgtttggtgtgatttcgtaaacagataattcgtctctagcccaggctaggaggaggaggagataaccgccggtggaggcttccccattcgggttacaacgacttagacatgtggttctcgcagtaccattgaacctggacctcccttcacacagcccctcaatcgtgggaaactgaggcgaacagagcttctaaacccacctcagaagtcagtgagtcccgaatatcctgggtgggaatgactaagacacacac	NULL	No	NULL	In	83.94	9.79	-7.35	48.02	13.08	-0.98	-4.41	-4.41	-4.23	9.1	15.9	NULL	-8	-1	8	NULL	3	0.95	109700	ENSG00000147889	25	31	"cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)"
32	1	Human	21	CDKN2A	122	Melanoma	IVS1+3A>G	-115	NULL	Exon	1	ggtgggagtgggggtggggtgggggtgggggtgaaggtggggggcgggcgCGCTCAGGGAAGGCGGGTGCGCGCCTGCGGGGCGGAGATGGGCAGGGGGCGGTGCGTGGGTCCCAGTCTGCAGTTAAGGGGGCAGGAGTGGCGCTGCTCACCTCTGGTGCCAAAGGGCGGCGCAGCGGCTGCCGAGCTCGGCCCTGGAGGCGGCGAGAACATGGTGCGCAGGTTCTTGGTGACCCTCCGGATTCGGCGCGCGTGCGGCCCGCCGCGAGTGAGGGTTTTCGTGGTTCAC/ATCCCGCGGCTCACGGGGGAGTGGGCAGCGCCAGGGGCGCCCGCCGCTGTGGCCCTCGTGCTGATGCTACTGAGGAGCCAGCGTCTAGGGCAGCAGCCGCTTCCTAGAAGACCAGgt(a>g)ggaaaggccctcgaaaagtccggggcgcattcggcacttgttttgtttggtgtgatttcgtaaacagataattcgtctctagcccaggctaggaggaggaggagataaccgccggtggaggcttccccattcgggttacaacgacttagacatgtggttctcgcagtaccattgaacctggacctcccttcacacagcccctcaatcgtgggaaactgaggcgaacagagcttctaaacccacctcagaagtcagtgagtcccgaatatcctgggtgggaatgactaagacacacac	NULL	No	NULL	In	83.94	9.79	-17.06	28.16	13.08	-5.4	-10.24	-10.24	-11.75	9.1	15.9	NULL	-8	2.8	8	NULL	3	0.95	109700	ENSG00000147889	25	32	"cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)"
142	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E21+355G>A	-90	NULL	Exon	0	ggtttaattcatgctttgcacaaaaattttgtgtttagGCTGCTGAAAGCCTTCACAAGACCATTGTTAAGAGGCGAATGTCCCATGTGAGTGGAGGAGGATCCATAGATTTGTCTGACACAGACTCCCTACAGGAATGGATCAACATGACTGGCTTCCTTTGTGCCCTTGGGGGAGTGTGCCTCCAGCAGAGAAGCAATTCTGGCCTGGCAACCTATAGCCCACCCATGGGTCCAGTCAGTGAACGTAAGGGTTCTATGATTTCAGTGATGTCTTCAGAGGGAAACGCAGATACACCTGTCAGCAAATTTATGGATCGGCTGTTGTCCTTAATGGTGTGTAACCATGAGAAAGTGGGACTTCAAATACGGACCAATGTTAAGGATCTG/GTG(G>A)GTCTAGAATTGAGTCCTGCTCTGTATCCAATGCTATTTAACAAATTGAAGAATACCATCAGCAAGTTTTTTGACTCCCAAGGACAGgtaaagtgttctcttatttttcacctttctctatgaatagagtgacttgtttgaaataagcctttttctttcagattatttaaattaggtactcacagtttttaaaaatttccaaaaaattgcagaaagaagagtcatctcaatgtaggggtcagcttgcctcttaggaactctggtgtgtatgtgtgcctaagggtatacgtgccctgtgtatgggtacgagtgtctgcgtatatctgt	NULL	No	4	Out	60.24	-1.5	10.1	85.92	3.38	14.48	9.66	9.66	9.36	3.33	9	16.3	-0.8	-7.2	4	0.99	9	0.01	162200	ENSG00000196712	38	142	neurofibromin 1
152	1	Human	83	HBB	19	Beta-thalassemia	E1+251T>A	-16	100	Exon	1	ggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGG(T>A)G/GTGAGGCCCTGGGCAGgttggtatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	NULL	No	-2	Out	78.85	8.08	8.41	89.44	11.68	11.78	9.56	9.56	9.2	7.2	16.4	15.7	-7	-8.6	9	0.91	7	0.64	603902	ENSG00000221842	120	152	"hemoglobin, beta"
25	1	Human	66	FGB	35	Afibrinogenemia	IVS7+1G>T	-106	NULL	Exon	1	gtaacgaacaggcatgcaaaataaaatcattctatttgaaatgggattttttttaattaaaaaacattcattgttggaagcctgttttaggcagttaagaggagtttcctgacaaaaatgtggaagctaaagataagggaagaaaggcagtttttagtttcccaaaattttatttttggtgagattttattttgtttttcttttagGTGAATATTGGCTTGGAAATGATAAAATTAGCCAGCTTACCAGGATGGGACCCACAGAACTTTTGATAGAAATGGAGGACTGGAAAGGAGACAAAGTAAAGGCTCACTATGGAGGATTCACTGTACAGAATGAAGCCAACAAATACCAGATCTCAGTGAACAAATACAGAGGAACAGCCG/GTAATGCCCTCATGGATGGAGCATCTCAGCTGATGGGAGAAAACAGGACCATGACCATTCACAACGGCATGTTCTTCAGCACGTATGACAGAGACAATGACGGCTG(g>t)tatgtgtggcactctttgctcctgctttaaaaatcacactaatatcattactcagaatcattaacaatatttttaatagctaccacttcctgggcacttactgtcagccactgtcctaagctctttatgcatcactcgaaagcatttcaactataaggtagacattcttattctcattttacagatgagatttagagagattacgtgatttgtccaatgtcacacaactacccagagataaaactagaatttgagcacagttactttctgaataatgagcatttagataaatacctata	NULL	No	NULL	In	80.69	8.14	6.21	72.47	12.38	9.18	5.89	5.89	6.73	8.08	15	12.2	-3.9	-4	9	0.83	6	0.72	202400	ENSG00000171564	21	25	fibrinogen beta chain
24	1	Human	66	FGB	35	Afibrinogenemia	IVS7+1G>T	-40	NULL	Exon	1	gtaacgaacaggcatgcaaaataaaatcattctatttgaaatgggattttttttaattaaaaaacattcattgttggaagcctgttttaggcagttaagaggagtttcctgacaaaaatgtggaagctaaagataagggaagaaaggcagtttttagtttcccaaaattttatttttggtgagattttattttgtttttcttttagGTGAATATTGGCTTGGAAATGATAAAATTAGCCAGCTTACCAGGATGGGACCCACAGAACTTTTGATAGAAATGGAGGACTGGAAAGGAGACAAAGTAAAGGCTCACTATGGAGGATTCACTGTACAGAATGAAGCCAACAAATACCAGATCTCAGTGAACAAATACAGAGGAACAGCCGGTAATGCCCTCATGGATGGAGCATCTCAGCTGATGGGAGAAAACAGGACCATGACCATTCACAACG/GCATGTTCTTCAGCACGTATGACAGAGACAATGACGGCTG(g>t)tatgtgtggcactctttgctcctgctttaaaaatcacactaatatcattactcagaatcattaacaatatttttaatagctaccacttcctgggcacttactgtcagccactgtcctaagctctttatgcatcactcgaaagcatttcaactataaggtagacattcttattctcattttacagatgagatttagagagattacgtgatttgtccaatgtcacacaactacccagagataaaactagaatttgagcacagttactttctgaataatgagcatttagataaatacctata	NULL	No	NULL	In	80.69	8.14	2.19	62.15	12.38	5.42	-0.34	-0.34	1.9	8.08	15	NULL	-3.9	-0.1	9	NULL	6	0.72	202400	ENSG00000171564	21	24	fibrinogen beta chain
316	1	Human	75	GHR	78	Growth hormone insensitivity	IVS6+792A>G	-32768	-90	Intron	-32768	gtaagatgttgctacaccttacactttgacttttctttctatttcaacaaactctctctcatttatcattagactttcctttgacctaataccacatgttcatgctgtatgctccataatttcttaattgagaaaacattatttaaccggtaaaatattgtcttgaaattctgtaagacaggagatgcttatgtatatatggaggcctgtggaaggaaaggaaaactatttctccattcattcttgctgtccagtttaactttagagcaaaattatagactggccacttagctgtctttggggatgtggataaaaatgggaaagtttgtgatccagtcaacagtgactatggccaaatattttcccatgatttcagttgctgctactcaaaggactcccactaaaacaaattcatacgtgtctataggaaaacagagggagggaatttgtctcttagaggtttcagaaggatgttttgttacatacctcagagaagaatcaagctgagattcttatgtaggcaattagagagcatggtaccagttgacctctgaatccctctcttccttaccaagcatatggaactcagcattttgataaatttcacatggcacataacaagaggaaaaacaggagtatcatgctgctcccaatataactaattctaaatctgtctaaccacagCCACAGCCACAGCCACAGCCAAGCCAAGCAGTTTCTGGCCACTCATCAGGTGATGCCCAGCAGCCTGGCACAGATCACTCCCAGAATTTTGAGACACCAGGACATTC(A>G)/gtgagccactgaaaaagatgccaattttgtcattagaggaaagttaag	Creates pseudoexon. Distance between authentic and aberrant 5'ss is 1.7 kb according to the reference.	No	-1	Out	NULL	NULL	4.04	66.7	NULL	8.38	NULL	2.92	4.83	NULL	NULL	10.1	NULL	-2.7	NULL	0.35	5	NULL	262500	ENSG00000112964	239	316	growth hormone receptor
257	1	Human	13	BTK	184	agammaglobulinemia	E7+68G>C	17	10	Intron	2	gtaagcaatctgatcgatataatttctttctcctttgactgtttccatcactctcccaagggtctgtcaagcccagggtcatagcataaggttgtacactttgggtgctaaacaaagggtcctgggggagggaggaggcacatgggggctgaaatccagctggtaatctgctctccaagctatgtgacctggcatgcctagctactttttctaacttgcctaaaggcactcaatatggacggcaaagtccctgaccaaacctgtccttggcccctttcctaaagtgcattccatatcatcactggcttcttgttttgcagGCTTAAAACCTGGGAGTTCTCACCGGAAGACAAAAAAGCCTCTTCCCCCAACGCCTGAGGAGGACCA(G>C)gtatacagggaaactgg/gtgctgccactgcttaaatggaaacttatagtcaagccctaagaacacactagagtcttagaattaccctgggacttggcagtgttaattggtattcttgctaagatgggggatttgttcttctaattaggatttcctcctcgatggaaagatagaaggctctcagcaaccatgtaatccaatcacctgtttagaacaaaacctgatttttttaatgtaaagtttttgttgttgttttgtttttgcttttgtttttgttttgagacggagtctcgctctgtcgcccaggttcgagtgtaatggcatgatctcggctcactgcaacctccgcctcccagattcaagtgattctcctgtctcagcctcctgagtagctgggattacaggcatgcaccaccacgcccagctaatttttgtatttttagtagagatgggggtgtcaccatgttgttcaggctggtctcgaacccgcctcggcctcct	NULL	No	NULL	In	71.15	7.48	-2.53	56.12	11.38	2.78	-0.45	-0.45	2.06	6.47	14	8	-4.9	-4.3	7	0.01	5	0.79	300300	ENSG00000010671	194	257	Bruton agammaglobulinemia tyrosine kinase
258	1	Human	13	BTK	184	agammaglobulinemia	E7+68G>C	108	30	Intron	0	gtaagcaatctgatcgatataatttctttctcctttgactgtttccatcactctcccaagggtctgtcaagcccagggtcatagcataaggttgtacactttgggtgctaaacaaagggtcctgggggagggaggaggcacatgggggctgaaatccagctggtaatctgctctccaagctatgtgacctggcatgcctagctactttttctaacttgcctaaaggcactcaatatggacggcaaagtccctgaccaaacctgtccttggcccctttcctaaagtgcattccatatcatcactggcttcttgttttgcagGCTTAAAACCTGGGAGTTCTCACCGGAAGACAAAAAAGCCTCTTCCCCCAACGCCTGAGGAGGACCA(G>C)gtatacagggaaactgggtgctgccactgcttaaatggaaacttatagtcaagccctaagaacacactagagtcttagaattaccctgggacttggcagtgttaattg/gtattcttgctaagatgggggatttgttcttctaattaggatttcctcctcgatggaaagatagaaggctctcagcaaccatgtaatccaatcacctgtttagaacaaaacctgatttttttaatgtaaagtttttgttgttgttttgtttttgcttttgtttttgttttgagacggagtctcgctctgtcgcccaggttcgagtgtaatggcatgatctcggctcactgcaacctccgcctcccagattcaagtgattctcctgtctcagcctcctgagtagctgggattacaggcatgcaccaccacgcccagctaatttttgtatttttagtagagatgggggtgtcaccatgttgttcaggctggtctcgaacccgcctcggcctcct	NULL	No	NULL	In	71.15	7.48	0.59	62.04	11.38	3.38	0.92	0.92	1.82	6.47	14	10.2	-4.9	-2.6	7	0.01	6	0.79	300300	ENSG00000010671	194	258	Bruton agammaglobulinemia tyrosine kinase
259	1	Human	13	BTK	184	agammaglobulinemia	E7+68G>C	190	60	Intron	1	gtaagcaatctgatcgatataatttctttctcctttgactgtttccatcactctcccaagggtctgtcaagcccagggtcatagcataaggttgtacactttgggtgctaaacaaagggtcctgggggagggaggaggcacatgggggctgaaatccagctggtaatctgctctccaagctatgtgacctggcatgcctagctactttttctaacttgcctaaaggcactcaatatggacggcaaagtccctgaccaaacctgtccttggcccctttcctaaagtgcattccatatcatcactggcttcttgttttgcagGCTTAAAACCTGGGAGTTCTCACCGGAAGACAAAAAAGCCTCTTCCCCCAACGCCTGAGGAGGACCA(G>C)gtatacagggaaactgggtgctgccactgcttaaatggaaacttatagtcaagccctaagaacacactagagtcttagaattaccctgggacttggcagtgttaattggtattcttgctaagatgggggatttgttcttctaattaggatttcctcctcgatggaaagatagaaggctctcagcaaccat/gtaatccaatcacctgtttagaacaaaacctgatttttttaatgtaaagtttttgttgttgttttgtttttgcttttgtttttgttttgagacggagtctcgctctgtcgcccaggttcgagtgtaatggcatgatctcggctcactgcaacctccgcctcccagattcaagtgattctcctgtctcagcctcctgagtagctgggattacaggcatgcaccaccacgcccagctaatttttgtatttttagtagagatgggggtgtcaccatgttgttcaggctggtctcgaacccgcctcggcctcct	NULL	No	NULL	In	71.15	7.48	-2.24	68.31	11.38	0.98	3.83	3.83	1.86	6.47	14	11.1	-4.9	-0.6	7	0.08	6	0.79	300300	ENSG00000010671	194	259	Bruton agammaglobulinemia tyrosine kinase
334	1	Human	139	QDPR	47	Dihydropteridine reductase deficiency	IVS3+2552A>G	-32768	100	Intron	-32768	gtaagcctttatttccctatctgtggagtggggttgcttaccttgcttgctggggctgctgggcactttcatgggatgaggactgttaaagcctttaccctctaagctgcttaacagatagatggattttgtcttcttttgggcctgaatcattttagggagaagagttctgatcttttgtttgcctgtccttatgtttatggtggtggtaaggaacgctatgatctggtaacccccatttagtttatttatctgtgatctacactggaatgaatggtttagtggatattaattaattaataaacatggattattattatcacattgaatccatgtgttccagggaagcagcttagcagctggaaatagcataagtttaaaatgagagaggttcatttggccagcacagtggctcacacgtgtaatcccagcacttttgggaggctgaagcaggaggattgcttgagcccaggagttcaagaccagcctgggcaacatagtgagaccctatctctacattagaaaacaaaaagagagtgagagggttgggggtggattctttatcctagatgtgtgaccctgaaccagttcttcagtctctgaccagatgtctactgtagtttccttaattgtaaaatagtgacagtgacatctaacttgaagagtactgtaaaactgtagaggtgtagctatgtagaaagtgcacatggtaggcacccataaatggcaagtcttactgttattcacaataaatggtaggtcttatagtcactcttttcatttcacatatattctcactttaatctcatcaatattatctttttcagtttacaggttaggaaactaaaacttggagagttaagtaacttgtctgggtttgtgcaggaagtaagttgcagacttacttgaaccaaaaccctaatcatctaccaactgtgtattttttccattatgtcatttcttttgcattttttatgacctgtattagtttgtttgggtagccacagactgggtggcctaaacaacagagatttattttctcataactctggaggctaaaagtctggagatcaaggtatctgcagggctggctccttctgaatcctctttttttatagatggctgccttctccttttgtctgcatgtggtcttccctctgtgtgtctgtcctcgtttcctcctcttctaaggaaaccaggcatattggactagggcccatctcaatgggctcattttaactttgttgcctctttaaagatcttcgaatacagtcccattctgaggtactgggaattaggacttcaatatacgaatgttggggggatctatttcagcccataacactccctgtgggatagggctaaaggaatttaagcaggggtagaaaggggcagcatagggaggcagaaagtgtctacctcaactacctaagttgaactcttcttttaaaaaaatgggagcttttggccgggtgcagtggctcacacctgtaatcccagaactttgggaggccaaggcgggtggatcatgaggtggagattgagaccaccctggctaacacgatgaaaccctgtccctactaaaaatacaaaaaattagccaggcgtgatggtggctgaagcaggagaatggcgtgaacccaggaggtggagcttgcagtgagccgagatcgcgccactgcactccagcctgggcaacagagcaagactccctctcaaaagaaaaaaaaaaaaggtggggggagctctttttgactctcttgtaagtggtagagaccttgggacccttctcagttgtttatttttttagagacagggtctcacccaggctggaatgtagtggtatgatctagctcactgtagcttggaactcctgggctcaagcaatcctttgcctcggcctcctgagtagctgggactgcagacacacactgccatgcctggctaatttttgtattttttgtagaagcagggtctcgctatgatgcccaggctggtctcaaattcctggcttcaggtgatgctcctgccttggcctcccggagcactgagactactggcatgagccactacgccaggccccttctcaattttaatgtaactcactgaactgtgaggctgtgactactagcaataccttccctctcattttcttcttccatttcttagagcatgtgatgttacaagtccatggctatagcaatcattaaagctgtgtaaatgttagctgtctggttggttgagatctgatttttatttaagatgacacggaacagaggcagtagaaagtaaacagagaaatgagtcttagcttgacattttaaaaaacaaaaccctaggaccaaaagactgatttttctaaatgacagaagagtctcctactttcctttggtttgcag/GTATCCTTTGATTACATTTTGGGTAGTGGTTAAGACTGCAGGCTCTGGAACTGTGCACGTTGGACTTCTCTTAAGGCTCTGCCACTTACTGTGACACGTTCGGCAAGTTACTTCGCCTTTCTGAGTCTGCGTTTTGTCATCTGTAAAATAAG/(a>g)taaaatagtgtctcctttatatatatggtggttgtaccttgtaaatgtctcaatggatctaaatggatgagaaaggtattacagagagtcaatagtaagtgtgagccattattattatttactccaggcttatttctgcccagctgttctgcctcagatgttaatgaatttgttcatctttaacctcttaagttagattttgttaagctattaataatttgagtcatgagatcttttaagtatgctgcagacctcagaaaaatctggggaaatagatctacaatttgaaagtaaatgatgaatcaggcttagtagtccctcaaactcaagaagatttgtttgcacatcagaagtttttcacttggaaggatactgagaaaacctcaccctcctatttccaagtttgtatttctagactgtcttctgtaggacaaacagtattaaaatggtgttcacttttgtttaccattaaaggatctgtgctgtgattggaaatcagttttgggggaccacactgatcattcagtaatttggaagtgttgaccttcttagtgaaatgtcttttttttcatatcttgcaaataaccccttttgtgtccccaaggaaaggtcattctttagaattaagccattacggttgctatttgcttgtttctttcctttgtcagagtccctgctcttgtgttgtgttgttcgaatggagtcaagagagagctctgggattttgaggaccagggctgggttaatgagcacttatgccctggtttattttaatcactgaagagtttgttatgccccctgattaaacagagaagctaaggatggcgaaatattcttcttgtgcttccaaatagctctttgagacct	Creates pseudoexon	No	1	Out	NULL	NULL	8.38	82.16	NULL	13.28	NULL	7.91	7	NULL	NULL	14.1	NULL	-5.4	NULL	0.94	6	NULL	261630	ENSG00000151552	253	334	quinoid dihydropteridine reductase
4	1	Human	155	TP53	110	Li-Fraumeni-like syndrome	E4+279G>A	-200	-50	Exon	2	gtaaggacaagggttgggctggggacctggagggctggggacctggagggctggggggctggggggctgaggacctggtcctctgactgctcttttcacccatctacagTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAG/GTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCCCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCAC(G>A)gtcagttgccctgaggggctggcttccatgagacttcaatgcctggccgtatccccctgcatttcttttgtttggaactttgggattcctcttcaccctttggcttcctgtcagtgtttttttatagtttacccacttaatgtgtgatctctgactcctgtcccaaagttgaatattccccccttgaatttgggcttttatccatcccatcacaccctcagcatctctcctggggatgcagaacttttctttttcttcatccacgtgtattccttggcttttgaaaataagctcctgaccaggcttggtggctcacacctgcaatcccagcactctcaaagaggccaaggcaggcagatcacctgagcccaggagttcaagaccagcctgggtaacatgatgaaacctcgtctctacaaaaaaatacaaaaaattagccaggcatggtggtgcacacctatagtcccagccacttaggaggctgaggtgggaagatcacttgaggccaggagatggaggctgcagtgagctgtgatcacaccactgtgctccagcctgagtgacagagcaagaccctatctcaaaaaaaaaaaaaaaaaagaaaagctcctgaggtgtagacgccaactctctctagctcgctagtgggttgcaggaggtgcttacgcatgtttgtttctttgctgccgtcttccagttgctttatctgttcacttgtgccctgactttcaactctgtctccttcctcttcctacagTACTC	NULL	No	NULL	In	79.82	8.02	-0.26	60.46	11.28	8.18	1.18	1.18	1.02	7.96	13.1	11.8	-4.8	-3.3	6	0.05	5	0.59	151623	ENSG00000141510	3	4	tumor protein p53
171	1	Human	155	TP53	110	Li-Fraumeni-like syndrome	E4+279G>A	391	NULL	Intron	1	gtaaggacaagggttgggctggggacctggagggctggggacctggagggctggggggctggggggctgaggacctggtcctctgactgctcttttcacccatctacagTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCCCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCAC(G>A)gtcagttgccctgaggggctggcttccatgagacttcaatgcctggccgtatccccctgcatttcttttgtttggaactttgggattcctcttcaccctttggcttcctgtcagtgtttttttatagtttacccacttaatgtgtgatctctgactcctgtcccaaagttgaatattccccccttgaatttgggcttttatccatcccatcacaccctcagcatctctcctggggatgcagaacttttctttttcttcatccacgtgtattccttggcttttgaaaataagctcctgaccaggcttggtggctcacacctgcaatcccagcactctcaaagaggccaaggcaggcagatcacctgagcccaggagttcaagaccagcctgg/gtaacatgatgaaacctcgtctctacaaaaaaatacaaaaaattagccaggcatggtggtgcacacctatagtcccagccacttaggaggctgaggtgggaagatcacttgaggccaggagatggaggctgcagtgagctgtgatcacaccactgtgctccagcctgagtgacagagcaagaccctatctcaaaaaaaaaaaaaaaaaagaaaagctcctgaggtgtagacgccaactctctctagctcgctagtgggttgcaggaggtgcttacgcatgtttgtttctttgctgccgtcttccagttgctttatctgttcacttgtgccctgactttcaactctgtctccttcctcttcctacagTACTC	NULL	No	NULL	In	79.82	8.02	3.35	71.95	11.28	6.68	3.58	3.58	4.04	7.96	13.1	12	-4.8	-5.7	6	0.23	6	0.59	151623	ENSG00000141510	3	171	tumor protein p53
67	1	Human	29	COL2A1	166	"Stickler syndrome, type I"	IVS27+1G>A	-8	100	Exon	2	gtaagtctatcctctgagggctgctaggagggtggggggatctccctggggaagcaagggaaaagagagatggagtttgggttagggaggcctgaagtactgtgaattttgagaattgtgacagggggtagatggtaggcactggggccagatgtaacctgtgcagtagctgtgagcactgaaaatgccaccccagtatgcattcggggcttatccttgggggaatgatgacatcgtgtgtgcactttctggggcagctttctaagctcagcggtgtcttgttgtagatgggcccatgggtgtgatgtggtcaatcctagatgctgagcatgtgtggctggtgcctagtcctgggcctgccatgtaggcccttagtggatgttgggtggatggatgtggtcagagtgtctatgttctgagaatggtgttctgtctttcagGGAGCCCCTGGTGAAGATGGTCGTCCTGGACCTCCAGGTCCTCAGGGGGCTCGTGGGCAGCCTGGTGTCATGGGTTTCCCTGGCCCCAAAG/GTGCCAAC(g>a)taagtaataatttgctcttctatttccttccatgtggtgctacctacctccctgccctcttggggaaagggctgggtcctgagtagagtttaaccagggacagtgatgagtggggctcctgtgccatgggtggcagtgggggtctgtatgtgatttggggaaaatccatggccccacagagcctcggggcattgcggccataattgttccatgtggcagtgcccagcaggctggttgccattatggcccctgaacagaagagaagggctgatactttgctttatcttggctgtccatcaggatgtggccccaggcctcagtccctgcagcccgctctgcccccaactccctcccaaaccatccgcctcatggccctgccctctctttccttcag	NULL	No	NULL	In	86.21	10.74	3.41	65.1	15.08	8.48	3.16	3.16	4.31	9.16	16.1	10.1	-4.3	-3.7	7	0.72	5	0.99	108300	ENSG00000139219	55	67	"collagen, type II, alpha 1"
260	1	Human	125	PGK1	141	Phosphoglycerate kinase deficiency	IVS4+1G>T	30	100	Intron	0	gtaagtgccaggctctggtgctggtagactttgtggcgggggaagttgtcaagcacgttgttactggtttttaactttcatactgctcaagtgtcttcatctcttcctcttctcagGGATGTTCTGTTCTTGAAGGACTGTGTAGGCCCAGAAGTGGAGAAAGCCTGTGCCAACCCAGCTGCTGGGTCTGTCATCCTGCTGGAGAACCTCCGCTTTCATGTGGAGGAAGAAGGGAAGGGAAAAGATGCTTCTGGGAACAAG(g>t)taggacctgtgattttgacattattgggg/gtgagggcctgagtctgtaagagactgtggttgaagaatagagaaagctcatttattttaacttagacaccttttattgaagcatacaatgccgacacagcttgatgggttatctcaaagtaaacacacttgtgtaaccaccacccaggtcaaggaatagaatattaccagcatcccagaagccctccttcatgttcaggtggtgtttaaatatgtttgaaaaatatgtgaacacctttgaggtgaaagagtattcagtgaatatgatggtcatgatgatgtcaccttggatttaaggcattttcttaagatgtgtaaagtatgttcctttaaatctctctttaagatagaggtacaggtatcgacttatttcataaagaaactaagtctcaaaaaaaaaaaaacttaagtttctgaaaggcagtcatacgattaaagttagaggcagtggtgctgttggtctttagagc	NULL	No	NULL	In	83.94	9.45	5.5	79.89	13.68	9.98	7.28	7.28	6.2	8.54	14	13.6	-7.2	-9.1	7	0.61	7	0.98	311800	ENSG00000102144	195	260	phosphoglycerate kinase 1
133	1	Human	101	KRIT1	26	Cerebral cavernous malformations	E8+116C>G	-131	50	Exon	2	gtaatattcacaagtgtcatatatcagagttagatagtaatctatctttttcatcttcactttcgaatggctacttctacctgtttttttattttgccagGTGGTTAGATGAACGTCATGCACAATCTCACTTTATTCCAGCTTTATTCCGACCTTCTCCTCTTGAGCGGATAAAAACTAATGTCATAAATCCTGCATATGCTACTGAATCAG/GT(C>G)AGACAGAAAACTCACTACATATGGGCTATAGTGCACTAGAAATAAAGAGTAAAATGTTAGCCCTAGAGAAAGCAGATACCTGTATTTACAACCCTTTGTTTGGATCAGATCTTCAGTATACAAATCGGgtaagagttgaatgaattttagctctgatttaaaagacgttttatctcaagtgtaattttttttcctgagatatatacatctattactaattataaacat	NULL	No	3	Out	84.96	9.84	9.22	89.33	13.38	13.38	10.35	10.35	10.23	9.36	15.4	17.4	-8	-8.1	8	0.99	8	0.99	116860	ENSG00000001631	105	133	"KRIT1, ankyrin repeat containing"
170	1	Human	116	MUTYH	115	Lung cancer cell line	IVS1+5G>C	237	100	Exon	0	GTAATCTTTCTCTCCTGCTCTCGCGGCGGGAACGCGGGGCCTCCGTGTTCTGCTGTCTTCATCAGCGTGGGCCGCGGgtag(g>c)gggtagtggggtggctgggtttgggctttccagagaaggtgacgctgcctgagctgagcttaaagcacgcccaggagttagactaggagagggtcgtgtgggggaaagaagggcgttctgggcatcggtaaattcccagagaggatggagagctcagtgatctccagaaagtgaaagaggcggggagtgggccatcggaggaggctgcccagggtgtaagagcgaccgattg/gtagggaagcttttgtaataatccaatcaagtgataatgtgaacttgaattaaggctggcagtatggatggcgaggaagggacaaattgtgaagcagctaggcggtatagtcgacctagagggtgattg	The C allele creates cryptic 5'ss associated with lower translation (~30%)	No	NULL	In	73.13	6.74	2.16	61.49	10.68	8.08	3.65	3.65	4.95	6.92	11.7	10.6	-4.6	-5.3	6	0.01	7	0.4	604933	ENSG00000132781	137	170	mutY homolog (E. coli)
166	1	Human	127	PKD1	144	Polycystic kidney disease	IVS43+16del18	-66	NULL	Exon	0	gtacgcccgtccccggccagaccccgcgcctcccaccggcagcgtcccgccccctcgcggggccccgccccggcagcgtctcacccctcgcagcgccccgccccctcgcagcgtcccgccccctcgcagggccccgccccggcagcgtcccgccccctcgtagggccccgccccggcagcgtcccgccccctcgcagggccccgccccggcagcgtccctcccgccctcctgaccgcgccccccacagGTGTGCCTGCTGCTGTTCGCCGTGCACTTCGCCGTGGCCGAGGCCCGTACTTGGCACAGGGAAGGGCGCTGGCGCGTGCTGCGGCTCGGAGCCTGGGCGCGGTGGCTGCTGGTGGCGCTGACGGCGGCCACGGCACTGGTACGCCTCGCCCAGCTGGGTGCCGCTGACCGCCAGTGGACCCGTTTCGTGCGCGGCCGCCCGCGCCGCTTCACTAGCTTCGACCAG/GTGGCGCAGCTGAGCTCCGCAGCCCGTGGCCTGGCGGCCTCGCTGCTCTTCCTGCTTTTGGTCAAGgtgagggctgggccg(gtgggcgcggggctgggc)gcacaccccagggctgcaagcagacagatttctcgtccgcag	NULL	No	81	Out	89.44	9.16	2.99	65.86	13.98	8.28	4.55	4.55	4.5	9.62	15.7	11.8	-8.5	-5.1	7	0.14	6	0.99	173900	ENSG00000008710	133	166	polycystic kidney disease 1 (autosomal dominant)
53	1	Human	33	COL6A1	20	Bethlem myopathy	IVS3+1G>A	-66	NULL	Exon	0	GTACTACCGCTGTGACCGAAACCTGGTGTGGAACGCAGGCGCGCTGCACTACAGTGACGAGGTGGAGATCATCCAAGGCCTCACGCGCATGCCTGGCGGCCGCGACGCACTCAAAAGCAGCGTGGACGCGGTCAA/GTACTTTGGGAAGGGCACCTACACCGACTGCGCTATCAAGAAGGGGCTGGAGCAGCTCCTCGTGGG(g>a)tgagtggcccccagcctcctgcccacgccagttctcacgcgtggtacccagcctgggctggggttggcctggggtccctgtgcggcttcagctgcagcctccctgttctcttggaggctgcacggcctccctgacccactttgtgggcaggaaagagacggagacagacagagacagagagaaacagaaacagggagaaacagacacagagagagacagagacagagagagatagagac	NULL	No	NULL	In	85.28	7.93	1.99	63.81	12.38	5.88	3.01	3.01	3.87	7.89	15.6	9.3	-9.3	-1.7	8	0.2	6	0.91	158810	ENSG00000142156	41	53	"collagen, type VI, alpha 1"
160	1	Human	63	FANCG	64	Fanconi anaemia	E8+142C>T	-18	NULL	Exon	0	gtagggaactgccaggtgaagatgtggggtggaggattcctgaggtgcttgtgatggggtgacttgactagtcaagatccaagtataaggaagtatggctcccaaagattatagatacaatttttttctttctcttttagGCCTTGAATGTCCCATGCAGTTCCAAAGCCCCGCAGTTTCTCATTGAGGTAGAATTACTACTGCCACCACCTGACCTAGCCTCACCCCTTCATTGTGGCACTCAGAGCCAGACCAAGCACATACTAGCAAGCAG/GTGCCTA(C>T)AGACGGGGAGgtgaggttccccttgctcacctgagcttctcttcccacttctgatgcctcccctggggtgtgactctgcttttgttcttgtgacttgggggatgaatgaggcagtggcaggacataggtcgccactcctcagcctcttaccttgcttctagacctgaactgaggactcttctctaagaca	NULL	No	8	Out	89.44	8.41	5.4	70.59	11.78	9.08	4.87	4.87	5.2	9.2	15.7	11.8	-8.6	-4.5	7	0.78	7	0.32	227650	ENSG00000221829	128	160	"Fanconi anemia, complementation group G"
288	1	Human	13	BTK	184	agammaglobulinemia	IVS14+6T>G	5	NULL	Intron	2	gtagggatttttgtctattgtaagaattatacattcatgaccccaaagaatcacaccaagactttattgttagGATCATGGGAAATTGATCCAAAGGACCTGACCTTCTTGAAGGAGCTGGGGACTGGACAATTTGGGGTAGTGAAGTATGGGAAATGGAGAGGCCAGTACGACGTGGCCATCAAGATGATCAAAGAAGGCTCCATGTCTGAAGATGAATTCATTGAAGAAGCCAAAGTCATGATgtgag/(t>g)tatagcccaaactcaactctcaatctatttgctggagtctaggaattcacacaacaacccactgaggcttaaagatgacttacagtaagagaggtttgggacgagggactgaag	NULL	No	NULL	In	81.78	7.77	7.13	71.86	11.58	10.48	4.54	4.54	6.27	6.64	12.5	12.3	-3.9	-4.2	7	0.38	6	0.96	300300	ENSG00000010671	123	288	Bruton agammaglobulinemia tyrosine kinase
65	1	Human	95	INSR	108	Leprechaunism (Heritable insulin resistence)	IVS13+1G>A	-27	100	Exon	0	gtagggctgctgctccggggtccgagtgtcatgggtgggacatcaaggctgaccaaggacagattctccaccctctaagcagtgcatatctgtattttaccttattggccttcatttttgtttgagacggagccttgctctgtcgcccaggctggagtacagtggtgcgacctcagctcactccagcctctgccacctatgtcaagtgattccctgcttcagcctcccaagtagctgggactacaggtgtctgccaccacgcccagctaatttttgtatttttagtagagatggggtttcaccatattgcccaggctggtcttgaactcctgggctcaagtgatccacccacatcggcctctcaaagtgctgggattacaggcatgagcaccgaacctggccttttttttttttttttttttttttgagatgaagtcttgctctgtcgcccaggctggagtacaatggcgcaatcttggctcactgcaatctccgcctccctggttcaagcaattctcctgcctcagcctcctgagtagctgggactacatgcgtgtgccaccacacctgtattttcagtagagatggttccaccatgttgcccaggctggtctccaatgcctgagctcaagtggtccgccaaccttgagctcccaaagtgctgggattacaggcatgagccaccatgccaggtcatattttaaaattatgagtcataggcaatcattatgtaaactttagaaaatacaccactgcactcccgcctgggtgacagagcaagactctgtctcaaaaaaaaaaaaaagttatacgcagaaagtaacccatttaatcttcctaacaatcttgtgggatgagttttagatgtccgttctctgacgaggaaaatgggttgtgggaaaatgacgtcaccagcccaaggttgcaccatggacaggtggcagaagtgggatctcatccaagagttacatccctgcctctcacttcctctccttacagCCAAGGCTGATGACATTGTTGGCCCTGTGACGCATGAAATCTTTGAGAACAACGTCGTCCACTTGATGTGGCAGGAGCCGAAGGAGCCCAATGGTCTGATCGTGCTGTATGAA/GTGAGTTATCGGCGATATGGTGATGAG(g>a)taaggcccttgactcttgggcatgcccctgcacacttcagcatgccccttcagagttgcacttggtacctccttcctctgctgaaattttgattccagtgcttctctcatcaggtactgtgctattagtacttaaagccttgatacctgacttcgcaggaagatgggtcagaaatgccaatctaccagcttgttacttttcttagtttctcacattgctttccagctgtgtcctctaagttgaatgatgtctgcctcccaccacaacaggagactcatttcactttagaaggagttatttgagtcttaaaaccttataaattgctgggtacagtggctcacacctgtaatccaagcactttgggaggccgaggcaggcagatcacttgaggccaggagtttgagaccagcctggccaacatggtgaaaccccatctctacaaaaatacaaaaattagccaggcgtggtggtgggtgcctgtaatcccagctactcagga	NULL	No	NULL	In	94.61	10.28	7.97	82.41	13.38	12.08	7.32	7.32	7.37	10.08	17.1	12.5	-8.7	-4.1	7	0.92	7	1	147670	ENSG00000171105	53	65	insulin receptor
164	1	Human	9	ATR	160	Seckel syndrome	E9+137A>G	-83	NULL	Exon	2	gtatgattttcaatttgcatttccttgattatttagtaaggttgtgtatagacctttttcagtgcacttgctttattttctgaaaaggagcttttaattaaattaggtattaaatgtattttaagtgttacttgacttttatttatatatatgtatacacaaatgttactttacttatatatatgtatatgtgtatacataaaattaacattagtagaaatcttgtttaatagacttaattttttcagCACCACAGGCACAATCACGATGTGTGTTTCTTCTGACTCTGTTTCCAAGAAGAATATTCCTTGAGTGGAGAACAGCAGTTTACAACTGGGCCCTGCAGAGCTCCCATGAA/GTAATCCGGGCTAGTTGTGTTAGTGG(A>G)TTTTTTATCTTATTGCAGCAGCAGAATTCTTGTAACAGAGTTCCCAAGATTCTTATgtatgtactaagattttaatttgaatatatcactctattggaaagatcataattgtctggctatgtatgcagggttgtgtttattgttgaatatgtaaagcaaatgttgcttttagttttagaatttaacattttttccttctaggctttgttttaccagtacttttgtcccaaattaagcaagactatttagaccacaaaattaggcaagaaagtttagtactttttcttttttttccccag	Only patient cell line and minigene analyses	No	27	Out	76.55	3.25	0.24	68.93	7.88	5.28	3.57	3.57	1.93	3.09	12.8	9.4	-0.6	-1.8	8	0.15	5	0.54	210600	ENSG00000175054	131	164	ataxia telangiectasia and Rad3 related
163	1	Human	9	ATR	160	Seckel syndrome	E9+137A>G	-61	NULL	Exon	1	gtatgattttcaatttgcatttccttgattatttagtaaggttgtgtatagacctttttcagtgcacttgctttattttctgaaaaggagcttttaattaaattaggtattaaatgtattttaagtgttacttgacttttatttatatatatgtatacacaaatgttactttacttatatatatgtatatgtgtatacataaaattaacattagtagaaatcttgtttaatagacttaattttttcagCACCACAGGCACAATCACGATGTGTGTTTCTTCTGACTCTGTTTCCAAGAAGAATATTCCTTGAGTGGAGAACAGCAGTTTACAACTGGGCCCTGCAGAGCTCCCATGAAGTAATCCGGGCTAGTTGTGTTA/GTGG(A>G)TTTTTTATCTTATTGCAGCAGCAGAATTCTTGTAACAGAGTTCCCAAGATTCTTATgtatgtactaagattttaatttgaatatatcactctattggaaagatcataattgtctggctatgtatgcagggttgtgtttattgttgaatatgtaaagcaaatgttgcttttagttttagaatttaacattttttccttctaggctttgttttaccagtacttttgtcccaaattaagcaagactatttagaccacaaaattaggcaagaaagtttagtactttttcttttttttccccag	Only patient cell line and minigene analyses	No	5	Out	76.55	3.25	-1.35	62.94	7.88	5.38	2.08	2.08	1.42	3.09	12.8	8.1	-0.6	-3.6	8	0	6	0.54	210600	ENSG00000175054	131	163	ataxia telangiectasia and Rad3 related
159	1	Human	92	IDS	96	"Mucopolysaccharidosis, type II"	E3+155C>G	-22	5	Exon	1	gtatgtctgggaacctctagctgtgggtgtgtgctgcttcgtgcactgagggttgggggcggggagcttcagctattgtcagatggcacagattgtgcgggacatcttgttagagggaagcatagtctggaaaatggtagtggagaaaatctggttttccactcatgggaaagcttgaccttcaagggtggccttctccttgggtgcaaggtgcgccctggccctgatgtgttcatggcagccctggccagctttctcccagaacgggcgcttgcctggtgctcagaaggaaggggtgctgcagaagggcacccacaggtctgcaggctgggcctcaggtgagagctagccagggtggccctgctccctgaaccccctcatggctctgcccccagcaacactggccgctctgtgtgcctggggaggccattgcgtaggaggagataagcatctgctggtttcaggggctgattgcttcccttttctctcccggaagcagtctgttgcctaggtgacacccaaatcccagtgtctggtttgagctctgcatgactcagctaccaagctgtttgctaggagcctcgggaggcggttgcttggttacctaagagatggcagacatgttttgctgtggcgatgcttacctctgcttctgctccctaacagCAAGCAGTGTGCGCCCCGAGCCGCGTTTCTTTCCTCACTGGCAGGAGACCTGACACCACCCGCCTGTACGACTTCAACTCCTACTGGAGGGTGCACGCTGGAAACTTCTCCACCATCCCCCAGTACTTCAAGGAGAATGGCTATGTGACCATGT(C>G)G/GTGGGAAAAGTCTTTCACCCTGgtactgctccatgtccagagtctgggttctcttggtttgtggtgtctgaatccagcattcccatcctggggatggggctgtctttgcagagccctcttctggctgggcgagtccctcgctagtcagtgcttcctttctaaaaaactgacttgtcaacccagccacgttttcacccaaagtgaaaaagggtagaaagagctttgcttcctttcagaaaccactgagggtgtgctgttgggtctttcagctcctcgggtggtagggaggacacaggctggggaggtggcagtgttgggtggagtccagctcagggccccaccctctcccctgcagggtacctgtcagtaaacctaggggtggggtgaggacacctgagggcctcccgtgtggccagcattgctgttgctgacttattgcccaatgagggggctgtgcttaggtaggggctgctatccactctggaaattaagtcagaaagatgagtgtaatctggtacccag	NULL	No	-2	Out	61.94	4.41	0.72	69.22	8.38	7.48	3.66	3.66	3.39	5.3	10.4	9.3	-2.5	-7.4	6	0.04	7	0.39	309900	ENSG00000010404	127	159	iduronate 2-sulfatase
223	1	Human	92	IDS	96	"Mucopolysaccharidosis, type II"	IVS3+1G>A	34	NULL	Intron	1	gtatgtctgggaacctctagctgtgggtgtgtgctgcttcgtgcactgagggttgggggcggggagcttcagctattgtcagatggcacagattgtgcgggacatcttgttagagggaagcatagtctggaaaatggtagtggagaaaatctggttttccactcatgggaaagcttgaccttcaagggtggccttctccttgggtgcaaggtgcgccctggccctgatgtgttcatggcagccctggccagctttctcccagaacgggcgcttgcctggtgctcagaaggaaggggtgctgcagaagggcacccacaggtctgcaggctgggcctcaggtgagagctagccagggtggccctgctccctgaaccccctcatggctctgcccccagcaacactggccgctctgtgtgcctggggaggccattgcgtaggaggagataagcatctgctggtttcaggggctgattgcttcccttttctctcccggaagcagtctgttgcctaggtgacacccaaatcccagtgtctggtttgagctctgcatgactcagctaccaagctgtttgctaggagcctcgggaggcggttgcttggttacctaagagatggcagacatgttttgctgtggcgatgcttacctctgcttctgctccctaacagCAAGCAGTGTGCGCCCCGAGCCGCGTTTCTTTCCTCACTGGCAGGAGACCTGACACCACCCGCCTGTACGACTTCAACTCCTACTGGAGGGTGCACGCTGGAAACTTCTCCACCATCCCCCAGTACTTCAAGGAGAATGGCTATGTGACCATGTCGGTGGGAAAAGTCTTTCACCCTG(g>a)tactgctccatgtccagagtctgggttctcttg/gtttgtggtgtctgaatccagcattcccatcctggggatggggctgtctttgcagagccctcttctggctgggcgagtccctcgctagtcagtgcttcctttctaaaaaactgacttgtcaacccagccacgttttcacccaaagtgaaaaagggtagaaagagctttgcttcctttcagaaaccactgagggtgtgctgttgggtctttcagctcctcgggtggtagggaggacacaggctggggaggtggcagtgttgggtggagtccagctcagggccccaccctctcccctgcagggtacctgtcagtaaacctaggggtggggtgaggacacctgagggcctcccgtgtggccagcattgctgttgctgacttattgcccaatgagggggctgtgcttaggtaggggctgctatccactctggaaattaagtcagaaagatgagtgtaatctggtacccag	NULL	No	NULL	In	61.94	4.41	1.94	70.11	8.38	4.98	1.1	1.1	3.02	5.3	10.4	9.4	-2.5	-3.2	6	0.05	8	0.39	309900	ENSG00000010404	174	223	iduronate 2-sulfatase
216	1	Human	161	WASP	93	Hereditary X-linked thrombocytopenia	IVS9+2T>C	114	80	Intron	0	GTGAACAACCTCGACCCAGATCTGCGGAGTCTGTTCTCCAGGGCAGGAATCAGCGAGGCCCAGCTCACCGACGCCGAGACCTCTAAACTTATCTACGACTTCATTGAGGACCAGGGTGGGCTGGAGGCTGTGCGGCAGGAGATGAGGCGCCAGGg(t>c)gagaccctgcttccatacgctcccttctctagcccaagcagctcatagctaagatacgcactaagtcactcagtccttatgggagcacctatactgcttcagtcaggagttg/gtcagtgggggtacccattttacaaatgagcaaaactgaggctcagaagaaatcaatgagagttacagctatgtgttataccccctccacag	NULL	No	NULL	In	79.78	6.65	5.07	80.51	11.58	9.68	4.48	4.48	5.25	7.48	13.6	13.1	-7.9	-4.5	7	0.1	7	0.97	300392	ENSG00000015285	170	216	Wiskott-Aldrich syndrome (eczema-thrombocytopenia)
286	1	Human	105	LGMD2B	111	Limb girdle muscular dystrophy	IVS45+5G>A	114	NULL	Intron	0	GTGAGACGGTCGTCGACCTGGAGAACAGGCTGCTGTCCAAGTTTGGGGCTCGCTGTGGACTCCCACAGACCTACTGTGTgtac(g>a)tggatgggggctggctgcctgcttctctgacaacacaccacccctgtcttctctgacaacacaccaccactgagcacttactgtgtgccagccctgggcttagcacttc/gtaggcattctctcattgagtccaatgggagtcctatccccactccacagatgaagaaactgaagcccagagatgttattgcttgtaagtggtggaattaggatttgaaccaagaacctggctcatcacattgttataatccagttatctgtaatgcacatagaaggcctagagagggctaggtac	NULL	No	NULL	In	66.18	3.32	-0.17	60.64	7.68	5.18	2.54	2.54	3.49	5.15	10.7	10.4	-0.6	-2.7	5	0.01	5	0.15	253601	ENSG00000135636	84	286	"dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive)"
287	1	Human	105	LGMD2B	111	Limb girdle muscular dystrophy	IVS45+5G>A	202	NULL	Intron	1	GTGAGACGGTCGTCGACCTGGAGAACAGGCTGCTGTCCAAGTTTGGGGCTCGCTGTGGACTCCCACAGACCTACTGTGTgtac(g>a)tggatgggggctggctgcctgcttctctgacaacacaccacccctgtcttctctgacaacacaccaccactgagcacttactgtgtgccagccctgggcttagcacttcgtaggcattctctcattgagtccaatgggagtcctatccccactccacagatgaagaaactgaagcccagagatgttattgcttgtaa/gtggtggaattaggatttgaaccaagaacctggctcatcacattgttataatccagttatctgtaatgcacatagaaggcctagagagggctaggtac	NULL	No	NULL	In	66.18	3.32	-13.63	53.91	7.68	-1.22	-0.72	-0.72	-2.97	5.15	10.7	4.9	-0.6	-2	5	0	5	0.15	253601	ENSG00000135636	84	287	"dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive)"
137	1	Human	34	COL7A1	54	Epidermolysis bullosa	E73+102del28	-62	100	Exon	2	gtgagcagaagtggctcagtgggttgtgccccgtggagtggggtgtagctgtacagccaccagcattctctcttccactcctgcagGGCCCCATCGGCTTTCCTGGAGAACGCGGGCTGAAGGGCGACCGTGGAGACCCTGGCCCTCAGGGGCCACCTGGTCTGGCCCTTGGGGAGAGGGGCCCCCC(CGGGCCTTCCGGCCTTGCCGGGGAGCCT)GGAAAGCCTG/GTATTCCCGGGCTCCCAGGCAGGGCTGGGGGTGTGGGAGAGGCAGGAAGGCCAGGAGAGAGGgtgaggctgggggctggccaggagagtgagggaagaggggttgggaggggtgggaccccccatgggcttggccctcacccgctatttgcatttcag	NULL	No	-11	Out	79.89	7.13	1.5	62.04	11.18	6.58	2.96	2.96	2.97	7.43	13.6	10.4	-9.1	-2.6	7	0.06	7	0.49	120120	ENSG00000114270	109	137	"collagen, type VII, alpha 1"
271	1	Human	155	TP53	165	Squamous cell oral carcinoma	E6+113G>A	5	NULL	Intron	2	gtgagcagctggggctggagagacgacagggctggttgcccagggtccccaggcctctgattcctcactgattgctcttagGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGA(G>A)gtctg/gtttgcaactggggtctctgggaggaggggttaagggtggttgtcagtggccctccaggtgagcagtaggggggctttctcctgctgcttatttgacctccctataaccccatgagatgtgcaaagtaaatgggtttaactattgcacagttgaaaaaactgaagcttacagagg	NULL	No	NULL	In	73.63	2.59	0.72	64.01	6.48	4.58	1.92	1.92	2.6	3.46	10.1	8.2	-2.6	-1	6	0	8	0.05	191170	ENSG00000141510	203	271	tumor protein p53
272	1	Human	155	TP53	165	Squamous cell oral carcinoma	IVS6+1G>A	5	NULL	Intron	2	gtgagcagctggggctggagagacgacagggctggttgcccagggtccccaggcctctgattcctcactgattgctcttagGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAG(g>a)tctg/gtttgcaactggggtctctgggaggaggggttaagggtggttgtcagtggccctccaggtgagcagtaggggggctttctcctgctgcttatttgacctccctataaccccatgagatgtgcaaagtaaatgggtttaactattgcacagttgaaaaaactgaagcttacagagg	NULL	No	NULL	In	73.63	2.59	0.72	64.01	6.48	4.58	1.92	1.92	2.6	3.46	10.1	8.2	-2.6	-1	6	0	8	0.05	191170	ENSG00000141510	203	272	tumor protein p53
285	1	Human	104	LDLR	61	Familial hypercholesterolemia	IVS10+5G>A	66	60	Intron	0	gtgagcgtcgcccctgcctgcagccttggcccgcaggtgagatgagggctcctggcgctgatgcccttctctcctcctgcctcagCACCCAGCTTGACAGAGCCCACGGCGTCTCTTCCTATGACACCGTCATCAGCAGAGACATCCAGGCCCCCGACGGGCTGGCTGTGGACTGGATCCACAGCAACATCTACTGGACCGACTCTGTCCTGGGCACTGTCTCTGTTGCGGATACCAAGGGCGTGAAGAGGAAAACGTTATTCAGGGAGAACGGCTCCAAGCCAAGGGCCATCGTGGTGGATCCTGTTCATGGgtgc(g>a)tatccacgacgctgagggctgcagagggaatggagggagcaggaaggagcttcaggaactg/gttagtgggctgggcatggtggctcaaagcacct	NULL	No	NULL	In	74.05	5.46	6.32	80.51	10.48	9.28	6.09	6.09	5.26	6.25	13.3	13.3	-5.7	-4.5	7	0.7	9	0.94	144010	ENSG00000130164	214	285	low density lipoprotein receptor
51	1	Human	97	ITGB4	54	Epidermolysis bullosa	IVS30+1G>A	-51	NULL	Exon	0	gtgaggcctcgccatgtctgtccatttgtcccctggctgccctgatgccagcatgcccagacctccctccctctgccactgacagcactcttcctgtattccccgctccctagTGCCCAGCGAGCCAGGGCGTCTGGCCTTCAATGTCGTCTCCTCCACGGTGACCCAGCTGAGCTGGGCTGAGCCGGCTGAGACCAACG/GTGAGATCACAGCCTACGAGGTCTGCTATGGCCTGGTCAACGATGACAACC(g>a)taagaaccagatccttctttcctgcccacagggagaacagccatggaaggggaggggacaaagctggagggagctcttggtcactccctggacctgctgtgcagggcactcgaggccttcatcctggtcagcggataagcctgaggcatctttagggttttggccagatttgggctgggttgcattctaagaccaaacccagaaggttgcagggtgggtggttacctatgtggagtgaggtcacaggcccaggggtacccctccccatgcaggtaaccagggagctcacacgtgcatgg	Minigene assay only	No	NULL	In	71.11	6.66	8.94	79.73	10.58	13.28	7.64	7.64	9.29	6.85	12.2	13.6	-2.9	-6.1	5	0.99	6	0.95	120120	ENSG00000132470	39	51	"integrin, beta 4"
100	1	Human	34	COL7A1	54	Epidermolysis bullosa	E95+72G>A	-7	NULL	Exon	1	gtgaggggctgggaacagcatgtaggggcatggtgaatccatggtgggtgaggagggggccctgccttgggggttcccagtcttgagggggcagagggtaggagggttcccaagtcactctctgcctctcttgccccatttttctggtagGGTCTGGCAGGCCCCCCAGGGAGAGAAGGAATCCCAGGACCCCTGGGGCCACCTGGACCACCGGG/GTCAGT(G>A)gtgagtagaggtgccctaaagccccacgtatttgatttcctgtcctcgtgaggacttaggatggggcgggccacactgtggggtgttgggggaggcgctttgagagccacaggaccctcacctcactctgacctaca	NULL	No	NULL	In	85.92	8.95	3.99	79.87	12.88	8.38	5.07	5.07	4.92	8.31	17.3	14.8	-7.2	-6.6	8	0.76	7	0.98	120120	ENSG00000114270	76	100	"collagen, type VII, alpha 1"
188	1	Human	161	WASP	179	Wiskott-Aldrich syndrome	IVS6+2T>G	38	NULL	Intron	2	gtgagtcctctagtgcaagtaggggtaataaggggctagcccaggaacctgtggcagggctgtgataactctctacacattccatcttcccagAGAGAAGAGGAGGGCTCCCACCCCTGCCCCTGCATCCAGGTGGAGACCAAGGAGg(t>g)gcgtgctgattcttccctgtgtctctggatggatgg/gtaagagtggatggaggaatgaggagttggatgggtgcgtaagtgggtgaatggataggtagattgataggtatgtggatggacgagcaggtgcatggatgtgtggactgatggatgggtggatggattggcggtagatggctgagtagagggatgaattga	NULL	No	NULL	In	83.6	8.42	8.91	84.96	13.18	12.58	7.41	7.41	7.6	8.79	12.4	15	-5.2	-8	7	0.88	7	0.94	301000	ENSG00000015285	149	188	Wiskott-Aldrich syndrome (eczema-thrombocytopenia)
215	1	Human	161	WASP	93	Hereditary X-linked thrombocytopenia	IVS6+5G>A	38	70	Intron	2	gtgagtcctctagtgcaagtaggggtaataaggggctagcccaggaacctgtggcagggctgtgataactctctacacattccatcttcccagAGAGAAGAGGAGGGCTCCCACCCCTGCCCCTGCATCCAGGTGGAGACCAAGGAGgtgc(g>a)tgctgattcttccctgtgtctctggatggatgg/gtaagagtggatggaggaatgaggagttggatgggtgcgtaagtgggtgaatggataggtagattgataggtatgtggatggacgagcaggtgcatggatgtgtggactgatggatgggtggatggattggcggtagatggctgagtagagggatgaattgatgggaggatgaaagtctaagtagatagatgcataggtgaatgggtatgtggataaatgaatgaaaaggtagatggatgactgagtaaattaatcaatgagtgaatgaatgaacagtgaataaatgactaaatgacaagtttcagtcagtgaagaaagcatgattgaatgaataaatgagtaaatgaatattttaacaaattcattagtcaatgagccagtgaatgataaagcatgagggaatgaaaacatgaatgaatcagtgaatgtatgaatggtttgtgggatccacccacttctccatagaccctacttgaacccttcacccactacctccatgaccatccaacacacacacagatttccctcaaggcttccgtttcttgcccctgtgctttggttggttggtaagtgggtcaatgagccaaccaccctattttccccacag	NULL	No	NULL	In	83.6	8.42	8.91	84.96	13.18	12.58	7.41	7.41	7.6	8.79	12.4	15	-5.2	-8	7	0.88	7	0.94	300392	ENSG00000015285	170	215	Wiskott-Aldrich syndrome (eczema-thrombocytopenia)
117	1	Human	26	COL11A2	138	Otospondylomegaepiphyseal dysplasia	IVS53+5G>A	-17	NULL	Exon	2	gtgagtcttactcagagaagggaaggggcaaaaagggtggggcttctatgggggggtcctctgtgtggccgctgggcttgggtattgggaagccgggggtatggcagggtgggcaaggggatggggtattgacagttttggaggtgatgccagccaggttgggggcccacctctgaccttgcttcacttctgcagGGCCAGGATGGTGCTAAGGGTGACCGAGGCGAGGATG/GTGAGCCAGGACAGCCTgtga(g>a)tgcctggtgaccccaccacccccctgagcccaagcctcatcctctttacccctcttctgtgccccactcctgaggggtcccttggctggaggataaacactcagccaccccaattcctctctccctag	NULL	No	NULL	In	72.18	7.21	8.27	79.82	11.58	12.88	8.06	8.06	7.65	6.27	12.1	13.6	-3.9	-5.8	7	0.72	7	0.94	215150	ENSG00000206290	92	117	"collagen, type XI, alpha 2"
66	1	Human	74	GH1	62	Familial isolated growth hormone deficiency	IVS4+1G>C	-73	100	Exon	1	gtgagtggatgccttctccccaggcggggatgggggagacctgtagtcagagcccccgggcagcacagccaatgcccgtccttcccctgcagAACCTAGAGCTGCTCCGCATCTCCCTGCTGCTCATCCAGTCGTGGCTGGAGCCCGTGCAGTTCCTCAGGAGTGTCTTCGCCAACAGCCTGGT/GTACGGCGCCTCTGACAGCAACGTCTATGACCTCCTAAAGGACCTAGAGGAAGGCATCCAAACGCTGATGGGG(g>c)tgagggtggcgccaggggtccccaatcctggagccccactgactttgagagctgtgttagagaaacactgctgccctctttttagcagtcaggccctgacccaagagaactcaccttattcttcatttcccctcgtgaatcctccaggcctttctctacaccctgaaggggagggaggaaaatgaatgaatgagaaagggagggaacagtacccaagcgcttggcctctccttctcttccttcactttgcag	NULL	No	NULL	In	79.89	5.5	0.79	60.8	9.98	5.18	1.55	1.55	3	6.2	13.6	8.7	-9.1	-2.1	7	0.02	4	0.19	262400	ENSG00000189162	54	66	growth hormone 1
107	1	Human	74	GH1	62	Familial isolated growth hormone deficiency	IVS4+5G>C	-73	100	Exon	1	gtgagtggatgccttctccccaggcggggatgggggagacctgtagtcagagcccccgggcagcacagccaatgcccgtccttcccctgcagAACCTAGAGCTGCTCCGCATCTCCCTGCTGCTCATCCAGTCGTGGCTGGAGCCCGTGCAGTTCCTCAGGAGTGTCTTCGCCAACAGCCTGGT/GTACGGCGCCTCTGACAGCAACGTCTATGACCTCCTAAAGGACCTAGAGGAAGGCATCCAAACGCTGATGGGGgtga(g>c)ggtggcgccaggggtccccaatcctggagccccactgactttgagagctgtgttagagaaacactgctgccctctttttagcagtcaggccctgacccaagagaactcaccttattcttcatttcccctcgtgaatcctccaggcctttctctacaccctgaaggggagggaggaaaatgaatgaatgagaaagggagggaacagtacccaagcgcttggcctctccttctcttccttcactttgcag	NULL	No	NULL	In	79.89	5.5	0.79	60.8	9.98	5.18	1.55	1.55	3	6.2	13.6	8.7	-9.1	-2.1	7	0.01	4	0.75	262400	ENSG00000189162	83	107	growth hormone 1
154	1	Human	106	LMNA	98	Hutchinson-Gilford progeria	E11+126C>T	-146	100	Exon	2	gtgagtggtagccgccgctgaggccgagcctgcactggggccacccagccaggcctgggggcagcctctccccagcctccccgtgccaaaaatcttttcattaaagaatgttttggaactttactcgctggcctggcctttcttctctctcctccctataccttgaacagggaacccaggtgtctgggtgccctactctggtaaggaagggagtgggaactttctgatgccatggaatattcctgtgggagcagtggacaagggtctggatttgtcttctgggaaagggaggggaggacagacgtggggcatgcccgccctgcctctctcccccattcttgttgcatgcatatcctctcatttccctcatttttcctgcaagaatgttctctctcattcctgaccgcccctccactccaattaatagtgcatgcctgctgccctacaagcttgctcccgttctctcttcttttcctcttaagctcagagtagctagaacagagtcagagtcactgctctggttctctgtccccaagtcttcctgagccttctccccttttatgtcttccctctcctcctccgggcccctagcctcccaaacccccattgcccgctggctccttgggcacagaaccacaccttcctgcctggcggctgggagcctgcaggagcctggagcctggttgggcctgagtggtcagtcccagactcgccgtcccgcctgagccttgtctcccttcccagGGCTCCCACTGCAGCAGCTCGGGGGACCCCGCTGAGTACAACCTGCGCTCGCGCACCGTGCTGTGCGGGACCTGCGGGCAGCCTGCCGACAAGGCATCTGCCAGCGGCTCAGGAGCCCAGGTGG/G(C>T)GGACCCATCTCCTCTGGCTCTTCTGCCTCCAGTGTCACGGTCACTCGCAGCTACCGCAGTGTGGGGGGCAGTGGGGGTGGCAGCTTCGGGGACAATCTGGTCACCCGCTCCTACCTCCTGGGCAACTCCAGCCCCCGAACCCAGgtgagttgtctctgctttgtctccaaatcctgcaggcgggtccctggtcatcgaggggtaggacgaggtggccttgcaggggggagagcctgccttctcttccgcagcccgggggagtgggagcctcctccccacagcctgagtcctagacagcccacctctgcatcctgcccctcttgtctgagccccagactggagggcaggggcagggctggagtgtgagggatgggggagatgctacctcccttctaggggccaggggagggagggtctgggtccaggccctgctgctcacacctctctcctctgttttctctcttag	NULL	No	2	Out	94.83	10.67	-5.54	56.26	14.88	1.78	0.33	0.33	0.15	11.87	19.4	8	-9.5	-5.2	9	0	5	0.99	176670	ENSG00000160789	122	154	lamin A/C
231	1	Human	140	RB1	155	Retinoblastoma	del(E15-16_IVS15+37)	45	NULL	Intron	0	gtgccatttcaccccagcctggcaacagagcaagacaccatctaaaaaaaaaaaaaaaaaaaaaaaaaattcaatgctgacacaaataaggtttcaattaaacaacttctttttttttttttaaattatctgtttcagGAAGAAGAACGATTATCCATTCAAAA(TTTTAGgtaaattttttacttttagtaaaaaatttttttcttt)ttatagaa/gtaagtattttataatctttttttttttcctttagCAAACTTCTGAATGACAACATTTTTCATATGTCTTTATTGGCGTGCGCTCTTGAGGTTGTAATGGCCACATATAGCA	NULL	No	NULL	In	87.65	6.62	9.82	87.58	10.68	13.98	8.7	8.7	8.09	5.49	14.3	17.4	-5.3	-4.2	8	0.99	7	0.87	180200	ENSG00000139687	179	231	retinoblastoma 1
37	1	Human	109	MAN2B1	6	Alpha mannosidase	IVS17+1G>A	-24	NULL	Exon	0	gtgcccgcagACACCCTTGGTGCAGGAGGTGCACCAGAACTTCTCAGCTTGGTGTTCCCAGGTGGTTCGCCTGTACCCAGGACAGCGGCACCTGGAGCTAGAGTG/GTCGGTGGGGCCGATACCTGTGGG(g>a)tgagtggcacaggctgggagaggggtgtggaagcaagggcagaggggtttatccaaggctcacaaccttgccatcccattgggtacagCGACACCTGGGGGAAGGAGGTCATCAGCCGTTTTGACACACCGCTGGAGACAAAGGGACGCTTCTACACAGACAGCAATGGCCGGGAGATCCTGGAGAGGAG	Minigene assay only	No	NULL	In	85.28	7.93	0.89	69.95	12.38	5.18	2.94	2.94	3.14	7.89	15.6	9.6	-9.3	-4.7	8	0.03	7	0.96	248500	ENSG00000104774	28	37	"mannosidase, alpha, class 2B, member 1"
189	1	Human	128	PKLR	82	Hemolytic anemia	IVS5+1G>A	51	1	Intron	0	gtgcgggacgggccgccgggcagtgggtggggcaggaggatgcctcgaggtcctggccaccttcccctgaaaccctcgctccgctccctcccccagTACCATGCTGAGTCCATCGCCAACGTCCGGGAGGCGGTGGAGAGCTTTGCAGGTTCCCCACTCAGCTACCGGCCCGTGGCCATCGCCCTGGACACCAAGGGACCGGAGATCCGCACTGGGATCCTGCAGGGG(g>a)tgagcagtggggctgggactcgctgggccagggccggaaaggcggcgcct/gtagggttgggcccaggcgtgggcaggggcgggtcccggactccggggctcagaactcacatctcctctggctccctccttag	NULL	No	NULL	In	79.18	5.97	-0.51	61.4	11.18	5.68	3.3	3.3	2.97	6.33	13.8	8.9	-7.9	-3.6	7	0.02	6	0.62	609712	ENSG00000143627	150	189	"pyruvate kinase, liver and RBC"
150	1	Human	79	GUSB	129	Mucopolysaccharidosis Type VII	E10+141C>T	-38	NULL	Exon	2	gtgctgggattacaggcatgagccaccgtgccctgctaattttcttactactattttttgtaatgctgcagtcttgctgtgttgcccaggctggtcttaagccatcctcctgcctcagcctcccagagtgctgggattacatcccccttaccttctctgccagaggagcccccgcagtgtgtgaatgctgagtcatgctgtctactgagtgctgaacgggctctgctgctctggtcctagGCTCCGTATGTGGATGTGATCTGTTTGAACAGCTACTACTCTTGGTATCACGACTACGGGCACCTGGAGTTGATTCAGCTGCAGCTGGCCACCCAGTTTGAGAACTGGTATAAGAAGTATCAGAAGCCCATTATTCAGA/G(C>T)GAGTATGGAGCAGAAACGATTGCAGGGTTTCACCAGgtaagcagtgttgagctttctgcttgtgtgttctctcagggcagagatgtcactcacctcctccagcctgacctgcgcccactgcactgctcccctcgcttcagctttgggctctcctcccacggccccgtccacgttccctcaccgccaacagccaggcctgtgccccactcacttggtcctcagaggtggcctccttactggctttgtttccagatagcctcctatcacccgtgcccaagtggtctttctaacagatccaaatttgtatttgtttttgagaccggatctctctgtcac	NULL	No	2	Out	93.9	9.88	7.36	72.86	15.48	10.98	5.88	5.88	6.86	11.18	19	15.1	-8.2	-4.5	8	0.97	6	1	253220	ENSG00000169919	118	150	"glucuronidase, beta"
313	1	Human	121	PDHA1	152	Pyruvate dehydrogenase deficiency	IVS7+26G>A	45	NULL	Intron	0	gtgctggttcactctggctatccagtgggcctgatagatttcatattgatcttttttccagtgtgttccttactgctagcatggccccaaagaaacaagtagtagttggtttgtcaccttccttagttgcaagagtatgatgcctgctacttctcctccaccacccaccccgctttccctcaccacccaaagctcggttttagaagaggaggctttctgtgctttatgaaagctttctgtgccaggcagagcagcagctgttagagatgatgaagcctggagaaagaagccaaatgaaaccccttttcgtaactacttccagGGCCAGATATTCGAAGCTTACAACATGGCAGCTTTGTGGAAATTACCTTGTATTTTCATCTGTGAGAATAATCGCTATGGAATGGGAACGTCTGTTGAGAGAGCGGCAGCCAGCACTGATTACTACAAGAGAGGCGATTTCATTCCTGGGCTGAGAgtaaggacacctgtggtggggccgg(g>a)gccaaggccaaggccaagg/gtatgtccttgtgcagacccttgacgatcttaGAAACATTGGAGAGTTTCATTCTCATACAGGAGCAGGTCATGTGAAAGTAAAATGGTTTGGGGCAGTTGGATTCATGCTTCGCCCCTCCCCTGTTTATTACCAGGTGGATGGAATGGATATCCTG	NULL	No	-20	Out	72.64	5.42	8.34	80.05	10.08	11.48	7.48	7.48	7.84	5.89	12.2	13.7	-4.4	-6	5	1	8	0.76	300502	ENSG00000131828	236	313	pyruvate dehydrogenase (lipoamide) alpha 1
226	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	del(E1-2_IVS1+34)	49	NULL	Intron	1	gtggcggggcgggcagagggcggggcctgcttctcctcagcttcaggcggctgcgacgagccctcaggcgaacctctcggctttcccgcgcggcgccgccTCTTGCTGCGCCTCCGCCTCCTCCTCTGCTCCGCCACCGGCTTCCTCCTCCTGAGCAGTCAGCCCGCGCGCCGGCCGGCTCCGTTATGGCGACCCGCAGCCCTGGCGTCG(TGgtgagcagctcggcctgccggccctggccggttc)aggcccacgcggcag/gtggcggccgggccctgaggcgcgggatccgcagtgcgggctcgggcggccgggcccagggaaccccgcag	NULL	No	NULL	In	79.82	6.64	2.99	65.86	11.68	8.28	4.55	4.55	4.5	6.74	13.8	11.8	-5.8	-5.1	7	0.01	6	0.95	300322	ENSG00000165704	177	226	hypoxanthine phosphoribosyltransferase 1
112	1	Human	91	HSPG2	158	Schwartz-Jampel syndrome	E70+133delA	-69	50	Exon	0	gtgggcccaggggcacaggctggcagcaccaagacacgagaaggaccaggtcaatcctctctcaccctcccccatgcaacctcacagACAACGTCCACATCAGTCCCAATGGCTCCATCATCACCATCGTGGGCACCCGGCCCAGCAACCACG/GTACCTACCGCTGCGTGGCCTCCAATGCCTACGGTGTGGCCCAGAGTGTGGTGAACCTCAGTGTGC(A)CGgtgaggggacgttgaccctgtggggctct	NULL	No	NULL	In	79.84	9.2	6.79	66.17	12.88	7.38	3.54	3.54	6.5	9.24	13.6	10.2	-7.3	-2.8	6	0.71	5	0.97	255800	ENSG00000142798	88	112	heparan sulfate proteoglycan 2
96	1	Human	138	PYGM	121	McArdle Disease (Myophosphorylase deficiency)	IVS14+1G>A	-67	100	Exon	1	gtggggagagatgcaatgtgggacagctgtgctgtgtggagagcgctggaggggccagatgtctgggtcaggcgtggcaaatagagctcatctctcctgccagcccaggccgttggtggaagttgcctggagtctgtggtgggaaggcatcatctgacctcacatgaacagtgctgacattgattagcaatgtctgccctggtacaggagtggacagaagtagccagtgagcctcctggtagccatcctcctggggctgactggagtgtggactgtaggatttcctgaggctgtggcctgttggtgagcccttccccgtctctgcctccagGAAAACAAGTTGAAGTTTGCTGCCTACCTAGAGAGGGAATACAAAGTCCACATCAACCCCAACTCACTCTTCGACATCCAG/GTGAAGCGGATTCACGAATATAAACGACAGCTCCTCAACTGCCTCCATGTCATCACCCTGTACAACC(g>a)tgagtggcagccactctaccctgtctctcagtgctcccccgtgttcctgcggcatagtacatattgcccaaccaacatctcctttggacttgggactactcttgggacatggaattatccccatttcacagatgggcaaactgaggctaagagagcatagcaagtgattgttcgagtcaggcctacggtgtcccagcccagcctctgtcaggagctactacccagagggaaaggtaggcccactggatccctctcgtttctccacag	NULL	No	NULL	In	71.43	9.4	6.66	77.09	12.38	11.18	7.31	7.31	7.41	7.69	12.1	12.4	-4.2	-6.1	6	0.77	7	0.95	232600	ENSG00000068976	74	96	"phosphorylase, glycogen, muscle"
103	1	Human	53	ENG	86	Hereditary haemorragic telangiectasia	IVS8+3del6	-24	NULL	Exon	0	GTGGTAGGCTGCAGACCTCACCCGCACCGATCCAGACCACTCCTCCCAAGGACACTTGTAGCCCGGAGCTGCTCATGTCCTTGATCCAGACAAAGTGTGCCGACGACGCCATGACCCTG/GTACTAAAGAAAGAGCTTGTTGCGgt(aaggga)actcctgcccctctggctcaggatgacatggacatctggttcctcccctagcccaagactcttggggtcctagcccaggcaggggggcaagtcacgtccctctgcaagccttagttttcccacttgtataatggaattgataatggtacctaccacgtggtgagaattaaaggcagtctgacaggccaatcacgtggcacagtaagatgtggtacatagtaagtgcttagtaaataatgccagcactaggtagttgtcattattaatcctaaatgctccctgagctggctggtcacttagcagaatacctacacaggccaggcatggtggttcacgcctgtaatctcagcactttgggaggccaagatgggtggatcacttgaggtcaggagtttgagaccagcctggccaacatggtgaaaccctgtctttactaaaatacaaaaattagccagaggtgatgggacacacc	NULL	No	NULL	In	85.01	9.63	3.1	61.83	13.08	7.88	2.8	2.8	4.71	9.59	15	10.4	-7.4	-2.5	6	0.05	6	0.99	187300	ENSG00000106991	79	103	endoglin
130	1	Human	4	ALG3	37	"Congenital disorder of glycosylation, type Id"	E1+170C>T	-37	100	Exon	1	GTTAAGATGGCGGCTGGGCTGCGGAAACGCGGCCGGTCCGGTTCCGCGGCCCAGGCAGAGGGACTCTGCAAGCAATGGCTGCAGCGCGCCTGGCAAGAGCGGCGCCTGCTGCTGCGGGAGCCGCGCTACACGCTGCTGGTGGCCGCCTGCCTCTGCCTGGCGGAG/GTGGG(C>T)ATCACCTTCTGGGTCATTCACAGGGTGGCATgtgagtgcgccgagggggaggggaggggagggagggagacctgaacccgcgacccaaactggatctcagacctggaactccaaaccagactctgtatccactcactcgtcaattgcgaacccatccatatcccttacctgagcgccaagcctgctctacagaaaaccggatcttaatctgcccgcatggcagaggtggataccctagagattggccttctgcactgaacttacagcctgcaaaccagcttagaagtcagatttgagccaaaattgttgtactgctgctgctgctgcttttctctgtggctttggacacctcaggtctcctcctggatctcagctttttccatgtgttcagttctgtgatctttgaacgtcccttctcaatgatggcatcttgtgaccacttgagtccattaggcattattggctactcctttccaggctgaaactatactctaggcttaaggcacttggctttcttgctaaagactcttaattcaacaaatatttatttagtgcttattatatgcctagcattatgctggttac	NULL	No	6	Out	81.78	7.83	7.07	84.26	12.38	12.98	8.12	8.12	7.57	7.62	14.2	17.1	-4.1	-8.3	8	0.49	8	0.84	601110	ENSG00000214160	103	130	"asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)"
50	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS28+1G>A	-54	NULL	Exon	0	GTTCAAAACTGGTCAAATCAATGGTGATTTGCTGATATACCATGTCTTACTGACTTTAAAGCCATATTATGCAAAGCCATATGAAATTGTAGTGGACCTTACCCATACCGGGCCTAGCAATCGCTTTAAAACAGACTTTCTCTCTAAGTGGTTTGTTGTTTTTCCTGGCTTTGCTTACGACAACGTCTCCGCAGTCTATATCTATAACTGTAACTCCTGGGTCAGGGAGTACACCAAGTATCATGAGCGGCTGCTGACTGGCCTCAAAGGTAGCAAAAGGCTTGTTTTCATAGACTGTCCTGGGAAACTGGCTGAGCACATAGAGCATGAACAACAGAAACTACCTGCTGCCACCTTGGCTTTAGAAGAGGACCTGAAG/GTATTCCACAATGCTCTCAAGCTAGCTCACAAAGACACCAAAGTTTCTATTAAA(g>a)taagttccagtctgtgttttgtaaacgattcattgcttttcttgactaactagactatatcctggcctccctaggtgtcctacccctatagtggtgtataaaatgtcacgtaaggctgtcgcggtggctcacgcctgtaatccaagcactttgggatgtcaaggtgggcagatcacgtgaggtcaggagttcaagaccagcctggccaacacggtgaaaccccgtctctactaaaaata	NULL	No	NULL	In	87.58	9.72	6.8	70.95	14.58	10.08	4.63	4.63	4.92	8.51	14.4	12.3	-4.2	-4.1	7	0.72	6	0.98	162200	ENSG00000196712	38	50	neurofibromin 1
312	1	Human	103	L1CAM	186	X-linked hydrocephalus	IVS5+12C>T	10	NULL	Intron	1	GTTCCGCTGGACGAGGGATGGTGTCCACTTCAAACCCAAGGAAGAGCTGGGTGTGACCGTGTACCAGTCGCCCCACTCTGGCTCCTTCACCATCACGGGCAACAACAGCAACTTTGCTCAGAGGTTCCAGGGCATCTACCGCTGCTTTGCCAGCAATAAGCTGGGCACCGCCATGTCCCATGAGATCCGGCTCATGGCCGAGGgtgcgaggcgctgcagggaccagggagggcaggtcccggagttcgtgtgggattgtgggctggaagctgctgtcagccagttgtctcgtggcgaggggcctgggtgtcctgccagccctccaccccaccccagcttctcccctggcccatcttgtttcttgtgcagtctcctcctttgccctgtctctgtctccattgcacttccggtcatctcatgccctttcactccctcaggctttcctggtgcctgcctcatggctgagcaggaaggtggcggggggaggggggggcgggctggtggggggagtgactgattctgggcagacctgcctgagtcactgcagtcatctctgtctacacctgcactccttagcagggcccctcttctctggcttttccacttggctctccatctcctcccctccacctccgacttggtctctcttgctccacggctctgtcttgatctgtgtcgccttttccctggggttttccctttgcattccatcctccctgagctttctgcttcctgagcgctctcctctcccctccccacccctccagttaccttgggaaccgttgccatggtttctgtgtcaggatgatggaagggtctgtgactcctgcatccctccacagctcccctcccccatcactgcacctcagcctcagcctccccccacccgtcctttcctagggtgggcagggagagctgagaaccgtggaaggttaacccttcctggcctcctggtctcctgctcaccctggcctccctaagtgctagtctctgctatgagtccagaaggtatccagagtgtctgcctccttttctgtgaagtttctactggcctgaccctctcgccccctcgtccatccctggtgtagcccgccacccccctgcccccacctcccttctcctgcctagcaccatctggaccaggaggagagtgtcagcccgtctgtcccttctagGTGCCCCCAAGTGGCCAAAGGAGACAGTGAAGCCCGTGGAGGTGGAGGAAGGGGAGTCAGTGGTTCTGCCTTGCAACCCTCCCCCAAGTGCAGAGCCTCTCCGGATCTACTGGATGAACAGCAgtgggtgccg/g(c>t)gagcggctgcctcgtggggtcggggtgttagcgggggtgtcttcctggacggggtcatgacttcggcctccttgccccctgcagAGATCTTGCACATCAAGCAGGACGAGCGGGTGACGATGGGCCAGAACGGCAACCTCTACTTTGCCAATGTGCTCACCTCCGACAACCACTCAGACTACATCTGCCACGCCCACTTCCCAGGCACCAGGACCATCATTCAGAAGGAACCCATTGACCTCCGGGTCAAGGCCA	NULL	No	2	Out	62.24	1.33	8.69	79.12	6.28	14.48	8.12	8.12	9.06	3.21	7.6	13.8	-3.6	-6.1	6	0.84	7	0.03	307000	ENSG00000198910	235	312	L1 cell adhesion molecule
281	1	Human	48	DRCTNNB1A (HCC)	101	Hypomyelination and congenital cataract	IVS5+1G>T	20	NULL	Intron	2	gttttaacttaaaattcctttctattcaggtctttttcaaaaaaatgttttagactatttaaatttagtttgtaaatttgtgtgtaagaaagtatgtattttaatatattttctttcacttctatagGAAATAGTTGACAAACAGGGACATACCAAAGTATTGAGTTTTACGATTCCATCTTTATCCAAACCATCTGTATACCATGAA(g>t)taagtgacattttatcaca/gtaagtttattgaccctaagctttgatattgccacaagttataatctagttatttaggaaaaaaattgatcaatttattagtacctgcaaaagtataaacacccacaaagtatttactatttccaaattgagataagaaatcaaaataaatgaacatc	NULL	No	NULL	In	87.58	9.82	9.49	77.98	13.98	13.78	7.19	7.19	7.8	8.09	14.4	14.5	-4.2	-4.2	7	0.98	6	0.99	610532	ENSG00000122591	211	281	"family with sequence similarity 126, member A"
#167	1	Human	165	XPA	181	Xeroderma pigmentosum	IVS3-1G>T	-100	NULL	Exon	1	gttttcttgctctgttagactagctgggaccttcagtataatgttgaatagaagtagtgattgtggacatccttgtgttgtttgagatatattgaattcaaaggaattttctatttatgaacaaggtaacatacaggcttacctacttcaattgttgactgcttttacttacttttgtagGCATGGCTAAT/GTAAAAGCAGCCCCAAAGATAATTGACACAGGAGGAGGCTTCATTTTAGAAGAGGAAGAAGAAGAAGAACAGAAAATTGGAAAAGTTGTTCATCAACCAGgtaaagtgagtttttcaaaaataagtatctagattggttattttgagtaacatgcataattctatgcaaagtgatgctaaataatgccataactactttaatcagtgagtacattatctttataaaagtgataaagtttggcagttttgctagtagattaaaaaaacaatcaaagaaacagccatgcatatggaaatgattatttaacttgtggctgatgtacttaggggttgctgctctctgttgttttataataggcagggttagccagtatattgattggtagaataaatactcaaaattatcttgataggctgaaatgaggcaccagaatccaagagataacatttaggacattcttttatttatctgtggagaaagaaagcagcttacaaagtataagatagaccagcataaaaagaaggatgtaactatgatctaaggttagtgctttggtaaatcacttatatgtacacatatcttcacagtgagggtactttcacactctttgggaaaaagatagaaacactttatttgttcataagtttggcagccaacagtgcaatataacagctttttattaaaaaaaaaaaaaaaagacctattccagtctttagttgcagctacagaagtgttgtgcattcatcaatgtaggtggttgctctgctttgatctatgtgtgtctatattgttgtttgcagaagctgagacttgaaggattaaaatatttgtttttatttgcatcagggactggttttgtggaagacaaaacccagggtggggttggggggtggctggggatggtttcaggatgattcaagcatattacattttattgtgtactttatttccattattattacattgtaatatataatgaaataattacacaactcttgcttatggtagactgccagtttctgagtggtaaatgtaaaagggagtgacagtttgaaaattatcattgtgtttatttaggaattcccattataaagaatattttaaattagaaaactgcacattttaaatgttttgattaataatgctatgtaatagcttcctaattggtatttctaccacactttctcttcattctaatgcatcctggtaaatttttcaaagataccactttgactatcactagccttgttccaaagtttttagttttccttttgtctatagatatgcttctctaatattctacaaaaaaagcatgatttttttgtttgtttgttttcttaaagtttggagattagtgtgttataatgaaggaggtaagggaaggcagtgataggaatattttgaaacaaacaattaatgacataatgacaattccccttttcttttttttttctttgagacagagtttcactctcgttgcccaggctggagtgtaatggtgcgatctcagctcaccgcaacctctgcctcctgggttcaagcgattctcctgcctcagcctcccgagtagctgggattataggcatgcaccaccaggcccagctaattttgtacttttagtagagacggggtttctccatgttggtcagctggtcttgagcacccaatctcaggtgatccaccctcctcggcctcccaaagtgctgggattacaggcgtgagccactgcacctggccgacaactccttttttcttcttgttggaaattgtggcagttctgagagttggagcattcagcctaaagacttcttagtaaaatttatttatttacatatatatatatatatatatatatatatatttatttagaaagagccttgctctgtcgccagcctggagtgcagtggcatgatcttggcttactgcaacctccacctcctgggttcaagcgattctcttacctcagcctcccaagtagctgggactacaggcacacactaccatgcctggctaattttttttgtttttgtttttgagacggagtttcactcttgttgcccaggctggaatgcagtggggcaatcttggcttgctgcaacctccacctcatgggcacaagcgattctcctgcccagcctccagagtagctggaattacaggtgcccgtcacccagctaattgacacctggctaatttttggattttttttgtagagacagggctttgccatgttgaccaggctggtgtcgaactcctggactcaagtgatccacccaccttggcctcccaaagtgctgggattataggtgtgagccactgtgccagccttactagtaaaatttaaagacttgctgggagaaacagttcttacaggattaagttccttagctaggcatttgaagtccttaaataatctagctttaccttacctagagtggtttttctgtgctgggagttgaggatacatggctgaatacagcctctccccttaaagagtttataatccacaaggtgagacagttgaagaagctatttgctttgttggtaggggatagaatggagggagacaaaatttttttccatttggaagtgaattctgttgttgtctctcttctattaccatgctgtttattgctttttcttgtgcaatgttggtgccctgtctgtaagcagatccctttttgccctaccactctgggactaatctcttttgtactttcagcagtgctgtggtgggcagaataatggcccccaaagatgtccatgccttaatcaccctggaacctgtgaatatattatccttatcatagcaaaaaggactttgcagatatgattaaggttaaagaccttgacatagggagaatatcctgggttattcaggtagacccaatgtaagcacacaggtttccttaaaagtggaagaggggccgggcacggtggctcacgcctgtaatcccagcactctgggaggccaaggcaggtggatcacctgcggtcaggagttcaagaccaacctggccaacatggcaaaactctgtctctactaaaaatacaaaaattagggctgggtacagtggctcatgcctgtaatcccagcactttgggaggctgaggtgggtggatcacgaggttaggagatcgagaccagcctggccaacatggtaaaaccccatctctactaaaaatacaagaattaactgggcatggtggtgcgtgcctgtaatcccagctacttgggaggctgaggcaggagaatcgcttgaacccaggaggtgaaggttgcagtgagctgagattgcaccactgcactaaaacctgagcaacagagcgagattccatctcaaaaaacaaaacaaaacaaaaacaaaaattatccgggcatggtggcttgcacctgtaatcccagctacttgggaggctaaggcaggagaatcgcttgaacccgagaggtggaggttacactgagctgagatcgtgccactgcactccagcctgggtggcagagcaagactccatttcaaaaaaacaaaaaaagtagaagaggaaagccaagagtcagagggacatgtgattatggaagaagtgggtgatgccgtgtgagaagccaccattgctggctatgaagatggaggaaggggtcatgagtcaaggaatgcaggcagcctatagaagctggaaaaggcaaggagatggattcttgcctagagcctccagaaaggaacacagccctgccaacaccttgattttagcctgctgagacccatgtcagaataaactagagatccgtgtgataataaatgtgtgttgttttaagtcactctgtctgtggtagtttcttataactaatgtagcactaatacaagtaccttgtacatggctgggattcagaaatatttgtggaattgctacgtttttttctttatgttacttccttttcttttttcctctttaatttttttttttagataaacataaggtcttattttgtcttttacttaaatgtatttatgtcaggcattgcatacatgctgataagctaataaaatagaggaaaatatattgttctagtcataaaaaaggaaactagagttcattttccttttcttagGACCTGTTATGGAATTTGATTATGTAATATGCGAAGAATGTGGGAAAGAATTTATGGATTCTTATCTTATGAACCACTTTGATTTGCCAACTTGTGATAACTGCAGgtacttattttagatggtgttcttaattgctaatgtttatgtgtaggtttagggcaaaacaagttatatctgtttggatttgatattttcttagtaattatgaatttcattttgggtgtttcctaaaatttctatggtttctattttgccaaatactgtaaatctgtgcttattaaagcttatgatataccccataaaataggaaggatgccgatggttctgccatagaaatttccttttctttttctgctggcctgagtttttttttgtttttgttttttaacgtctctcagtagtaggctgctaacccttctcttcacccagccctaatgatccctctatttcttaattattccagggtgtgttacatcttggtcagaggagtggggccttcagtgaaaggacagtagctccgaatacctttttcattcatcttttgctaccctcatagagagaatagatgaggaagaactatattcttccattctttttcttcttctagactttatcctttttttttatatcacccagaataacctttctcacttcacgtggttctcctatcactactgtttactcagccaaatgctgtgttgatatcttttgcacattgaaggtcttatcttggaatcttagttggccctcttacctgttccctgtgcttactttgtccctacagtcctaaatcaactcctcacctgcctgaaggacctgccctttcagagtccctgctgcagacattgggagccatcatgattggcttgttgctgagcagaatccttggtagatagagagggagatgtggtccctggtctcatgatcagatacatggctgggaatgctctggcaccacagctggaactatagattacaaactcatttcccaccgacacagtggttaaagtccacagtattgtcgtcattcttaaaggccagtatagcttttgggaactgaaacactacatagaattttatttccaagagaaaatggaagcaactcttgtaccagtttaaagaaagttgtgaatatattaccttgccatagcaaaaggactttgcagatatgattaaggttaaagacctcgagatggggagattatcctgggttatccaggtagaccgaatacaagcacatgagctttcttagaagtggaagaggaaagctgagagtcagagggacatgcgattagtgaagaagtgagtgatgcaatgtgagaagccatcatcactgcctgtcaaagtggaaggagggggtcgtgttcaggaatgcaggtggcctctagaagctagaaaaggcaaggagatggattcttacctagtgcctccagaaaggaacgtggtcctgccaacaccttgaaaagtctggaaacattacacttttatatttaatcataatcaggaacacagtcctccattctttttcaacatcatcaaagatgatagttttagtaccatatagtctacatgtctcctgttagtttatacttctgaattatttagcttttgtatagctcttcccagttttaacttttatgtttttgtgatagaatcctctgatagaacctttgatttctcccctccctgatctgtacctgctctttagtgtttaccatttcagtaaagccagcttcattcgctggctatgtctccactctcctgtgtgtattaattccaaacctgtttggctctaggttcaccatatcctgaattcatcggcatctcatcctctcccactgctgccttagtctaggccaccatcagctcttgcctggaccaccgcagtagtgttctaactggtctctcccccattacccctttcgcacccctagggtctccttttcatatagtattttgctcaaaaccttctagtggtttctaaccattgtcttcaccattgcttgcaaggtcctgactgtctctgactgtatctcccaccactcctcaccatcgcttacttcaggtcttctagttacactggtcctcttgctgtaagctctctttgcaaaatacacccctgccctagagccttttcccttgctgttccctttgctaggaatgtttttttctctagataatgtaacttaccagaataagtaaaagataaagtatttttctgttagaattcttatgttgctaatttaaccatgagagttgcaggaaaaagtattttatatgtcctttttgctgtgtgtgcccctaagttgctgggctatttgcaaacttagcttatttaaaataactaatttatataatggacttaatctgttttca(g>t)AGATGCTGATGATAAACACAAGCTTATAACCAAAACAGAGGCAAAACAAGAATATCTTCTGAAAGACTGTGATTTAGAAAAAAGAGAGCCACCTCTTAAATTTATTGTGAAGAAGAATCCACATCATTCACAATGGGGTGATATGAAACTCTACTTAAAGTTACAG	NULL	No	6486	Out	82.26	9.65	-0.78	69.11	14.28	1.38	3.79	3.79	2.28	8.28	15.8	9.4	-6.2	-0.6	7	0.06	5	0.93	278700	ENSG00000136936	134	167	"xeroderma pigmentosum, complementation group A"
#319	1	Human	165	XPA	181	Xeroderma pigmentosum	IVS3-1G>T	5	NULL	Intron	2	gttttcttgctctgttagactagctgggaccttcagtataatgttgaatagaagtagtgattgtggacatccttgtgttgtttgagatatattgaattcaaaggaattttctatttatgaacaaggtaacatacaggcttacctacttcaattgttgactgcttttacttacttttgtagGCATGGCTAATGTAAAAGCAGCCCCAAAGATAATTGACACAGGAGGAGGCTTCATTTTAGAAGAGGAAGAAGAAGAAGAACAGAAAATTGGAAAAGTTGTTCATCAACCAGgtaaa/gtgagtttttcaaaaataagtatctagattggttattttgagtaacatgcataattctatgcaaagtgatgctaaataatgccataactactttaatcagtgagtacattatctttataaaagtgataaagtttggcagttttgctagtagattaaaaaaacaatcaaagaaacagccatgcatatggaaatgattatttaacttgtggctgatgtacttaggggttgctgctctctgttgttttataataggcagggttagccagtatattgattggtagaataaatactcaaaattatcttgataggctgaaatgaggcaccagaatccaagagataacatttaggacattcttttatttatctgtggagaaagaaagcagcttacaaagtataagatagaccagcataaaaagaaggatgtaactatgatctaaggttagtgctttggtaaatcacttatatgtacacatatcttcacagtgagggtactttcacactctttgggaaaaagatagaaacactttatttgttcataagtttggcagccaacagtgcaatataacagctttttattaaaaaaaaaaaaaaaagacctattccagtctttagttgcagctacagaagtgttgtgcattcatcaatgtaggtggttgctctgctttgatctatgtgtgtctatattgttgtttgcagaagctgagacttgaaggattaaaatatttgtttttatttgcatcagggactggttttgtggaagacaaaacccagggtggggttggggggtggctggggatggtttcaggatgattcaagcatattacattttattgtgtactttatttccattattattacattgtaatatataatgaaataattacacaactcttgcttatggtagactgccagtttctgagtggtaaatgtaaaagggagtgacagtttgaaaattatcattgtgtttatttaggaattcccattataaagaatattttaaattagaaaactgcacattttaaatgttttgattaataatgctatgtaatagcttcctaattggtatttctaccacactttctcttcattctaatgcatcctggtaaatttttcaaagataccactttgactatcactagccttgttccaaagtttttagttttccttttgtctatagatatgcttctctaatattctacaaaaaaagcatgatttttttgtttgtttgttttcttaaagtttggagattagtgtgttataatgaaggaggtaagggaaggcagtgataggaatattttgaaacaaacaattaatgacataatgacaattccccttttcttttttttttctttgagacagagtttcactctcgttgcccaggctggagtgtaatggtgcgatctcagctcaccgcaacctctgcctcctgggttcaagcgattctcctgcctcagcctcccgagtagctgggattataggcatgcaccaccaggcccagctaattttgtacttttagtagagacggggtttctccatgttggtcagctggtcttgagcacccaatctcaggtgatccaccctcctcggcctcccaaagtgctgggattacaggcgtgagccactgcacctggccgacaactccttttttcttcttgttggaaattgtggcagttctgagagttggagcattcagcctaaagacttcttagtaaaatttatttatttacatatatatatatatatatatatatatatatttatttagaaagagccttgctctgtcgccagcctggagtgcagtggcatgatcttggcttactgcaacctccacctcctgggttcaagcgattctcttacctcagcctcccaagtagctgggactacaggcacacactaccatgcctggctaattttttttgtttttgtttttgagacggagtttcactcttgttgcccaggctggaatgcagtggggcaatcttggcttgctgcaacctccacctcatgggcacaagcgattctcctgcccagcctccagagtagctggaattacaggtgcccgtcacccagctaattgacacctggctaatttttggattttttttgtagagacagggctttgccatgttgaccaggctggtgtcgaactcctggactcaagtgatccacccaccttggcctcccaaagtgctgggattataggtgtgagccactgtgccagccttactagtaaaatttaaagacttgctgggagaaacagttcttacaggattaagttccttagctaggcatttgaagtccttaaataatctagctttaccttacctagagtggtttttctgtgctgggagttgaggatacatggctgaatacagcctctccccttaaagagtttataatccacaaggtgagacagttgaagaagctatttgctttgttggtaggggatagaatggagggagacaaaatttttttccatttggaagtgaattctgttgttgtctctcttctattaccatgctgtttattgctttttcttgtgcaatgttggtgccctgtctgtaagcagatccctttttgccctaccactctgggactaatctcttttgtactttcagcagtgctgtggtgggcagaataatggcccccaaagatgtccatgccttaatcaccctggaacctgtgaatatattatccttatcatagcaaaaaggactttgcagatatgattaaggttaaagaccttgacatagggagaatatcctgggttattcaggtagacccaatgtaagcacacaggtttccttaaaagtggaagaggggccgggcacggtggctcacgcctgtaatcccagcactctgggaggccaaggcaggtggatcacctgcggtcaggagttcaagaccaacctggccaacatggcaaaactctgtctctactaaaaatacaaaaattagggctgggtacagtggctcatgcctgtaatcccagcactttgggaggctgaggtgggtggatcacgaggttaggagatcgagaccagcctggccaacatggtaaaaccccatctctactaaaaatacaagaattaactgggcatggtggtgcgtgcctgtaatcccagctacttgggaggctgaggcaggagaatcgcttgaacccaggaggtgaaggttgcagtgagctgagattgcaccactgcactaaaacctgagcaacagagcgagattccatctcaaaaaacaaaacaaaacaaaaacaaaaattatccgggcatggtggcttgcacctgtaatcccagctacttgggaggctaaggcaggagaatcgcttgaacccgagaggtggaggttacactgagctgagatcgtgccactgcactccagcctgggtggcagagcaagactccatttcaaaaaaacaaaaaaagtagaagaggaaagccaagagtcagagggacatgtgattatggaagaagtgggtgatgccgtgtgagaagccaccattgctggctatgaagatggaggaaggggtcatgagtcaaggaatgcaggcagcctatagaagctggaaaaggcaaggagatggattcttgcctagagcctccagaaaggaacacagccctgccaacaccttgattttagcctgctgagacccatgtcagaataaactagagatccgtgtgataataaatgtgtgttgttttaagtcactctgtctgtggtagtttcttataactaatgtagcactaatacaagtaccttgtacatggctgggattcagaaatatttgtggaattgctacgtttttttctttatgttacttccttttcttttttcctctttaatttttttttttagataaacataaggtcttattttgtcttttacttaaatgtatttatgtcaggcattgcatacatgctgataagctaataaaatagaggaaaatatattgttctagtcataaaaaaggaaactagagttcattttccttttcttagGACCTGTTATGGAATTTGATTATGTAATATGCGAAGAATGTGGGAAAGAATTTATGGATTCTTATCTTATGAACCACTTTGATTTGCCAACTTGTGATAACTGCAGgtacttattttagatggtgttcttaattgctaatgtttatgtgtaggtttagggcaaaacaagttatatctgtttggatttgatattttcttagtaattatgaatttcattttgggtgtttcctaaaatttctatggtttctattttgccaaatactgtaaatctgtgcttattaaagcttatgatataccccataaaataggaaggatgccgatggttctgccatagaaatttccttttctttttctgctggcctgagtttttttttgtttttgttttttaacgtctctcagtagtaggctgctaacccttctcttcacccagccctaatgatccctctatttcttaattattccagggtgtgttacatcttggtcagaggagtggggccttcagtgaaaggacagtagctccgaatacctttttcattcatcttttgctaccctcatagagagaatagatgaggaagaactatattcttccattctttttcttcttctagactttatcctttttttttatatcacccagaataacctttctcacttcacgtggttctcctatcactactgtttactcagccaaatgctgtgttgatatcttttgcacattgaaggtcttatcttggaatcttagttggccctcttacctgttccctgtgcttactttgtccctacagtcctaaatcaactcctcacctgcctgaaggacctgccctttcagagtccctgctgcagacattgggagccatcatgattggcttgttgctgagcagaatccttggtagatagagagggagatgtggtccctggtctcatgatcagatacatggctgggaatgctctggcaccacagctggaactatagattacaaactcatttcccaccgacacagtggttaaagtccacagtattgtcgtcattcttaaaggccagtatagcttttgggaactgaaacactacatagaattttatttccaagagaaaatggaagcaactcttgtaccagtttaaagaaagttgtgaatatattaccttgccatagcaaaaggactttgcagatatgattaaggttaaagacctcgagatggggagattatcctgggttatccaggtagaccgaatacaagcacatgagctttcttagaagtggaagaggaaagctgagagtcagagggacatgcgattagtgaagaagtgagtgatgcaatgtgagaagccatcatcactgcctgtcaaagtggaaggagggggtcgtgttcaggaatgcaggtggcctctagaagctagaaaaggcaaggagatggattcttacctagtgcctccagaaaggaacgtggtcctgccaacaccttgaaaagtctggaaacattacacttttatatttaatcataatcaggaacacagtcctccattctttttcaacatcatcaaagatgatagttttagtaccatatagtctacatgtctcctgttagtttatacttctgaattatttagcttttgtatagctcttcccagttttaacttttatgtttttgtgatagaatcctctgatagaacctttgatttctcccctccctgatctgtacctgctctttagtgtttaccatttcagtaaagccagcttcattcgctggctatgtctccactctcctgtgtgtattaattccaaacctgtttggctctaggttcaccatatcctgaattcatcggcatctcatcctctcccactgctgccttagtctaggccaccatcagctcttgcctggaccaccgcagtagtgttctaactggtctctcccccattacccctttcgcacccctagggtctccttttcatatagtattttgctcaaaaccttctagtggtttctaaccattgtcttcaccattgcttgcaaggtcctgactgtctctgactgtatctcccaccactcctcaccatcgcttacttcaggtcttctagttacactggtcctcttgctgtaagctctctttgcaaaatacacccctgccctagagccttttcccttgctgttccctttgctaggaatgtttttttctctagataatgtaacttaccagaataagtaaaagataaagtatttttctgttagaattcttatgttgctaatttaaccatgagagttgcaggaaaaagtattttatatgtcctttttgctgtgtgtgcccctaagttgctgggctatttgcaaacttagcttatttaaaataactaatttatataatggacttaatctgttttca(g>t)AGATGCTGATGATAAACACAAGCTTATAACCAAAACAGAGGCAAAACAAGAATATCTTCTGAAAGACTGTGATTTAGAAAAAAGAGAGCCACCTCTTAAATTTATTGTGAAGAAGAATCCACATCATTCACAATGGGGTGATATGAAACTCTACTTAAAGTTACAG	NULL	No	6381	Out	82.26	9.65	8.4	82.41	14.28	12.68	8.16	8.16	7.78	8.28	15.8	13	-6.2	-4.1	7	0.97	7	0.93	278700	ENSG00000136936	134	319	"xeroderma pigmentosum, complementation group A"
156	1	Human	140	RB1	155	Retinoblastoma	E22+31G>T	-85	NULL	Exon	1	taaaatatagtgcttttactaaatgtctacttcttgcaattgcgtaatgtatactgaaacccttatagattgggggggataccgggaggtacaggccagagaatgtagtccaaatattggtggataatattattggctttcgctcagctctggccctttgattcccatcatgctttccattctaccagtctatctactcctctcttcccagtctatatactcttctcttcttggatggccagctcttccatctgctgctgcctggctatttctctcaatcattctgtgacatttcacttctagaagagcagctataatccaagcctaagaagtaattttatttatttattattttttcctttataatatgtgcttcttaccagtcaaaaagtattataaactattagaaaagaaaatctaaaggtagaaattttaaaattcatttaacaagtaaattttacttttttttttttttttttttttttactgttcttcctcagACATTCAAACGTGTTTTGATCAAAGAAGA/G(G>T)AGTATGATTCTATTATAGTATTCTATAACTCGGTCTTCATGCAGAGACTGAAAACAAATATTTTGCAGTATGCTTCCACCAGGgtaggtcaaaagtatcctttgattggaaaaatctaatgtaatgggtccaccaaaacattaaataaataatctacttttttgtttttgctctagCCCCCTACCTTGTCACCAATACCTCACATTCCTCGAAGCCCTTACAAGTTTCCTAGTTCACCCTTACGGATTCCTGGAGGGAACATCTATATTTCACCCCTGAAGAGTCCATATAAAATTTCAGAAGGTCTGCCAACACCAACAAAAATGACTCCAAGATCAAG	Minigene assay only	No	2	Out	79.89	8.1	-8.52	49.43	11.28	0.78	-0.36	-0.36	-0.21	7.98	13.9	7.2	-9.2	-2.3	8	0	4	0.98	180200	ENSG00000139687	124	156	retinoblastoma 1
222	1	Human	88	HMGCL	97	Hereditary 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency	IVS8+1G>C	78	NULL	Intron	0	taaagaatgagagttcaccatgaaaggaaagatactgctggcagaggaaacagtttaacagaaactaaaaggagaagcactgtctctttctgtgggattgtcatgtcaacagaatcataagccaaagcaaagaatgactctagaatttcaggcaacagacgattgggaggtttgcaaggctcatctctgtggcctcttgtccccagcaacaactgtgtttcaccatccttatgtttctagATGGGAGTGAGTGTCGTGGACTCTTCTGTGGCAGGACTTGGAGGCTGTCCCTACGCACAGGGGGCATCAGGAAACTTGGCCACAGAAGACCTGGTCTACATGCTAGAGGGCTTGGGCATTCACACG(g>c)taagcccacccaccccctggtggcgacagccccgaactgaccagggggcctgaagctgagaacaaaagtggatgggg/gtatttggggttgttaaggtgctgaggagtaaagagggaaagggttagccaggcgcagtggctcatgcctgtaatctcagcactttgggaggctgaggcaggagggtcacttgagcccaggagtttgaggctgcagtgagctatgatcctgccagtgtactccagcctgggtgaaacagcaagaccctatctcttcaaaacaaaacaaaagaggggaagggt	NULL	No	NULL	In	84.3	9.89	3.64	67.51	15.48	5.98	2.74	2.74	2.64	10.24	15	10.2	-6.2	-4.7	6	0.05	7	1	246450	ENSG00000117305	173	222	3-hydroxymethyl-3-methylglutaryl-CoA lyase
187	1	Human	28	COL1A2	52	Ehlers-Danlos syndrome	IVS11+5G>A	61	NULL	Intron	1	taaattgtgttttctacaaataccgtattattagttactcacattagagcaagttaatttgtcactctgtgcttagaggtatactagactttggttcaaagcttgaactttgatgagaataaatactttggagggaagaagtcactgtctttttatttatggtaaaacattattcaccatcttctgtatttctttctaagGGTGCTCGTGGTTTCCCTGGAACTCCTGGACTTCCTGGCTTCAAAGGCATTAGGgtga(g>a)cacattctttactcagaagagagaaaatgcctattaatttttggaaaaaactcaa/gtatgtttaaaatcttgggtgacatatactcactttcaaatccctggagtttgccaaagggaagaaagagttaaagagtcagatttcttgaaagtaaagtggggtgcaattttttcagtctgttcatagctaccaaaaaa	NULL	No	NULL	In	79.18	7.75	7.44	77.18	12.38	9.48	6.96	6.96	6.91	7.55	13.8	13.3	-7.9	-1.7	7	0.86	8	0.99	120150	ENSG00000164692	93	187	"collagen, type I, alpha 2"
5	1	Human	136	PTEN	40	Cowden's disease	IVS2+1G>A	-5	20	Exon	2	taatgttttaaaaagtattcttttagtttgattgctgcatatttcagatatttctttccttaactaaagtactcagATATTTATCCAAACATTATTGCTATGGGATTTCCTGCAGAAAGACTTGAAGGCGTATACAGGAACAATATTGATGATGTA/GTAAG(g>a)taagaatgctttgattttctatttcaaatattgatgtttatattcatgttgtgttttcatttagaaaagatttctaagccacagaaaaagatactttgtgatgtaaactattattgtagtgctctataatcattttttggcttaccgtacctaatggacttcagggggatacagttcatttgataagaactgaccttatacattacataatcaggtacttatgtgatatcatttcctggactccataaaatgctggtcaccaggtttaatacctggattccattacagtgtgatttttgtcttatttcatagttggggattaggcttaaaatcctagagtggatttattcagttaaatttattcacactaagatgtagatgactaatactgtatatttttatgtagaccaaattttaaggtaccactgtgcatatgtataccaactacctgaagaagtatttggttggtacaagagatatagaaaggaatcgctgggtgtaccaaggctaatcagttttataattttgcataattttct	NULL	No	NULL	In	94.5	10.57	3.51	73.18	15.58	8.88	5.32	5.32	3.94	10.55	18.6	12	-7.4	-2.8	7	0.13	5	1	158350	ENSG00000171862	4	5	phosphatase and tensin homolog
#341	1	Human	158	UT1	106	JK null phenotype (Kidd negative)	del(~1.6kb)	-314	NULL	Intron	0	taatttaaaaaggctacctgtcttggcaagtagctgatcagcctgcattggtgagcaggccattccataacctggtttcttgctccttaattgacagcatggagctaacgtacttaatttcagctctttctacgtgatttgactcattctgttaacattaactgtttttcag/TCTTCTCAACTAGACTGAACTCCTTAAGTGCAAGAAATACACGCTTAGTAAATGTTTGTTGGACCAGACACTGCACCTTATGAAATTAAAGACCAGAACATTCTCATGGTAGCATTACAGACACTGATGGCAAAG/gtactgtgggatttgggtttggctaataagctctgtggtggtgtttcagaaggaaaatggtgctctcttagttctatggaacatagtggtccagatcttctactgtaaccaggcccaaagctggctaatctggagggctctgccttagggatacttataagctctgtccttccctcaagGAGCCAGAGGAAGAGATAGCCATGGAGGACAGCCCCACTATGGTTAGAGTGGACAGCCCCACTATGGTTAGGGGTGAAAACCAGGTTTCGCCATGTCAAGGGAGAAGGTGCTTCCCCAAAGCTCTTGGCTATGTCACCGGTGACATGAAAGAACTTGCCAACCAGCTTAAAG	Missing exons 4 and 5 are replaced by a 136-bp intron 3 sequence	No	NULL	Out	NULL	NULL	8.56	70.84	NULL	11.88	NULL	4.88	7.25	NULL	NULL	12.3	NULL	-4	NULL	0.88	5	NULL	111000	ENSG00000141469	259	341	"solute carrier family 14 (urea transporter), member 1 (Kidd blood group)"
280	1	Human	61	FAH	174	"Tyrosinemia, type I"	IVS12+5G>A	105	NULL	Intron	0	TACATGTACTGGACGATGCTGCAGCAGCTCACTCACCACTCTGTCAACGGCTGCAACCTGCGGCCGGGGGACCTCCTGGCTTCTGGGACCATCAGCGGGCCGgtga(g>a)tatctggctgcactgagggctgcccacgcagagcatccctgctccccacacagccccaagggccctcagctcagcctcgagaagagatttcaggcccgag/gtgggtgtatctcacaactctgtcttcctcgtagcctttctctctgggtgcaggagggacttctcatccaaattcaaacctaaagagactggtgtgagaacggaagcctgggtctctgcctctgtaggggagcagcgcagtgacacgtggggaggagtcaggagacagtgatagtgtcttggttgtcaccatctcacactacaccctcccaggatgaggtggccatgctgctgtgccccttcccacccgcttgtccccctgtaagcctgcgggagtcacagaaccttcagagatgatgaccttggggtggtgcatgtgtcactcacttcctgcagggggctggccgagccctcttgttccttgagctgtcgacaggagggtgttaagcatcacgatatctgggcaaactgcagcctccagagcagggaggggatg	NULL	No	NULL	In	85.22	10.9	7.07	84.26	15.68	12.98	8.12	8.12	7.57	10.63	18.8	15.2	-7.5	-8.3	8	0.81	8	0.99	276700	ENSG00000103876	210	280	fumarylacetoacetate hydrolase (fumarylacetoacetase)
280	1	Human	61	FAH	174	"Tyrosinemia, type I"	IVS12+5G>A	105	NULL	Intron	0	TACATGTACTGGACGATGCTGCAGCAGCTCACTCACCACTCTGTCAACGGCTGCAACCTGCGGCCGGGGGACCTCCTGGCTTCTGGGACCATCAGCGGGCCGgtga(g>a)tatctggctgcactgagggctgcccacgcagagcatccctgctccccacacagccccaagggccctcagctcagcctcgagaagagatttcaggcccgag/gtgggtgtatctcacaactctgtcttcctcgtagcctttctctctgggtgcaggagggacttctcatccaaattcaaacctaaagagactggtgtgagaacggaagcctgggtctctgcctctgtaggggagcagcgcagtgacacgtggggaggagtcaggagacagtgatagtgtcttggttgtcaccatctcacactacaccctcccaggatgaggtggccatgctgctgtgccccttcccacccgcttgtccccctgtaagcctgcgggagtcacagaaccttcagagatgatgaccttggggtggtgcatgtgtcactcacttcctgcagggggctggccgagccctcttgttccttgagctgtcgacaggagggtgttaagcatcacgatatctgggcaaactgcagcctccagagcagggaggggatg	NULL	No	NULL	In	85.22	10.9	7.07	84.26	15.68	12.98	8.12	8.12	7.57	10.63	18.8	15.2	-7.5	-8.3	8	0.81	8	0.99	276700	ENSG00000103876	263	280	fumarylacetoacetate hydrolase (fumarylacetoacetase)
2	1	Human	66	FGB	35	Afibrinogenemia	IVS7+1G>T	-24	2	Exon	0	TACCAGgtaacgaacaggcatgcaaaataaaatcattctatttgaaatgggattttttttaattaaaaaacattcattgttggaagcctgttttaggcagttaagaggagtttcctgacaaaaatgtggaagctaaagataagggaagaaaggcagtttttagtttcccaaaattttatttttggtgagattttattttgtttttcttttagGTGAATATTGGCTTGGAAATGATAAAATTAGCCAGCTTACCAGGATGGGACCCACAGAACTTTTGATAGAAATGGAGGACTGGAAAGGAGACAAAGTAAAGGCTCACTATGGAGGATTCACTGTACAGAATGAAGCCAACAAATACCAGATCTCAGTGAACAAATACAGAGGAACAGCCGGTAATGCCCTCATGGATGGAGCATCTCAGCTGATGGGAGAAAACAGGACCATGACCATTCACAACGGCATGTTCTTCAGCAC/GTATGACAGAGACAATGACGGCTG(g>t)tatgtgtggcactctttgctcctgctttaaaaatcacactaatatcattactcagaatcattaacaatatttttaatagctaccacttcctgggcacttactgtcagccactgtcctaagctctttatgcatcactcgaaagcatttcaactataaggtagacattcttattctcattttacagatgagatttagagagattacgtgatttgtccaatgtcacacaactacccagagataaaactagaatttgagcacagttactttctgaataatgagcatttagataaatacctatatctctatattctaaagtgtgtgtgaaaactttcattttcatttccagggttctctgatactaagggttgtaaaagctattattccagtataaagtaacaaacacagtccctagatggattggccacaaaggcccagttatctctctttcttgctatagggcacaggaggtctttggtgtattagtgtgactctatgtatagcacccaaaggaaagactactgtgcacacgagtgtagcagtcttttatgggtaatctgcaaaacgtaacttgaccaccgtagttctgtttctaataacgccaaacacattttctttcagGTTAACATCAGATCCCAGAAAAC	NULL	No	NULL	In	80.69	8.14	4.31	70.31	12.38	6.28	5.93	5.93	5.93	8.08	15	10.8	-3.9	0.4	9	0.34	7	0.72	202400	ENSG00000171564	1	2	fibrinogen beta chain
252	1	Human	43	CYP19A1	142	Placental aromatase deficiency	IVS6+2T>C	87	NULL	Intron	0	tagaacccccagactgttaggagaatctgcagggaatgttttctgctcagagcaaccttcttaggctcacattttgctcaactgctctttcttgtgtatgtgtgtttttttttcctacagAAAGTGCTATCGTGGTTAAAATCCAAGGTTATTTTGATGCATGGCAAGCTCTCCTCATCAAACCAGACATCTTCTTTAAGATTTCTTGGCTATACAAAAAGTATGAGAAGTCTGTg(t>c)aagtaatacaactttggaagatttatgagtacaattggattggtttttttcccttgtgtctttgctgtttttcttggcctctcag/gtaacttttctgctctctagagcccacaagggagctgttgattaagttgctgatgaaacactttttacagcaatttggctgcatttggccagaccagagagtaaatgaagcctttggctgggcagcttctcggcaagggggctgagtgtgtggtctgggagcttcagcttggtaactaggacactagtgtattttgagttgaagagaagggtc	NULL	No	NULL	In	77.41	7.65	8.63	86.99	11.48	13.28	9.24	9.24	7.88	5.9	15.7	16	-4	-5.9	6	0.93	8	0.97	107910	ENSG00000137869	190	252	"cytochrome P450, family 19, subfamily A, polypeptide 1"
165	1	Human	31	COL4A5	9	Alport syndrome	E49+78G>T	-39	100	Exon	0	tagacatttagggcataatggaatattaaaaggccattgcactggttctgcagttttttgaaaaaagtttacagtttattatgtatactgggagacaatacttagcaaatgcaatcctcaaagtgcattttttcaccttttgtgatcattgaaagagacattaatcggcttccatactaagaaggcttccaatgaagcaggatggctacttctcacatgctcactctgtagattatgttccttctccttttcctttaccagATGTGCAGTATGTGAAGCTCCAGCTGTGGTGATCGCAGTTCACAGTCAGACGATCCAGATTCCCCATTGTCCTCAG/G(G>T)ATGGGATTCTCTGTGGATTGGTTATTCCTTCATGATGgtattttacactcttccttgcatttgtcatcatagctgactgtccattccatctacatttcttcccaatatgaggaatccctgtcatttgcataataagaagcttaaacttcaaacagcttctatccaagcactgtgttccccctcacacattttttgtaacatattttcataatctgcctattacttttttttgactacccttggtgtggatactattgtcttacctctgggcctgttccttcactagatttgaatttggccaagctcagcacacatctttggatattcactaagctat	NULL	No	2	Out	68.15	3.85	9.99	84.21	6.28	11.98	9.2	9.2	8.9	3.97	10.2	15.5	-2.6	-4.9	7	0.96	8	0.13	301050	ENSG00000188153	132	165	"collagen, type IV, alpha 5"
42	1	Human	50	EDA	188	X-linked hypohidrotic ectodermal dysplasia	IVS8+5G>A	-6	NULL	Exon	0	taggctaccctggttgcactgggataggggtgggggttgtgaactccttggtatttattttctgttgcctcgattattctgacatgtactgagtgactgcccttctctcatactgagATCTTTCAGGTGGAGTGCTCAATGACTGGTCTCGCATCACTATGAACCCCAAGGTGTTTAAGCTACATCCCCGCAGCGGGGAGCTGGAGGTACTGGTGGACGGCACCTACTTCATCTATAGTCAG/GTAGAAgtga(g>a)tacggtcttaggcctaactcttcttatatccagaatgcagatccggtgcaggccacataggggcactgtggagccagccaagaccatccaatggctaacttcctgctttgggtgagggggtggggggaccgcactgggagggagttgaaaggaggaaagagagagggggccagcttcttttgttttgttttgttttgtttttccttagccaaatattattgaaaaactgtgaaaaagacccctcccacaccctgccatctgattccctcctgcagggcctcaggcccctgtttaccctctgagctgtttggctgcactgccaaacttgaacttggtctcagtacattctttgaaagtcagttccagggttactgagaaccctttccctcaacactgctggctcggacgttgtaatgaatagtgctcctgcagactttctttccacctcaaaaagatttctgactgtctttccttc	NULL	No	NULL	In	82.41	7.97	6.68	71.59	12.08	11.48	5.9	5.9	5.91	7.37	14.2	14	-4.1	-5.8	7	0.84	7	0.96	305100	ENSG00000158813	31	42	ectodysplasin A
328	1	Human	24	CFTR	43	Cystic fibrosis	IVS22+12191C>T	-32768	92	Intron	-32768	tagtcctctgattaaatagatatttgatagtactttaaggtctatacttttggatgaacttaactgctttctccatttgtagtctcttgaaaatacagaaatttcagaaataatttataagaatatcaaggattcaaatcatatcagcacaaacacctaaatacttgtttgctttgttaaacacatatcccattttctatcttgataaacattggtgtaaagtagttgaatcattcagtgggtataagcagcatattctcaatactatgtttcattaataattaatagagatatatgaacacataaaagattcaattataatcaccttgtggatctaaatttcag/TTGACTTGTCATCTTGATTTCTGGAGACCACAAGGTAATGAAAAATAATTACAAGAGTCTTCCATCTGTTGCAGTATTAAAATG/g(c>t)gagtaagacaccctgaaaggaaatgttctattcatggtacaatgcaattacagctagcaccaaattcaacactgtttaactttcaacatattattttgatttatcttgatccaacattctcagggaggaggtgcattgaagttattagaaaacactgacttagatttagggtatgtcttaaaagcttatttgcgggaagtactctagccttattcaacagatcactgagaagcctggaaaaacaaatcccggaaactaattattatgtgccagttatataaacaagaagactttgttgggtacaaaccagtgattccttgcctttgaaaaatgtgtcagatatcatgcattaccagcagttcaatgatataaggaaaccagagtaatagctaaaacctttaaagctaaaccaaagatttacaaattgcctcttcatccagtctttcccaacctaaaaactgagttctct	Creates pseudoexon	No	2	Out	NULL	NULL	10.13	85.92	NULL	14.08	NULL	9.29	9.22	NULL	NULL	17.3	NULL	-7.2	NULL	0.99	8	NULL	602421	ENSG00000001626	247	328	"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
60	1	Human	92	IDS	96	"Mucopolysaccharidosis, type II"	IVS3+1G>A	-22	NULL	Exon	1	tatgtctgggaacctctagctgtgggtgtgtgctgcttcgtgcactgagggttgggggcggggagcttcagctattgtcagatggcacagattgtgcgggacatcttgttagagggaagcatagtctggaaaatggtagtggagaaaatctggttttccactcatgggaaagcttgaccttcaagggtggccttctccttgggtgcaaggtgcgccctggccctgatgtgttcatggcagccctggccagctttctcccagaacgggcgcttgcctggtgctcagaaggaaggggtgctgcagaagggcacccacaggtctgcaggctgggcctcaggtgagagctagccagggtggccctgctccctgaaccccctcatggctctgcccccagcaacactggccgctctgtgtgcctggggaggccattgcgtaggaggagataagcatctgctggtttcaggggctgattgcttcccttttctctcccggaagcagtctgttgcctaggtgacacccaaatcccagtgtctggtttgagctctgcatgactcagctaccaagctgtttgctaggagcctcgggaggcggttgcttggttacctaagagatggcagacatgttttgctgtggcgatgcttacctctgcttctgctccctaacagCAAGCAGTGTGCGCCCCGAGCCGCGTTTCTTTCCTCACTGGCAGGAGACCTGACACCACCCGCCTGTACGACTTCAACTCCTACTGGAGGGTGCACGCTGGAAACTTCTCCACCATCCCCCAGTACTTCAAGGAGAATGGCTATGTGACCATGTCG/GTGGGAAAAGTCTTTCACCCTG(g>a)tactgctccatgtccagagtctgggttctcttggtttgtggtgtctgaatccagcattcccatcctggggatggggctgtctttgcagagccctcttctggctgggcgagtccctcgctagtcagtgcttcctttctaaaaaactgacttgtcaacccagccacgttttcacccaaagtgaaaaagggtagaaagagctttgcttcctttcagaaaccactgagggtgtgctgttgggtctttcagctcctcgggtggtagggaggacacaggctggggaggtggcagtgttgggtggagtccagctcagggccccaccctctcccctgcagggtacctgtcagtaaacctaggggtggggtgaggacacctgagggcctcccgtgtggccagcattgctgttgctgacttattgcccaatgagggggctgtgcttaggtaggggctgctatccactctggaaattaagtcagaaagatgagtgtaatctggtacccag	NULL	No	NULL	In	61.94	4.41	3.89	69.16	8.38	9.18	3.59	3.59	5.29	5.3	10.4	9.3	-2.5	-5.6	6	0.04	6	0.39	309900	ENSG00000010404	48	60	iduronate 2-sulfatase
253	1	Human	46	DMD	133	Muscular dystrophy	IVS64+5G>C	57	NULL	Intron	0	tatgttttctaggctatttttgtggtggttgtagttattggcaaatcactgggcgtcgggggtgggttgtctgttatttctgatggaataacaaatgctctttgttttccctcttttcagCTGACCTGAATAATGTCAGATTCTCAGCTTATAGGACTGCCATGAAACTCCGAAGACTGCAGAAGGCCCTTTGCTgtaa(g>c)tattggccagtatttgaagatcttgatactatgtctttgcttagaataaaaa/gtaggttgggtacatttttacttagagaggggagaaacagctgtcacaattcctgttgcaatgtataattcattctttaatgtatccttggcctagagtttgcctagaatgttttgttttatt	NULL	No	NULL	In	71.25	4.47	6.84	77.02	10.08	9.58	7.17	7.17	6.49	4.89	12	11.3	-2.6	-4	5	0.5	7	0.42	181350	ENSG00000198947	191	253	dystrophin
183	1	Human	7	ATM	14	Ataxia-telangiectasia	IVS28+159A>G	83	100	Intron	2	tcatacaacttaatgatagacctgaagtcttatttaaaatgattctctaaaattgaagaattggattaagggggccttgtttggctgattttcatactttttcctcttagTCTACAGGTTGGCTGCATAGAAGAAAAAGgt(a>g)gagttatttataatcttgtaaatcttggactttgagtcatctattttcttttacagtcatcgaatacttttggaaataag/gtaatatatgccttttgagctgtcttgacgttcacagatataaaatattaaatatattttaattttgtgcccttgcagATTGATCACTTATTCATTAGTAATTTACCAGAGATTGTGGTGGAGTTATTGATGACGTTACATGAGCCAGCAAATTCTAGTGCCAGTCAGAGCACTGACCTCTGTGACTTTTCAGG	NULL	No	NULL	In	71.7	6.38	8.49	81.96	11.48	12.48	7.46	7.46	6.83	6.07	12.3	14.1	-5	-5.2	6	0.92	6	0.69	208900	ENSG00000149311	145	183	ataxia telangiectasia mutated
174	1	Human	57	F7	58	Factor 7 deficiency	IVS7+3delGGGT	33	70	Intron	1	tcatcagagaaacaatgacagcaatgtgacttccacacctcctgtccccccgcccagGTCCTGTTGTTGGTGAATGGAGCTCAGTTGTGTGGGGGGACCCTGATCAACACCATCTGGGTGGTCTCCGCGGCCCACTGTTTCGACAAAATCAAGAACTGGAGGAACCTGATCGCGGTGCTGGgt(gggt)accactctcccctgtccgaccgcggtgctgg/gtgggtgccactcttccctgtccgaccgcggtgctgggtgggtgccactctcccctgtccgaccgcggtgctgggtgggtgccactctcccctgtccgaccgcggtgctgggtgggtgccactctccgctgtccgaccgcggtgctgggtgggtaccactctcccctgtctgaccgcagctctcaagtgtctcaggggctgtggctctgggcttcgtgctgtcacttccacagacagacagacatccccaaaaggggagcaaccatgctgggcacgactgctgtggccaccgtgctctcagccactttcccatgcccaaataaaacgataaaagactgggggcttctgcccatcctgcctcacttgaccaagagcccagaagaggatgcgacacccagggcctcatgggaccaccggctggcaggggttctgctcactgggtttatgggtgagacgagcactcccaggagggccactgggccgggaagaactgtggagaatcggggcacgccctgtcctcccagctgccagggcacagcatcccttccccacctcaacacccagaccccagattcaccccagttcacttgtccccacacgagccacaggctgccacctggggcaggctggccccaccttggggttagatgcaggtccccttgccccagaaggagactgcagcccctgcagacctagaaatggccacagcccatccccatgcaccagggggtgaggtggcaggtggtggaaagggcctgaggggggcttcttccttccagGCGAGCACGACCTCAGCGAGCACGA	NULL	Yes	NULL	In	74.71	3.82	3.82	74.71	9.48	9.48	5	5	5.02	5.02	13.7	12	-8.8	-8.8	8	0.17	8	0.44	227500	ENSG00000057593	139	174	coagulation factor VII (serum prothrombin conversion accelerator)
173	1	Human	57	F7	58	Factor 7 deficiency	IVS7+5G>A	37	99	Intron	1	tcatcagagaaacaatgacagcaatgtgacttccacacctcctgtccccccgcccagGTCCTGTTGTTGGTGAATGGAGCTCAGTTGTGTGGGGGGACCCTGATCAACACCATCTGGGTGGTCTCCGCGGCCCACTGTTTCGACAAAATCAAGAACTGGAGGAACCTGATCGCGGTGCTGGgtgg(g>a)taccactctcccctgtccgaccgcggtgctgg/gtgggtgccactcttccctgtccgaccgcggtgctgggtgggtgccactctcccctgtccgaccgcggtgctgggtgggtgccactctcccctgtccgaccgcggtgctgggtgggtgccactctccgctgtccgaccgcggtgctgggtgggtaccactctcccctgtctgaccgcagctctcaagtgtctcaggggctgtggctctgggcttcgtgctgtcacttccacagacagacagacatccccaaaaggggagcaaccatgctgggcacgactgctgtggccaccgtgctctcagccactttcccatgcccaaataaaacgataaaagactgggggcttctgcccatcctgcctcacttgaccaagagcccagaagaggatgcgacacccagggcctcatgggaccaccggctggcaggggttctgctcactgggtttatgggtgagacgagcactcccaggagggccactgggccgggaagaactgtggagaatcggggcacgccctgtcctcccagctgccagggcacagcatcccttccccacctcaacacccagaccccagattcaccccagttcacttgtccccacacgagccacaggctgccacctggggcaggctggccccaccttggggttagatgcaggtccccttgccccagaaggagactgcagcccctgcagacctagaaatggccacagcccatccccatgcaccagggggtgaggtggcaggtggtggaaagggcctgaggggggcttcttccttccagGCGAGCACGACCTCAGCGAGCACGA	Minigene assays only	Yes	NULL	In	74.71	3.82	3.82	74.71	9.48	9.48	5	5	5.02	5.02	13.7	12	-8.8	-8.8	8	0.17	8	0.9	227500	ENSG00000057593	139	173	coagulation factor VII (serum prothrombin conversion accelerator)
89	1	Human	85	HEXB	156	Sandhoff disease	IVS8+5G>C	-4	-8	Exon	1	tcatcttttgtgtataaaatcttgtagcttcaataaaatgacgtagtaaaatcatgtggaaaaccagatctttataatgagtacacttcttttaaaaagaatcttaatattttcttctagGTCAGAAAGACCTCCTGACTCCATGTTACAGTAGACAAAACAAGTTGGACTCTTTTGGACCTATAAACCCTACTCTGAATACAACATACAGCTTCCTTACTACATTTTTCAAAGAAATTAGTGAGGTGTTTCCAGATCAATTCATTCATTTGGGAGGAGATGAAGTGGAATTTAAAT/GTTGgtaa(g>c)atgattccttaaaacccctttaaaaaaaaaaaaaagagaggctgggtgcggtggctcacgcctataatcccagcactttgggaggcagaggcaggcagatcacctgaggtcaggagttcaagaccagcctggccaacatggtgaaaccccatctctactaaaaatacaaaaatta	NULL	No	NULL	In	85.6	8.85	-4.7	65.81	13.08	1.48	1.27	1.27	-6.05	7.46	15	6.7	-5.9	-1.4	7	0.01	7	0.91	268800	ENSG00000049860	68	89	hexosaminidase B (beta polypeptide)
306	1	Human	42	CYBB	29	Chronic granulomatous disease	IVS5+978G>T	-32768	NULL	Intron	-32768	tccctgtggcttatcatagagtcagaggctgtcccagaaacccagcttacaataaatttgttcatacccttcattctctttgtttctcttctctgcccttttcagCGATTCACACCATTGCACATCTATTTAATGTGGAATGGTGTGTGAATGCCCGAGTCAATAATTCTGATCCTTATTCAGTAGCACTCTCTGAACTTGGAGACAGGCAAAATGAAAGTTATCTCAATTTTGCTCGAAAGAGAATAAAGgtaagcctctcattatctgacttagatattctctaggccattacaattgaggactagatttcagtgagtgaagacctctcctttgccaaaaaaaaaaaaagttggctaaccatcagagggacaagtctgtaggttacaataatgggagtatagaaaaaaatgtctcccacactcctcacctcatgtgtggaggtctctagatgttttccaggtctttaagctcatccatgagaatgtgtgcatgtgaagcctggagtaactcaggcttacctgtgactatgcccaccagtcaaagaaagctgggaacacatgtctagtcgaacaaggtttggtttattacttgctacagcaaaagaaatctcacaccttgaggaactctgggcatctcaaggggatgtaaagtggatttagaatttaggattctgttagatggtttgggggaggatttaagaatgcaaggattttctctggatcagttatggtcaggaattgggggtagttctcagataaggtatcttaattattttttctaggaggcagagggaacagaataggactaagtctataataggcaaagaagcagtagtcattgtctaggctcagacatgattttggagtggttttgcttttatctcactccatcacagtcacagagtgacctcctcagaagctggtgttttgtgaaattatttatgtgaagtagggaacatcctggcctaagtattagtgtaaggccagccaccagctgacagttgtgtgatgcctttttcttttcttaccaacaacatctgagggatggcctgtgtctacagattgtcattccttgagaagcacatgtgcactgggagtaactcagcatttctctaggggtagccaggagggtatccagaagtaagaacttcttctatcccagcagTTGTTGAAGCTTCCTACACTCAAAGACAGAAGCTCCAAGTCTTCATGCACCCAATGACTTG/g(g>t)aagatgactaaatcacattaatatgcactgaattctaaaaatgttttcttgtgtttagaaaacatccttagttttggaaaaaataattattattctcagacttacatgagaaaaacttgcctgatatacttagggagggaattaaacagcatcataaaaaacagattttttctacaatatattgggtaatttttcttttacattattcattgtttgcccaatgatatatgagggtggcaacattaacataactaggtaaatctacactatcatgctctattcagttgttcctggatcacttttactgtatctatgctctcctactcttctaaatgttttcattttcaataacctgtaactgtttcctcctcagaggactgccctggggctactaaagtccc	Creates pseudoexon. IVS5+979G>C in the Ensembl sequence.	No	2	Out	NULL	NULL	8.85	85.6	NULL	13.08	NULL	7.65	7.46	NULL	NULL	15	NULL	-5.9	NULL	0.97	7	NULL	233710	ENSG00000165168	229	306	"cytochrome b-245, beta polypeptide"
205	1	Human	46	DMD	133	Muscular dystrophy	IVS65+1G>A	4	NULL	Intron	1	tcctagctaggattctcagaggaaaaaggacactgaaaggaaggttttactctttgagtcatttgtgattttatttgttttttgcagTGGATCTCTTGAGCCTGTCAGCTGCATGTGATGCCTTGGACCAGCACAACCTCAAGCAAAATGACCAGCCCATGGATATCCTGCAGATTATTAATTGTTTGACCACTATTTATGACCGCCTGGAGCAAGAGCACAACAATTTGGTCAACGTCCCTCTCTGCGTGGATATGTGTCTGAACTGGCTGCTGAATGTTTATGATAC(g>a)tac/gtatggcatgtttttatttcccgggctctgtcacaggaggcttagcgtacagaatggtgaagtgtaattagcattacaacagggccctggaagctgtggacctaatgctcttcctgtgataaatcatttttgcatttatgacttgaaaaatattttgataagctaggagttaagag	NULL	No	NULL	In	74.98	6.81	2.23	70.41	10.38	6.08	4.3	4.3	3.09	6.19	14.1	9.1	-0.9	0.4	7	0.13	7	0.94	181350	ENSG00000198947	162	205	dystrophin
237	1	Human	94	INS	146	Predisposition to type 1 diabetes	IVS1+5insTTGC	30	100	Intron	0	tcctgaggaagaggtgctgacgaccaaggagatcttcccacagacccagcaccagggaaatggtccggaaattgcagcctcagcccccagccatctgccgacccccccaccccaggccctaatgggccaggcggcaggggttgagaggtaggggagatgggctctgagactataaagccagcgggggcccagcagccctcAGCCCTCCAGGACAGGCTGCATCAGAAGAGGCCATCAAGCAGgtct[ttgc]gttccaagggcctttgcgtcag/gtgggctcaggattccagggtggctggaccccaggccccagctctgcagcagggaggacgtggctgggctcgtgaagcatgtgggggtgagcccaggggccccaaggcagggcacctggccttcagcctgcctcagccctgcctgtctcccag	NULL	No	NULL	In	79.01	6.84	8.07	78.16	10.18	11.98	8.1	8.1	6.97	6.13	13.2	12.9	-4.5	-7.6	8	0.25	8	0.69	125852	ENSG00000129965	184	237	insulin
149	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	E2+100G>T	-38	50	Exon	2	tctacaaatactaaagttaaaagggagagagatgtaattagaactcgttaactgacacattgcaaattaacttctttttataaagcactgcatcacaaacactaaaatgaagtgggcaaattagctctgcagaaaactattttctaggctgatgtttataatgaccaatcattactgaagcaatgagaaatgtgacaattacagaatattgctgctatagtatgttgaaaaaatatgcattttgtagtgaacatttagtagaatagctctgatttctacctggagtttctgataacatgacatcttaattgctgtcttttatagatttttaaactgcaaatacaaaatagcaatcagccaatataataacttattattctccatttatgcctgaaagtcctcctcttgttgatgccgtggaaatgaatgtagaggcagatatcattagctgtattctccttccgaatgacatttatcatatccttgttattccaaaatagATAGAAGATGAAAGGAATCTTCATGAAGATTTTGTATTCATGAAAACGATACAGAGATGCAACACAGGAGAAAGATCCTTATCCTTACTGAACT/GTGAG(G>T)AGATTAAAAGCCAGTTTGAAGGCTTTGTGAAGgtaagcagcttaattactggtaaaagtgtcattgaaatattttactacatttgctagatcgggaaactgacaatgccaatgtttaaagattggttatagacacagacacacagacacacacacacatatatatgcatgcagatatacacacatacatgggtgtgtgtgtgggggttaaaaaaaaaaaacacaaagacactctctggggaaaatacacccttaggggcacagtcacacatatttgtcagcttacatatgcagctaccactaggcaaaatgatgaagtccaccaagcttggtttttgcattgctgtgtctccccatccaaaccttgatgctctcgcactggggacccagagtctgatccccatttcccagggaagcaatagccgtcaacagctgccgtggcagcaggccacaagtgaagggacacctgaagactggtaacagtctctggtgcttctctgatgatggaattttaggtgtcctgacagtgagat	NULL	No	6	Out	93.9	10.22	7.94	72.18	16.08	11.38	4.86	4.86	6.57	10.62	17.3	13.8	-7.4	-3.9	7	0.86	6	1	308230	ENSG00000102245	117	149	CD40 ligand
184	1	Human	112	MLH1	89	Hereditary nonpolyposis colorectal cancer	E14+108G>T	88	100	Intron	1	TCTCCGGGAGATGTTGCATAACCACTCCTTCGTGGGCTGTGTGAATCCTCAGTGGGCCTTGGCACAGCATCAAACCAAGTTATACCTTCTCAACACCACCAAGCTTA(G>T)gtaaatcagctgagtgtgtgaacaagcagagctactacaacaatggtccagggagcacaggcacaaaagctaaggagagcagcatgag/gtagttgggagggcacaggctttggagtcagacacatgtggtttcaaatccaagttcgaccatttcccatttatttgactgtagacaagttacattcctaaactatgtctcagatttctcatctgtaagttgtggtattactagttaacatgcaggggttttgtttgtttgtttgtttgtttgtttgtgagggtaagaaataacccaagaag	NULL	No	NULL	In	87.65	6.62	2.59	67.34	10.68	6.98	4.15	4.15	2.53	5.49	14.1	10.2	-5.3	-5.4	8	0.12	7	0.99	609310	ENSG00000076242	146	184	"mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)"
256	1	Human	24	CFTR	43	Cystic fibrosis	E23+156G>C	29	NULL	Intron	2	tcttccactggtgacaggataaaatattccaatggtttttattgaagtacaatactgaattatgtttatggcatggtacctatatgtcacagaagtgatcccatcacttttaccttatagGTGGGCCTCTTGGGAAGAACTGGATCAGGGAAGAGTACTTTGTTATCAGCTTTTTTGAGACTACTGAACACTGAAGGAGAAATCCAGATCGATGGTGTGTCTTGGGATTCAATAACTTTGCAACAGTGGAGGAAAGCCTTTGGAGTGATACCACA(G>C)gtgagcaaaaggacttagccagaaaaaag/gcaactaaattatattttttactgctatttgatacttgtactcaagaaattcatattactctgcaaaatatatttgttatgcattgctgtcttttttctccagtgcagttttctcataggcagaaaagatgtctctaaaagtttggaattc	NULL	No	NULL	In	88.72	9.6	1.26	69.15	13.88	5.02	1.12	1.12	-0.44	10.3	17.6	NULL	-8.1	-1.4	8	NULL	6	1	602421	ENSG00000001626	193	256	"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
330	1	Human	24	CFTR	43	Cystic fibrosis	IVS11+194A>G	-32768	100	Intron	-32768	tcttgcatactgtcttcaaaaataagttacactataaaggttgttttagacttttaaagttttgccattggtttttaaaaaaatttttaaattggctttaaaaatttcttaattgtgtgctgaatacaattttctttattacag/AAGTACCAACAATTACATGTATAAACAGAGAATCCTATGTACTTGAGAT/(a>g)taagtaaggttactatcaatcacacctgaaaaatttaaatgttatgaagaaattatctcatttctattaatatgggaactgtgtcttcatctttattactgttctaaggtcaactcaatgtagattttacttgcttatggtttcatattttagctaaatagtaaaataatatggatatacattttgttgtgacttactcatactttccttatttggaacttttatgaatatgatatagagactgaaactacaaggaacaaaatgcaatatcaattatacagttgtggcagcactgctatcaatttgttgatagtggttaacacttagaaaaacattttaaaaataatttcacataagtaatgtaatttattagctgtctctgacattttacagtttggaatagtttattttctttttggtgtcctcaccaaaacccaacatcttcaagggcaggaactgtataatttttgccattgtattttgagcacatagcatggtacttgcctctaaatagatactattgttaaaatattttttaaggtaatattttaaagtgtatgctatggtacagttcagtttgtgacttttgctagtttatgccacttacagttagcaaaatcacttcagcagttcttggaatgttgtgaaaagtgataaaaatcttctgcaacttattcctttattcctcatttaaaataatctaccatagtaaaaacatgtataaaagtgctacttctgcaccacttttgagaatagtgttatttcagtgaatcgatgtggtgaccatattgtaatgcatgtagtgaactgtttaaggcaaatcatctacactagatgaccaggaaatagagaggaaatgtaatttaatttccattttctttttagAGCAGTATACAAAGATGCTGATTTGTATTTATTAGACTCTCCTTTTGGATACCTAGATGTTTTAACAGAAAAAGAAATATTTGAAAG	Creates pseudoexon	No	1	Out	NULL	NULL	9.11	86.96	NULL	13.48	NULL	7.75	7.06	NULL	NULL	16.1	NULL	-4	NULL	0.93	7	NULL	602421	ENSG00000001626	249	330	"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
39	1	Human	65	FGA	35	Afibrinogenemia	IVS4+1G>T	-66	NULL	Exon	0	tctttctttctttctttctttctttctccttccttcctttcttcctttcttttttgctggcaattacagacaaatcactcagcagctacttcaataaccatattttcgatttcagACCGTGATAATACCTACAACCGAGTGTCAGAGGATCTGAGAAGCAGAATTGAAGTCCTGAAGCGCAAAGTCATAGAAAAA/GTACAGCATATCCAGCTTCTGCAGAAAAATGTTAGAGCTCAGTTGGTTGATATGAAACGACTGGAG(g>t)taagtatgtggctgtggtcccagatgtccttgtttctgagtagagggaaaaggaaggcgatagttatgcactgagtgtctactatatgcagagaaaagtgttatatccatcatctacctaaaagtaggtattattttcctcactccacagttgaagaaaaaaaattcagagatattaagtaaattttccaacggtacatagatagtaaatttcaaaagcaaatgttcagtccctgtctaattccaaagcccattacatcaccacacctctgagccctcagcctgagtttcaccaaggatcatttaattagcgtttcctttgagagggaatagcaccttactcttgatccattctgaggctaagatgaattaaacagcatccattgcttatcctggctagccctgcaatacccaacatctcttccactgagggtgctcgataggcagaaaacagagaatattaagtggtaggtctccgagtcaaaaaaaatgaaaccagtttccagaaggaaaattaactaccaggaactcaatagacgtagtttatgtatttgtatctacattttctctttatttttctcccctctctctagGTGGACATTGATATTAAGATCCGATCTTGTCGAGGGTCATGCAGTAGGGCTTTAGCTCGTGAAGTAGATCTGAAGGACTATGAAGATCAGCAGAAGCAACTTGAACAGGTCATTGCCAAAGACTTACTTCCCTCTAGAGATAGGCAACACTTACCACTGATAAAAATGAAACCAGTTCCAGACTTGGTTCCCGGAAATTTTAAGAGCCAGCTTCAGAAGGTACCCCCAGAGTGGAAGGCATTAACAGACATGCCGCAGATGAGAATGGAGTTAGAGAGACCTGGTGGAAATGAGATTACT	NULL	No	NULL	In	100	11.08	-0.9	58.62	14.68	6.58	2.17	2.17	3.36	11.77	22.1	7.6	-8.9	-1.7	8	0.04	4	1	202400	ENSG00000171560	29	39	fibrinogen alpha chain
40	1	Human	65	FGA	35	Afibrinogenemia	IVS4+1G>T	-36	NULL	Exon	0	tctttctttctttctttctttctttctccttccttcctttcttcctttcttttttgctggcaattacagacaaatcactcagcagctacttcaataaccatattttcgatttcagACCGTGATAATACCTACAACCGAGTGTCAGAGGATCTGAGAAGCAGAATTGAAGTCCTGAAGCGCAAAGTCATAGAAAAAGTACAGCATATCCAGCTTCTGCAGAAAAAT/GTTAGAGCTCAGTTGGTTGATATGAAACGACTGGAG(g>t)taagtatgtggctgtggtcccagatgtccttgtttctgagtagagggaaaaggaaggcgatagttatgcactgagtgtctactatatgcagagaaaagtgttatatccatcatctacctaaaagtaggtattattttcctcactccacagttgaagaaaaaaaattcagagatattaagtaaattttccaacggtacatagatagtaaatttcaaaagcaaatgttcagtccctgtctaattccaaagcccattacatcaccacacctctgagccctcagcctgagtttcaccaaggatcatttaattagcgtttcctttgagagggaatagcaccttactcttgatccattctgaggctaagatgaattaaacagcatccattgcttatcctggctagccctgcaatacccaacatctcttccactgagggtgctcgataggcagaaaacagagaatattaagtggtaggtctccgagtcaaaaaaaatgaaaccagtttccagaaggaaaattaactaccaggaactcaatagacgtagtttatgtatttgtatctacattttctctttatttttctcccctctctctagGTGGACATTGATATTAAGATCCGATCTTGTCGAGGGTCATGCAGTAGGGCTTTAGCTCGTGAAGTAGATCTGAAGGACTATGAAGATCAGCAGAAGCAACTTGAACAGGTCATTGCCAAAGACTTACTTCCCTCTAGAGATAGGCAACACTTACCACTGATAAAAATGAAACCAGTTCCAGACTTGGTTCCCGGAAATTTTAAGAGCCAGCTTCAGAAGGTACCCCCAGAGTGGAAGGCATTAACAGACATGCCGCAGATGAGAATGGAGTTAGAGAGACCTGGTGGAAATGAGATTACT	NULL	No	NULL	In	100	11.08	-6.89	70.88	14.68	2.78	2.29	2.29	-7.11	11.77	22.1	5.3	-8.9	0.2	8	0.02	6	1	202400	ENSG00000171560	29	40	fibrinogen alpha chain
38	1	Human	65	FGA	35	Afibrinogenemia	IVS4+1G>T	-1	NULL	Exon	1	tctttctttctttctttctttctttctccttccttcctttcttcctttcttttttgctggcaattacagacaaatcactcagcagctacttcaataaccatattttcgatttcagACCGTGATAATACCTACAACCGAGTGTCAGAGGATCTGAGAAGCAGAATTGAAGTCCTGAAGCGCAAAGTCATAGAAAAAGTACAGCATATCCAGCTTCTGCAGAAAAATGTTAGAGCTCAGTTGGTTGATATGAAACGACTGGA/G(g>t)taagtatgtggctgtggtcccagatgtccttgtttctgagtagagggaaaaggaaggcgatagttatgcactgagtgtctactatatgcagagaaaagtgttatatccatcatctacctaaaagtaggtattattttcctcactccacagttgaagaaaaaaaattcagagatattaagtaaattttccaacggtacatagatagtaaatttcaaaagcaaatgttcagtccctgtctaattccaaagcccattacatcaccacacctctgagccctcagcctgagtttcaccaaggatcatttaattagcgtttcctttgagagggaatagcaccttactcttgatccattctgaggctaagatgaattaaacagcatccattgcttatcctggctagccctgcaatacccaacatctcttccactgagggtgctcgataggcagaaaacagagaatattaagtggtaggtctccgagtcaaaaaaaatgaaaccagtttccagaaggaaaattaactaccaggaactcaatagacgtagtttatgtatttgtatctacattttctctttatttttctcccctctctctagGTGGACATTGATATTAAGATCCGATCTTGTCGAGGGTCATGCAGTAGGGCTTTAGCTCGTGAAGTAGATCTGAAGGACTATGAAGATCAGCAGAAGCAACTTGAACAGGTCATTGCCAAAGACTTACTTCCCTCTAGAGATAGGCAACACTTACCACTGATAAAAATGAAACCAGTTCCAGACTTGGTTCCCGGAAATTTTAAGAGCCAGCTTCAGAAGGTACCCCCAGAGTGGAAGGCATTAACAGACATGCCGCAGATGAGAATGGAGTTAGAGAGACCTGGTGGAAATGAGATTACT	NULL	No	NULL	In	100	11.08	-16.89	49.71	14.68	-2.72	-2.92	-2.92	-5.75	11.77	22.1	1.9	-8.9	-1.5	8	0	4	1	202400	ENSG00000171560	29	38	fibrinogen alpha chain
197	1	Human	65	FGA	35	Afibrinogenemia	IVS4+1G>T	4	85	Intron	1	tctttctttctttctttctttctttctccttccttcctttcttcctttcttttttgctggcaattacagacaaatcactcagcagctacttcaataaccatattttcgatttcagACCGTGATAATACCTACAACCGAGTGTCAGAGGATCTGAGAAGCAGAATTGAAGTCCTGAAGCGCAAAGTCATAGAAAAAGTACAGCATATCCAGCTTCTGCAGAAAAATGTTAGAGCTCAGTTGGTTGATATGAAACGACTGGAG(g>t)taa/gtatgtggctgtggtcccagatgtccttgtttctgagtagagggaaaaggaaggcgatagttatgcactgagtgtctactatatgcagagaaaagtgttatatccatcatctacctaaaagtaggtattattttcctcactccacagttgaagaaaaaaaattcagagatattaagtaaattttccaacggtacatagatagtaaatttcaaaagcaaatgttcagtccctgtctaattccaaagcccattacatcaccacacctctgagccctcagcctgagtttcaccaaggatcatttaattagcgtttcctttgagagggaatagcaccttactcttgatccattctgaggctaagatgaattaaacagcatccattgcttatcctggctagccctgcaatacccaacatctcttccactgagggtgctcgataggcagaaaacagagaatattaagtggtaggtctccgagtcaaaaaaaatgaaaccagtttccagaaggaaaattaactaccaggaactcaatagacgtagtttatgtatttgtatctacattttctctttatttttctcccctctctctagGTGGACATTGATATTAAGATCCGATCTTGTCGAGGGTCATGCAGTAGGGCTTTAGCTCGTGAAGTAGATCTGAAGGACTATGAAGATCAGCAGAAGCAACTTGAACAGGTCATTGCCAAAGACTTACTTCCCTCTAGAGATAGGCAACACTTACCACTGATAAAAATGAAACCAGTTCCAGACTTGGTTCCCGGAAATTTTAAGAGCCAGCTTCAGAAGGTACCCCCAGAGTGGAAGGCATTAACAGACATGCCGCAGATGAGAATGGAGTTAGAGAGACCTGGTGGAAATGAGATTACT	NULL	No	NULL	In	100	11.08	4.58	77.18	14.68	8.38	4.92	4.92	4.12	11.77	22.1	11.1	-8.9	-2.3	8	0.72	8	1	202400	ENSG00000171560	29	197	fibrinogen alpha chain
320	1	Human	46	DMD	133	Muscular dystrophy	IVS25+2240A>G	-32768	NULL	Intron	-32768	tgaaaggtatttgttttttgtttgttgaatgttcttaatggatgaataaaaagaacatcaccaatttatgtagagcaaggggaaaacatcagccaaaaaaaaaaagtataaaaccaacaatattactaaaacctcaaggtttttacattttacaggagtacaatttgtaaaggctctctaaaaatgtctttgcttaagaccttatgtctgttatatgtactaagaatttgttgttcaagagatatattttaaacacactcatctgttgcatagcaaaaaagctatagatccaagctatgttctgatctccattttctaatcttagaatattatatgtatctgtgcttttcctacaag/(3?ss2)TATCACTCTGGCCATGTTCTGACTTTGTAG/(3?ss1)CCAAATGAGTTAGGTTGTAAAAGGAAGGAACAATGGCGCTCAAGGAGAAGAAGAAGACGATGCGGTAAAAACAAGGAAGCCATATGTGAATATTGTTACCAATTCAGCATTCCAGAGAGAATAATGGAAATGAAGTGTAAATCTATGCATTACAGAAATATCTACAGACAAA/(a>g)taagtgtgtgatacactcttttgggttaaagataattccttttttgtcaccagatgccaatgtctgcgaaaacataaataatttgaaacaaaattgtccaaatatctgatacatttgaagatgctttcacatcccatgatctaattttgggtatataaaatggttattattttaaattttaaagggtatgtatataagtttaaaaatctagattctagct	Creates pseudoexon	No	1	Out	NULL	NULL	9.72	87.58	NULL	14.58	NULL	9.54	8.51	NULL	NULL	15.5	NULL	-4.2	NULL	1	7	NULL	181350	ENSG00000198947	241	320	dystrophin
161	1	Human	75	GHR	78	Growth hormone insensitivity	E6+155A>G	-24	NULL	Exon	0	tgagttaaaaaaaaaagttactctcttataaagtgaaagttataataagaaaaatattggaagaaataagagcatgaatgatcaaaaatgtagaaagtaatttggtcttctgagaagaatgccttccattaatattaaattgtgtctgtctgtgtactaatgctctgttgaattgcacagTGCAACCAGATCCACCCATTGCCCTCAACTGGACTTTACTGAACGTCAGTTTAACTGGGATTCATGCAGATATCCAAGTGAGATGGGAAGCACCACGCAATGCAGATATTCAGAAAGGATGGATGGTTCTGGAGTATGAACTTCAATACAAAGA(A>G)/GTAAATGAAACTAAATGGAAAATGgtaagatgttgctacaccttacactttgacttttctttctatttcaacaaactctctctcatttatcattagactttcctttgacctaataccacatgttcatgctgtatgctccataatttcttaattgagaaaacattatttaaccggtaaaatattgtcttgaaattctgtaagaca	NULL	No	-1	Out	85.6	9.48	8.39	87.65	13.48	12.38	8.42	8.42	7.31	8.46	15	14.1	-5.9	-5.5	7	0.97	7	0.99	262500	ENSG00000112964	129	161	growth hormone receptor
199	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	E1+?del27	49	NULL	Intron	1	tgcgacgagccctcaggcgaacctctcggctttcccgcgcggcgccgccTCTTGCTGCGCCTCCGCCTCCTCCTCTGCTCCGCCACCGGCTTCCTCCTCCTGAGCAGTCAGCCCGCGCGCCGGCCGGCTCCGTTATG(GCGACCCGCAGCCCTGGCGTCGTGgtg)agcagctcggcctgccggccctggccggttcaggcccacgcggcag/gtggcggccgggccctgaggcgcgggatccgcagtgcgggctcgggcggccgggcccagggaaccccgcaggcgggggcggccagtttcccgggttcggctttacgtcacgcgagggcggcagggaggacggaatggcggggtttggggtgggtccctcctcgggggagccctgggaaaagaggactgcgtgtgggaagagaaggtggaaatggcgttttggttgacatgtgccgcctgcgagcgtgctgcggggaggggccgagggcagattcgggaatgatggcgcggggtgggggcgtgggggctttc	NULL	No	NULL	In	79.82	6.64	2.99	65.86	11.68	8.28	4.55	4.55	4.5	6.74	13.8	11.8	-5.8	-5.1	7	0.01	6	0.95	300322	ENSG00000165704	157	199	hypoxanthine phosphoribosyltransferase 1
204	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	E1+112G>A	49	NULL	Intron	1	tgcgacgagccctcaggcgaacctctcggctttcccgcgcggcgccgccTCTTGCTGCGCCTCCGCCTCCTCCTCTGCTCCGCCACCGGCTTCCTCCTCCTGAGCAGTCAGCCCGCGCGCCGGCCGGCTCCGTTATGGCGACCCGCAGCCCTGGCGTCGT(G>A)gtgagcagctcggcctgccggccctggccggttcaggcccacgcggcag/gtggcggccgggccctgaggcgcgggatccgcagtgcgggctcgggcggccgggcccagggaaccccgcaggcgggggcggccagtttcccgggttcggctttacgtcacgcgagggcggcagggaggacggaatggcggggtttggggtgggtccctcctcgggggagccctgggaaaagaggactgcgtgtgggaagagaaggtggaaatggcgttttggttgacatgtgccgcctgcgagcgtgctgcggggaggggccgagggcagattcgggaatgatggcgcggggtgggggcgtgggggctttc	NULL	No	NULL	In	79.82	6.64	-3.45	56.96	11.68	4.28	2.51	2.51	1.99	6.74	13.8	8.2	-5.8	-2.8	7	0	6	0.95	300322	ENSG00000165704	161	204	hypoxanthine phosphoribosyltransferase 1
201	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	IVS1+1G>A	49	NULL	Intron	1	tgcgacgagccctcaggcgaacctctcggctttcccgcgcggcgccgccTCTTGCTGCGCCTCCGCCTCCTCCTCTGCTCCGCCACCGGCTTCCTCCTCCTGAGCAGTCAGCCCGCGCGCCGGCCGGCTCCGTTATGGCGACCCGCAGCCCTGGCGTCGTG(g>a)tgagcagctcggcctgccggccctggccggttcaggcccacgcggcag/gtggcggccgggccctgaggcgcgggatccgcagtgcgggctcgggcggccgggcccagggaaccccgcaggcgggggcggccagtttcccgggttcggctttacgtcacgcgagggcggcagggaggacggaatggcggggtttggggtgggtccctcctcgggggagccctgggaaaagaggactgcgtgtgggaagagaaggtggaaatggcgttttggttgacatgtgccgcctgcgagcgtgctgcggggaggggccgagggcagattcgggaatgatggcgcggggtgggggcgtgggggctttc	NULL	No	NULL	In	79.82	6.64	-3.45	56.96	11.68	4.28	2.51	2.51	1.99	6.74	13.8	8.2	-5.8	-2.8	7	0	6	0.95	300322	ENSG00000165704	159	201	hypoxanthine phosphoribosyltransferase 1
200	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	IVS1+1G>T	49	NULL	Intron	1	tgcgacgagccctcaggcgaacctctcggctttcccgcgcggcgccgccTCTTGCTGCGCCTCCGCCTCCTCCTCTGCTCCGCCACCGGCTTCCTCCTCCTGAGCAGTCAGCCCGCGCGCCGGCCGGCTCCGTTATGGCGACCCGCAGCCCTGGCGTCGTG(g>t)tgagcagctcggcctgccggccctggccggttcaggcccacgcggcag/gtggcggccgggccctgaggcgcgggatccgcagtgcgggctcgggcggccgggcccagggaaccccgcaggcgggggcggccagtttcccgggttcggctttacgtcacgcgagggcggcagggaggacggaatggcggggtttggggtgggtccctcctcgggggagccctgggaaaagaggactgcgtgtgggaagagaaggtggaaatggcgttttggttgacatgtgccgcctgcgagcgtgctgcggggaggggccgagggcagattcgggaatgatggcgcggggtgggggcgtgggggctttc	NULL	No	NULL	In	79.82	6.64	-3.45	56.96	11.68	4.28	2.51	2.51	1.99	6.74	13.8	8.2	-5.8	-2.8	7	0	6	0.95	300322	ENSG00000165704	158	200	hypoxanthine phosphoribosyltransferase 1
198	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	IVS1+2T>A	49	NULL	Intron	1	tgcgacgagccctcaggcgaacctctcggctttcccgcgcggcgccgccTCTTGCTGCGCCTCCGCCTCCTCCTCTGCTCCGCCACCGGCTTCCTCCTCCTGAGCAGTCAGCCCGCGCGCCGGCCGGCTCCGTTATGGCGACCCGCAGCCCTGGCGTCGTGg(t>a)gagcagctcggcctgccggccctggccggttcaggcccacgcggcag/gtggcggccgggccctgaggcgcgggatccgcagtgcgggctcgggcggccgggcccagggaaccccgcaggcgggggcggccagtttcccgggttcggctttacgtcacgcgagggcggcagggaggacggaatggcggggtttggggtgggtccctcctcgggggagccctgggaaaagaggactgcgtgtgggaagagaaggtggaaatggcgttttggttgacatgtgccgcctgcgagcgtgctgcggggaggggccgagggcagattcgggaatgatggcgcggggtgggggcgtgggggctttc	NULL	No	NULL	In	79.82	6.64	-3.45	56.96	11.68	4.28	2.51	2.51	1.99	6.74	13.8	8.2	-5.8	-2.8	7	0	6	0.95	300322	ENSG00000165704	157	198	hypoxanthine phosphoribosyltransferase 1
202	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	IVS1+5G>A	49	NULL	Intron	1	tgcgacgagccctcaggcgaacctctcggctttcccgcgcggcgccgccTCTTGCTGCGCCTCCGCCTCCTCCTCTGCTCCGCCACCGGCTTCCTCCTCCTGAGCAGTCAGCCCGCGCGCCGGCCGGCTCCGTTATGGCGACCCGCAGCCCTGGCGTCGTGgtga(g>a)cagctcggcctgccggccctggccggttcaggcccacgcggcag/gtggcggccgggccctgaggcgcgggatccgcagtgcgggctcgggcggccgggcccagggaaccccgcaggcgggggcggccagtttcccgggttcggctttacgtcacgcgagggcggcagggaggacggaatggcggggtttggggtgggtccctcctcgggggagccctgggaaaagaggactgcgtgtgggaagagaaggtggaaatggcgttttggttgacatgtgccgcctgcgagcgtgctgcggggaggggccgagggcagattcgggaatgatggcgcggggtgggggcgtgggggctttc	NULL	No	NULL	In	79.82	6.64	-3.45	56.96	11.68	4.28	2.51	2.51	1.99	6.74	13.8	8.2	-5.8	-2.8	7	0	6	0.95	300322	ENSG00000165704	160	202	hypoxanthine phosphoribosyltransferase 1
203	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	IVS1+5G>T	49	NULL	Intron	1	tgcgacgagccctcaggcgaacctctcggctttcccgcgcggcgccgccTCTTGCTGCGCCTCCGCCTCCTCCTCTGCTCCGCCACCGGCTTCCTCCTCCTGAGCAGTCAGCCCGCGCGCCGGCCGGCTCCGTTATGGCGACCCGCAGCCCTGGCGTCGTGgtga(g>t)cagctcggcctgccggccctggccggttcaggcccacgcggcag/gtggcggccgggccctgaggcgcgggatccgcagtgcgggctcgggcggccgggcccagggaaccccgcaggcgggggcggccagtttcccgggttcggctttacgtcacgcgagggcggcagggaggacggaatggcggggtttggggtgggtccctcctcgggggagccctgggaaaagaggactgcgtgtgggaagagaaggtggaaatggcgttttggttgacatgtgccgcctgcgagcgtgctgcggggaggggccgagggcagattcgggaatgatggcgcggggtgggggcgtgggggctttc	NULL	No	NULL	In	79.82	6.64	-3.45	56.96	11.68	4.28	2.51	2.51	1.99	6.74	13.8	8.2	-5.8	-2.8	7	0	6	0.95	300322	ENSG00000165704	160	203	hypoxanthine phosphoribosyltransferase 1
155	1	Human	13	BTK	184	agammaglobulinemia	E11+48A>G	-33	NULL	Exon	0	tggaacttggcagtaaaatcaggggttgttctattttctctctcaagtttgggcaggtgggatgcaggtgtgagcaccacttcctcctacagacagcttctttttcgttgtttcagGGGAAAGAAGGAGGTTTCATTGTCAGAGACTCCAGCAAAGCTGGCAA/(A>G)TATACAGTGTCTGTGTTTGCTAAATCCACAGGgtgagtgctactattccaaggccctgaggacaaagaacaggggtaccctcctaatagctccttgatgctgtgcccgtcccacttcctctgtctctgaaactcaaaactcatctcacttca	NULL	No	1	Out	85.28	9.25	-0.06	58.73	13.58	5.28	2.28	2.28	2.79	9.12	15.6	9.3	-9.3	-1.7	8	0	6	0.99	300300	ENSG00000010671	123	155	Bruton agammaglobulinemia tyrosine kinase
218	1	Human	84	HEXA	170	Tay-Sachs disease	IVS9+1G>A	17	NULL	Intron	2	tggaagagcagataggaaagccgaaatccagtgtgctggagcttcaagttaagaccttggattctcatgttgcagtccagagaggattaatatgttttctctttgggagtttgaacttaaaactcttcaggtccagactcagcctttctcagcctgtgtcaacagcccacctgcttcacataactttgcttggccacactttccacatgtagggcttctgagatccttgcttatttgatttttcaggtgaaaagaggaagttatagggggccaggtgactaatccccaggcattaggctttcaggatgttgaaagattaatcttcattttctcttgggattcagGAAGTCCAACCCAGAGATCCAGGACTTTATGAGGAAGAAAGGCTTCGGTGAGGACTTCAAGCAGCTGGAGTCCTTCTACATCCAGAC(g>a)tgaggaaggaaggagg/gtgggtggggtcccttgggggtcctcctgtggggtcctccctttccataccgagtcaggccctgcttggccactgtctggtccctgcagggttcccttgtcctttgtcccatcctttcagatttggagtggttggttttcagcccaggggaaagacactgcttaatgaggaataggcccctggccaggctcaacccctagagcactggcacaaacagtctagaacccatctgagctaagcagacacttactagacactcctctcctctccag	NULL	No	NULL	In	75.64	4.68	5.37	74.71	9.78	9.88	6.67	6.67	5.79	6.26	10.7	12	-4	-8.8	6	0.16	8	0.71	272800	ENSG00000213614	171	218	hexosaminidase A (alpha polypeptide)
77	1	Human	160	VHL	177	Von Hippel-Lindau disease	E2+122delA	40	NULL	Exon	1	tggctaatttttttgtatttttagtagagacgaggtttcaccacgttagccaggacggtcttgatctcctgacctcatgatccgcctgcctcggcctcccaaagtgctgggattacaggtgtgggccaccgtgcccagccaccggtgtggctctttaacaacctttgcttgtcccgatagGTCACCTTTGGCTCTTCAGAGATGCAGGGACACACGATGGGCTTCTGGTTAACCAAACTGAATTATTTGTGCCATCTCTCAATGTTGACGGACAGCCTATTTTTGCCAATATCACACTGCC(A)Ggtactgacgttttactttttaaaaagataaggttgttgtg/gtaagtacaggatagaccacttgaaaaattaagcccagttctcaatttttgcctgatgtcaggcacgttatccaatctttttgtatcctattctctaccataaataaaatggaagtgatgtatttgtacgttatgtgtta	NULL	No	NULL	In	70.84	9.04	10.36	91.1	12.38	14.28	9.83	9.83	9.19	7.81	14	18.7	-4.8	-7.3	6	1	8	0.82	193300	ENSG00000134086	64	77	von Hippel-Lindau tumor suppressor
261	1	Human	124	PFKM	169	Tarui Disease (Glycogenosis Type VII)	E13+65G>A	155	100	Intron	2	tggctcacgcctataatcccagcactttgggaggccgaggcaggcagatcacaaggtcaggagattgagaccatcctggctaacatggtgaaaaataccaaaaaaattagccgggtgtggttgcacacgcctataatcccagctacttgggaggctgaggcagaagaattgcttgaacccgggaggcagggggttgcagtgagccaagatcacgccactgcactccagcctgggcgacagagcgagactccgtctcaaaaaaaaaataaaataaacagagcatagaatcagttcttttcttttgctgctcattacttagacaactcaggaaaaacaaaaatacttccatgaaagtttgggggcataggaaaggtggggtgtagaatggacaggatctagtcacaatcccagagatgggcagagttcgactgtgggatggagttccagctgtgcagaatcctgaccctggagttgaaactgtcgctgtgctcccccctcagACCAAAGATGTGACCAAGGCCATGGATGAGAAGAAATTTGACGAAGCCCTGAAGCTGAGAGGCC(G>A)gtgaggagatgacgggaagctcactagctacagaaatcagaggcgtgaacgaagccaaagatctccatggctccaggcccaaaacatgagcttctgctgcttccttttctgattctctctgcagcaagttcctgcccaagaaaattagttgtgag/gtgactgggaggctcagttcatctcaggggtgtggtccctggcatcaaccttttataatctgttatttctatatgtgagccccagcaagatgataagttcctctaggcaagggacagtctcttgtgctgagcatagtgcctgaagaagagtactgagggagtgtttgatgaactagtggcccttttgcagcccctgccctgtccctgctctgccccagttctgtcctcagaggtttgccctatggaacttccctctgggagcaacacttcagaccaggatctccatggctgctggctgtggggaatggcctgaagacacctctctctatttgtacttcctacagGAGCTTCATGAACAACTGGGAGGTGTACAAGCTTCTAGCTCATGTCAGACCCCCGGTATCTAAG	NULL	No	NULL	In	79.84	9.35	5.88	81.82	13.28	8.68	6.65	6.65	6.03	8.93	14	10.7	-7.3	-5.1	7	0.17	7	0.87	232800	ENSG00000152556	196	261	"phosphofructokinase, muscle"
47	1	Human	164	WT1	68	Frasier syndrome	IVS9+4C>T	-9	NULL	Exon	0	tggggatcatcctaccctaacaagctccagcgaagtgccttaggcattttgggatctgttcagtcctagtaggagaggttgcctttaatgagatccccttttccagtatcattttcaaatagaatatgtgtcttccccaagGTGAGAAACCATACCAGTGTGACTTCAAGGACTGTGAACGAAGGTTTTCTCGTTCAGACCAGCTCAAAAGACACCAAAGGAGACATACAGgtttgtaggttcacttctcattgctggcagctgtgttcccttgggctagggttgatttcatgattctctttgttgttgaatatgaatgagagagtcagccatgtgtttagtttttccagtattttccccccataatctctggagatgttcctcctcttaaataaagaaaaagaaagaaaaggaaacaccccacatttcccctgcaaaccacagaacagtgagatcccactagcagtgggctgatgatacactgagcatcagcaaagaatgagggtgatggagagcggaatccaatttgtagcgtgtgattcacttttcctgtctctgacacagctgagatcttccagctggtgagaagctggacctctgtggttaaggaatggttgttcccaagacagaagcaggtccttgaagattactgtgcagaatcagtgattcttgttgggcctgggggactggggaaatctaagggtgaggcagatgcagacattgcaggcatggcaggaaatgctgggctcctccagctgccggaagtcagccttgtgggcctcactgtgcccacattgttagggccgaggctagaccttctctgtccatttagGTGTGAAACCATTCCAGTGTAAAACTTGTCAGCGAAAGTTCTCCCGGTCCGACCACCTGAAGACCCACACCAGGACTCATACAG/GTAAAACAAgtg(c>t)gtaaacttttcttcacatttatttttcattatttttttaaactattgtggaatgaaattgtgatgagagggattggaaaagactagtgtaaaagttctaaggtttagactcagttgagagaaggaatagtgcgtggctatctttaaataataaataataacattttttaaagaagg	NULL	Yes	NULL	In	71.18	6.68	-4.45	60.19	9.08	2.88	1.62	1.62	1.17	6.24	10.6	9	-1.4	-2.3	7	0.05	4	0.76	136680	ENSG00000184937	36	47	Wilms tumor 1
46	1	Human	164	WT1	68	Frasier syndrome	IVS9+5G>A	-9	NULL	Exon	0	tggggatcatcctaccctaacaagctccagcgaagtgccttaggcattttgggatctgttcagtcctagtaggagaggttgcctttaatgagatccccttttccagtatcattttcaaatagaatatgtgtcttccccaagGTGAGAAACCATACCAGTGTGACTTCAAGGACTGTGAACGAAGGTTTTCTCGTTCAGACCAGCTCAAAAGACACCAAAGGAGACATACAGgtttgtaggttcacttctcattgctggcagctgtgttcccttgggctagggttgatttcatgattctctttgttgttgaatatgaatgagagagtcagccatgtgtttagtttttccagtattttccccccataatctctggagatgttcctcctcttaaataaagaaaaagaaagaaaaggaaacaccccacatttcccctgcaaaccacagaacagtgagatcccactagcagtgggctgatgatacactgagcatcagcaaagaatgagggtgatggagagcggaatccaatttgtagcgtgtgattcacttttcctgtctctgacacagctgagatcttccagctggtgagaagctggacctctgtggttaaggaatggttgttcccaagacagaagcaggtccttgaagattactgtgcagaatcagtgattcttgttgggcctgggggactggggaaatctaagggtgaggcagatgcagacattgcaggcatggcaggaaatgctgggctcctccagctgccggaagtcagccttgtgggcctcactgtgcccacattgttagggccgaggctagaccttctctgtccatttagGTGTGAAACCATTCCAGTGTAAAACTTGTCAGCGAAAGTTCTCCCGGTCCGACCACCTGAAGACCCACACCAGGACTCATACAG/GTAAAACAAgtgc(g>a)taaacttttcttcacatttatttttcattatttttttaaactattgtggaatgaaattgtgatgagagggattggaaaagactagtgtaaaagttctaaggtttagactcagttgagagaaggaatagtgcgtggctatctttaaataataaataataacattttttaaagaagg	NULL	Yes	NULL	In	71.18	6.68	-4.45	60.19	9.08	2.88	1.62	1.62	1.17	6.24	10.6	9	-1.4	-2.3	7	0.05	4	0.76	136680	ENSG00000184937	35	46	Wilms tumor 1
48	1	Human	164	WT1	68	Frasier syndrome	IVS9+6T>A	-9	NULL	Exon	0	tggggatcatcctaccctaacaagctccagcgaagtgccttaggcattttgggatctgttcagtcctagtaggagaggttgcctttaatgagatccccttttccagtatcattttcaaatagaatatgtgtcttccccaagGTGAGAAACCATACCAGTGTGACTTCAAGGACTGTGAACGAAGGTTTTCTCGTTCAGACCAGCTCAAAAGACACCAAAGGAGACATACAGgtttgtaggttcacttctcattgctggcagctgtgttcccttgggctagggttgatttcatgattctctttgttgttgaatatgaatgagagagtcagccatgtgtttagtttttccagtattttccccccataatctctggagatgttcctcctcttaaataaagaaaaagaaagaaaaggaaacaccccacatttcccctgcaaaccacagaacagtgagatcccactagcagtgggctgatgatacactgagcatcagcaaagaatgagggtgatggagagcggaatccaatttgtagcgtgtgattcacttttcctgtctctgacacagctgagatcttccagctggtgagaagctggacctctgtggttaaggaatggttgttcccaagacagaagcaggtccttgaagattactgtgcagaatcagtgattcttgttgggcctgggggactggggaaatctaagggtgaggcagatgcagacattgcaggcatggcaggaaatgctgggctcctccagctgccggaagtcagccttgtgggcctcactgtgcccacattgttagggccgaggctagaccttctctgtccatttagGTGTGAAACCATTCCAGTGTAAAACTTGTCAGCGAAAGTTCTCCCGGTCCGACCACCTGAAGACCCACACCAGGACTCATACAG/GTAAAACAAgtgcg(t>a)aaacttttcttcacatttatttttcattatttttttaaactattgtggaatgaaattgtgatgagagggattggaaaagactagtgtaaaagttctaaggtttagactcagttgagagaaggaatagtgcgtggctatctttaaataataaataataacattttttaaagaagg	NULL	Yes	NULL	In	71.18	6.68	-4.45	60.19	9.08	2.88	1.62	1.62	1.17	6.24	10.6	9	-1.4	-2.3	7	0.05	4	0.76	136680	ENSG00000184937	37	48	Wilms tumor 1
90	1	Human	64	FBN1	118	Marfan syndrome	IVS37+5G>T	-48	NULL	Exon	0	tgggtttgaattttcaaccccagtagaaagattctgcctgatgcttttgtgtttgtatatggtaaatagATACCCGCTCTGGAAATTGCTATTTGGATATTCGACCTCGAGGAGACAATGGAGATACAGCCTGCAGCAATGAAATTGGAGTTGGTGTTTCCAAAGCTTCCTGCTGCTGTTCTCTGG/GTAAAGCCTGGGGTACTCCTTGTGAGATGTGTCCTGCTGTGAACACATgtaa(g>t)tggacatcctcctatttattattatttcaactccagccagttctcctttctagatcagaagacaaaccttttctactcttagatcagagaagaaagatcagtcctctcagccctgtagaggggaccttattcccaattcgagagtcagaaaatattcctggttggctcacactaa	NULL	No	NULL	In	86.96	8.31	4.2	72.72	14.28	7.78	4.37	4.37	4.77	8.03	16.1	12	-4.2	-6	8	0.6	6	0.98	154700	ENSG00000166147	69	90	fibrillin 1
44	1	Human	153	TCIRG1	39	Congenital thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS)	IVS2+4A>T	-42	NULL	Exon	0	tggtaacagcagcttccaggattcagtgagtgaaggtgcacaggtgcccgtggttgggaactgtctgtggtctgcccctgactggcccccatccgtgtccacccacagGACCATGGGCTCCATGTTCCGGAGCGAGGAGGTGGCCCTGGTCCAGCTCTTTCTGCCCACAGCGGCTGCCTACACCTGC/GTGAGTCGGCTGGGCGAGCTGGGCCTCGTGGAGTTCAGAGACgtg(a>t)gttgggtgggcaggcgtgggaagggggctactgccaaggttagcccggaggccggtccaggatggggactgccccccctccgccatagggccctggccccatttgaaccccagcggcccctgccatgggcactgctcatgggaagcccgcagctgaggcccctgagctggctcctccccataccctcctggggcatggggtctggtctgtgctctgatctgcgtcttgtggctcccagggcactccacacctttctggaggaggcagctaaggcctggggagagtcaggcctgggctctagggtgaggagctccctgacccccttcccgggacactcacccctccgtgtggcacccacagCTCAACGC	NULL	No	NULL	In	81.03	9.22	7.55	71.48	12.58	10.58	4.52	4.52	6.58	7.95	12.5	12.1	-4.2	-4.2	7	0.97	6	0.92	274150	ENSG00000110719	33	44	"T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3"
19	1	Human	6	ARH	15	Autosomal recessive hypercholesterolemia	IVS4+2T>G	-78	NULL	Exon	0	tggtaagggttcagctattactgttttggggtgtggctcagtgtgggatgggagggagagggggaagtgccctgcttccagtctttaccccattccttccttcctgcctggcctgggcccctcctgcacagatggcctaggtacccagcctggaggccaaggctggattcccagagtctgccctggtggagtgggaatagcaggttctctgcaactcaggggagctgccctgcagggcttcccacatgtgctcaggcccctgtgccaggtctggtgatgcttcctccttgcctttcagGATCTCCTATTGCACAGCAGACAAGATGCACGACAAG/GTGTTTGCATACATCGCCCAGAGCCAGCACAACCAGAGCCTCGAGTGCCACGCCTTCCTCTGCACCAAGCGGAAGATGg(t>g)cagcggggagggctggggcggggacagggtccagtggccttggcagccttgctctgggtggggggctgtctggtgtgggaggcaggacccaaaggtgaccattacttaagaagagggtgaaatctctgggaaccccaagtgggtgccgagagctaaggggtacagtggtggggctgcaggcaggcaggtgaaccgccggtcagctttgtgtgggcagtagctggcccatgtccccagtgtgtgtctgggcctgttctctctgtaacgggatttgctgggttgagattgttttggatct	NULL	No	NULL	In	74.41	4.01	2.06	71.88	8.88	7.18	4.48	4.48	2.74	4.68	11.1	10.1	-3.1	-3.8	6	0.21	6	0.11	603813	ENSG00000157978	17	19	low density lipoprotein receptor adaptor protein 1
20	1	Human	6	ARH	15	Autosomal recessive hypercholesterolemia	IVS4+2T>G	-34	NULL	Exon	1	tggtaagggttcagctattactgttttggggtgtggctcagtgtgggatgggagggagagggggaagtgccctgcttccagtctttaccccattccttccttcctgcctggcctgggcccctcctgcacagatggcctaggtacccagcctggaggccaaggctggattcccagagtctgccctggtggagtgggaatagcaggttctctgcaactcaggggagctgccctgcagggcttcccacatgtgctcaggcccctgtgccaggtctggtgatgcttcctccttgcctttcagGATCTCCTATTGCACAGCAGACAAGATGCACGACAAGGTGTTTGCATACATCGCCCAGAGCCAGCACAACCAGAGCCTCGA/GTGCCACGCCTTCCTCTGCACCAAGCGGAAGATGg(t>g)cagcggggagggctggggcggggacagggtccagtggccttggcagccttgctctgggtggggggctgtctggtgtgggaggcaggacccaaaggtgaccattacttaagaagagggtgaaatctctgggaaccccaagtgggtgccgagagctaaggggtacagtggtggggctgcaggcaggcaggtgaaccgccggtcagctttgtgtgggcagtagctggcccatgtccccagtgtgtgtctgggcctgttctctctgtaacgggatttgctgggttgagattgttttggatct	NULL	No	NULL	In	74.41	4.01	-10.2	43.13	8.88	-0.42	-1.92	-1.92	0.87	4.68	11.1	4.5	-3.1	-2	6	0	5	0.11	603813	ENSG00000157978	17	20	low density lipoprotein receptor adaptor protein 1
179	1	Human	19	CDH1	147	Primary ciliary dyskinesia	IVS9+2_10delTTTGTATGGT	57	NULL	Intron	0	tgtaaatgacacatctctttgctctgcagTACAAGGGTCAGGTGCCTGAGAACGAGGCTAACGTCGTAATCACCACACTGAAAGTGACTGATGCTGATGCCCCCAATACCCCAGCGTGGGAGGCTGTATACACCATATTGAATGATGATGGTGGACAATTTGTCGTCACCACAAATCCAGTGAACAACGATGGCATTTTGAAAACAGCAAAGg(tttgtatggt)acctggcaagatgcagaaactggcatcctcacagctgttcatacccttgtcccctg/gtatcttcttagaagtagattcgctttggcagggggacagggtgactttcccagattgtagtggaccatgtgggatttgcagtggctcttcctgctcatgtaagaaatcaagaaactgtgctgtgtgtggtggctcacgcctgtaatcccagcacttagggacgctgaggcaggcagatcacgaggtcaggagtttgagtctctgctaaaaatacaaaaattagccaggcatggtggcacgtgcctgtaatctcagctactagggaggctgaggcaggagaattgcttgaacctgggaggtggaggttgcagtgagccaagatcgtgccattgcactccagctctgggtgacagagcaagactcagtctccaggggtgggcggggaaaaggaggccgggcgtggtggctcacgcctgtaatcatagcactttgggaggccaaggcgggcagatcacaaggtcaagagatcgagatcatcctgaccaacatggtgaaaccccatctctactaaaaatacaaaaattagctgggcatggtggtgtgcacctatagtcccagctactagggaggctgaggcaggagaatcgcttgaacctaggagagggaggttgcagtgagccaggatcgtgccactgcactccagcccggcaacagagtgagacttcgtctcaaaaaaaggaaatcaagaagctaaggcttcttggtggctcatggtggctcatgcctgcaatcccagcactttgggaggccgaggcgggcagatcacctgaggtcgggagtttgggaccagcctggccaacatggtgaaaacctgtctctaccaaaaatacaaaaattaactgggcgtggtggtgcacacttgtaatccctgctgcttgggaggctgaagcaggagaatcgcttgagcctggaagacagaggttgtagtgagccaagatcgtgctactgcaccctggcctgggcaacagagtgagactctgtctgaaaaaaaaaagaaatcaagaagctgttacacaggatcctgaaattgaaaaagaagtactatctgctttaataggctctttcccagaaacattctccttccctcagctctttccattttgcggtgacagagaaaatgatttactggtctctgctcttgtgctggtttattttagaagtggggcagatatggttgtttttgaaaaatgtcctagaaacttgaaaactagccaagcgcagtagtgtatggcggtgggcccaactacttgggaggctgaggtgggagaatcacttgagcccagggggttgaagctgcactcagctatgatcatgccactgtactccaacctgggcaatagaatgagactccatctcttaaaaaaaaaaaaaaaaaaagatggccgggtgcagttgctgatgtctgtaatcccaacactttgggaggccaaggcgggtggatcacctgaggtcaggagttcgagaccagcctggccaacatggtgaaacgtcgtctctactaaaaatacaaaaaattagccaggtgtggtggcgggctcctgtaatcccagctactagggaggctgaggcaggagaattgcttgaacccaggaggtggaggttgcagtgagccattgcattccagcctgggtgacaagagcaaaaattctgtctcagaaaaaaataaaataaggaaagaaacttgaaaactaagaatttgagtgaattgcttgttgaagtgactggatccctagaatagccccagctttgccttcctcttgagtaggtgagcagatttgagaagccatggtaagtaattgtggtttctgccattgaaagtcatggcagaaaccacagttacttttgcaccaacctaatatattaccaaaagcaacagttaaggatttaattttatttttactaacacaaaatgtttcgttttgtttttaacttcattgtttctgctctctagGGCTTGGATTTTGAGGCCAAGCAGCAGTACATTCTACACGTAGCAGTGACGAATGTGGTACCTTTTGAGGTCTCTCTCACCACCTCCACAGCCACCGTCACCGTGGATGTGCTGGATGTGAATGAAGCCCCCATCTTTGTGCCTCCTGAAAAGAGAGTGGAAGTGTCCGAGGACTTTGGCGTGGGCCAGGAAATCACATCCTACACTGCCCAGGAGCCAGACACATTTATGGAACAGAAAATAAC	NULL	No	NULL	In	79.01	7.81	2.7	67.68	11.58	6.98	4.26	4.26	3.86	6.11	14.5	10.4	-4.7	-2.6	8	0.2	8	0.92	242650	ENSG00000039068	143	179	"cadherin 1, type 1, E-cadherin (epithelial)"
193	1	Human	57	F7	58	Factor 7 deficiency	IVS7+2T>G	37	100	Intron	1	tgtcacgtcgtcctcacggttactctttgaggtgggatctttgcctgatctttgcaaaatcaggagcattggatcaaagctatgtgaagatcctgtgaggtgaacagtgaaatctcacagcgacatttgtattcttgggccgtgcccaagagcacgtctcggctagagaggggcacagcctcccagagccaggtctgagcagctttgcctgggagggatctgcaaagaccccaggatttcagaaagaaattgtgcaatgccagaggttccttggcatgcccgggagggcgagtcatcagagaaacaatgacagcaatgtgacttccacacctcctgtccccccgcccagGTCCTGTTGTTGGTGAATGGAGCTCAGTTGTGTGGGGGGACCCTGATCAACACCATCTGGGTGGTCTCCGCGGCCCACTGTTTCGACAAAATCAAGAACTGGAGGAACCTGATCGCGGTGCTGGg(t>g)gggtaccactctcccctgtccgaccgcggtgctgg/gtgggtgccactcttccctgtccgaccgcggtgctgggtgggtgccactctcccctgtccgaccgcggtgctgggtgggtgccactctcccctgtccgaccgcggtgctgggtgggtgccactctccgctgtccgaccgcggtgctgggtgggtaccactctcccctgtctgaccgcagctctcaagtgtctcaggggctgtggctctgggcttcgtgctgtcacttccacagacagacagacatccccaaaaggggagcaaccatgctgggcacgactgctgtggccaccgtgctctcagccactttcccatgcccaaataaaacgataaaagactgggggcttctgcccatcctg	NULL	No	NULL	In	74.71	3.82	3.82	74.71	9.48	9.48	5	5	5.02	5.02	13.7	12	-8.8	-8.8	8	0.17	8	0.44	227500	ENSG00000057593	153	193	coagulation factor VII (serum prothrombin conversion accelerator)
11	1	Human	156	TSC2	173	Tuberous sclerosis	IVS1+1G>A	-52	NULL	Exon	1	tgttgctcagatgtccccattcctgtttcgtttgcacagaggggttttctGGTGCGTCCTGGTCCACCATGGCCAAACCAACAAGCAAAGATTCAGGCTTGAAGGAGAAGTTTAAGATTCTGTTGGGACTGGGAACACCGAGGCCAAATCCCAG/GTCTGCAGAGGGTAAACAGACGGAGTTTATCATCACCGCGGAAATACTGAGA(g>a)tgagtgagctacctgtgtctttgctaggctagagggaaatgcagagaaggctgggtttggtcttgcaccaggttctgtgggagacgggttgctggcaactgtctacacaggaatgctgtctccagtacttggaggccgacatgtccttcctcaggagacttcgaaagtcaggatcttggtgacctggttcaggcacacttgagttactattcagatgttgatgaaagaaagcccatctt	NULL	No	NULL	In	72.86	7.36	5.61	72.91	10.98	8.58	4.39	4.39	4.56	6.86	12.1	11.8	-4.5	-3.3	6	0.17	7	0.82	191100	ENSG00000103197	9	11	tuberous sclerosis 2
206	1	Human	46	DMD	133	Muscular dystrophy	IVS26+2T>A	117	NULL	Intron	0	tgttttgtttgtttgttttgtggaagGTCTATGCCAGAAAGGAGGCCTTGAAGGGAGGTTTGGAGAAAACTGTAAGCCTCCAGAAAGATCTATCAGAGATGCACGAATGGATGACACAAGCTGAAGAAGAGTATCTTGAGAGAGATTTTGAATATAAAACTCCAGATGAATTACAGAAAGCAGTTGAAGAGATGAAGg(t>a)aaaaaaaaaaaaagaaaaactaagtaaaacaaaggaaataaatggaaaaagaaagaaatgcaacaatgcttgaagttgtatacagtctgctctttcctggttctaagagaagag/gttgatttttaattaataattttaatttagcttcaagtttaatatacattttaacaaccttaaactgtttaattttaatgcattgtggtcaattatgaaaattgaaaatcacaatttgaaacaa	Distance between authentic and aberrant 5'ss is 116 nt according to the sequence in Ensembl	No	NULL	In	82.16	8.38	1.52	66.51	13.28	3.98	1.09	1.09	2.13	7	14.1	10.1	-5.4	-2.6	6	0.04	6	0.91	181350	ENSG00000198947	162	206	dystrophin
225	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	IVS5+1delG	66	NULL	Intron	0	tgtttttaaaatttccattatgatgaaaatttcagtattacaggcttccaaatcccagcagatgggccacttgtttaaaggagagtttgatataataaagcatctaaaaacaagagtttggataattccttagggttgttatgatgtgatttgacttataattggaaataccgttttattcattgtactgattttcatttctctttttcttctagAATGTCTTGATTGTGGAA(g)taagttcacatttacttttaatataacatttatgacttttctaacttagtatgcaccatcctaaag/gtaagccagggagagaaattcctctgcatcagttttaatggtgggcttgtgttctaaaggagtgagattggttttttgtaaagactacttagtaatttgtttttaccaataatggaatggtatacttcctacctctctttttttagtttgaagtattttctttctaaacataactctctctctctatttatctatatataatatatacatatatatcttatattttatgtatatatatat	NULL	No	NULL	In	87.58	9.82	10.22	93.9	13.98	16.08	11.48	11.48	10.62	8.09	14.4	17.1	-4.2	-7.4	7	1	7	0.95	300322	ENSG00000165704	176	225	hypoxanthine phosphoribosyltransferase 1
227	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	IVS5+2T>C	67	NULL	Intron	1	tgtttttaaaatttccattatgatgaaaatttcagtattacaggcttccaaatcccagcagatgggccacttgtttaaaggagagtttgatataataaagcatctaaaaacaagagtttggataattccttagggttgttatgatgtgatttgacttataattggaaataccgttttattcattgtactgattttcatttctctttttcttctagAATGTCTTGATTGTGGAAg(t>c)aagttcacatttacttttaatataacatttatgacttttctaacttagtatgcaccatcctaaag/gtaagccagggagagaaattcctctgcatcagttttaatggtgggcttgtgttctaaaggagtgagattggttttttgtaaagactacttagtaatttgtttttaccaataatggaatgg	NULL	No	NULL	In	87.58	9.82	10.22	93.9	13.98	16.08	11.48	11.48	10.62	8.09	14.4	17.1	-4.2	-7.4	7	1	7	0.95	300322	ENSG00000165704	177	227	hypoxanthine phosphoribosyltransferase 1
228	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	IVS5+3_4AA>GT	67	NULL	Intron	1	tgtttttaaaatttccattatgatgaaaatttcagtattacaggcttccaaatcccagcagatgggccacttgtttaaaggagagtttgatataataaagcatctaaaaacaagagtttggataattccttagggttgttatgatgtgatttgacttataattggaaataccgttttattcattgtactgattttcatttctctttttcttctagAATGTCTTGATTGTGGAAgt(aa>gt)gttcacatttacttttaatataacatttatgacttttctaacttagtatgcaccatcctaaag/gtaagccagggagagaaattcctctgcatcagttttaatggtgggcttgtgttctaaaggagtgagattggttttttgtaaagactacttagtaatttgtttttaccaataatggaatgg	NULL	No	NULL	In	87.58	9.82	10.22	93.9	13.98	16.08	11.48	11.48	10.62	8.09	14.4	17.1	-4.2	-7.4	7	1	7	0.95	300322	ENSG00000165704	177	228	hypoxanthine phosphoribosyltransferase 1
229	1	Human	89	HPRT1	102	Hypoxanthine phosphoribosyltransferase deficiency	IVS5+5G>A	67	NULL	Intron	1	tgtttttaaaatttccattatgatgaaaatttcagtattacaggcttccaaatcccagcagatgggccacttgtttaaaggagagtttgatataataaagcatctaaaaacaagagtttggataattccttagggttgttatgatgtgatttgacttataattggaaataccgttttattcattgtactgattttcatttctctttttcttctagAATGTCTTGATTGTGGAAgtaa(g>a)ttcacatttacttttaatataacatttatgacttttctaacttagtatgcaccatcctaaag/gtaagccagggagagaaattcctctgcatcagttttaatggtgggcttgtgttctaaaggagtgagattggttttttgtaaagactacttagtaatttgtttttaccaataatggaatgg	NULL	No	NULL	In	87.58	9.82	10.22	93.9	13.98	16.08	11.48	11.48	10.62	8.09	14.4	17.1	-4.2	-7.4	7	1	7	0.95	300322	ENSG00000165704	177	229	hypoxanthine phosphoribosyltransferase 1
147	1	Human	75	GHR	78	Growth hormone insensitivity	E7+105C>T	-63	NULL	Exon	0	ttaagcaagtctatcatatctttgggtttatgccaaactaaatttgtgaactattatccatttacaaaatgattatttacatcaatcttcctttaaataacaaatgctcacaatgcattttaaaatattacctactttataaaaatccattctgaataaaaatgggagaatacctgtagtgttcattgcattgagttgttgactctttggccaatatgcgtttatattttgtcttgaaagATGGACCCTATATTGACAACATCAGTTCCAGTGTACTCATTGAAAGTGGATAAGGAATATGAAGTGCGTGTGAGATCCAAACAACGAAACTCTGGAAATTATG/G(C>T)GAGTTCAGTGAGGTGCTCTATGTAACACTTCCTCAGATGAGCCAATTTACATGTGAAGAAGgtaaaagaaataaaagattaaaatagtagctaacctggcttttgtcaatataacagttgattcacccctgcactggtagtgtgttgtccaaatcaaaatatattaacatcagatatcaggatgagagaccttgagctcactatctgtaacagatattgttcattgcaaaagcagaaggaagatttagtttccaaatttttcattcaggagaagtccggggggcaggtggaagtttagagacaggaatttggtggcaatctccggatggtagaattcagatgattcttttctttatatatt	NULL	No	2	Out	82.16	8.38	10.13	85.92	13.28	14.08	9.29	9.29	9.22	7	14.1	15.6	-5.4	-7.2	6	0.98	8	0.89	262500	ENSG00000112964	115	147	growth hormone receptor
194	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS6+1G>A	60	20	Intron	0	ttctaacacatagacagtattacattgcttgtctacttaccagaatgcatttgtgtagttgcttaaatgaagttccatgtttatcttttaaaaatgttgcccttgggtttttacatagtgtcagcttttactttaatgccagggattttgttcctatctaataatgtcatttaatatatttttcatgcagAATGTGCAGAAAAGCTATTTGACTTGGTGGATGGTTTTGCTGAAAGCACCAAACGTAAAGCAGCAGTTTGGCCACTACAAATCATTCTCCTTATCTTGTGTCCAGAAATAATCCAGGATATATCCAAAGACGTGGTTGATGAAAACAACATGAATAAG(g>a)taaggagggcaaaattatttccattatatctagatgtgaagcagtttattttactcaag/gtgtgtattactttaggcttattatttaagcaaagtatttcagggaatcatttaaattatcattttaggtttctttgtttgatggacttagaagagacatactcatacataattttatttggcagagggaaaataataccaggcaatgaacaaagatttaaaataatcccttagtttcattcttttgtctga	NULL	No	NULL	In	94.61	10.51	6.64	84.42	15.58	13.28	8.38	8.38	6.72	10.49	17.3	15.4	-8.6	-5.1	7	0.99	8	1	162200	ENSG00000196712	154	194	neurofibromin 1
113	1	Human	13	BTK	184	agammaglobulinemia	IVS8+1G>T	-136	100	Exon	1	ttgacaaaccctcctaccttttctcctaactacatagATCTTGAAAAAGCCACTACCGCCTGAGCCAGCAGCAGCACCAGTCTCCACAA/GTGAGCTGAAAAAGGTTGTGGCCCTTTATGATTACATGCCAATGAATGCAAATGATCTACAGCTGCGGAAGGGTGATGAATATTTTATCTTGGAGGAAAGCAACTTACCATGGTGGAGAGCACGAGATAAAAATGG(g>t)tgagtccacaccagcccttcctga	NULL	No	NULL	In	85.28	8.73	6.39	76.3	13.18	10.28	7.3	7.3	6.77	8.36	15.6	12.2	-9.3	-2.7	8	0.53	7	0.99	300300	ENSG00000010671	89	113	Bruton agammaglobulinemia tyrosine kinase
126	1	Human	7	ATM	14	Ataxia-telangiectasia	E55+77C>T	-64	NULL	Exon	1	ttgacgagagtatgtatctttgatgtatttcatttatgactgttttgtttgtatctgaggaattataatcattccattgtctagatttgtgcataaattctgtttttctctttgtttttctaactctgagaagtttaaatgttgggtagttccttatgtaatgttttttgttttttattaatagGATCGAACAGAGGCTGCAAATAGAATAATATGTACTATCAGAAGTAGGAGACCTCAGATGGTCAGAAGTGTTGAG/G(C>T)ACTTTGTGATGCTTATATTATATTAGCAAACTTAGATGCCACTCAGTGGAAGACTCAGAGAAgtatgttttttttaaagaagaaacgttactttcttgctgtgttactctctgtagagatatattagttatagagcctaataagtaaatctgcttaaaatcacaaacgtaatccaaaagcttaatttatatctgatggcttcagcattccctggttactttttcacttaatatctcttaatagaactggtaataggtgactacactaaattaattatttgatttcttctgataatcttctgg	NULL	No	2	Out	77.18	6.97	7.82	76.23	8.68	10.48	4.98	4.98	6.58	5.94	11.6	12.3	-1.8	-4.1	7	0.8	6	0.72	208900	ENSG00000149311	99	126	ataxia telangiectasia mutated
92	1	Human	83	HBB	19	Beta-thalassemia	IVS1+5G>A	-38	NULL	Exon	2	ttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAG/GTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGgttg(g>a)tatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	Minigene assay only	No	NULL	In	78.85	8.08	5.54	76.37	11.68	10.08	6.65	6.65	6.07	7.2	16.4	10.7	-7	-5.3	9	0.21	6	0.64	603902	ENSG00000221842	71	92	"hemoglobin, beta"
93	1	Human	83	HBB	19	Beta-thalassemia	IVS1+5G>A	-16	NULL	Exon	1	ttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTG/GTGAGGCCCTGGGCAGgttg(g>a)tatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	Minigene assay only	No	NULL	In	78.85	8.08	6.13	80.53	11.68	10.48	7.52	7.52	6.62	7.2	16.4	13.6	-7	-7	9	0.54	7	0.64	603902	ENSG00000221842	71	93	"hemoglobin, beta"
250	1	Human	83	HBB	19	Beta-thalassemia	IVS1+5G>A	12	NULL	Intron	0	ttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGgttg(g>a)tatcaag/gttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	NULL	No	NULL	In	78.85	8.08	-0.83	70.91	11.68	6.58	2.58	2.58	2.02	7.2	16.4	10.2	-7	-2.5	9	0.26	6	0.64	603902	ENSG00000221842	71	250	"hemoglobin, beta"
121	1	Human	154	TCN2	171	Transcobalamin deficiency	IVS3+2T>G	-81	NULL	Exon	0	ttggagcttttatcaaagtttcccactgttaagattttttcccgctttgtgatgcgggtggggtgggtgctgtaagcaggcttacggggtggcagtttctcacaaaggcattaactggccttgtcctagGTCTGCCTTCAGCGAGGATGACGGTGACTGCCAGGGCAAGCCTTCCATGGGCCAGCTGGCCCTCTACCTGCTCGCTCTCAGAGCCAACT/GTGAGTTTGTCAGGGGCCACAAGGGGGACAGGCTGGTCTCACAGCTCAAATGGTTCCTGGAGGATGAGAAGAGAGCCATTGg(t>g)gagcagacaccatccgctgggggtggggagcagctgggagggctcatcagatgatattctccaatgagaatcagaactttgggttttctccccaggcgtctttcccaccatccattctgcccatctcactgcctacgtagaggctcgaacctgtccccatagccatccttgacccagc	NULL	No	NULL	In	79.82	7.43	7.94	72.18	12.48	11.38	4.86	4.86	6.57	6.65	13.8	12.6	-5.8	-3.9	7	0.85	6	0.91	275350	ENSG00000185339	95	121	transcobalamin II
135	1	Human	84	HEXA	18	Beta-hexosaminidase deficiency	E8+167T>A	-17	NULL	Exon	2	ttgggagcaagggtagcacctgctagaagcagtgtgtccaggcaagagtgtgcgcactgacagttgtctggctggaacttagcctctgcctatgattgtggatatatttgtatctttttactgtgactaaatggtggtgactaccagtgtctgtgagtgcctaagtgtgcctacctaaatgtgtgtgatgtttatgaatacacttgtcttgctttgtgtgactcgtgtccttacgtgtaggactgtgcgtgggggtttatgtatttgtgacactcatatggggttttctcttggcttagGTATCCCTGGATTACTGACTCCTTGCTACTCTGGGTCTGAGCCCTCTGGCACCTTTGGACCAGTGAATCCCAGTCTCAATAATACCTATGAGTTCATGAGCACATTCTTCTTAGAAGTCAGCTCTGTCTTCCCAGATTTTTATCTTCATCTTGGAGGAGATGAG/GT(T>A)GATTTCACCTGCTGgtatgagccctttgatcttcccactgtggcctgatcagttgcttactcagaatagaagttagcacccgaggggctgcttagctcagctgctgctctcaggggtctgtatgggctcacattgctcaggtcttaggccttcctctgcccatctacgtagagatcctacctgattttggcaaggctttcactgtgaacctcttccttcctactctcatatccttgaggtattgatagaaaaaacagccctgggcacagaattgtcttggaaaagttcgggatagagaaaaataatccctgttt	NULL	No	3	Out	75.2	6.69	6.04	77.09	10.38	10.08	6.04	6.04	5.66	6.45	11.9	12.3	-2.6	-5.1	8	0.82	7	0.81	606869	ENSG00000213614	107	135	hexosaminidase A (alpha polypeptide)
139	1	Human	136	PTEN	40	Cowden's disease	E5+81C>G	-159	NULL	Exon	0	TTGTGCTGAAAGACATTATGACACCGCCAAATTTAATTGCAGAGgtaggtatgaatgtactgtactatgttgtataacttaaacccgatagactgtatcttactgtcataacaataatgagtcatccagattatcgagtgagatacatatttaagaattatctttaaaaatttcaaaaattttaattttactgttgtgttttaggaaaaagtattgcataaagctattaatattgtcaggaagactaaagtgcagcatagactaagaattaggaaaattcctagactaaaaatagtataaggagagggtttacctactatttgaggcagttggtctaatagtaagcaatcacagggagaaagcagaactacttaactcttctgtgttgaggaatgacataaaaggtaggaaaggatataacaaatgttgataagaggagtctgatggatgagaggagggaactgctttaaatgagtttctacttcagacataagttaattctcagagcccacaaaaactttcacttttatttgtgaaatacaactcagttctcatggcttaacactttaaaccatgagaaaactgaagagttgagaagcttggcagatgctgctgtgatagtcaaaaagaaagtgggtgccatgagctactattgatgtatttgccattgatccctcctgaaaatctagaatggactttcagacaaatggtttgaaaattctaaatcactaatgattgagatttagtataggtttactaagaacgggttttttttgtttttgtttttggtggatttaggctgttgcttactaagcaaagcaggctttagttgaggtttatcttgctttaaacagatatttaacagattttcctggaggtttttgtgtaccactgggaaaatgaagttaggcagatgactaagtgaaagctgtcctgctgactccttataatgatagtcattgtctaccagaagatctctcctgtcacaccaaaggataattgattatatcctgtaccatattatgagtcacctgattggagatataagacatacttctcacatatttagatgacacaggttagtacattgaatatcagccagggtttttaaggatcttaatagagtggaactaaggtagaaactattaagagcaattaatagtgatatatctatagtcctgtttctaaacaagtttttttaaaaacctcaactctgactatagtgaacagagaagtcttggactcttacaattcatgtgagaagacctgaaactttgataacaattatatacattttgtgagtaatttctttggtgtatgccttcacatatctctggtatgtgacctatgctgcagtccattgagcatagattcccagaatgtattctcctgcagaaaatggaggaaaataatacttggcttccctaatgattacatgtgtatacaacactaacatttgcaagaccacctttaaataacacacttagcatttttattttatgaaatgtaatatgtagttctttgcatagtttatcctattagtaatctattctgtctttggaatatgttttgtgatgatgaaataaatactataaatagtattattccttttgcattgagagtcctgacgaaatgtccatgtgacagttcattttgggtttagctctacctctaatatgtgacctatgctaccagtccgtatagcgtaaattcccagaatatatcctcctgaataaaatgggggaaaataatacctggcttccttaatgattatatttaagacttatcaagagactattttctatttaacaattagaaagttaagcaatacattatttttctctggaatccagtgtttcttttaaatacctgttaagtttgtatgcaacatttctaaagttacctacttgttaattaaaaattcaagagtttttttttcttattctgaggttatctttttaccacagTTGCACAATATCCTTTTGAAGACCATAACCCACCACAGCTAGAACTTATCAAACCCTTTTGTGAAGATCTTGACCAATGG/(C>G)TAAGTGAAGATGACAATCATGTTGCAGCAATTCACTGTAAAGCTGGAAAGGGACGAACTGGTGTAATGATATGTGCATATTTATTACATCGGGGCAAATTTTTAAAGGCACAAGAGGCCCTAGATTTCTATGGGGAAGTAAGGACCAGAGACAAAAAGgtaagttattttttgatgtttttcctttcctcttcctggatctgagaatttattggaaaacagattttgggtttctttttttccttcagttttattgaggtgtaattgacaagtaaaaattatatataaatacaatgtataatatgatgttttgatgtatgtgtatatacattgtgaaatgattactacagtcaaactacttaacatattcatcacctcacataattattattctccccccagggtgaaagcatttaagatctacaagctacaattttcaattatacaatgttattattaactatagtcactatgctgtccagtagagcttcagatcttgttcatcttgtgttcctccctccccaccctcagtccctggaaaacaggttttaaagatagttgctaatccttattt	NULL	No	1	Out	100	11	10.24	90.45	15.48	14.58	8.76	8.76	9.23	12.19	19.1	17	-8.8	-9.4	8	1	8	1	158350	ENSG00000171862	111	139	phosphatase and tensin homolog
143	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E25+17del11	-104	NULL	Exon	2	ttgtttaatgaaataggtagttcctaaggtttatatctgttagtaagaggtttatttgaggggaagtgaaagaacttgaaagattcatggtctctaaattttttttttttttttttttttttttcagAGATTTGGACCAG/GCA(AGCATGGAAGC)AGTAGTTTCACTTCTAGCTGGTCTCCCTCTGCAGCCTGAAGAAGGAGATGGTGTGGAATTGATGGAAGCCAAATCACAGTTATTTCTTAAgtaaatttcagtcaccaaaaaacataaagcaaaaagcaaataaagccccccaccacacaaaaaaagcaaagaaataatacccatgacaggactaggataggaaaataactgtgttttgtgatttttttaaagaaagtaatatgatcagtgaaattttgcttataataaaacccagattgcttcattaagtcatttacaaaagtgacattgtctaagctgtttggaccactaattttatatactaacattaaaagtgacacatttaccaggtaatattgcatctatttgatgctaatgtta	NULL	No	4	Out	75.23	1.48	3.1	82.16	4.58	7.32	5.32	5.32	4.99	1.81	9.6	NULL	-2.3	-5.6	7	NULL	8	0.13	162200	ENSG00000196712	38	143	neurofibromin 1
318	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS30+332A>G	-32768	NULL	Intron	-32768	tttaaaaatagttgatcatactttgtaacagaatcacaaattgtatgttatgaaaaaattttggaactataaggaaaaatacgttttaaaacaacttcatttgtgttttctcctagGTCAGCTGCCTATAATCTTCTGTGTGCCTTAACTTGTACCTTTAATTTAAAAATCGAGGGCCAGTTACTAGAGACATCAGGTTTATGTATCCCTGCCAACAACACCCTCTTTATTGTCTCTATTAGTAAGACACTGGCAGCCAATGAGCCACACCTCACGTTAGAATTTTTGGAAGAGTGTATTTCTGGATTTAGCAAATCTAgtaagtaatgataattttctttaatactaacaattattctaagagaattcaaagaaaaccctttcatttcagaattttccagtgaagactttcacttacatttttactttttttcctcttctgattttatatctgtggtatcctgtaactgaag/GAACTCTGAAGGAACTTTTTGGTAGGCCACATTGAGAAATCCACCAAAATTCTGATAATAAAAGCAAAGCGGCAAGAGTTTGGTACTTTACACACCTCTGGACCACTTACAAAGTATTTTCTTCACTGTTGCAGTTTAATTAGCTTCAGCATTTCTCTTCATAGCAGAAAAGTCCAC/(a>g)taagtatccatgttgcctccttaattttagagaactagtcattttctcttttctttaggttgactttgaacaatgaatttattgtaaatgtacagttcacggagagcacagtggcacataatacagggcccagagtcagttctgactttgttttaactaagtcttataaatttaatatccactctttatatttgtccatctttatatcctatagttttataaatgttgatcttctcccagcatatttcctgaccttttcttccctttc	Creates pseudoexon	No	1	Out	NULL	NULL	10.16	86.21	NULL	15.28	NULL	10.22	9.72	NULL	NULL	19.1	NULL	-4.3	NULL	1	8	NULL	162200	ENSG00000196712	38	318	neurofibromin 1
13	1	Human	44	CYP27A1	28	Cerebrotendinous xanthomatosis	E6+166C>A	-89	NULL	Exon	2	tttccagtgctttcatcctgttgggtttctctgtgttgccgtcccctcctccactgaaggtgcgattcttcatcatatcggccctcatcccactgtggattcatgtttagcatggagactgccatgaacctgcatgttttttcctgctaggctagtggcaaattcatttctcccacattttgcatacacccactcatacaccctcccattactggcctctttcctagaaatcgccctcacctgatctcccactctatcttctagACATCCAACACGCTGACATGGGCCCTGTACCACCTCTCAAAGGACCCTGAGATCCAGGAGGCCTTGCACGAGGAAGTG/GTGGGTGTGGTGCCAGCCGGGCAAGTGCCCCAGCACAAGGACTTTGCCCACATGCCGTTGCTCAAAGCTGTGCTTAAGGAGACTCTG(C>A)GgtaggacagaatgctgttctggggggcacaggatctctttgtggggagggaatcagaggaggaaatctgaagtgaagacaggtgggctggggctagtgacaaggatgagatgggagaggtaggggagaaggagtggggcactttgtacccccatgaatccagagcagactccagacattcttttccctgcagTCTCTACCCTGTGGTCCCCACAAACTCCCGGATCATAGAAAAGGAAATTGAAGTTGATGGCTTCCTCTTCCCCAAGAAC	NULL	No	NULL	In	74.34	6.86	4.29	75.36	9.78	9.18	6.08	6.08	4.98	7.63	11.9	13.1	-6	-6.7	6	0.05	8	0.29	213700	ENSG00000135929	11	13	"cytochrome P450, family 27, subfamily A, polypeptide 1"
14	1	Human	44	CYP27A1	28	Cerebrotendinous xanthomatosis	E6+167G>A	-89	42	Exon	2	tttccagtgctttcatcctgttgggtttctctgtgttgccgtcccctcctccactgaaggtgcgattcttcatcatatcggccctcatcccactgtggattcatgtttagcatggagactgccatgaacctgcatgttttttcctgctaggctagtggcaaattcatttctcccacattttgcatacacccactcatacaccctcccattactggcctctttcctagaaatcgccctcacctgatctcccactctatcttctagACATCCAACACGCTGACATGGGCCCTGTACCACCTCTCAAAGGACCCTGAGATCCAGGAGGCCTTGCACGAGGAAGTG/GTGGGTGTGGTGCCAGCCGGGCAAGTGCCCCAGCACAAGGACTTTGCCCACATGCCGTTGCTCAAAGCTGTGCTTAAGGAGACTCTGC(G>A)gtaggacagaatgctgttctggggggcacaggatctctttgtggggagggaatcagaggaggaaatctgaagtgaagacaggtgggctggggctagtgacaaggatgagatgggagaggtaggggagaaggagtggggcactttgtacccccatgaatccagagcagactccagacattcttttccctgcagTCTCTACCCTGTGGTCCCCACAAACTCCCGGATCATAGAAAAGGAAATTGAAGTTGATGGCTTCCTCTTCCCCAAGAAC	NULL	No	NULL	In	74.34	6.86	4.29	75.36	9.78	9.18	6.08	6.08	4.98	7.63	11.9	13.1	-6	-6.7	6	0.05	8	0.29	213700	ENSG00000135929	12	14	"cytochrome P450, family 27, subfamily A, polypeptide 1"
162	1	Human	92	IDS	96	"Mucopolysaccharidosis, type II"	E8+116C>T	-60	NULL	Exon	0	tttctgtggtaattccaagtgaatatttttcttctaggtgatgagtttctacttcctctggtttttacaacaggaaatgaaatggtatctaaaataaacaagctgtggtatgatgattattcattttctgtcattctgtgctttttatgaactagGGTGGGCTCTAGGTGAACATGGAGAATGGGCCAAATACAGCAATTTTGATGTTGCTACCCATGTTCCCCTGATATTCTATGTTCCTGGAAGGACGGCTTCACTTCCGGAGGCAG/G(C>T)GAGAAGCTTTTCCCTTACCTCGACCCTTTTGATTCCGCCTCACAGTTGATGGAGCCAGgtataaaatatgctgaaatgatattgcttgacagtaagatcacctttagtttatatgtgaaccactttattgaatcataggctttgggggttacacagacccccccttcctgccttgtgttggaatttcttctcaacattttgtggtcagcacacgctttctgagcatctcccatactct	NULL	No	2	Out	71.75	7.46	9.22	89.33	11.48	13.38	10.35	10.35	10.23	6.52	14	17.6	-4.9	-8.1	7	0.94	8	0.71	309900	ENSG00000010404	130	162	iduronate 2-sulfatase
45	1	Human	107	LPA	113	Lipoprotein A deficiency	IVS26+1G>A	-64	100	Exon	1	tttgtttgttttccagggttgaattaaaatatttatgactacttattaaatttctagaatcctataagtctatttgtatttttattctacatttcaatttgcatgctaatatagaagagtgtaaattgttaatcctcagattattccactttgtgtgtcataatttttttcacatttcccttttctaggcaatactgagcttgattttctcttttaatttcagCACCAACTGAAAACAGCACTGGGGTCCAGGACTGCTACCGAGGTGATGGACAGAGTTATCGAGGCACACTCTCCACCACTATCACAGGAAGAACAT/GTCAGTCTTGGTCGTCTATGACACCACATTGGCATCGGAGGATCCCATTATACTATCCAAATGC(g>a)tatgtctatcatgttagccataaaaggaacaatagtcaactaaaatttctcttagctggcccatgctacaagctcacttcctaggtccaaatttctcatagactcagagtttgtagcaaaatgtctcaggaaacttacttttgagcaaaaggtctgaatgaagagaagttttaggattgctatctttcataacaatttgatggaagcagcaggatatatggaggtggtgaagtctcattaatgtaaagctaaggagatcaaatgaccaaatgctgagacaaagtatcattccacaatgcccactaaaggtccatgcagtctttcaaccatgcaattctatcattctatcctccattccctgaagtgaaatttgtgtttgccatttttgacacgaatcagaagtaacaaattcaggctgggtgcagtggctcaggcctgtgatcccaacactttgggaggacaagacgggcagatc	NULL	No	NULL	In	66.26	5.09	2.02	76.37	7.18	6.88	4.44	4.44	0.32	5.23	11.2	9.5	-0.9	-1.4	6	0.53	7	0.66	152200	ENSG00000198670	34	45	"lipoprotein, Lp(a)"
169	1	Human	10	ATRX	30	Chronic myelomonocytic leukemia	IVS4+2T>C	43	NULL	Intron	1	ttttaatttttatttttttgcatctgtgttccttatgtggtagagaattagtttttgaagttccttttagaaaaatattctaggcacataaatagcatctcattatatcactgtattgaagttgctatagggaaatagctaattgtagggatgccgtttcgagaattttattcacttttatatttatgtctcacatctagGGAACTAGCTCTTCAGAAAAATCCAAGTCTTCAGGATCGTCACGATCAAAGAGg(t>c)tggttgatgttgaagggacaaaaagttattttctttttcag/gttattttctgtttctaaaaccatgtttttttctgaactcatgtcaaccactattctgagttaactattctatacaaatatacatatttgaaaatgattagcataatataatgaatccctttgtatctatcacctgatttcaacaattattattcat	NULL	No	NULL	In	78.85	6.36	3.49	76.87	11.28	6.98	4.22	4.22	2.75	6.23	11.7	12.1	-6.3	-3.3	8	0.1	8	0.76	300032	ENSG00000085224	136	169	alpha thalassemia/mental retardation syndrome X-linked
327	1	Human	39	CUBN	87	Hereditary megaloblastic anaemia 1	IVS23+881C>G	-32768	NULL	Intron	-32768	ttttcatgttcaggtaataaaagtctaggcttgtgaatttcagtacaaggcattattctttcattatcatcattttgaaagaatgtgtttaaaaagttatatttgcagtaaaagtaagttagcttatatgttactatctctccatgccactactttgagttaaattaggctaatcattctggtgggcatctatatcaaatgttttatttgggattttaaatctggaatcttatgtattataaatgttattctataatataaagtaaggtattaaaataataaatcataattggaccctatcgtgctaaaatgacataattttcttaatttacag/(3?ss1)CAGTTACTCACTGGACTTTGATGTTGAATAAATCCCTTTTTTGTTGTTTGTTTCAAAAAG/(3?ss2)CTACAGATTATAAACTAGAATTAAGGCCCCAGAAGTTTTTAGGAAAATGCTATTTCCAGAATTTTG/(c>g)taagtatatcaaatatgatatattacatttcaaaaatttccaaatcagaaggaaaacgttgaaagattctctgtaaaatacagcagtatgtttatatagttaatagtatagtttctttatcgtgttttctctgacacatttgccagaggctttattcgaaagggtgaagattaaacatattctctcagtttgtgattggttatataaaacaccataccagctatgaatgatggttattctttgttaagtcattcaaatatgatttttaaaaatttaaaagtgaaaatcgtgttttttagagtaagtgtagtgtttgagagaaattacttcatccaataaactgctaatgtttgcaatcccaaagttcaaattatgttaa	Creates pseudoexon	No	1	Out	NULL	NULL	10.47	91.1	NULL	15.08	NULL	9	9.09	NULL	NULL	20	NULL	-7.3	NULL	1	8	NULL	261100	ENSG00000107611	246	327	cubilin (intrinsic factor-cobalamin receptor)
29	1	Human	56	F5	57	Factor 5 deficiency	E10+215G>T	-35	NULL	Exon	2	ttttgcaatattaattggttccagcgaaagcttatttatttatttattatcatgaaataactttgcaaatgaaaacaattttgaatatattttctttcagGCAGGAACAACACCATGATCAGAGCAGTTCAACCAGGGGAAACCTATACTTATAAGTGGAACATCTTAGAGTTTGATGAACCCACAGAAAATGATGCCCAGTGCTTAACAAGACCATACTACAGTGACGTGGACATCATGAGAGACATCGCCTCTGGGCTAATAGGACTACTTCTAATCT/GTAAGAGCAGATCCCTGGACAGGCAAGGAATACA(G>T)gtattttgtccttgaagtaacctttcagaaattctgagaatttcttctggctagaacatgttaggtctcctggctaaataatggggcatttccttcaaga	NULL	No	NULL	In	77.05	7.51	4.08	71.86	10.78	8.68	3.23	3.23	4.67	6.62	14	12	-4.9	-2.6	8	0.33	5	0.67	227400	ENSG00000198734	24	29	"coagulation factor V (proaccelerin, labile factor)"
106	1	Human	111	MDR3 (ABCB4)	105	Intrahepatic cholestasis of pregnancy	IVS26+5G>A	-54	100	Exon	0	ttttttatacccttcttatagtttgtggactttggttttcagCTTCTCGATGGTCAAGAAGCAAAGAAACTCAATGTCCAGTGGCTCAGAGCTCAACTCGGAATCGTGTCTCAGGAGCCTATCCTATTTGACTGCAGCATTGCCGAGAATATTGCCTATGGAGACAACAGCCGGGTTGTATCACAGGATGAAATT/GTGAGTGCAGCCAAAGCTGCCAACATACATCCTTTCATCGAGACGTTACCCCACgtaa(g>a)ttaaagagtagctgaaatcagaagagactactttttatcccccaaacaattaccaaagttatgccaacaaaatcttgtaacaaaatatgttgatttactaacattaacaacttggacaaggcacttcaggataccaagcttccttatttgtaaatgggaatacattatgcctacctcatacaaatgtagtgagaagctcaaaaccaccatacttcaggttacagactggtggttg	NULL	No	NULL	In	86.21	10.16	7.35	72.88	15.28	10.78	5.17	5.17	5.98	9.72	16.1	12.1	-4.3	-3.9	8	0.89	6	0.99	147480	ENSG00000005471	82	106	"ATP-binding cassette, sub-family B (MDR/TAP), member 4"
347	1	Human	11	BRCA1	24	Breast cancer predisposition	IVS7+1G>A	-62	30	Exon	2	agtgttaaggtagaaaacaaggactctaaataactttgatggtctgtgtatttgtttttgtttcctaggagtaaaatttccagttgattttttaaaatttgatttttaaaaaaaatcacaggtaaccttaatgcattgtcttaacacaacaaagagcatacatagggtttctcttggtttctttgattataattcatacatttttctctaactgcaaacataatgttttcccttgtattttacagATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAA/GTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTG(g>a)taaaaccatttgttttcttcttcttcttcttcttcttttcttttttttttcttttttttttttgagatggagtcttgctctgtggcccaggctagaagcagtcctcctgccttagcccccttagtagctgggattacaggcacgcgccaccatgccaggctaattt	NULL	No	NULL	In	73.25	3.23	3.77	71.79	6.58	6.48	4.2	5.66	4.66	3.9	12	9.1	-3.9	-1.7	6	0.54	6	0.39	113705	ENSG00000012048	264	347	"breast cancer 1, early onset"
348	1	Human	11	BRCA1	24	Breast cancer predisposition	IVS16+6T>G	65	100	Intron	2	AGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTgtgag(t>g)gtatccatatgtatctccctaatgactaagacttaacaacattctggaaagagttttat/gtaggtattgtcaattaataacctagaggaagaaatctagaaaacaatcacagttctgtgtaatttaatttcgattactaatttctgaaaatttagatctagataaagctatagtgtggattattttatgtatat	NULL	No	NULL	In	72.88	5.91	2.16	76.39	9.88	8.18	3.5	4.55	3.22	4.98	13.2	14.3	-3.9	-3.8	6	0.35	8	0.66	113705	ENSG00000012048	264	348	"breast cancer 1, early onset"
350	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS39+332A>G	331	100	Intron	-32768	GTCAGCTGCCTATAATCTTCTGTGTGCCTTAACTTGTACCTTTAATTTAAAAATCGAGGGCCAGTTACTAGAGACATCAGGTTTATGTATCCCTGCCAACAACACCCTCTTTATTGTCTCTATTAGTAAGACACTGGCAGCCAATGAGCCACACCTCACGTTAGAATTTTTGGAAGAGTGTATTTCTGGATTTAGCAAATCTAgtaagtaatgataattttctttaatactaacaattattctaagagaattcaaagaaaaccctttcatttcagaattttccagtgaagactttcacttacatttttactttttttcctcttctgattttatatctgtggtatcctgtaactgaag/GAACTCTGAAGGAACTTTTTGGTAGGCCACATTGAGAAATCCACCAAAATTCTGATAATAAAAGCAAAGCGGCAAGAGTTTGGTACTTTACACACCTCTGGACCACTTACAAAGTATTTTCTTCACTGTTGCAGTTTAATTAGCTTCAGCATTTCTCTTCATAGCAGAAAAGTCCAC/(a>g)taagtatccatgttgcctccttaattttagagaactagtcattttctcttttctttaggttgactttgaacaatgaatttattgtaaatgtacagttcacggagagcacagtggcacataatacagggcccagagtcagttctgactttgttttaactaagtcttataaatttaatatccactctttatatttgtccatctttatatcctatagttttataaatgttgatcttctcccagcatatttcctgaccttttcttccctttcctttccctgtaatatataaaacttttttttctgcattcaaacacatttcttgacttttatatattagataattaaaagcttcagcaattcactaagactctttgtcaggtaagagatgtaggactataaccctaacaaaaaaatgtgtaggactgacaaaacaagaaaagtataaactttattcataaatattaatatgagagaagatttgagtgaatgtaaaggcatattgtgttcctgcatgaacagttcttcccagattattacaaatttaatgtaatttcatcaaaataaccatgg	Creates pseudoexon	No	NULL	Out	NULL	NULL	10.16	86.21	NULL	15.28	NULL	10.22	9.72	NULL	NULL	19.1	NULL	-4.3	NULL	1	8	NULL	162200	ENSG00000196712	265	350	neurofibromin 1
351	1	Human	66	FGB	35	Afibrinogenemia	IVS6+13C>T	11	90	Intron	2	GATGGACAGTGATTCAGAACCGTCAAGACGGTAGTGTTGACTTTGGCAGGAAATGGGATCCATATAAACAGGGATTTGGAAATGTTGCAACCAACACAGATGGGAAGAATTACTGTGGCCTACCAGgtaacgaacag/g(c>t)atgcaaaataaaatcattctatttgaaatgggattttttttaattaaaaaacattcattgttggaagcctgttttaggcagttaagaggagtttcctgacaaaaatgtggaagctaaagataagggaagaaaggcagtttttagtttcccaaaattttatttttggtgagattttattttgtttttcttttag	NULL	No	NULL	Out	81.6	10.52	9.37	83.49	13.68	12.48	8.3	8.9	9.03	8.77	15.8	15.7	-5.9	-4.9	7	0.98	8	0.94	202400	ENSG00000171564	21	351	fibrinogen beta chain
401	1	Human	172	FANCD2	64	Fanconi anaemia	IVS28+1G>A	27	NULL	Intron	0	AAAGGAAACAAAAAACAGATGGCAGCAAGACATCCTCCTCTGACACACTTTCAGAAGAGAAAAATTCAGAATGTGACCCTACGCCATCTCATAGAGGCCAGCTAAACAAG(g>a)tattggaatgatgggtatccgtgaag/gtttgtgacatcccagtgagattaacagaaacccagctttattctcggcattttacaaagaaaaaaaaattaggaaacagcgagccaaaactctcttaggcgttggagtaatctccttagtagcaaagttcagattagacttcaggtccttat		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	227650	ENSG00000144554	297	401	"Fanconi anemia, complementation group D2"
410	1	Human	190	SNF5/INI1	211	Rhabdoid tumors	IVS1+559A>G	559	100	Intron	1	AACGCCAGCGCCTGCGCACTGAGGGCGGCCTGGTCGTCGTCTGCGGCGGCGGCGGCGGCTGAGGAGCCCGGCTGAGGCGCCAGTACCCGGCCCGGTCCGCATTTCGCCTTCCGGCTTCGGTTTCCCTCGGCCCAGCACGCCCCGGCCCCGCCCCAGCCCTCCTGATCCCTCGCAGCCCGGCTCCGGCCGCCCGCCTCTGCCGCCGCAATGATGATGATGGCGCTGAGCAAGACCTTCGGGCAGAAGCCCGTGAAGTTCCAGCTGGAGGACGACGGCGAGTTCTACATGATCGGCTCCGAGgtagcccggggcgcgttctcgccctccccgggctcggccccgcgggagccccggggcgggcccatgcgccgagagcgcgcgtctccattcatcggggcgggcgggcgcgcgcgcgcgcgctcggggctgtggggcgtggcctagtgggcgtgtcgggtgtggcccccgccccctcatcgacctgggatttccttacttatttcgccgaggtccgccgccttcagtgctgccaagattttggcgccgcgaggggccccagtggttccgcgctgggttggtttccagtcagacgcaaagaaacgggatattgagttagcccctgcgacgcttgggggactgcactgctgcctttgaccctttttagatgtcgtaaatttcacgtgcacccctccccgtattgctacttgtgggaacctcaaatggcaggctggaaaccctggacttagtgagggctcatccccattgtgtttgttgcctcttag/GTGAGCAGTGGAGGTCTTTTGACCTTTGTTTACCGGTGAAGAAACAGATTGGAGGAAGATGTTTGCTTTTGG/gtga(a>g)taagggccccatgcctaagctagatctttcagcagttctgaagcgattgacactttccatatctgtgaactgattctgaattattacaggggaaagagcctaaggatgtttaacccttaactagagtggctgcattttgttgcatcaactggatgactgacttcaggaaaactctactggcctttgaatgggtgtttgttccaagtctattaggttcttgttttttgttttttatagagacagggtctggctatgttgcgcaggcaggtctccaactcctgggctcaagcagtctgcccgtctgggtctcccaaagtgctaggattacaggcatgagccaccacacccggccatatattaggtttttacagattgtctcaaactagccttttttgctccaaaggcagtccccagctagtatatgttacctttttaaaaaaa	Creates pseudoexon	No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	ENSG00000099956	304	410	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"
388	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E7+101C>T	-75	NULL	Exon	0	AAGTTATTTCTGGACAGTCTACGAAAAGCTCTTGCTGGCCATGGAGGAAGTAGGCAGCTGACAGAAAGTGCTGCAATTGCCTGTGTCAAACTGTGTAAA/G(C>T)AAGTACTTACATCAATTGGGAAGATAACTCTGTCATTTTCCTACTTGTTCAGTCCATGGTGGTTGATCTTAAGgtaacatgcttattctttctctactacaaactttaagaaaattaaatgaattttctagcataagtattatgtcaaagataattgctaacattaaagttctgactcttcgttgataagttc		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	162200	ENSG00000196712	282	388	neurofibromin 1
402	1	Human	167	B2M	122	Melanoma	IVS1+2T>A	27	NULL	Intron	0	AATATAAGTGGAGGCGTCGCGCTGGCGGGCATTCCTGAAGCTGACAGCATTCGGGCCGAGATGTCTCGCTCCGTGGCCTTAGCTGTGCTCGCGCTACTCTCTCTTTCTGGCCTGGAGGCTATCCAGCg(t>a)gagtctctcctaccctcccgctctg/gtccttcctctcccgctctgcaccctctgtggccctcgctgtgctctctcgctccgtgacttcccttctccaagttctccttggtggcccgccgtggggctagtccagggctggatctcggggaagcggcggggtggcctgggagtggggaagggggtgcgcacccgggacgcgcgctacttgcccctttcggcggggagcaggggagacctttggcctacggcgacgggagggtcgggacaaagtttagggcgtcgataagcgtcagagcgccgaggttgggggagggtttctcttccgctctttcgcggggcctctggctcccccagcgcagctggagtgggggacgggtaggctcgtcccaaaggcgcggcgctgaggtttgtgaacgcgtggaggggcgcttggggtctgggggaggcgtcgcccgggtaagcctgtctgctgcggctctgcttcccttagactggagagctgtggacttcgtctaggcgcccgctaagttcgcatgtcctagcacctctgggtctatgtggggccacaccgtggggaggaaacagcacgcgacgtttgtagaatgcttggctgtgatacaaagcggtttcgaataattaacttatttgttcccatcacatgtcacttttaaaaaattataagaactacccgttattgacatctttctgtgtgccaaggactttatgtgctttgcgtcatttaattttgaaaacagttatcttccgccatagataacta		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	109700	ENSG00000166710	298	402	beta-2-microglobulin
403	1	Human	167	B2M	122	Melanoma	IVS1+2T>A	407	NULL	Intron	2	AATATAAGTGGAGGCGTCGCGCTGGCGGGCATTCCTGAAGCTGACAGCATTCGGGCCGAGATGTCTCGCTCCGTGGCCTTAGCTGTGCTCGCGCTACTCTCTCTTTCTGGCCTGGAGGCTATCCAGCg(t>a)gagtctctcctaccctcccgctctggtccttcctctcccgctctgcaccctctgtggccctcgctgtgctctctcgctccgtgacttcccttctccaagttctccttggtggcccgccgtggggctagtccagggctggatctcggggaagcggcggggtggcctgggagtggggaagggggtgcgcacccgggacgcgcgctacttgcccctttcggcggggagcaggggagacctttggcctacggcgacgggagggtcgggacaaagtttagggcgtcgataagcgtcagagcgccgaggttgggggagggtttctcttccgctctttcgcggggcctctggctcccccagcgcagctggagtgggggacgggtaggctcgtcccaaaggcgcggcgctgag/gtttgtgaacgcgtggaggggcgcttggggtctgggggaggcgtcgcccgggtaagcctgtctgctgcggctctgcttcccttagactggagagctgtggacttcgtctaggcgcccgctaagttcgcatgtcctagcacctctgggtctatgtggggccacaccgtggggaggaaacagcacgcgacgtttgtagaatgcttggctgtgatacaaagcggtttcgaataattaacttatttgttcccatcacatgtcacttttaaaaaattataagaactacccgttattgacatctttctgtgtgccaaggactttatgtgctttgcgtcatttaattttgaaaacagttatcttccgccatagataacta		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	109700	ENSG00000166710	298	403	beta-2-microglobulin
390	1	Human	186	RHCE	212	Rh-deficiency syndrome	IVS4+1G>T	11	NULL	Intron	2	ACAGACTACCACATGAACCTGAGGCACTTCTACGTGTTCGCAGCCTATTTTGGGCTGACTGTGGCCTGGTGCCTGCCAAAGCCTCTACCCAAGGGAACGGAGGATAATGATCAGAGAGCAACGATACCCAGTTTGTCTGCCATGCTGG(g>t)taaggacaag/gtggggtgagtggtctcatacttgggctgagcagaatggctcagaaaaggctctggctgaaaaaatctccctcctttaccaacttcccctgggtgtctgaagcccttccatcatgattcacttctttgagtagtgtttgctaaattcatacctttgaattaagcacttccttttagggacctctcttcattaatatccactagaaaggagagactcattatgtgtgagtttcaataagtttatccaatccctttgttttcaactgaaaggagggaaacggacaagtgaa		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	111700	ENSG00000188672	292	390	"Rh blood group, CcEe antigens"
391	1	Human	186	RHCE	212	Rh-deficiency syndrome	IVS4+1G>T	15	NULL	Intron	0	ACAGACTACCACATGAACCTGAGGCACTTCTACGTGTTCGCAGCCTATTTTGGGCTGACTGTGGCCTGGTGCCTGCCAAAGCCTCTACCCAAGGGAACGGAGGATAATGATCAGAGAGCAACGATACCCAGTTTGTCTGCCATGCTGG(g>t)taaggacaaggtggg/gtgagtggtctcatacttgggctgagcagaatggctcagaaaaggctctggctgaaaaaatctccctcctttaccaacttcccctgggtgtctgaagcccttccatcatgattcacttctttgagtagtgtttgctaaattcatacctttgaattaagcacttccttttagggacctctcttcattaatatccactagaaaggagagactcattatgtgtgagtttcaataagtttatccaatccctttgttttcaactgaaaggagggaaacggacaagtgaa		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	111700	ENSG00000188672	292	391	"Rh blood group, CcEe antigens"
355	1	Human	44	CYP27A1	28	Cerebrotendinous xanthomatosis	IVS6+1G>A	-89	NULL	Exon	2	ACATCCAACACGCTGACATGGGCCCTGTACCACCTCTCAAAGGACCCTGAGATCCAGGAGGCCTTGCACGAGGAAGTG/GTGGGTGTGGTGCCAGCCGGGCAAGTGCCCCAGCACAAGGACTTTGCCCACATGCCGTTGCTCAAAGCTGTGCTTAAGGAGACTCTGCG(g>a)taggacagaatgctgttctggggggcacaggatctctttgtggggagggaatcagaggaggaaatctgaagtgaagacaggtgggctggggctagtgacaaggatgagatgggagaggtaggggagaaggagtggggcactttgtacccccatgaatccagagcagactccagacattcttttccctgcag		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	213700	ENSG00000135929	268	355	"cytochrome P450, family 27, subfamily A, polypeptide 1"
385	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E19B+81T>A	-40	NULL	Exon	1	AGATTTGGACCAGGCAAGCATGGAAGCAGTAGTTTCACTTCTAGCTGGTCTCCCTCTGCAGCCTGAAGAAGGAGATG/GTG(T>A)GGAATTGATGGAAGCCAAATCACAGTTATTTCTTAAgtaaatttcagtcaccaaaaaacataaagcaaaaagcaaataaagccccccaccacacaaaaaaagcaaagaaataatacccatgacaggactaggataggaaaataactgtgttttgtg		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	162200	ENSG00000196712	282	385	neurofibromin 1
392	1	Human	170	DFNA1	197	"Deafness, nonsyndromic"	IVS25+1G>T	4	NULL	Intron	1	AGGGCGATGAGACAGGTGTGATGGACAGTCTTCTAGAAGCCCTGCAGTCAGGGGCAGCATTCCGACGGAAGAGAGGGCCCCGTCAAG(g>t)taa/gtaagcacatggagctcatcctgggtgtcgaagggggtgagggctctctactcctgccagtctgcggctaaagagcaaataatgatgctctaagcatctttttagtccctgcatccagaacggattatctagtcctcttcttcccatgttacagagtagcgacttagaaaactggggtttaagggactggcaataaatcagttacattggattatgccgcatttctccccactcttgaagcagatatttggaacaaaggaactgagctgcaggacccagggatttgagttggcatt		Yes	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	602121	ENSG00000131504	293	392	diaphanous homolog 1 (Drosophila)
404	1	Human	189	SLC12A3	200	Gitelman syndrome	E15+100G>A	100	32	Intron	1	AGGTAAATTGGGGCTCCTCGGTACAGGCTGGCTCCTACAACCTGGCCCTCAGCTACTCGGTGGGCCTCAATGAGGTGGAAGACCACATCAAGAACTACC(G>A)gtgagcagagctgctgggacccacctgggaccccagggccagtgatggctccaccctgggagtttccaagcctagacctgtcacctgacccaggcagacccagg/gtatgtgcagcctccactcagagagggaacagacatggaggagccacccagccaccacaagacaggggtggacatatcctgatggggaccaagcaagtcaaggggcctctccatgccttggtttccacagtggaaa		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	263800	ENSG00000070915	299	404	"solute carrier family 12 (sodium/chloride transporters), member 3"
366	1	Human	183	p67-PHOX	29	Chronic granulomatous disease	IVS4+1G>A	-4	NULL	Exon	1	ATATGATTTGGCTATCAAAGACCTTAAAGAAGCCTTGATTCAGCTTCGAGGGAACCAGCTGATAGACTATAAGATCCTGGGGCTCCAGTTCAAGCTGTTTGCCT/GTGAG(g>a)taaggagaacagggcctggcctgggcaggaggggatcatggctggatggatggctgacagttcagatgcacagtgatctgttgacacctccaggagcttggaaaagccattttgcctcc		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	233710	ENSG00000116701	279	366	neutrophil cytosolic factor 2
365	1	Human	171	EPB41	198	Elliptocytosis	E20+81G>A	-71	100	Exon	2	atctcagcctcccaaagtgttgagattacaagtgtgaaccactaaacctggcctctttttctttttttttaattcttgttatatcgctgatctcatatgacatcttctctttggttccagACTGTAAAAG/GTGGGATTTCAGAGACACGTATTGAAAAGAGAATTGTGATCACAGGAGATGCTGATATTGACCATGATCA(G>A)gtgggaatgttgaagagatctgggcctgggaggggtccctgggcaggaagaccgatgaatacaggagtttgtttgccatcttcatctgcaaaaagcctctttggccactctagctcttaa		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	130500	ENSG00000159023	278	365	"erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked)"
407	1	Human	104	LDLR	61	Familial hypercholesterolemia	IVS12+11C>G	11	50	Intron	2	ATCTCCTCAGTGGCCGCCTCTACTGGGTTGACTCCAAACTTCACTCCATCTCAAGCATCGATGTCAACGGGGGCAACCGGAAGACCATCTTGGAGGATGAAAAGAGGCTGGCCCACCCCTTCTCCTTGGCCGTCTTTGAGgtgtggctta(c>g)/gtacgagatgcaagcacttaggtggcggatagacacagactatagatcactcaagccaagatgaacgcagaaaactggttgtgactaggaggaggtcttagacctgagttatttctattttcttctttctttttttttttttttttgagacagagttttgctctcgtttcccaggctggagggcaatggcatgatctcggctcaccgcaacctccacctcccaggttca		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	144010	ENSG00000130164	301	407	low density lipoprotein receptor
362	1	Human	181	MUT	203	Methylmalonic acidemia	E10+132G>A	-62	40	Exon	2	ATGTACAGTGGGAGAAATCACAGATGCCCTGAAAAAGGTATTTGGTGAACATAAAGCGAATGATCGAATG/GTGAGTGGAGCATATCGCCAGGAATTTGGAGAAAGTAAAGAGATAACATCTGCTATCAAGA(G>A)gtaatatgtaaggtttcttaggccagaatttcatcttttctgttagcacaatccccttgaatctactgggagcttaatttccttacatacaactgagaaaatttttgaattttataataataaatagtaaattaaatattaattatatagactatataacatataatagagtatataatttattcattacatataatatataattagaaatatatcatacatgatacatattatatatct		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	251000	ENSG00000146085	275	362	methylmalonyl CoA mutase
393	1	Human	181	MUT	203	Methylmalonic acidemia	E10+132G>A	7	10	Intron	1	ATGTACAGTGGGAGAAATCACAGATGCCCTGAAAAAGGTATTTGGTGAACATAAAGCGAATGATCGAATGGTGAGTGGAGCATATCGCCAGGAATTTGGAGAAAGTAAAGAGATAACATCTGCTATCAAGA(G>A)gtaatat/gtaaggtttcttaggccagaatttcatcttttctgttagcacaatccccttgaatctactgggagcttaatttccttacatacaactgagaaaatttttgaattttataataataaatagtaaattaaatattaattatatagactatataacatataatagagtatataatttattcattacatataatatataattagaaatatatcatacatgatacatattatatatct		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	251000	ENSG00000146085	275	393	methylmalonyl CoA mutase
400	1	Human	188	SGCB	133	Muscular dystrophy	IVS2+3delGAGT	6	NULL	Intron	0	CAAAGTTCCAATGGTCCTGTAAAGAAGTCCATGCGTGAGAAGGCTGTTGAGAGAAGGAGTGTCAATAAAGAGCACAACAGTAACTTTAAAGCTGGATACATTCCGATTGATGAAGATCGTCTCCACAAAACAGGGTTGAGAGGAAGAAAGGGCAATTTAGCCATCTGTGTGATTATCCTCTTGTTTATCCTGGCTGTCATCAATTTAATAgt(gagt)attt/gtaagaatactcattttaattgccatggggaattttttatctgctttatagtgaaatcatagactttattttctccttttctatacatgtcttgtctcttactgaattttaatgaatactttattaaaaaaactagtgtgctaatattttcatatattaatttcatttacaaaaaaatgtgcatgggtttatccctttaatggacttaatttttagcaaggatagaatta		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	181350	ENSG00000163069	296	400	"sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)"
364	1	Human	92	IDS	205	"Mucopolysaccharidosis, type II"	E3+1G>C	-22	NULL	Exon	1	CAAGCAGTGTGCGCCCCGAGCCGCGTTTCTTTCCTCACTGGCAGGAGACCTGACACCACCCGCCTGTACGACTTCAACTCCTACTGGAGGGTGCACGCTGGAAACTTCTCCACCATCCCCCAGTACTTCAAGGAGAATGGCTATGTGACCATGTCG/GTGGGAAAAGTCTTTCACCCTG(g>c)tactgctccatgtccagagtctgggttctcttggtttgtggtgtctgaatccagcattcccatcctggggatggggctgtctttgcagagccctcttctggctgggcgagtccctcgctagtcagtgcttcctttctaaaaaactgacttgtcaacccagccacgttttcacccaaagtgaaaaagggtagaaagagctttgcttcctttcagaaaccactgagggtgtgctgttgggtctttcagctcctcgggtggtagggaggacacaggctggggaggtggcagtgttgggtggagtccagctcagggccccaccctctcccctgcagggtacctgtcagtaaacctaggggtggggtgaggacacctgagggcctcccgtgtggccagcattgctgttgctgacttattgcccaatgagggggctgtgcttaggtaggggctgctatccactctggaaattaagtcagaaagatgagtgtaatctggtacccaggatctatagggtcccagagacggacattccttacctcaaatgctgcctgataaactggctctctttaatgccaatatggggatagtgaaaagcaaacaaactttaaaactttttatttatagaagtaatgcatgagtatttgagaaaaaaaatggagaaaaaagtattggaagacaagagcaccatagggacaataatgcttatcatttgggaatgacgaatgttttcagtctctttccctttgctcagtggttacaccggcaggcttggcagccttctgcaggagctcagctggccagcccaggttgagagtgacattcagctctactaagtcaggccagtttcagaggtgaacctgtcaggaatcatattgcacagccaaaagtccagtgtcaggagaactttctgcagtttggtgttctcattaccataccccttgcccaaatgcagctggagggaagtgatgattttggagagaggaggaaacacagcagagggaggagattgtgctttgggaggggaaaccaggcaaggactgagtgatgttgcttgacctcctccctcctgatgattggattttggcaccaggctctaagcaccatgtccttctcagagaataaacctttccctgcagcccttgtgggaacacatttttcagctgaatctttgttctcaagacctttttctgttagcattgggcctgcttcaagatgacagtagccaccactgtgtgccaggtatgtaccgtttaccatgctggccactcctttaatcctcccaacagcaagcaaggtgggtttttatcatcatcatcatttcccaaggaagacatgaaggctcatgggagtcaagtagcttgccagaggttgcaaggatgctaagaggcagcatcaggatttggacctgtggttgttggcttcctgtgtgctctttccacagtgcttgctgtcttcataggccctccacccgctgccctctttctctccattcctgtctcttctggtactccctatgggagtcccactgtgtgactgctgctgatgctttctcacgaggttctgcctgtgatcccctccactcccagctaaccactataggcagcacttcccttcagatccctcacaggcctcactggctcctagaagtcctccctgccagtcctcacctgactcacaataacctctgtgcttggaggatcccccacttggcacttcgatgcttttgaaagctggaagtccttccttggtttccagtgctgttatactgtcttcacaaataaactataaactactaagcttaagggtgggtttctgcttcatgaatgagcacttgaacttggaattctaaaacaaggttttgagtcctggctcccttatctaatatctggttagcataggtaagtcacataccttccctgagcctccctctcctgcccccatcggctccctgatggtgctgatgcctctgctgcctccttcatagggtgagagataggtttcagcatgggctctaaggagctgactgatcttgtccttgtgggtcccttccacagagcctagcacaaatcatcagggcttagggaccaggaagtcagatgcttagttctcaaatagaaactagagagtttggctttagaggggacttttgtagatgaggaaactgagccccaaagaagggaggttccacttgcccatttgtttacagagttttaattatggggagtggggtgttgaaagactcatcatgttttaacaacctttttttttttccaag		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	309900	ENSG00000010404	277	364	iduronate 2-sulfatase
397	1	Human	92	IDS	205	"Mucopolysaccharidosis, type II"	E3+1G>C	1237	NULL	Intron	1	CAAGCAGTGTGCGCCCCGAGCCGCGTTTCTTTCCTCACTGGCAGGAGACCTGACACCACCCGCCTGTACGACTTCAACTCCTACTGGAGGGTGCACGCTGGAAACTTCTCCACCATCCCCCAGTACTTCAAGGAGAATGGCTATGTGACCATGTCGGTGGGAAAAGTCTTTCACCCTG(g>c)tactgctccatgtccagagtctgggttctcttg/gtttgtggtgtctgaatccagcattcccatcctggggatggggctgtctttgcagagccctcttctggctgggcgagtccctcgctagtcagtgcttcctttctaaaaaactgacttgtcaacccagccacgttttcacccaaagtgaaaaagggtagaaagagctttgcttcctttcagaaaccactgagggtgtgctgttgggtctttcagctcctcgggtggtagggaggacacaggctggggaggtggcagtgttgggtggagtccagctcagggccccaccctctcccctgcagggtacctgtcagtaaacctaggggtggggtgaggacacctgagggcctcccgtgtggccagcattgctgttgctgacttattgcccaatgagggggctgtgcttaggtaggggctgctatccactctggaaattaagtcagaaagatgagtgtaatctggtacccaggatctatagggtcccagagacggacattccttacctcaaatgctgcctgataaactggctctctttaatgccaatatggggatagtgaaaagcaaacaaactttaaaactttttatttatagaagtaatgcatgagtatttgagaaaaaaaatggagaaaaaagtattggaagacaagagcaccatagggacaataatgcttatcatttgggaatgacgaatgttttcagtctctttccctttgctcagtggttacaccggcaggcttggcagccttctgcaggagctcagctggccagcccaggttgagagtgacattcagctctactaagtcaggccagtttcagaggtgaacctgtcaggaatcatattgcacagccaaaagtccagtgtcaggagaactttctgcagtttggtgttctcattaccataccccttgcccaaatgcagctggagggaagtgatgattttggagagaggaggaaacacagcagagggaggagattgtgctttgggaggggaaaccaggcaaggactgagtgatgttgcttgacctcctccctcctgatgattggattttggcaccaggctctaagcaccatgtccttctcagagaataaacctttccctgcag/CCCTTGTGGGAACACATTTTTCAGCTGAATCTTTGTTCTCAAGACCTTTTTCTGTTAGCATTGGGCCTGCTTCAAGATGACAGTAGCCACCACTGTGTGCCAG/gtatgtaccgtttaccatgctggccactcctttaatcctcccaacagcaagcaaggtgggtttttatcatcatcatcatttcccaaggaagacatgaaggctcatgggagtcaagtagcttgccagaggttgcaaggatgctaagaggcagcatcaggatttggacctgtggttgttggcttcctgtgtgctctttccacagtgcttgctgtcttcataggccctccacccgctgccctctttctctccattcctgtctcttctggtactccctatgggagtcccactgtgtgactgctgctgatgctttctcacgaggttctgcctgtgatcccctccactcccagctaaccactataggcagcacttcccttcagatccctcacaggcctcactggctcctagaagtcctccctgccagtcctcacctgactcacaataacctctgtgcttggaggatcccccacttggcacttcgatgcttttgaaagctggaagtccttccttggtttccagtgctgttatactgtcttcacaaataaactataaactactaagcttaagggtgggtttctgcttcatgaatgagcacttgaacttggaattctaaaacaaggttttgagtcctggctcccttatctaatatctggttagcataggtaagtcacataccttccctgagcctccctctcctgcccccatcggctccctgatggtgctgatgcctctgctgcctccttcatagggtgagagataggtttcagcatgggctctaaggagctgactgatcttgtccttgtgggtcccttccacagagcctagcacaaatcatcagggcttagggaccaggaagtcagatgcttagttctcaaatagaaactagagagtttggctttagaggggacttttgtagatgaggaaactgagccccaaagaagggaggttccacttgcccatttgtttacagagttttaattatggggagtggggtgttgaaagactcatcatgttttaacaacctttttttttttccaag	Creates pseudoexon and activates a cryptic site +34	No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	309900	ENSG00000010404	277	397	iduronate 2-sulfatase
396	1	Human	92	IDS	205	"Mucopolysaccharidosis, type II"	E3+1G>C	34	NULL	Intron	1	CAAGCAGTGTGCGCCCCGAGCCGCGTTTCTTTCCTCACTGGCAGGAGACCTGACACCACCCGCCTGTACGACTTCAACTCCTACTGGAGGGTGCACGCTGGAAACTTCTCCACCATCCCCCAGTACTTCAAGGAGAATGGCTATGTGACCATGTCGGTGGGAAAAGTCTTTCACCCTG(g>c)tactgctccatgtccagagtctgggttctcttg/gtttgtggtgtctgaatccagcattcccatcctggggatggggctgtctttgcagagccctcttctggctgggcgagtccctcgctagtcagtgcttcctttctaaaaaactgacttgtcaacccagccacgttttcacccaaagtgaaaaagggtagaaagagctttgcttcctttcagaaaccactgagggtgtgctgttgggtctttcagctcctcgggtggtagggaggacacaggctggggaggtggcagtgttgggtggagtccagctcagggccccaccctctcccctgcagggtacctgtcagtaaacctaggggtggggtgaggacacctgagggcctcccgtgtggccagcattgctgttgctgacttattgcccaatgagggggctgtgcttaggtaggggctgctatccactctggaaattaagtcagaaagatgagtgtaatctggtacccaggatctatagggtcccagagacggacattccttacctcaaatgctgcctgataaactggctctctttaatgccaatatggggatagtgaaaagcaaacaaactttaaaactttttatttatagaagtaatgcatgagtatttgagaaaaaaaatggagaaaaaagtattggaagacaagagcaccatagggacaataatgcttatcatttgggaatgacgaatgttttcagtctctttccctttgctcagtggttacaccggcaggcttggcagccttctgcaggagctcagctggccagcccaggttgagagtgacattcagctctactaagtcaggccagtttcagaggtgaacctgtcaggaatcatattgcacagccaaaagtccagtgtcaggagaactttctgcagtttggtgttctcattaccataccccttgcccaaatgcagctggagggaagtgatgattttggagagaggaggaaacacagcagagggaggagattgtgctttgggaggggaaaccaggcaaggactgagtgatgttgcttgacctcctccctcctgatgattggattttggcaccaggctctaagcaccatgtccttctcagagaataaacctttccctgcagcccttgtgggaacacatttttcagctgaatctttgttctcaagacctttttctgttagcattgggcctgcttcaagatgacagtagccaccactgtgtgccaggtatgtaccgtttaccatgctggccactcctttaatcctcccaacagcaagcaaggtgggtttttatcatcatcatcatttcccaaggaagacatgaaggctcatgggagtcaagtagcttgccagaggttgcaaggatgctaagaggcagcatcaggatttggacctgtggttgttggcttcctgtgtgctctttccacagtgcttgctgtcttcataggccctccacccgctgccctctttctctccattcctgtctcttctggtactccctatgggagtcccactgtgtgactgctgctgatgctttctcacgaggttctgcctgtgatcccctccactcccagctaaccactataggcagcacttcccttcagatccctcacaggcctcactggctcctagaagtcctccctgccagtcctcacctgactcacaataacctctgtgcttggaggatcccccacttggcacttcgatgcttttgaaagctggaagtccttccttggtttccagtgctgttatactgtcttcacaaataaactataaactactaagcttaagggtgggtttctgcttcatgaatgagcacttgaacttggaattctaaaacaaggttttgagtcctggctcccttatctaatatctggttagcataggtaagtcacataccttccctgagcctccctctcctgcccccatcggctccctgatggtgctgatgcctctgctgcctccttcatagggtgagagataggtttcagcatgggctctaaggagctgactgatcttgtccttgtgggtcccttccacagagcctagcacaaatcatcagggcttagggaccaggaagtcagatgcttagttctcaaatagaaactagagagtttggctttagaggggacttttgtagatgaggaaactgagccccaaagaagggaggttccacttgcccatttgtttacagagttttaattatggggagtggggtgttgaaagactcatcatgttttaacaacctttttttttttccaag		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	309900	ENSG00000010404	277	396	iduronate 2-sulfatase
373	1	Human	51	ELA2	161	Severe congenital neutropenia	E4+192C>A	-42	NULL	Exon	0	cactctacagatggggaaaccgaggcttgccttggggagcagagtgtggggtgggtatcctgccctgcaggatcccagaaccacagtggaacctgagatggggaaactgaggcccggagaggggagggtcatcatcactgccccgtgtgacgcgctgacgatctgtccccaccgccacagCTCAACGGGTCGGCCACCATCAACGCCAACGTGCAGGTGGCCCAGCTGCCGGCTCAGGGACGCCGCCTGGGCAACGGGGTGCAGTGCCTGGCCATGGGCTGGGGCCTTCTGGGCAGGAACCGTGGGATCGCCAGCGTCCTGCAGGAGCTCAACGTGACGGTGGTGACGTCCCTCTGCCGTCGCAGCAAC/GT(C>A)TGCACTCTCGTGAGGGGCCGGCAGGCCGGCGTCTGTTTCgtacgtgccctgggtgtccctctgctccccacccgctcccagcccggactgcagcaacaggcaccgtggctagaccctaggagggacttcccaaccctgacaggcggcgggcaggtgggcagggcctcgcagtccagcttccccaccttgtctgcctccacag		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	202700	ENSG00000197561	267	373	"elastase, neutrophil expressed"
372	1	Human	51	ELA2	161	Severe congenital neutropenia	E4+ins5T	-35	NULL	Exon	2	cactctacagatggggaaaccgaggcttgccttggggagcagagtgtggggtgggtatcctgccctgcaggatcccagaaccacagtggaacctgagatggggaaactgaggcccggagaggggagggtcatcatcactgccccgtgtgacgcgctgacgatctgtccccaccgccacagCTCAACGGGTCGGCCACCATCAACGCCAACGTGCAGGTGGCCCAGCTGCCGGCTCAGGGACGCCGCCTGGGCAACGGGGTGCAGTGCCTGGCCATGGGCTGGGGCCTTCTGGGCAGGAACCGTGGGATCGCCAGCGTCCTGCAGGAGCTCAACGTGACGGTGGTGACGTCCCTCTGCCGTCGCAGCAACGTCTGCACTCTC/GTGAGGGGCCGGCAGGCCGGC[TTTTT]GTCTGTTTCgtacgtgccctgggtgtccctctgctccccacccgctcccagcccggactgcagcaacaggcaccgtggctagaccctaggagggacttcccaaccctgacaggcggcgggcaggtgggcagggcctcgcagtccagcttccccaccttgtctgcctccacag		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	202700	ENSG00000197561	267	372	"elastase, neutrophil expressed"
353	1	Human	51	ELA2	161	Severe congenital neutropenia	IVS4+3A>T	-30	NULL	Exon	0	cactctacagatggggaaaccgaggcttgccttggggagcagagtgtggggtgggtatcctgccctgcaggatcccagaaccacagtggaacctgagatggggaaactgaggcccggagaggggagggtcatcatcactgccccgtgtgacgcgctgacgatctgtccccaccgccacagCTCAACGGGTCGGCCACCATCAACGCCAACGTGCAGGTGGCCCAGCTGCCGGCTCAGGGACGCCGCCTGGGCAACGGGGTGCAGTGCCTGGCCATGGGCTGGGGCCTTCTGGGCAGGAACCGTGGGATCGCCAGCGTCCTGCAGGAGCTCAACGTGACGGTGGTGACGTCCCTCTGCCGTCGCAGCAACGTCTGCACTCTC/GTGAGGGGCCGGCAGGCCGGCGTCTGTTTCgt(a>t)cgtgccctgggtgtccctctgctccccacccgctcccagcccggactgcagcaacaggcaccgtggctagaccctaggagggacttcccaaccctgacaggcggcgggcaggtgggcagggcctcgcagtccagcttccccaccttgtctgcctccacag		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	202700	ENSG00000197561	267	353	"elastase, neutrophil expressed"
354	1	Human	51	ELA2	161	Severe congenital neutropenia	IVS4+5G>A	-30	NULL	Exon	0	cactctacagatggggaaaccgaggcttgccttggggagcagagtgtggggtgggtatcctgccctgcaggatcccagaaccacagtggaacctgagatggggaaactgaggcccggagaggggagggtcatcatcactgccccgtgtgacgcgctgacgatctgtccccaccgccacagCTCAACGGGTCGGCCACCATCAACGCCAACGTGCAGGTGGCCCAGCTGCCGGCTCAGGGACGCCGCCTGGGCAACGGGGTGCAGTGCCTGGCCATGGGCTGGGGCCTTCTGGGCAGGAACCGTGGGATCGCCAGCGTCCTGCAGGAGCTCAACGTGACGGTGGTGACGTCCCTCTGCCGTCGCAGCAACGTCTGCACTCTC/GTGAGGGGCCGGCAGGCCGGCGTCTGTTTCgtac(g>a)tgccctgggtgtccctctgctccccacccgctcccagcccggactgcagcaacaggcaccgtggctagaccctaggagggacttcccaaccctgacaggcggcgggcaggtgggcagggcctcgcagtccagcttccccaccttgtctgcctccacag		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	202700	ENSG00000197561	267	354	"elastase, neutrophil expressed"
352	1	Human	179	MCOLN1	204	Mucolipidosis IV	E13+129A>T	-4	11	Exon	1	CATCCCGGCGGCGCAGGCGCAGAGGAGAGCGAGCTGCAGGCCTACATCGCACAGTGCCAGGACAGCCCCACCTCCGGCAAGTTCCGCCGCGGGAGCGGCTCGGCCTGCAGCCTTCTCTGCTGCTGCG/G(A>T)AGgttcgagtcccgggtctggcacattcagattggaggttagggaatggggaaaggggagcgagccagagaaaactgacgcccctcttccctgcttccttcctccag		Yes	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	252650	ENSG00000090674	266	352	mucolipin 1
#356	1	Human	169	CTNS	196	Cystinosis	E8+IVS8del27	-1260	40	Exon	0	CCCGAGGATACGCTTTCTTGTGATCCGCAGCAGCGCCATTAGCATCATAAACCAGGTGATTGGCTGGATCTACTTTGTGGCCTGGTCCATCTCCTTCTACCCTCAG/GTGATCATGAATTGGAGGCGGAAAAGgtaaccccctgggccgtatgtgcaggctctctcggggcccctaggagcagggcgttccagcaaggctgccgatagcgcagcctccaacgtcccctctacccttctgtctgcctaccctttccagaaagttgtcccagtgcgaaggctcggagagcctgggtcggattcccgtgctgggcgtttcatcccttgcccagctcagcccctccctgggaaagcaggaaaacagggaaaaggggctccttagtttagtggagaatgggcgggggagggagggcagtccatcgtgaatctcctctgcgctgggtccatccgaccctggaggattgcggcgtcaagtcctgtagtctcggtctttgggacgaagctgtcccaccttgacttgcaaagacacaagctgtcctgcagtcaccctggccacgtcggcctcctgggtgatggcaagcagagagccgggagggagacgctttcttccgggggcctcctgactcccctctggagccaggacttgaggggcagggagatcttgggcaggggaggaagggaggagggaagtagctcttcaagagggcagggattaggtggcatccgtggtggtagcaggagggacctaaggacagtaccctgcttgagaagggccgagtcctccttccccgtggcctgggagccctgtccctcccattccccacagtggtgccagtcctcacccctggccctgccatgcccttccacccccgccagccctcaccccctgccctgcccctccacccctcgccagtcctcgcccctggccctgccatgcccttccacccccgccagccctcaccccctgccatgcccctccacccccgccagtccttacccactgccctgcccctccaccccccaccagtcctcaccccctggggtcctcacccctgccctgcccctccacccctgccagtcctcaccccctgccctgccccaccacccctcgccagtccttaccccccaccctgccctgcccctccacccccgccagtcctcaccctctgccctgcccctccacccccgccagtcctcaccctctgccctgtccctccacccctgccagtcttcaccccctgccctgtcttgtccctccaccccctgcagTGTCATTGGTCTGAGCTTCGACTTCGTGGCTCTGAACCTGACGGGCTTCGTGGCCTACAGTGTATTCAACATCGGCCTCCTCTGGGTGCCCTACAT(CAAGgtacggccttgcctgccctacat)ctctgcccacatggcgtggtggcccggctgcccctcaccacccagcttctcccacccaccaaacag		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	219800	ENSG00000040531	269	356	"cystinosis, nephropathic"
361	1	Human	168	CHRNE	206	Myasthenic syndrome	E8+113C>T	-4	100	Exon	1	CCGGCGGCCAGAAATGCACGGTCTCCATCAACGTCCTGCTCGCCCAGACCGTCTTCTTGTTCCTCATTGCCCAGAAAATCCCAGAGACTTCTCTGAGCGTGCCGCTCCTGG/G(C>T)AGgtgaagccggagcccccgcgggggtgtggccagtgtgaagggtgggggcgtggccaaaacccagagaccccgggaaaagctctggctgtctcgccccgccctgggctttattcggacgctgggtggggctggtacggggatggagtccctggtccgccgtcctcctcactgctgctggac		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	601462	ENSG00000108556	274	361	"cholinergic receptor, nicotinic, epsilon"
377	1	Human	184	PKD2	209	Polycystic kidney disease	E14+92C>T	-58	20	Exon	1	CCTGGTGAGACGAGTGGACCGGATGGAGCATTCCATCGGCAGCATAGTGTCCAAGATTGACGCCGTGATCGTGAAGCTAGAGATTATGGA/G(C>T)GAGCCAAACTGAAGAGGAGGGAGGTGCTGGGAAGGCTGTTGGATGGGGTGGCCGAGgtcagtagtcatgagctgaaaacaccgctgctgagcatggtgttattaatgaaaatatatgttgctgacagttgtatttgaagtattgaagaagagtaaaaaaaatttacgtttatagaaattcacaatgatgtttccatttactctcattttcagatttttttctctgaaacagaaaca		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	173900	ENSG00000118762	285	377	polycystic kidney disease 2 (autosomal dominant)
378	1	Human	184	PKD2	209	Polycystic kidney disease	E14+135A>G	-37	50	Exon	1	CCTGGTGAGACGAGTGGACCGGATGGAGCATTCCATCGGCAGCATAGTGTCCAAGATTGACGCCGTGATCGTGAAGCTAGAGATTATGGAGCGAGCCAAACTGAAGAGGAG/GGAGGTGCTGGGAAGGCTGTTGG(A>G)TGGGGTGGCCGAGgtcagtagtcatgagctgaaaacaccgctgctgagcatggtgttattaatgaaaatatatgttgctgacagttgtatttgaagtattgaagaagagtaaaaaaaatttacgtttatagaaattcacaatgatgtttccatttactctcattttcagatttttttctctgaaacagaaaca	5'GG donor site	No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	173900	ENSG00000118762	285	378	polycystic kidney disease 2 (autosomal dominant)
394	1	Human	181	MUT	203	Methylmalonic acidemia	E10+132G>A	3684	50	Intron	0	ctgcaaaggacacgatctcattctttttttctggctgcatagtattctttagtgtgtgtgtatcacattttctttatccagtctatcactgatgggcatttaggttgattccatgtctttgctgtggtgaatagtgctacaatgaacatacatgtgaatgtgtatttttttttttttttttgaaacag/AGTCTCGCTCTTTCATCCATGCTGGAGTGCAGTGGTATGATCTTGGCTCACTACAACCTCCACCTCCTGGGTTCAA/gtgagtcttctgcctcagccatatgagtatctggtactacaggcacgtgccaccatacctggccaatttttgtatttttagtagagatgggtttcaccatgttggccaggctggtctcgaactcatgacctcaagtgatccacccgcctctgcctcccaaagtgctagaattacaggcatgaaccaccacgcccagctgcaagcatgtttttataatagaaagatttctgttcatttgggtatatgtacggtaatgggattgctgggttgggaggt	Creates pseudoexon in the downstream intron	No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	251000	ENSG00000146085	275	394	methylmalonyl CoA mutase
405	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS43+1G>A	39	NULL	Intron	0	GAACAAGGAAAAGTTTTGATCACTTGATATCAGACACAAAGGCTCCTAAAAGGCAAGAAATGGAATCAGGGATCACAACACCCCCCAAAATGAGGAGAGTAGCAGAAACTGATTATGAAATGG(g>a)tgagaaacaaagtattgatctagatcattgaaaataag/gtgggagagtacatgaaagtcatgtttattttccagccatttcttagaatctttagagtgaaatatagaaacgtttgccatttctcaaaagataaactctaccattcaagacagttatcttgaagcttgtgtaaaaattaa		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	162200	ENSG00000196712	282	405	neurofibromin 1
387	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E22+123C>T	-41	NULL	Exon	2	GATGAACTAGCTCGAGTTCTGGTTACTCTGTTTGATTCTCGGCATTTACTCTACCAACTGCTCTGGAACATGTTTTCTAAAGAAGTAGAATTGGCAGACTCCATGCAGACTCTCTTCCGAG/G(C>T)AACAGCTTGGCCAGTAAAATAATGACATTCTGTTTCAAGgtttgtatcattcattttgtgtgtatgtgtgtgctgaggtatgtcaagtaatgattatgtacagaatgtgcagggctgattgtcttcttttaaggtaaaatatatggagcaggtataataaactcctattcgtgcatttctgtag		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	162200	ENSG00000196712	282	387	neurofibromin 1
408	1	Human	174	GNAT2	194	Congenital achromatopsia	IVS4+24G>A	21	100	Intron	0	GATGACGGGCGACAGCTCAACAACCTGGCTGACTCCATTGAGGAGGGAACCATGCCTCCTGAGCTCGTGGAGGTCATTAGGAGGTTGTGGAAGGATGGTGGGGTGCAAGCCTGCTTCGAGAGAGCTGCAGAATACCAGCTTAATGACTCCGCATCTTAgtaagactgactggtgagagg/gt(g>a)ggttgatgcttaagcaatcttctagccagtcttctctctggttgggagaaacctcacccaacccaaaatttcaggcattgaaagctggagacccagactgaattcagcctgtggatctgttttgttaggcttcagcaatgttttgaatttaatgctatggggagatctgccacagttgtcatgactttctattgctttacactggctcactacagc		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	262300	ENSG00000134183	302	408	"guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2"
371	1	Human	178	MCCB	193	3-methylcrotonyl-CoA carboxylase deficiency	E14+93A>G	-65	100	Exon	2	GATTTATGGTTGGTAGAGAGTATGAAGCTGAAGGAATTGCCAAGGATGGTGCCAAGATGGTGGCCGCTGTGGCCTGTGCCCAAGTGCCTAAG/(A>G)TAACCCTCATCATTGGGGGCTCCTATGGAGCCGGAAACTATGGGATGTGTGGCAGAGCATATAGgtaggtgtcatgattttctctgaaacaaagaaacatgcttcaagtataaaatacatggtcagtttatttcaggtgtatttgaaatatagaatgccattcccagatctcaatcaattataccgtaatttgtatcatttggaggggtgaaatgaaatttaatgccaaaggtgttatttggaagaaatctacaatgggagtcaagaaatacttgaaatggctgataatgaaaatgccacacattaagatttgtgcagtgcagctaaagtctggctctgagaaaggtatgtagccttaaaggca		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	609014	ENSG00000131844	283	371	methylcrotonoyl-CoA carboxylase 2 (beta)
363	1	Human	173	FGFR2	195	Crouzon syndrome	E8+3A>G	-51	100	Exon	0	GCCGCCGGTGTTAACACCACGGACAAAGAGATTGAGGTTCTCTATATTCGGAATGTAACTTTTGAGGACGCTGGGGAATATACGTGCTTGGCGG/GTAATTCTATTGGGATATCCTTTCACTCTGCATGGTTGACAGTTCTGCCAGgt(a>g)tatactgttctttctctctgggtttttttcccttttcttggttgactgctataaaattaacacagcttctgttatcagaaatggccccttttatccttgcataaagatataaaaaatgttaaaaatgatccctcagggataagaaaactgccttggaaattcacacacagtgagatc		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	123500	ENSG00000066468	276	363	fibroblast growth factor receptor 2
358	1	Human	175	HSD11B2	214	Syndrome of apparent mineralocorticoid excess	IVS3+1G>A	-94	100	Exon	1	GCCTGTGGGGCCTCGTCAACAACGCAGGCCACAATGAAGTAGTTGCTGATGCGGAGCTGTCTCCAGTGGCCACTTTCCGTAGCTGCATGGAG/GTGAATTTCTTTGGCGCGCTCGAGCTGACCAAGGGCCTCCTGCCCCTGCTGCGCAGCTCAAGGGGCCGCATCGTGACTGTGGGGAGCCCAGCGG(g>a)tgagtgcccccccccactggagcaaaaaggagccccctggggtgggggagggcttagggagccccttgccaaagctgagctgccccactcccaatccatccgcagGGGACATGCCATATCCGTGCTTGGGGGCCTATGGAACCTCCAAAGCGGCCGTGGCGCTACTCATGGACACATTCAGCTGTGAACTCCTTCCCTGGGGGGTCAAGGTCAGCATCATCCAGCCTGGCTGCTTCAAGACAGgtgggaatcagggctgggggtggggtgggggtggggaatggggctgggaatggtcttatgggggcaggtcaggtttgatgaatggtcatggttttggttgggggtgtagttttggctgcagacctggcgcgggttaaacagtcctaattggctttggctcccctagctgatcccactctgaccttgccactccttccccag		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	218030	ENSG00000176387	271	358	hydroxysteroid (11-beta) dehydrogenase 2
374	1	Human	175	HSD11B2	214	Syndrome of apparent mineralocorticoid excess	E4+107C>G	-34	100	Exon	1	GCCTGTGGGGCCTCGTCAACAACGCAGGCCACAATGAAGTAGTTGCTGATGCGGAGCTGTCTCCAGTGGCCACTTTCCGTAGCTGCATGGAGGTGAATTTCTTTGGCGCGCTCGAGCTGACCAAGGGCCTCCTGCCCCTGCTGCGCAGCTCAAGGGGCCGCATCGTGACTGTGGGGAGCCCAGCGGgtgagtgcccccccccactggagcaaaaaggagccccctggggtgggggagggcttagggagccccttgccaaagctgagctgccccactcccaatccatccgcagGGGACATGCCATATCCGTGCTTGGGGGCCTATGGAACCTCCAAAGCGGCCGTGGCGCTACTCATGGACACATTCAGCTGTGAACTCCTTCCCTGGGGGGTCAAG/GT(C>G)AGCATCATCCAGCCTGGCTGCTTCAAGACAGgtgggaatcagggctgggggtggggtgggggtggggaatggggctgggaatggtcttatgggggcaggtcaggtttgatgaatggtcatggttttggttgggggtgtagttttggctgcagacctggcgcgggttaaacagtcctaattggctttggctcccctagctgatcccactctgaccttgccactccttccccag		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	218030	ENSG00000176387	271	374	hydroxysteroid (11-beta) dehydrogenase 2
406	1	Human	180	MECP2	210	Rett Syndrome	IVS1+delGT	51	100	Intron	0	GCGCGACGTCGGCCGTGCGGGGTCCCGGCGTCGGCGGCGCGCGCGCTCCCTCCTCTCGGAGAGAGGGCTGTGGTAAAAGCCGTCCGGAAAATGGCCGCCGCCGCCGCCGCCGCGCCGAGCGGAGGAGGAGGAGGAGGCGAGGAGGAGAGACT(gt)gagtgggaccgccgtggccgcgggcggggacccttgccggggggcgggg/gtcaggggcgggacgtggcgcgggaggggcccgcggggtcggacgacacggctggcggatggcgtccctcctctctaccctccccctcccgccgccgccggtggcgactctcccctcggcccgtcaccc		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	312750	ENSG00000169057	300	406	methyl CpG binding protein 2 (Rett syndrome)
386	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E16+300G>A	-144	NULL	Exon	0	GCTGCTGAAAGCCTTCACAAGACCATTGTTAAGAGGCGAATGTCCCATGTGAGTGGAGGAGGATCCATAGATTTGTCTGACACAGACTCCCTACAGGAATGGATCAACATGACTGGCTTCCTTTGTGCCCTTGGGGGAGTGTGCCTCCAGCAGAGAAGCAATTCTGGCCTGGCAACCTATAGCCCACCCATGGGTCCAGTCAGTGAACGTAAGGGTTCTATGATTTCAGTGATGTCTTCAGAGGGAAACGCAGATACACCTGTCAGCAAATTTATGGATCGGCTGTTGTCCTTAATG/GT(G>A)TGTAACCATGAGAAAGTGGGACTTCAAATACGGACCAATGTTAAGGATCTGGTGGGTCTAGAATTGAGTCCTGCTCTGTATCCAATGCTATTTAACAAATTGAAGAATACCATCAGCAAGTTTTTTGACTCCCAAGGACAGgtaaagtgttctcttatttttcacctttctctatgaatagagtgacttgtttgaaataagcctttttctttcagattatttaaattaggtactcacagtttttaaaaatttccaaaaaat		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	162200	ENSG00000196712	282	386	neurofibromin 1
382	1	Human	191	XPC	181	Xeroderma pigmentosum	E8+665delTG	-246	100	Exon	0	ggatttctatcatatcattagcaaaagaggggggagaaaaaaaagcaaaatttcttattctgtttaagGGAAAGAAACCTTCCAAGGAAAGATTGACTGCGGATCCAGGAGGCTCCTCAGAAACTTCCAGCCAAGTTCTAGAAAACCACACCAAACCAAAGACCAGCAAAGGAACCAAACAAGAGGAAACCTTTGCTAAGGGCACCTGCAGGCCAAGTGCCAAAGGGAAGAGGAACAAGGGAGGCAGAAAGAAACGGAGCAAGCCCTCCTCCAGCGAGGAAGATGAGGGCCCAGGAGACAAGCAGGAGAAGGCAACCCAGCGACGTCCGCATGGCCGGGAGCGGCGGGTGGCCTCCAGGGTGTCTTATAAAGAGGAGAGTGGGAGTGATGAGGCTGGCAGCGGCTCTGATTTTGAGCTCTCGCAGTGGAGAAGCCTCTGATCCCTCTGATGAGGATTCCGAACCTGGCCCTCCAAAGCAGAGGAAAGCCCCCGGATCCTCAGAGGACAAAGGCTGGGTCCAAGAGTGCCTCCAGGACCCATCGTGGGAGCCATCGTAAGGACCCAAGCTTGCCAGCGGCATCCTCAAGCTCTTCAAGCAGTAAAAGAGGCAAGAAAATGTGCAGCGATGGTGAGAAGGCAGAAAAAAGAAGCATAGCTGGTATAGACCAGTGGCTAGAGGTGTTCTGTGAGCAGGAGGAAAAGTGG/GTATGTGTAGACTGTG(TG)CACGGTGTGGTGGGCCAGCCTCTGACCTGTTACAAGTACGCCACCAAGCCCATGACCTATGTGGTGGGCATTGACAGTGACGGCTGGGTCCGAGATGTCACACAGAGGTACGACCCAGTCTGGATGACAGTGACCCGCAAGTGCCGGGTTGATGCTGAGTGGTGGGCCGAGACCTTGAGACCATACCAGAGCCCATTTATGGACAGGGAGAAGAAAGAAGACTTGGAGgtaaggccttggctgccaggggctccaagacacagtcaggttattaaaattattcctgtttttgagcaccttatatatgcccagcactatgttgggtgtttttaatgggttgtctcattt	Long exon	No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	278700	ENSG00000154767	288	382	"xeroderma pigmentosum, complementation group C"
381	1	Human	191	XPC	181	Xeroderma pigmentosum	E8+747C>T	-246	100	Exon	0	ggatttctatcatatcattagcaaaagaggggggagaaaaaaaagcaaaatttcttattctgtttaagGGAAAGAAACCTTCCAAGGAAAGATTGACTGCGGATCCAGGAGGCTCCTCAGAAACTTCCAGCCAAGTTCTAGAAAACCACACCAAACCAAAGACCAGCAAAGGAACCAAACAAGAGGAAACCTTTGCTAAGGGCACCTGCAGGCCAAGTGCCAAAGGGAAGAGGAACAAGGGAGGCAGAAAGAAACGGAGCAAGCCCTCCTCCAGCGAGGAAGATGAGGGCCCAGGAGACAAGCAGGAGAAGGCAACCCAGCGACGTCCGCATGGCCGGGAGCGGCGGGTGGCCTCCAGGGTGTCTTATAAAGAGGAGAGTGGGAGTGATGAGGCTGGCAGCGGCTCTGATTTTGAGCTCTCGCAGTGGAGAAGCCTCTGATCCCTCTGATGAGGATTCCGAACCTGGCCCTCCAAAGCAGAGGAAAGCCCCCGGATCCTCAGAGGACAAAGGCTGGGTCCAAGAGTGCCTCCAGGACCCATCGTGGGAGCCATCGTAAGGACCCAAGCTTGCCAGCGGCATCCTCAAGCTCTTCAAGCAGTAAAAGAGGCAAGAAAATGTGCAGCGATGGTGAGAAGGCAGAAAAAAGAAGCATAGCTGGTATAGACCAGTGGCTAGAGGTGTTCTGTGAGCAGGAGGAAAAGTGG/GTATGTGTAGACTGTGTGCACGGTGTGGTGGGCCAGCCTCTGACCTGTTACAAGTACGCCACCAAGCCCATGACCTATGTGGTGGGCATTGACAGTGACGGCTGGGTC(C>T)GAGATGTCACACAGAGGTACGACCCAGTCTGGATGACAGTGACCCGCAAGTGCCGGGTTGATGCTGAGTGGTGGGCCGAGACCTTGAGACCATACCAGAGCCCATTTATGGACAGGGAGAAGAAAGAAGACTTGGAGgtaaggccttggctgccaggggctccaagacacagtcaggttattaaaattattcctgtttttgagcaccttatatatgcccagcactatgttgggtgtttttaatgggttgtctcattt	Long exon	No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	278700	ENSG00000154767	288	381	"xeroderma pigmentosum, complementation group C"
368	1	Human	28	COL1A2	52	Ehlers-Danlos syndrome	E46+2T>C	-17	100	Exon	2	GGCCCACAAGGCATTCGTGGCGATAAGGGAGAGCCCGGTGAAAAGGGGCCCAGAGGTCTTCCTGGCTTAAAGGGACACAATGGATTGCAAG/GTCTGCCTGGTATCGCTg(t>c)aagtaaactgtagccatctcgcacataaactgatcctgaaggccttcagctcagaaggattttcatattttcactgctattgttccagtatagcctatataatatccatttcccattctctggctaactccatctcactcttggaggtaatgctatttcataccaacatgaaaggtgaggattaagggagatagaaatagacatacaataaaatctcctggtaacaatgtccttcaac		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	120150	ENSG00000164692	281	368	"collagen, type I, alpha 2"
360	1	Human	192	ZDHHC9	190	X-linked mental retardation	IVS2+5G>C	-140	100	Exon	2	GGCTAGCAATTGGACTTTTGATGATGTTTGACCCAGCGGCAGGAATAGCAGGCAACGTGATTTCAAAGCTGGGCTCAGCCTCTGTTTCTTCTCTCGTGTAATCGCAAAACCCATTTTGGAGCAGGAATTCCAATCATGTCTGTGATGGTGGTGAGAAAGAAG/GTGACACGGAAATGGGAGAAACTCCCAGGCAGGAACACCTTTTGCTGTGATGGCCGCGTCATGATGGCCCGGCAAAAGGGCATTTTCTACCTGACCCTTTTCCTCATCCTGGGGACATGTACACTCTTCTTCGCCTTTGAgtga(g>c)tttcggttgagtagagttacctgattatggttactttgggtccaggggaagaacctgctttctggggagtttggggctggtccttggatgactttaacgtcctcttgagcgatgtctgtagagatgccagctgaattcattgcttcgtggtcatcacagagtatgtacttcctaa		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	300304	ENSG00000188706	273	360	"zinc finger, DHHC-type containing 9"
409	1	Human	177	LAMB3	54	Epidermolysis bullosa	IVS7+42G>A	66	50	Intron	0	ggggcacactatttgtctcttcttcagcgcttctctttcccttccctctgtagGTCCAACTTAACCTTATGGATTTAGTGTCTGGGATTCCAGCAACTCAAAGTCAAAAAATTCAA(G>A)gtcagtgtggttacttctcttgtccatggaactatgggtgg(g>a)aaaggaaacagagttggagcccag/gtcatggaaatttcctggtctttcatgtttttgtcaacgtggttggggatttgatacttgccctgcttgccccatagggatattgtctgtgggatgctatgggatggttgaggtctggagaggatggcccacggtatcacatatgaaggagactctatgtgcctctaacttcctttctttattttccattctccaactcttccctccttgctgtttggccctctcag	Second-site mutation correcting the germline mutation c.628G?A	No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	120120	ENSG00000196878	303	409	"laminin, beta 3"
389	1	Human	134	PROS1	151	Protein S deficiency	IVS1+4A>G	111	NULL	Intron	0	GGGTCGCTGGCGCCGCCGCGCAGCACGGCTCAGACCGAGGCGCACAGGCTCGCAGCTCCGCGGCGCCTAGCGCTCCGGTCCCCGCCGCGACGCGCCACCGTCCCTGCCGGCGCCTCCGCGCGCTTCGAAATGAGGGTCCTGGGTGGGCGCTGCGGGGCGCTGCTGGCGTGTCTCCTCCTAGTGCTTCCCGTCTCAGAGGCAAACTgtg(a>g)gtaatcaatagcgtctcttctcccttccccagcattgtcgactgaactgcgtgccctggttggtaggattttcttctctagagctgcagcctcctagaaagtttcca/gtaagtaccgacagacacccagcggatggaaacagccgtggatagagcaggcagtgcaatggtggggcaggatcactatttgcacagttgcgagaatgtattgcctacaggacagatctaagaacctagatgacactaagtatcaatggagggatgagaacacctgcccatttcccttcaaagctgaagttcccagtcagagaactaggatgagcagattctagcttatgagtagggaagaaaaggtaacacactgtgtcttccctttgtccaagcgcctgcccccaacctgcacccgtctcctgaaacctgcctcccttttgcaatttctggactttgagcttggtttgcttgtctcacattaacgaa		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	176880	ENSG00000184500	291	389	protein S (alpha)
411	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E10b+1159C>T	1158	NULL	Intron	0	gtaagtatttttttatgaaatgtctcaaaattatcacactaagttaattgggtttagctgaaacgccaagaccttgaggataatttttagctcaagagcacttactgatcctttctgatcatacctgaaaactaagacgtctctaagaaaactaatgtataatgaatactaatataattagatcagattcttaattgcccttatcatttcctaacatttctctttcttcttaatttccctatcattaaactaacatactttgatgagatctctgttctcatcctattactaagttatatattattcaggtataatcctggtatgggggatagaagtgaccatcgatcacagtgtctacatctatactgttggtttaaaaaatctccagattgcttttgccagtttagcttttctatccccctttctttgtgttatcagctttctgttatcattggctctgcctacaaatactgtattggaaaaagaatgaggtgaaaatgggtgtggttagtacttgagttagtgtgattatcattattattattattttgagacagggtcttgctctgcttcccaagctagagagcagtggagcagtgatggctcactgccttcgaactcctgacctcaagccatcctccagcctcggcctccccaagtgctgtgattacaggcatgagcccccatgcctggctagtagtcagttattgtcataactactcttactgcctcagatgatattaaatttctgagaacatcactctggtacacagagtaattaggaacaacgcaaataataaaaatgagtcataatgaagtgattaacagcatggacgctggagactacctactagctatgtgatttggatgactatttaatctttctatgccttagttttctcatctgatatattgggatcataatagttcctatctcagagatactgttaggaaaattgaaatagtacatacaatgctttaggaacaatgcctggtgcataataagcactaaataaatgttagctattattgctattaataagatacaatttaacactaattaatgcaccaaatgtaatagttctatattgtgtctttcatag/GATGACATGTTTAACCTTTGTTGAGCTTCTTCAGTCCCTGGAGAGCAGCATCAA/g(c>t)aaggtttcttatcgttttgctcagtaactggctttttaaaaagtgttaaggtgctttcgattttggtggcatattttttaaattactgtaatacagggagtttgtaactacatgcctatgattccaagagttct	Creates pseudoexon	No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	162200	ENSG00000196712	282	411	neurofibromin 1
395	1	Human	166	APOB	199	Familial hypobetalipoproteinemia	E9+220G>A	40	100	Intron	1	GTACTAAGAAGATGGGCCTCGCATTTGAGAGCACCAAATCCACATCACCTCCAAAGCAGGCCGAAGCTGTTTTGAAGACTCTCCAGGAACTGAAAAAACTAACCATCTCTGAGCAAAATATCCAGAGAGCTAATCTCTTCAATAAGCTGGTTACTGAGCTGAGAGGCCTCAGTGATGAAGCAGTCACATCTCTCTTGCCACAGCTGATTGAGGTGTCCA(G>A)gtatctaatggttacagctcaactttttataaaactgatg/gtaactgactgaactttcaaaccttggccaaatggagaatctcagggaccatttggatatcaatccagttaatcaattagtcaatcagttcatgattgctggatagagaactatcagctgctgcgctgagttccatgaaa		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	107730	ENSG00000084674	294	395	apolipoprotein B (including Ag(x) antigen)
383	1	Human	27	COL1A1	52	Ehlers-Danlos syndrome	E49+259A>G	-25	NULL	Exon	1	gtatgtagcccctcatcccctctgctcatggccctccagcccccaaagcacttggatgccggtaatccccactctcttccctctctgtgcagGGTCCCCCCGGCCCTCCTGGACCTCCTGGTCCCCCTGGTCCTCCCAGCGCTGGTTTCGACTTCAGCTTCCTGCCCCAGCCACCTCAAGAGAAGGCTCACGATGGTGGCCGCTACTACCGGGCTGATGATGCCAATGTGGTTCGTGACCGTGACCTCGAGGTGGACACCACCCTCAAGAGCCTGAGCCAGCAGATCGAGAACATCCGGAGCCCAGAGGGCAGCCGCAAGAACCCCGCCCGCACCTGCCGTGACCTCAAG/(A>G)TGTGCCACTCTGACTGGAAGAGTGgtgagggcctgccctagcctctccctccctcctactcctgccatgccagggtccccatgcccatatgtgcccctaccatatggtgctggctgctccctttccctgactccatcttgccctgccctaccacag		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	120150	ENSG00000108821	289	383	"collagen, type I, alpha 1"
370	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E31+194G>A	-4	NULL	Exon	1	GTATTGAATTGAAACACCTTTGTTTGGAATACATGACTCCATGGCTGTCAAATCTAGTTCGTTTTTGCAAGCATAATGATGATGCCAAACGACAAAGAGTTACTGCTATTCTTGACAAGCTGATAACAATGACCATCAATGAAAAACAGATGTACCCATCTATTCAAGCAAAAATATGGGGAAGCCTTGG/GCA(G>A)gtattgagtttgctcaaatatttatctagtatctcctttgtgcacatatttatctggtgccacattgggcaaagcactgcgctagacactagggatagagttgtaaaaaacacagtttcc		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	162200	ENSG00000196712	282	370	neurofibromin 1
412	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E30+332A>G	332	NULL	Intron	2	GTCAGCTGCCTATAATCTTCTGTGTGCCTTAACTTGTACCTTTAATTTAAAAATCGAGGGCCAGTTACTAGAGACATCAGGTTTATGTATCCCTGCCAACAACACCCTCTTTATTGTCTCTATTAGTAAGACACTGGCAGCCAATGAGCCACACCTCACGTTAGAATTTTTGGAAGAGTGTATTTCTGGATTTAGCAAATCTAgtaagtaatgataattttctttaatactaacaattattctaagagaattcaaagaaaaccctttcatttcagaattttccagtgaagactttcacttacatttttactttttttcctcttctgattttatatctgtggtatcctgtaactgaag/GAACTCTGAAGGAACTTTTTGGTAGGCCACATTGAGAAATCCACCAAAATTCTGATAATAAAAGCAAAGCGGCAAGAGTTTGGTACTTTACACACCTCTGGACCACTTACAAAGTATTTTCTTCACTGTTGCAGTTTAATTAGCTTCAGCATTTCTCTTCATAGCAGAAAAGTCCAC/(a>g)taagtatccatgttgcctccttaattttagagaactagtcattttctcttttctttaggttgactttgaacaatgaatttattgtaaa	Creates pseudoexon	No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	162200	ENSG00000196712	282	412	neurofibromin 1
398	1	Human	185	PLEKHM1	207	Osteopetrosis	IVS3+1G>A	95	50	Intron	2	GTCATCAAGAAGAAGCTGGTGGGATCCGTGAAGGCCTTGCAGAAGCAGTACGTGTCCCTGGACACGGTGGTCACTAGTGAAGACGGAGATGCCAACACCATGTGCAGCGCCCTGGAGGCCGTATTTATCCATGGCCTGCACGCCAAGCACATCCGAGCTGAGGCCGGAGGAAAAAGGAAGAAAAGTGCCCACCAGAAGCCTCTGCCCCAGCCTGTCTTCTGGCCCCTCCTGAAAGCTGTCACCCACAA(g>a)tgagatttagctggagaggttttgctttgcggaggagcagcagactatgggacacttggcttttcctccccagctgttcaggaagccaacagag/gtgccctgtgttctagcatagagagagggtgaggtaggggttgaaagtgtcttctagaaaggcttatctctagaccaagcttcccagccagtgtgccagcagatcttgagaccctcagcactcaggcaagagcctgtggctgctttgagactggtcacaaaaagcaggtgagactggccacctttagcaggaacagccttttttgccacactggggcagagttacatagttacaacagaggt		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	611497	ENSG00000225190	295	398	"pleckstrin homology domain containing, family M (with RUN domain) member 1"
399	1	Human	185	PLEKHM1	207	Osteopetrosis	IVS3+1G>A	262	50	Intron	1	GTCATCAAGAAGAAGCTGGTGGGATCCGTGAAGGCCTTGCAGAAGCAGTACGTGTCCCTGGACACGGTGGTCACTAGTGAAGACGGAGATGCCAACACCATGTGCAGCGCCCTGGAGGCCGTATTTATCCATGGCCTGCACGCCAAGCACATCCGAGCTGAGGCCGGAGGAAAAAGGAAGAAAAGTGCCCACCAGAAGCCTCTGCCCCAGCCTGTCTTCTGGCCCCTCCTGAAAGCTGTCACCCACAA(g>a)tgagatttagctggagaggttttgctttgcggaggagcagcagactatgggacacttggcttttcctccccagctgttcaggaagccaacagaggtgccctgtgttctagcatagagagagggtgaggtaggggttgaaagtgtcttctagaaaggcttatctctagaccaagcttcccagccagtgtgccagcagatcttgagaccctcagcactcaggcaagagcctgtggctgctttgagactggtcacaaaaagcag/gtgagactggccacctttagcaggaacagccttttttgccacactggggcagagttacatagttacaacagaggt		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	611497	ENSG00000225190	295	399	"pleckstrin homology domain containing, family M (with RUN domain) member 1"
357	1	Human	182	NDUFS7	202	Leigh Syndrome	E1+2702C>G	2697	100	Intron	0	gtgagcgcggcaccggcggcgggtgtggggccgcgcgggtctggggccgtgggagcctcgggtgtcgtggtggcgtcgggggtcggtgccggcgtcgtggccgcggtcctctccgggcttctccgagccggccgctcctcgggctccccgcccggcttgcgatgaacggtcgccgttattgcgtccagagtacagtcggggaaaccgaggcccggtaggtcatgacgcaagcctccagcctcaggaaggcgctcggggtggaggctggaggggccccattcacgtccccgagaccagggcacggcccgcgaggctgctcttgagatgccctggagagagcggggcctgcctgacaggctgggaaactgaggcccattgagggtcttcgaggtcacagggccgggcctgggaaggaacaggacccaggacatccacgccaccctgctggaccctccacctccctccccacccctgggaggtaagggcctctcgcagagcctgtcctgctccagggacttttttgggatcagctgaagcctgcggacctctgctcagataaagttattaaatgcatggaataaaatccatagaattgcaaggaaatcagttacacggagaggcagttattaaaagattgtcttgaaacctgattggcgacttagtaatctaagtgcttcccttatgaacgcgatctagcggcaggtctaattgcgactgtgatttggaaggagtgaggagtggaaatgaggctttgatgatacggaaacgtctgcagcccctgcaccatagctaggaaacatctgtgattccgcttggtgaaaagttacaggtcctgctaatactgccgtattttgttgtctatgctaagaattttttatttatttattaagacagggtctgcctctgtcgctcagactggagtgcagtggtgccatcttggctcatcactgcaacctgtgcctcccaggctcaagcgattctggcacttcagtgtcctgtgtagctgggaccacaggtgtgcgccaccatgcctggctagtttttgtatttttagtagagatgggggtcttgccctgttgcccaggctggtctcgaacttctgagttcaagcaatcctcccacctgagcctcccaaagtgctgggagccacggcacccagcctacgctaagaattgaatgaagggctaattttccataagatgctggtgacaacaaagacatatatatttttttattccaagcaaattcacagttctgaatcctcaccaggccccttgttaagaatgcctggcccacgcgcggtggctcacgcctgtaatcccagcactttggaaggccaaggtgggcggatcacctgaggtccggagttcgagaccagcctggccaacatggagaaaccccgtctctactaaaaatacaaaatcagctgggtgtggtggcgcatgcctgtaatcgcagctactggggggctggggcaagagaatcgcttgaacccgggaggcggaggttgcagtgagctaagattgcaccattgcactccatcctgggcaacaagagtgaaactccgtctcaaaaacaaaaacaaaaacaaaccagctgggcgtggtggctcaggcctgtaatcccagcactttgggaggccgaggtgggcggatcccctgagttcgggagttcaagaccagcctgatcaacatggagaaaccctgtctctactaaaaaatgcaaaattagctgagcgtggtagcaggcgcctgtaatcccagctactcgggaggctgaggcaggagaatagcttgaacctgggaggtggaggttgcagtgagccaagattgtgccgttgcactccagcctgggtgacaagagcgaaactccgtctcaaaacaacaacaacaacaacaaaaaccctgacccagaggcacagaatcccatcacctcagaggttctcagaagagtatctcctctgctaggagctcatccaaagtcctgcattttcagcttgggaaactgacacctggagtggggcagctcccaccagagcctggggctgggcagttagcctgtctgctgtgcccagcctcaggcatgccaagaagtaggtcacaggcttgtgtccttcagagagttgtggcctggacggggccatgggaaacagcaaccccggatgaggctaaggctggggtgagggaggggctcagaggcaggagaaggccccatggatcgctgcattcaggggcatcaaaccctggccctggcccctggaggctgcccacagcctctccatcgggcctcacctcacccacagcgacaaagtaccatcacctgggcagcttcaacagaagctgattgttctcacagttctgggggctggaaggccaagattgggggtcagcagggttggttcctgctgaggcctctgtccttggcttgcccgtggccatcttctccctgcgtctttcctctgtacatgtttgtgtcctgatcgccttttcttacaaggacataagtcatatcggatgagggcccaccctcgtgacctcactgtcctttataatgaccctttattttattttttgag/ATGGAGTCTCCCTCTGTCACCCAAGCTGGAGTGCAGTGGCGCAGCCTCTGCTCACTGCAACCTCTACCTCCCGGGTTCAAGTGATTCTCCTGCCTCAGCCTCTCGAGTAGCTGGGATTACAG/gtac(c>g)tgctactacacccagctaatttttgtatttttagtagagacggggtttcaccatgttgcccaggctggtctcgaactcctgacctcaggtgatccacctgcctcggcctcctgaagtgctggaattacaggcatgagccaccacgcccaggcattaatgatccctttaaagaccccatctccaaaagcagtcacattctgaggtcctggggttagggcttcagatgcaggtcgggtggagggtcacagttcagccgtcaccagcaccaagcctgcctttctggattcttccttgtgagccaggattcctggcacctccaggtttcctcccgctgagtgccccgggcgtggcaaggccctgctctggccttagtcttcgcctcgggaaggctctcccaggagacttcgtgcaggcgcgttccctcctctgcgcttcctttgaggctggctcctctaggggtgcttttctgtgtagattgacgtgggcagcgccctccccgcttagcggactgcagattcctgcaggatggggcctgtgctcagctgcgtgggaaacgcccgagcagcagccagggcctggagcacccagcacacgcttgtcaggcacagctgaggccaggacgagcactgggtgcccagggaggccccagcattgctggagtggcaggcaccccacaagcacgcatagatggagatagaaccgggtgccggcaaccggaggacctggggtcctggtgtaggcgggacgccccgggtatctgaactgaaacctgcctcatgagaaggggccagcagtgtgcaagtgtgaggcggggtgtcccccgcagggcagcagccagtgtgcaagtgtgaggcggggtgtcccccacagggcagcagccagtgcgggggccctggcgcaggaaagcggcaggtgccagtgaagatcgccagggcggggagacggggcagcgtttgggttccttccggggccatgcagtctcaagcaggggactaagactctctcgtgttctgaaaaccccctcgttacctaacgtttgttaagtggcactcgagttgggatcagagctaggctgtgcgggcaggagcctgatggggaagcgcctggaggccggccctgcgtgctgcccgcagctcactgttcccaccccgtggtcctctctgcag	Creates pseudoexon	No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	256000	ENSG00000115286	270	357	"NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)"
380	1	Human	67	FLNA	201	"Heterotopia, periventricular"	E31+31C>T	-112	NULL	Exon	1	gtgagtggggacttgggaaggagctcgggagccaaggaggccagactgtgccaatgagctgccctgacctcagccccactgccccacagGGGAGGTTCGGATGCCCTCAGGCAAGGTG/G(C>T)GCAGCCCACCATCACTGACAACAAAGACGGCACCGTGACCGTGCGGTATGCACCCAGCGAGGCTGGCCTGCACGAGATGGACATCCGCTATGACAACATGCACATCCCAGgtgggcctgccctgcctctgcccactccaccgccaccacctcacagagagatggggctgggggacacacgaggctgccattccacaaggcccttcttcctgcctcag		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	ENSG00000196924	287	380	"filamin A, alpha"
376	1	Human	106	LMNA	98	Hutchinson-Gilford progeria	E11+123G>A	-150	100	Exon	0	gtgagtggtagccgccgctgaggccgagcctgcactggggccacccagccaggcctgggggcagcctctccccagcctccccgtgccaaaaatcttttcattaaagaatgttttggaactttactcgctggcctggcctttcttctctctcctccctataccttgaacagggaacccaggtgtctgggtgccctactctggtaaggaagggagtgggaactttctgatgccatggaatattcctgtgggagcagtggacaagggtctggatttgtcttctgggaaagggaggggaggacagacgtggggcatgcccgccctgcctctctcccccattcttgttgcatgcatatcctctcatttccctcatttttcctgcaagaatgttctctctcattcctgaccgcccctccactccaattaatagtgcatgcctgctgccctacaagcttgctcccgttctctcttcttttcctcttaagctcagagtagctagaacagagtcagagtcactgctctggttctctgtccccaagtcttcctgagccttctccccttttatgtcttccctctcctcctccgggcccctagcctcccaaacccccattgcccgctggctccttgggcacagaaccacaccttcctgcctggcggctgggagcctgcaggagcctggagcctggttgggcctgagtggtcagtcccagactcgccgtcccgcctgagccttgtctcccttcccagGGCTCCCACTGCAGCAGCTCGGGGGACCCCGCTGAGTACAACCTGCGCTCGCGCACCGTGCTGTGCGGGACCTGCGGGCAGCCTGCCGACAAGGCATCTGCCAGCGGCTCAGGAGCCCAG/GT(G>A)GGCGGACCCATCTCCTCTGGCTCTTCTGCCTCCAGTGTCACGGTCACTCGCAGCTACCGCAGTGTGGGGGGCAGTGGGGGTGGCAGCTTCGGGGACAATCTGGTCACCCGCTCCTACCTCCTGGGCAACTCCAGCCCCCGAACCCAGgtgagttgtctctgctttgtctccaaatcctgcaggcgggtccctggtcatcgaggggtaggacgaggtggccttgcaggggggagagcctgccttctcttccgcagcccgggggagtgggagcctcctccccacagcctgagtcctagacagcccacctctgcatcctgcccctcttgtctgagccccagactggagggcaggggcagggctggagtgtgagggatgggggagatgctacctcccttctaggggccaggggagggagggtctgggtccaggccctgctgctcacacctctctcctctgttttctctcttag		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	176670	ENSG00000160789	272	376	lamin A/C
359	1	Human	106	LMNA	98	Hutchinson-Gilford progeria	IVS11+1G>A	-150	100	Exon	0	gtgagtggtagccgccgctgaggccgagcctgcactggggccacccagccaggcctgggggcagcctctccccagcctccccgtgccaaaaatcttttcattaaagaatgttttggaactttactcgctggcctggcctttcttctctctcctccctataccttgaacagggaacccaggtgtctgggtgccctactctggtaaggaagggagtgggaactttctgatgccatggaatattcctgtgggagcagtggacaagggtctggatttgtcttctgggaaagggaggggaggacagacgtggggcatgcccgccctgcctctctcccccattcttgttgcatgcatatcctctcatttccctcatttttcctgcaagaatgttctctctcattcctgaccgcccctccactccaattaatagtgcatgcctgctgccctacaagcttgctcccgttctctcttcttttcctcttaagctcagagtagctagaacagagtcagagtcactgctctggttctctgtccccaagtcttcctgagccttctccccttttatgtcttccctctcctcctccgggcccctagcctcccaaacccccattgcccgctggctccttgggcacagaaccacaccttcctgcctggcggctgggagcctgcaggagcctggagcctggttgggcctgagtggtcagtcccagactcgccgtcccgcctgagccttgtctcccttcccagGGCTCCCACTGCAGCAGCTCGGGGGACCCCGCTGAGTACAACCTGCGCTCGCGCACCGTGCTGTGCGGGACCTGCGGGCAGCCTGCCGACAAGGCATCTGCCAGCGGCTCAGGAGCCCAG/GTGGGCGGACCCATCTCCTCTGGCTCTTCTGCCTCCAGTGTCACGGTCACTCGCAGCTACCGCAGTGTGGGGGGCAGTGGGGGTGGCAGCTTCGGGGACAATCTGGTCACCCGCTCCTACCTCCTGGGCAACTCCAGCCCCCGAACCCAG(g>a)tgagttgtctctgctttgtctccaaatcctgcaggcgggtccctggtcatcgaggggtaggacgaggtggccttgcaggggggagagcctgccttctcttccgcagcccgggggagtgggagcctcctccccacagcctgagtcctagacagcccacctctgcatcctgcccctcttgtctgagccccagactggagggcaggggcagggctggagtgtgagggatgggggagatgctacctcccttctaggggccaggggagggagggtctgggtccaggccctgctgctcacacctctctcctctgttttctctcttag		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	176670	ENSG00000160789	272	359	lamin A/C
375	1	Human	106	LMNA	98	Hutchinson-Gilford progeria	E11+170C>G	-105	70	Exon	0	gtgagtggtagccgccgctgaggccgagcctgcactggggccacccagccaggcctgggggcagcctctccccagcctccccgtgccaaaaatcttttcattaaagaatgttttggaactttactcgctggcctggcctttcttctctctcctccctataccttgaacagggaacccaggtgtctgggtgccctactctggtaaggaagggagtgggaactttctgatgccatggaatattcctgtgggagcagtggacaagggtctggatttgtcttctgggaaagggaggggaggacagacgtggggcatgcccgccctgcctctctcccccattcttgttgcatgcatatcctctcatttccctcatttttcctgcaagaatgttctctctcattcctgaccgcccctccactccaattaatagtgcatgcctgctgccctacaagcttgctcccgttctctcttcttttcctcttaagctcagagtagctagaacagagtcagagtcactgctctggttctctgtccccaagtcttcctgagccttctccccttttatgtcttccctctcctcctccgggcccctagcctcccaaacccccattgcccgctggctccttgggcacagaaccacaccttcctgcctggcggctgggagcctgcaggagcctggagcctggttgggcctgagtggtcagtcccagactcgccgtcccgcctgagccttgtctcccttcccagGGCTCCCACTGCAGCAGCTCGGGGGACCCCGCTGAGTACAACCTGCGCTCGCGCACCGTGCTGTGCGGGACCTGCGGGCAGCCTGCCGACAAGGCATCTGCCAGCGGCTCAGGAGCCCAGGTGGGCGGACCCATCTCCTCTGGCTCTTCTGCCTCCAGTGTCACG/GTCA(C>G)TCGCAGCTACCGCAGTGTGGGGGGCAGTGGGGGTGGCAGCTTCGGGGACAATCTGGTCACCCGCTCCTACCTCCTGGGCAACTCCAGCCCCCGAACCCAGgtgagttgtctctgctttgtctccaaatcctgcaggcgggtccctggtcatcgaggggtaggacgaggtggccttgcaggggggagagcctgccttctcttccgcagcccgggggagtgggagcctcctccccacagcctgagtcctagacagcccacctctgcatcctgcccctcttgtctgagccccagactggagggcaggggcagggctggagtgtgagggatgggggagatgctacctcccttctaggggccaggggagggagggtctgggtccaggccctgctgctcacacctctctcctctgttttctctcttag		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	176670	ENSG00000160789	284	375	lamin A/C
367	1	Human	187	RUNX1/AML1	29	Chronic granulomatous disease	IVS4+3delA	-23	100	Exon	2	GTGGTGGCCCTAGGGGATGTTCCAGATGGCACTCTGGTCACTGTGATGGCTGGCAATGATGAAAACTACTCGGCTGAGCTGAGAAATGCTACCGCAGCCATGAAGAACCAGGTTGCAAGATTTAATGACCTCAG/GTTTGTCGGTCGAAGTGGAAGAGgt(a)cgttatctgtcaaaactatgcttgaaacacgtttcatggcaacaaacccacatttcaaaattctagtgatttctgtgatggaatccctagaaactcggtctgtcttaacattcttattgctatgtcaagctcttaaaaatatttatttgaagtttaatatttttagcagaatctcta		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	233710	ENSG00000159216	280	367	runt-related transcription factor 1
379	1	Human	19	CDH1	85	Gastric cancer	E12+190C>T	-37	NULL	Exon	1	GTTCTCCAGTTGCTACTGGAACAGGGACACTTCTGCTGATCCTGTCTGATGTGAATGACAACGCCCCCATACCAGAACCTCGAACTATATTCTTCTGTGAGAGGAATCCAAAGCCTCAGGTCATAAACATCATTGATGCAGACCTTCCTCCCAATACATCTCCCTTCACAGCAGAACTAACACACGGG/G(C>T)GAGTGCCAACTGGACCATTCAGTACAACGACCCAAgtgggtacctgagttttattttggcaactttgctccaactgccatgcttcccttcccccagatccccacctttcaatttcccttctcaacttctagatgtcaccccttccattgatactt		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	137215	ENSG00000039068	286	379	"cadherin 1, type 1, E-cadherin (epithelial)"
369	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS2+1G>T	-105	NULL	Exon	0	taggtatctgtggttgatgcagttttcctaaaacgtcatgattttcaatggcaagtaagttatttatggtcgtttttaaggataagctgttaacgtgttttttttttctttttttttcagCTTCCAATAAAAACAGGACAGCAGAACACACATACCAAA/GTCAGTACTGAGCACAACAAGGAATGTCTAATCAATATTTCCAAATACAAGTTTTCTTTGGTTATAAGCGGCCTCACTACTATTTTAAAGAATGTTAACAATATG(g>t)tgagtatttgggttactgtgttttggggaatttgctttcttttctttttgattaaaaagtttagaacagcatattttgaagtatggaaagtgattttctgtggactttggatataaccattaatcttattttgtttacgagcacagataaccttttaattttattttgtcaaattttta		No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	162200	ENSG00000196712	282	369	neurofibromin 1
384	1	Human	176	JAK3	213	Severe combined immunodeficiency	E12+67C>T	-21	100	Exon	0	tgggattattggagtggaagaaacccacgcatcttctctcccttcccaccttccccagTCATTCCTGGAAGCAGCGAGCTTGATGAGCCAAGTGTCGTACCGGCATCTCGTGCTGCTCCACG/G(C>T)GTGTGCATGGCTGGAGACAgtgagagccccccacccacccaccccacccctgcctcacccaagtctaggctgttcttcccacctctgttctgagccgctatatgacagccccagcaacacactgggccaccctggatgg		No	NULL	Out	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	300400	ENSG00000105639	290	384	Janus kinase 3
413	1	Human	83	HBB	19	Beta-thalassemia	IVS1+1G>T	-38	40	Exon	-32768	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAG/GTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAG(g>t)ttggtatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	NULL	No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	603902	ENSG00000221842	305	413	"hemoglobin, beta"
414	1	Human	83	HBB	19	Beta-thalassemia	IVS1+1G>T	-16	60	Exon	-32768	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTG/GTGAGGCCCTGGGCAG(g>t)ttggtatcaaggttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	NULL	No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	603902	ENSG00000221842	305	414	"hemoglobin, beta"
415	1	Human	83	HBB	19	Beta-thalassemia	IVS1+1G>T	12	NULL	Intron	-32768	ataagaaaattgggaaaacgatcttcaatatgcttaccaagctgtgattccaaatattacgtaaatacacttgcaaaggaggatgtttttagtagcaatttgtactgatggtatggggccaagagatatatcttagagggagggctgagggtttgaagtccaactcctaagccagtgccagaagagccaaggacaggtaCGGCTGTCATCACTTAGACCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAG(g>t)ttggtatcaag/gttacaagacaggtttaaggagaccaatagaaactgggcatgtggagacagagaagactcttgggtttctgataggcactgactctctctgcctattggtctattttcccacccttag	NULL	No	NULL	In	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	603902	ENSG00000221842	305	415	"hemoglobin, beta"
422	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	IVS1+1G>A	-82	NULL	Exon	1	ACTTTGACAGTCTTCTCATGCTGCCTCTGCCACCTTCTCTGCCAGAAGATACCATTTCAACTTTAACACAGCATGATCGAAACATACAACCAAACTTCTCCCCGATCTGCGGCCACTGGACTGCCCATCAGCATGAAAATTTTTAT/GTATTTACTTACTGTTTTTCTTATCACCCAGATGATTGGGTCAGCACTTTTTGCTGTGTATCTTCATAGAAGGTTGGACAAG(g>a)taagatgaaccacaagcctttattaactaaatttggggtccttactaattcataggttggttctacccaaatgatggatgatggtagaaaccaaatagaagaatggtcttgtggcataatgtttgttgcctagtcaatgaagtctcatattcttgtctctggttaggatcttgggatctggagtcagactgcctgggttcaaatcttggctctgcccataccatctctgttatcctggggcaagtgcctcagtttccacatctgagaaatggggatggtattggtgtccatttcataga	NULL	No	NULL	In	94.49	NULL	NULL	61.41	15.58	-0.89	0.07	0.07	NULL	NULL	17.1	7.6	-7.4	0.7	7	0.01	1	NULL	308230	ENSG00000102245	309	422	CD40 ligand
423	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	IVS1+1G>T	-82	NULL	Exon	1	ACTTTGACAGTCTTCTCATGCTGCCTCTGCCACCTTCTCTGCCAGAAGATACCATTTCAACTTTAACACAGCATGATCGAAACATACAACCAAACTTCTCCCCGATCTGCGGCCACTGGACTGCCCATCAGCATGAAAATTTTTAT/GTATTTACTTACTGTTTTTCTTATCACCCAGATGATTGGGTCAGCACTTTTTGCTGTGTATCTTCATAGAAGGTTGGACAAG(g>t)taagatgaaccacaagcctttattaactaaatttggggtccttactaattcataggttggttctacccaaatgatggatgatggtagaaaccaaatagaagaatggtcttgtggcataatgtttgttgcctagtcaatgaagtctcatattcttgtctctggttaggatcttgggatctggagtcagactgcctgggttcaaatcttggctctgcccataccatctctgttatcctggggcaagtgcctcagtttccacatctgagaaatggggatggtattggtgtccatttcataga	NULL	No	NULL	In	94.49	NULL	NULL	61.41	15.58	-0.89	0.07	0.07	NULL	NULL	17.1	7.6	-7.4	0.7	7	0.01	1	NULL	308230	ENSG00000102245	309	423	CD40 ligand
424	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	IVS1+1G>T	-43	NULL	Exon	1	ACTTTGACAGTCTTCTCATGCTGCCTCTGCCACCTTCTCTGCCAGAAGATACCATTTCAACTTTAACACAGCATGATCGAAACATACAACCAAACTTCTCCCCGATCTGCGGCCACTGGACTGCCCATCAGCATGAAAATTTTTATGTATTTACTTACTGTTTTTCTTATCACCCAGATGATTGG/GTCAGCACTTTTTGCTGTGTATCTTCATAGAAGGTTGGACAAG(g>t)taagatgaaccacaagcctttattaactaaatttggggtccttactaattcataggttggttctacccaaatgatggatgatggtagaaaccaaatagaagaatggtcttgtggcataatgtttgttgcctagtcaatgaagtctcatattcttgtctctggttaggatcttgggatctggagtcagactgcctgggttcaaatcttggctctgcccataccatctctgttatcctggggcaagtgcctcagtttccacatctgagaaatggggatggtattggtgtccatttcataga	NULL	No	NULL	In	94.49	NULL	NULL	70.78	15.58	3.82	3.01	3.01	NULL	NULL	17.1	11.3	-7.4	-5.2	7	0.13	1	NULL	308230	ENSG00000102245	309	424	CD40 ligand
426	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	IVS1+1G>T	-14	NULL	Exon	2	ACTTTGACAGTCTTCTCATGCTGCCTCTGCCACCTTCTCTGCCAGAAGATACCATTTCAACTTTAACACAGCATGATCGAAACATACAACCAAACTTCTCCCCGATCTGCGGCCACTGGACTGCCCATCAGCATGAAAATTTTTATGTATTTACTTACTGTTTTTCTTATCACCCAGATGATTGGGTCAGCACTTTTTGCTGTGTATCTTCATA/GAAGGTTGGACAAG(g>t)taagatgaaccacaagcctttattaactaaatttggggtccttactaattcataggttggttctacccaaatgatggatgatggtagaaaccaaatagaagaatggtcttgtggcataatgtttgttgcctagtcaatgaagtctcatattcttgtctctggttaggatcttgggatctggagtcagactgcctgggttcaaatcttggctctgcccataccatctctgttatcctggggcaagtgcctcagtttccacatctgagaaatggggatggtattggtgtccatttcataga	GA donor site	No	NULL	In	94.49	NULL	NULL	52.05	15.58	-3.71	-3.06	-3.06	NULL	NULL	17.1	NULL	-7.4	-2.4	7	NULL	1	NULL	308230	ENSG00000102245	309	426	CD40 ligand
425	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	IVS1+1G>T	-10	NULL	Exon	1	ACTTTGACAGTCTTCTCATGCTGCCTCTGCCACCTTCTCTGCCAGAAGATACCATTTCAACTTTAACACAGCATGATCGAAACATACAACCAAACTTCTCCCCGATCTGCGGCCACTGGACTGCCCATCAGCATGAAAATTTTTATGTATTTACTTACTGTTTTTCTTATCACCCAGATGATTGGGTCAGCACTTTTTGCTGTGTATCTTCATAGAAG/GTTGGACAAG(g>t)taagatgaaccacaagcctttattaactaaatttggggtccttactaattcataggttggttctacccaaatgatggatgatggtagaaaccaaatagaagaatggtcttgtggcataatgtttgttgcctagtcaatgaagtctcatattcttgtctctggttaggatcttgggatctggagtcagactgcctgggttcaaatcttggctctgcccataccatctctgttatcctggggcaagtgcctcagtttccacatctgagaaatggggatggtattggtgtccatttcataga	NULL	No	NULL	In	94.49	NULL	NULL	74.2	15.58	5	4.04	4.04	NULL	NULL	17.1	10.1	-7.4	-4.8	7	0.35	1	NULL	308230	ENSG00000102245	309	425	CD40 ligand
436	1	Human	120	PCCB	150	Propionic acidemia	IVS6+462A>G	462	100	Intron	-32768	AGGAATGTTACGGCATCCGGAGTCATCCCTCAGATTTCTCTGATCATGGGCCCATGTGCTGGTGGGGCCGTCTACTCCCCAGCCCTAACAGACTTCACGTTCATGGTAAAGgtaagaaagaagggcctgtttttggtgccgtttgagatttgtgcagttccttacctgcaataaaaataattcctgacccagatctaggttgttacctgcattctcattggctttcagcatagtgatgataaggtgttaatggagagagggttttggcatgaaatctgtagcttgtgggggttcagtggcaggggatgcttatgtacttcattggtgggtgattttacttgttgatctgaattgcaaatgattttcaggtaatcaaagaatcctgtcctttgaccagatagatgactgtttactgagtcctattcaagaagtttctcatggaaggcttttctgtaatctgtttattgggaagttgtttcttcctttatttcttcag/CTCCTTGCCATTTTATTACATTGTGTCCATAATGGTAAAGGATAAATCTGATCTCACACTTCATTTTCAGAG/gtac(a>g)tatctttattacatgactttaatggacttatattttaaaaatatttttaaatgaagtctatttgaagttatacatgagtaattaccattcatctcaaaccttgctttaaaaaaatcagccttttcttcttaaaatattaataaaaatgaacattggatgccaagacagaatggttggggggaaaaagtagtgatagccatccaacttgaggagaggagttctagagggagtgtaaatgggaaaccctttgttctcaagggaagttaggcagtaggaattcaaaagtttcacaaagtgcttaccactttgacccaacta	Creates pseudoexon	No	NULL	Out	NULL	NULL	NULL	86.22	NULL	11.03	NULL	8.88	NULL	NULL	NULL	18.8	NULL	-5.5	NULL	1	NULL	NULL	606054	ENSG00000114054	312	436	"propionyl CoA carboxylase, beta polypeptide"
428	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	IVS2+1G>A	19	NULL	Intron	1	ATAGAAGATGAAAGGAATCTTCATGAAGATTTTGTATTCATGAAAACGATACAGAGATGCAACACAGGAGAAAGATCCTTATCCTTACTGAACTGTGAGGAGATTAAAAGCCAGTTTGAAGGCTTTGTGAAG(g>a)taagcagcttaattactg/gtaaaagtgtcattgaaatattttactacatttgctagatcgggaaactgacaatgccaatgtttaaagattggttatagacacagacacacagacacacacacacatatatatgcatgcagatatacacacatacatgggtgtgtgtgtgggggttaaaa	NULL	No	NULL	In	93.91	NULL	NULL	74.34	16.08	5.05	6.24	6.24	NULL	NULL	17.3	12.2	-7.4	-3.9	7	0.83	1	NULL	308230	ENSG00000102245	309	428	CD40 ligand
429	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	IVS2+2T>A	19	NULL	Intron	1	ATAGAAGATGAAAGGAATCTTCATGAAGATTTTGTATTCATGAAAACGATACAGAGATGCAACACAGGAGAAAGATCCTTATCCTTACTGAACTGTGAGGAGATTAAAAGCCAGTTTGAAGGCTTTGTGAAGg(t>a)aagcagcttaattactg/gtaaaagtgtcattgaaatattttactacatttgctagatcgggaaactgacaatgccaatgtttaaagattggttatagacacagacacacagacacacacacacatatatatgcatgcagatatacacacatacatgggtgtgtgtgtgggggttaaaa	NULL	No	NULL	In	93.91	NULL	NULL	74.34	16.08	5.05	6.24	6.24	NULL	NULL	17.3	12.2	-7.4	-3.9	7	0.83	1	NULL	308230	ENSG00000102245	309	429	CD40 ligand
433	1	Human	197	OAT	220	Ornithine 8-aminotransferase deficiency	IVS3+303C>G	303	100	Intron	-32768	ATCTGTGGTTTTTCTACTTGAAGGACACAATGTTTTCCAAACTAGCACATTTGCAGAGGTTTGCTGTACTTAGTCGCGGAGTTCATTCTTCAGTGGCTTCTGCTACATCTGTTGCAACTAAAAAAACAGTCCAAGGCCCTCCAACCTCTGATGACATTTTTGAAAGGGAATATAAGTATGGTGCACACAACTACCATCCTTTACCTGTAGCCCTGGAGAGAGGAAAAGgtacgtttcaaattaatccgtcttttcccttttcttgaaaccttttataaaaaaaaattgcttccatattttcacaatatacatttttctagatgtgtttaatgtgtatattgcagacatggttaattcttcttcttctttttttttttttttttttgag/ACGGAGTCTCACTCTGTCACCCAGGCTGGAGTACAGTGGCACAATCCCAGCTCACTGCAACCTCTGCCTCCCAGGTTCAAGCGATTCTTCTGCCTCAGCCTCCTGAGTAGCTGGGACTACAGGCGTGCGCCACCACACCCAG/(c>g)taatttttgtatttttagtagagatggggtttcaccatgttggccaggctggtctcagactcctgactttgtgatcctcccaccttggcctcccaaagtgctgggattacaggtgtgagccaccacgcctggccagttaattcatttattgagtgtctagtgctgctgtgttaggtgctatggaggcttcaaagaggaaccattgtctttgtcatgtagaccttaccaagagggaatgcaagagaaataaggaaagtactatcatattgctgtcatttttttcttttaacttttattttggcatagttttagacttaagaaaagttgtaacaaatagtactgacattttccttttatacttctcccagattttccaagtgctaactttttgctgctttggtcttagtgtgttcactcccttctcttctccccccgccgcctgcatattctacattgttttctgaactgttttgagaggaagttgcagacatgacatctcttcttctttttttttttttttttttttttttgagacggaatgtcgctttgtcacccaggctggagtgcaatggtgggatctcggctcactgcaacctctacctctcggtttcaagtgattctcttgcctcagcctcccgaggagctgggactacaggcccacgccaccacgtccagctaatttttgtatttttagtagagacagggtttcatcatgttggccgggctggtctcgaactcctgacctcaggtgatccacccacctcagcctcccaaagtgctggattacaggcgtgagccaccgcgccccgccacatgacatctctttacccataaatacttagtgtgtctttccaaaaacgcaatgactttttgagatagggtctcattctgttgccc	Creates pseudoexon	No	NULL	Out	NULL	NULL	NULL	87.96	NULL	7.72	NULL	9.17	NULL	NULL	NULL	16	NULL	-6	NULL	0.94	NULL	NULL	258870	ENSG00000065154	311	433	ornithine aminotransferase
421	1	Human	196	MR	215	"Autosomal dominant pseudohypoaldosteronism, type I"	E5+351G>T	-10	NULL	Exon	1	CACGAAAGTCAAAGAAGTTGGGAAAGTTAAAAGGGATTCACGAGGAGCAGCCACAGCAGCAGCAGCCCCCACCCCCACCCCCACCCCCGCAAAGCCCAGAGGAAGGGACAACGTACATCGCTCCTGCAAAAGAACCCTCGGTCAACACAGCACTGGTTCCTCAGCTCTCCACAATCTCACGAGCGCTCACACCTTCCCCCGTTATGGTCCTTGAAAACATTGAACCTGAAATTGTATATGCAGGCTATGACAGCTCAAAACCAGATACAGCCGAAAATCTGCTCTCCACGCTCAACCGCTTAGCAGGCAAACAGATGATCCAAGTCGTGAAGTGGGCAAAG/GTACTTCCA(G>T)gtaggattgcctctcctttcacaggctgcatcctgaacttaacaagtctgggcaactgacttcgccatctccaaccatgcaggaggagtttgcgttctatgaaatcctgatatcagattttttaaattgataacaaattgatcaagtgtataggaaaaatatggttaatgtgctcatttcttccgagaatgcagggttaaggattttattgttaaaatgacagatacggctgggcgcagt	NULL	No	NULL	In	84.59	NULL	NULL	76.96	13.08	6.99	5.82	5.82	NULL	NULL	15.7	12.3	-8	-4	8	0.96	0.95	NULL	177735	ENSG00000151623	308	421	"nuclear receptor subfamily 3, group C, member 2"
427	1	Human	11	BRCA1	24	Breast cancer predisposition	IVS20+1G>A	87	NULL	Intron	0	CATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAG(g>a)taaagctccctccctcaagttgacaaaaatctcaccccaccactctgtattccactcccctttgcagagatgggccgcttcatttt/gtaagacttattacatacatacacagtgctagatactttcacacaggttcttttttcactcttccatcccaaccacataaataagtattgtctctactttatgaatgataaaactaagagatttagagaggctgtgtaatttggattcccgtctcgggttcagatcttagctgataagtggaagagctgggactttaagcagatgagaatctaaagactttgctcttttcacttcactggggtgtctttctctctctctctcttgctctctct	NULL	No	NULL	In	82.74	NULL	NULL	69.61	13.78	3.75	3.54	3.54	NULL	NULL	14.1	12	-5.4	-2.6	6	0.31	0.93	NULL	113705	ENSG00000012048	310	427	"breast cancer 1, early onset"
434	1	Human	181	MUT	219	Methylmalonic acidemia	IVS11+3691C>A	3684	100	Intron	-32768	ctcctcctgctcctctaccctctgataggccccagtgtgtgttgtttccctctttgccttgtttgtgtccatgtgttctcataatttagctcccaattataagaaagaacatgtggtatttggttttctgttcctgtattagtttgctaagggtaatggcttccagcttcatccatgttcctgcaaaggacacgatctcattctttttttctggctgcatagtattctttagtgtgtgtgtatcacattttctttatccagtctatcactgatgggcatttaggttgattccatgtctttgctgtggtgaatagtgctacaatgaacatacatgtgaatgtgtatttttttttttttttttgaaacag/AGTCTCGCTCTTTCATCCATGCTGGAGTGCAGTGGTATGATCTTGGCTCACTACAACCTCCACCTCCTGGGTTCAA/gtgagt(c>a)ttctgcctcagccatatgagtatctggtactacaggcacgtgccaccatacctggccaatttttgtatttttagtagagatgggtttcaccatgttggccaggctggtctcgaactcatgacctcaagtgatccacccgcctctgcctcccaaagtgctagaattacaggcatgaaccaccacgcccagctgcaagcatgtttttataatagaaagatttctgttcatttgggtatatgtacggtaatgggattgctgggttgggaggtatttctgttttgaggtctgtgcggaatcaccacactgtcgtctacaatggttgaactaatttacactctcaccaacactgtataaacgttccattttctccacaaccttgctagcatctgttattttttgactttttaataatagccattctgactggtgtgaaatggtgtctcattggggtttttatttgcatttctctaacaatcagtgatttggagctttttaaaaatacgattgttggccacatgtatgtcttttttggaaagtgtctgttcatgtcttttgcctgctttttaatgtttttttgtaaatttgtttaagttttttatagatgcaggtattagacctttgtcagattcacagtttgcaaaagttttctcccattctgtaggttatctgtttactgtgttgatagtatccttttcagtgcagatgctttttagtttaattatatctcatttgtcaatttttgcttttgttgtaattgcttttggcatcttcatcatgaagtctttgcccattagtatgttctgaatggtattgcctagattgtcttccagggtttttatagtcattatctagtaataaacaatgatttatctttactttctgactgtttagACTCCTCGTGAAGTGGCCCAGCAGGCTGTGGATGCGGATGTGCATGCTGTGGGCATAAGCACCCTCGCTGCTGGTCATAAAACCCTAGTTCCTGAACTCATCAAAGAACTTAACTCCCTTGGACGGCCAGATATTCTTGTCATGTGTGGAGGGGTGATACCACCTCAG	Creates pseudoexon	No	NULL	Out	NULL	NULL	NULL	83.12	NULL	8.34	NULL	8.53	NULL	NULL	NULL	17.2	NULL	-4.1	NULL	0.99	NULL	NULL	251000	ENSG00000146085	312	434	methylmalonyl CoA mutase
430	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	IVS4+1G>C	23	NULL	Intron	2	gaccagatagttttgtgggcagtttttgcattattttagcctgacagtttttggttccatttcagGTGATCAGAATCCTCAAATTGCGGCACATGTCATAAGTGAGGCCAGCAGTAAAACAACATCTG(g>c)taagtcacacagcatctgagcg/gtagccacccaaggggaaaggctgggatgccgaagtcatgttacctaatggttaaactcctcttttcccctgggacccaatttacaaacctacccctacacttctcctattcccttctttgtcttcaaagtgagttcaaatgcacagatgggacttagagggacaaaaggaggtggaatgcaatctggatgttctcattatgttcttgctcaatggctgattctaaatgatgaattactgggtggagggaccattgttctgacaacatagaagaaatggcatgtagtgacctcctgactgggagcatccctcctcctaacccatcttcactgtgtgg	NULL	No	NULL	In	91.46	NULL	NULL	59.3	15.88	4.41	2.09	2.09	NULL	NULL	17.2	10.2	-7.3	-3.5	9	0.04	1	NULL	308230	ENSG00000102245	309	430	CD40 ligand
431	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	IVS4+1G>C	73	NULL	Intron	1	gaccagatagttttgtgggcagtttttgcattattttagcctgacagtttttggttccatttcagGTGATCAGAATCCTCAAATTGCGGCACATGTCATAAGTGAGGCCAGCAGTAAAACAACATCTG(g>c)taagtcacacagcatctgagcggtagccacccaaggggaaaggctgggatgccgaagtcatgttacctaatg/gttaaactcctcttttcccctgggacccaatttacaaacctacccctacacttctcctattcccttctttgtcttcaaagtgagttcaaatgcacagatgggacttagagggacaaaaggaggtggaatgcaatctggatgttctcattatgttcttgctcaatggctgattctaaatgatgaattactgggtggagggaccattgttctgacaacatagaagaaatggcatgtagtgacctcctgactgggagcatccctcctcctaacccatcttcactgtgtgg	NULL	No	NULL	In	91.46	NULL	NULL	63.94	15.88	-0.06	0.92	0.92	NULL	NULL	17.2	8.1	-7.3	-1	9	0.03	1	NULL	308230	ENSG00000102245	309	431	CD40 ligand
432	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	IVS4+1G>C	152	NULL	Intron	2	gaccagatagttttgtgggcagtttttgcattattttagcctgacagtttttggttccatttcagGTGATCAGAATCCTCAAATTGCGGCACATGTCATAAGTGAGGCCAGCAGTAAAACAACATCTG(g>c)taagtcacacagcatctgagcggtagccacccaaggggaaaggctgggatgccgaagtcatgttacctaatggttaaactcctcttttcccctgggacccaatttacaaacctacccctacacttctcctattcccttctttgtcttcaaa/gtgagttcaaatgcacagatgggacttagagggacaaaaggaggtggaatgcaatctggatgttctcattatgttcttgctcaatggctgattctaaatgatgaattactgggtggagggaccattgttctgacaacatagaagaaatggcatgtagtgacctcctgactgggagcatccctcctcctaacccatcttcactgtgtgg	NULL	No	NULL	In	91.46	NULL	NULL	82.88	15.88	7.78	8.16	8.16	NULL	NULL	17.2	12.5	-7.3	-4.1	9	0.89	1	NULL	308230	ENSG00000102245	309	432	CD40 ligand
437	1	Human	18	CD40L	187	X-linked hyperimmunoglobulinemia M	IVS3+1011A>T	1010	NULL	Intron	-32768	gtaggtttgctatttgctaatttctatgaatgcctaaaaactaaaaggaagctttaggctgatcatattgaacaacccagtgttgttgcatcagggaacttttagccctggaaataaaacaggaacacaattgtcaaattgacaccttctctggtccctgtgatttggaaagactttgtacatatatatttatgaaaaaaggatgtgttcctttaatgccgatgataccaaatctgaagaaatcccattatgttcaataccttaatagaagcaaccatacagcctgataccacctacagtggaataagaagacaggaaagtcatcatttggtaacagtggcattcatcactcattgataacagtttttcatggggcacagtggccggtggagcctctgggatcaaggagtgacaatgtcacagtgttctattatttgcccggttcttaaagtgagagcatcctgaacatctcagggttggaagagaacttgagagttctcaaatccagcaccatccccacaacaaaaatctccttcacaataacactgaccgtccagcctctgatcaaacatgtcgagggatgaggcaccttccacctcataaggcagcctgatccgtctttgaatggctctaataataccaagattactatactactccagagaagtctttcctcctcaagtcaaactttgttcctataatctccactcattggtcccagttctgctctttgaggccctagtaaacaaagtataattgctctcctacccagcagctgtccagatatggaagacagcaatcatggtggccaagccttgactgagctttttcttctccaggctaaagatccctgatgtcttccactgtttctcctatgaccctttccaggacctttcttctgccactcacctccttttcttggacacactaacgttttcctgttcttttag/AATGTGGCATCGCAAACCAATACAATAATGCGTGAAGTGACTTCAGCAGCAGATTATGG/g(a>t)aagacggggtgttgttagagagaattttatatcacaaagttggtgaacatgatgttatggcttctgcaaatttaatacacacaaaaacatacatacatacagggatagagatactattttctgaggcaaagagagtactcagaccttgccttaactgttgttctggatactaaatggtcatccgacttccatgaaggttttatcttcagaatgactgcaagatatgttgagtaatagtaccacgctgtctgttaattacagagaaatctgaggaaacagtttatgtagatgctgcctagaagtcttcagggaaatgataatattaaccaaactggtcatttaggtcatgcaatttaactcaacatttatagggcacttacaaagtgcccaatatcaggctcataactggacaaaaagaaacttccacacagtctctgcccttagaagattgacacatctcattagggagcagggctttaacacaagaaataattaaagacagatacaatagttcagccagttgcttgaccaattcagaaaccataagaatcttactaagtgtgcagactttggagcccactaaaatccccagtgtatggagttgttcctaaaagcaagattcacggtatgtttaatgaagaccagtgtttttagcctgtgtcaatctatgcaaaatggaatcgagtattgatcaactgttaggagaatgagaccgatggaaacagccaattcaattactcagatattagaaaccaacttttccttcagtgggagagatgtcagaccattttatctttccttttatataatctatttttgcacagtctctattacacagttgtagaactggaccagatagttttgtgggcagtttttgcattattttagcctgacagtttttggttccatttcag	Creates pseudoexon	No	NULL	Out	NULL	NULL	NULL	81.51	NULL	7.6	NULL	7.41	NULL	NULL	NULL	15	NULL	-8	NULL	0.99	NULL	NULL	308230	ENSG00000102245	309	437	CD40 ligand
438	1	Human	195	HCN2	218	Idiopathic generalized epilepsy	IVS5+7C>T	5	NULL	Intron	2	TACAAGCAGGTGGAGCAGTACATGTCCTTCCACAAGCTGCCAGCTGACTTCCGCCAGAAGATCCACGACTACTATGAGCACCGTTACCAGGGCAAGATGTTTGACGAGGACAGCATCCTGGGCGAGCTCAACGGGCCCCTGCGGGAGgtgag/g(c>t)gggcgccgggcgggcgggaggcagcctccggtacagggccggcctccctctcctggagcccaggagccggtccctgagggaggcgaggtgcctaggctgcagcaggagggactcgagctagacctgcgtacacaccctcccctccccgccccgtgagcctctgcacccccagg	NULL	No	NULL	Out	86.85	NULL	NULL	76.03	11.78	6	6.89	6.89	NULL	NULL	15.7	11.2	-8.6	-6.9	7	0.15	0.7	NULL	602781	ENSG00000099822	313	438	hyperpolarization activated cyclic nucleotide-gated potassium channel 2
435	1	Human	198	PCCA	150	Propionic acidemia	IVS14+2778A>G	2778	100	Intron	-32768	tcaaattagctctttcactttttagtactaaaattaagaaaatgaaaactcacagatatattttctgttatgtaacccgtttactagttgccattttggggctctttaatgtggggaaaaggtagattgtgattttattgcttttaaagctgctccattaatttttttctag/TTTTTGTCAACACTGTGAATTTCAT(A>G)GAACATCAGTTTATGTCCTGAAATATGTTTTCAGAAAATAGAAAGCCAAGTATATTTC/gtaagtgtgctgaatgatttttgtttataattaagatttttgtatatgaatgtgaatacgaatacagatatctatatttttgtttgtgcttgcaaatacagaaataaaagcccttcaggtatgttatagtgttccttttacaaccttacaaagagaataatagtagtgtgaattttaagaaaatgaaactatcgcttgtcttctgatgtcaccgtataataaagccatcattataccctcatgtggatatcctagacaagaggttctacatgtggtcccttgataattgcctaaattaaaatattaaaggcctaacagccgctgtgttgacctttttctgccttgctgcagacagatgagctgctgtttattaggaaggcttcttcccacaggtggaaggctacgtgagcttccgctcttctcttcccacccctttacaatgttgggcatcaaagtcctgctgttccagcagctttgattcagttcctccatcctcaagacccctaggatgtgcctgacagtctgaagtattttgattagcttttaaatacttcagattccaaaacttctttctaataatttaataaatgttctgtcctcagtaactgctcatttttaaagttttgcatggctaacctccgtgccttgctgctggtatcaaactgggaaatgaaaacaagaatcagtgatgtactaactcactcgttggctggttaacagcaatcagcctcttcaaaagaatattttgaacttgtgctatccccctaccccccaccccaagaaaatcacaaaatcagaactctaattggggctttacaaagcaaagccataggaaaagctgtgtaaacatgaaagcctcaggggagcaacagtaacagaaaaatagtgttttacagttgagagggtgaggcagaaaaggaaagtgttacagacatgaaaggcccaggcccacattcctatggagctgaggaccaggcttgacgaggggcctcactggtgggctcagaagggtctggcagggagtgcagttagcaagggcatcgtccatgccatgcttcagctggaagacaccatcagagagccacagcatcctggcatagtgatgtaggaagtcttcattttttattttttatttttgctgttttttagtttcgtcattcagtggcagaacaaaaaatgtgttgcattacatattaacggatcaagattttagattgttttcctattttccagaagttgaaatgttatttgagattgaaattctctatccattttctccatggaaatgaaattggtggttacaaaaaaatatctacacaatatgaattacttttctttttttctttttttctcccagGTCCGAGTGGACAGTGGCATCCAACCAGGAAGTGATATTAGCATTTATTATGATCCTATGATTTCAAAA	Creates pseudoexon	No	NULL	Out	NULL	NULL	NULL	74.17	NULL	7.07	NULL	6.14	NULL	NULL	NULL	15.1	NULL	-4.3	NULL	0.98	NULL	NULL	606054	ENSG00000175198	312	435	"propionyl CoA carboxylase, alpha polypeptide"
416	1	Human	193	ALDOB	217	Hereditary fructose intolerance	E3+66G>A	-12	100	Exon	0	tctctgtggacagttccatcaaccagagcatcgggggtgtgatccttttccacgagaccctctaccagAAGGACAGCCAGGGAAAGCTGTTCAGAAACATCCTCAAGGAAAAGGGGATCGTG/GTGGGAATCAA(G>A)gtgaacacctccattcacacctcacttctgctttgtcctaggcaaactccaagcacactggcaaggacagggccaacactctgaacattctcctcatcaaatttctcttctcaccctttt	NULL	No	NULL	In	77.09	NULL	NULL	68.07	10.08	3.34	4.73	4.73	NULL	NULL	10.7	10.6	-5.3	-5.3	6	0.04	0.85	NULL	229600	ENSG00000136872	306	416	"aldolase B, fructose-bisphosphate"
420	1	Human	194	BMPR2	216	Familial pulmonary arterial hypertension	IVS2+2delC	-108	NULL	Exon	0	ttcggataagacaaagattttatataatattttgaaaacattaaataatttgtcattcctttatttcctttattttagCTTCGCAGAATCAAGAACGGCTATGTGCGTTTAAAGATCCGTATCAGCAAGACCTTGGGATAG/GTGAGAGTAGAATCTCTCATGAAAATGGGACAATATTATGCTCGAAAGGTAGCACCTGCTATGGCCTTTGGGAGAAATCAAAAGGGGACATAAATCTTGTAAAACAAGg(c)aagtgatactttccttacctgaaatgactgtgttttatacaattgatatttatctaaaaaggacatgggagtatgttaaaatcctgttcagaaaaacagtgaatttaaaagtgtatatataaagccaggtgtggtggctcatgcctgtaattccagcacttttcgaggctgaggtgggcggatcacttgaggccaggagtttgagaccagcctgggtaataacatggtgaaaccccgt	GC donor site	No	NULL	In	82.64	NULL	NULL	85.7	7.72	7.44	8.31	8.31	NULL	NULL	10.7	15.7	-4.8	-7.2	7	0.64	NULL	NULL	178600	ENSG00000204217	307	420	"bone morphogenetic protein receptor, type II (serine/threonine kinase)"
418	1	Human	194	BMPR2	216	Familial pulmonary arterial hypertension	IVS2+6T>G	-108	NULL	Exon	0	ttcggataagacaaagattttatataatattttgaaaacattaaataatttgtcattcctttatttcctttattttagCTTCGCAGAATCAAGAACGGCTATGTGCGTTTAAAGATCCGTATCAGCAAGACCTTGGGATAG/GTGAGAGTAGAATCTCTCATGAAAATGGGACAATATTATGCTCGAAAGGTAGCACCTGCTATGGCCTTTGGGAGAAATCAAAAGGGGACATAAATCTTGTAAAACAAGgcaag(t>g)gatactttccttacctgaaatgactgtgttttatacaattgatatttatctaaaaaggacatgggagtatgttaaaatcctgttcagaaaaacagtgaatttaaaagtgtatatataaagccaggtgtggtggctcatgcctgtaattccagcacttttcgaggctgaggtgggcggatcacttgaggccaggagtttgagaccagcctgggtaataacatggtgaaaccccgt	GC donor site	No	NULL	In	82.64	NULL	NULL	85.7	7.72	7.44	8.31	8.31	NULL	NULL	10.7	15.7	-4.8	-7.2	7	0.64	NULL	NULL	178600	ENSG00000204217	307	418	"bone morphogenetic protein receptor, type II (serine/threonine kinase)"
419	1	Human	194	BMPR2	216	Familial pulmonary arterial hypertension	IVS2+2delC	-60	NULL	Exon	0	ttcggataagacaaagattttatataatattttgaaaacattaaataatttgtcattcctttatttcctttattttagCTTCGCAGAATCAAGAACGGCTATGTGCGTTTAAAGATCCGTATCAGCAAGACCTTGGGATAGGTGAGAGTAGAATCTCTCATGAAAATGGGACAATATTATGCTCGAAAG/GTAGCACCTGCTATGGCCTTTGGGAGAAATCAAAAGGGGACATAAATCTTGTAAAACAAGg(c)aagtgatactttccttacctgaaatgactgtgttttatacaattgatatttatctaaaaaggacatgggagtatgttaaaatcctgttcagaaaaacagtgaatttaaaagtgtatatataaagccaggtgtggtggctcatgcctgtaattccagcacttttcgaggctgaggtgggcggatcacttgaggccaggagtttgagaccagcctgggtaataacatggtgaaaccccgt	GC donor site	No	NULL	In	82.64	NULL	NULL	71.87	7.72	4.92	5.15	5.15	NULL	NULL	10.7	12.3	-4.8	-4.7	7	0.85	NULL	NULL	178600	ENSG00000204217	307	419	"bone morphogenetic protein receptor, type II (serine/threonine kinase)"
417	1	Human	194	BMPR2	216	Familial pulmonary arterial hypertension	IVS2+6T>G	-60	NULL	Exon	0	ttcggataagacaaagattttatataatattttgaaaacattaaataatttgtcattcctttatttcctttattttagCTTCGCAGAATCAAGAACGGCTATGTGCGTTTAAAGATCCGTATCAGCAAGACCTTGGGATAGGTGAGAGTAGAATCTCTCATGAAAATGGGACAATATTATGCTCGAAAG/GTAGCACCTGCTATGGCCTTTGGGAGAAATCAAAAGGGGACATAAATCTTGTAAAACAAGgcaag(t>g)gatactttccttacctgaaatgactgtgttttatacaattgatatttatctaaaaaggacatgggagtatgttaaaatcctgttcagaaaaacagtgaatttaaaagtgtatatataaagccaggtgtggtggctcatgcctgtaattccagcacttttcgaggctgaggtgggcggatcacttgaggccaggagtttgagaccagcctgggtaataacatggtgaaaccccgt	GC donor site	No	NULL	In	82.64	NULL	NULL	71.87	7.72	4.92	5.15	5.15	NULL	NULL	10.7	12.3	-4.8	-4.7	7	0.85	NULL	NULL	178600	ENSG00000204217	307	417	"bone morphogenetic protein receptor, type II (serine/threonine kinase)"
683	1	Human	202	BRCA2	232	Breast Cancer	IVS21+1G>A	46	100	Intron	1	AAAACACAACAAAACCATATTTACCATCACGTGCACTAACAAGACAGCAAGTTCGTGCTTTGCAAGATGGTGCAGAGCTTTATGAAGCAGTGAAGAATGCAGCAGACCCAGCTTACCTTGAG(g>a)tgagagagtaagaggacatataatgaggcttgatgattattcaag/gtgagaagctgttttagactctctggccatcacaggaaggagtatgttgaaatgctgcatttctcaaaagggatgtgtacatttctgggattttcagtgatgtgccagacgagtgtggtggtatgttttcaactatataccgagtagaggatgggagggttctagaattttatatattaattaaatttggttta	NULL	No	NULL	In	86.75	7.66	8.68	89.52	11.78	13.98	9.98	9.98	9.67	9.26	15.7	15.9	-7.4	-7.3	7	1	7	0.98	612555	ENSG00000139618	486	683	"breast cancer 2, early onset"
686	1	Human	202	BRCA2	24	Breast cancer predisposition	IVS21+5G>A	46	NULL	Intron	1	AAAACACAACAAAACCATATTTACCATCACGTGCACTAACAAGACAGCAAGTTCGTGCTTTGCAAGATGGTGCAGAGCTTTATGAAGCAGTGAAGAATGCAGCAGACCCAGCTTACCTTGAGgtga(g>a)agagtaagaggacatataatgaggcttgatgattattcaag/gtgagaagctgttttagactctctggccatcacaggaaggagtatgttgaaatgctgcatttctcaaaagggatgtgtacatttctgggattttcagtgatgtgccagacgagtgtggtggtatgttttcaact	NULL	No	NULL	In	86.75	7.66	8.68	89.52	11.78	13.98	9.98	9.98	9.67	9.26	15.7	15.9	-7.4	-7.3	7	1	7	0.98	113705	ENSG00000139618	487	686	"breast cancer 2, early onset"
603	1	Human	108	LPL	262	Lipoprotein Lipase Deficiency	IVS2+1G>A	-18	98	Exon	0	AAAGAAGAGATTTTATCGACATCGAAAGTAAATTTGCCCTAAGGACCCCTGAAGACACAGCTGAGGACACTTGCCACCTCATTCCCGGAGTAGCAGAGTCCGTGGCTACCTGTCATTTCAATCACAGCAGCAAAACCTTCATG/GTGATCCATGGCTGGACG(g>a)taagggaggctctttggggaagagtggattggggtggtgaggtatcctgactggcctgcccaattgttggggacccagtgatgggtccgcaccccacatctcacgtggatctccttacacttgaataaagacagttctggctcaggtgggatctgaagccacaggttcatgagaactccccctaggcagtgccagccttcattttaacactgtacctggttggtgcccttgagccagagcttcctgcgaggttggtaaaggatgctctgcccagctactgagcagaagataggtgattgctgtggggaaccggtggaaccctggcatgatcccgcatcacccagcacattgccaggagaacctttctaaagaagacagcatggaagagtgaggagagggctggagtggagtgaggaagtgtggcgtccatgctggctttgccattctccagctctgtgctgtggatcaagtcacttgtcatctctgggcctccatttac	NULL	No	NULL	In	85.38	10.38	0.74	68.36	14.28	5.28	4.16	4.16	3.06	10.12	15	8.6	-7.4	-3.6	6	NULL	6	0.99	246650	ENSG00000175445	434	603	lipoprotein lipase
672	1	Human	108	LPL	262	Lipoprotein Lipase Deficiency	IVS2+1G>A	42	NULL	Intron	0	AAAGAAGAGATTTTATCGACATCGAAAGTAAATTTGCCCTAAGGACCCCTGAAGACACAGCTGAGGACACTTGCCACCTCATTCCCGGAGTAGCAGAGTCCGTGGCTACCTGTCATTTCAATCACAGCAGCAAAACCTTCATGGTGATCCATGGCTGGACG(g>a)ataagggaggctctttggggaagagtggattggggtggtgag/gtatcctgactggcctgcccaattgttggggacccagtgatgggtccgcaccccacatctcacgtggatctccttacacttgaataaagacagttctggctcaggtgggatctgaagccacaggttcatgagaactccccctaggcagtgccagccttcattttaacactgtacctggttggtgcccttgagccagagcttcctgcgaggttggtaaaggatgctctgcccagctactgagcagaagataggtgattgctgtggggaaccggtggaaccctggcatgatcccgcatcacccagcacattgccaggagaacctttctaaagaagacagcatggaagagtgaggagagggctggagtggagtgaggaagtgtggcgtccatgctggctttgccattctccagctctgtgctgtggatcaagtcacttgtcatctctgggcctccatttac	NULL	No	NULL	In	85.38	10.38	7.59	68.67	14.28	9.28	3.86	3.86	5.47	10.12	15	12.3	-7.4	-4.2	6	NULL	6	0.99	246650	ENSG00000175445	434	672	lipoprotein lipase
673	1	Human	108	LPL	262	Lipoprotein Lipase Deficiency	IVS2+1G>A	146	NULL	Intron	2	AAAGAAGAGATTTTATCGACATCGAAAGTAAATTTGCCCTAAGGACCCCTGAAGACACAGCTGAGGACACTTGCCACCTCATTCCCGGAGTAGCAGAGTCCGTGGCTACCTGTCATTTCAATCACAGCAGCAAAACCTTCATGGTGATCCATGGCTGGACG(g>a)taagggaggctctttggggaagagtggattggggtggtgaggtatcctgactggcctgcccaattgttggggacccagtgatgggtccgcaccccacatctcacgtggatctccttacacttgaataaagacagttctggctcag/gtgggatctgaagccacaggttcatgagaactccccctaggcagtgccagccttcattttaacactgtacctggttggtgcccttgagccagagcttcctgcgaggttggtaaaggatgctctgcccagctactgagcagaagataggtgattgctgtggggaaccggtggaaccctggcatgatcccgcatcacccagcacattgccaggagaacctttctaaagaagacagcatggaagagtgaggagagggctggagtggagtgaggaagtgtggcgtccatgctggctttgccattctccagctctgtgctgtggatcaagtcacttgtcatctctgggcctccatttac	NULL	No	NULL	In	85.38	10.38	6.71	79.63	14.28	11.48	7.98	7.98	6.9	10.12	15	12.9	-7.4	-7.6	6	0.52	8	0.99	246650	ENSG00000175445	434	673	lipoprotein lipase
674	1	Human	108	LPL	262	Lipoprotein Lipase Deficiency	IVS2+1G>A	251	NULL	Intron	2	AAAGAAGAGATTTTATCGACATCGAAAGTAAATTTGCCCTAAGGACCCCTGAAGACACAGCTGAGGACACTTGCCACCTCATTCCCGGAGTAGCAGAGTCCGTGGCTACCTGTCATTTCAATCACAGCAGCAAAACCTTCATGGTGATCCATGGCTGGACG(g>a)taagggaggctctttggggaagagtggattggggtggtgaggtatcctgactggcctgcccaattgttggggacccagtgatgggtccgcaccccacatctcacgtggatctccttacacttgaataaagacagttctggctcaggtgggatctgaagccacaggttcatgagaactccccctaggcagtgccagccttcattttaacactgtacctggttggtgcccttgagccagagcttcctgcgag/gttggtaaaggatgctctgcccagctactgagcagaagataggtgattgctgtggggaaccggtggaaccctggcatgatcccgcatcacccagcacattgccaggagaacctttctaaagaagacagcatggaagagtgaggagagggctggagtggagtgaggaagtgtggcgtccatgctggctttgccattctccagctctgtgctgtggatcaagtcacttgtcatctctgggcctccatttac	NULL	No	NULL	In	85.38	10.38	6.36	76.7	14.28	11.28	4.55	4.55	6.23	10.12	15	13.4	-7.4	-6.3	6	NULL	8	0.99	246650	ENSG00000175445	434	674	lipoprotein lipase
675	1	Human	108	LPL	262	Lipoprotein Lipase Deficiency	IVS2+1G>A	388	NULL	Intron	1	AAAGAAGAGATTTTATCGACATCGAAAGTAAATTTGCCCTAAGGACCCCTGAAGACACAGCTGAGGACACTTGCCACCTCATTCCCGGAGTAGCAGAGTCCGTGGCTACCTGTCATTTCAATCACAGCAGCAAAACCTTCATGGTGATCCATGGCTGGACG(g>a)taagggaggctctttggggaagagtggattggggtggtgaggtatcctgactggcctgcccaattgttggggacccagtgatgggtccgcaccccacatctcacgtggatctccttacacttgaataaagacagttctggctcaggtgggatctgaagccacaggttcatgagaactccccctaggcagtgccagccttcattttaacactgtacctggttggtgcccttgagccagagcttcctgcgaggttggtaaaggatgctctgcccagctactgagcagaagataggtgattgctgtggggaaccggtggaaccctggcatgatcccgcatcacccagcacattgccaggagaacctttctaaagaagacagcatggaaga/gtgaggagagggctggagtggagtgaggaagtgtggcgtccatgctggctttgccattctccagctctgtgctgtggatcaagtcacttgtcatctctgggcctccatttac	NULL	No	NULL	In	85.38	10.38	2.6	68.55	14.28	8.18	4.95	4.95	5.17	10.12	15	10.3	-7.4	-4.3	6	NULL	5	0.99	246650	ENSG00000175445	434	675	lipoprotein lipase
678	1	Human	166	APOB	199	Familial hypobetalipoproteinemia	IVS24+2T>C	40	NULL	Intron	1	aaaggaagcttcaggacaccagctaggaggctgactatgttagacattccttttataaatatggacagtgatcagtgactggcaacgaagattcataattttctgttatttatttttaactttcagtgcattgtccagcttaataattaacttgtcaaatcggtatttttgcctaatgttcattgctctttgaggctcatccaagcccattaccttaaaaatctcctgtcattttgtagGCAATGAGCTCATGGCTTCAGAAGGCATCTGGGAGTCTTCCTTATACCCAGACTTTGCAAGACCACCTCAATAGCCTGAAGGAGTTCAACCTCCAGAACATGGGATTGCCAGACTTCCACATCCCAGAAAACCTCTTCTTAAAAAGg(t>c)aaaagaagaaagcagcaaggcttcttgaaccatgcaaa/gtaaatgaaagattttacatagcatgatttagacatttttttaaatttttaaaggaaataatttaagcattttaaggagattaataactatagcacaaacactgtggcatctttgcattagtaaacatgagaacaccaaccctgtcaggaagaatctaagaaagtcattagaggattctggtactttcaccctaagatattttattcagtacaacctgttataagcaaattctccctctgactgtgaagaattcagaatg	NULL	No	NULL	In	82.64	8.38	4.06	76	13.28	7.28	6.09	6.09	4.04	7	14.1	9.4	-5.4	-1.7	6	0.6	6	0.82	107730	ENSG00000084674	482	678	apolipoprotein B (including Ag(x) antigen)
657	1	Human	247	TNFRSF1A	291	TNF-receptor associated periodic syndrome (TRAPS)	IVS4+1G>A	45	100	Intron	0	AAATGGGTCAGGTGGAGATCTCTTCTTGCACAGTGGACCGGGACACCGTGTGTGGCTGCAGGAAGAACCAGTACCGGCATTATTGGAGTGAAAACCTTTTCCAGTGCTTCAATTGCAGCCTCTGCCTCAATGGGACCGTGCACCTCTCCT(g>a)tgagcgcagctctcctgaggccaagccctctccccaccccaggg/gttggccccttccccatgcggtggcacttcctttccttccccctcctgtattctgtgggtctgacaaccaactcctctctggccgcccccaccctgtccctcgtcacttcctctgtcctgtggggtgggggtgcaggcgcttctcctttagctgtgccgcacttctccctacag	NULL	No	NULL	In	67.45	3.28	-3.13	61.68	8.98	2.28	1.04	1.04	1.66	4.7	10.1	8	-2.5	-5.4	6	NULL	7	NULL	142680	ENSG00000067182	470	657	"tumor necrosis factor receptor superfamily, member 1A"
652	1	Human	245	SPG11	230	Autosomal recessive spastic paraplegia	E15+213A>G	65	100	Intron	2	AATACAAATCATATTCCCCTGAAGCCCTCTGGAGATACCTCACAGCTCGCCATGATTGGTTAAACATTATCTTATGGATTGGAGAATTTCAAACCCAGCATAGTTATGCTTCACTTCAGCAGAACAAATGGCCCCTTCTGACTGTTGATGTTATTAACCAGAATACTTCCTGTAACAACTACATGAGGAATGAAATTTTAGATAAGCTGGCC(A>G)Ggtattataactgttgaactaatacccaatgggaagaatacaagggaagagcaagaaaaaataatg/gtatagcttttcctttgaaatgccataaatccagtgtagtgttgtttcatattactataaaatttaaagggcatcatcttacagtgaggttttaaaatcatactcatttggccaagtgcggtggctcatgcctgtaatctcagcactttgggaggccaaggcgggcagatcacct	NULL	No	NULL	In	72.71	7.26	2.86	64.22	10.68	7.48	3.34	3.34	4.6	6.28	14	10.2	-4.9	-2.6	7	NULL	6	0.71	604360	ENSG00000104133	466	652	spastic paraplegia 11 (autosomal recessive)
698	1	Human	214	HGSNAT/TMEM76	285	Sanfilippo Syndrome	IVS9+5G>A	89	NULL	Intron	2	acactagatttaggaggtatttgtattctagagtccttttgcttatgctttgtacttgttctgcagGGCTGACAGTGGCTGACCTCGTGTTCCCGTGgtga(g>a)ttgccggtctgccctcttctcttccacgggttgactccaatctcctgtttttcagatgatgctggagcctctcttctgagacgg/gcatgtgttatgtggttaggaagtccttccaaaagtcctgttactggatagttctcatacttgacccagtgcctacacgtgtgtataaaag	activates GC cryptic site	No	NULL	In	83.48	8.95	1.03	63.74	12.88	4.12	0.1	0.1	1.09	8.31	15.6	NULL	-7.2	-1.9	8	NULL	8	0.89	252930	ENSG00000165102	496	698	heparan-alpha-glucosaminide N-acetyltransferase
594	1	Human	226	NDUFA11	267	Mitochondrial complex I deficiency	IVS1+5g>a	-78	100	Exon	0	ACCTAGGACTCCCTGAGCTGGGACTAGCGAAATCTGTCTGCACTGATCGCAGTCGTCCTCAGTTTCACCCTCTAGGAATCGGCCTGGGGATGCACGTGCTACTCTCTTCCTCCAGGCCGGTCCCCGGCGCGTGCGCGCGATCCATGTCCATGTCCGCGCCTATCAATAAAGTTGCTCACTTGTTGCCGGCCCGCTAGCCCGAAAGGTTGCGCGCGCAGCCCGAGAAGTCTCGCGATAGCCAGCCGCGGCTGCCCTTGCGCTTCCCGAGCTGGCGGGGTCCGTGGTGCGGGATCGAGATTGCGGGCTATGGCGCCGAAGGTTTTTC/GTCAGTACTGGGATATCCCCGATGGCACCGATTGCCACCGCAAAGCCTACAGCACCACCAGTATTGCCAGCGTCGCTGgtga(g>a)cgccggccgggccccgagggtggagggccgaggccgcagggaggtcgtggggttactgggggctgtttggatcgaacgggtctgggagtctcgcgggtacgcacgtggttgtcatcggggtgtcttgggcggtcgtagggggggatcttgtgtgaaatggatgttggtagggggt	NULL	No	NULL	In	80.64	8.05	1.5	64.01	13.28	5.38	1.62	1.62	0.94	7.79	13.8	8.6	-5.8	-1.5	8	NULL	5	0.89	252010	ENSG00000174886	427	594	"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa"
644	1	Human	32	COL5A1	248	Ehlers-Danlos Syndrome	E49+22G>A	-35	NULL	Exon	2	agaaacccctgggtcctgggtgcccaggggcaggcagacagcaggcaggatttggcaaatgcttgaaaccgtagcactgcgttcatcgcggtgctcaccgctgccataaccacatgcactgtctccctagGGCGAGCCTGGCGAAGCAG/GT(G>A)AGCCTGGCCTTCCGGGAGAAGGCGGCCCCCCGgtgagtgagcgggcgctgcgggaggggtgggatatggccgagcgggtgtgtggacggggtgctgggttggaggctctggctctgccttagcttttccatccacgaaatgggagttgtaacccctcttgtgcccatttcatggaatgaccgtgaacaaggtgtgtgatgtgggagtcagca	NULL	No	NULL	Out	85.82	10.9	9.88	94.14	15.68	15.48	11.85	11.85	11.18	10.63	15.8	18.8	-7.5	-8.2	8	1	8	0.98	130010	ENSG00000130635	462	644	"collagen, type V, alpha 1"
688	1	Human	242	SHANK3	227	Autism	IVS19+1delG	76	100	Intron	1	AGAAGCTGGACGAGATGCTGGCAGCCGCCGCAGAGCCAACGCTGCGGCCAGACATCGCAGACGCAGACTCCAGAGCCGCCACCGTCAAACAGAGGCCCACCAGTCGGAGGATCACACCCGCCGAGATTAGC(g)taagggccacgggcggctgggagcgctgggtcgggcaggcatgggggtcagactgtcctgggccctcttgacggag/gtgagagcctatcatgtggacccctctccagaggggtgtgtgcaccccatggcctctctcagagactcttggggctgtctctgccccctaaatggccacagctcagcacctgctgggtttgctcttgtagcttttggtgcctctgccttcaggcagtccctgt	NULL	No	NULL	In	72.2	5.87	7.66	86.75	10.58	11.78	9.14	9.14	9.26	6.45	12	15.7	-4.4	-7.4	5	0.86	7	0.94	209850	ENSG00000251322	489	688	SH3 and multiple ankyrin repeat domains 3
651	1	Human	212	GHRHR	259	Isolated Growth Hormone Deficiency (IGHD)	E1+2T>G	427	100	Intron	1	AGCCAAGGCTTACTGAGGCTGGTGGAGGGAGCCACTGCTGGGCTCACCATGGACCGCCGGATGTGGGGGGCCCACGTCTTCTGCGTGTTGAGCCCGTTACCGACCg(t>g)gagtagccagctgagaccctctggcctctgccactgggctccagatttgggagccacagggccaactggagcctggcggagaccctactgcccttctcctgctctagagtccctccctacgagcaggtggcaggctgtggcttggagagcccctgacactggggctccctccctcatctccctctgcccagcaatctgtagtgactctgggtagtgctattaacatgtccttccaggggctgagctgagctcaccttcttgttgcttcccccagggcctggctgtgcctctgggggccacagagactctgtctgccacaagacagtgcctcagaattggtgaggcaaagtcaggctcccctcttagtccctgcagtttgctctttctctcagctgtgcacctgtgatgcttccacacgctcctgtg/gtaagctttctggacccttccttagccctatgactccctgagccactctccagtttggtggtttcctttgaagagggtgtggccagggaaggaatggaacctaaggagttgg	NULL	No	NULL	In	72.35	9.4	8.15	82.59	12.38	13.08	8.61	8.61	7.62	7.69	13.8	15	-4.2	-5.9	6	0.99	7	0.83	139191	ENSG00000106128	465	651	growth hormone releasing hormone receptor
676	1	Human	246	SUMF1	271	Multiple Sulfatase Defieciency	IVS7+5G>T	89	100	Intron	2	aggcttaaggtaagatgatgagttggcagaaacttgtggagaggacagagctaactgacttggggtcgctcagtgctgaaagacattgtgtggccaggaaagctgagctgtgatgacaagactcatattgggtccaatgggattttcctgtgaatgattttgaaagtctaagtatcatctatcctctccctactcacccaatgtttgacacaaatttttgattgatgataatattagtaactctattaggaataatttctctgactttcataccatttaatatgaactctctttaggtttctgaattcctctaagagctcaaagccaaaaaaaaaatgcccctttctttgtctttatgttggtcaaattgtactttgactgttggaataaaacccaacattcatactctgaaattaaagctcttgctgcatttctgcactgaagatgttttttaaaccaggtgaatagtttgacagcatttttcctgtctttgtttttagGTTGATGCCTTCCCTCCCAATGGTTATGGCTTATACAACATAGTGGGGAACGCATGGGAATGGACTTCAGACTGGTGGACTGTTCATCATTCTGTTGAAGAAACGCTTAACCCAgtga(g>t)tattattcacagagcatgtgtcttggaatggtggcatctgtcctctgggcagtctgcagccaggctgtcatgtgtttccgaggg/gtatttacatactctggaaattaatcttgggatttccctaaaggcacattaagcgcatgtttcttatttcaacctcagagcattttgtaaaaatgtctgtgagcatgttatcttttcctggattgtgatggtgataactatttgaggaaatctgcctataactttagaaattgtattcagtctcgtaaatttgatcaaagcatgcatgatatataaataactataaagtttattactgttttattatgaactattaagatctgctaggtggtatttatcatgcctctagttgcctgagttctgatgggttgaaattttgattcagcagcattgtttggagagaaagagaaagggtgttttctggttaaatgttgaagcaggaagttgtgtcatttagtgattaattcctga	minigene analysis only	No	NULL	In	73.91	8.28	3.64	65.81	12.08	5.98	2.74	2.74	2.64	6.77	15.1	10.2	-4.1	-4.7	7	NULL	7	0.97	272200	ENSG00000144455	480	676	sulfatase modifying factor 1
685	1	Human	11	BRCA1	24	Breast cancer predisposition	IVS16+5G>T	65	100	Intron	2	AGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTgtga(g>t)tgtatccatatgtatctccctaatgactaagacttaacaacattctggaaagagttttat/gtaggtattgtcaattaataacctagaggaagaaatctagaaaacaatcacagttctgtgtaatttaatttcgattactaatttctgaaaatttagatctagataaagctatagtgtggattattttatgtatat	NULL	No	NULL	In	69.92	5.91	2.16	73.29	9.88	8.18	4.55	4.55	3.22	4.98	13.2	14.3	-3.9	-3.8	6	NULL	8	0.66	113705	ENSG00000012048	487	685	"breast cancer 1, early onset"
605	1	Human	124	PFKM	289	"Glycogenosis, type VII"	IVS16+1G>T	-75	100	Exon	0	AGTGGTTCGCACACAGTGGCTGTGATGAACGTGGGGGCTCCGGCTGCAGGCATGAATGCTGCTGTTCGCTCCACT/GTGAGGATTGGCCTTATCCAGGGCAACCGAGTGCTCGTTGTCCATGATGGTTTCGAGGGCCTGGCCAAGGGGCAG(g>t)tatggggactattctgggacctaggagcagtcatggggaagataagtgtagcaagaatgacctgtccattctcttggcttcctctgttcctcactacctctctctcctctctcagggtccaggcagaagtagatatttaatactagggcagtaggaacagcaggaattactgcagtgaaccattgcaaacaacatgtcttatttaattctctgtcccaaagctcagcacagtgcctggcataggtagatgcttaatatttgtgaatgagcagtaagggtagaagaagttgagtgcgtggggaaaagctaatacctggtgtaccttttccaaccaagggggatccaggggtagggttagaactcaagcagtggcaccagtcccacacaggcctcctagtgctttagccttgtgcagagctctgtggcttatccccacag	NULL	No	NULL	In	84.85	9.99	3.71	67.9	11.98	8.58	3.93	3.93	4.88	8.9	15.5	11.6	-4.9	-3.7	8	NULL	5	0.82	232800	ENSG00000152556	436	605	"phosphofructokinase, muscle"
591	1	Human	243	SLC40A1	253	Hemochromatosis	E7+642G>A	-413	NULL	Exon	2	ATACTGAGCCAAAACCCCTGGAGGGAACTCATCTAATGGGTGTGAAAGACTCTAACATCCATGAGCTTGAACATGAGCAAGAGCCTACTTGTGCCTCCCAGATGGCTGAGCCCTTCCGTACCTTCCGAGATGGATGGGTCTCCTACTACAACCAGCCTGTGTTTCTGGCTGGCATGGGTCTTGCTTTCCTTTATATGACTGTCCTGGGCTTTGACTGCATCACCACAGG/GTACGCCTACACTCAGGGACTGAGTGGTTCCATCCTCAGTATTTTGATGGGAGCATCAGCTATAACTGGAATAATGGGAACTGTAGCTTTTACTTGGCTACGTCGAAAATGTGGTTTGGTTCGGACAGGTCTGATCTCAGGATTGGCACAGCTTTCCTGTTTGATCTTGTGTGTGATCTCTGTATTCATGCCTGGAAGCCCCCTGGACTTGTCCGTTTCTCCTTTTGAAGATATCCGATCAAGGTTCATTCAAGGAGAGTCAATTACACCTACCAAGATACCTGAAATTACAACTGAAATATACATGTCTAATGGGTCTAATTCTGCTAATATTGTCCCGGAGACAAGTCCTGAATCTGTGCCCATAATCTCTGTCAGTCTGCTGTTTGCAGGCGTCATTGCTGCTAGAATC(G>A)gtaagaaatctctttttatatattaatgaactaaagtgtctttttgtaatgtaggttcagagaatccattaataaatgatctgaaatgttccctaaatgttaatttaagcaaaatccactcttacgaaatttttattttacatatttatactttatatttattgtgttttttattttata	very long exon	No	NULL	In	81.46	10.53	8.18	73.98	14.28	11.08	6.22	6.22	7.68	9.5	15.2	11.7	-6.2	-4.6	6	0.97	6	0.99	235200	ENSG00000138449	424	591	"solute carrier family 40 (iron-regulated transporter), member 1"
599	1	Human	204	CACNA1A	249	Episodic Ataxia Type 2	IVS26+3insT	-32	100	Exon	2	atagagtgttctgagcagaggagggacttgatccaggtgttcacaggtgccctttggcatctgtgggaagccagaggacctgtgagcaggtgatcacactggtccccatgggcgatgacggggacaggatcaggctggtgaccaaagaagaggtgagaagtggacagattcttggaaggttctggaaatagagccagtgagttttgctgatagagccaccaatgagggatttgggacaaagaggcatcaaagaggatcccaaagtttggatctaagagccggcaagccagagctggcttccatcaggcaaaggggggccgcctcatggggcaggggctccccactcctccctggagtcctctggccactgcccatccctgcaagatgaggtggcctcattggcttccctgcctctccccgagaggctagagagtgggtggcagcaccccagggtggggatcaggtgggggttctgagcaccctctcttctcccccacagATGATTGACCTGGGGCTCGTCCTGCATCAGGGTGCCTACTTCCGTGACCTCTGGAATATTCTCGACTTCATAGTG/GTCAGTGGGGCCCTGGTAGCCTTTGCCTTCACgt[t]aagtctcctcgcaagggttcctcttgcctcttttcccccaacccccagcctgggccacacatcggattacaggacatgttctcagggtctagggatggggtgtgtgggctccggggacgtgggagatatcagcatgccaccaggaagagcttcgatggctttttgcatgatgtccatggaggaagaaggagaagggaccccccctcctgccaaccttctacctcctcacacagcaacgggcctcagccacatcactggccccttgctgtgcagcttcctgtagactagcctcgccggaacatctcatccccctactactccacaagcgccgcccaaaccgctgtctctttggaaagtccctaaagagacaatcaggaaacgaatgtgcatgagaattctgaccccctccctatgcctgaaggccccgtagttgtagacctggtgactccctttgtgtgtctttcacttctcctggcagtcctaggattctctgccctc	NULL	No	NULL	In	86.77	10.16	4.85	78.29	15.28	8.88	5.31	5.31	5.34	9.72	16.6	13.1	-4.3	-4.5	8	NULL	7	1	108500	ENSG00000141837	431	599	"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit"
590	1	Human	104	LDLR	61	Familial hypercholesterolemia	IVS8+1G>A	-51	100	Exon	0	ATATCGATGAGTGTCAGGATCCCGACACCTGCAGCCAGCTCTGCGTGAACCTGGAGGGTGGCTACAAGTGCCAGT/GTGAGGAAGGCTTCCAGCTGGACCCCCACACGAAGGCCTGCAAGGCTGTGG(g>a)tgagcacgggaaggcggcgggtgggggcggcctcaccccttgcaggcagcagtggtgggggagtttcatcctctgaactttgcacagactcatatcccctgaccgggaggctgtttgctcctgagggctctggcaggggagtctgccgccctgttaggacttgggcttgccagggggat	NULL	No	NULL	In	75.96	7.23	2.87	67.95	11.98	7.68	4	4	4.56	6.79	13.8	10.3	-7.9	-4.3	7	NULL	5	0.69	144010	ENSG00000130164	423	590	low density lipoprotein receptor
723	1	Human	46	DMD	244	Duchenne Muscolar Distrophy	IVS27+6298C>A	6295	NULL	Intron	1	atatgttgggagttacctcatcagctccatctactattttgaacagaagtttagttttttatttgtactttccttcaaagccactttggattctgtgatttcaaagtaattttaagatccaaactgttaagcttaacagttattctaagtggcttttagctccaattcgggcttcaagactatattttattttgcaaaggtgacctgtaaagctggtacattcagcctctccagctgtgtccttcagatgcattgaggacagaagaagctatccattctgacagttaaatcagcaaggtagttcattacctcaatctgcaccaaagttaataagacacattaccaatcacgtctccttgtcttcaaagctctaaggtaccctcgggtatttaagaagatatttatattttcccactgggatctttgcccagaatgaagacagcctgtagtccagcaggagctggaaatgacccagattttagatttctatcaccttttaaagcaaaacacttaatttcactttttgcaataaactgtacataagatatcaagcaggtatgaaaggttggtacgtttgccaagcaggtgagactgatacttttcatcagatagagatcgaatactctgtgtcattctaagggctatgaacatagagaactttgggaaatctgattaattttttagatccttctgaaataaatcttcctttcaagcctttaattttggtggtagtgaggcgggggcaggtggtagtaagtggtgatgattgctgcattgtgtttactgtacttataggttcattcaacagttacaaagctaacagaaaatgaccgttgttacattcttatcctctctcgcatcttcctatcttttccccaatagacataatcaccatctagaaagctacctttgttattcctttgtttaaaaaaaatccacacacatatgagtgaaaaaacaattgtgcttaatttcagtattacagtaatggtaaactataatatagtttttttagggctttgtctttcacccaacatatttgtgtctgagattcattcttatggttctttttgatgagatttttcattgtcacgtctgtattctctgtttaaagatgacggtatatttttccattctccttgcagtggacattatttccttttttttgattactacaaaaagggctgaaatgatcattgttgtaacagtcttgttatccatgttaaacagtttctctgaggatgcacatatcaaaaagtggagttgttgtcttgatgggtatgtgaatgttcaccttattgagaataacaaattgttttctgaaatggccatttcagtacacacacccaccaacaataaatacaaatttttgttcatgtatatcttctctcacacgtggaattgtcaaacttctcatttgtgtcaatcaacatggtatctcattgtaatcctggcctacatgtccttgattactaatgagattgaacatatcttcatgtttaatgtatatacatatttctctttaagattttggttcaggttttcttttcattatcgattgggttattcatcttctatttgacttgctggcatttttcatattcttatgtgttacag/ATGTTGCAGTTGTTTTCTTCTATTTTGAGTCTGTTTTTCAATTACTTGATGGTGTCCTTTGATGAATAGAAGGTCCTAATTTTAATGTAGTCGAATGTATTCATCTCTTTTTTCTTACG/gt(c>a)agttttttacgagatgtcttacttaagatattcttctctatgccaaagtcagaaatattttcttctatattttcttgtagaaattttaaagttctgcttttttatgagtacttctgtgtataaatcagtttcataatacaaattaatggccatttaaaataatcaaacctttgaattagtggtaatatttccgataatatacctcaaggaaataataagaatgtggaaaaatagtccatattcacgatgatgtttaccataaatttataatagcaaacaaaactaaaagtagtctatctaaaaaaaggaaattgctaaactaagatagagccactttaaagaagtcttagattttcattaaaaatatgtcttcttagtaatacagaaaatggtatgatataatgtttagtgaaaagagagctatagttaaactcacttaaattttaactatcaaattatatatgataaatttcagaggaggtcacagaatactggtaacagtgatgtgtgagggagttagatttacatatgcatttttacatatgcttttatttttctgtttcccagactgcaatgttggtgcttatttttattttaaaaagtaaattactgtcttttgaatttattcattattcatgtaataaaatgttttcttaatgacttttgattgtagaggtattagatgatgaaactgtctagctgcattttgaattacctgctacaaagtaaaggtgaaaaatacaaagtgttatattttcagaagttttaataatgaaatggcaaaatttcacatttacttttctaccataatatttaatctgtgatatatatttctttcttag	creates pseudoexon	No	NULL	Out	NULL	NULL	11.81	90.55	NULL	16.68	NULL	10.36	11.81	NULL	NULL	17.5	NULL	-7.6	NULL	1	7	NULL	310200	ENSG00000198947	516	723	dystrophin
692	1	Human	32	COL5A1	248	Ehlers-Danlos Syndrome	IVS35+1G>A	118	NULL	Intron	1	atatttgactcagacgttttgatgacgttgtgggccagagtcttttcatccaaataataacaatcataagcttttcccccctctccttccctctcaagGGCAACTCCGGAGGTGACGGCCCAGCTGGCCCTCCTGGTGAACGG(g>a)taagcagctggagccttcgggggtgtctccaagggcagagcctgcctcgaatgccccctgcactttgtcctggggtgggctggggccagggaggcacgcctcagaccctgctgaagg/gtagggttttcctaagatcccaagggtgggtcacgccctgggagtgaactcttccgtaggtc	NULL	No	NULL	In	84.99	9.14	5.76	75.3	14.18	8.88	7.12	7.12	6.29	9.43	15.6	11.9	-8	-9	8	0.52	7	1	130010	ENSG00000130635	462	692	"collagen, type V, alpha 1"
589	1	Human	225	NALP12	256	Hereditary periodic fever syndromes	IVS3+3insT	-170	100	Exon	2	ATCCCCAGGAAACCTACAGGGACTATGTCCGCAGGAAATTCCGGCTCATGGAAGACCGCAATGCGCGCCTAGGGGAATGTGTCAACCTCAGCCACCGGTACACCCGGCTCCTGCTGGTGAAGGAGCACTCAAACCCCATGCAGGTCCAGCAGCAGCTTCTGGACACAGGCCGGGGACACGCGAGGACCGTGGGACACCAGGCTAGCCCCATCAAGATAGAGACCCTCTTTGAGCCAGACGAGGAGCGCCCCGAGCCACCGCGCACCGTGGTCATGCAAGGCGCGGCAGGGATAGGCAAGTCCATGCTGGCACACAAGGTGATGCTGGACTGGGCGGACGGGAAGCTCTTCCAAGGCAGATTTGATTATCTCTTCTACATCAACTGCAGGGAGATGAACCAGAGTGCCACGGAATGCAGCATGCAAGACCTCATCTTCAGCTGCTGGCCTGAGCCCAGCGCGCCTCTCCAGGAGCTCATCCGAGTTCCCGAGCGCCTCCTTTTCATCATCGACGGCTTCGATGAGCTCAAGCCTTCTTTCCACGATCCTCAGGGACCCTGGTGCCTCTGCTGGGAGGAGAAACGGCCCACGGAGCTGCTTCTTAACAGCTTAATTCGGAAGAAGCTGCTCCCTGAGCTATCTTTGCTCATCACCACACGGCCCACGGCTTTGGAGAAGCTCCACCGTCTGCTGGAGCACCCCAGGCATGTGGAGATCCTGGGCTTCTCTGAGGCAGAAAGGAAGGAATACTTCTACAAGTATTTCCACAATGCAGAGCAGGCGGGCCAAGTCTTCAATTACGTGAGGGACAACGAGCCTCTCTTCACCATGTGCTTCGTCCCCCTGGTGTGCTGGGTGGTGTGTACCTGCCTCCAGCAGCAGCTGGAGGGTGGGGGGCTGTTGAGACAGACGTCCAGGACCACCACTGCAGTGTACATGCTCTACCTGCTGAGTCTGATGCAACCCAAGCCGGGGGCCCCGCGCCTCCAGCCCCCACCCAACCAGAGAGGGTTGTGCTCCTTGGCGGCAGATGGGCTCTGGAATCAGAAAATCCTATTTGAGGAGCAGGACCTCCGGAAGCACGGCCTAGACGGGGAAGACGTCTCTGCCTTCCTCAACATGAACATCTTCCAGAAGGACATCAACTGTGAGAGGTACTACAGCTTCATCCACTTGAGTTTCCAGGAATTCTTTGCAGCTATGTACTATATCCTGGACGAGGGGGAGGGCGGGGCAGGCCCAGACCAGGACGTGACCAGGCTGTTGACCGAGTACGCGTTTTCTGAAAGGAGCTTCCTGGCACTCACCAGCCGCTTCCTGTTTGGACTCCTGAACGAGGAGACCAGGAGCCACCTGGAGAAGAGTCTCTGCTGGAAGGTCTCGCCGCACATCAAGATGGACCTGTTGCAGTGGATCCAAAGCAAAGCTCAGAGCGACGGCTCCACCCTGCAGCAGGGCTCCTTGGAGTTCTTCAGCTGCTTGTACGAGATCCAGGAGGAGGAGTTTATCCAGCAGGCCCTGAGCCACTTCCAG/GTGATCGTGGTCAGCAACATTGCCTCCAAGATGGAGCACATGGTCTCCTCGTTCTGTCTGAAGCGCTGCAGGAGCGCCCAGGTGCTGCACTTGTATGGCGCCACCTACAGCGCGGACGGGGAAGACCGCGCGAGGTGCTCCGCAGGAGCGCACACGCTGTTGGTGCAGCTgt[t]aagtatccctggggtatcccctggggctgcttaggttcgtgtgttttttttttttttttttttttttgctctgttgcctaggctggagtacactggcgtgacctcagctcactgcaacctccgcctcccgggttcaagagattctcctgcttcagcctcccaagtagctgggactaca	exceptionally long exon	No	NULL	In	75.26	8.56	4.28	77.14	12.68	9.78	6.56	6.56	5.71	6.46	17	12.4	-4	-5.9	6	NULL	7	0.97	611762	ENSG00000142405	422	589	"NLR family, pyrin domain containing 12"
646	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E43+54C>T	-71	NULL	Exon	2	atgtccaaacattttctttttagtgtattcccatttatagacactgtagttaatgaacttgcatattcttaacttttgtttatagGAACAAGGAAAAGTTTTGATCACTTGATATCAGACACAAAGGCTCCTAAAAG/G(C>T)AAGAAATGGAATCAGGGATCACAACACCCCCCAAAATGAGGAGAGTAGCAGAAACTGATTATGAAATGGgtgagaaacaaagtattgatctagatcattgaaaataaggtgggagagtacatgaaagtcatgtttattttccagccatttcttagaatctttagagtgaaatatagaaacgtttgccatttctcaaaagataaactctaccattcaagacagttatcttgaagcttgtgtaaaaattaa	NULL	No	NULL	Out	76.55	6.04	10.57	94.49	11.18	15.58	11.36	11.36	10.55	6.72	13.8	17.3	-7.9	-7.4	7	1	7	0.77	162200	ENSG00000196712	441	646	neurofibromin 1
667	1	Human	236	PTCH1	275	Nevoid basal cell carcinoma syndrome	IVS6+5G>T	-87	NULL	Intron	0	attaacttatgagtcctctctctgcttagcatcttcagtcatgaattattttcctgacctaagtttttatgcagatatgctggaaaggagcatttgttttgatgccagagtcccagaactgcagcattgccaggaacctcctacaaggtggatgcagtgggcgcagccgtgttactttacgatgcgtttagaaggctcttttcatggtctcgtctcctaatttcttttgcagAGGTAAACCTCCTTTGCGGTGGACAAACTTCGACCCTTTGGAATTCCTGGAAGAGTTAAAGAAAATAAACTATCAAGTGGACAGCTGGGAGGAAATGCTGAATAAGGCTGAG/GTTGGTCATGGTTACATGGACCGCCCCTGCCTCAATCCGGCCGATCCAGACTGCCCCGCCACAGCCCCCAACAAAAATTCAACCAAAgtga(g>t)taccagcagtgagcgctctcagaagggtggagagcaaaacacttttttgtgtccattcatcgttcactttattattttcatttttaacatttcattctccatgatcgtctttgtctatggaactaagtttatttatagagctaaattttgctgtaagatttgccatacacctcccattagccttgctattaatgttctctctgaaacacacaagcccttaatgc	NULL	No	NULL	In	82.88	8.4	6.36	76.7	12.68	11.28	4.55	4.55	6.23	7.78	14.2	11.7	-4.1	-6.3	7	NULL	8	0.98	109400	ENSG00000185920	476	667	patched 1
592	1	Human	114	MSH2	300	Hereditary nonpolyposis colon cancer	IVS7+2T>A	-48	20	Exon	0	ATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGG/GTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGg(t>a)aacaagtgattttgtttttttgttttccttcaactcatacaatatatacttggcaatgtgctgtcctcataaagttggtggtggtgactcactcttaggacacattcagatttcttttttttttttttttgagaaggagtcttgctccgttgccaaggctagagtgcagtggcacaat	NULL	No	NULL	In	82.01	8.92	2.31	63.5	12.68	7.68	2.68	2.68	3.77	6.99	14.1	10.2	-5.1	-4.7	6	NULL	6	0.91	120435	ENSG00000095002	425	592	"mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)"
625	1	Human	250	USH2A	293	Usher syndrome	IVS12+5G>A	-30	NULL	Exon	0	ATTGGAGGACAGTGTAATTGTAAGAGACACGTGTCTGGCAGGCAGTGCAATCAGTGCCAGAATGGATTCTACAATCTACAAGAGTTGGATCCTGATGGCTGCAGTCCCTGTAACTGCAATACCTCTGGGACAGTGGATGGAGATATTACCTGTCACCAAAATTCAG/GCCAGTGCAAGTGCAAAGCAAACGTTATTGgtac(g>a)tgtaacgcaaaagtttacagtcacatctctattaccatctggaataaaattctctatttgatttcttaactgaagagtaaagcaaatttctttgctcaagacaggctggaaaaaaaaacaatttggatgaaattaactgtttaaaatgattaaattaataattctatcaaactgcagcttgaagcttagtttaatcaaccctttagaagtttctttattctgtagatgcattaat	activats GC donor site	No	NULL	In	76.63	8.11	1.19	72.73	12.38	4.42	0.8	0.8	1.15	8.35	14.8	NULL	-3.9	-3.1	7	NULL	7	0.98	276901	ENSG00000042781	448	625	"Usher syndrome 2A (autosomal recessive, mild)"
716	1	Human	112	MLH1	89	Hereditary nonpolyposis colorectal cancer	E1+173A>G	227	10	Intron	2	ATTGGCTGAAGGCACTTCCGTTGAGCATCTAGACGTTTCCTTGGCTCTTCTGGCGCCAAAATGTCGTTCGTGGCAGGGGTTATTCGGCGGCTGGACGAGACAGTGGTGAACCGCATCGCGGCGGGGGAAGTTATCCAGCGGCCAGCTAATGCTATCAAAGAGATGATTGAGA(A>G)CTGgtacggagggagtcgagccgggctcacttaagggctacgacttaacgggccgcgtcactcaatggcgcggacacgcctctttgcccgggcagaggcatgtacagcgcatgcccacaacggcggaggccgccgggttccctgacgtgccagtcaggccttctccttttccgcagaccgtgtgtttctttaccgctctcccccgagaccttttaagggttgtttggagt/gtaagtggaggaatatacgtagtgttgtcttaatggtaccgttaactaagtaaggaagccacttaatttaaaattatgtatgcagaacatgcgaagttaaaagatgtataaaagcttaagatggggagaaaaa	NULL	No	NULL	Out	75.52	8.6	-20.17	15.63	10.78	-22.45	-17.72	-17.72	-16.25	7.8	12.1	NULL	-2.5	-2.4	7	NULL	1	0.93	609310	ENSG00000076242	488	716	"mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)"
687	1	Human	112	MLH1	89	Hereditary nonpolyposis colorectal cancer	IVS1+5G>C	227	NULL	Intron	2	ATTGGCTGAAGGCACTTCCGTTGAGCATCTAGACGTTTCCTTGGCTCTTCTGGCGCCAAAATGTCGTTCGTGGCAGGGGTTATTCGGCGGCTGGACGAGACAGTGGTGAACCGCATCGCGGCGGGGGAAGTTATCCAGCGGCCAGCTAATGCTATCAAAGAGATGATTGAGAACTGgtac(g>c)gagggagtcgagccgggctcacttaagggctacgacttaacgggccgcgtcactcaatggcgcggacacgcctctttgcccgggcagaggcatgtacagcgcatgcccacaacggcggaggccgccgggttccctgacgtgccagtcaggccttctccttttccgcagaccgtgtgtttctttaccgctctcccccgagaccttttaagggttgtttggagt/gtaagtggaggaatatacgtagtgttgtcttaatggtaccgttaactaagtaaggaagccacttaatttaaaattatgtatgcagaacatgcgaagttaaaagatgtataaaagcttaagatggggagaaaaa	NULL	No	NULL	In	75.52	8.6	-20.17	15.63	10.78	-22.45	-17.72	-17.72	-16.25	7.8	12.1	NULL	-2.5	-2.4	7	NULL	1	0.93	609310	ENSG00000076242	488	687	"mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)"
684	1	Human	92	IDS	269	Mucopolysaccharidosis type II	E3+178G>A	1238	NULL	Exon	2	CAAGCAGTGTGCGCCCCGAGCCGCGTTTCTTTCCTCACTGGCAGGAGACCTGACACCACCCGCCTGTACGACTTCAACTCCTACTGGAGGGTGCACGCTGGAAACTTCTCCACCATCCCCCAGTACTTCAAGGAGAATGGCTATGTGACCATGTCGGTGGGAAAAGTCTTTCACCCT(G>A)gtactgctccatgtccagagtctgggttctcttggtttgtggtgtctgaatccagcattcccatcctggggatggggctgtctttgcagagccctcttctggctgggcgagtccctcgctagtcagtgcttcctttctaaaaaactgacttgtcaacccagccacgttttcacccaaagtgaaaaagggtagaaagagctttgcttcctttcagaaaccactgagggtgtgctgttgggtctttcagctcctcgggtggtagggaggacacaggctggggaggtggcagtgttgggtggagtccagctcagggccccaccctctcccctgcagggtacctgtcagtaaacctaggggtggggtgaggacacctgagggcctcccgtgtggccagcattgctgttgctgacttattgcccaatgagggggctgtgcttaggtaggggctgctatccactctggaaattaagtcagaaagatgagtgtaatctggtacccaggatctatagggtcccagagacggacattccttacctcaaatgctgcctgataaactggctctctttaatgccaatatggggatagtgaaaagcaaacaaactttaaaactttttatttatagaagtaatgcatgagtatttgagaaaaaaaatggagaaaaaagtattggaagacaagagcaccatagggacaataatgcttatcatttgggaatgacgaatgttttcagtctctttccctttgctcagtggttacaccggcaggcttggcagccttctgcaggagctcagctggccagcccaggttgagagtgacattcagctctactaagtcaggccagtttcagaggtgaacctgtcaggaatcatattgcacagccaaaagtccagtgtcaggagaactttctgcagtttggtgttctcattaccataccccttgcccaaatgcagctggagggaagtgatgattttggagagaggaggaaacacagcagagggaggagattgtgctttgggaggggaaaccaggcaaggactgagtgatgttgcttgacctcctccctcctgatgattggattttggcaccaggctctaagcaccatgtccttctcagagaataaacctttccctgcag/CCCTTGTGGGAACACATTTTTCAGCTGAATCTTTGTTCTCAAGACCTTTTTCTGTTAGCATTGGGCCTGCTTCAAGATGACAGTAGCCACCACTGTGTGCCAG/gtatgtaccgtttaccatgctggccactcctttaatcctcccaacagcaagcaaggtgggtttttatcatcatcatcatttcccaaggaagacatgaaggctcatgggagtcaagtagcttgccagaggttgcaaggatgctaagaggcagcatcaggatttggacctgtggttgttggcttcctgtgtgctctttccacagtgcttgctgtcttcataggccctccacccgctgccctctttctctccattcctgtctcttctggtactccctatgggagtcccactgtgtgactgctgctgatgctttctcacgaggttctgcctgtgatcccctccactcccagctaaccactataggcagcacttcccttcagatccctcacaggcctcactggctcctagaagtcctccctgccagtcctcacctgactcacaataacctctgtgcttggaggatcccccacttggcacttcgatgcttttgaaagctggaagtccttccttggtttccagtgctgttatactgtcttcacaaataaactataaactactaagcttaagggtgggtttctgcttcatgaatgagcacttgaacttggaattctaaaacaaggttttgagtcctggctcccttatctaatatctggttagcataggtaagtcacataccttccctgagcctccctctcctgcccccatcggctccctgatggtgctgatgcctctgctgcctccttcatagggtgagagataggtttcagcatgggctctaaggagctgactgatcttgtccttgtgggtcccttccacagagcctagcacaaatcatcagggcttagggaccaggaagtcagatgcttagttctcaaatagaaactagagagtttggctttagaggggacttttgtagatgaggaaactgagccccaaagaagggaggttccacttgcccatttgtttacagagttttaattatggggagtggggtgttgaaagactcatcatgttttaacaacctttttttttttccaag	pseudoexon inclusion	No	NULL	In	63.48	4.41	9.8	90.02	8.38	13.08	10.13	10.13	10.59	5.3	10.4	19.2	-2.5	-6.2	6	1	9	NULL	309900	ENSG00000010404	438	684	iduronate 2-sulfatase
728	1	Human	201	BCKDHA	117	Maple syrup urine disease	IVS2+9C>T	7	50	Intron	1	CACCCCCCCAGGCAGCAGCAGCAGTTTTCATCTCTGGATGACAAGCCCCAGTTCCCAGGGGCCTCGGCGGAGTTTATAGATAAGTTGGAATTCATCCAGCCCAACGTCATCTCTGGAATCCCCATCTACCGCGTCATGGACCGGCAAGGCCAGATCATCAACCCCAGCGAGGACCCCCACgtgagag/g(c>t)ggcctcccccacttcccgtgccccccacgcccaggccccttgcctgtctcctctctggtcccaactgccccacgtctatctgtgcctccacccgcag	NULL	No	NULL	Out	76.53	5.23	1.66	63.55	9.68	6.18	3.05	3.05	2.71	7.29	12.2	10.1	-2.8	-4.4	7	NULL	5	0.76	248600	ENSG00000248098	520	728	"branched chain keto acid dehydrogenase E1, alpha polypeptide"
640	1	Human	248	TSC1	173	Tuberous sclerosis	E5+104A>G	-50	NULL	Exon	2	CACCTCTTGGACAGGATTAACGAATATGTGGGCAAAGCCGCCACTCGTTTATCCATCCTCTCGTTACTGGGTCATGTCATAAGACTGCAGCCATCTTGGAAGC/(A>G)TAAGCTCTCTCAAGCACCTCTTTTGCCTTCTTTACTAAAATGTCTCAAGgtaggatgtttgtaaggatttgaatgaaatggttttatgagtatagtttctgaaattttaggcaacttaaagcaaggaagctagattttaacttttagagtttaaaaccttctaggcatttggcttttctcaaatagaatgttgtccagagttggtacttagtaagttctcaaatacatcactatgactattgaataccttgtccatgcaagtatggaaaaatttcgatcagatgggttc	NULL	No	NULL	Out	84.35	9.45	6.06	71.51	13.68	10.78	6.35	6.35	6.57	8.54	14	12	-7.2	-3.2	7	0.9	5	0.95	191100	ENSG00000165699	459	640	tuberous sclerosis 1
691	1	Human	32	COL5A1	248	Ehlers-Danlos Syndrome	IVS19+1G>A	4	NULL	Intron	1	cagaattagagaaaaacaaagtgggaccttggacaagccctgcatgacctgctcaggagaggctgacgttgaccctttcacttcctagGGTGACCCTGGTCCTTCCGGCCCACCAGGACCTCCGGGAGACGATGGAGAAAGG(g>a)tag/gtattctgccgtccctccgactgctcctgcctgccctactcctcagtgatttgggcaggaaaaccacagaagagaggcccaggtgtgggattggcctgccgcatgtggagggccagctgggagaaggcagatggggattccagtgggcaaagcgattgatcagatgccaagaggct	NULL	No	NULL	In	80.47	8.1	4.57	68.07	11.28	7.38	2.96	2.96	2.69	7.98	16.9	12.3	-9.2	-4	8	NULL	7	0.99	130010	ENSG00000130635	462	691	"collagen, type V, alpha 1"
636	1	Human	83	HBB	282	Reduced Haemoglobin (A2)	E1+133G>T	-16	80	Exon	1	cagggaggacaggaccagcataaaaggcagggcagagtcgactgttgcttACACTTTCTTCTGACATAACAGTGTTCACTAGCAACCTCAAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGACTGCTGTCAATGCCCTGTGGGGCAAAGTGAACGTGGATGCAGTTGGTG/GTGAG(G>T)CCCTGGGCAGgttggtatcaaggttataagagaggctcaaggaggcaaatggaaactgggcatgtgtagacagagaagactcttgggtttctgataggcactgactctctgtcccttgggctgttttcctaccctcag	NULL	No	NULL	Out	79.71	8.08	8.95	83.48	11.68	12.88	8.45	8.45	8.31	7.2	16.4	15.6	-7	-7.2	9	0.99	8	0.64	141900	ENSG00000221842	455	636	"hemoglobin, beta"
670	1	Human	211	FTSJ1	277	Nonsyndromic X-linked mental retardation	IVS2+1delG	10	NULL	Intron	1	catctatgggatgaatgttgggtttatggggtcttttgtgggaactgtggggtaagtgatgggggcgaggagggtctgtgtgataagcagtggagcctgagagttcagtgattgggtccttcaggccctataaggtcagtggggtcagtgccagggcttcagtcagcccatcttctgtgtgagctgtcatgtgggtcagatgagcccagtttagtttgtgtggttctctccgccctacagAGGTAGGTGGTAGCCCATTCATCTGGTTACTGATACTGGCCGGCATCAGTGGACTGTCGGCAGGTCCTTGAGCAACTGGTGTGTGAAATGGGACGGACGTCAAAGGACAAGCGGGATGTCTACTACCGCCTGGCCAAGGAGAATGGCTGGCGTGCTCGCAGCGCCTTCAAACTGCTACAACTGGATAAGGAATTCCAACTCTTCCAAG(g)tccctgactg/gtgggcaggtcactgggcggtgaggtgggcacaggaggtaaacaagtaggctgggtctgcagagctccctgtggtaggtgggctgactcagagggtctctggggcagggagacaggcaggaagataggcagaataccggagaggagttgggcacctgggcaatggagatatgtgggtgctccccaggggagaggggtgaattttgcaagggtctccaggttggagaagtgggtgcagctgatcaggatgctttcactatgtatgcccag	NULL	No	NULL	In	66.36	0.61	4.81	70.5	6.68	9.58	6.06	6.06	4.46	0.3	10.1	9.5	-2.5	-5.3	5	NULL	8	NULL	309549	ENSG00000068438	478	670	FtsJ homolog 1 (E. coli)
671	1	Human	207	DLG3	277	Nonsyndromic X-linked mental retardation	IVS6+5G>A	26	NULL	Intron	2	catctgtgttgtgtttgcccagatacaaaggccctaattctttctgtggccagggtcttgccctatcccctacctcctgcctctgctcctcacagcactatacttgggcctttgttagcatgctgttgaatttcactgaaaaggcatccctcgagttccctggagaagcctctccttcttccaagtcccagcctgaggcctctcctcttctagGTGAACAACACCAATCTGCAGGATGTGAGGCACGAGGAAGCTGTGGCCTCACTGAAGAACACATCTGATATGGTGTATTTGAAGGTGGCCAAGCCAGGCAGCCTCCACCTCAACGACAT/GTACGCTCCCCCTGACTACGCCAGCAgtac(g>a)tactcatcagcccctgtccctggtctaaagctctgtcccctggtttctggaggggaagaagttcataccctttgttaagagagggcaagcagctttgctcagtggtggcactgtagcagccaataaggtttatctgaggcgccattattgctaattgaaaactttgctcagtaccccatcgtgaagacttgccatagagtcagcattggcaatttttgacaatttctatggagagtgaattttaaaaagaggagagagagaagccgcagaggatagtgcacagaactgagtccagatcccagttctgtctttgtttttttgtttgtttgtttgagacggagtcttgctctgtcgc	NULL	No	NULL	In	65.09	6.49	4.06	70.86	9.38	7.88	4.74	4.74	5.72	6.53	12.4	10.8	-0.8	0.6	5	0.75	6	0.54	309549	ENSG00000082458	479	671	"discs, large homolog 3 (Drosophila)"
694	1	Human	230	PAK3	190	X-linked mental retardation	IVS6+4A>G	4	100	Intron	1	CCAATAAGAAGAAGGAGAAAGAGCGCCCAGAGATCTCTCTTCCTTCAGACTTTGAGCATACGATTCATGTGGGGTTTGATGCAGTCACCGGGGAATTCACTgta(a>g)/gtaagctccttgttttgttttgtaagccacgaaagaattcctttgtgaaaatagttttcaagcaagaattgccatgtcccaaaatgtcagacttaatatttttgatggttccaaataagatggacattgcctaggcaatcatagatggaaatagaggatggcaacagcattgacca	NULL	No	NULL	In	78.03	8.59	8.89	90.09	13.28	12.68	9.81	9.81	8.39	6.98	15.7	17.1	-4	-7.3	6	1	8	0.92	300304	ENSG00000077264	493	694	p21 protein (Cdc42/Rac)-activated kinase 3
627	1	Human	205	CYP11B1	221	11beta-hydroxylase deficiency	E4+204G>A	-46	NULL	Exon	1	CCAGCAACTTGGCTCTTTTTGGAGAGCGGCTGGGCCTGGTTGGCCACAGCCCCAGTTCTGCCAGCCTGAACTTCCTCCATGCCCTGGAGGTCATGTTCAAATCCACCGTCCAGCTCATGTTCATGCCCAGGAGCCTGTCTCGCTGGACCAGCCCCAAG/GTGTGGAAGGAGCACTTTGAGGCCTGGGACTGCATCTTCCAGTAC(G>A)gtgaggccagggacccgggcagtgctatggggaagggacaccatgggggcccaatttctccctctccaccacccagtggggaatggaggccacagggaggggtcggggattcctcaccttcctgccagggagattggtgcgaggctggggctgggctgggctgatccggagaatttgggatgagagcagggagacttgggtgtcggggcagtctgggcaggaggaggacactgaaggatgtctcccagcaccaaagtctgagggctgcctcccgctccccggatag	NULL	No	NULL	In	80.41	9.2	5.28	79.64	12.88	10.98	7.45	7.45	5.03	9.24	13.6	10.6	-7.3	-3.8	6	0.9	7	0.98	202010	ENSG00000160882	450	627	"cytochrome P450, family 11, subfamily B, polypeptide 1"
704	1	Human	220	LRP5	279	Osteoporosis-pseudoglioma syndrome	IVS7+1G>A	63	100	Intron	0	CCTCATGTACTGGACAGACTGGGGAGAGAACCCTAAAATCGAGTGTGCCAACTTGGATGGGCAGGAGCGGCGTGTGCTGGTCAATGCCTCCCTCGGGTGGCCCAACGGCCTGGCCCTGGACCTGCAGGAGGGGAAGCTCTACTGGGGAGACGCCAAGACAGACAAGATCGAG(g>a)tgaggctcctgtggacatgtttgatccaggaggccaggcccagccaccccctgcagccagat/gtacgtattggcgaggcaccgatgggtgcctgtgctctgctatttggccacatggaatgcttgagaaaatagttacaatactttctgacaaaaacgccttgagagggtagcgctatacaacgtcctgtggttacgtaagatgttatcattcggccaggtgcctgtagacacagctac	NULL	No	NULL	In	86.85	8.41	6.45	73.7	11.78	9.68	4.76	4.76	6.31	9.2	15.7	14.1	-8.6	-0.6	7	0.89	6	0.99	259770	ENSG00000162337	499	704	low density lipoprotein receptor-related protein 5
700	1	Human	236	PTCH1	275	Nevoid basal cell carcinoma syndrome	IVS7+1G>C	77	NULL	Intron	2	CCTCTTGATATGGCCCTTGTTTTGAATGGTGGATGTCATGGCTTATCCAGAAAGTATATGCACTGGCAGGAGGAGTTGATTGTGGGTGGCACAGTCAAGAACAGCACTGGAAAACTCGTCAG(g>c)taagccagctcccgaggacaatctatgccctgtagtcttcttcctttcctcaaaagccacttccctcctgacatcg/gcaagtgtatttgtattaatacttaaaccgttatcctcgctagccaggtggcgtcatagaatattaagaaatagtagcagactgcaacagcttgaaaaagcaccttgtggggaatttttcaagaatggatttgtagttttcatcaggaccatagttcctgactatagggtttaaggagatctgcccattaggtagagaatgggagcaggtgtaaagtaggccgggacacactggtcagagagagttggtggtgcgagctgcacagtgtcatagactgttagcaaaagatggagagccagcggctcaataagaattatcctttgtgcacttgtggactctggtcagtcaggtgtctggcgtttcgtgtaagatttctcccttgggaacgccaccgtctgggatt	activates GC cryptic site	No	NULL	In	94.14	9.88	4.02	69.61	15.48	8.52	0.94	0.94	3.38	11.18	18.8	NULL	-8.2	-3.6	8	NULL	6	1	109400	ENSG00000185920	498	700	patched 1
690	1	Human	234	POMT2	231	Becker Muscolar Dystrophy	IVS1+5G>C	72	NULL	Intron	0	CGCCTCCTGCCGCCTCCTAGCGGCCCGGGCCGCGACCACGCTGCCCGCCCCGCCCCGAGCCCGGGGCCCCGCGCTCCGCTGCAGTGAAGGGCGTTGCATTTCCCGGGGTACCCCGAGCTGCCCTCTTGTGACTCCTTGGCGGGGCGGCTGGTCAGACAAAGTGTGCCTCCGGGCCGGAGGGCGACCCAGAGGAGGGGGAAGATGCCGCCGGCCACGGGCGGAGGCCTGGCAGAGTCCGAGCTGCGTCCCCGGAGGGGCCGCTGTGGCCCCCAGGCTGCTAGGGCCGCAGGCCGGGACGTGGCCGCTGAGGCTGTGGCGCGAAGCCCCAAACGGCCTGCTTGGGGCTCACGGCGCTTCGAGGCGGTCGGCTGGTGGGCCCTGCTGGCCTTGGTGACGCTGCTGTCCTTCGCCACCCGCTTCCACCGCTTGGACGAGCCGCCGCACATCTGgtga(g>c)tgatgggagggactcggcgggcaccatggcaaccgcgacgggacgccgccctctgattggcccgagg/gtacggagggggcgggatctataggaggagggccacggtggaggggaacttgaggtatcgggtgggttggcctctggcgaggtgcattctctgggagggggatcgttttgctctggtggtggggcagtgggattcttagtatctgaggaagcagccctcatgtcttcc	NULL	No	NULL	In	86.49	10.1	7.86	74.66	14.48	9.88	6.51	6.51	7.56	9.36	15.8	11.9	-7.2	-4.6	9	0.76	6	0.94	300376	ENSG00000009830	491	690	protein-O-mannosyltransferase 2
642	1	Human	140	RB1	155	Retinoblastoma	E7+58C>G	-61	NULL	Exon	1	ctaccctgcgattttctctcatacaaagatctgaatctctaactttctttaaaaatgtacatttttttttcagGGGAAGTATTACAAATGGAAGATGATCTGGTGATTTCATTTCAGTTAATG/(C>G)TATGTGTCCTTGACTATTTTATTAAACTCTCACCTCCCATGTTGCTCAAAGAACCATATAgtaagtatttaatttatgccccttttactttctcattcagcagttgcttattgaatgtctagtgggtaccaaacatggttctaaggctgacaggatgataaaaaataaatcagacatgga	NULL	No	NULL	Out	79.3	8.65	8.35	81.24	13.18	11.98	7.72	7.72	7.95	6.49	17	14.8	-4.2	-3.9	6	0.98	8	0.96	180200	ENSG00000139687	440	642	retinoblastoma 1
729	1	Human	250	USH2A	293	Usher syndrome	IVS66+39C>T	37	NULL	Intron	1	CTATCCGAAGGCATGGCCACCCAGCAGACTCTCCATGGCCTTCAAGCCTTCACTAACTACTCTATTGGAGTAGAGGCCTGCACCTGCTTCAACTGTTGCAGCAAAGGACCGACAGCTGAACTGAGAACCCATCCTGCCCCACCCTCAGGACTGTCCTCTCCACAAATCGGGACGCTGGCCTCAAGGACGGCCTCCTTCCGGTGGAGTCCCCCCATGTTCCCCAATGGTGTCATTCACAGgtaatgggtcaggcagaaggatgaagaaactaacaag/g(c>t)atgtgtacagacatatgaactcatggtatagcctactctgcacctaggctacaaacctgtatagctacctggcactccccagggaggacttgcttattgaacagatatctatagcaaagtagacaaacaaattgatttgagtggtaatgttacctgcgatgtatttaaatcataaaagcaactaatgatagaaaggagaac	NULL	No	NULL	Out	82.79	9.43	9.79	89.78	13.48	13.48	9.76	9.76	10.03	7.98	15.8	16.9	-6	-5.4	7	1	8	0.75	276901	ENSG00000042781	521	729	"Usher syndrome 2A (autosomal recessive, mild)"
730	1	Human	227	NPC1	276	Niemann-Pick disease type C	IVS9+2021G>A	2023	NULL	Intron	1	ctcaagagctaaggactctcacttctggttctaaagaactttgaccttgagttctgtttgtttgttactggagtaagactttttatgcagttgggctatatttactctgtttcaagaatatcacccctaaaaacatgagttatactcatgaaaacacaatagcttatgctccataccctaaaccggcattctccacagggtagacggtgcagacgagccatgggtaatttgaagaaacaaaaaacatttaatgttacataatttttataattggacaaccatttaatgttacataaattttatagtttactctctgtggcacaagataaaagtcaacaaaaatgatgggggacagaggtgcgtgagccttgtgtttcctcaaagcggacgtggttcccaccagtgtggaagcggtacagggagtggcaggctcctggtggcagggacctgaattggtttgtagttatgcttgtgcgcgtcctcataaccccagtctcgccctagcgctgtcccctttcctctccctccagcttttcctggactttttcacctgagggtcctgcagtaatggcaggtggcctgcccagaaccatgcccttacctgcttcttctccccattttgtttaaag/GCAGTGACAGCTACCAGTTACTCAGGCTTGAGGCTTTATCCCTGAATTCTGCCTCGCCCTCGCCTTCCTCATGGGGTTCTTACGGGTCTGAGCCTCTGGATGCTCTCTCAGATTTCTGCTGTGGATGAAGGGACTCAGCTGCTCGCTGCAGGTCACCTGACCTCCCTCATGCCGTCACCCATCCACTCTGAC(G>A)G/gtgggtcatatgcagaagcttctcagcacctggccaagttgtagctgatggtctgtccgaaaatgctggttcactctccactggccaactgtctgtctgcactgcactgccagttgcctcttgcctgcgccattgcgctaacatctccacttactgttccacctgcttcctgtttctttgccgtttccagaccttccactttgccacgcaagctatctttgtaaaacagctcatgacatttctttcccggaaatctctaattgttccccagtgcctccagaataaaaatccaaactacttaactggcactgagtccttttattttgcatttgtctgtccattactcttcccagactggccccctccttcaggagcccccttggtgggcaccccatgctctaggacaggacatcttttctttgaattattattattttttttttagagatgggatcttgctatgttgtccaggctggactcaaactcctgggttatagccatccttctgcctcagcttcctgagtacttgagattaggcgtgccaccatacccggcatacaggacttgccaaaccaccatcttgctctcattccctctcactgttctctctccctccctttttcctcccacagttgtaattgtgtgagacacccttttgtcctccctctttggtgaaatccccctcatcctcggagctctgggtctgtacagtctcttcctcttggctataattttgccttttagtgtttgctccctcctctgtgcctgcatagcgccatgcaccatgtgccattgatggcactgggctgtatttgcctgcctcttgcccagtgattctgagctcccaaaggtgagtgctgagctgtattactcaactgagaaacctcagggcccatgttgtccttagaatacagccagcctcatcaaatgttcactgtgtaaatgtttaggtccctgatgtcttgaggcccttctaactgggaggtgttttctaaactttttggcag	creates pseudoexon	No	NULL	Out	NULL	NULL	8.56	84.9	NULL	13.38	NULL	9.32	8.54	NULL	NULL	15.8	NULL	-9	NULL	0.87	9	NULL	257220	ENSG00000141458	522	730	"Niemann-Pick disease, type C1"
626	1	Human	184	PKD2	281	Polycistic kidney disease	IVS8+5G>A	-4	NULL	Exon	1	CTCTTCAAATTCATCAATTTTAACAGGACCATGAGCCAGCTCTCGACAACCATGTCTCGATGTGCCAAAGACCTGTTTGGCTTTGCTATTATGTTCTTCATTATTTTCCTAGCGTATGCTCAGTTGGCATACCTTGTCTTTGGCACTCAGGTCGATGACTTCAGTACTTTCCAAGAGT/GTATgtaa(g>a)tatatatgaaattaagaagaaaaatttaatcagagttgtcactgcttctcaagaataaatcttcatatgaggttgctatatgaccaccaattatttaaaaccagttattttaagtaagaattaattaccttttcccaaaacattgatctacccatgcaaagaagacaatgcatcctgaaatgctgatgcttaagatagcagcccaaagtagtaaaatacagttaacagacataggaaaccaacactgttctgaagactgagtttttctttgcaccaaatgcagatggtagcttct	NULL	No	NULL	In	83.43	6.69	4.8	68.1	13.18	7.08	3.36	3.36	4.51	5.24	17.4	12.4	-4	-1.2	8	NULL	6	0.98	613095	ENSG00000118762	449	626	polycystic kidney disease 2 (autosomal dominant)
702	1	Human	184	PKD2	281	Polycistic kidney disease	IVS8+5G>A	76	NULL	Intron	1	CTCTTCAAATTCATCAATTTTAACAGGACCATGAGCCAGCTCTCGACAACCATGTCTCGATGTGCCAAAGACCTGTTTGGCTTTGCTATTATGTTCTTCATTATTTTCCTAGCGTATGCTCAGTTGGCATACCTTGTCTTTGGCACTCAGGTCGATGACTTCAGTACTTTCCAAGAGTGTATgtaa(g>a)tatatatgaaattaagaagaaaaatttaatcagagttgtcactgcttctcaagaataaatcttcatatgag/gttgctatatgaccaccaattatttaaaaccagttattttaagtaagaattaattaccttttcccaaaacattgatctacccatgcaaagaagacaatgcatcctgaaatgctgatgcttaagatagcagcccaaagtagtaaaatacagttaacagacataggaaaccaacactgttctgaagactgagtttttctttgcaccaaatgcagatggtagcttct	NULL	No	NULL	In	83.43	6.69	-2.77	64.22	13.18	3.38	0.71	0.71	1.3	5.24	17.4	10.1	-4	-2.6	8	NULL	6	0.98	613095	ENSG00000118762	449	702	polycystic kidney disease 2 (autosomal dominant)
703	1	Human	184	PKD2	281	Polycistic kidney disease	IVS8+5G>A	118	NULL	Intron	1	CTCTTCAAATTCATCAATTTTAACAGGACCATGAGCCAGCTCTCGACAACCATGTCTCGATGTGCCAAAGACCTGTTTGGCTTTGCTATTATGTTCTTCATTATTTTCCTAGCGTATGCTCAGTTGGCATACCTTGTCTTTGGCACTCAGGTCGATGACTTCAGTACTTTCCAAGAGTGTATgtaa(g>a)tatatatgaaattaagaagaaaaatttaatcagagttgtcactgcttctcaagaataaatcttcatatgaggttgctatatgaccaccaattatttaaaaccagttattttaa/gtaagaattaattaccttttcccaaaacattgatctacccatgcaaagaagacaatgcatcctgaaatgctgatgcttaagatagcagcccaaagtagtaaaatacagttaacagacataggaaaccaacactgttctgaagactgagtttttctttgcaccaaatgcagatggtagcttct	NULL	No	NULL	In	83.43	6.69	5.17	78.75	13.18	9.98	6.52	6.52	4.64	5.24	17.4	13.9	-4	-2.8	8	0.9	7	0.98	613095	ENSG00000118762	449	703	polycystic kidney disease 2 (autosomal dominant)
593	1	Human	202	BRCA2	24	Breast cancer predisposition	E16+188G>C	-100	NULL	Exon	1	CTGTATACGTATGGCGTTTCTAAACATTGCATAAAAATTAACAGCAAAAATGCAGAGTCTTTTCAGTTTCACACTGAAGATTATTTTG/GTAAGGAAAGTTTATGGACTGGAAAAGGAATACAGTTGGCTGATGGTGGATGGCTCATACCCTCCAATGATGGAAAGGCTGGAAAAGAAGAATTTTATA(G>C)gtactctatgcaaaaagattgtgtgttaacttttatgtattccctcatccctctttcttctcttaactgtctctcgaactaaaaagttggctagaaatcaaatttttatgcatttaattgttttaagtgcattatggttaagcattctgtagaagtcttttgaaaagtgctgtttgtcct	observed only in minigene	No	NULL	In	67.28	4.68	8.92	82.23	8.58	12.68	8.07	8.07	7.4	3.62	12.3	15.2	-3.9	-7.1	6	0.99	7	NULL	113705	ENSG00000139618	426	593	"breast cancer 2, early onset"
727	1	Human	252	WRN	294	Werner Syndrome	IVS18+7636A>G	7636	NULL	Intron	1	ctgtgactgcaggcataaactgggaatgtcctggcaaatgaggatgtattgtcacctttctcagcctgcctgtgtgttgtttttaagcttcactctagtttatatattttaaatgtcataaaataccacatacttataagagaaaaggttctattcattgctgaagtggaagcttatcattaatttttatttatttatttttttttccag/TTTTGGAATTCTTATTACTTTGAACCCAAGAACCACTGATAACTAGCACAATCCAGTGAAACAGAGGAAGCAGCAGCTTAATCAAAGGAAAAATACATTTAAGATT/(a>g)taagtctggttataagcttaaaaagtgacccagaaagggatatcattgctaaaaaaaaaaatccccttgtgacctgggtacattttgcaaagccacaggtttgcagtgttacacaagggccaaaggaggccatgagttgtctttggttgtggggccggagggtaactgttcatgaaaatagtgagtgtctgaagattaagaaaatcatgctgcagcagaggag	creates pseudoexon	Yes	NULL	Out	NULL	NULL	8.54	78.7	NULL	12.68	NULL	6.55	6.4	NULL	NULL	14.5	NULL	-4	NULL	0.98	6	NULL	277700	ENSG00000165392	519	727	"Werner syndrome, RecQ helicase-like"
653	1	Human	219	LCA5	107	Leber congenital amaurosis	E6+97G>A	5	100	Intron	2	GAAAAGGAGAGAGAACTGGATATAAAAAATATATATTCTAATCGTCTGCCAAAGTCCTCTCCAAATAAAGAGAAAGAACTTGCATTAAGAAAAAAT(G>A)gtatg/gtaaatatgattgttcaaaaactgatattattgctattatttagtgatagtacaataattctgaaatggaagggaaggaaaagaacctcattgaaatatatttaaaataaatgtatttgttgcaatttaaatttcctaataattttcagaaatccttttctgttttctccatttt	NULL	No	NULL	In	76.07	6.63	6.41	79.37	9.58	9.38	7.22	7.22	5.63	6.25	11.7	14.7	-2.6	-3.9	7	0.98	7	0.86	204000	ENSG00000135338	467	653	Leber congenital amaurosis 5
622	1	Human	46	DMD	247	Duchenne Muscular Dystrophy	IVS45+1G>A	-32	NULL	Exon	2	GAACTCCAGGATGGCATTGGGCAGCGGCAAACTGTTGTCAGAACATTGAATGCAACTGGGGAAGAAATAATTCAGCAATCCTCAAAAACAGATGCCAGTATTCTACAGGAAAAATTGGGAAGCCTGAATCTGCGGTGGCAGGAG/GTCTGCAAACAGCTGTCAGACAGAAAAAAGAG(g>a)tagggcgacagatctaataggaatgaaaacattttagcagactttttaagctttctttagaagaatatttcatgagagattataagcagggtgaaaggcactaacattaaagaacctat	NULL	No	NULL	In	81.68	7.81	3.9	71	11.48	6.98	3.18	3.18	3.59	8.07	14	10.1	-8.5	-2.6	7	NULL	6	0.96	310200	ENSG00000198947	445	622	dystrophin
659	1	Human	112	MLH1	89	Hereditary nonpolyposis colorectal cancer	E17+93G>T	43	NULL	Intron	1	GAAGGGAACCTGATTGGATTACCCCTTCTGATTGACAACTATGTGCCCCCTTTGGAGGGACTGCCTATCTTCATTCTTCGACTAGCCACTGA(G>T)gtcagtgatcaagcagatactaagcatttcggtacatgcatgt/gtgctggagggaaagggcaaatgaccaccctttgatctggaatgataaagatgataagggtgggatagctgaaggcctgctctcatccccactaatattcattcccagcaatattcagcagtcccatttacagttttaacgcctaaagtatcacatttcgttttttagctttaagtagtctgtgatctccgtttagaatgagaatgtttaaattcgtacctattttgaggtattgaatttctttggaccag	NULL	No	NULL	In	86.83	7.7	-14.14	41.33	11.78	-9.12	-4.57	-4.57	-0.81	7.93	15.2	4.5	-6.1	1	7	NULL	3	0.91	609310	ENSG00000076242	472	659	"mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)"
713	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS3+2025T>G	2025	100	Intron	0	gaatgtattttggagaatgattaccgatattattggcctctgtttgatttaatactctttgaagatagcctaattgaaatgctaataagtgggcctagtataacttatgtaatgcataaaatgtatattatcttgccgtgctctactgttgaaaaatgtgtatgctttttcattaaatttactatttaaaaagtaatgctatttatattattgaacaattgttttatttccttcag/TGATTTTACAGATGTTTCTTGATTCTTACTTTTAAATCAAAGTAAATTGAGGCAGTTTAAGAAGAACGGAGCTCACAAGTATACGTTTGTTATACATAGTTGGAATAT/(t>g)taagtgaaagaaaaatacttaccaatatgttatgagtgcaattttgtagaatttgaggaatcttaagtatttttgttcctgtgaatatgactattatttaaaagatttaatacttcttagatttttatttgttagagttaacatctgtattgtttggttagcctataaacaagaaataggcattgtaatgtgaat	creates pseudoexon	No	NULL	Out	NULL	NULL	6.69	83.43	NULL	13.18	NULL	6.92	5.24	NULL	NULL	14.4	NULL	-4	NULL	0.98	8	NULL	162200	ENSG00000196712	508	713	neurofibromin 1
695	1	Human	241	SEDL/TRAPPC2	298	X-linked spondyloepiphyseal dysplasia tarda	IVS4+1A>G	23	NULL	Intron	2	GACGACCATCGTCATCTGAACCAGTTCATAGCTCATGCTGCTCTCGACCTCGTAGATGAGAACATGTGGCTATCGAACAACATGTACTTGAAAACTGTGGACAAGTTCAACGAGTGGTTTGTGTCGGCATTTGTCACTGCGGGGC(a>g)tatccttaccttcttagtaaag/gtaactaactaaagtttgggctcacaaaccagaagaacatggaacatagatgccaggctctgagtctgtagacttcacagtcaggtgaaaatgtaagtttccatttatggggctacttttctttttttaggggggaaaaacattttgtttaatagctaattttaaaactaagtctcatacacaaaaagagtttatctggaccctatcaagggtgattttactttattttacagttattttctaactttgaaagcttatgttctctttatgataaaactaagctaattttaaacccagtttatatattcaacttttccatcacaaatacactgcatgtgactaatttgaagaatactgtatcaacgaactggttgctttttgtttttcatttctaagaaagattatgccttaattatttcacATATGAGGTTTATTATGCTTCATGACATAAGACAAGAAGATGGAATAAAGAACTTCTTTACTGATGTTTATGATTTATATATAAAGGTATGGTATGTTCTATAATTTTTAAATTCTGATGAGAAAGGATTCGACCTTTGTCAGGAAACTGGCCTATTGAAGTAACTCCCTTAGGCTGCAGTTTACCTTTCAGACTAGCTTTCCCCCATCAGAACTATCTCTGGCAACTCCCTCCGCAGGTAAGTCTTCACAGCCAGGTGAATATGTATTTAGGAACACAACTTCATGGTAGTTACCTTTAGATGATTGTGAAGGTAAATTGGTTTCATTCTTCACCTTGTTGTCCTCATAGCTGATTTTATTAGGGATCCCTAAAGACAGCAAGAAAGCAGCCTATATAAGGGAAAATTACTTCATAATTTAATCTAAAATGTTTCCATCTACTTTACAAATAAGTTACAGTGCAATAGAGATCATAAACTGGCAGGAAGTGATTTTTATATGATCAAATAGCCACTCAAGAAGAATGGCGCCACTTGCATTTCTTGATTTTGAAAAATAAAATAATAATAGGACGTCATGGTTACACTGCAG	changes AT-AC intron in GT-AC intron	No	NULL	In	29.16	-12.94	9.01	87.28	-7	12.78	8.87	8.87	7.32	-7.57	NULL	15.5	0.7	-5.1	3	1	7	NULL	313400	ENSG00000196459	494	695	trafficking protein particle complex 2
#696	1	Human	241	SEDL/TRAPPC2	298	X-linked spondyloepiphyseal dysplasia tarda	IVS4+1A>G	115	NULL	Intron	1	GACGACCATCGTCATCTGAACCAGTTCATAGCTCATGCTGCTCTCGACCTCGTAGATGAGAACATGTGGCTATCGAACAACATGTACTTGAAAACTGTGGACAAGTTCAACGAGTGGTTTGTGTCGGCATTTGTCACTGCGGGGC(a>g)tatccttaccttcttagtaaaggtaactaactaaagtttgggctcacaaaccagaagaacatggaacatagatgccaggctctgagtctgtagacttcacagtcaggtgaaaat/gtaagtttccatttatggggctacttttctttttttaggggggaaaaacattttgtttaatagctaattttaaaactaagtctcatacacaaaaagagtttatctggaccctatcaagggtgattttactttattttacagttattttctaactttgaaagcttatgttctctttatgataaaactaagctaattttaaacccagtttatatattcaacttttccatcacaaatacactgcatgtgactaatttgaagaatactgtatcaacgaactggttgctttttgtttttcatttctaag/aaagattatgccttaattatttcacATATGAGGTTTATTATGCTTCATGACATAAGACAAGAAGATGGAATAAAGAACTTCTTTACTGATGTTTATGATTTATATATAAAGGTATGGTATGTTCTATAATTTTTAAATTCTGATGAGAAAGGATTCGACCTTTGTCAGGAAACTGGCCTATTGAAGTAACTCCCTTAGGCTGCAGTTTACCTTTCAGACTAGCTTTCCCCCATCAGAACTATCTCTGGCAACTCCCTCCGCAGGTAAGTCTTCACAGCCAGGTGAATATGTATTTAGGAACACAACTTCATGGTAGTTACCTTTAGATGATTGTGAAGGTAAATTGGTTTCATTCTTCACCTTGTTGTCCTCATAGCTGATTTTATTAGGGATCCCTAAAGACAGCAAGAAAGCAGCCTATATAAGGGAAAATTACTTCATAATTTAATCTAAAATGTTTCCATCTACTTTACAAATAAGTTACAGTGCAATAGAGATCATAAACTGGCAGGAAGTGATTTTTATATGATCAAATAGCCACTCAAGAAGAATGGCGCCACTTGCATTTCTTGATTTTGAAAAATAAAATAATAATAGGACGTCATGGTTACACTGCAG	changes AT-AC intron in GT-AG intron	No	NULL	In	29.16	-12.94	8.62	87.25	-7	14.08	8.59	8.59	7.47	-7.57	NULL	14.9	0.7	-4	3	0.98	7	NULL	313400	ENSG00000196459	494	696	trafficking protein particle complex 2
596	1	Human	120	PCCB	150	Propionic acidemia	E6+110A>G	-6	100	Exon	0	gagtagacactgggtactcagtgtcaagaagcacctgcttgtacccttgcgtgccttctgtggagggtgtggagggactcaaaatagaggtcagggtgccaagataagtgttggctctgcaaactctgcatgaggttttcagtcttctttcaggcagctttgcacagatggggggctttgcatttggagctgtggtgaggatggtgggatacactctgtacctcatgcccttagtgaaggttttagggaactgctgcccaggaggggaggggagagaaaatacttgcctcagaaagtaatatgctgaccatcctaccagttacggggagaaaatgcacatataattcttaaagaacttcactgattaggtctgttgcctcctgtatagaatttctgtgggaaaaaagccaaatgttatcttattgttgtctttatctttccacagataatgcctcaaacatctctgtaaccagatgcttttgcttttctgttttggcagAGGAATGTTACGGCATCCGGAGTCATCCCTCAGATTTCTCTGATCATGGGCCCATGTGCTGGTGGGGCCGTCTACTCCCCAGCCCTAACAGACTTCACGTTCATG/GTAA(A>G)Ggtaagaaagaagggcctgtttttggtgccgtttgagatttgtgcagttccttacctgcaataaaaataattcctgacccagatctaggttgttacctgcattctcattggctttcagcatagtgatgataaggtgttaatggagagagggttttggcatgaaatctgtagcttgtgggggttcagtggcaggggatgcttatgtacttcattggtgggtgattttacttgttgatctgaattgcaaatgattttcaggtaatcaaagaatcctgtcctttgaccagatagatgactgtttactgagtcctattcaagaagtttctcatggaaggcttttctgtaatctgtttattgggaagttgtttcttcctttatttcttcagctccttgccattttattacattgtgtccataatggtaaaggataaatctgatctcacacttcattttcagaggtacatatctttattacatgactttaatggacttatattttaa	NULL	No	NULL	In	94.49	10.57	9.33	86.05	15.58	13.08	9.74	9.74	8.41	10.55	17.3	15	-7.4	-7.1	7	1	7	1	606054	ENSG00000114054	428	596	"propionyl CoA carboxylase, beta polypeptide"
611	1	Human	140	RB1	155	Retinoblastoma	IVS6+1delG	-1	NULL	Exon	1	gatatatctggaaaactttctttcagtgatacatttttcctgttttttttctgctttctatttgtttaatagGATATCTACTGAAATAAATTCTGCATTGGTGCTAAAAGTTTCTTGGATCACATTTTTATTAGCTAAA/G(g)taagttcattatatttattaaatgctaatatttcaaatgtaataattaaattggcattcctttggactaaattccccaatttttattgagtaatgtactcctccctcattctctgcttggcttattaactgttagcaagttcctataattctggtactagaaacaaccttggaaatgct	NULL	No	NULL	In	99.76	11	9.72	87.84	15.48	14.58	9.54	9.54	8.51	12.19	19.1	14.4	-8.8	-4.2	8	1	7	1	180200	ENSG00000139687	440	611	retinoblastoma 1
614	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS22+1G>C	-26	NULL	Exon	2	GATGAACTAGCTCGAGTTCTGGTTACTCTGTTTGATTCTCGGCATTTACTCTACCAACTGCTCTGGAACATGTTTTCTAAAGAAGTAGAATTGGCAGACTCCATGCAGACTCTCTTCCGAGGCAACAGCTTGGCCA/GTAAAATAATGACATTCTGTTTCAAG(g>c)tttgtatcattcattttgtgtgtatgtgtgtgctgaggtatgtcaagtaatgattatgtacagaatgtgcagggctgattgtcttcttttaaggtaaaatatatggagcaggtataataaactcctattcgtgcatttctgtag	NULL	No	NULL	In	79.63	7.81	-1.74	61.75	11.58	3.38	2.76	2.76	2.31	6.11	14.5	9	-4.7	-0.8	8	NULL	5	0.92	162200	ENSG00000196712	441	614	neurofibromin 1
648	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E19B+17del11	-104	NULL	Exon	2	gatgattttgtattctgggatctgcatattaactcaaattatttgggttgtgctaataatttgtttaatgaaataggtagttcctaaggtttatatctgttagtaagaggtttatttgaggggaagtgaaagaacttgaaagattcatggtctctaaattttttttttttttttttttttttttcagAGATTTGGACC/AGGCA(AGCATGGAAGC)AGTAGTTTCACTTCTAGCTGGTCTCCCTCTGCAGCCTGAAGAAGGAGATGGTGGAATTGATGGAAGCCAAATCACAGTTATTTCTTAAgtaaatttcagtcaccaaaaaacataaagcaaaaagcaaataaagccccccaccacacaaaaaaagcaaagaaataatacccatgacaggactaggataggaaaataactgtgttttgtgatttttttaaagaaagtaatatgatcagtgaaattttgcttataataaaacccagattgc	activates AG donor site	No	NULL	Out	72.18	1.48	-29.32	10.22	4.58	-15.85	-17.49	-17.49	-15.37	1.81	9.6	NULL	-2.3	-2.1	7	NULL	0	NULL	162200	ENSG00000196712	441	648	neurofibromin 1
647	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E19B+80G>A	-40	NULL	Exon	1	gatgattttgtattctgggatctgcatattaactcaaattatttgggttgtgctaataatttgtttaatgaaataggtagttcctaaggtttatatctgttagtaagaggtttatttgaggggaagtgaaagaacttgaaagattcatggtctctaaattttttttttttttttttttttttttcagAGATTTGGACCAGGCAAGCATGGAAGCAGTAGTTTCACTTCTAGCTGGTCTCCCTCTGCAGCCTGAAGAAGGAGATG/GT(G>A)TGGAATTGATGGAAGCCAAATCACAGTTATTTCTTAAgtaaatttcagtcaccaaaaaacataaagcaaaaagcaaataaagccccccaccacacaaaaaaagcaaagaaataatacccatgacaggactaggataggaaaataactgtgttttgtgatttttttaaagaaagtaatatgatcagtgaaattttgcttataataaaacccagattgc	NULL	No	NULL	Out	72.18	1.48	6.63	76.07	4.58	9.58	6.79	6.79	6.25	1.81	9.6	11.9	-2.3	-2.6	7	NULL	7	NULL	162200	ENSG00000196712	441	647	neurofibromin 1
621	1	Human	208	EXT1	270	Multiple Osteochondromas	IVS9+del36	-69	NULL	Exon	0	gattttgcattatgaattagtggggagaaggtaatgttttgttgacatttgttaacactgttgattgcttgtttggcttgtgttctgcctgcagGTGGATTTCGCCTTCACAGTGTGGCAGAGCTTCCCTGAGAGGATTGTGGGGTACCCCGCGCGCAGCCACTTCTGGGATAACTCTAAGGAGCG/GTGGGGATACACATCAAAGTGGACGAACGACTACTCCATGGTGT(TGACAGGAGCTGCTATTTACCACAAgtgaggaatct)ggacatgtctcttacagactttacatagctttttatattggctgctgcataaataggaactaaggccaaatcttgttaacagcattgaggaaaattagtctgtatccccgcttaagttttgctgatgtgtcaaatgtgtgtttttgaaaccagtgaaacctcttggcat	NULL	Yes	NULL	In	77.95	5.85	2.99	67.51	10.08	7.98	4.84	4.84	5.38	6.65	12.4	10.6	-3.9	-6.8	7	NULL	6	0.86	133700	ENSG00000182197	444	621	exostosin 1
620	1	Human	208	EXT1	270	Multiple Osteochondromas	IVS9+del36	-29	NULL	Exon	2	gattttgcattatgaattagtggggagaaggtaatgttttgttgacatttgttaacactgttgattgcttgtttggcttgtgttctgcctgcagGTGGATTTCGCCTTCACAGTGTGGCAGAGCTTCCCTGAGAGGATTGTGGGGTACCCCGCGCGCAGCCACTTCTGGGATAACTCTAAGGAGCGGTGGGGATACACATCAAAGTGGACGAACGACTACTCCATG/GTGT(TGACAGGAGCTGCTATTTACCACAAgtgaggaatct)ggacatgtctcttacagactttacatagctttttatattggctgctgcataaataggaactaaggccaaatcttgttaacagcattgaggaaaattagtctgtatccccgcttaagttttgctgatgtgtcaaatgtgtgtttttgaaaccagtgaaacctcttggcat	NULL	Yes	NULL	In	77.95	5.85	2.28	71.1	10.08	8.18	5.41	5.41	2.94	6.65	12.4	8.5	-3.9	-2.3	7	NULL	7	0.86	133700	ENSG00000182197	444	620	exostosin 1
610	1	Human	56	F5	250	Factor 5 deficiency	IVS24+4delGTGA	-85	NULL	Exon	1	GCAAACAACAATAAGCAGTGGCTAGAAATTGATCTACTCAAGATCAAGAAGATAACGGCAATTATAACACAGGGCTGCAAGTCTCTGTCCTCTGAAAT/GTATGTAAAGAGCTATACCATCCACTACAGTGAGCAGGGAGTGGAATGGAAACCATACAGGCTGAAATCCTCCATGGTGGACAAG(gtag)agtggcatctgggcaaagagaaagcaatctgaagactgtgctataatgagaataacagtattttgcatttgacaaatatgcagtgacatgtaccacctctttaagtcttctaaatcttagttcttaaggtgcctggtctcagacaaactcctggttgtctgttttggtttgttttatttctcactacaccaggttgccctcataggaggataaatatcattgtcataaaaaaaaag	minigene evidence	Yes	NULL	In	72.61	6.38	-13.46	41.16	11.48	-14.35	-10.69	-10.69	-12.83	6.07	12.3	NULL	-5	1.8	6	NULL	4	0.68	227400	ENSG00000198734	439	610	"coagulation factor V (proaccelerin, labile factor)"
587	1	Human	114	MSH2	300	Hereditary nonpolyposis colon cancer	IVS1+1G>C	-17	20	Exon	2	GCAGTAGCTAAAGTCACCAGCGTGCGCGGGAAGCTGGGCCGCGTCTGCTTATGATTGGTTGCCGCGGCAGACTCCCACCCACCGAAACGCAGCCCTGGAAGCTGATTGGGTGTGGTCGCCGTGGCCGGACGCCGCTCGGGGGACGTGGGAGGGGAGGCGGGAAACAGCTTAGTGGGTGTGGGGTCGCGCATTTTCTTCAACCAGGAGGTGAGGAGGTTTCGACATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAA/GTACATGGGGCCGGCAG(g>c)tgagggccgggacggcgcgtgctggggagggacccggggccttgtggcgcggctcctttcccgcctcagagagtgggcggtgagcagcctctccagtgcggaggcacgggggcggaacgttggtgcttgtgcggattccgccgtccccaggttctgcttggctccggagggacgccccc	NULL	No	NULL	In	89.86	10.07	1.99	65.47	13.38	6.68	3.47	3.47	3.92	10.18	17.4	9.3	-9.3	-1.7	8	NULL	6	0.95	120435	ENSG00000095002	420	587	"mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)"
619	1	Human	240	SDHB	257	Pheochromocytoma	IVS4+1G>A	-54	NULL	Exon	0	GCATCTGTGGCTCTTGTGCAATGAACATCAATGGAGGCAACACTCTAGCTTGCACCCGAAGGATTGACACCAACCTCAATAAG/GTCTCAAAAATCTACCCTCTTCCACACATGTATGTGATAAAGGATCTTGTTCCC(g>a)tgagtttctgcatctctctggttttgtttttatttgcatggggggcagtgctatgtgtgttacgctattagtttttcagggcaggatttgtttgagtatttaaggctcctcttctagtcagatagtaaatagatgggactgtttcctatattatggcaggaggaggaccacagtgtcac	NULL	No	NULL	In	72.59	8.4	-0.88	61.87	12.58	5.38	0.06	0.06	1.02	7.39	12.6	10.1	-4.2	-2.5	7	NULL	4	0.94	171300	ENSG00000117118	443	619	"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)"
633	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E19b+del17-27	-104	NULL	Exon	2	gccaagattactttgtagaaagtaagtattaccttctccccatttgagatgattttgtattctgggatctgcatattaactcaaattatttgggttgtgctaataatttgtttaatgaaataggtagttcctaaggtttatatctgttagtaagaggtttatttgaggggaagtgaaagaacttgaaagattcatggtctctaaattttttttttttttttttttttttttcagAGATTTGGACCAG/GCA(AGCATGGAAGC)AGTAGTTTCACTTCTAGCTGGTCTCCCTCTGCAGCCTGAAGAAGGAGATGGTGTGGAATTGATGGAAGCCAAATCACAGTTATTTCTTAAgtaaatttcagtcaccaaaaaacataaagcaaaaagcaaataaagccccccaccacacaaaaaaagcaaagaaataatacccatgacaggactaggataggaaaataactgtgttttgtgattttttta	NULL	No	NULL	Out	72.18	1.48	3.1	82.88	4.58	7.32	5.32	5.32	4.99	1.81	9.6	NULL	-2.3	-5.6	7	NULL	8	NULL	162200	ENSG00000196712	433	633	neurofibromin 1
637	1	Human	249	TYMP	299	Mitochondrial neurogastrointestinal encephalopathy syndrome	IVS1-1G>C	-31	NULL	Intron	1	GCCCGGAGCGATGGCAGCCTTGATGACCCCGGGAACCGGGGCCCCACCCGCGCCTGGTGACTTCTCCGGGGAAGGGAGCCAGGGACTTCCCGACCCTTCGCCAGAGCCCAAGCAGCTCCCGGAGCTGATCCGCATGAAGCGAGACGGAGGCCGCCTGAGCGAAGCGGACATCAGGGGCTTCGTGGCCGCTGTG/GTGAATGGGAGCGCGCAGGGCGCACAGATCGgtgcgtggggagggttgggcgttcctgaccccgactgggaggtcagcccgagagactttgggtccctgggggtgcgacggtgccccactaccagcaccggccccagggtgccccaccgctgtgggctgccaccctcacgcgtacccccacatacca(g>c)GGGCCATGCTGATGGCCATCCGACTTCGGGGCATGGATCTGGAGGAGACCTCGGTGCTGACCCAGGCCCTGGCTCAGTCGGGACAGCAGCTGGAGTGGCCAGAGGCCTGGCGCCAGCAGCTTGTGGACAAGCATTCCACAGGGGGTGTGGGTGACAAGGTCAGCCTGGTCCTCGCACCTGCCCTGGCGGCATGTGGCTGCAAG	upstream 3' splice site deletion	No	NULL	Out	71	8.67	1.79	71.63	12.18	5.28	5	5	3.84	8.15	10.3	8.6	-3.9	-3.8	6	NULL	7	0.91	603041	ENSG00000025708	456	637	thymidine phosphorylase
681	1	Human	104	LDLR	61	Familial hypercholesterolemia	IVS12+2T>C	11	NULL	Intron	2	gcctccttgaagtttttctgacctgcaactcccctacctgcccattggagagggcgtcacaggggaggggttcaggctcacatgtggttggagctgcctctccaggtgcttttctgctaggtccctggcagggggtcttcctgcccggagcagcgtggccaggccctcaggaccctctgggactggcatcagcacgtgacctctccttatccacttgtgtgtctagATCTCCTCAGTGGCCGCCTCTACTGGGTTGACTCCAAACTTCACTCCATCTCAAGCATCGATGTCAACGGGGGCAACCGGAAGACCATCTTGGAGGATGAAAAGAGGCTGGCCCACCCCTTCTCCTTGGCCGTCTTTGAg(t>c)gtggcttac/gtacgagatgcaagcacttaggtggcggatagacacagactatagatcactcaagccaagatgaacgcagaaaactggttgtgactaggaggaggtcttagacctgagttatttctattttcttctttctttttttttttttttttgagacagagttttgctctcgtttcccaggctggagggcaatggcatgatctcggctcaccgcaacctccacctcccaggttcaagtgattctcctgtctcaggctccccagtagctgggattacaggcatgcaccaccaccatgcccggctaattttgtatttttagtagagacggagtttctccatgttggtcaggctggtc	NULL	No	NULL	In	54.75	-5.16	3.14	66.67	1.98	6.68	3.85	3.85	4.55	-0.19	4.8	9.1	-2	0.4	5	NULL	6	NULL	144010	ENSG00000130164	484	681	low density lipoprotein receptor
658	1	Human	85	HEXB	156	Sandhoff disease	IVS13+2T>G	48	100	Intron	0	GCCTCGGGCAAGTGCTGTTGGTGAGAGACTCTGGAGTTCCAAAGATGTCAGAGATATGGATGACGCCTATGACAGACTGACAAGGCACCGCTGCAGGATGGTCGAg(t>g)aagaaatctattaagtccagtgtgatttttaaccttcttattcagt/gttagtttcttttgctataaatagaaatgtatgttacctaacaaatagtaattagaagaaaccaggaattatttttttgtaagtaataatacctgtaaagatatattcagacttgtgactgttttatagata	NULL	No	NULL	In	73.65	6.87	-4.97	67.93	9.38	4.78	1.36	1.36	-6.28	6.95	12.2	7.4	-2.8	-1.8	7	NULL	6	NULL	268800	ENSG00000049860	471	658	hexosaminidase B (beta polypeptide)
588	1	Human	228	OPA1	228	Autosomal dominant optic atrophy	IVS17+1G>T	-40	100	Exon	1	gcctgtccaacatggtgaaaccccatctctactaaaagtacaaaaaaaattagctgggcatggcgatgggcagctgtaaccccagctactcaggaggctgaggcgggagaatcgcttgaaccccgagggggtggggggcggaagttgtagtgacccaatatcacgccactgcactccagcccggacgacagtgcaagattccaattcaaaaaaataataaaataaaatataacattaaatttaaattagttaaaattcaacaaaattcaaaatacagttcctcagttacactagccacacatttccagggctcaataacccagtgtgccagtagctaccgtattggaatgttttcctcctcacataaatttttattgaacagcactggtatgaaaggtaagagtggctgttagcaagcacattcgcagacttggtggtagtattgttgtcctttttgtcattttaatatactttagctcttgttatttttttttaatagGACAAGCATGCTAAAGGCACACCAAGTGACTACAAGAAATTTAAGCCTTGCAGTATCAGACTGCTTTTGGAAAATG/GTACGAGAGTCTGTTGAACAACAGGCTGATAGTTTCAAAG(g>t)taagttggattttttaaagaagcaagcaaattaagacattttattagctggcaatctttggcatccatacgattctgtacttctttcctttaacagttgcttggtagttcatttacaattagacagtatctggaaaatagaagaatacaaaccttcagttgttatacaagaacaagatttttcctttcagaggaaacatctctagaaacacatttgcagagttcaaacagatgagaacatttgctagtgcttggaagtacacaataaactatagagaattctagattcaccctgttgaggatgaaggagcagatgtgttgggaagcagagccctctgaacttcctttacttggcaccatttcctgaatcccacactttcctgctcagtgtcttttatcggaagagaatatatttgctttctcttttcccatatgtaaatcctacctgatcctacctatttatgccagttagtccctctgcaatcttgtattactttcatttccattttacagaagaggaaacagaagacagttacttacccaaataacttatcctattacccagtgtcacacaacatgggtaataggcccaggatttggctgttggtggtacaactgcagagtccattctctcagcagctctatggtactaaactacttcagctgtgtgctaatggatttaacatggagaaactagaatcagggagaatagttttgaaagctattgcaaaaatgaaattctgagacgttgagatcccagagtactaaggggtcataggcgcactctcagaaattcagttaatacagaggatatgtattttaaccactttaaccactacatctggaaagaaggagggtcatcaaacttgaacttttccttcttcctcagCAACACGTTTTAACCTTGAAACTGAATGGAAGAATAACTATCCTCGCCTGCGGGAACTTGACCGG	NULL	No	NULL	In	99.76	11	7.82	75.18	15.48	10.78	6.34	6.34	7.72	12.19	19.1	11.7	-8.8	-2.5	8	0.87	6	1	165500	ENSG00000198836	421	588	mediator complex subunit 12
615	1	Human	206	DAX1/NR0B1	223	Adrenal Hypoplasia congenita X-linked	IVS1+1G>C	-1024	30	Exon	1	GCGCCGCGGGCCATGGCGGGCGAGAACCACCAGTGGCAGGGCAGCATCCTCTACAACATGCTTATGAGCGCGAAGCAAACGCGCGCGGCTCCTGAGGCTCCAGAGACGCGGCTGGTGGATCAGTGCTGGGGCTGTTCGTGCGGCGATGAGCCCGGG/GTGGGCAGAGAGGGGCTGCTGGGCGGGCGGAACGTGGCGCTCCTGTACCGCTGCTGCTTTTGCGGTAAAGACCACCCACGGCAGGGCAGCATCCTCTACAGCATGCTGACGAGCGCAAAGCAAACGTACGCGGCACCGAAGGCGCCCGAGGCGACGCTGGGTCCGTGCTGGGGCTGTTCGTGCGGCTCTGATCCCGGGGTGGGCAGAGCGGGGCTTCCGGGTGGGCGGCCCGTGGCACTCCTGTACCGCTGCTGCTTTTGTGGTGAAGACCACCCGCGGCAGGGCAGCATCCTCTACAGCTTGCTCACTAGCTCAAAGCAAACGCACGTGGCTCCGGCAGCGCCCGAGGCACGGCCAGGGGGCGCGTGGTGGGACCGCTCCTACTTCGCGCAGAGGCCAGGGGGTAAAGAGGCGCTACCAGGCGGGCGGGCCACGGCGCTTCTGTACCGCTGCTGCTTTTGCGGTGAAGACCACCCGCAGCAGGGCAGCACCCTCTACTGCGTGCCCACGAGCACAAATCAAGCGCAGGCGGCTCCGGAGGAGCGGCCGAGGGCCCCCTGGTGGGACACCTCCTCTGGTGCGCTGCGGCCGGTGGCGCTCAAGAGTCCACAGGTGGTCTGCGAGGCAGCCTCAGCGGGCCTGTTGAAGACGCTGCGCTTCGTCAAGTACTTGCCCTGCTTCCAGGTGCTGCCCCTGGACCAGCAGCTGGTGCTGGTGCGCAACTGCTGGGCGTCCCTGCTCATGCTTGAGCTGGCCCAGGACCGCTTGCAGTTCGAGACTGTGGAAGTCTCGGAGCCCAGCATGCTGCAGAAGATCCTCACCACCAGGCGGCGGGAGACCGGGGGCAACGAGCCACTGCCCGTGCCCACGCTGCAGCACCATTTGGCACCGCCGGCGGAGGCCAGGAAGGTGCCCTCCGCCTCCCAGGTCCAAGCCATCAAGTGCTTTCTTTCCAAATGCTGGAGTCTGAACATCAGTACCAAGGAGTACGCCTACCTCAAGGGGACCGTGCTCTTTAACCCGG(g>c)taagggtactggccttaggcgccggcttttcccagctcacaaaagcatcgggcagtgcctatctaggggcgcgggcagtaacgagttttcagtgatcaggagagtgtcggggcaaaggt	Very long exon	No	NULL	In	85.67	10.17	1.95	66.87	12.98	7.48	4.61	4.61	2.99	9.31	15.4	9.3	-9.2	-7.4	8	NULL	7	1	300200	ENSG00000169297	442	615	"nuclear receptor subfamily 0, group B, member 1"
616	1	Human	206	DAX1/NR0B1	223	Adrenal Hypoplasia congenita X-linked	IVS1+1G>C	-899	30	Exon	2	GCGCCGCGGGCCATGGCGGGCGAGAACCACCAGTGGCAGGGCAGCATCCTCTACAACATGCTTATGAGCGCGAAGCAAACGCGCGCGGCTCCTGAGGCTCCAGAGACGCGGCTGGTGGATCAGTGCTGGGGCTGTTCGTGCGGCGATGAGCCCGGGGTGGGCAGAGAGGGGCTGCTGGGCGGGCGGAACGTGGCGCTCCTGTACCGCTGCTGCTTTTGCGGTAAAGACCACCCACGGCAGGGCAGCATCCTCTACAGCATGCTGACGAGCGCAAAGCAAAC/GTACGCGGCACCGAAGGCGCCCGAGGCGACGCTGGGTCCGTGCTGGGGCTGTTCGTGCGGCTCTGATCCCGGGGTGGGCAGAGCGGGGCTTCCGGGTGGGCGGCCCGTGGCACTCCTGTACCGCTGCTGCTTTTGTGGTGAAGACCACCCGCGGCAGGGCAGCATCCTCTACAGCTTGCTCACTAGCTCAAAGCAAACGCACGTGGCTCCGGCAGCGCCCGAGGCACGGCCAGGGGGCGCGTGGTGGGACCGCTCCTACTTCGCGCAGAGGCCAGGGGGTAAAGAGGCGCTACCAGGCGGGCGGGCCACGGCGCTTCTGTACCGCTGCTGCTTTTGCGGTGAAGACCACCCGCAGCAGGGCAGCACCCTCTACTGCGTGCCCACGAGCACAAATCAAGCGCAGGCGGCTCCGGAGGAGCGGCCGAGGGCCCCCTGGTGGGACACCTCCTCTGGTGCGCTGCGGCCGGTGGCGCTCAAGAGTCCACAGGTGGTCTGCGAGGCAGCCTCAGCGGGCCTGTTGAAGACGCTGCGCTTCGTCAAGTACTTGCCCTGCTTCCAGGTGCTGCCCCTGGACCAGCAGCTGGTGCTGGTGCGCAACTGCTGGGCGTCCCTGCTCATGCTTGAGCTGGCCCAGGACCGCTTGCAGTTCGAGACTGTGGAAGTCTCGGAGCCCAGCATGCTGCAGAAGATCCTCACCACCAGGCGGCGGGAGACCGGGGGCAACGAGCCACTGCCCGTGCCCACGCTGCAGCACCATTTGGCACCGCCGGCGGAGGCCAGGAAGGTGCCCTCCGCCTCCCAGGTCCAAGCCATCAAGTGCTTTCTTTCCAAATGCTGGAGTCTGAACATCAGTACCAAGGAGTACGCCTACCTCAAGGGGACCGTGCTCTTTAACCCGG(g>c)taagggtactggccttaggcgccggcttttcccagctcacaaaagcatcgggcagtgcctatctaggggcgcgggcagtaacgagttttcagtgatcaggagagtgtcggggcaaaggt	Very long exon	No	NULL	In	85.67	10.17	6.56	69.9	12.98	8.68	5.64	5.64	6.85	9.31	15.4	9.1	-9.2	0.4	8	0.81	5	1	300200	ENSG00000169297	442	616	"nuclear receptor subfamily 0, group B, member 1"
617	1	Human	206	DAX1/NR0B1	223	Adrenal Hypoplasia congenita X-linked	IVS1+1G>C	-864	30	Exon	0	GCGCCGCGGGCCATGGCGGGCGAGAACCACCAGTGGCAGGGCAGCATCCTCTACAACATGCTTATGAGCGCGAAGCAAACGCGCGCGGCTCCTGAGGCTCCAGAGACGCGGCTGGTGGATCAGTGCTGGGGCTGTTCGTGCGGCGATGAGCCCGGGGTGGGCAGAGAGGGGCTGCTGGGCGGGCGGAACGTGGCGCTCCTGTACCGCTGCTGCTTTTGCGGTAAAGACCACCCACGGCAGGGCAGCATCCTCTACAGCATGCTGACGAGCGCAAAGCAAACGTACGCGGCACCGAAGGCGCCCGAGGCGACGCTGG/GTCCGTGCTGGGGCTGTTCGTGCGGCTCTGATCCCGGGGTGGGCAGAGCGGGGCTTCCGGGTGGGCGGCCCGTGGCACTCCTGTACCGCTGCTGCTTTTGTGGTGAAGACCACCCGCGGCAGGGCAGCATCCTCTACAGCTTGCTCACTAGCTCAAAGCAAACGCACGTGGCTCCGGCAGCGCCCGAGGCACGGCCAGGGGGCGCGTGGTGGGACCGCTCCTACTTCGCGCAGAGGCCAGGGGGTAAAGAGGCGCTACCAGGCGGGCGGGCCACGGCGCTTCTGTACCGCTGCTGCTTTTGCGGTGAAGACCACCCGCAGCAGGGCAGCACCCTCTACTGCGTGCCCACGAGCACAAATCAAGCGCAGGCGGCTCCGGAGGAGCGGCCGAGGGCCCCCTGGTGGGACACCTCCTCTGGTGCGCTGCGGCCGGTGGCGCTCAAGAGTCCACAGGTGGTCTGCGAGGCAGCCTCAGCGGGCCTGTTGAAGACGCTGCGCTTCGTCAAGTACTTGCCCTGCTTCCAGGTGCTGCCCCTGGACCAGCAGCTGGTGCTGGTGCGCAACTGCTGGGCGTCCCTGCTCATGCTTGAGCTGGCCCAGGACCGCTTGCAGTTCGAGACTGTGGAAGTCTCGGAGCCCAGCATGCTGCAGAAGATCCTCACCACCAGGCGGCGGGAGACCGGGGGCAACGAGCCACTGCCCGTGCCCACGCTGCAGCACCATTTGGCACCGCCGGCGGAGGCCAGGAAGGTGCCCTCCGCCTCCCAGGTCCAAGCCATCAAGTGCTTTCTTTCCAAATGCTGGAGTCTGAACATCAGTACCAAGGAGTACGCCTACCTCAAGGGGACCGTGCTCTTTAACCCGG(g>c)taagggtactggccttaggcgccggcttttcccagctcacaaaagcatcgggcagtgcctatctaggggcgcgggcagtaacgagttttcagtgatcaggagagtgtcggggcaaaggt	Very long exon	No	NULL	In	85.67	10.17	-0.12	65.86	12.98	6.48	1.25	1.25	1.91	9.31	15.4	9.4	-9.2	-3.3	8	NULL	6	1	300200	ENSG00000169297	442	617	"nuclear receptor subfamily 0, group B, member 1"
654	1	Human	228	OPA1	228	Autosomal dominant optic atrophy	E20+166G>A	20	100	Intron	2	gcgtccacctgtagtcccacctactcgggaggataaggtgggaggatggcttgagcccaggaggttgaggctccagtgagccatgaatgtgccactgtactccatccagcctgggcaactaagcaagaccctgtctcaaaaaaaaaaaaagtgaaatattaatacatacaacagcatgatgaacctcaaaataattatgctggagtggaagaacaaagacaaaaaaagagtatatgccacatgattgcatttatataaatttctagaaaatacaaagtaatcacagtgacagaaagcagttccagtggttacaacttttgaggatgatggatgcgttcattatcttgactggtgcgatttacaggtatatacacatgtgaaaacttatcaaaattttaaatatgtacagtttattataagttaatgatacttcagtcaagctgtttttaaaaacaatattatatttagatttggtgcttttgatacttttttatttcagGGAGGAAATCCTTCAACAATCTTTGTGGGAAAGAGTATCAACTCATGTGATTGAAAACATCTACCTTCCAGCTGCGCAGACCATGAATTCAGGAACTTTTAACACCACAGTGGATATCAAGCTTAAACAGTGGACTGATAAACAACTTCCTAATAAAGCAGTAGA(G>A)gttaggatataatttaattaaatgg/gtaagaagcattatctgaagggagtaggagctgtgaattttagattttattcccatcacagcctctatctttcttttaggtctttatatctcatttattctttattcctcatctctgttttgggactaaccttaatgttgctaccagttactacggttataaaaatttactaattggtatgatgttggcctgagggtattggtacttcttccaaagacaatatttaacaagcaaattttgcttgaatatgaaatatttgcttgagtatttgcttgaatgtgaaatattttgaacattttctgtggattctgtggattatagagattccataaagaaaatacttaatagatgaagcatttcatctgagctcagttatacttaaattatcattttcttaggatcctgacagaagattaaactaggaattattaaaaaacaaaacaaaacaaaacaaaaaactaccttaaagaatcta	NULL	No	NULL	In	81.66	4.36	8.91	81.51	8.98	12.58	7.41	7.41	7.6	5.11	14.7	15.2	-5.9	-8	7	0.99	7	0.84	165500	ENSG00000198836	421	654	mediator complex subunit 12
638	1	Human	27	COL1A1	278	Osteogenesis Imperfecta	E33+del552	-10	NULL	Exon	1	gctgcagagggcctctcaggaaacccagacacaagcagaacactataggtcacctccttgccccacactggaaatctcaagcttatccatgtctttagGGTGATGCTGGTCCCAAAGGTGCTGATGGCTCTCCTGGCAAAGATGGCGTCCGTGGTCTGACTGGCCCCATTGGTCCTCCTGGCCCTGCTGGTGCCCCTG/GTGAC(AAGgtgaggtggccgcctccccaccttctgccctaacacatagcctcctcagcaggcctgggcacggttccgtggggttgcgttgggagagcaggtcctgccaaactgagctgtcaacctgggaacctggagggaccagaaggaggggaggctctcctggggtcatctactaggagtattcaggggaggccctgaccctgagcctcttgtcccttgctctcagGGTGAAAGTGGTCCCAGCGGCCCTGCTGGTCCCACTGGAGCTCGTGGTGCCCCCgtaagtacagaagacctgttaagaccccatacttggcccttccctcccttcacacagcacccctggccctgtctgtgccttcaccccttgcctctcccctcaccgcatccccgccttccctcctgtcagcgcatctctccaatctgactccttttcttctagGGAGACCGTGGTGAGCCTGGTCCCCCCGGCCCTGCTGGCTTTGCTGGCCCCCCgtgagtaccaagacccccatcatttttcatcaccgactgggacctgggacctcgagggac)ggaatgaggacaaaggcgtcagccatcctcaggggagaagggtggagacgggattgtttcccacccaagcatcttcctgcctccattactgctcctcccccaggtagtggaaactcctgcctccttccctccattcaccgccctgcttcctcccccagGGTGCTGACGGCCAACCTGGTGCTAAAGGCGAACCTGGTGATGCTGGTGCTAAAGGCGATGCTGGTCCCCCTGGCCCTGCCGGACCCGCTGGACCCCCTGGCCCCATTgtgagtggcttggccctctgtgcccacgaggctggtgggctgggacccaggacgggtccaggcttgatgcctctgtgctctcctacag	NULL	No	NULL	Out	89.63	9.16	2.93	68.84	13.98	6.58	4.89	4.89	5.38	9.62	15.7	8.8	-8.5	-3.5	7	NULL	7	0.98	130060	ENSG00000108821	457	638	"collagen, type I, alpha 1"
645	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E16+355G>A	-90	NULL	Exon	0	GCTGCTGAAAGCCTTCACAAGACCATTGTTAAGAGGCGAATGTCCCATGTGAGTGGAGGAGGATCCATAGATTTGTCTGACACAGACTCCCTACAGGAATGGATCAACATGACTGGCTTCCTTTGTGCCCTTGGGGGAGTGTGCCTCCAGCAGAGAAGCAATTCTGGCCTGGCAACCTATAGCCCACCCATGGGTCCAGTCAGTGAACGTAAGGGTTCTATGATTTCAGTGATGTCTTCAGAGGGAAACGCAGATACACCTGTCAGCAAATTTATGGATCGGCTGTTGTCCTTAATGGTGTGTAACCATGAGAAAGTGGGACTTCAAATACGGACCAATGTTAAGGATCTG/GTG(G>A)GTCTAGAATTGAGTCCTGCTCTGTATCCAATGCTATTTAACAAATTGAAGAATACCATCAGCAAGTTTTTTGACTCCCAAGGACAGgtaaagtgttctcttatttttcacctttctctatgaatagagtgacttgtttgaaataagcctttttctttcagattatttaaattaggtactcacagtttttaaaaatttccaaaaaat	NULL	No	NULL	Out	82.98	9.65	10.1	86.49	14.28	14.48	9.66	9.66	9.36	8.28	15.8	16.3	-6.2	-7.2	7	0.99	9	0.92	162200	ENSG00000196712	441	645	neurofibromin 1
660	1	Human	210	FREM2	67	Fraser syndrome	IVS14+1G>A	100	100	Intron	1	GCTTGCAACCCCAAATATTCAGACTACGATAAAACAGGCTCTATCTGTGCAAGTGAGAACATCAATGACACTTTGACGCGGTACCGGTGGCTGATTAGTGCACCTGCGGGCCCTGACGGTGTGACCAGCCCTATGAGAGAAGTGGACTTCGACACCTTTTTTACGTCATCCAAGATGGTCACACTGGACTCCATATACTTTCAGCCTGGCTCCCGGGTACAGTGCGCAGCTCGTGCTGTGAACACCAATGGGGATGAAGGCCTGGAGCTCATGAGCCCTATTGTAACCATCAGCAGAGAAGAAG(g>a)tcagtcattgccattttcccctgaagatcactggaatactgtgcaatattacaaatgtctactttctggttattaatacttccaatgtcccacatattccatatatttt/gtaagtagtgaaaaattaaaatctatttttacaaaattatgtattagaaaacaaaatatttattcattctacctttaagtatctattatatgccagacacaatgctttgtgctggcaataaaataaagaagacaggatccctgcttttgaggaattcttggtccagttgaagatgcagacacattttagtctagacagggcacaggaatgcacaggtagaagtgattagttttaccctgagtgggtcagg	NULL	No	NULL	In	89.61	8.68	7.4	74.88	12.58	11.78	4.88	4.88	5.39	8.34	15.2	15.7	-6	-4	7	0.91	6	0.96	219000	ENSG00000150893	473	660	FRAS1 related extracellular matrix protein 2
595	1	Human	28	COL1A2	52	Ehlers-Danlos syndrome	IVS24+1G>A	-8	NULL	Exon	2	ggaaagccacaaaaaaatagaagaaaaatttcagaactcttttcacacttcccagctagtggctaatattcctaatgatttaccctaggcaacaaacaaaaagtcgggggaaaaggtgcctttgttagacttcagttaatctaaggcttgagtatgtaagttaaagtgccaatataaaaacatcctcatttattttatagGGTCTTCCTGGTTCCCCTGGAAATATCGGCCCCGCTGGAAAAGAAG/GTCCTGTC(g>a)taagtattgctcattttccattatattttcaaggacacttattgcacccttatcaagtctattttgtggcttatttatacatgaacacattgaaaataaatatcagacacatacatcatctgggaatgcagagtaatagattgtaattatggagtccaaatgaatacaggactgaaagcagagcaggggagagaaaaac	NULL	No	NULL	In	75.21	9.9	-0.19	61.63	13.08	6.88	0.36	0.36	0.67	7.17	17	10.1	-4.3	-2.5	6	NULL	4	0.96	120150	ENSG00000164692	93	595	"collagen, type I, alpha 2"
649	1	Human	104	LDLR	61	Familial hypercholesterolemia	E4+308C>T	-75	100	Exon	0	ggcctcactgcggcagcgtccccggctatagaatgggctggtgttgggagacttcacacggtgatggtggtctcggcccatccatccctgcagCCCCCAAGACGTGCTCCCAGGACGAGTTTCGCTGCCACGATGGGAAGTGCATCTCTCGGCAGTTCGTCTGTGACTCAGACCGGGACTGCTTGGACGGCTCAGACGAGGCCTCCTGCCCGGTGCTCACCTGTGGTCCCGCCAGCTTCCAGTGCAACAGCTCCACCTGCATCCCCCAGCTGTGGGCCTGCGACAACGACCCCGACTGCGAAGATGGCTCGGATGAGTGGCCGCAGCGCTGTAGGGGTCTTTACGTGTTCCAAGGGGACAGTAGCCCCTGCTCGGCCTTCGAGTTCCACTGCCTAAGTG/G(C>T)GAGTGCATCCACTCCAGCTGGCGCTGTGATGGTGGCCCCGACTGCAAGGACAAATCTGACGAGGAAAACTGCGgtatgggcggggccagggtgggggcggggcgtcctatcacctgtccctgggctcccccaggtgtgggacatgcagtgatttaggtgccgaagtggatttccaacaacatgccaagaaagt	NULL	No	NULL	Out	72.62	7.67	10.67	95.04	9.58	14.88	11.69	11.69	11.87	7.44	11.7	19.4	-2.9	-9.5	6	0.99	9	0.87	144010	ENSG00000130164	463	649	low density lipoprotein receptor
624	1	Human	215	HNF1A	243	Diabetes susceptibility	E4+242G>A	-12	NULL	Exon	0	GGCGGAATGCATCCAGAGAGGGGTGTCCCCATCACAGGCACAGGGGCTGGGCTCCAACCTCGTCACGGAGGTGCGTGTCTACAACTGGTTTGCCAACCGGCGCAAAGAAGAAGCCTTCCGGCACAAGCTGGCCATGGACACGTACAGCGGGCCCCCCCCAGGGCCAGGCCCGGGACCTGCGCTGCCCGCTCACAGCTCCCCTGGCCTGCCTCCACCTGCCCTCTCCCCCA/GTAAGGTCCAC(G>A)gtaagtggtatgtggggacaagggacacgtgggaaggtgggagggttggggaggactgtcccagtgacagcagtcacctaaacctctttgcacttcagtttggttccattccattcatgccactccttatcactctacttcactctgttcattcatccattccactctatctcattccattcactctactcctttccactctattcactccatccaccacaattaaccccattccatccactccatccactaccttcgactccactccatccactctactccattcactccactcaactccactccatccactccactccgtccaacttcatcccatccactacattcaactccactcca	NULL	No	NULL	In	90.55	11.81	5.74	73.7	16.68	11.18	6.63	6.63	5.8	11.81	17	12	-7.6	-4	7	0.94	6	0.99	600496	ENSG00000135100	447	624	HNF1 homeobox A
701	1	Human	215	HNF1A	243	Diabetes susceptibility	E4+242G>A	7	NULL	Intron	1	GGCGGAATGCATCCAGAGAGGGGTGTCCCCATCACAGGCACAGGGGCTGGGCTCCAACCTCGTCACGGAGGTGCGTGTCTACAACTGGTTTGCCAACCGGCGCAAAGAAGAAGCCTTCCGGCACAAGCTGGCCATGGACACGTACAGCGGGCCCCCCCCAGGGCCAGGCCCGGGACCTGCGCTGCCCGCTCACAGCTCCCCTGGCCTGCCTCCACCTGCCCTCTCCCCCAGTAAGGTCCAC(G>A)gtaagtg/gtatgtggggacaagggacacgtgggaaggtgggagggttggggaggactgtcccagtgacagcagtcacctaaacctctttgcacttcagtttggttccattccattcatgccactccttatcactctacttcactctgttcattcatccattccactctatctcattccattcactctactcctttccactctattcactccatccaccacaattaaccccattccatccactccatccactaccttcgactccactccatccactctactccattcactccactcaactccactccatccactccactccgtccaacttcatcccatccactacattcaactccactcca	NULL	No	NULL	In	90.55	11.81	7.64	78.46	16.68	10.78	6.89	6.89	7.04	11.81	17	13.7	-7.6	-3.9	7	0.88	8	0.99	600496	ENSG00000135100	447	701	HNF1 homeobox A
634	1	Human	118	NF1	135	"Neurofibromatosis, type I"	E20+113C>T	-71	NULL	Exon	2	ggctgattatcgcgagagaggagagaaacagttaacccagggccattcacaccatgcacatatgattgttttggaatgtctggttagctttctagttgatacggccttcactatgtaaaggtcagtctttttatttctcagATACTTCACATTATTTATGAACCTTTTGAATGACTGCAGTGAAGTTGAAGATGAAAGTGCGCAAACAGGTGGCAGGAAACGTGGCATGTCTCGGAGGCTGGCATCACTGAG/G(C>T)ACTGTACGGTCCTTGCAATGTCAAACTTACTCAATGCCAACGTAGACAGTGGTCTCATGCACTCCATAGgtgagatcaaatgaaagtttcatatagaaatacaaaacctagagaactggcatgtaagagaagcaaaaattacttcagcaaggccatgttagtaaatttgcatctgtttgtccacattagGCTTAGGTTACCACAAGGATCTCCAGACAAGAGCTACATTTATGGAAGTTCTGACAAAAATCCTTCAACAAGGCACAGAATTTGACACACTTGCAGAAACAGTATTGGCTGATCGGTTTGAGAGATTGGTGGAACTGGTCACAATGATGGGTGATCAAGGAGAACTCCCTATAGCGATGGCTCTGGCCAATGTGGTTCCTTGTTCTCAGTGGgtaag	NULL	No	NULL	Out	85.7	6.95	7.67	69.01	10.58	10.88	4.04	4.04	6.84	7.44	15.7	12.3	-7.2	-4.1	8	0.77	5	0.79	162200	ENSG00000196712	433	634	neurofibromin 1
628	1	Human	237	RAD51	234	Breast Cancer Risk	E1+160G>C	-111	50	Exon	0	GGGAATTCTGAAAGCCGCTGGCGGACCGCGCGCAGCGGCCAGAGACCGAGCCCTAAGGAGAGTGCGGCGCTTCCCGAGGCGTGCAGCTGGGAACTGCAACTCATCTGGGTTGTGCGCAGAAGGCTGGGGCAAGCGAGTAGAGAA/GTGGAGCGTAAGCCA(G>C)GGGCGTTGGGGGCCGTGCGGGTCGGGCGCGTGCCACGCCCGCGGGGTGAAGTCGGAGCGCGGGGCCTGCTGGAGAGAGGAGCGCTGCGGACCGAGgtgagtgtgtgaggcgcaggctgggccctccagagccgcggctcgtcctcgcccacctgcgtcctggccggtccagtgctcagcggcagttggggcctccgcgcgcagtgtgaaacccggacgtggcagggcgtgtccgcgcccgaccgaccctcagctgctggggcgaaaacacaagtggacctcagtctttagaactaggggagaaacattagagcctttataggcaacacctatttt	NULL	No	NULL	Out	92.02	10.03	-10.93	52.95	14.48	1.28	0.56	0.56	-0.06	10.9	18.8	4.9	-8.8	-1.5	8	NULL	4	1	602948	ENSG00000051180	451	628	"RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae)"
635	1	Human	173	FGFR2	195	Crouzon syndrome	EIIIc+93G>A	-51	NULL	Exon	0	ggtcagtgttgctccgtgtctctcggttgtgggctttgtggatgggctgcagtcggaatctcccagtggccagcaccccctgaagcccccggtgcgacgccttgtggttccacagccccctccacaatcattcctgtgtcgtctagccttttcttttgcttcccttgttttctagGCCGCCGGTGTTAACACCACGGACAAAGAGATTGAGGTTCTCTATATTCGGAATGTAACTTTTGAGGACGCTGGGGAATATACGTGCTTGGC(G>A)G/GTAATTCTATTGGGATATCCTTTCACTCTGCATGGTTGACAGTTCTGCCAGgtatatactgttctttctctctgggtttttttcccttttcttggttgactgctataaaattaacacagcttctgttatcagaaatggccccttttatccttgcataaagatataaaaaatgttaaaaatgatccctcagggataagaaaactgccttggaaattcacacacagtgagatcccacactcacatttatgatcaagggaaatttcacccttaa	NULL	No	NULL	Out	78.17	7.88	8.55	87.96	11.58	13.08	9.17	9.17	7.72	7.24	14	16	-4.9	-6	8	0.87	8	0.88	123500	ENSG00000066468	454	635	fibroblast growth factor receptor 2
663	1	Human	30	COL3A1	248	Ehlers-Danlos Syndrome	IVS19+1G>A	24	53	Intron	0	GGTCCCGCTGGCATTCCTGGAGCTCCTGGACTGATGGGAGCCCGGGGTCCTCCAGGACCAGCCGGTGCTAATGGTGCTCCTGGACTGCGAGGTGGTGCAgtaagttgccttgttttttctctgttgactgaaaggtatagtttaattccatcaacaaaaaattaatagcaaaattttgctcctgttcagttgaatttatattgacttcactcttgtcttataacttataactgaattatgtgttactggtgatgatttgttagtcgaatcctccctgtgtttcaaccaagactttgttatactttagGGTGAGCCTGGTAAGAATGGTGCCAAAGGAGAGCCCGGACCACGTGGTGAACGC(g>a)taagttttactgcaacagatctg/gttatttcttgaaaaaatgcaacataattagaaagtaaacaggtaaaaactttgaactaaattcagtcataatttctttattttaccatcttttttttttttcag	NULL	No	NULL	In	77.61	9.93	-0.56	69.27	13.58	2.98	2.18	2.18	0.24	9.15	14.5	8.3	-4.3	-1	8	NULL	8	0.99	130010	ENSG00000168542	475	663	"collagen, type III, alpha 1"
705	1	Human	30	COL3A1	248	Ehlers-Danlos Syndrome	IVS42+5G>A	30	100	Intron	0	GGTGAAAGTGGGAAACCAGGAGCTAACGGTCTCAGTGGAGAACGTGGTCCCCCTGGACCCCAGGGTCTTCCTGGTCTGGCTGGTACAGCTGGTGAACCTGGAAGAGATgtga(g>a)tagcagtttttattcaaccagccag/gtagaatttgataatttatttcagcaaaggtgaaattgagctttaatgtctaagagtgtaaatatggccacatagcaaagttcttctatctctaataacagaaattctttcattacaatttaggatagacttaaaagctcttgttcattagtatttacccaatgaataatcatttgtggagaaaatattatctctaactaaattaggaaaaaagttagtggggagaaccacaattgacatgttttctgagtgaaaatattctacggttat	NULL	No	NULL	In	79.51	7.77	6.68	72.74	11.58	11.48	5.9	5.9	5.91	6.64	14.2	14	-3.9	-5.8	7	0.89	7	0.97	130010	ENSG00000168542	500	705	"collagen, type III, alpha 1"
604	1	Human	229	OXCT1	286	Succinyl-CoA 3-ketoacid CoA transferase deficiency	IVS1+1_6delGTAAAG	-7	100	Exon	1	GGTGGCGTGCGGCTCGAAAGGCCGGGAGGACGTCATCGACGCGCTGTCGAGCCTCCAGCCCGCCCGGGTTTCCTTCGCAGTCGCGCACCGACGCTCAAACGCGCGCTCCAACCCGCAGCCTCCTCCTGCCTCACCGCCCGAAGATGGCGGCTCTCAAACTCCTCTCCTCCGGGCTTCGGCTCTGCGCCTCTGCCCGCGGATCTGGGGCAACCTG/GTACAAG(gtaaag)tgcgggggaagaggaaggccatgggcaggaagaacgtggaccaaaccctgagtggtgcccgcgttttcttctctgcccctacccgctctctccagcctgggatctggcatccgtggcgcggtgccctggtcacggacacgcggcgacgcgttcctggcctcgccggcccctcggatgaccgcctttgcttggttctgcagtcgcttccctgatggagcgagacgcgataaagaagcgcgcggagaggctgagaaggggcgggaggactcctggcagcgctcccgagccctttggcgctcgtcggcttccctcctggcacccgcccttggatagggactctgagggtctgaacggggggaggagggcgccagtatatggaggtttaggagtgaggcaacagcgggtaggtttgcgcccccgatgttggatctctgggcagaggaacctctagaggcccagaacctgaggctgggttagccatggctctgctcgag	NULL	No	NULL	In	82.74	9.06	2.41	63.57	13.78	8.68	3.25	3.25	4.37	7.72	14.1	10.4	-5.4	-2.5	6	0.67	6	0.92	245050	ENSG00000083720	435	604	3-oxoacid CoA transferase 1
664	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS9+5G>C	13	NULL	Intron	1	ggttcacttttatcggtatttctcactattatgtattgatgttcgtttcaagaccttaaaaacttagtgttttttttttaaactttctatttgctgttctttttggcttcatttgtattactgagtatttttctcatagaaataatctgcttttttttttctttttctatagATCTGCCTGGCTCAGAATTCACCTTCTACATTTCACTATGTGCTGGTAAATTCACTCCATCGAATCATCACCAATgtaa(g>c)tccaaaag/gtattgctaaattactaaaaaaatttttttctttcttttctttgcgtatttctttttaagaaatgcactcttggttttcaaaaaggttctgaatttagatgtatgaaataggaaaatttctccatggtgattctatttgataattgataaatatttgtatttttcatattaagtcttgaccgaagggaccatattaaggaagatggagttaataagatgc	NULL	No	NULL	In	87.25	8.62	7.76	72.57	14.08	10.68	4.92	4.92	6.31	7.47	14.4	12.3	-4	-4.1	7	0.83	6	0.99	162200	ENSG00000196712	433	664	neurofibromin 1
731	1	Human	189	SLC12A3	200	Gitelman syndrome	IVS13+1361C>T	1360	100	Intron	1	gtaagcaaacccttcacccacctcaggaggaggcacccagggggcaggaggaactggggcatggggtgggagtgggaggcatgggtggaggttggcagcccaaggtcacctctcaatttaaaaccattgaaagggaacattaatataataatagcagctctcggctgggctcggtggctcatgcctgtaatcctagcatttttgggaggcggaggtgggcggatcacttgaggtcaggagtttgtgaccagcctggccaacatggtgaaaccctgtctctacaaaaacacaaaaattagccagatgtggtagcggtcacctgtaatccaagctattcgggaggctgaggcaggagaatcacttgaactgggaaaggggaggttacagtgagcagagatcgcgccattgcactccagcctgggtgacagagcaagactctgtctcaaataatagtaataataataatgataataataatagcggctctcctttctcgcgcactgacagtgtgcactttacatggattcatacattgcttaccatctgtaggggttttccagtcttttccttccccagttttacaggaatcaggagcctggttcttcagagaaagagaattgcccaaagtcacagctagggctgtcacagacagtgctgcaggttgcacactgcataactctaggaggcaccattcatatcatagatttcatatatttgcatgtttatgatggaaaacttctggcagatggcaataaagaggcttgaggaagactttttctttctttttttttttttttttttgagacggagtctggctctgttgtccaggctggagagcagttgcacgatctcggctcactgcaagctccacctcccgggttcatgccattctcccacctcagcctccccagtagctgggattacaggcgcccaccaccacgcccagctaattttttgtatttttagtagagacggggtttcagcatgttagccaggatggtctcgatctcctgacctcatgatccgcccgcctcagcctcccaaagtgctgggattacagttgtgcctggctgaggaagactttttctaaccagctccaaattgccattgtcttttactag/GCCACCTTTTACATAGATCCCAATGTGTATGATGGCCCTGGAGTTGCACCATGAGGCAGCTGTCACTAGTGGCAGCCCTGGCCTGACCTGCTGGTGGGGAGCCAGGCAGAATCATGTCCTTCCCCCTCCATCTCACCCCCTTGGCACCATGGGAGCTGGTGCTGTTGCTGACATGGGATGTCCTGTGGCTGTATTTGGCCAGAGCTGGATGCTCCTGGTGAAATGCCAGCCAAAGCAG/g(c>t)gtgtgatttgccccagagcctgtagacccagcccaggaggcagggtgggtggtgctcatggctggtgggtacaggctgggaccccggctctgggcactgctggcattactgccaggccctgcccagcagctctggcctagaaagaggctcgactgccaggcatgcccactgactggtgcccttggcccag	creates pseudoexon	No	NULL	Out	NULL	NULL	6.99	85.05	NULL	12.88	NULL	8.75	7.28	NULL	NULL	14.1	NULL	-5.9	NULL	0.89	9	NULL	263800	ENSG00000070915	523	731	"solute carrier family 12 (sodium/chloride transporters), member 3"
710	1	Human	64	FBN1	264	Marfan syndrome	IVS63+375G>T	375	100	Intron	0	gtaagcagtgctcttcctggtcatggttggagattctttcattcgtaatataattaagtatactgaactcaaaattacctgtcctagcagaggagaaccatgctttttgtaatcctaaaattaattccagttagcttggcaaaagttttaggttattttatttggaaggaagcatctggatttctggaaacgtcaaacaaagtaatgaaactacattgtaaatatctcgctatatgacttctctatcttattctcttgatcttcacatcttgttgggaag/TGATTCATCTCTCTGTAAATACACCTCTCTGCCAACCCATGACAGAACTGGGCTCACCCTGCACACGACTGATCCACTCTTCTCCTGGGGCAG/g(g>t)aggattctatctggacttaaaatgcctttgtatctagctcctgttagaataagtcaaagacatccctttgggttgaaaattatttagggttttaaattatattttacatttcagacttgaatttacattaaattttaccaaaggtgcattgaaacacttactgtattttcctggttaaaaaaagaaaaacaaaaaaaacacttcaccaaattataggtgtgtctgtgtgagagttggggcagggaaggccttttttttttttttttagacggagtcttgctctgtcgcccaggctggagtgcagtggtgcaatctcagctcactgcaagctctgcctcccgggttcacgcgattctcctgcctcagcctctggagtagctgggactacaggtgcccgccaccacgcccggctaattttttgtatttttaatagaaacggggtttcaccgtgttagccaggatggtctcgatctccggacctcgtgatctgcccgtcttgacctcccaaagtgctgagattacaggcgagagccactgtacccggccgggaaggcctatttttattttacccagtgatttaaaagtttagtgttaagttttcaaagtttggatcttttttcctgctgaattaatctggactcgggtgtccacctagttttagctatcctgagaggaagtgcacattttaactttttaattaggaac	creates pseudoexon	No	NULL	Out	NULL	NULL	9.79	84.59	NULL	13.08	NULL	9.36	9.1	NULL	NULL	15.7	NULL	-8	NULL	0.64	8	NULL	154700	ENSG00000166147	505	710	fibrillin 1
662	1	Human	30	COL3A1	248	Ehlers-Danlos Syndrome	IVS15+1G>A	24	21	Intron	0	gtaagtaactttctatctcttatgtgttgtagggtaatgagaagttatggattgtggattatttaatattttatatatgtatatactcttaggtatatatatatgcatatgtatatctctaatatacacattagcatctctgttgaccatttttacaatttaaaaagtgaaaaaatattgtagccccaatacttaatattgtatatacactcctgtgattaaaactgacactgagcccataaacaaaatctaggttctgacactcattctgcttgatcaactgctaacatttgaatggtgctcccaatgttagttaatatcctatgtaagacatggcactttaaagagtcctacaaaatggataaaatagatgttacctccattttgtagactggagtacaaaagcccagggaaaagtagcctgcactaagtcacagaattcatggcaaagtagggagaaaccaagaatttctaactttagatttcactcttttcttattttaccacattgtttctctacataatatccataaaatatgaatatcatttttatctgcataaatatcttctttactttatatgtgctcacttatttactagtatgtcagctttcatttagttgaaaaagagctcttgaaattgtatttaattttttcagGGCCCTCCTGGTCCTCCTGGAACTGCCGGATTCCCTGGATCCCCTGGTGCTAAG(g>a)taaacatgtgtttctatagaagg/gtataaaaatatcttggaggcaagagaaaagcattagattgcttcttgcaactgatttttttaatcagtcaaatggatagcttttatctatacatgtctttaaagccctattcttgattctaaaagaggtgttgtccctagtattcaactatcttgatatttcttctgctaccttctttttttccccagactctttctaggaaactgataatgcaatcacacacacatagttacatttttctctgcctttacgattaatgattccttgctttacctgcagtatagagtcccactactccaacttttgggagatgtgtttaaacaggactgaagggtgaagtggctaagtgagtagaagtggtaagagaaactgactacacaaggttttaccattag	NULL	No	NULL	In	82.06	8.14	2.31	63.5	13.18	7.68	2.68	2.68	3.77	6.95	14.1	10.2	-5.4	-4.7	6	NULL	6	0.97	130010	ENSG00000168542	475	662	"collagen, type III, alpha 1"
714	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS54+790C>G	790	100	Intron	1	gtaagtatctccttttgattttaattcaccttcgtgcctgtctttaagttaaatgcttacccagtaatgtgcactggttgcaaagagggcaaaatgagatattgtgatagtgattttagctttgagacagtaggtttaatgagggttaagattagttttgacctactagatctattagaaagtttataaggaaagacttttaaaaaatctggttgatttatttaagtggtttattttgatgatcattgctcattttcctcacttagaagcaaactattagactgctatatctaaatcagcatatctgttttggtttactttttagtagagcttttgtatttatccacagctgagtgaaaacaaaattgaccttctgtttaggaggtgaattgtttactctctcttaaggactaaaaaatattaacctcaaagtgttcaaatttaaatagttcaaataaattcttttcctgatctaggccttctatatcatgtcattattttctttttttaatctcatgttagaattttagagagttagaactcagttatttttattaatggagtgtagccgggttagaaataatttttttcctaagtttcagttggatcatgtatttcactccctctaaactattttgctttccctatttgatctgactcagcattttaaaagcactgattaacattaaatttaatttttttctttttgttttgcacag/ATCCTAAATTTAGTTTTAACTTCCTAAGCGCATGTCAGTATACAACAGATGGAAATAGTACTAAAACATG/(c>g)taagtagcagacagagccaaccttgtcttaagcaaacatttaccgtatatggttacacatggttatatgacactaccagttgtttgttttcacaatttcttccctggtgactaaaaacaaaagacaaacaaaaacagacacacacacatgttcattgtagaaaatttggaaaatgaagaaatgccccagaaagtaaaaagcactcatctccctttaattttggcacattattctggggaatgtatattatgttttccactacatattttcatttaattttcctctaaaatgttcctctgttgactttttttttcttttag	creates pseudoexon	No	NULL	Out	NULL	NULL	-21.26	28.37	NULL	-14.28	NULL	-16.08	-18.82	NULL	NULL	NULL	NULL	0.3	NULL	NULL	2	NULL	162200	ENSG00000196712	508	714	neurofibromin 1
707	1	Human	231	PKHD1	229	Autosomal recessive polycystic kidney disease	IVS46+653A>G	653	100	Intron	2	gtaagtgccttagtgtggttgttttaggctgtcaatcacaacaaaattacatgtgctgggccccctgatgatccaggatatgcaattttaatagcattctttagtgaatctcatatttaattagtaaaagttaaaagacctttttatttgtaatagtggtgatattgataatagaactcatatatacacagtgctttagtgttatgagtacagataaatcacagaagtcataagtagctgacagaattttatttggttgcaatttagaattattactcatagtaagaggtcaaatcatgaaatagaaatttgcctagttcgttattttgtatgtgattcactaatatgtgcctaagtatggatttccacatgataaaaatcagactctagatgacttctcagggtacaaggatgcagatggggcaaagagtactcccgggtgggaagcactagttcctaagtgggggttcctggctgccattggtctcttaggcttcaggtctataatggatcccctatgttcttgtttttattag/AACTACATTCATACTAGTCATCACATCATTATGGAAATCATAGATTTATTGGGAGCCAAGGAAGAATATTCTCTTCAGTTTGTTCCTGAGTGCTTAGTTCAATTGAAATTTAAATG/(a>g)taagttttgattcttatacttccattgaagattatttatttcacagctatagataaaaatgtgaagattttaaaagtcattttcttattgagctacattttcctggatttaactctcaacttttcttagtaaaatctcctttgaactatacttttcaggagataaataagtgccagtttttttttccctctaaaaggattaccaccttgagagatgattcttcctttcagactgtgtagttttcaagagaggatggtacccagatttagattctgtgatgctgtggtacatcagaggtccttaacttttccagaaataaccttagagtagatgttaaaaacaaaattcccagcaaactgagtaactgtcttggtaaattaatgttgcagtatcttaattgatgttaaatagacatcataattaatgggaaagtgacaaaaattaagatgtaaattatgacaaaagggtggctatcatgagataatcaaaaataatcacacccttggggtgtaattcactaggaatgtagtacagctgagggcctttc	creates pseudoexon	No	NULL	Out	NULL	NULL	11.01	91.22	NULL	15.48	NULL	10.67	10.1	NULL	NULL	17.5	NULL	-7.3	NULL	1	8	NULL	263200	ENSG00000170927	502	707	polycystic kidney and hepatic disease 1 (autosomal recessive)
724	1	Human	46	DMD	244	Duchenne Muscolar Distrophy	IVS67+2714C>T	2713	NULL	Intron	1	gtaagttattcaccttctaggtaacatatttattctttcatattttagaaattaattaaaaaacccacagagcttcgttttctcatattagctcttcagtaggcagtaggtatgggatttgggatatttggaacctctgtaagtaagcagcttctggaactctaggttttgggaaagaagacagtgctgaggaaggaaaagaaatctccatctgcagcagggaccccacagttattgaggtgctagaggggaagaagttcagcaagggaggaaataagtctctagccacagaaatcctatgtatataagaaaatggcctttgtaggcgagtctcttagtctctgagtcctttctctaattctatcattatagcctcctttcaatggctgttggtaaattgttagcacagctgtccttttttttaaaactgtcctttgtagctttgacattcccctattattccaaagtctagaggtgtatactctctgctaatgtccatcactgactgaacacactcttgtccgttctctttcctatcctgtcccattgctttttctctgtcgtagtcagtgccccagaaacaccctcttcttcccaaatgcctgagcactccactggtagacattcatcttgttctaatttttttttctctttccttttttttttttttttcttttttgagttgcagtctcgctctgtcacccaggctggagtgcagtggtgagatctctgctcactgcaacctccacctcccgggttcaagtgattctgctacctcagcctcccgagtagctgggattacaggcgcccaccgccaccccaagctaatttttgtatttttagtagagacagggtttcaccaggttggccaggctggtctcaaactcctgacctcaggtgatccacctgcctcgaactcccaaagtgctcggattacaggcgtaagccaccgtgcctggcctctaatttttattaggtagatagtgctacaatgaacatccttatcgtttagcttttgtctttgaagctttctttataggatcaattctcaggcgtgtgattgccagacaaaataatataaacattttttgtggcctttcttcaaaagttgttctaattgtaacgctatcagtattgaaggagtaagatgctttcggtatcacattattcacagtgttcttatgtttttgtttttggttttttcaagtgctaagagctgtttttcttatgtagggtttctcaatccattctaattctattaacaatggctgagatttacaaaatggaactagctgtagaactaactgggttatatctgaagtctttgaccacagactaggatgaaactatagaaggtttcctgggcagatcactgtgaatatttaggtgtttaaagcagtttgagtatttatttaatagttagttggatagatttaccggatgcacacataataagttcatttatgtaaagtgggatatactgtttgaattattttgccaaaattatggcaaattagttgtaaatgtaaaatgcatgtggagaaataaatatcttttcctcctcatacccaaaccttccaaaatgcagatagatgatcaatccaatcaatcatcaaaatgtagacacaagtaacttccatacaatgaatattaatggccacaggcaatctaggttcattttgattttttaaaatccaattataaaacaacttgccataaacgcgagttatttcctaatcttttggttgtgtgttttttttgttttgttttgttttgagatggagtctccctctgtcgcccaggctggagtgcaatggcgcgatctcggctcactgcaacctccgcctccctggttcaagcaattgtcatgcctcagcctcccgagtagctgggattacagggtgcctgccaccatgcctggctaattttttgtggagacagggtttcaccatgttggccaggctgagctcaaactcctgatctcaagcaatccacctgcctcggcctcccaaagtgctgggattacaggtcctaatcatttttcccctttagtcaagtctcagttactctttgagttctagtgaaacacacacacgtgttcatatatagggatatataaacatatgtgtgtgcattgtgacttgggttaaaggtaaggctcagtgatggtccctgctgcaaagtaaactaggctgtattcagggccagctggattctttgttttctcgcccgagtactgactcatcaggaagccaccaccatcctcactgcagcctctggccctcttggatttggttgtcaggataagcggtggccatacagaagctctgctttccctgggctgccccccttatcaggagaccaacctattccatttctgcctgctacatccttttgctggataacctcctactcccctaagcccatgtctctggtttggttacatttctgtctctgtaataacaactctgtattctcagtctcaaagctttgaattcagtccatccttgcatatttgttgaatgcctcctggttggccagccagtctccaagctctttgaaatgtgaaatgtgttttgttttgttttcag/AAGGGGTCTAACTTCGTCACCCAGGCTGGAGTGCAGTGGCACGATCACAGCTCATTGCAGCCTCGACCTCTGGGCTCAAGTGATCCTCCCACCTCAGCCTCCTGAGTAGCTGGGACTACAG/g(c>t)atggaccgccacgcctggcatttttttggtgtatgtgtgtgtgtgtgcgtgtgtgtgtgtgtgtgtgtgtgtgtgtgtgtgtgtgtgtacagggtctctcgccatgttgcctaggctggtctcgagctcttgggctcaagctgtccacccacctcagcctcccaaaatgttgggagtacaggcgtgagccacggcatccagccttgaaatgttttctatgagactggggggaaatcagtcaagatatgaatggtggtaacaggtggcttttgattttctctgtactatttttattttctgagttttcttctttgaacatttataattagaaaaaaaattagtaaagtgctgcctctttttttagggaaagaaacatgttttgtttgattgctttccattgccattcttacattgtttccaggccttctcatcattgcactggcttcctagcaagcctccacttcacactccagtccttttcattggtcttattgccctcatactagttttagagaaaagcatttcccatatgatgccgtccttgaaaatgtcagtatctttctgttgtctagtgaacaaatcctaattcctctatttaactctcagacctttcctactctggtttcataaccacccatagtttgctttcactatcatgaaacagcttctccttaccatttgtacctattatgcttataaataatattgttaccattgctactaacaaaactttgttcacatgaattctctcatttaatcctcaccaagtctttgaggggaacagaatagtcaggctttggagattttgcttttattattgtttaagtggatgaataatttatttgcgcccttaaagtccctcagctggtggaagggtttgattcctagtccagtatgcccaccgccacatttactacctcattcccaaatatgtagtttctgatacttctgctctccagcttcccaaggccaaacaacagctacttttcctgagtcctggatagaataagaaaaggtataacaagacaggggacccttgagggggaagaggaattagtttgaagtgctggcaaatgtagtatttctaatcagatgctagtaaattccatatgtatggcgaggcttt	creates pseudoexon	No	NULL	Out	NULL	NULL	9.99	84.85	NULL	11.98	NULL	9.2	8.9	NULL	NULL	15.7	NULL	-4.9	NULL	1	8	NULL	310200	ENSG00000198947	516	724	dystrophin
661	1	Human	203	C4B	235	C4B deficiency	IVS28+1G>A	7	NULL	Intron	1	gtaagttcagtggcgtttctgccctctgctggcccccagctctctccctttttcctcaggaacccaggggtccaggcccaagaccctcctcccgttttcttccagGAAGCCTCCATCTCAAAGGCAAGCTCATTTTTGGGGGAGAAAGCAAGTGCTGGGCTCCTGGGTGCCCACGCAGCTGCCATCACGGCCTATGCCCTGACACTGACCAAGGCCCCTGCGGACCTGCGGGGTGTTGCCCACAACAACCTCATGGCAATGGCCCAGGAGACTGGAG(g>a)tgaggg/gtgaggggctctggcagtgagcctgaggcccaggggaccttaggatccctgagtgtgcccagagggagaggctggatgaagactcagaggaggaatgaagttataagcaggggtgggttgggggagactcaggagagcccagcagggggtggctaagggccaggggaccaggctcttctccctgccttcctgtttactcgtggtctcccttcactttcagATAACCTGTACTGGGGCTCAGTCACTGGTTCTCAGAGCAATGCCGTGTCGCCCACCCCGGCTCCTCGCAACCCATCCGACCCCATGCCCCAGGCCCCAGCCCTGTGGATTGAAACCACAGCCTACGCCCTGCTGCACCTCCTGCTTCACGAGGGCAAAGCAGAGATGGCAGACCAGGCTGCGGCCTGGCTCACCCGTCAGGGCAGCTTCCAAGGGGGATTCCGCAGTACCCAA	NULL	No	NULL	In	86.85	8.41	5.5	77.69	11.78	9.98	7.28	7.28	6.2	9.2	15.7	13.6	-8.6	-9.1	7	0.76	7	0.95	120820	ENSG00000224389	474	661	complement component 4B (Chido blood group)
720	1	Human	223	MTRR	258	Homocystinuria	IVS6+469T>C	590	NULL	Intron	2	gtaagttgcaaaatttatttctcagcacagtaatattgtcaggatgtgcagaaagagttgtgtggtgcttggttatatatgctgagtggtgtgctgcttggttacatatgctgagttgtgtgcggcttggttacatgtgctgagttgtgtggtgcttggttacatatgctgagttgtgtggtgcttggttacatatgctgagttgtgtggtgcttggttacatatgctgagttgtgtggtgcttggttacatatgctgagttgtgtggtgcttggttacatatgctgagttgtgtggtgcttggttatgtatgctgagttgtgtggtgcttggttatacatgctcagaagaatgagaggtctctgacaggacatcttgccattttattcctgacccatcatttttttctctcttctattttcacacctattttctttccacttcag/GGAAGGACTAGGGAAGAATGGC(T>C)GGAGGAGATTCAGCCTGAGAGGAAGATGCTGGCTTACTCAATAAGCCATGAAAGAATAATGGGATCAGAACAGCATTTTATATATAAGAGGCCCAGGAAAGGAAGCTGTCCACTAAG/gtcagccaggaagttagaaatagagcctaaggtcaaacgaggtggctctcgcctataatcccagcactttgggaggctgaaggcggtcacttgaacccaggagttcctgggtaacatggcaagaccttgtctctacaaaaaaatacaataagtagctgggcatggtggtgtgtaccgatggtcccagctacttgggaggctgaggtgggaggactgcttgagcctgggaggttgagactacagtgggctgtaattgtgccactgcactccagcctgggtgacagagtgagaccctgcctcaatttttttaaaaaaagaaaagaaatagaacccagacaggcaggttagggttaattcctcagagcagtggttttgatttcttgagaatctggaaaaaattatggactctcccaaaaaatgattacacttgtcccttagtatcttcgaaggatttgtcccaggacccctttcagatacccaaatcctcaaagctcaagtcccttatgtaaaatgttacagtatttgtatataatctatgcacatcctcccctacactttaagtcatctgtagattacttacagtatctaacaccacgtaagtagttgctatactgtatttttaagtttacattatttttattgttattttttattgtttttttccgtcccaaatattttccattcaggtttggttgattctgagggtggagaacctgaggatatggagggccaactgtatatagaaacatttacgtacagttttagtctgagatgtgcctcgatgcaccccctccatgggcccccttcctaccctccacaccctgctggaatccattgaccttaggttaagaaactgactgataatcctaaaataagtgtttgagtacctcttcaaagtcatttagctcaaccgtttattttatgaaagtcttgagaggttaagtgggttattctttcagaaaagcaagggcacattaaggctgttggtgtagatttaatcaaacttcctaacagaaaaaaatacaatgtgtcaaaactagatggttttgcatccataaatattaatactatgtacaccaaaatattttttattctggtattttacatttttgtcataaagaggcaagggttggtctgtgcttagtccagtctctctcccttgctggcaagaaatgtgagcttgtgtcattgtgagaggctcctccccagagccctggcctgcatctgtatcactctggggcttagaggcaatgggcctagtaatagacttgacttgggaagtggtgactttttcagcccatgtttgctcacaaccagtatcgagccagatagtgtaatgttttatacttaaggaaataaagtaccctttcctgtcccctaaaggaaaagagtaaagtaaggagaagaaaattgaaaaccaatgcatttgaccataattagtttcttttggtcataatgtatgttttcgtgtgtgtgtgcatgtatgtttttgtaagagggatttttatatttacatgggttattgaaaacaccataggaccttactttgtagagaacaaggaaggtctgacttccattctttaagtatgataaaaggcaaaacactgggtaactaccagatttcgttttaatagtaactgctaataatgaaagtatgtttatttggttagttgggcttattttttaaaacaattgtgtgtttttttttttgaaattctattttctgagttcacatattaaaatcataatattgaaaactatatttttgttaccctacagcttaaactatgtaacacgtataatgtattttttttttttcattttggctcttctctag	creates pseudoexon	No	NULL	Out	NULL	NULL	7.09	83.75	NULL	12.18	NULL	6.96	6.77	NULL	NULL	13.2	NULL	-4.6	NULL	0.9	6	NULL	236270	ENSG00000124275	513	720	5-methyltetrahydrofolate-homocysteine methyltransferase reductase
718	1	Human	244	SOD1	226	Amyotrophic Lateral Sclerosis	IVS4+792C>G	787	100	Intron	1	gtaagttttcataaaaggatatgcataaaacttcttctaacatacagtcatgtatcttttcactttgattgttagtcgcggtttctaaagatccagataaactgtacttgcagttcaaattaggaaaagcaattttattggacaattacggtgaaaatgaattattttatctaggtcagttaagaacactgttctgctaagatgcagtaaaaagcaggttacatttgaccatattagatctgagtttggaaaacagaagtagtctttagttttaaaatggccagattttcttgccaggattgggtttctcacttgttaaacagaacattttgttaagtttaaaacctgggatggacttaagtattcatgttcattcatgttcattcaggactgcaggttatcatgacttgtttaacttgtgggaagctgttgtcccaagttatcctggggaactgcatctggttcttgcaaaacaccaagtagacaggctctcttttacctccccttgagggcattaacattcagtagtcacttccattcagttaaccctttatttttatggtttttcttgagccatagttgtaaagcagaaaaatcatttataaaggtttgttgaacaaaattcaaaatactgttgcttaaagtattaagattttttaggattataccttacttataggcccgtcattcatttggcatgaaattttgagttttattcactttcactttcctttttttccaaag/CAATTAAAAAAACTGCCAAAGTAAGAGTGACTGCGGAACTAAG/gtta(c>g)tgtaacttaccatggaggattaagggtagcgtgtggtggtctacaacatagttatttgggttttagtatttcatttagacagcaacacttacctaatgtttaaaggtaatgtctttgcaacaccaagaaaaagctttgagtagtagtttctacttttaaactactaaatattagtatatctctctactaggattaatgttatttttctaatattatgaggttcttaaacatcttttgggtattgttgggaggaggtagtgattacttgacagcccaaagttatcttcttaaaattttttacag	creates pseudoexon	No	NULL	Out	NULL	NULL	8.54	89.61	NULL	13.58	NULL	7.76	7.21	NULL	NULL	16.3	NULL	-6	NULL	0.99	8	NULL	105400	ENSG00000142168	511	718	"superoxide dismutase 1, soluble"
717	1	Human	209	FGG	237	Congenital Afibrinogenaemia	IVS6+660A>T	654	100	Intron	0	gtaattttttccccaccatgtgtatttaataaattcctacattgtttctgccatatggcagatacttttctaagcaccttgtgaaccgtagctcatttaatccttgcaatagccctaagaggaaggtacttctgttactcctatttacagaaaaggaaactgaggcacacaaggttaaataacttgcccaagaccacataactaataagcaacagagtcagcatttgaacctaggcagtatagtttcagagtttgtgacttgactctatattgtactggcactgactttgtagattcatggtggcacataatcatagtaccacagtgacaaataaaaagaaggaaactcttttgtcaggtaggtcaagacctgaggtttcccatcacaagatgaggaagcccaacaccaccccccaccaccccaccaccatcaccaccctttcacacaccagaggatacacttgggctgctccaagacaaggaacctgtgttgcatctgccacttgctgatacccactaggaatcttggctcctttactttctgtttacctcccaccactgttataactgtttctacag/GGGGCGCTCAGAGGGAATGAATGGTGGAAGCATTAGTTGCCAGACACCGATTGAGCAATGGGTTCCATCATAAGT/gtaag(a>t)atcagtaatatccagctagagttctgaagtcgtctaggtgtctttttaatattaccactcatttagaatttatgatgtgccagaaaccctcttaagtatttctcttatattctctctcatgatccttgcagcaaccctaagaagtaaccatcatttttcctatttgatacatgaggaaactgaggtagcttggccaagatcacttagttgggagttgatagaaccagtgctctgtatttttgacaaaatgttgacagcattctctttacatgcattgatagtctattttctccttttgctcttgcaaatgtgtaattag	creates pseudoexon	No	NULL	Out	NULL	NULL	8.46	78.09	NULL	12.38	NULL	6.31	6.66	NULL	NULL	17	NULL	-4.6	NULL	0.99	6	NULL	202400	ENSG00000171557	510	717	fibrinogen gamma chain
721	1	Human	235	PRPF31	283	Retinitis Pigmentosa	IVS13+654C>G	654	100	Intron	0	gtacctcccctgggccggctctgtccccagccctgagaccttggcaaggccccttgccctctgcccctgtgaagaaggccaggatgagtctcctcatggggctgttgtggagggtgtggtgacgaggtatgcagaggacgtagacagctcctggcacacaggaagaggttagcagagacgagagcccagcgctgagcagtcctcgtgagcacgcactgctttagaaccaggcccacagctgtgttcagggcacccagttcctctgtcgggctgtgagcgggtaacactgctcagcctccaggccctccagttcaaaacggccaggacggttaaggtaacctcaggaccccactcgagaaagttcccggctaggcgggcttggatgtcaagtgtgggtccaggccccagccagtcagcagtgagcagcgtggagcatggcagtcaccgcatcgtcggagcctcggtttaccatccacag/AGCAGGGCGAGCCTGCACCACGGAGGCGAGACAGCAGCGAGCTCATCTGCCCAGTCAGCGGGTGTCTACGCAGCACCTGCTGAGTTCTGTCAGTGTTCCCGGCTCTGGGGATGAAGCAACGAATGAGAGACAAGTCTTACCTTCTTGGAGCCAGTGGGTGGCCGGGCGCAGACAG/(c>g)tcagtaagatgtccagtgtaggagaaggcagaaatgccaggccgggcgcagacagctcagtaagatgtccagtgtaggagaaggcagaaatgccaggctgggcgcagacagctcagtaagatgtccagtgtaggagaaggcagaaatgccaggccgggcgcagacagctcagtaagatgtccagtgtaggagaaggcagaaatgccaggccgggcgcagacagctcagtaagatgtccagtgtaggagaaggcagaaatgccaggccgggcgcagacagctcagtaagatgtccagtgtaggagaaggcagaaatgccaggctgggcgcagacagctcagtaagatgcccagtgtagtagaaggcagaaatgccaggccgggcgcggtggctcacgcctgtaatcccagcactttgggaggccgaggcaggtggatcatgaggtcaggagatcgagaccatcctggctaacacggtgaaaccccgtctctactaaaaatacaaaaacttagccgggcgtggtggcgggcgcctgtagtcccagctacttgggaggctgaggcaggagaatggcgtgaacccgggaggcggagcttgcagtgagccgagatcgcgccactgcacttcagcctgggcgacagagccagactctgtctcaaaaaaaaaaaaaagaaggcagaaatgccagggaggggaggaggtggaaggtaggaggtgggacaggggaggctctcgtttcggagcagccagggagggcctctttgagaagatgaggccagtggctgtgcctttccaagcctcccctcctccatcatgaggtgctcaggactgaaaagaacgcacaggaagcacttggcactgggctcaccattagagcccaatgactgggtcctgttattatttttagagacgggggctcgctctgttgccttgaaaatatttaggaagtgccagccaggtgttggctcccattgctgccactatgatcgtcagtggtgttggtgtgatttgtgctaggacctcgggccagccatgtcccccagggactcagtttccttatgcagaaactgggcaggattggctgtcctcaagcattggttgtttttagcacccctgaggaacttcgtacaaatccaggcgccctggttcctccccaccctctccctctagacccactgagtcagaatctcccaagacagggcaactccagggacaggcaaactgtctcatgcccaccaaggcctgagtgccatggggaagggcctggggggctctgatgggtcacagttggggccttctcctcacctaacccatcatcctctctccctcacctgcccag	creates pseudoexon	Yes	NULL	Out	NULL	NULL	8.94	89.85	NULL	12.18	NULL	8.56	8.9	NULL	NULL	18.6	NULL	-6.8	NULL	0.96	8	NULL	600138	ENSG00000105618	514	721	PRP31 pre-mRNA processing factor 31 homolog (S. cerevisiae)
708	1	Human	224	MYO6	252	Hearing Loss	IVS23+2321T>G	2321	100	Intron	2	gtaggtgttttcctttacacctataggatctttcattgtttcaagatggtttgtggagtgttgtaaagctgtctcagaggtgatgctgagcaacagagactgagacttgttcacactgggtcccaggttcctatttgtagatgttctttctttttttattttttgagtgtatgatatttattttctttattcaaatgtgttataagagtgtcagtttcatagtgtcctaacaaaacagaattcactatcttgatctctcgtccccgcacccctcaccatcccctaatctctcagacttaaaccagaacttttctttctgcctgcatggcatctacaatacacataccccgaaaattctaattgtaattgattttcctttcttatccctgaaatattgtcagtcaccagatcctgttgattccttctccaaatactgtacattcctttctttttcttgccagtgccttagtgaagtccttttccaccttttgcataataattccattagctcccagactggttttcctggtttcttagagatatctctctaaactagaagccttttataactttcctttcataaaaggtgaagtctaaattatttgatgtctttcaagatcatgtaaaatggtgtgtcagttttttgtttcagtctcttcccccaccatcccctcttaaatcctgttttttgaacggaagtctgtcataatcctgaaagacactgtcttgaacaccataatcccaaatgttgaaatcttaaaagatgaaagtcccaaaactaggattctgtaaaaataataaaaaaagatatttatttacattttaaaaaggggatttgagaaacgtataaaaacatgacagaactcttcataggccacttttcacaataaaataggcaataacatatatataggcaataaacatatatgtttattgaaactataaacacatatactaacaatagttgcatgggtataacaggagcagacaaaccgtattcataaagaatagggcgaaaggtgaaatgcataaacacatattattgtggttggtaattgtgcacccagctttgttactgcagtcatctgaaatactgtgatgatgaacaagctgtcttttgatgagatcagtcaaaaaccatagtgagtcaccactgcatttgtagttgcccagagaactgaaatcttgagaaattttatcttttacaagtgcagatgtatgataaaggacatctgttcattgattaagtttcagtgtttttatatacatacacaatgtttacccagaaagtaaatgttgtggtaatgcattttcatggagttaaatttgcaaaaaatgaatacagtaaattagaactctccaaaaatttctacataattaaaaaatgctaacaatttaagatagtgaaaataaaaacaaagaaaaaaaaaacacccaaaactaaaaaggaagtttgacataaaaaaaagtgtatcacagggacagattataggcagttgcatggagatagtccatagagctggctgtctttctcagtcattaactatattttgaagtcttgtaccacgaataataggtgctttttttcttttaggacatggttcttggagaatatgttcatattcattttcttcatgagattgctctttttggaattcttctgtgattcctctgattgggatttttaggatttttgatgttagggattttaatctaggaattttgatcttttgggatttcaacatttgggattatggcttttgggattaggaattcaaacccctttgacatactgggctaagctgcttttatgtgtggtttggccaggtcatagcagctacatagctggcccaagacaaaagtgagggacagaacattttggggttacctaaggatctgtggcaaacctttaattgttgggagctgtgtaggaatcagtaacttgattacatttacagttgccccttatactcatcagagtacctgaaatagtgctaggtacatgaaaaggatccagcgaatttttccttatcagtagaaaaggaaaattcttttggcctaatgaaaaagaatcatgctaacaaagattatttttgaggtattttgttagacaattgtgaatatagataaaaagagaactattaatataaaaagaaaaaagatagcagaatcttttccccatcattttccaaataaaatacagaaacatctttattactgtagtttaatacgttcagctttacacattgcattatgataggaaacacattatagtaaactcatctgttacaccattcatttgtggactgtgttctacag/TGGTACCGAAGTCAGTAACCGGGCAGGGATCTTTGCAGAATGTTAATAGGAAACTCTGAAAAAAAAGTTCAAGGTCAGATCATCCTAGGAAATTGTGAGTAACTGAAG/(t>g)taagtagatttctttgctgtaggattctcagaggcttcactcagtatgttcattgtgaacctccatacagaagtatagtgtacagcttttcataaactcatttgacaggtaaatccttttttcaggacatacctattcacatttcatagaacaaatgttgcctaagacagtttgggaggtagcagtgtagcatactaaggaaataatgcatttaaaatgtaagcctaaccagatacatgatattgtaactgcccagtgggttctccttgcccactacccagacagagctgatttatcaagataggaattgcagtagagagacagtaattaatgtagagtcggctgtacgggacactggagttttatgattactcaaatcagtctctctgaaaactcggagatctgaatttttaaggataatttggtaggtaggggcttgggttggagatgaaatcatagggggtcaaaattgagtttttcttgcttgcttctgttcctgtgtgggagcacagaactggctgggccggattacctatctaggtggcatcagctggtgcattggaaggtctgcaaaatatctggagcactgattttaggtgttacaactgtgatgttatacctgggagcaatttgaggaggttcagattcatgcagctggaggctgtgtggctcctaaaccgtaatttctaatcttggagctaatttgttagtcctacaaaggctgactggttccccaggcaagaagggggttt	creates pseudoexon	No	NULL	Out	NULL	NULL	11	99.76	NULL	15.48	NULL	12.71	12.19	NULL	NULL	20.8	NULL	-8.8	NULL	1	8	NULL	606346	ENSG00000196586	503	708	myosin VI
722	1	Human	178	MCCB	222	3-methylcrotonyl-CoA carboxylase deficiency	E11+55G>A	922	100	Intron	1	gtatgtgaaagtggaactgtgagctttatgaccagctgtgagtctctttgtatgtgtatctatttgcaaagctaaagtttgttaagatatgttcatgcctagaaatagatgtggatctcagtaaggagtgacatatgtggcaatgatacctttccatactgtggatatcattggcacagagtaaatactgaaagaggggagtgggggacctcaatgattggaaagttttcattgcgcaaaaagtgtgatttggtcataagtaagactccatgtcctgtgcacattatgaatgatgtaaggcaacttaacaattgtcagctatttcttttcattgttcttattttgggaaatgggtgaaatgtcagtaagttgttggaagaaaaaacatacccttttagatcaatatgacatttgcaatgattagacctgattacagttgaaaatgttgctatggttacacattgtcgacatagtgttctgtaatttagatggacaacttttagggtttagagcatatagtcttttattttgttcagtatccatagttggcagagtagtttttaaattaggaaattatcttaatatcaaattctgtactggaagttttaatatttcaaattatattttccccttgactataaaatattatatattagttgtgaaaaatatagaaaatacagaaaagaaaaaaattaaattgcatataattccaccctctagagaaggtggctaatatttggatgttttaggttaatgtgtatatacgcacatttttatgtagttgagatagtctatacgtatatttttttgttttactttttctagtttaaattataaacattttcccatgtctttag/AAATTCTTCATGAAATATTTTCTACGGCTAGATCTTAATTCCTATAATAGTACTTGGCAACATG/gtaagtagtcagtaactattttctgaatgcattgatggatataatgttctgttgtatggatttatttaggcaataccccagcattgctagtgggtcttaaatcctggattttattgagcttcaagtgatacttcactttagcaaacgtgacttagttaattgtaaatttttaaatgaggtttttagtttaacttttaattaattataagcacaggaaaaaatggtacttaaactctgacatacttgaaaaatgtgttgggccaggcgcagtggttcatgcctgtaatcccagcactttgggaagtggaggcaggcagatcccttgagtctaggagatcagctggctaacatggtgaaaccccatctctactaaacatacaaaaattagccgggcgtggtagcacatgcctgtaatcccagctactcgggaggccgaaacaagagaatcgcttgaacctgggagcagaggttgcagtgaaccgagattgcactactgcactccagcctgggtgacagagtgagactctgtctcaaataaataaataaataaataaagataaaaataaacaaataaataaaagagaaaaatgagttgttccaggtagccaagttctctggttggctgagaattcaccctttttcgtgtaaccactgcaaccactgcttcccaggttcaagcgattctcctgcctcagcctcccgagtagctgggattacaggcacccgccaccatacctggctaatttttgtatttttagtagaggcggggtttcaccatgttggtctggcttttctcgaactcctgaccttaggtgatccgcccacctcagccttccgaagtgctgggattacagatgtgagccaccacacctggccaattaatacattcttttaaaaaaaatgtattaaagttatagcttttaagttcagcttaaagatacattattctatgtataagtctaggaaattttaacatttccccccttcttcctaagaaattttcaaatatgctgagatgttcaaagaataatacaatgatcacctgtatatgaacctcatagagtcaacaattgttagaacttgtgtcatttgtgtgtgaaatacattttaaagcacaggcacacctcagatacattgtgggttcagttccagatcactgcaataaagttaatatcacaataaagtgagtcacatgaactttttggttttccagagcatataaaagttatatttatactatattgtagtctgttcagtgtgcaggagcaccttgcctttaaaaagtacatacattaatttaaaaataccttattgcttttaaaaatgctaacaatcatctgaaccttcagtgaatcatcttttgctggtggagggtcttgccttgatgctaatgacagccaactaatcagggtagaggttgctgaaggttggggtggctgtggcaatttcttaaaagaagacaacaatgaagtctgccacactgactgactcttgcttttatgaaatattctctgtagtatgcaatactgtttgctagcatttgatccagggtagaactttgttttttttcagactgagtctcactctgtcacccaggctggagtgcagtggcgcgatctcagctcactgcaagctcagcctcctgggttcatgccattctcctgcctcctgagtagcagggactacaggtgcccgccactgcgcctggctaattttttgtatttttagtagagacggggtttcaccgtattagccaggatagtcttgatctccggacttcatgatctgcccgcctcggcctcccaaagtgctgggattacaggcatcacccaccgcgcctggcccagggtagaactttcaaaatgagtcagtcctctcaaacctgactactgctttattaactaaatttatgtaatactctatatccgtaattgtcatttcacagtgtttgtagcatcttcaccaggagtacattctatctcaagaaacttctttttttgctcattcataagaagcagctcctcatctgttcaagtttgaacatgaaattgcagcagttcagttacatcttcagactccacttctaactctagttatctccaccacatctgaagtgacttcatccattgaaatcttgaacccctcaaagttacccatgagggttggaatcaacttcttccagtatctttaatttaattaaatatccttaatgttgatattttgacctcctcgcatgaatcgtgaatattctcaatggcatctagaatggtgaatcctttccaaaaggttttcgatttactttgcccagatctgtcagaggaatcactatctatggcagctatagcctgaggaaatgtatttctttttttttgagacggagtctcgctctgtcgcccaggctggaatgcagtggcgcaatcttggctcactgcaacctctatcttccaggttcaagcaattctcctgcctcagcctcccaagtagctgggattacaggtgcatgccaccattcccagctaatttttgtatttttagtagagacagggttttaccatattggtcaggctggtcttgaactcctgacctcaggtgatccacccgtcttggcctcccaaagtgctgagaatacaggtgtgagccaccacgcccggcccaggaaatgtatttcttaaataataagacttaaaagtaaaaatgactccttgctccgtgggctacagagtggatgttataacagcaggcatgaaaagaacactcatctctttgtgcatctctatcagagtcttgagtgaccaggtatattgttagtgagcagtaatattttgaaagaaatctttttttctgagtagtaggtctcaacagtggccttaaaaattcattaaaccatgccacaaatacgtatgctgtcatccagggtttgctgttacatttatagagcacaggcagagtagatttaggataattctgcaacttaaagtcaccagctgcattagcctttaacgagagagtaagcctgtcctcagacgacgtgcactaacctctccccagctatgaaagtcctaggtggcatcttcttccaccagaaggctgtttcatctacactgaaaatctgttgtttaatgtagccaccttcatcaatgatcttagctagatcttctggataacttgctgtagcttctataatacatcagcacttgctgcctcaccttatacttttgtggtacaaatggcttttttttttttaaacctcatgaaccaatctctgctagcttcaaatttttcttctgcgacttcacctatccaagccttcagggaactgaagagagttaagaccttgctctggattaaagggaatgttgtgcctggcttgattttctatccagactactcaaaccttctccatatcagcaacaaggctgtttttgctttctcgacattatggattttttgtgaagataagtgaatgtattttatgtggcctggtggtgttaattgtaatgcaaatacaacatagtttttcactaaatggtcctaaattgctgtgccctttgagcagccgtatctctgtgtggaagaatgatagttgttacgtgttgattgcttgttaaaggtacaatttttacaggtatatagcacccaaaacagataactgttacattcccattgtattattggattttttaggaaaagaagtaaaaaataattcagagtaaacttttacttgatggtgagaaagatgttgggaagcattcactcagttttcagcctttgcatcatacaaaacaagattttgattgatgtggcagacagaaaaagcgaagtgcaaactatgtagaaaaatagtatgtatcatctaaaatagtttctgaaattgaaaatatgcttcctgtttagaactccttacagtagtcctgatatataatgataagccccagggataaactatttagtaatttccactcctttatacatatgtggatgatccttcaagtataccagattcagaatcaatgagtctttattaagtgcttaataatagtgatagctacactttaatgagagcctgacagtatgctttagttagcactttatttttattttttacttttttatttttcttttttctaccctgttaactgatagtgctgtttatccttttatttttttttctaatttattatttcttgctgaaaggaatagttagcactttttacatttttttttttttttttttttaacagatgaggaaactgaagcttaaagaattttctagtttctcagtcggagagctgggagtcagagctggcttttcatgtcagcatgatttttgtaggttcctacttccttacaagtagatcatatcttcacagctcttctgttccatcattccagaagtgagaactgagactcagaggggtgaagtgacttactccagggcataccagtcatacttgataccttagattggagcctgtgtcttttgactctgagccctgtctctacccagctttctcattgcatccctgaacctctgccggtacattcgaacagtccttgaagctctaagtctagcaaccagcccttggagcctttcctgcttttcttgcatgcagcatggtgctgttgcttgtatagtgaagtataaaatcagaacccagaatgacttcagggcattaaccaggcatgtcaaatgaaattctagtgagattttctgtgtagtgtgaaattttgtgaaagtgacaacttcactgtgaattgttttcctataagtaactttaatacaaaaattcttttgcaatataatttctcaaggccattgttgtttttcctcttagGTCATTGCTAGAATCGTGGATGGAAGCAGATTCACTGAGTTCAAAGCCTTTTAT(G>A)GAGACACATTAGTTACAG	creates pseudoexon by inactivating ESE in upstream exon 11.	No	NULL	Out	NULL	NULL	11.01	91.22	NULL	15.48	NULL	10.67	10.1	NULL	NULL	18.7	NULL	-7.3	NULL	0.99	8	NULL	210200	ENSG00000131844	515	722	methylcrotonoyl-CoA carboxylase 2 (beta)
709	1	Human	80	HADHB	268	Mitochondrial trifunctional protein deficiency	IVS7+615A>G	615	100	Intron	0	gtatgtttaaatggaaacagacagtacatgttaattattctcctttgtcttttacttgattataaaaatgtacttttttttttttttttttttttaacacagaacctcactctgtcactcaggctggagtgcagtggtaccatcatagctcactgcaggctcaaactcttgagctcaagagatcatcctgccttaggatcccaagtagctgggtctacaggtgctccaccacacccagctaatttttaaattttttgtggagacgggatctcgccatgttgcccaggctggtcttaaacctctggcctcaagtgatccttctacctcagcctccaaagtgctgggattacaggcgtgagccaccatgctcatcccaaaaagtactcttaacagaagtaaaagattagcacagatctctatacttgtgttttttaaaaagtaaggtcaggtttaaaatttgggggttctaaccgtagttaacctctttttttgctctccatacctgag/GAACATTACCATTGGCGTGGTTCCTCTGTGAATAATGTGGCTGGCTGCAG/CAGGGATTATCAACTGGAGGAGTGTATCTCTAGGAAGGTACTTCAGCATCTGAGGC/(a>g)tgagtaaatagtttacaacctgccaggctttcaacctaggtgcttcagatatgatattttcccacaaagatatggtcttccttccttcaccactaccatacttgtaaatcattgctttagatggcacagctctttccttcactttctccttacatccttgtcatttttataaatcactgaaaaccccactaacaaactttagcaaaactgtgggatattttgtagcatcagctcttagtgtgaggaggcaaggaagcctgaaagatttagtaatcatgtgctcatctagtaacatcaaggcccaggtgggcaccccacctcatgtgtggcggggaatgatgcccgtgactgggggcgttcgccactctaggcagcatgtgaccaactcctggttagagaaacagaatactggccagtggccataaggagagagggggcctgccttacgtttcaacagctgtaatttctctgctttgcagcagaagttaacattctctttataggataaaaaatctttattaaaactaaagctgggagcatataaatatgcaagatgttctggtttggaatatgatttgttcaagagttggtccaatggatattcctagaagttgacgtccatatggcaggaatgaaacttgtttttctctaacgtgttgaatgtgtttttagtcatttaagaaaattaccttaattcttctgaaaagttgaaaactttaattacagatgttgtacaaagctgataactgtcattcagctttttaatcaagaagcttaaattggaatggtatgttattttctgtaaaagatattcatgaagtataacctgtgccctgtag	creates pseudoexon	No	NULL	Out	NULL	NULL	7	69.63	NULL	10.88	NULL	5.35	6.12	NULL	NULL	13.8	NULL	-5.2	NULL	0.93	6	NULL	609015	ENSG00000138029	504	709	"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit"
641	1	Human	46	DMD	245	Duchenne Muscolar Dystrophy	E14+82C>T	-22	NULL	Exon	1	GTATTGGGAGATCGATGGGCAAACATCTGTAGATGGACAGAAGACCGCTGGGTTCTTTTACAAGACATCCTTCTCAAATG/G(C>T)AACGTCTTACTGAAGAACAGgtgtgtcatgtgtgagaaactagctgtaaaagacacggggggatattaaattggaaaagtaaagatttatgtttatttattccttggaattctttaatgtcttgcagTGCCTTTTTAGTGCATGGCTTTCAGAAAAAGAAGATGCAGTGAACAAGATTCACACAACTGGCTTTAAAGATCAAAATGAAATGTTATCAAGTCTTCAAAAACTGGCC	NULL	No	NULL	Out	85.05	6.99	6.05	73.57	12.88	9.18	5.9	5.9	6.12	7.28	14.1	12	-5.9	-3.6	9	0.73	6	0.97	310200	ENSG00000198947	460	641	dystrophin
656	1	Human	75	GHR	261	Growth hormone insensitivity	IVS2+1insG	1	100	Intron	1	GTCCTACAGGTATGGATCTCTGGCAGCTGCTGTTGACCTTGGCACTGGCAGGATCAAGTGATGCTTTTTCTGGAAGTGAGGg/[g]tgagttctgcttttccatttccaccctcagtgttttgaaacaacactgaactgtattcgctacatccaagttttttggatgattttattaaaagatgcaagttttacatagcagcaaaaaggaaacttgacttagctttaaaatcagaaactagtaggacttttctgtggatgtttagg	NULL	No	NULL	In	85.64	9.25	7.93	82.86	13.58	12.38	8.21	8.21	7.89	9.12	15.6	15.6	-9.3	-9.3	8	0.98	8	0.98	262500	ENSG00000112964	469	656	growth hormone receptor
598	1	Human	156	TSC2	292	Tuberous Sclerosis	E37+2insA	-29	NULL	Intron	2	gtcctgctaccccacgccctggggcatggccctggcacccccacctgctccagctccccacgcctcaggttccgagcctaacagcgtgggcatggaggcagtgatggggctggtggctttgcgtcccaaagccctgcccctggggagagccgaggaccactggccaggcaccagaggacgtggtccccgcaggcccccagagcccctggagtaatcaggaggtgccccagtgcaaggcacagagggcctcagcactggccccacaaacccatccggccctgctcaccctcagCCGTCTTCCACATCGCCACCCTGATGCCCACCAAGGACGTGGACAAGCACCGCTGCGACAAGAAGCGCCACCTGGGCAACGACTTTGTGTCCATTGTCTACAATGACTCCG/GTGAGGACTTCAAGCTTGGCACCATCAAGg[a]tgagtgaggggccgtcagtgaggctgggccccaggcaggtgcccactgctgtgtcccgggttggtggcaggtcctcctccctgagcttcggtcacgaggagcaggaggagaggccgcagtgctcagggccccgtgggcacgagcttcaccccgagcctgcgttgtgtcctctgtgccctgaagcctgtggcgcctgctgctgagtgtctgtcaggagtaactggcaagtgcagactgggtgtgctgggtgggcacagtgtagttggtgcttcctgtctgtccggcgcggcccttgggcccccaccatctccccagtggcagctgtcaggctgctcagttggttatcgccacgcaccact	NULL	No	NULL	In	94.8	10.47	9.35	80.65	15.28	13.28	8.42	8.42	8.93	11.31	17.7	14	-8.7	-7.3	8	0.98	7	1	613254	ENSG00000103197	430	598	tuberous sclerosis 2
689	1	Human	46	DMD	231	Becker Muscolar Dystrophy	IVS26+3A>T	116	100	Intron	2	GTCTATGCCAGAAAGGAGGCCTTGAAGGGAGGTTTGGAGAAAACTGTAAGCCTCCAGAAAGATCTATCAGAGATGCACGAATGGATGACACAAGCTGAAGAAGAGTATCTTGAGAGAGATTTTGAATATAAAACTCCAGATGAATTACAGAAAGCAGTTGAAGAGATGAAGgt(a>t)aaaaaaaaaaaagaaaaactaagtaaaacaaaggaaataaatggaaaaagaaagaaatgcaacaatgcttgaagttgtatacagtctgctctttcctggttctaagagaagag/gttgatttttaattaataattttaatttagcttcaagtttaatatacattttaacaaccttaaactgtttaattttaatgcattgtggtcaattatgaaaattgaaaatcacaatttgaaacaa	NULL	No	NULL	In	82.64	8.38	1.52	64.85	13.28	3.98	1.09	1.09	2.13	7	14.1	10.1	-5.4	-2.6	6	NULL	6	0.91	300376	ENSG00000198947	490	689	dystrophin
706	1	Human	66	FGB	224	Afibrinogenemia	IVS1+2076A>G	2103	100	Intron	0	gtgaattttttaaagcattattatattattagtagtattattaatataagatgtaacataatcatattatgtgcttattttaatgaaattagcattgcttatagttatgaaatggaattgttaacctctgacttattgtatttaaagaatgtttcatagtatttcttatataaaaacaaagtaatttcttgttttctagtttatcacctttgttttcttaagatgaggatggcttagctaatgtaagatgtgtttttctcacttgctattctgagtactgtgattttcatttacttctagcaatacaggattacaattaagaggacaagatctgaaaatctcacaaactataaaataataaaagagcagaattttaagataaaagaaactggtggtaggtagattgttctttggtgaaggaaggtaatatatattgttactgagattactatttataaaaattataactaagcctaaaagcaaaatacatcaagtgtaatgatagaaaatgaaatattgcttttttcagatgaaaagttcaaattagagttagtgtgtattgttattattaatagttatgaaacacggttcagtctaatttatttatttgtagaacagtttgtcctcaactattatttttgctgacttattgctgttaatttgcagttactaaaaatacagaaatgcatttaggacaatggatatttaagaaatttaaattttatcatcaaacgtatcatggccaaatttcttacatatagcatagtatcattaaactagaaataagaatacacaataatatttaaatgaagtgattcatttcggatcattattgagtttcaagggaacttgagtgttgtacttatcagactctacatgtaagaacatatagttaatctggttgtgtgtgtaaaaacatatggttaatctggttaagtctggttaatcatattaggtaagaaaaatgtaaagaatgtgtaagacgaaatttttgtaaagtactctgcaaagcactttcacatttctgcttatcaactaaacctcacagagatagtttaatagtttaggctttaaaatggattttgattattcaacaagtggccttcataatttctttaagtgtttttctttaagtatatactttctttaaatattttttaaaatttccttttctctagtaaagccagaccatccatgctacctctctagtggcactctgaaataaaaagaaaatagttttctctgttataattgtatttgtaataagcagatgaatcacatttcttaaaatttgttttagagagggtaagctctgactaggaccatgacttcaatgtgaaatatgtatatatcctccgaatctttacatattaagaatgtatatagtcaactggttaaacaggaaaatctggaaccagcctggctgggttttaatcttagcaccatcctactaaatgttaaataatattataatctaatgaataaatgacaatgcaattccaaatagagttcatctgatgacttctagactcacaaaattgcaagagagctcagttgttgctcagttgttccaaatcatgtcgtttgttaatttgtaattaagctccaaaggatgtatagctactgacaaaaaaaaaaatgagaatgtagttaatccaaatcaaaactttcctattgcaatgcgtattttctgcttcattatcctttaatataatattttaagttagcaagtaattttaattacaatgcacaagccttgagaattattttaaatataagaaaatcataatgtttgataaagaaatcatgtaagaaatttcaagataatggtttaacaaataattttgttgatagaagataagactaaaagtgaaattcgaagtggagaggacacttaaactgtagtacttgttatgtgtgattccagtaaaaatagtaatgagcacttattattgccaagtactgttctgagggtaccatatgcaataagttatttaatccttacaataatcttgtaaggcagattcaaactatcattacacttattttacag/ATGAGAAAACTGGGGCACAGAT(A>G)AAGCAACTTGCCCAAGGTCTCATAGCT/gtaagtcaaccctacggtcaagacctacaagtagccgagctccagagtacattatgagggtcaaagattgtcttattacaaataaattccaagtagaatcaacctttaataagtctttaatgtctcttaaatatgtttatataggagtctaatcaccaattcacaaaaatgaaagtagggaaatgattaacaataatcataggaatctaacaatccaagtggcttgagaatattcattcttcttgacagtatagattctttacaatttcgtaagttccaatgtatgttttaggaatatgaggtcattactattcataatctgatacagctttatcctaaggcctctctttaaaaactacactgcatcatagcttttttgtgcagttggtctttctactgttactgaacagtaagcaacctacagattcactatcaccaaccagccagttgatggatcttaagcaaattatcaagcttgtgataacctaaattataaaatgagggtgttggaatagttacattccaaatcttctataacactctgtattatatttctgcctcattccttgtag	creates pseudoexon	No	NULL	Out	NULL	NULL	8.56	75.26	NULL	12.68	NULL	5.41	6.46	NULL	NULL	14	NULL	-4	NULL	0.96	6	NULL	202400	ENSG00000171564	501	706	fibrinogen beta chain
715	1	Human	31	COL4A5	9	Alport syndrome	IVS6+1873G>A	1975	100	Intron	1	gtgagatccatccatttaatcttgggtagtatacttgacaataattaacttaaaaacctaaagaaatcaatatgaagaatgtagaagaagggatatagtgtcttcaggtcttggctattacataaagtatgctctgactataattttctatatattgaactatcaataatttcattaaacatgtataattagctgggatattgcattgggttaaagattacttaccaaacccttttttgactttagcataaagtaggatgagaattaaaacgaaattaggatatatatgtttcaaatattatatcaattgttgaaagtaatacttctgaatgtcattcatttgctttgccattattaaaaaactaggtacaatttatgttttcaaatatttcatgtttttaagattttttaacacgccgaataacttccttaagaaaaatcttaaaaaattatatgtaatacagcacatccgtttttactataaactgtcagtatgaaacctgaaacttcttcatcagcaaagatgatacatttaacaattttaaataaccctaactttagatatagcaaacatttttttttctgatccaatgtttcttctctttagtcaactgttggattgaatataaagtaatagataataagaaaaaatgaggaaaatttgctctgcttgtaagcttacaatattatagccaattcttattccctcccctttctccttttcctttaggttaatgcaatatattgttattctctgtattttcttttggtattttctgtttttcacataatattctgtaaaactattcataaaataccttaggtccttctttctttctttctttgtttttgtttgttttttgttttttgttttttgagacagagtcttgctctgttgcccatgctggagtgcaatgtcacgatctcggctcactgcaacctctgcctcccgggttcaagtgattctcctgcctcagcctcctgagcagctgggattacaggcacgcaccacaatgcccagctaattgttttgtatttttagtagagatggggtttcaccatgttggtcaggctggtctcgaattcctgacctcttgatccgcctgcctcagcctctcaaagtgctgggattacaggtgcgagccaccgcgcccggccagatctttctaactaatggcatatgtcagattttatatagggcatatttttaaaataacttgaacaactattttgcattacagtggccatattttgtgataattactgtactctatacttgaggcagtacagttcttttcatctccagtatttcttcaggtcaatgtaacccttgtcaataataataatttttaaaaaaaattttggattcatgaggactaatcgtgttcttcattttagctagggcaaccttaaagtgataagaccaatgtggagttggtttgcctgatacatttcatgttaaattggactaaatttttgtgcctcttctggttatttgtttatttttatttacttatttatttttgccagtgtgctttaagaaacaaacagaccactaaccaaagtttcaaatttgaagggccaatgtatctataatcagtacagtgtgctatatgattaaagggagcattgattaacttgtgtttcaggcttccaattatgtgagtaacaaattttaaacaaattaaattgatttattatgcatatttttaaagtctgaatgcttttcttatatttcttactatgtaagtaaaagaatgaactttaaagttggagccacaatgtataggtttttttctttttctgtcttttaaacttgatgtctag/GCCACTTCCTTTCTCTCGGGACCTACTTTTTCCATGTGTAACAAG(G>A)TGGAGAGAAGGGTATTGGACTCACAAAGACACACAACAGTAGTAATTTTATTCTTTCAAACCTTCTGATGAAGTTGTTTCTAGGATTACCGTGGCATACAG/gtatttgaaaggaggttgctttggtgttcttctacagcaatttcagcttttgttttctaaaccaagtgtccatattagtactttacagtagtgagtgagaaaagctgggtgcctagaaaacataatgacctgcaattgctagaactattgctattattgtcctcttggtgatattaatggccttctttcttaccatcttttcccctttacaaaaataatttgaaatagtttacaataaaagaaaaatgcaacagagcagttaaaataagaatctatataacacatgggcaggaaatggggcagatcattaactattaaatgtgatgatagaatttatggcgtgatcgtctcaaaatgtctttgttggaagaaaagaactgaggtagataattttttttctttacttctaattgggatagatgaattgggataaaagttgaattgatatggatagttgatattgaagtaattggaaagtgaaggctaatgaactttttggcaatctggcatgtttcaaaatggcttttatagaaatcttttcaagaagtcatatcttgatggtatagttattctttgtttcttgttcctccatgctctttatttttaactccttctag	creates pseudoexon	No	NULL	Out	NULL	NULL	7.51	77.98	NULL	10.78	NULL	6.22	6.62	NULL	NULL	14	NULL	-4.9	NULL	0.81	8	NULL	301050	ENSG00000188153	509	715	"collagen, type IV, alpha 5"
639	1	Human	251	WAS	296	Wiskott-Aldrich syndrome	E9+136C>T	-39	NULL	Exon	0	gtgagtaacttcagagtctcttggactccactaaacttccacccacccttccaaagaccactgctgagaccccacccccagatcgtgcccttcccacacccctctcagatcccttgctgggatggacccaacgacaatccatgtcgcttgtctcctcgccttattcctctactcctgcccctggcctttttcctcctgggcagGTGAACAACCTCGACCCAGATCTGCGGAGTCTGTTCTCCAGGGCAGGAATCAGCGAGGCCCAGCTCACCGACGCCGAGACCTCTAAACTTATCTACGACTTCATTGAGGACCAGG/GTGGGCTGGAGGCTGTGCGG(C>T)AGGAGATGAGGCGCCAGGgtgagaccctgcttccatacgctcccttctctagcccaagcagctcatagctaagatacgcactaagtcactcagtccttatgggagcacctatactgcttcagtcaggagttggtcagtgggggtacccattttacaaatgagcaaaactgaggctcagaagaaatcaatgagagttacagctatgtgttataccccctccacag	NULL	No	NULL	Out	80.36	6.65	4.44	69.65	11.58	8.68	5.45	5.45	4.22	7.48	13.6	9.1	-7.9	-7.4	7	NULL	7	0.97	301000	ENSG00000015285	458	639	Wiskott-Aldrich syndrome (eczema-thrombocytopenia)
668	1	Human	138	PYGM	265	McArdle disease (Myophosphorylase deficiency)	E15+59G>A	49	NULL	Intron	1	gtgagtggcagccactctaccctgtctctcagtgctcccccgtgttcctgcggcatagtacatattgcccaaccaacatctcctttggacttgggactactcttgggacatggaattatccccatttcacagatgggcaaactgaggctaagagagcatagcaagtgattgttcgagtcaggcctacggtgtcccagcccagcctctgtcaggagctactacccagagggaaaggtaggcccactggatccctctcgtttctccacagGCATCAAGAGGGAGCCCAATAAGTTTTTTGTGCCTCGGACTGTGATGATTGGAGGGAA(G>A)gtgagaagccaggctccagccctgggctcccgtcctttgatatatccag/gttgaggtcagcccagctgagttgcaggatagggggtggggggccaggcagtagagctgaccccagactttgtcccctcag	NULL	No	NULL	In	89.52	8.68	1.68	62.69	13.98	5.88	1.36	1.36	3.1	9.67	15.9	11.8	-7.3	-3.3	7	NULL	6	0.96	232600	ENSG00000068976	477	668	"phosphorylase, glycogen, muscle"
669	1	Human	138	PYGM	265	McArdle disease (Myophosphorylase deficiency)	E15+59G>A	55	NULL	Intron	1	gtgagtggcagccactctaccctgtctctcagtgctcccccgtgttcctgcggcatagtacatattgcccaaccaacatctcctttggacttgggactactcttgggacatggaattatccccatttcacagatgggcaaactgaggctaagagagcatagcaagtgattgttcgagtcaggcctacggtgtcccagcccagcctctgtcaggagctactacccagagggaaaggtaggcccactggatccctctcgtttctccacagGCATCAAGAGGGAGCCCAATAAGTTTTTTGTGCCTCGGACTGTGATGATTGGAGGGAA(G>A)gtgagaagccaggctccagccctgggctcccgtcctttgatatatccaggttgag/gtcagcccagctgagttgcaggatagggggtggggggccaggcagtagagctgaccccagactttgtcccctcag	NULL	No	NULL	In	89.52	8.68	5.66	80.98	13.98	9.98	6.13	6.13	6.36	9.67	15.9	13.2	-7.3	-4.7	7	NULL	6	0.96	232600	ENSG00000068976	477	669	"phosphorylase, glycogen, muscle"
632	1	Human	156	TSC2	292	Tuberous Sclerosis	E23+76G>T	-29	NULL	Intron	2	gtgagtggtcgccccaggccctgtgcctcccagccgtggcccccgctaggccttgcggcagaaagccccggcagcctttgtccccaaggcctgagcgcctcggttttttgcacttcatgccctggggatgtttccctgctgccaggatggagtgccagcccccttctcatctcagGTTTAATCAGTACATCGTGTGTCTGGCCCATCACGTCATAGCCATGTGGTTCATCAGGTGCCGCCTGCCCTTCC/G(G>T)AAGGATTTTGTCCCTTTCATCACTAAGgtgggctcagggccggtgaaggctgtgtctctcggtaggccagggcttgctttgcccttggctgtccatggtcgggcagagtgacaggcaggtggagggcagtgggagggtgtttggggctgtgcctgtggcgctgggggctctgctgggcagcctgcagggctttgatgcgcggcaggcattgaggggtgggagctgggtgccgccgccttgcccctagcctgcagcttgtccctggccagggggcacccggcaggcctggtgagggcctccagcccccattgccacccctcactgtctgggtgtgctcactctgccag	NULL	No	NULL	Out	78.8	7.93	6.06	68.33	12.58	10.58	4.9	4.9	6.12	6.41	11.2	13.5	-6.8	-4.1	7	0.53	5	0.82	613254	ENSG00000103197	430	632	tuberous sclerosis 2
712	1	Human	42	CYBB	29	Chronic granulomatous disease	IVS6+1657A>G	1658	100	Intron	2	gtgagtgtttaaattctgaagtgaaggatttcatgtccctcaatttctaggcaggatgctccattagaggcacagtgacctccttgcctgtgtgtggttagcctgtctgctaagggaatgtgagaggatagcagaggtcagtttgatagaaaccagtcaacattggcatttttgtttcatgcacccatgtaattgctattcatggtgaagttatatatagcaagcttgaaaaatacaccaaagtctgagtatctttgcaaatgtataaaacatattgagagcactggtaggatctggaacatctgcaatgatatcctctatggtttaatcactagtaaattaaacaaacctccagactagaagagttaatgattaatcagttgaagaggtttgttatagttcaataagttttgatttaagcccacagtcatttatttgttgtctaccatgtatgaggacctatctcaggcactgcaggaaatacaagcaggaaaaatatgtggttgttgccttcaaacattctaatataatgaaagtagcagctaacttctattaagggtctgtgctaagggtttgacatgatatatttcttttaacccccaaaatgtatagatttctcactatcaccatttcttggggatagtaattgcagacaagaaacctggagctaaaatgttaaaatatgcagcctaagccacctctctggtaagtggcccagctgagattggagccaggcagtctaaagcaggctgtgataaatgttctcttagagacacacagttcctggctatgtggttaggagagtttgcctgattggagatcctctttcataccaagtttccttttttgtgcagtttcataccacctgcacacaaaggcaggcctggggaagttccctggtgggtatagggctccaggaaattagggttggaggaagtagaagctcaagactcactctgcccagagcccagttggtggccaagacatgactgtgaaaaaggggaagggtggggaaagctgcattgggcactgcattcttaaactacttgctgactgtgacccctgataaactctttgtaagcatggagaaatcaatggagaccaagaatctgatgactctcttaaagcactcaaatatctttaaatgggacttagtcataatcccgtgtttcaggtaatcctagagaagagaaataatttcttcccctctccaatttagtaattccaccactttctgtttgtatggtttcgcagatactcatcttcctttgaagcagacagaggagatatgtttatctccttctccacttgaagagaatctgctctttacactggttaggtgatttctcacagtctcatggctccgtagcagctgaattgggtttaaaatgcaggtttctggactcctggtcctggcattgagaagagaaggagaaaatcagattattttcctatcatttacttaccatgggaacttaggcattttgaactttaatagttattttttggactcttactttgtgtctggcattttttatacatcatgcaaattgcttattataatgaacctttaatgaggtactattacatctgttttacag/CTGAAGGAACTGAGGCTCAGAAGAAGTTAAATAATTTGCCTGAGTCCACCAAACT(A>G)/gtaaggggtagaaatgagatttgaacccaagtctgtctgacacaaaacacaattgttttcaccaaaacattctgctttgagttactaaatcattctgatttacattctcatgtaaaatgggggtaataatacttgcctctcaggcttgtcatgaggattaactgagataatttgtgtaaaatgactttccccaagcctggcacatgataagtgctcaatacatgataattctcttccccaagacctaaggatagaaaggagtggttaatgaacttgaattaaaacattctcagaatacaccaaatgacacaataaattttaggtctccaaaacaaacctttacaatgggttttctgtgtcttttcttcttatatattctgaagatgctgtcatttatgttccttgaagtctactcaacgttgggccttcctctctctatcaccaataattgtcttatgatttggtagttgctcaactagcatttattgaattgaaatgaatgggctctgagcaattcaaggtacacactattagtgttgatgtctgtgagaatgttataatccctatatagttaagtatctcaaactggtttcaaaatttggtttgatttagataatttccaaacccacaaataaggcacttcttgtaagcttcagggctactgtatatgactgtctcagttgtctactatagtgggtgcctggccaaggacaataaagttagcccacactttgatgattgagccctttgcttatatcttcataggaagggtaccattttctaatttgcacaaaggcactgtaggggccagcagtcactctgttagatttgcaatttttctgcttttgtttgtttgtaaatgaaaatgatacttgagacagaagtagaaattctcccttaagagaatttgatccaacacttaccctctataatgttacatgtaaatatccctttggtaattgcacatatattttttctgttgctgagtgttatgcattttctttcctttcatctattcagagggagcaataagctatcgcttttaagtgaaaagtacagggcctacatcagagcacttaaaatatatgcagaatcttttaataaaacaatttaatttcctattactaaatgatctggacttacatttttcacccag	creates pseudoexon	No	NULL	Out	NULL	NULL	9.68	86.29	NULL	13.48	NULL	10.1	8.54	NULL	NULL	15.2	NULL	-7.1	NULL	0.99	8	NULL	233710	ENSG00000165168	507	712	"cytochrome b-245, beta polypeptide"
655	1	Human	213	HERG	263	long QT syndrome	IVS9+1G>C	54	100	Intron	0	GTGCTGAAGGGCTTCCCTGAGTGCCTGCAGGCTGACATCTGCCTGCACCTGAACCGCTCACTGCTGCAGCACTGCAAACCCTTCCGAGGGGCCACCAAGGGCTGCCTTCGGGCCCTGGCCATGAAGTTCAAGACCACACATGCACCGCCAGGGGACACACTGGTGCATGCTGGGGACCTGCTCACCGCCCTGTACTTCATCTCCCGGGGCTCCATCGAGATCCTGCGGGGCGACGTCGTCGTGGCCATCCTGG(g>c)tatggggtggggggcgggcactggactggaaatgccctctgcagcctcaagag/gtgcgagccttctgaatatgcagtcactggggctgtggacctgggactgcctgcagggtcactgggctcctttaattcacctaaactcaggccctccaagcggggccatggagaggagccccacgt	NULL	No	NULL	In	71.63	6.23	5.51	75.98	8.68	10.38	6.16	6.16	7.15	5.39	11.7	10.4	-4.7	-3.8	7	0.89	6	0.63	192500	ENSG00000055118	468	655	"potassium voltage-gated channel, subfamily H (eag-related), member 2"
609	1	Human	56	F5	250	Factor 5 deficiency	IVS21+1G>A	-6	NULL	Exon	0	GTGGACATGCAAAAGGAAGTCATAATCACAGGGATCCAGACCCAAGGTGCCAAACACTACCTGAAGTCCTGCTATACCACAGAGTTCTATGTAGCTTACAGTTCCAACCAGATCAACTGGCAGATCTTCAAAGGGAACAGCACAAGGAAT/GTGATG(g>a)tttgtgtgcatatttctatctgaatctctagactctagacttggcctagaattattatgactatacctaatgattatgtattttaaaaaatacctttctgggtattagaaatgtgaatggctttctaagggtcatatggagaaaagcagtaatatgataggtctgtgtcttacaaattaaagagagaagcagggttactgaaacttcaaaaccccacaaaactttaaaaaatcatttta	minigene evidence	No	NULL	In	71.08	4.88	-4.39	65.07	5.38	-2.02	2.37	2.37	2.29	4.03	10.5	5.5	-3.2	-0.3	8	NULL	5	NULL	227400	ENSG00000198734	439	609	"coagulation factor V (proaccelerin, labile factor)"
677	1	Human	233	POMGnT1	272	Muscle-eye-brain Disease	IVS9+5G>T	25	100	Intron	1	gtggagttagtggagcatggatggggcagggcctgggctgggggtgggcatttagatctctctgtggagctttattcctttgattgtgtgcctggggctcttcaaaccttgctggccccatgcctccatgacaaccgcatccttccctcagAGGCAGAGTGCCACTGGGCAGACACAGAGCTGAACCGTCGCCGCCGGCGCTTCTGCAGCAAAGTTGAGGGCTATGGAAGTGTATGCAGCTGCAAGGACCCCACACCCATCGAGTTCAGCCCTGACCCAgtga(g>t)tggggccttaagacagtgag/gtttggactccttcccagctcagcaggggggccccaggaatgatctaggttgggctttccctacctgagcctgggagagaaccaggggcaggatttacactgcgctctgaaagacagggctggggtgaaggggcaggccatgtgagtaaagctcagcgctagagttgggctgagtgtgtggagagcccagaacagggaagatcctctatcccttccctgtctactccagtctgcacctaccctcacctgagaagtcttccctaggtggggatcccagtttgaagggggaataaggcaagagctaaacgctatttctcccacag	NULL	No	NULL	In	73.91	8.28	3.53	71.68	12.08	5.98	3.04	3.04	4.01	6.77	12.1	10.1	-4.1	-3.3	7	NULL	7	0.95	253280	ENSG00000085998	481	677	"protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase"
711	1	Human	232	PMM2	238	"Congenital disorder of glycosylation, type Ia "	IVS7+19139C>T	19139	100	Intron	2	gtggctgagttccccaactagaatcaagtaacctttagtgcatatgcaaatccagcatttgaaatttccggttctctagccttattattctagagggcagccagctttcctttcatttcatttggggtccgcttcacttgctttgcag/CTACTCTGGTATGCAAGCTCGACACAGCCCCAAGAAGGCTGCACCCCAGGAAGGAGCCCACCATGCTCTGAGAGTCACAAAGAAAGAAGCAGACCCTTGGCGGGAGAGAAAGGAAGGCCTGAG/g(c>t)aggttgtgtttgtgatgcagatgctcctgcgagccgtgcggctctctgaaagcgggtggagctgagaagcaacccagagaggctcctgcagccagggtcgggaggatttcaccttcctggatgggaattgattctccagacctagctttattaagtgtcagcgagttacatgcacacagatcactcagattccacagacacctccccaccagcccccagcaggaccacgggaggagactcg	creates pseudoexon	No	NULL	Out	NULL	NULL	9.65	86.85	NULL	13.18	NULL	9.5	9.76	NULL	NULL	16	NULL	-8.7	NULL	0.94	8	NULL	212065	ENSG00000140650	506	711	phosphomannomutase 2
725	1	Human	238	RHD	242	DEL phenotype	E9+1G>A	1088	30	Intron	2	gtgggtcactgggcttaccccccatccccttaacactcccctccaactcaggaagaaatgtgtgcagagtccttagctggggcgtgtgcactcggggccaggtgctcagtaggcttcggtgaatatttgttggctgatttattcagaaattctgtccagcccctaccttggatggatttatcacctctccaggccacctcttctttccaaatagggccacctaggtatagaccaaagacacgaaatcttttgtgatcccacaaacacagagcaggtcaaataggcccaagccaattgagactgtggttcaggtcgtgatgcagagctttgctgtggacgtgctcccactgcgtactagctgggcatgtggcttaacctttctcagcctcagtcgccccattgtaaatggagataatgatactatctcccctcacaggactgttgggatgctactggatttaataagctaatgcagggacatgctaagcacaacccatccctgaggcccagagaggggtgggccttggctgaggtctcactgcgaggtgggaatgtgggcctccagaccagaggtaggtcctgtggcccctagacagtggacagcaatggtcagtttgacacaccagagccctagccattacttcctggatgttgtgtgaatattttctggacatggcttatataaaatgaaaaagtgaattgggcacgatacagggatagatttttagagatgaactggtagcatgatgataatcatattcactgataacatttactactgttattgactgctttaaaagtgttgggcattgtgctagaaaccattatatgcattatctccttgaattctcacaaccgcctactgaggtattctcagactctaagaaatgagatttaagagaagttatctgcccaag/GTCACTCGGCTGGAACCTGGCTGTAAAAATGGCTGAAGCAGGTGATGAGGAGCTGATGCGTTTGGACGTGTCTCAGAGAAATCATGGAGGCGCTGCGGTTCCTACCGGTTCTTGGATGCCTTCTACAGAGACAACCATAGCCCCAAATTATAGGGATCACATATCAGTGG/gtgagacatccttgcttgggatgaggaggggatgagctgtgtgaagcaaggcgcctctgtgatgggttccagtgatgtgtctgccactgtcttaataactgtgcaattctaagcagaacctttcctgtctctgggcctgagagttcccctctgaaagatgaggacttgacctagcaaggtcctactcacatgcctgtagagaacaggcaggggaagttagaaaaaaaaaaaagccagtgaaggaagggagctcttcagcttgcacccatcatcacagtgcagggacccaggctcagtgttgccagatccaatgacttctcaagagctcaaaatctagagttttgcatgtgctctcccaagtactggcagaaaattcaagattgttagtaacactgtgtggctaaattctgcttgtgggctgcctagattcccaattctgtgattctgtggttctctggaagcattggttctcc.........ttcgattaatcttgagattaaaaatcctgtgctccaaatcttttaacattaaattatgcatttaaacag(G>A)TTTGCTCCTAAATCTTAAAATATGGAAAGCACCTCATGAGGCTAAATATTTTGATGACCAAGTTTTCTGGAAGgtaagatttttcacctattaacgtgatagattttgagtgcatgaacttaaaaacatacctgagtatatatgttgacttgctgtttatgagtaaaacaaaaacaaaaatggagtaaggagc	creates pseudoexon by weakening 3'ss in upstream exon 9.	No	NULL	Out	NULL	NULL	6.04	76.55	NULL	11.18	NULL	6.03	6.72	NULL	NULL	13.6	NULL	-7.9	NULL	NULL	7	NULL	111680	ENSG00000187010	517	725	"Rh blood group, D antigen"
719	1	Human	221	MFGE8	287	Systemic Lupus Erythematosus	IVS6+936A>G	894	100	Intron	0	gtgggtcagccttcttgggatatggggctggggttgggtgggatgaggtgggactgccagatctttgacctctctccagcccaggcttctcttctgctccccaaaagagttctggaaaagccttgtttttcttcggcttttctttcttcttcccacctgtactcccttctcttgatcctgcttccaccaaggtggagaaagggtgtgtgtgtgtatgtgtgtgtgtgtgtgaatgtgtgtgtgtgagtgtgtgaatgtgtgtgaatgtgagtgtgtgtgaatgcgtgcgtgtgaatgcgtgcgtgtgaatgtgtgtgtgaatgtgtatgtgtgaatgtgtgtgtgtgaatgtgtgaatgtgtgtgtgaatgtgtgagaatgtgtgtgaatgtgtgtgtgagaatgtgtgtgtgaatgtgtgtgtgtgaatgtgtatgtgtgaatgtgtatttgtgaatgtgtgtgaatgtgtatgtgaatgtgtatgtgaatgtgtatgtgtgaatgtgtgtgaatatgtgtgtgtgagaatgtgtgtgtgtgtgtgaatgtgtgtgtgtgaatgtgtgtgtgtgaatgtgtgtgtatgtgtgtacacaaggggagagccattccatgggctgccacaggattgacaaggctcagcctatggacagacagcagggcggaggcggaagagggagacatgacccaggcatcttgggacctctcccttgagcacagcatacatattctctgactcagtgtctaagaagccaccatgtgacagcccttgtctgtcattgaaactag/GAAACAAAAGAGAGCCATGGAAAACCGGAGCTTGTTTTATAGATGAGGAAGCCGAGAGCTGGCAGGACGATGATCTGCCTAGTACCCACCTGCTGGCTGGCA/gtgagttgggtttacacctggatgttggggaactgtgtgtcc(a>g)ggtgcagctggcaggttctccagggaggtcagggaccggggacaggaggtctgtctcagggccccatggagcacactgcggagctgggttccctgaggagctgcctgcctgtggacaccctcaggaccagtgtcagactgtgggcggcgccgcagggagcctctagagcagttcatgcccctccaggctgtggcctctcctgtccttcttcccatcacagtgcagtgcaggtctcaggcaggggtggttggcgtggagttggccagggcccagaccctatgagctttatagcagtgaggtaccgaacaccatgtgtggcaaagtaggtggtattatttatgccccctcaccgctttttttttttttttttctgagacagagccttgctctgtcacccaggctggagtgcagtggcgccatctcggctcaccgcaacctccgcctcccaggttcaagcggttcttctgactcagcctccctagtagctgggattacaggcagccaccatcatgcccagctaattttttgtatttttagtagagacggggtttcaccatgttggtcaggctggtctcgaactcctgacctcaggtgatccacctgcctcaagtctctcccaaagtgttgggattataggcatgagacaccatgtccggccttatgcccattttatagccaaagaaactgaggctcacccaagtagtttttttcaaaactagaattcatgcctcagtgtgtctgcctcttttcaccttactggagatggtccaagcagagaaaatgtggttggtttcttctgtag	creates pseudoexon	No	NULL	Out	NULL	NULL	7.39	70.9	NULL	11.28	NULL	4.98	6.55	NULL	NULL	12.1	NULL	-4.1	NULL	NULL	6	NULL	602281	ENSG00000140545	512	719	milk fat globule-EGF factor 8 protein
665	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS16+1G>A	-233	NULL	Intron	2	gtgtatgataaaaatagatcagtggctctttaaaaatgtatatggtaattttatgggttgattttaatgtatattttacattttttgtacttttgtcatggaagaaatgttggataaagcataatttgtcaagtctcaactaattaaggtttaattcatgctttgcacaaaaattttgtgtttagGCTGCTGAAAGCCTTCACAAGACCATTGTTAAGAGGCGAATGTCCCATGTGAGTGGAGGAGGATCCATAGATTTGTCTGACACAGACTCCCTACAGGAATGGATCAACATGACTGGCTTCCTTTGTGCCCTTGGGGGAGTGTGCCTCCAGCAGAGAAGCAATTCTGGCCTGGCAACCTATAGCCCACCCATGGGTCCAGTCAGTGAAC/GTAAGGGTTCTATGATTTCAGTGATGTCTTCAGAGGGAAACGCAGATACACCTGTCAGCAAATTTATGGATCGGCTGTTGTCCTTAATGGTGTGTAACCATGAGAAAGTGGGACTTCAAATACGGACCAATGTTAAGGATCTGGTGGGTCTAGAATTGAGTCCTGCTCTGTATCCAATGCTATTTAACAAATTGAAGAATACCATCAGCAAGTTTTTTGACTCCCAAGGACAG(g>a)taaagtgttctcttatttttcacctttctctatgaatagagtgacttgtttgaaataagcctttttctttcagattatttaaattaggtactcacagtttttaaaaatttccaaaaaattgcagaaagaagagtcatctcaatgtaggggtc	NULL	No	NULL	In	82.98	9.65	7.34	81.36	14.28	12.28	8.92	8.92	7.47	8.28	15.8	12.4	-6.2	-4.1	7	0.95	6	0.92	162200	ENSG00000196712	433	665	neurofibromin 1
618	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS16+1G>T	-233	NULL	Exon	2	gtgtatgataaaaatagatcagtggctctttaaaaatgtatatggtaattttatgggttgattttaatgtatattttacattttttgtacttttgtcatggaagaaatgttggataaagcataatttgtcaagtctcaactaattaaggtttaattcatgctttgcacaaaaattttgtgtttagGCTGCTGAAAGCCTTCACAAGACCATTGTTAAGAGGCGAATGTCCCATGTGAGTGGAGGAGGATCCATAGATTTGTCTGACACAGACTCCCTACAGGAATGGATCAACATGACTGGCTTCCTTTGTGCCCTTGGGGGAGTGTGCCTCCAGCAGAGAAGCAATTCTGGCCTGGCAACCTATAGCCCACCCATGGGTCCAGTCAGTGAAC/GTAAGGGTTCTATGATTTCAGTGATGTCTTCAGAGGGAAACGCAGATACACCTGTCAGCAAATTTATGGATCGGCTGTTGTCCTTAATGGTGTGTAACCATGAGAAAGTGGGACTTCAAATACGGACCAATGTTAAGGATCTGGTGGGTCTAGAATTGAGTCCTGCTCTGTATCCAATGCTATTTAACAAATTGAAGAATACCATCAGCAAGTTTTTTGACTCCCAAGGACAG(g>t)taaagtgttctcttatttttcacctttctctatgaatagagtgacttgtttgaaataagcctttttctttcagattatttaaattaggtactcacagtttttaaaaatttccaaaaaattgcagaaagaagagtcatctcaatgtaggggtc	NULL	No	NULL	In	82.98	9.65	7.34	81.36	14.28	12.28	8.92	8.92	7.47	8.28	15.8	12.4	-6.2	-4.1	7	0.95	6	0.92	162200	ENSG00000196712	441	618	neurofibromin 1
682	1	Human	216	KRT31	288	Tailless Keratin	IVS6+1G>A	41	NULL	Intron	2	gtgtgtattgttcagacctgctggtgagcgacgggaacttgggaggcagagtcccggggatgtgcttggggccacacactctccttagctcttggagcttgtgacttccttgtaatcctgtgaagaaaccctttgaaggagcagctctctgacattcccaatcttctccaccacagCGAGACTCTCTGGAAAACACGCTGACAGAGAGTGAGGCCCGCTACAGCTCCCAGCTGTCCCAGGTGCAGAGCCTGATCACCAACGTGGAGTCCCAGCTGGCGGAGATCCGCAGTGACCTGGAGCGGCAGAACCAGGAGTACCAGGTGCTGCTGGATGTGCGTGCCCGGCTGGAGTGTGAGATCAACACATACCGGAGCCTGCTGGAGAGCGAGGACTGCAA(g>a)tgagtacatgggcagacgtgtttgatgaaatgatgcacgt/gtgagtgtaacagttagacaccatgcaaatattgcataccttggaaaggaaattatgccttcacactagacatgctcaaacagaactcagacaacataatatggccatcatttaaaacataaatggtttggtagcaagagttgtttgatgtacaaactgaaattgcactgccaagtctttgcattctagtatgataata	NULL	No	NULL	In	83.12	9.1	7.42	73.36	12.88	10.68	5.3	5.3	7.25	8.34	15.9	13.2	-4.1	-3.9	8	0.87	8	0.99	601077	ENSG00000094796	485	682	keratin 31
643	1	Human	199	ACAT1	266	Mitochondrial acetoacetyl-CoA thiolase deficiency	E11+119A>G	-44	100	Exon	2	GTTCTTAAAGATGTGGGATTGAAAAAAGAAGATATTGCAATGTGGGAAGTAAATGAAGCCTTTAGTCTGGTTGTACTAGCAAACATTAAAATGTTGGAGATTGATCCCCAAAAA/GTGA(A>G)TATCAATGGAGGAGCTGTTTCTCTGGGACATCCAATTGGgtaggtaaaaataataactatatctaggttaagagctgcctttgtgtttctagctaaacttaaaactgcttcataattcccattgctcttaagttttccttcctacccatctttcataaggcaaaaaccatttctgatagatggtatccaatactgaacagagacctgtcacatctgtta	NULL	Yes	NULL	Out	76.65	6.86	8.4	82.88	10.88	12.68	8.16	8.16	7.78	7.22	15.6	15.5	-9.2	-4.1	8	0.99	7	0.97	203750	ENSG00000075239	461	643	acetyl-CoA acetyltransferase 1
613	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS2+1G>A	-105	NULL	Exon	0	taggtatctgtggttgatgcagttttcctaaaacgtcatgattttcaatggcaagtaagttatttatggtcgtttttaaggataagctgttaacgtgttttttttttctttttttttcagCTTCCAATAAAAACAGGACAGCAGAACACACATACCAAA/GTCAGTACTGAGCACAACAAGGAATGTCTAATCAATATTTCCAAATACAAGTTTTCTTTGGTTATAAGCGGCCTCACTACTATTTTAAAGAATGTTAACAATATG(g>a)tgagtatttgggttactgtgttttggggaatttgctttcttttctttttgattaaaaagtttagaacagcatattttgaagtatggaaagtgattttctgtggactttggatataaccattaatcttattttgtttacgagcacagataaccttttaattttattttgtcaaattttta	NULL	No	NULL	In	86.25	10.13	1.98	77.69	14.08	7.18	5.02	5.02	0.06	9.22	18.6	9	-7.2	-1.4	8	NULL	6	0.99	162200	ENSG00000196712	441	613	neurofibromin 1
607	1	Human	92	IDS	269	Mucopolysaccharidosis type II	E3+178G>A	-26	NULL	Exon	2	tatgtctgggaacctctagctgtgggtgtgtgctgcttcgtgcactgagggttgggggcggggagcttcagctattgtcagatggcacagattgtgcgggacatcttgttagagggaagcatagtctggaaaatggtagtggagaaaatctggttttccactcatgggaaagcttgaccttcaagggtggccttctccttgggtgcaaggtgcgccctggccctgatgtgttcatggcagccctggccagctttctcccagaacgggcgcttgcctggtgctcagaaggaaggggtgctgcagaagggcacccacaggtctgcaggctgggcctcaggtgagagctagccagggtggccctgctccctgaaccccctcatggctctgcccccagcaacactggccgctctgtgtgcctggggaggccattgcgtaggaggagataagcatctgctggtttcaggggctgattgcttcccttttctctcccggaagcagtctgttgcctaggtgacacccaaatcccagtgtctggtttgagctctgcatgactcagctaccaagctgtttgctaggagcctcgggaggcggttgcttggttacctaagagatggcagacatgttttgctgtggcgatgcttacctctgcttctgctccctaacagCAAGCAGTGTGCGCCCCGAGCCGCGTTTCTTTCCTCACTGGCAGGAGACCTGACACCACCCGCCTGTACGACTTCAACTCCTACTGGAGGGTGCACGCTGGAAACTTCTCCACCATCCCCCAGTACTTCAAGGAGAATGGCTATGTGACCAT/GTCGGTGGGAAAAGTCTTTCACCCT(G>A)gtactgctccatgtccagagtctgggttctcttggtttgtggtgtctgaatccagcattcccatcctggggatggggctgtctttgcagagccctcttctggctgggcgagtccctcgctagtcagtgcttcctttctaaaaaactgacttgtcaacccagccacgttttcacccaaagtgaaaaagggtagaaagagctttgcttcctttcagaaaccactgagggtgtgctgttgggtctttcagctcctcgggtggtagggaggacacaggctggggaggtggcagtgttgggtggagtccagctcagggccccaccctctcccctgcagggtacctgtcagtaaacctaggggtggggtgaggacacctgagggcctcccgtgtggccagcattgctgttgctgacttattgcccaatgagggggctgtgcttaggtaggggctgctatccactctggaaattaagtcagaaagatgagtgtaatctggtacccag	NULL	No	NULL	In	63.48	4.41	-2.18	67.2	8.38	1.88	2.06	2.06	-1.88	5.3	10.4	5.5	-2.5	-1.6	6	NULL	7	NULL	309900	ENSG00000010404	438	607	iduronate 2-sulfatase
608	1	Human	92	IDS	269	Mucopolysaccharidosis type II	E3+178G>A	-22	NULL	Exon	1	tatgtctgggaacctctagctgtgggtgtgtgctgcttcgtgcactgagggttgggggcggggagcttcagctattgtcagatggcacagattgtgcgggacatcttgttagagggaagcatagtctggaaaatggtagtggagaaaatctggttttccactcatgggaaagcttgaccttcaagggtggccttctccttgggtgcaaggtgcgccctggccctgatgtgttcatggcagccctggccagctttctcccagaacgggcgcttgcctggtgctcagaaggaaggggtgctgcagaagggcacccacaggtctgcaggctgggcctcaggtgagagctagccagggtggccctgctccctgaaccccctcatggctctgcccccagcaacactggccgctctgtgtgcctggggaggccattgcgtaggaggagataagcatctgctggtttcaggggctgattgcttcccttttctctcccggaagcagtctgttgcctaggtgacacccaaatcccagtgtctggtttgagctctgcatgactcagctaccaagctgtttgctaggagcctcgggaggcggttgcttggttacctaagagatggcagacatgttttgctgtggcgatgcttacctctgcttctgctccctaacagCAAGCAGTGTGCGCCCCGAGCCGCGTTTCTTTCCTCACTGGCAGGAGACCTGACACCACCCGCCTGTACGACTTCAACTCCTACTGGAGGGTGCACGCTGGAAACTTCTCCACCATCCCCCAGTACTTCAAGGAGAATGGCTATGTGACCATGTCG/GTGGGAAAAGTCTTTCACCCT(G>A)gtactgctccatgtccagagtctgggttctcttggtttgtggtgtctgaatccagcattcccatcctggggatggggctgtctttgcagagccctcttctggctgggcgagtccctcgctagtcagtgcttcctttctaaaaaactgacttgtcaacccagccacgttttcacccaaagtgaaaaagggtagaaagagctttgcttcctttcagaaaccactgagggtgtgctgttgggtctttcagctcctcgggtggtagggaggacacaggctggggaggtggcagtgttgggtggagtccagctcagggccccaccctctcccctgcagggtacctgtcagtaaacctaggggtggggtgaggacacctgagggcctcccgtgtggccagcattgctgttgctgacttattgcccaatgagggggctgtgcttaggtaggggctgctatccactctggaaattaagtcagaaagatgagtgtaatctggtacccag	NULL	No	NULL	In	63.48	4.41	3.89	66.36	8.38	9.18	3.59	3.59	5.29	5.3	10.4	9.3	-2.5	-5.6	6	NULL	6	NULL	309900	ENSG00000010404	438	608	iduronate 2-sulfatase
693	1	Human	90	HRPT2	248	Ehlers-Danlos Syndrome	IVS2+1G>C	4	NULL	Intron	1	tcattattagattttatactttttttttgttagctatgttaaactcattgttgttagcaaagttgtttatataaatgaatccagcctgaagagttgaattagaattgtcagtaaaaaaaatcttgccttaattatttcagGACTGGAAAGGAAGGCCAACCCAGAGAGTACTACACATTGGATTCCATTTTATTTCTACTTAATAACGTGCACCTTTCTCATCCTGTTTATGTCCGACGTGCAGCT(g>c)taa/gtagaattcattttacttatctatctatttatcagttttatttttatttatttaagagacagggtctggccttgttgcccgggctagggtgcagtggtgtgatcatagctcattgcagcctcgaactcctaggctcaagtgatcttcccacctctgccttcaagtagccaggactg	only minigene analysis	No	NULL	In	75.26	8.56	-6.74	56.77	12.68	2.18	0.7	0.7	-0.56	6.46	15.7	7.6	-4	-2.3	6	NULL	6	0.96	130010	ENSG00000134371	492	693	"cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)"
631	1	Human	236	PTCH1	251	Gorlin syndrome	E18+168G>T	-189	NULL	Exon	0	TCCCGGCAGCAGAGCCCATCGAGTATGCCCAGTTCCCTTTCTACCTCAACGGCTTGCGGGACACCTCAGACTTTGTGGAGGCAATTGAAAAA/GTAAGGACCATCTGCAGCAACTATACGAGCCTGGGGCTGTCCAGTTACCCCAACGGCTACCCCTTCCTCTTCTGG(G>T)AGCAGTACATCGGCCTCCGCCACTGGCTGCTGCTGTTCATCAGCGTGGTGTTGGCCTGCACATTCCTCGTGTGCGCTGTCTTCCTTCTGAACCCCTGGACGGCCGGGATCATTgtgagtgtattataaggggctttgtggaagtcaaattcctttcagcatagctctttctgcagccgggaagttttgtttatgtctgggcctctggaggagggtatagcttgcatcatccgtaatatgtttattctactcgaggtggtgaggtccatggttaaggtagaacctctaatggccttattcgtaggtcctctctcctgtagcttgaagatttttgtggaaagataggggactttt	NULL	No	NULL	Out	73.74	7.35	6.6	82.67	10.78	11.78	8.61	8.61	6.81	5.98	13.2	12.6	-3.9	-4	6	0.98	6	0.92	109400	ENSG00000185920	453	631	patched 1
726	1	Human	24	CFTR	240	Cystic fibrosis	IVS6b+2316-2319delTAAG	2368	100	Intron	1	tcttgttgaggagaaaggacacacattgtaaattcaaatatagacctctactgtgctatttaatcttggtaacaactccacaaaggagatgacatgttttccttctatagaggtagattctgtaaagttagagggaagagtgacttgcttaagatggcataagctgtaactggcagaaccaggattcaaagccaggtgggatgccaaaatcataatctgtcttcagtgtcaagttactgaaattggtaaacattagacctaaatagacggaattgcaatccgggttgggcacattaaactccattttcttcatcaatgtgctcagattacattttacttttcag/GCTAAAAATGGAAAAAAAGAGTCCCTCTTAGTTCTGCACTTGAGAATGA(GAAT)AGCTTTTCTGAATTATACAAGGAAGAAGAACTAATGCCCAAATGCCAG/gtacccacatgcactatgccatggcacagctgttgccccctttcaccagagccctctctctgtatcctggttgacctttccttgggcaagagctgggtggggaggatcacaagtgactccaatttggatggcttcgggaagactgggaccgagctgaaggcagtgttgtcctctgcactccctgttttctgtctgctggagcactgaagcctcacatatgtattaaaaaaataatttccatttgcatttcagactagaagattgaacgtatagtgtaatgtgattgcaaataattatattgaaatgagacagagaggatgtagtatctactgtcataatttttcaaaacccacctgcaacttgaattaaaagaaccacttgggtttttttttttg	creates pseudoexon	No	NULL	Out	NULL	NULL	8.63	70.9	NULL	11.98	NULL	5.03	7.51	NULL	NULL	14	NULL	-4.8	NULL	0.89	6	NULL	219700	ENSG00000001626	518	726	"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
697	1	Human	239	RS1	297	X-linked juvenile retinoschisis	IVS2+1G>C	10	NULL	Intron	1	tgacttcttccagaaggggtgttggtagctttcatgtgactatttctatttcacttttccatgtaacgagtgatgctgttggatttctctttcattaattagattttttctgtctcatccttttgctttagCCACATTGGGATTATCGTCTACCGAG(g>c)tatgtaaca/gtaagaaggctgtaatgtacatgcatagtacttttgaaaattttcctagccaaaaataacatagaggactatcactttgtttttaaatgtattttgaaatatattttggctgggcatggtggctcatgcctgtaatcccaacactttgggaggccgaggcaagcagatca	NULL	No	NULL	In	87.01	9.81	5.96	73.36	12.68	10.08	5.85	5.85	6.16	9.62	17.5	12.2	-5.5	-2.8	8	0.91	5	1	312700	ENSG00000102104	495	697	retinoschisin 1
597	1	Human	53	ENG	254	Hereditary Hemorrhagic Telangiectasia	IVS8+1G>A	-24	100	Exon	0	tgagcacccttcccctgcccctcccttcccttcccctcccttggatcagtggccacactgttggtgaagcacctctgtgtgagcttgggcaaggtacatcagcctctctgagcctcatttttctcatctgcacatgggaacaatgggagtagctaatcatagaagagcctgagaatcgcttgaacctgggagatggaggttgcagtgagccaagatcgtgccactgcactccagcccgggtaacagagcaaaactccgtctcaaaaaaaaaaaaaaaaaaaaaaaagcctggtgcgggcacacagtgatcacacagtgaccagccgcctggcctgcctctgctaccccacagGTGGTAGGCTGCAGACCTCACCCGCACCGATCCAGACCACTCCTCCCAAGGACACTTGTAGCCCGGAGCTGCTCATGTCCTTGATCCAGACAAAGTGTGCCGACGACGCCATGACCCTG/GTACTAAAGAAAGAGCTTGTTGCG(g>a)taagggaactcctgcccctctggctcaggatgacatggacatctggttcctcccctagcccaagactcttggggtcctagcccaggcaggggggcaagtcacgtccctctgcaagccttagttttcccacttgtataatggaattgataatggtacctaccacgtggtgagaattaaaggcagtctgacaggccaatcacgtggcacagtaagatgtggtacatagtaagtgcttagtaaataatgccagcactaggtagttgtcattattaatcctaaatgctccctgagctggctggtcacttagcagaatacctacacaggccaggcatggtggttcacgcctgtaatctcagcactttgggaggccaagatgggtggatcacttgaggtcaggagtttgagaccagcctggccaacatggtgaaaccctgtctttactaaaatacaaaaattagccagaggtgatgggacacacctgtagtcccagctacttggg	NULL	No	NULL	In	82.61	9.63	3.1	63.38	13.08	7.88	2.8	2.8	4.71	9.59	15	10.4	-7.4	-2.5	6	NULL	6	0.99	187300	ENSG00000106991	429	597	endoglin
679	1	Human	46	DMD	246	Duchenne muscular dystrophy	IVS32+5G>A	-98	NULL	Intron	2	tgatgtctaaacaatgagtgttttgctctctacattttaaagataaaataggttaataaattaccttttatttagtataacattaagaaaaaactactgaatcattctcccaaatgtatgttttcctgtgttggatgaatggaaaaatactgctttattttgtttttatttttctgtatatcttcagaaataaaggcagatctatcaataaaaataggaccagttattgtttgaaaggcaaaattaaatcagtgcctttttacactgtccttacagAAAAAATTACAAGATGTCTCCATGAAGTTTCGATTATTCCAGAAACCAGCCAATTTTGAGCAGCGTCTACAAGAAA/GTAAGATGATTTTAGATGAAGTGAAGATGCACTTGCCTGCATTGGAAACAAAGAGTGTGGAACAGGAAGTAGTACAGTCACAGCTAAATCATTGTGTGgtat(g>a)tatttctggtggcaaatacgcaggtaccccttgactttcctcattaagaagtaactgctcttttataagagagaattgttttcagataaccataataattatactatgtaattttaagattgagaacaaaaattggcacatgtattgtggcctattctgtgtgtcttttttgagtctataattctgctaagaactgtgcagaatataaaaggatgttgcttgtgtttaatttttatgattctttaaatatattttaaatggaaatctagaaaggaaatatattaatctaaaaata	NULL	No	NULL	In	78.46	7.64	6.91	82.57	10.78	10.88	8.19	8.19	6.87	7.04	16.7	12.4	-3.9	-2.8	8	0.72	6	0.96	310200	ENSG00000198947	483	679	dystrophin
680	1	Human	46	DMD	246	Duchenne muscular dystrophy	IVS32+5G>A	28	NULL	Intron	1	tgatgtctaaacaatgagtgttttgctctctacattttaaagataaaataggttaataaattaccttttatttagtataacattaagaaaaaactactgaatcattctcccaaatgtatgttttcctgtgttggatgaatggaaaaatactgctttattttgtttttatttttctgtatatcttcagaaataaaggcagatctatcaataaaaataggaccagttattgtttgaaaggcaaaattaaatcagtgcctttttacactgtccttacagAAAAAATTACAAGATGTCTCCATGAAGTTTCGATTATTCCAGAAACCAGCCAATTTTGAGCAGCGTCTACAAGAAAGTAAGATGATTTTAGATGAAGTGAAGATGCACTTGCCTGCATTGGAAACAAAGAGTGTGGAACAGGAAGTAGTACAGTCACAGCTAAATCATTGTGTGgtat(g>a)tatttctggtggcaaatacgcag/gtaccccttgactttcctcattaagaagtaactgctcttttataagagagaattgttttcagataaccataataattatactatgtaattttaagattgagaacaaaaattggcacatgtattgtggcctattctgtgtgtcttttttgagtctataattctgctaagaactgtgcagaatataaaaggatgttgcttgtgtttaatttttatgattctttaaatatattttaaatggaaatctagaaaggaaatatattaatctaaaaata	NULL	No	NULL	In	78.46	7.64	8.63	70.9	10.78	11.98	5.03	5.03	7.51	7.04	16.7	14	-3.9	-4.8	8	0.92	6	0.96	310200	ENSG00000198947	483	680	dystrophin
600	1	Human	141	RPGR	284	Retinitis Pigmentosa Type 3	IVS10+3A>G	-20	100	Exon	2	ttattttcctctaaggacttttaagcattaaacttagaaaatgttcatataaagaaggcttagagacataattagctcaagagactgatttatactttaaaaaaaatcttctagtagaacttctctgagtaatttttcacatttttaatgttcttcccagattaaaatacaacattttctaactgtaaggagaaatgtaatttgccaagtatttttttctctatattattttaaattgaaagtaaaatggtggattaaacttgttctaattttcaatcacaatgtttaaagaatatgtatggtaattgtgtacctattgtatacatattgtgtacacattctcattgtgcacacacatacgtatagacagagagattcaccaagccagtctgtctaggaagcctaccactaaataaatgtcttacagctgataactgttaaaaactcatttgtgtttgaagccaatgttgatgagtttttctgtggatttatgctgcagGTTGCTTGTGGTGGATGTCACATGGTAGTTTTTGCTGCTCCTCATCGTGGTGTGGCAAAAGAAATTGAATTCGATGAAATAAATGATACTTGCTTATCTGTGGCGACTTTTCTGCCGTATAGCAGTTTAACCTCAGGAAATGTACTGCAGAGGACTCTATCAGCAC/GTATGCGGCGAAGAGAGAGGgt(a>g)caattgtggcctattctgtataatagtattatctagcactgcaaagaaaactagaagaaaaaaatctgttttctttttaaatcaaagggtcttctcagataaatttgctacataaaattattagagttgagtgctaacaaacttttagagttaattcagaaaaattcagaaaagcttaatgctttttttaaagacacaaattagaaaatttaaattatagaaaacttttgcatatagacaatggtgctataaaagcatccttttatagtcctattttatcacctcacattgaatgctgaattgttttttcaactgcatgtggactgactttcactttgttatatgcttttttttattatggtagtaaaaatacaacaaatatacccccttaacagatttttaagtgtgcaatacggtattgttgactataggcacaatgttatgttgttcagaaatctgtagaacttaattatcttatataatgctacattcttttg	NULL	No	NULL	In	62.71	1.91	4.23	70.93	8.88	7.38	6.05	6.05	6	4.13	10.2	10.8	-4.6	0.4	5	0.62	7	NULL	300029	ENSG00000156313	432	600	retinitis pigmentosa GTPase regulator
699	1	Human	200	ATP7B	295	Wilson Disease	IVS1+4A>T	369	100	Intron	0	TTCCCGGACCCCTGTTTGCTTTAGAGCCGAGCCGCGCCGATGCCCTCACACTCTGCGCCTCCTCTCCCGGGACTTTAACACCCCGCTCTCCTCCACCGACCAGGTGACCTTTTGCTCTGAGCCAGATCAGAGAAGAATTCGGTGTCCGTGCGGGACGATGCCTGAGCAGGAGAGACAGATCACAGCCAGAGAAGGGGCCAGTCGGAAAgtg(a>t)gttttgttcccccgcgtccgcgcagcgtgctcactcccaccaggaggattttcctccccgcgttcggcgcttactcgcccccagggggtgcgcagggaaggccgagccagaccccagctccagggatgtcttggcgtgggagaaaaggaccctttagaaaaagtgtgccgtcaactgatgtttgggagcaatggaaaaccccgcacctcaaaattcatctttatgcttttaaggggtctgatgctggagagataaagtgagcgtcgagttgctgtgctagagccctaatggctcaaaacgatgaagttagttacctggagaagttactcagagcctggtgcttggaccagatatggtatatcgag/gtcctggaacttttataactgttttaaattcattttaattgtacaagtaatacattaagacagtcttttaaaaatggaaacagcacagaaatattttgcacaaaaagcagatctatttttcagtctttttctattcacgtacatatgtcttcattcggcaaatatttattgagaactttctatgtttcaggcacacagtgttgagttgatacagtggttaacaagacatgtatctatatgtaatatgcacacattcagagaaatctttaggtttcatttgtatgaggtgttaaaatttttgttttacctaaatgagatcactgtatgtgcattctcttttttcagtttaacgatatatcttagagattgtttcactaactgtctaattcagtgcaacctctgcacagtttggacgcatcatagtttattcatggtttcctagtggtggacgttctgtttgctactttttttctctctctcttgcaagtgaacatctttgtacatgatttttaatgctgacactatttcttt	NULL	No	NULL	In	72.9	2.99	-2.13	58.86	7.38	5.88	-0.48	-0.48	0.26	3.19	7.7	10.1	-1.4	-2.6	7	NULL	4	NULL	277900	ENSG00000123191	497	699	"ATPase, Cu++ transporting, beta polypeptide"
666	1	Human	236	PTCH1	275	Nevoid basal cell carcinoma syndrome	E3+190G>A	37	NULL	Intron	1	ttcctttctgccccccactttcgtcacacagtgtattagttagaattaggtttgtgtctgtgacaggcgggacagccattaatgggcttagtgagtattttttatgtttactattggtgaagttaacattgccattaataaagtgaatgttactgctcacacatcagccagtctcatgactagagttcatctattgtgtatcctatggcaggtagtcagataacagataaaacatgagtttgcagtgattttgctattctaattaaacctgtacatatttgtcagTTGGAGGACGAGTAAGTCGTGAATTAAATTATACTCGCCAGAAGATTGGAGAAGAGGCTATGTTTAATCCTCAACTCATGATACAGACCCCTAAAGAAGAAGGTGCTAATGTCCTGACCACAGAAGCGCTCCTACAACACCTGGACTCGGCACTCCAGGCCAGCCGTGTCCATGTATACATGTACAACA(G>A)gtaaggcccgccgcgtccacctactaatgagcagcag/gtaaggcggtgggagaaggctgctggtttaggccccgttattttagtaaatgaagttgccctggaaatgcacctggagtattagttcaaatagctttgcaatgaaaggatttttttcatcttgatttatcgtttctcgagtttggtaacaaagcaagtgcattacttgataatgtattgccagtaagtatcttggcactgtccccaaaagaggatgacgctgagccacttggggactatacacccaggctgtaagatgtttcattgc	NULL	No	NULL	In	94.83	11.08	11.08	94.83	14.98	14.98	12.14	12.14	11.06	11.06	18.8	18.8	-9.4	-9.4	8	1	8	1	109400	ENSG00000185920	476	666	patched 1
586	1	Human	217	LAMA3	260	Junctional Epidermolysis Bullosa	IVS25+1G>A	-61	NULL	Exon	1	ttcgctggcttgctgattcatctctcatttatttcagATTCAGATCAAAATTGGAAAACTCCAAAAGCGTATGTGGATAAATGTGGACGTTCAAAACACTATAATTGATG/GTGAAGTATTTGATTTCAGCACATATTATCTGGGAGGAATTCCAATTGCAATCAGGGAAAG(g>a)taagatgatttttttaaaacgagatttaaagcctttgttagtggttatgattgtgaccaaaaaaaatctggtctgccatttttaattccaccaacaaacaaacacaaaaagttaacttttccatattaacagtatagtcaacagaataaaacagatttaaatcccgaataatgagactg	NULL	No	NULL	In	94.49	10.57	1.69	69.23	15.58	6.68	4.9	4.9	4.76	10.55	17.1	8.6	-7.4	-3.8	7	NULL	6	0.99	226700	ENSG00000053747	419	586	"laminin, alpha 3"
629	1	Human	140	RB1	155	Retinoblastoma	E7+51C>G	-61	100	Exon	1	ttctctcatacaaagatctgaatctctaactttctttaaaaatgtacatttttttttcagGGGAAGTATTACAAATGGAAGATGATCTGGTGATTTCATTTCAGTTAATG/(C>G)TATGTGTCCTTGACTATTTTATTAAACTCTCACCTCCCATGTTGCTCAAAGAACCATATAgtaagtatttaatttatgccccttttactttctcattcagcagttgcttattgaatgtctagtgggtaccaaacatggttctaaggctgacaggatgataaaaaataaatcagacatgga	NULL	No	NULL	Out	79.3	8.65	8.35	81.24	13.18	11.98	7.72	7.72	7.95	6.49	17	14.8	-4.2	-3.9	6	0.98	8	0.96	180200	ENSG00000139687	452	629	retinoblastoma 1
602	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS28-2G>A	-54	NULL	Exon	0	ttcttcctttcttgactcatgggcaaattttttattgttgtcgtggctcaaaatttttgaattggagatttgtctcttctcttagccttatttctcagtgtccaaaaaacaactgatttaaaaaatgaatccagactttgaagaattgttttatattattctctctagaaaatgaatcataaaataaaattgattagtggcatctgtatatttattttaaacactgctaataatctttgtcttttttgtcattttccttagGTTCAAAACTGGTCAAATCAATGGTGATTTGCTGATATACCATGTCTTACTGACTTTAAAGCCATATTATGCAAAGCCATATGAAATTGTAGTGGACCTTACCCATACCGGGCCTAGCAATCGCTTTAAAACAGACTTTCTCTCTAAGTGGTTTGTTGTTTTTCCTGGCTTTGCTTACGACAACGTCTCCGCAGTCTATATCTATAACTGTAACTCCTGGGTCAGGGAGTACACCAAGTATCATGAGCGGCTGCTGACTGGCCTCAAAGGTAGCAAAAGGCTTGTTTTCATAGACTGTCCTGGGAAACTGGCTGAGCACATAGAGCATGAACAACAGAAACTACCTGCTGCCACCTTGGCTTTAGAAGAGGACCTGAAG/GTATTCCACAATGCTCTCAAGCTAGCTCACAAAGACACCAAAGTTTCTATTA(A>G)Agtaagttccagtctgtgttttgtaaacgattcattgcttttcttgactaactagactatatcctggcctccctaggtgtcctacccctatagtggtgtataaaatgtcacgtaaggctgtcgcggtggctcacgcctgtaatccaagcactttgggatgtcaaggtgggcagatcacgtgaggtcaggagttcaagaccagcctggccaacacggtgaaaccccgtctctactaaaaatacaaacattagccgggtatggtggtgggcacctgtaatctcagctacttggaggctgaggcaggagaatcgcttgaacccgggaggt	NULL	No	NULL	In	87.84	9.72	6.8	71.89	14.58	10.08	4.63	4.63	4.92	8.51	14.4	12.3	-4.2	-4.1	7	0.72	6	0.98	162200	ENSG00000196712	433	602	neurofibromin 1
612	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS28+1G>A	-54	NULL	Exon	0	ttcttcctttcttgactcatgggcaaattttttattgttgtcgtggctcaaaatttttgaattggagatttgtctcttctcttagccttatttctcagtgtccaaaaaacaactgatttaaaaaatgaatccagactttgaagaattgttttatattattctctctagaaaatgaatcataaaataaaattgattagtggcatctgtatatttattttaaacactgctaataatctttgtcttttttgtcattttccttagGTTCAAAACTGGTCAAATCAATGGTGATTTGCTGATATACCATGTCTTACTGACTTTAAAGCCATATTATGCAAAGCCATATGAAATTGTAGTGGACCTTACCCATACCGGGCCTAGCAATCGCTTTAAAACAGACTTTCTCTCTAAGTGGTTTGTTGTTTTTCCTGGCTTTGCTTACGACAACGTCTCCGCAGTCTATATCTATAACTGTAACTCCTGGGTCAGGGAGTACACCAAGTATCATGAGCGGCTGCTGACTGGCCTCAAAGGTAGCAAAAGGCTTGTTTTCATAGACTGTCCTGGGAAACTGGCTGAGCACATAGAGCATGAACAACAGAAACTACCTGCTGCCACCTTGGCTTTAGAAGAGGACCTGAAG/GTATTCCACAATGCTCTCAAGCTAGCTCACAAAGACACCAAAGTTTCTATTAAA(g>a)taagttccagtctgtgttttgtaaacgattcattgcttttcttgactaactagactatatcctggcctccctaggtgtcctacccctatagtggtgtataaaatgtcacgtaaggctgtcgcggtggctcacgcctgtaatccaagcactttgggatgtcaaggtgggcagatcacgtgaggtcaggagttcaagaccagcctggccaacacggtgaaaccccgtctctactaaaaatacaaacattagccgggtatggtggtgggcacctgtaatctcagctacttggaggctgaggcaggagaatcgcttgaacccgggaggt	NULL	No	NULL	In	87.84	9.72	6.8	71.89	14.58	10.08	4.63	4.63	4.92	8.51	14.4	12.3	-4.2	-4.1	7	0.72	6	0.98	162200	ENSG00000196712	441	612	neurofibromin 1
601	1	Human	118	NF1	135	"Neurofibromatosis, type I"	IVS28+5G>A	-54	NULL	Exon	0	ttcttcctttcttgactcatgggcaaattttttattgttgtcgtggctcaaaatttttgaattggagatttgtctcttctcttagccttatttctcagtgtccaaaaaacaactgatttaaaaaatgaatccagactttgaagaattgttttatattattctctctagaaaatgaatcataaaataaaattgattagtggcatctgtatatttattttaaacactgctaataatctttgtcttttttgtcattttccttagGTTCAAAACTGGTCAAATCAATGGTGATTTGCTGATATACCATGTCTTACTGACTTTAAAGCCATATTATGCAAAGCCATATGAAATTGTAGTGGACCTTACCCATACCGGGCCTAGCAATCGCTTTAAAACAGACTTTCTCTCTAAGTGGTTTGTTGTTTTTCCTGGCTTTGCTTACGACAACGTCTCCGCAGTCTATATCTATAACTGTAACTCCTGGGTCAGGGAGTACACCAAGTATCATGAGCGGCTGCTGACTGGCCTCAAAGGTAGCAAAAGGCTTGTTTTCATAGACTGTCCTGGGAAACTGGCTGAGCACATAGAGCATGAACAACAGAAACTACCTGCTGCCACCTTGGCTTTAGAAGAGGACCTGAAG/GTATTCCACAATGCTCTCAAGCTAGCTCACAAAGACACCAAAGTTTCTATTAAAgtaa(g>a)ttccagtctgtgttttgtaaacgattcattgcttttcttgactaactagactatatcctggcctccctaggtgtcctacccctatagtggtgtataaaatgtcacgtaaggctgtcgcggtggctcacgcctgtaatccaagcactttgggatgtcaaggtgggcagatcacgtgaggtcaggagttcaagaccagcctggccaacacggtgaaaccccgtctctactaaaaatacaaacattagccgggtatggtggtgggcacctgtaatctcagctacttggaggctgaggcaggagaatcgcttgaacccgggaggt	NULL	No	NULL	In	87.84	9.72	6.8	71.89	14.58	10.08	4.63	4.63	4.92	8.51	14.4	12.3	-4.2	-4.1	7	0.72	6	0.98	162200	ENSG00000196712	433	601	neurofibromin 1
623	1	Human	164	WT1	68	Frasier syndrome	IVS9+5G>A	-9	NULL	Exon	0	ttgtgggcctcactgtgcccacattgttagggccgaggctagaccttctctgtccatttagGTGTGAAACCATTCCAGTGTAAAACTTGTCAGCGAAAGTTCTCCCGGTCCGACCACCTGAAGACCCACACCAGGACTCATACAG/GTAAAACAAgtgc(g>a)taaacttttcttcacatttatttttcattatttttttaaactattgtggaatgaaattgtgatgagagggattggaaaagactagtgtaaaagttctaaggtttagactcagttgagagaaggaatagtgcgtggctatctttaaataataaataataacattttttaaagaagg	NULL	No	NULL	In	72.35	6.68	8.59	82.88	9.08	13.78	8.28	8.28	7.56	6.24	10.6	15.8	-1.4	-6.2	7	0.94	7	0.76	136680	ENSG00000184937	446	623	Wilms tumor 1
630	1	Human	202	BRCA2	24	Breast cancer predisposition	E18+47A>G	-309	100	Exon	0	ttgtttaaacagtggaattctagagtcacacttcctaaaatatgcatttttgttttcacttttagATATGATACGGAAATTGATAGAAGCAGAAGATCGGCTATAAAAAAG/(A>G)TAATGGAAAGGGATGACACAGCTGCAAAAACACTTGTTCTCTGTGTTTCTGACATAATTTCATTGAGCGCAAATATATCTGAAACTTCTAGCAATAAAACTAGTAGTGCAGATACCCAAAAAGTGGCCATTATTGAACTTACAGATGGGTGGTATGCTGTTAAGGCCCAGTTAGATCCTCCCCTCTTAGCTGTCTTAAAGAATGGCAGACTGACAGTTGGTCAGAAGATTATTCTTCATGGAGCAGAACTGGTGGGCTCTCCTGATGCCTGTACACCTCTTGAAGCCCCAGAATCTCTTATGTTAAAGgtaaattaatttgcactcttggtaaaaatcagtcattgattcagttaaattctagaagttttacatttaaattttaaatgcttactaaggatgctcaatttcttagatgtactgataatt	NULL	No	NULL	Out	87.91	8.88	8.99	82.55	13.38	12.98	7.87	7.87	7.42	7.72	14.1	14.1	-5.4	-5.2	7	0.92	6	0.96	113705	ENSG00000139618	426	630	"breast cancer 2, early onset"
650	1	Human	222	MPZ	236	Charcot-Marie-Tooth disease	E3+43G>A	-175	100	Exon	1	tttgcttttttctttctgtaacaaattatggagctaagctttgacagctgtgttctcattagggtcctctcacatgcttcccctcattcctcatagATCTTCCACTATGCCAAGGGACAACCCTACATTGACGAG/GTG(G>A)GGACCTTCAAAGAGCGCATCCAGTGGGTAGGGGACCCTCGCTGGAAGGATGGCTCCATTGTCATACACAACCTAGACTACAGTGACAATGGCACGTTCACTTGTGACGTCAAAAACCCTCCAGACATAGTGGGCAAGACCTCTCAGGTCACGCTGTATGTCTTTGAAAAAGgtgtgagaagggatggggacaagggtatgggaagcagtttgggaggggatcagggaggactgataggttgggggaagaggcaaaaagcccggcctaaggacctttattcaggctctgggagcgtgggcagaaggcagttttagctgggagtcctacatcctcaatgcagggcatacactc	NULL	No	NULL	Out	79.54	4.59	8.41	86.85	10.98	11.78	9.56	9.56	9.2	5.08	10.4	15.9	-3.8	-8.6	7	0.99	7	0.81	118200	ENSG00000158887	464	650	myelin protein zero
606	1	Human	218	LAMP2	241	Danon disease	IVS8+1G>C	-15	NULL	Exon	0	TTTTCAGCATTGCAAATAACAATCTCAGCTACTGGGATGCCCCCCTGGGAAGTTCTTATATGTGCAACAAAGAGCAGACTGTTTCAGTGTCTGGAGCATTTCAGATAAATACCTTTGATCTAAGGGTTCAGCCTTTCAATGTGACACAAG/GAAAGTATTCTACAG(g>c)taagaatcaagcaaacttcattaataatttatgttcttatgttgacaggtggcttttcctttgaatcatagacatttaaacgttgaaatagaggaatatgaattcatagccttgaccaaattgtgcaactctatatttggctcatcattttgctcaaccgagatgtttttgtgatcttaaaatcatttgcaaaaaaagttcttaaagctaaaactgatagaagctttaagtgagcttta	activates GA cryptic donor site	No	NULL	In	94.73	10.77	2.81	82.64	14.98	7.29	4.52	4.52	4	11.11	20.3	NULL	-8.2	-4.8	8	NULL	7	1	300257	ENSG00000005893	437	606	lysosomal-associated membrane protein 2
